Citrus Sinensis ID: 011498
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 484 | 2.2.26 [Sep-21-2011] | |||||||
| Q3EDL4 | 472 | Probable serine/threonine | yes | no | 0.900 | 0.923 | 0.862 | 0.0 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.869 | 0.963 | 0.620 | 1e-144 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.925 | 0.906 | 0.538 | 1e-133 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.818 | 0.818 | 0.535 | 1e-127 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.847 | 0.877 | 0.533 | 1e-122 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.762 | 0.541 | 0.414 | 3e-81 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.842 | 0.568 | 0.385 | 2e-80 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.938 | 0.630 | 0.366 | 3e-79 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.665 | 0.454 | 0.459 | 8e-79 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.861 | 0.587 | 0.386 | 1e-78 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/445 (86%), Positives = 412/445 (92%), Gaps = 9/445 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
SDFGLAKLL SE SYVTTRVMGTFGYVAPEYACTGMLNEKSD+YSFGILIMEIITGRNPV
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPV 356
Query: 356 DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
DYSRPQGE NLVDWLK+MVG+R+SEEVVDPK+P+ P+SKALKRVLLVALRCVDPDA KRP
Sbjct: 357 DYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRP 416
Query: 416 KMGHVIHMLEADDLLFRDERRIGRE 440
KMGH+IHMLEA+DLL+RDERR R+
Sbjct: 417 KMGHIIHMLEAEDLLYRDERRTTRD 441
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1322), Expect = e-144, Method: Compositional matrix adjust.
Identities = 268/432 (62%), Positives = 322/432 (74%), Gaps = 11/432 (2%)
Query: 14 SKRTSIFGLRLWVVIGIL-LGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPI 72
+ + S+FGL L++VI I + L++ L L +CL +R + ++ + S I P +
Sbjct: 13 TTKPSVFGLNLYLVIAICSVFILLISLLIFLFVCL-NRVSRARRMRVKHSSGSI---PLV 68
Query: 73 SKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEV 132
SKEI EI GKI + VV A+S E+ AS SG VG
Sbjct: 69 SKEISEI-KTVGKFINSDDSKGKIGNEVVVVVSATSKEATSGFDTLSVAS--SGDVGTSE 125
Query: 133 SHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK 192
+ +GWG+WY+L++LE AT G ++N+IGEGGYG+VYR SDG+ AVKNLLNN+GQAEK
Sbjct: 126 A-MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEK 184
Query: 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAY--RMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
EFKVEVE IG+VRHKNLV L+GYC + A RMLVYEY+DNGNL+QWLHGDVG VSPLTW
Sbjct: 185 EFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTW 244
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
DIRM I +GTAKGLAYLHEGLEPKVVHRDVKSSNILLD++WNA+VSDFGLAKLL SE SY
Sbjct: 245 DIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSY 304
Query: 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 370
VTTRVMGTFGYV+PEYA TGMLNE SDVYSFG+L+MEIITGR+PVDYSRP GE+NLVDW
Sbjct: 305 VTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWF 364
Query: 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430
K MV SR+ EEV+DPK+ P +ALKR LLV LRC+D D++KRPKMG +IHMLEA+D
Sbjct: 365 KGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFP 424
Query: 431 FRDERRIGREPS 442
FR E R +E S
Sbjct: 425 FRPEHRSNQERS 436
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1226), Expect = e-133, Method: Compositional matrix adjust.
Identities = 268/498 (53%), Positives = 339/498 (68%), Gaps = 50/498 (10%)
Query: 9 VNTELSKRTSIFGLR---LWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQ 65
+N E+SK+ S FGL+ LWV + +++G IV+ L +LSL +T RRK ++
Sbjct: 7 LNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKS----RRSSSKFP 62
Query: 66 ILNTPPISKEIQ-EIVHHPAPVPE---IQVD---IGK--IEH--RVVFSDR--------- 105
P +SK+I+ + P PE I+++ GK + H R SD
Sbjct: 63 FNQIPHVSKDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDNDTLSQCSSV 122
Query: 106 --------ASSGESRGTGSACETASFGSGSVG-------PEVSHLGWGRWYTLRELEAAT 150
+ SGE G GSA +G G V PE+SHLGWG W+TLR+LE AT
Sbjct: 123 NHHERACSSHSGEEGGFGSAGR--QYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELAT 180
Query: 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ NV+GEGGYG+VYRG L +GT+VAVK LLNN GQAEKEF+VEVE IG VRHKNLV
Sbjct: 181 NRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 240
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RLLGYC+EG +RMLVYEYV++GNL+QWLHG + LTW+ RM II GTA+ LAYLHE
Sbjct: 241 RLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEA 300
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+EPKVVHRD+K+SNIL+D ++NA++SDFGLAKLL S S++TTRVMGTFGYVAPEYA TG
Sbjct: 301 IEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTG 360
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+LNEKSD+YSFG+L++E ITGR+PVDY RP EVNLV+WLK MVG+R++EEVVDP+L
Sbjct: 361 LLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPR 420
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENR 450
P+ ALKR LLV+LRCVDP+A KRP+M V MLE+D+ F ERR R S + G E
Sbjct: 421 PSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKR--SKTAGME-- 476
Query: 451 DFARKVGDKQLGEGASDT 468
+ D+ LG S+T
Sbjct: 477 --IVETKDESLGPSGSET 492
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1168), Expect = e-127, Method: Compositional matrix adjust.
Identities = 235/439 (53%), Positives = 301/439 (68%), Gaps = 43/439 (9%)
Query: 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIV 80
GL LW +I I+L ++ V+ L +SL LT RRK S+ N P+S++I V
Sbjct: 15 GLELWEIIVIVLSAIFVVVL-AISLWLTFRRK---------TSRSSSNLIPVSRQIPPSV 64
Query: 81 HHPAPVPEIQVD-----------------IGKIEHRVVFSDRASSGESRGTGSACETASF 123
P + EI+VD G E + +G+S +GS
Sbjct: 65 --PEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLEKK 122
Query: 124 GSGSVG--------------PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYR 169
SV PE SHLGWG W+TLR+L+ AT+ +N+IG+GGYG+VYR
Sbjct: 123 DGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYR 182
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229
G L +GT VAVK LLNN GQA+K+F+VEVE IG VRHKNLVRLLGYC+EG RMLVYEYV
Sbjct: 183 GNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYV 242
Query: 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
+NGNL+QWL GD + LTW+ R+ I++GTAK LAYLHE +EPKVVHRD+KSSNIL+D
Sbjct: 243 NNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 302
Query: 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 349
++N+++SDFGLAKLL +++S++TTRVMGTFGYVAPEYA +G+LNEKSDVYSFG++++E I
Sbjct: 303 KFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAI 362
Query: 350 TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP 409
TGR PVDY+RP EV+LV+WLK MV R+SEEVVDP L P++ ALKR LL ALRCVDP
Sbjct: 363 TGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDP 422
Query: 410 DATKRPKMGHVIHMLEADD 428
+ KRP+M V MLE+++
Sbjct: 423 MSEKRPRMSQVARMLESEE 441
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1130), Expect = e-122, Method: Compositional matrix adjust.
Identities = 228/427 (53%), Positives = 306/427 (71%), Gaps = 17/427 (3%)
Query: 13 LSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPI 72
L+KR + L LW +I I L + ++ L +LS+ L+ R+K + + + +P
Sbjct: 9 LTKRYGV--LELWEIIVIALFAAFIVIL-VLSVWLSFRKKSK---RSNATTLPVTQSPRF 62
Query: 73 SKEIQEI-VHHPAP----VPEIQVD---IGKIEHRVVFSDRASSGESRGTGSACETASFG 124
++EI+EI V H + +D + IE+ FS G+ T S
Sbjct: 63 TEEIKEISVDHGSSNNNGTSYQTLDEKFVEDIENGDKFSGSLEKKPLVGSHLPPSTPSTT 122
Query: 125 SGS--VG-PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVK 181
+ S +G PEVSH+GWG W+TLR+L+ AT+ +E++IG+GGYG+VY G L++ T VAVK
Sbjct: 123 APSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVK 182
Query: 182 NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD 241
LLNN GQA+K+F+VEVE IG VRHKNLVRLLGYCVEG +RMLVYEY++NGNL+QWLHGD
Sbjct: 183 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGD 242
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ LTW+ R+ +++GTAK LAYLHE +EPKVVHRD+KSSNIL+D ++A++SDFGLA
Sbjct: 243 MIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLA 302
Query: 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361
KLL ++ +YV+TRVMGTFGYVAPEYA +G+LNEKSDVYS+G++++E ITGR PVDY+RP+
Sbjct: 303 KLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPK 362
Query: 362 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
EV++V+WLK MV ++ EEVVD +L P + LKR LL ALRCVDPDA KRPKM V
Sbjct: 363 EEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVA 422
Query: 422 HMLEADD 428
MLE+D+
Sbjct: 423 RMLESDE 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 169/408 (41%), Positives = 248/408 (60%), Gaps = 39/408 (9%)
Query: 26 VVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIVHHPAP 85
V IG+++G L+ L+LF++ + T +RK+ K+ V + P
Sbjct: 239 VAIGVIVG-LVFLSLFVMGVWFTRKRKR--------------------KDPGTFVGYTMP 277
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGES--RGTGSACETASFGSGSVGPEVSHLGWGRWYTL 143
G V+F+ R+S+ +GS AS SG V + S W++
Sbjct: 278 PSAYSSPQGS--DVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRS------WFSY 329
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR 203
EL TSG E+N++GEGG+G VY+G+LSDG +VAVK L Q E+EFK EVE+I R
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
V H++LV L+GYC+ +R+LVY+YV N L LH V +TW+ R+ + G A+G
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPV--MTWETRVRVAAGAARG 447
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGY 321
+AYLHE P+++HRD+KSSNILLD + A V+DFGLAK+ ++V+TRVMGTFGY
Sbjct: 448 IAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGY 507
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG----SR 377
+APEYA +G L+EK+DVYS+G++++E+ITGR PVD S+P G+ +LV+W + ++G +
Sbjct: 508 MAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENE 567
Query: 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ +E+VDP+L K + R++ A CV A KRPKM V+ L+
Sbjct: 568 EFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 300 bits (768), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 172/446 (38%), Positives = 255/446 (57%), Gaps = 38/446 (8%)
Query: 26 VVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIVHHPAP 85
VIGI + ++V+ LF+ + R++K +S Q L +S + +H
Sbjct: 262 TVIGIGIAGVLVI-LFIAGVFFVRRKQKKG--SSSPRSNQYLPPANVSVNTEGFIH---- 314
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVG---PEVSHLGWGR-WY 141
+ + +G S S+ +T S G+ G P+ + +G + +
Sbjct: 315 ----------------YRQKPGNGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHF 358
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVI 201
T EL T G C+ V+GEGG+G VY+GIL +G VA+K L + + +EFK EVE+I
Sbjct: 359 TYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEII 418
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
RV H++LV L+GYC+ +R L+YE+V N LD LHG ++ L W R+ I +G A
Sbjct: 419 SRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGK--NLPVLEWSRRVRIAIGAA 476
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
KGLAYLHE PK++HRD+KSSNILLD ++ A+V+DFGLA+L + +S+++TRVMGTFGY
Sbjct: 477 KGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGY 536
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW----LKTMVGSR 377
+APEYA +G L ++SDV+SFG++++E+ITGR PVD S+P GE +LV+W L +
Sbjct: 537 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKG 596
Query: 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL--FRDER 435
EVVDP+L + +++ A CV A KRP+M V+ L+ D L +
Sbjct: 597 DISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDDLSDLTNGV 656
Query: 436 RIGRE---PSNSYGEENRDFARKVGD 458
++G+ S Y E R F R D
Sbjct: 657 KVGQSRVYDSGQYSNEIRIFRRASED 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 296 bits (757), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 175/478 (36%), Positives = 268/478 (56%), Gaps = 24/478 (5%)
Query: 26 VVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIVHHPAP 85
++G+ + ++AL + + RRKK ++ S Q L P S + ++ P
Sbjct: 246 TMVGMAVAGFAIMAL--IGVVFLVRRKKKRNIDSYNHS-QYLPHPNFSVKSDGFLYGQDP 302
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGR-WYTLR 144
+ ++S G S GT S P+ + LG G+ ++
Sbjct: 303 GKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYE 362
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV 204
EL T G +N++GEGG+G VY+G L DG VAVK L GQ ++EFK EVE+I RV
Sbjct: 363 ELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRV 422
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
H++LV L+GYC+ +R+L+YEYV N L+ LHG V L W R+ I +G+AKGL
Sbjct: 423 HHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV--LEWSKRVRIAIGSAKGL 480
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
AYLHE PK++HRD+KS+NILLD ++ A+V+DFGLA+L + +++V+TRVMGTFGY+AP
Sbjct: 481 AYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAP 540
Query: 325 EYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM----VGSRKSE 380
EYA +G L ++SDV+SFG++++E++TGR PVD ++P GE +LV+W + + + +
Sbjct: 541 EYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLS 600
Query: 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML--EADDLLFRDERRIG 438
E++D +L K + R++ A CV KRP+M V+ L + D + +IG
Sbjct: 601 ELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIKIG 660
Query: 439 REPSNSYGEENRDFA--RKV---GDKQLGEG-------ASDTSEGDGSRNNHRPTMRR 484
+ + G+ N D RK+ GD + G A +S+ G+ + RP R
Sbjct: 661 QSTTYDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDFSGNESETRPFNNR 718
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 8e-79, Method: Compositional matrix adjust.
Identities = 153/333 (45%), Positives = 219/333 (65%), Gaps = 11/333 (3%)
Query: 105 RASSGESRGTGSACETASFGSGSVGPEVSHLGWGR-WYTLRELEAATSGLCEENVIGEGG 163
R+ S R SA AS SGS + LG + ++ EL AT+G +EN++GEGG
Sbjct: 328 RSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGG 387
Query: 164 YGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223
+G VY+GIL DG VAVK L GQ ++EFK EVE + R+ H++LV ++G+C+ G R+
Sbjct: 388 FGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRL 447
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
L+Y+YV N +L LHG+ S L W R+ I G A+GLAYLHE P+++HRD+KSS
Sbjct: 448 LIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSS 504
Query: 284 NILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGI 343
NILL+ ++ARVSDFGLA+L +++TTRV+GTFGY+APEYA +G L EKSDV+SFG+
Sbjct: 505 NILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGV 564
Query: 344 LIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG----SRKSEEVVDPKLPKMPASKALKRV 399
+++E+ITGR PVD S+P G+ +LV+W + ++ + + + + DPKL + R+
Sbjct: 565 VLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRM 624
Query: 400 LLVALRCVDPDATKRPKMGHVIHMLE---ADDL 429
+ A CV ATKRP+MG ++ E A+DL
Sbjct: 625 IEAAGACVRHLATKRPRMGQIVRAFESLAAEDL 657
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 170/440 (38%), Positives = 256/440 (58%), Gaps = 23/440 (5%)
Query: 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQE-- 78
G + + G + V+AL +++ RRKK ++ S+ + PP + I+
Sbjct: 230 GYQGKTMAGFAIAGFAVIAL--MAVVFLVRRKKKRNIDAYSDSQYL---PPSNFSIKSDG 284
Query: 79 IVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWG 138
++ P G + S S G RG G + S P+ + +G G
Sbjct: 285 FLYGQNPTKGYSGPGGYNSQQQSNSGN-SFGSQRGGGGYTRSGS------APDSAVMGSG 337
Query: 139 R-WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVE 197
+ +T EL T G + N++GEGG+G VY+G L+DG VAVK L GQ ++EFK E
Sbjct: 338 QTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAE 397
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
VE+I RV H++LV L+GYC+ + R+L+YEYV N L+ LHG V L W R+ I
Sbjct: 398 VEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPV--LEWARRVRIA 455
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
+G+AKGLAYLHE PK++HRD+KS+NILLD ++ A+V+DFGLAKL S +++V+TRVMG
Sbjct: 456 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMG 515
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW----LKTM 373
TFGY+APEYA +G L ++SDV+SFG++++E+ITGR PVD +P GE +LV+W L
Sbjct: 516 TFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKA 575
Query: 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL--F 431
+ + E+VD +L K + R++ A CV KRP+M V+ L+++ +
Sbjct: 576 IETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDI 635
Query: 432 RDERRIGREPSNSYGEENRD 451
+ ++G+ + G+ N D
Sbjct: 636 SNGNKVGQSSAYDSGQYNND 655
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 484 | ||||||
| 255541684 | 492 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.987 | 0.971 | 0.859 | 0.0 | |
| 224130370 | 485 | predicted protein [Populus trichocarpa] | 0.979 | 0.977 | 0.842 | 0.0 | |
| 14194119 | 479 | At1g01540/F22L4_6 [Arabidopsis thaliana] | 0.900 | 0.910 | 0.862 | 0.0 | |
| 15223428 | 472 | putative serine/threonine-protein kinase | 0.900 | 0.923 | 0.862 | 0.0 | |
| 297848354 | 472 | kinase family protein [Arabidopsis lyrat | 0.952 | 0.976 | 0.825 | 0.0 | |
| 297814211 | 481 | predicted protein [Arabidopsis lyrata su | 0.964 | 0.970 | 0.783 | 0.0 | |
| 8920590 | 497 | Contains a strong similarity to an unkno | 0.900 | 0.877 | 0.817 | 0.0 | |
| 359489654 | 492 | PREDICTED: probable serine/threonine-pro | 0.985 | 0.969 | 0.787 | 0.0 | |
| 240255713 | 479 | protein kinase family protein [Arabidops | 0.960 | 0.970 | 0.779 | 0.0 | |
| 449432126 | 492 | PREDICTED: probable serine/threonine-pro | 0.995 | 0.979 | 0.793 | 0.0 |
| >gi|255541684|ref|XP_002511906.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223549086|gb|EEF50575.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/498 (85%), Positives = 448/498 (89%), Gaps = 20/498 (4%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAFVNTELSK TSIFGLRLWVVIGILLGSLIVLALFLLSLC+TSRRK L+
Sbjct: 1 MSVYDAAFVNTELSKPTSIFGLRLWVVIGILLGSLIVLALFLLSLCITSRRKNKKTLKLT 60
Query: 61 QQSKQILNTPPISKEIQEIVHHPAP-----------VPEIQVDIGKIEHRVVFSDRASSG 109
TPPISKEIQEIVH P VPEIQV+IGK EHRVVFSDR SSG
Sbjct: 61 DTI-----TPPISKEIQEIVHFPTQDNHHHHHHAVQVPEIQVEIGKTEHRVVFSDRPSSG 115
Query: 110 ESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYR 169
ESRGT SACETASFGSGSVGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY
Sbjct: 116 ESRGTASACETASFGSGSVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYS 175
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229
G+LSDGT+VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV
Sbjct: 176 GVLSDGTRVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 235
Query: 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR
Sbjct: 236 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 295
Query: 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 349
QWN +VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSD+YSFGILIME+I
Sbjct: 296 QWNPKVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMELI 355
Query: 350 TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP 409
+GR+PVDYSRPQGEVNLVDWLKTMVG+RKSEEVVDPKLP+MPASKALKRVLLVALRCVDP
Sbjct: 356 SGRSPVDYSRPQGEVNLVDWLKTMVGNRKSEEVVDPKLPEMPASKALKRVLLVALRCVDP 415
Query: 410 DATKRPKMGHVIHMLEADDLLFRDERRIGREPSNS---YGEENRDFARKVGDKQLGEGAS 466
DAT+RPKMGHVIHMLEADDLLFRDERRIGRE SNS Y +EN A K+GD+Q GEG S
Sbjct: 416 DATRRPKMGHVIHMLEADDLLFRDERRIGRESSNSRHEYEQENPAVA-KLGDRQFGEGTS 474
Query: 467 DTSEGDGSRNNHRPTMRR 484
DTSEGD SRN H+ + R
Sbjct: 475 DTSEGDSSRNLHQQSRWR 492
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130370|ref|XP_002320820.1| predicted protein [Populus trichocarpa] gi|222861593|gb|EEE99135.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/495 (84%), Positives = 441/495 (89%), Gaps = 21/495 (4%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YD AFVNTELSK TSIFGLRLWVVIGILLGSLIVLALFLLSLC+TSRRK +Q
Sbjct: 1 MSVYDGAFVNTELSKPTSIFGLRLWVVIGILLGSLIVLALFLLSLCVTSRRK-----NRQ 55
Query: 61 QQSKQILNTPPISKEIQEIVH--------HPAPVPEIQVDIGKIEHRVVFSDRASSGESR 112
+ + TPPISKEIQEIVH H VPEIQV IGK+EHRVVFS SGESR
Sbjct: 56 FKLTKTDTTPPISKEIQEIVHLPVQDHNHHAIQVPEIQVGIGKVEHRVVFS----SGESR 111
Query: 113 GTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL 172
GT S ETASFGSGSVGPEVSHLGWGRWYTLRELEAAT GLCEENVIGEGGYGIVYRG+L
Sbjct: 112 GTASGGETASFGSGSVGPEVSHLGWGRWYTLRELEAATGGLCEENVIGEGGYGIVYRGVL 171
Query: 173 SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232
SDGTKVAVKNLLNNRGQAE+EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG
Sbjct: 172 SDGTKVAVKNLLNNRGQAEREFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 231
Query: 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
NLDQWLHGDVG+VSPLTWDIR NIILGTAKGLAYLH+GLEPKVVHRDVKSSNILLDRQWN
Sbjct: 232 NLDQWLHGDVGEVSPLTWDIRRNIILGTAKGLAYLHDGLEPKVVHRDVKSSNILLDRQWN 291
Query: 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR 352
++VSDFGLAKLL SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII+GR
Sbjct: 292 SKVSDFGLAKLLHSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIISGR 351
Query: 353 NPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 412
+PVDYSRPQGEVNLV+WLKTMVG+RKSEEVVDPKLP+MPASKALKR LLVAL+CVDPDAT
Sbjct: 352 SPVDYSRPQGEVNLVEWLKTMVGNRKSEEVVDPKLPEMPASKALKRALLVALKCVDPDAT 411
Query: 413 KRPKMGHVIHMLEADDLLFRDERRIGREPSNS---YGEENRDFARKVGDKQLGEGASDTS 469
KRPKMGHVIHMLEADDLLFRDERR+GREPS+S Y +EN A K DKQ GEG SDTS
Sbjct: 412 KRPKMGHVIHMLEADDLLFRDERRVGREPSHSQHDYEQENHA-AMKFIDKQSGEGTSDTS 470
Query: 470 EGDGSRNNHRPTMRR 484
EG+ R +H+PT R
Sbjct: 471 EGESGRKHHQPTRWR 485
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14194119|gb|AAK56254.1|AF367265_1 At1g01540/F22L4_6 [Arabidopsis thaliana] gi|20334728|gb|AAM16225.1| At1g01540/F22L4_6 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2003), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/445 (86%), Positives = 412/445 (92%), Gaps = 9/445 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
SDFGLAKLL SE SYVTTRVMGTFGYVAPEYACTGMLNEKSD+YSFGILIMEIITGRNPV
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPV 356
Query: 356 DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
DYSRPQGE NLVDWLK+MVG+R+SEEVVDPK+P+ P+SKALKRVLLVALRCVDPDA KRP
Sbjct: 357 DYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRP 416
Query: 416 KMGHVIHMLEADDLLFRDERRIGRE 440
KMGH+IHMLEA+DLL+RDERR R+
Sbjct: 417 KMGHIIHMLEAEDLLYRDERRTTRD 441
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223428|ref|NP_171661.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|158564340|sp|Q3EDL4.2|Y1154_ARATH RecName: Full=Probable serine/threonine-protein kinase At1g01540 gi|12083266|gb|AAG48792.1|AF332429_1 putative protein serine/threonine kinase [Arabidopsis thaliana] gi|2505874|emb|CAA73303.1| putative kinase [Arabidopsis thaliana] gi|332189181|gb|AEE27302.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/445 (86%), Positives = 412/445 (92%), Gaps = 9/445 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
SDFGLAKLL SE SYVTTRVMGTFGYVAPEYACTGMLNEKSD+YSFGILIMEIITGRNPV
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPV 356
Query: 356 DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
DYSRPQGE NLVDWLK+MVG+R+SEEVVDPK+P+ P+SKALKRVLLVALRCVDPDA KRP
Sbjct: 357 DYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRP 416
Query: 416 KMGHVIHMLEADDLLFRDERRIGRE 440
KMGH+IHMLEA+DLL+RDERR R+
Sbjct: 417 KMGHIIHMLEAEDLLYRDERRTTRD 441
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848354|ref|XP_002892058.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297337900|gb|EFH68317.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/469 (82%), Positives = 420/469 (89%), Gaps = 8/469 (1%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIV-HHPAPVP-EIQVDIGKIEHRVVFSDRASSGESRGTGSAC 118
+ + TPPISKEI+EIV VP EIQVDIGKIEHRVVFSDR SSGESRGT SA
Sbjct: 59 DFASAAIATPPISKEIKEIVPAQTQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTASAS 118
Query: 119 ETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTK 177
ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DGTK
Sbjct: 119 ETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTK 178
Query: 178 VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQW 237
VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+QW
Sbjct: 179 VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQW 238
Query: 238 LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297
+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+VSD
Sbjct: 239 IHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSD 298
Query: 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDY 357
FGLAKLL SE SYVTTRVMGTFGYVAPEYACTGMLNEKSD+YSFGILIMEIITGRNPVDY
Sbjct: 299 FGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDY 358
Query: 358 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
SRPQGE NLVDWLK+MVG+R+SEEVVDPK+P+ P+SKALKRVLLVALRCVDPDA KRPKM
Sbjct: 359 SRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKM 418
Query: 418 GHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDKQLGEGAS 466
GH+IHMLEA+D+L+RDERR R+ + E ++ A V + GE S
Sbjct: 419 GHIIHMLEAEDVLYRDERRTTRDHGS---RERQETAVVVAGSESGESGS 464
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814211|ref|XP_002874989.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297320826|gb|EFH51248.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/486 (78%), Positives = 418/486 (86%), Gaps = 19/486 (3%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+++ +N ELSK+TSIFGL+LWVVIGILLGSLIV+ALF LSLCLTSRR+
Sbjct: 3 MSIFNPDSINNELSKQTSIFGLKLWVVIGILLGSLIVIALFFLSLCLTSRRRNRKPRHAD 62
Query: 61 QQSKQILNTPPISKEIQEIVHHPA--------PVP-EIQVDIGKIEHRVVFSDRASSGES 111
S + TPPISKEIQEIV PA PV EIQVDIGKIEHRVVFSDR SSGES
Sbjct: 63 FASAAVA-TPPISKEIQEIVRSPAQDHYHPTQPVAAEIQVDIGKIEHRVVFSDRVSSGES 121
Query: 112 RGTGSACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRG 170
RGT SA ETAS+ GSG VGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY G
Sbjct: 122 RGTVSASETASYSGSGCVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYSG 181
Query: 171 ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230
IL+DGTKVAVKNLLNNRGQAEKEF+VEVE IGRVRHKNLVRLLGYCVEGAYRMLVY+YVD
Sbjct: 182 ILTDGTKVAVKNLLNNRGQAEKEFRVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYDYVD 241
Query: 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
NGNL+QW+HGDVGD SPLTWDIRMNIIL AKGLAYLHEGLEPKVVHRD+KSSNILLDRQ
Sbjct: 242 NGNLEQWIHGDVGDKSPLTWDIRMNIILCMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQ 301
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
WNA+VSDFGLAKLL SE SYVTTRVMGTFGYVAPEYACTGML EKSD+YSFGILIMEIIT
Sbjct: 302 WNAKVSDFGLAKLLFSESSYVTTRVMGTFGYVAPEYACTGMLTEKSDIYSFGILIMEIIT 361
Query: 351 GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPD 410
GRNPVDYSRPQGEVNLV+WLKTMVG+R+SEEVVDPK+P+ P SKALKRVLLVALRCVDPD
Sbjct: 362 GRNPVDYSRPQGEVNLVEWLKTMVGNRRSEEVVDPKIPEPPTSKALKRVLLVALRCVDPD 421
Query: 411 ATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDKQLGEGASDTSE 470
A KRPKMGH+IHMLEA+DL +RDERR RE + +RD+ + ++ A++TSE
Sbjct: 422 ANKRPKMGHIIHMLEAEDLFYRDERRATREHA------SRDYNQP--QTEVSAAAAETSE 473
Query: 471 GDGSRN 476
D S++
Sbjct: 474 SDSSKD 479
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|8920590|gb|AAF81312.1|AC061957_8 Contains a strong similarity to an unknown protein from Arabidopsis thaliana gi|2505874 and contains an eukaryotic protein kinase PF|00069 domain. ESTs gb|Z26473, gb|AI996016, gb|Z17558, gb|N97089, gb|BE039500, gb|AA712856, gb|Z26772 come from this gene [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/470 (81%), Positives = 412/470 (87%), Gaps = 34/470 (7%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNR-------------------------GQAEKEFKVEVEVIGRVRHKNLV 210
TKVAVKNLLNNR GQAEKEFKVEVEVIGRVRHKNLV
Sbjct: 177 TKVAVKNLLNNRWLRVIVIRVLLLFNCIAFGVSLIARGQAEKEFKVEVEVIGRVRHKNLV 236
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RLLGYCVEGAYRMLVY++VDNGNL+QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEG
Sbjct: 237 RLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEG 296
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
LEPKVVHRD+KSSNILLDRQWNA+VSDFGLAKLL SE SYVTTRVMGTFGYVAPEYACTG
Sbjct: 297 LEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTG 356
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
MLNEKSD+YSFGILIMEIITGRNPVDYSRPQGE NLVDWLK+MVG+R+SEEVVDPK+P+
Sbjct: 357 MLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEP 416
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 440
P+SKALKRVLLVALRCVDPDA KRPKMGH+IHMLEA+DLL+RDERR R+
Sbjct: 417 PSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTRD 466
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489654|ref|XP_003633957.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] gi|297745343|emb|CBI40423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1960), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/499 (78%), Positives = 428/499 (85%), Gaps = 22/499 (4%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+N+ELSK TSIFGLRLWVVIGI +G++IV+ LFLLSLC+TSRR++ +
Sbjct: 1 MSVYDAAFLNSELSKPTSIFGLRLWVVIGIFVGAVIVIILFLLSLCITSRRRRPPSSSKL 60
Query: 61 QQSKQILNTPPISKEIQEIVHHPAP--------VPEIQVDIGKIEHRVVFSDRASS---G 109
+ TP +SKEIQEIVH AP EIQ+DIGK EHRVVFSDR SS G
Sbjct: 61 GAGE---FTPVVSKEIQEIVHEAAPDHRPVLPPASEIQIDIGKSEHRVVFSDRLSSQASG 117
Query: 110 ESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYR 169
ESR T S ETAS G G PEVSHLGWGRWYTLRELEAAT+GL +ENVIGEGGYGIVYR
Sbjct: 118 ESRAT-SVTETASLGGGP--PEVSHLGWGRWYTLRELEAATNGLADENVIGEGGYGIVYR 174
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229
G+L+D T+VAVKNLLNNRGQAEKEFKVEVE IGRVRHKNLVRLLGYC EGAYRMLVYEYV
Sbjct: 175 GVLADNTRVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAYRMLVYEYV 234
Query: 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
DNGNLDQWLHGDVG+VSPLTWDIR+NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR
Sbjct: 235 DNGNLDQWLHGDVGEVSPLTWDIRINIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 294
Query: 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 349
QWN++VSDFGLAKLLCSE SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII
Sbjct: 295 QWNSKVSDFGLAKLLCSEISYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 354
Query: 350 TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP 409
+GRNPVDYS+ GEVNLVDWLKTMVG+RKSEEVVDPKLP+MP+SKALKRVLLVALRCVDP
Sbjct: 355 SGRNPVDYSQAPGEVNLVDWLKTMVGNRKSEEVVDPKLPEMPSSKALKRVLLVALRCVDP 414
Query: 410 DATKRPKMGHVIHMLEADDLLFRDERRIGREPSNS---YGEENRDFARKVGDKQLGEGAS 466
DATKRPKMGHVIHMLEADDLLFRDERRIGRE S+S Y +EN RK+ +KQL EGA
Sbjct: 415 DATKRPKMGHVIHMLEADDLLFRDERRIGRESSHSHHDYQQENH-ANRKIDNKQLDEGAC 473
Query: 467 DTSE-GDGSRNNHRPTMRR 484
D+SE D R+ + T R
Sbjct: 474 DSSECADSGRSQYPQTKWR 492
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|240255713|ref|NP_192042.5| protein kinase family protein [Arabidopsis thaliana] gi|332656610|gb|AEE82010.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/486 (77%), Positives = 413/486 (84%), Gaps = 21/486 (4%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+++ +N ELSK TSIFGL+LWVVIGILLGSLIV+ALF LSLCLTSRR+
Sbjct: 3 MSIFNPDSINNELSKPTSIFGLKLWVVIGILLGSLIVIALFFLSLCLTSRRRNRKPRHAD 62
Query: 61 QQSKQILNTPPISKEIQEIVHHPA--------PVP-EIQVDIGKIEHRVVFSDRASSGES 111
S + TPPISKEIQEIV PA PV EIQVDIGK EHRVVFSDR SSGES
Sbjct: 63 FASAAVA-TPPISKEIQEIVRPPAQDHCHPTQPVAAEIQVDIGKTEHRVVFSDRVSSGES 121
Query: 112 RGTGSACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRG 170
RGT S ETAS+ GSG VGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY G
Sbjct: 122 RGTVS--ETASYSGSGCVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYSG 179
Query: 171 ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230
IL+DGTKVAVKNLLNNRGQAEKEF+VEVE IGRVRHKNLVRLLGYCVEGAYRMLVY+YVD
Sbjct: 180 ILTDGTKVAVKNLLNNRGQAEKEFRVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYDYVD 239
Query: 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
NGNL+QW+HGDVGD SPLTWDIRMNIIL AKGLAYLHEGLEPKVVHRD+KSSNILLDRQ
Sbjct: 240 NGNLEQWIHGDVGDKSPLTWDIRMNIILCMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQ 299
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
WNA+VSDFGLAKLL SE SYVTTRVMGTFGYVAPEYACTGML EKSD+YSFGILIMEIIT
Sbjct: 300 WNAKVSDFGLAKLLFSESSYVTTRVMGTFGYVAPEYACTGMLTEKSDIYSFGILIMEIIT 359
Query: 351 GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPD 410
GRNPVDYSRPQGEVNLV+WLKTMVG+R+SEEVVDPK+P+ P SKALKRVLLVALRCVDPD
Sbjct: 360 GRNPVDYSRPQGEVNLVEWLKTMVGNRRSEEVVDPKIPEPPTSKALKRVLLVALRCVDPD 419
Query: 411 ATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDKQLGEGASDTSE 470
A KRPKMGH+IHMLEA+DL +RDERR RE +RDF + ++ ++TSE
Sbjct: 420 ANKRPKMGHIIHMLEAEDLFYRDERRATRE------HASRDFNQP--RTEISPAVAETSE 471
Query: 471 GDGSRN 476
D S++
Sbjct: 472 SDSSKD 477
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432126|ref|XP_004133851.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1926), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/494 (79%), Positives = 430/494 (87%), Gaps = 12/494 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSR-RKKHNHLQQ 59
MS+YDAAFVNTELSK TSIFGLRLWVVIGI +G+LIVLALFLLSLCLTSR R +H +
Sbjct: 1 MSVYDAAFVNTELSKPTSIFGLRLWVVIGIFVGALIVLALFLLSLCLTSRKRNRHKNQIG 60
Query: 60 QQQSKQILNTPPISKEIQEIVHHPAPV------PEIQVDIGKIEHRVVFSDRASSGESRG 113
+S + P +SKEIQEIVHH P PEI V+IGK+EHRVVFSDR SSGESRG
Sbjct: 61 FPKSTTPHSPPAVSKEIQEIVHHAVPDHHHHVQPEIHVEIGKLEHRVVFSDRPSSGESRG 120
Query: 114 TGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILS 173
T S ETASFGSG+VGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY GIL
Sbjct: 121 TVS--ETASFGSGTVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYLGILG 178
Query: 174 DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233
DGT++A+KNLLNNRGQAE+EFKVEVE IGRVRHKNLVRLLGYCVEGAYRMLVYEYV+NGN
Sbjct: 179 DGTRIAIKNLLNNRGQAEREFKVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYEYVNNGN 238
Query: 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293
LDQWLHGDVGDVSPLTW+IR+NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA
Sbjct: 239 LDQWLHGDVGDVSPLTWEIRVNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 298
Query: 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN 353
+VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII+GR+
Sbjct: 299 KVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIISGRS 358
Query: 354 PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK 413
PVDYSRPQGEVNLVDWLK MVG RKSEEVVDPKL + P SK LKRVLLVALRCVDPDATK
Sbjct: 359 PVDYSRPQGEVNLVDWLKAMVGDRKSEEVVDPKLREKPPSKGLKRVLLVALRCVDPDATK 418
Query: 414 RPKMGHVIHMLEADDLLFRDERRIGREPSNS---YGEENRDFARKVGDKQLGEGASDTSE 470
RPKMGHVIHMLEAD+LL DE R+G++ ++S + ENR +R+V +++ +S+ SE
Sbjct: 419 RPKMGHVIHMLEADNLLSHDEHRVGKDSTHSIEGHQHENRAVSRRVNNQKDEGASSNISE 478
Query: 471 GDGSRNNHRPTMRR 484
GD N H + R
Sbjct: 479 GDSDGNIHHQSRWR 492
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 484 | ||||||
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.948 | 0.972 | 0.772 | 7.9e-188 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.886 | 0.871 | 0.629 | 4.6e-144 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.762 | 0.844 | 0.672 | 2.2e-130 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.733 | 0.718 | 0.636 | 2.2e-122 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.747 | 0.707 | 0.612 | 9.5e-121 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.737 | 0.725 | 0.610 | 4.6e-120 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.754 | 0.783 | 0.591 | 9.5e-120 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.650 | 0.650 | 0.645 | 4.6e-112 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.665 | 0.689 | 0.626 | 4.2e-111 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.772 | 0.520 | 0.419 | 6.3e-76 |
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1821 (646.1 bits), Expect = 7.9e-188, P = 7.9e-188
Identities = 364/471 (77%), Positives = 394/471 (83%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRXXXXXXXXXXXXXXXXXXXXXXXXXXRRKKHNHLXXX 60
MS+YDAAF+NTELSK TSIFGLR RRK N
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 XXSKQILNTPPISKEIQEIVHHPAP---VP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
SDFGLAKLL SE SYVTTRVMGTFGYVAPEYACTGMLNEKSD+YSFGILIMEIITGRNPV
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPV 356
Query: 356 DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
DYSRPQGE NLVDWLK+MVG+R+SEEVVDPK+P+ P+SKALKRVLLVALRCVDPDA KRP
Sbjct: 357 DYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRP 416
Query: 416 KMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDKQLGEGAS 466
KMGH+IHMLEA+DLL+RDERR R+ + E ++ A + GE S
Sbjct: 417 KMGHIIHMLEAEDLLYRDERRTTRDHGS---RERQETAVVAAGSESGESGS 464
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1408 (500.7 bits), Expect = 4.6e-144, P = 4.6e-144
Identities = 284/451 (62%), Positives = 337/451 (74%)
Query: 3 MYDAAFVNTELSKRTSIFGLRXXXXXXXXXXXXXXXXXXXXXXXXXXRRK-KHNHLXXXX 61
M D+ VN +LS+ TSIFGLR RR K+ L
Sbjct: 1 MADSHSVNNQLSRHTSIFGLRLWVVLGVCVGAAIVLLLVLISLWFIYRRSNKNKSLESSS 60
Query: 62 XSKQILNTPPISKEIQEIVH--HPAPVPE------------IQVDIGKIEHRVVFSDRAS 107
S + P +SKEIQEI P P PE I ++IGK +HR+ + +R
Sbjct: 61 KSNHTI-VPVVSKEIQEIRPPIQPDPTPEPHQNQQREDDNKIHIEIGK-DHRIAYPERGG 118
Query: 108 -SGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGI 166
+G G+GS + SG PEVSHLGWG WYTLRELE +T+G +ENVIG+GGYGI
Sbjct: 119 WTGSGSGSGSGDQGLLMLSG---PEVSHLGWGHWYTLRELEVSTNGFADENVIGQGGYGI 175
Query: 167 VYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226
VYRG+L D + VA+KNLLNNRGQAEKEFKVEVE IGRVRHKNLVRLLGYCVEGA+RMLVY
Sbjct: 176 VYRGVLEDKSMVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVY 235
Query: 227 EYVDNGNLDQWLHGD-VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285
EYVDNGNL+QW+HG +G SPLTW+IRMNI+LGTAKGL YLHEGLEPKVVHRD+KSSNI
Sbjct: 236 EYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNI 295
Query: 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILI 345
LLD+QWN++VSDFGLAKLL SE SYVTTRVMGTFGYVAPEYA TGMLNE+SDVYSFG+L+
Sbjct: 296 LLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGVLV 355
Query: 346 MEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALR 405
MEII+GR+PVDYSR GEVNLV+WLK +V +R +E V+DP++ P+ ++LKR LLVALR
Sbjct: 356 MEIISGRSPVDYSRAPGEVNLVEWLKRLVTNRDAEGVLDPRMVDKPSLRSLKRTLLVALR 415
Query: 406 CVDPDATKRPKMGHVIHMLEADDLLFRDERR 436
CVDP+A KRPKMGH+IHMLEA+DL+ +D+RR
Sbjct: 416 CVDPNAQKRPKMGHIIHMLEAEDLVSKDDRR 446
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
Identities = 252/375 (67%), Positives = 292/375 (77%)
Query: 70 PPISKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVG 129
P +SKEI EI GKI + VV A+S E+ AS SG VG
Sbjct: 66 PLVSKEISEI-KTVGKFINSDDSKGKIGNEVVVVVSATSKEATSGFDTLSVAS--SGDVG 122
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
+ +GWG+WY+L++LE AT G ++N+IGEGGYG+VYR SDG+ AVKNLLNN+GQ
Sbjct: 123 TSEA-MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQ 181
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY--RMLVYEYVDNGNLDQWLHGDVGDVSP 247
AEKEFKVEVE IG+VRHKNLV L+GYC + A RMLVYEY+DNGNL+QWLHGDVG VSP
Sbjct: 182 AEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSP 241
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
LTWDIRM I +GTAKGLAYLHEGLEPKVVHRDVKSSNILLD++WNA+VSDFGLAKLL SE
Sbjct: 242 LTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSE 301
Query: 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
SYVTTRVMGTFGYV+PEYA TGMLNE SDVYSFG+L+MEIITGR+PVDYSRP GE+NLV
Sbjct: 302 TSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLV 361
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427
DW K MV SR+ EEV+DPK+ P +ALKR LLV LRC+D D++KRPKMG +IHMLEA+
Sbjct: 362 DWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAE 421
Query: 428 DLLFRDERRIGREPS 442
D FR E R +E S
Sbjct: 422 DFPFRPEHRSNQERS 436
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
Identities = 233/366 (63%), Positives = 281/366 (76%)
Query: 108 SGESRGTGSACETASFG----SGSVG-PEVSHLGWGRWYTLRELEAATSGLCEENVIGEG 162
SGE G GSA G S VG PE+SHLGWG W+TLR+LE AT+ NV+GEG
Sbjct: 133 SGEEGGFGSAGRQYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEG 192
Query: 163 GYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222
GYG+VYRG L +GT+VAVK LLNN GQAEKEF+VEVE IG VRHKNLVRLLGYC+EG +R
Sbjct: 193 GYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 252
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
MLVYEYV++GNL+QWLHG + LTW+ RM II GTA+ LAYLHE +EPKVVHRD+K+
Sbjct: 253 MLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKA 312
Query: 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFG 342
SNIL+D ++NA++SDFGLAKLL S S++TTRVMGTFGYVAPEYA TG+LNEKSD+YSFG
Sbjct: 313 SNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFG 372
Query: 343 ILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLV 402
+L++E ITGR+PVDY RP EVNLV+WLK MVG+R++EEVVDP+L P+ ALKR LLV
Sbjct: 373 VLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLV 432
Query: 403 ALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDKQLG 462
+LRCVDP+A KRP+M V MLE+D+ F ERR R S + G E + D+ LG
Sbjct: 433 SLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKR--SKTAGME----IVETKDESLG 486
Query: 463 EGASDT 468
S+T
Sbjct: 487 PSGSET 492
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1188 (423.3 bits), Expect = 9.5e-121, P = 9.5e-121
Identities = 234/382 (61%), Positives = 291/382 (76%)
Query: 108 SGESRGTGSACETASFGSGS-------VG-PEVSHLGWGRWYTLRELEAATSGLCEENVI 159
SGE G+A S G VG PE+SHLGWG W+TLR+L+ AT+ ENVI
Sbjct: 137 SGEDGSFGAAWRQNSLSQGGLVTASPLVGLPEISHLGWGHWFTLRDLQLATNRFAAENVI 196
Query: 160 GEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219
GEGGYG+VY+G L +G VAVK LLNN GQAEKEF+VEVE IG VRHKNLVRLLGYC+EG
Sbjct: 197 GEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 256
Query: 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279
RMLVYEYV++GNL+QWLHG +G S LTW+ RM I++GTA+ LAYLHE +EPKVVHRD
Sbjct: 257 VNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGTAQALAYLHEAIEPKVVHRD 316
Query: 280 VKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY 339
+K+SNIL+D +NA++SDFGLAKLL S S++TTRVMGTFGYVAPEYA TG+LNEKSD+Y
Sbjct: 317 IKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIY 376
Query: 340 SFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRV 399
SFG+L++E ITGR+PVDY RP EVNLV+WLK MVG+R++EEVVD ++ PA++ALKR
Sbjct: 377 SFGVLLLETITGRDPVDYERPANEVNLVEWLKMMVGTRRAEEVVDSRIEPPPATRALKRA 436
Query: 400 LLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKVGDK 459
LLVALRCVDP+A KRPKM V+ MLE+D+ FR+ERR ++R + ++ +
Sbjct: 437 LLVALRCVDPEAQKRPKMSQVVRMLESDEHPFREERR---------NRKSRTASMEIVET 487
Query: 460 QLGEGASDTSEGDG-SRNNHRP 480
E ++DTS+G G S N +P
Sbjct: 488 T--EESADTSKGPGHSENTTKP 507
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 4.6e-120, Sum P(2) = 4.6e-120
Identities = 219/359 (61%), Positives = 274/359 (76%)
Query: 94 GKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGL 153
G H + + S E S+ + S G SHLGWG W+TLR+LE AT+
Sbjct: 120 GSFHHLEIIDKHSDSAEEVSASSSLYNIATPSPLSGLPESHLGWGHWFTLRDLETATNRF 179
Query: 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ENVIGEGGYG+VYRG L +GT VAVK +LN GQAEKEF+VEV+ IG VRHKNLVRLL
Sbjct: 180 SKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDAIGHVRHKNLVRLL 239
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
GYC+EG +R+LVYEYV+NGNL+QWLHG + LTW+ RM +++GT+K LAYLHE +EP
Sbjct: 240 GYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIGTSKALAYLHEAIEP 299
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
KVVHRD+KSSNIL++ ++NA+VSDFGLAKLL + +S+VTTRVMGTFGYVAPEYA +G+LN
Sbjct: 300 KVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANSGLLN 359
Query: 334 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 393
EKSDVYSFG++++E ITGR+PVDY RP EVNLVDWLK MVG+R+SEEVVDP + P +
Sbjct: 360 EKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGTRRSEEVVDPNIEVKPPT 419
Query: 394 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL-LFRDERRIGREPSNSYGEENRD 451
++LKR LL ALRCVDPD+ KRPKM V+ MLE+++ + R++RR R S E N D
Sbjct: 420 RSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRSRTREGSM-EINSD 477
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1150 (409.9 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
Identities = 223/377 (59%), Positives = 290/377 (76%)
Query: 89 IQVDIGKIEHRVVFSDRASSGE-------SRGTGSACETASFGSGSVG--PEVSHLGWGR 139
+ +++ K + S R+ SG+ +R T S E A+ + PE SHLGWG
Sbjct: 85 LNLEMEKNRENGLSSSRSGSGKEGYLCVANRSTSSLYEMATPSPSPLSGLPE-SHLGWGH 143
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W+TLR+LE AT+ +ENVIGEGGYG+VYRG L +G+ VAVK +LN+ GQAEKEF+VEV+
Sbjct: 144 WFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVD 203
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
IG VRHKNLVRLLGYC+EG R+LVYEY++NGNL++WLHG + LTW+ RM ++ G
Sbjct: 204 AIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTG 263
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
T+K LAYLHE +EPKVVHRD+KSSNIL+D ++NA++SDFGLAKLL +S+VTTRVMGTF
Sbjct: 264 TSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTF 323
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
GYVAPEYA TG+LNEKSDVYSFG+L++E ITGR+PVDY+RP EVNLV+WLK MVGS++
Sbjct: 324 GYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRL 383
Query: 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL-LFRDERRIG 438
EEV+DP + PA++ALKRVLL ALRC+DPD+ KRPKM V+ MLE+++ + R+ERR+
Sbjct: 384 EEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLESEEYPVPREERRVR 443
Query: 439 R-EPSNSYGEENRDFAR 454
R + NS + +R +R
Sbjct: 444 RTQEENSDTDRSRPVSR 460
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 4.6e-112, P = 4.6e-112
Identities = 204/316 (64%), Positives = 259/316 (81%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PE SHLGWG W+TLR+L+ AT+ +N+IG+GGYG+VYRG L +GT VAVK LLNN GQ
Sbjct: 143 PEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQ 202
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
A+K+F+VEVE IG VRHKNLVRLLGYC+EG RMLVYEYV+NGNL+QWL GD + LT
Sbjct: 203 ADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLT 262
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
W+ R+ I++GTAK LAYLHE +EPKVVHRD+KSSNIL+D ++N+++SDFGLAKLL +++S
Sbjct: 263 WEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKS 322
Query: 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 369
++TTRVMGTFGYVAPEYA +G+LNEKSDVYSFG++++E ITGR PVDY+RP EV+LV+W
Sbjct: 323 FITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEW 382
Query: 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL 429
LK MV R+SEEVVDP L P++ ALKR LL ALRCVDP + KRP+M V MLE+++
Sbjct: 383 LKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEY 442
Query: 430 -LFRDERRIGREPSNS 444
+ R++RR R + +
Sbjct: 443 PIAREDRRRRRSQNGT 458
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1097 (391.2 bits), Expect = 4.2e-111, P = 4.2e-111
Identities = 203/324 (62%), Positives = 262/324 (80%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEVSH+GWG W+TLR+L+ AT+ +E++IG+GGYG+VY G L++ T VAVK LLNN GQ
Sbjct: 131 PEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQ 190
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
A+K+F+VEVE IG VRHKNLVRLLGYCVEG +RMLVYEY++NGNL+QWLHGD+ LT
Sbjct: 191 ADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLT 250
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
W+ R+ +++GTAK LAYLHE +EPKVVHRD+KSSNIL+D ++A++SDFGLAKLL ++ +
Sbjct: 251 WEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSN 310
Query: 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 369
YV+TRVMGTFGYVAPEYA +G+LNEKSDVYS+G++++E ITGR PVDY+RP+ EV++V+W
Sbjct: 311 YVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEW 370
Query: 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD- 428
LK MV ++ EEVVD +L P + LKR LL ALRCVDPDA KRPKM V MLE+D+
Sbjct: 371 LKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDEY 430
Query: 429 -LLFRDERRIGREPSNSYGEENRD 451
++ R+ERR R + E+ D
Sbjct: 431 PVMPREERRRRRNQNAETHRESTD 454
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 6.3e-76, P = 6.3e-76
Identities = 164/391 (41%), Positives = 240/391 (61%)
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVG---PEVSHLGWGR-WY 141
+P V + E + + + +G S S+ +T S G+ G P+ + +G + +
Sbjct: 300 LPPANVSVNT-EGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHF 358
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVI 201
T EL T G C+ V+GEGG+G VY+GIL +G VA+K L + + +EFK EVE+I
Sbjct: 359 TYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEII 418
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
RV H++LV L+GYC+ +R L+YE+V N LD LHG ++ L W R+ I +G A
Sbjct: 419 SRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGK--NLPVLEWSRRVRIAIGAA 476
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
KGLAYLHE PK++HRD+KSSNILLD ++ A+V+DFGLA+L + +S+++TRVMGTFGY
Sbjct: 477 KGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGY 536
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV--GSRKS 379
+APEYA +G L ++SDV+SFG++++E+ITGR PVD S+P GE +LV+W + + K
Sbjct: 537 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKG 596
Query: 380 E--EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA-DDLL-FRDER 435
+ EVVDP+L + +++ A CV A KRP+M V+ L+ DDL +
Sbjct: 597 DISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRDDLSDLTNGV 656
Query: 436 RIGRE---PSNSYGEENRDFARKVGDKQ-LG 462
++G+ S Y E R F R D LG
Sbjct: 657 KVGQSRVYDSGQYSNEIRIFRRASEDSSDLG 687
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q3EDL4 | Y1154_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8629 | 0.9008 | 0.9237 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.2 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT1G01540 | protein kinase family protein; protein kinase family protein; FUNCTIONS IN- protein serine/threonine kinase activity, protein tyrosine kinase activity, protein kinase activity, kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- plasma membrane; EXPRESSED IN- 23 plant structures; EXPRESSED DURING- 13 growth stages; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Serine/threonine protein kinase (InterPro-IPR002290), Tyrosine protein kinase (InterPro-IPR001245), Serine/threonine protein kinase-related (InterPro-IPR [...] (472 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | FEI1 | FEI1 (FEI 1); ATP binding / kinase/ protein serine/threonine kinase; Encodes a plasma membrane [...] (592 aa) | • | • | 0.424 | ||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 484 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 4e-50
Identities = 84/283 (29%), Positives = 130/283 (45%), Gaps = 36/283 (12%)
Query: 153 LCEENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRH 206
L +GEG +G VY+G L +VAVK L + Q +EF E ++ ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
N+V+LLG C E M+V EY+ G+L +L + L+ ++ L A+G+
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGM 116
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
YL +HRD+ + N L+ ++SDFGL++ L + Y ++AP
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSEE 381
E G KSDV+SFG+L+ EI T G P G N ++++LK G R
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEYLKK--GYRL--- 223
Query: 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
PK P P + + L+C D RP ++ +L
Sbjct: 224 ---PKPPNCP-----PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 5e-50
Identities = 71/194 (36%), Positives = 111/194 (57%), Gaps = 11/194 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEGG+G VY G KVA+K + + +E E+E++ ++ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ + LV EY + G+L L + G L+ D + I+L +GL YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 277 HRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTGMLNE 334
HRD+K NILLD +++DFGL+KLL S++S + T V GT Y+APE G +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 335 KSDVYSFGILIMEI 348
KSD++S G+++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 37/283 (13%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRH 206
L +GEG +G VY+G L +VAVK L + Q +EF E ++ ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
N+V+LLG C E +V EY++ G+L +L + L+ ++ L A+G+
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGM 115
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
YL +HRD+ + N L+ ++SDFGL++ L + Y ++AP
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSEE 381
E G KSDV+SFG+L+ EI T G P G N ++++LK G R
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEYLKN--GYRL--- 222
Query: 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
P+ P P + + L+C D RP ++ +L
Sbjct: 223 ---PQPPNCP-----PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 84/289 (29%), Positives = 124/289 (42%), Gaps = 47/289 (16%)
Query: 157 NVIGEGGYGIVYRGILSDG----TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVR 211
+GEG +G VY+G L T+VAVK L + + K+F E V+ ++ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDVSPLTWDIRMNIILGTAKGLAY 266
LLG C E LV EY++ G+L +L + S L+ ++ + AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-------RVMGTF 319
L K VHRD+ + N L+ ++SDFGL++ + + Y R M
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
APE G+ KSDV+SFG+L+ EI T G P Y +
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YP-------------GLSNEEV 216
Query: 379 SEEVVDPKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E + P L ++ L C D RP ++ LE
Sbjct: 217 LEYLRKGYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-47
Identities = 84/264 (31%), Positives = 125/264 (47%), Gaps = 26/264 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLL 213
+G G +G VY+ G VAVK +L R + K+ + E+ ++ R+ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVK-ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + LV EY + G+L +L PL+ D I L +GL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YACTGML 332
++HRD+K NILLD +++DFGLAK L S +TT V GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL-VDWLKTMVGSRKSEEVVDPKLPKMP 391
K DV+S G+++ E++TG+ P GE L L + E
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP-----FSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 392 ASKALKRVLLVALRCVDPDATKRP 415
+K L +C++ D +KRP
Sbjct: 232 EAKDL------IKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 9e-47
Identities = 86/278 (30%), Positives = 128/278 (46%), Gaps = 36/278 (12%)
Query: 158 VIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+GEG +G VY+G L TKVAVK L + E+ EF E ++ ++ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LLG C +G +V EY+ G+L +L LT + + L AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK- 121
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG---YVAPEYAC 328
VHRD+ + N L+ ++SDFGL++ + + Y G ++APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177
Query: 329 TGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
G KSDV+SFG+L+ EI T G P Y E +++ L+ G R L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNE-EVLELLED--GYR---------L 223
Query: 388 PKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
P+ L ++ L+C D RP ++ L
Sbjct: 224 PRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 24/261 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG +G VY G VA+K + + + E++++ +++H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ LV EY + G+L L G +S + R + L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSE--DEAR-FYLRQILSALEYLHS---KG 117
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
+VHRD+K NILLD + +++DFGLA+ L TT V GT Y+APE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLGKGYGK 175
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
D++S G+++ E++TG+ P G+ L++ K + + P+ S
Sbjct: 176 AVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIG-----KPKPPFPPPEWDISP 225
Query: 395 ALKRVLLVALRCVDPDATKRP 415
K ++ + + D KR
Sbjct: 226 EAKDLI---RKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 82/284 (28%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
++G G +G VY + D G +AVK L + + + + E+ ++ ++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 214 GYCVEGAYRML-VY-EYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHE 269
G + L ++ EYV G+L L G + IR IL +GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV--IRKYTRQIL---EGLAYLHS 119
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYAC 328
+VHRD+K +NIL+D +++DFG AK L E T V GT ++APE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+D++S G ++E+ TG+ P E+ +GS P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIGSSGE-------PP 223
Query: 389 KMPA--SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430
++P S+ K L +C+ D KRP AD+LL
Sbjct: 224 EIPEHLSEEAKDFL---RKCLRRDPKKRPT---------ADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 88/272 (32%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V G G KVAVK L ++ A+ F E V+ +RH NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
G +V EY+ G+L +L V +T ++ L +G+ YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D+ + N+L+ A+VSDFGLAK + G + APE + KS
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKS 180
Query: 337 DVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA-S 393
DV+SFGIL+ EI + GR P Y R P +V E K +M A
Sbjct: 181 DVWSFGILLWEIYSFGRVP--YPRIPLKDV-----------VPHVE-----KGYRMEAPE 222
Query: 394 KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
V V C + D KRP + L
Sbjct: 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 25/274 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRH-KNLVRLL 213
+GEG +G VY D VA+K L L ++ + + F E++++ + H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + LV EYVD G+L+ L +G PL+ + I+ L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSK--- 120
Query: 274 KVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERS-----YVTTRVMGTFGYVAPEYA 327
++HRD+K NILLDR ++ DFGLAKLL S + + +GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 328 ---CTGMLNEKSDVYSFGILIMEIITGRNPVD-YSRPQGEVNLVDWLKTMVGSRKSEEVV 383
+ SD++S GI + E++TG P + + + + + +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL- 239
Query: 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
SKA +L + + D R
Sbjct: 240 -SPSNPELISKAASDLL---KKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 4e-32
Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 25/263 (9%)
Query: 157 NVIGEGGYGIVYRG-ILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
IG+G +G VY SDG +K + L+N + E+E + EV+++ ++ H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
E +V EY D G+L Q + + P + ++ + L YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM-L 332
K++HRD+K NI L ++ DFG++K+L S T V GT Y++PE C
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQNKPY 180
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
N KSD++S G ++ E+ T ++P + L LK + G P +P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLE---LA--LKILKGQY-------PPIPSQY- 227
Query: 393 SKALKRVLLVALRCVDPDATKRP 415
S L+ ++ + D +RP
Sbjct: 228 SSELRNLV---SSLLQKDPEERP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 35/265 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+GG+G VY+ G +VA+K + + +++ E++++ + +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ +V E+ G+L L LT + KGL YLH ++
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQ---TLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN--- 333
HRD+K++NILL ++ DFGL+ L ++ ++GT ++APE ++N
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPE-----VINGKP 173
Query: 334 --EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP-KM 390
K+D++S GI +E+ G+ P P +K + + P L
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPP---------MKALFKIATNGP---PGLRNPE 221
Query: 391 PASKALKRVLLVALRCVDPDATKRP 415
S K L +C+ + KRP
Sbjct: 222 KWSDEFKDFL---KKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 79/266 (29%), Positives = 136/266 (51%), Gaps = 35/266 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
++IG G +G+VY+G+ L G VA+K +L + +A K E++++ ++H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGD--VSPLTWDIRMNIILGTAKGLAYLHE 269
G ++ EY +NG+L Q + G + V+ + + +L +GLAYLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVL---QGLAYLHE 117
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
V+HRD+K++NIL + +++DFG+A L + V+GT ++APE
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEM 173
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
+ SD++S G ++E++TG NP P ++N + L +V P LP+
Sbjct: 174 SGASTASDIWSLGCTVIELLTG-NP-----PYYDLNPMAALFRIVQDD------HPPLPE 221
Query: 390 MPASKALKRVLLVALRCVDPDATKRP 415
S LK L ++C D RP
Sbjct: 222 G-ISPELKDFL---MQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 77/262 (29%), Positives = 135/262 (51%), Gaps = 25/262 (9%)
Query: 157 NVIGEGGYGIVYRGIL-SDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
N IG+G +G+V++ + +D A+K + L+ + E+E + E V+ ++ ++R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++ +V EY +NG+L + L G PL D + GLA+LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK--- 120
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
K++HRD+KS N+ LD N ++ D G+AKLL ++ T ++GT Y++PE N
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKPYN 179
Query: 334 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 393
EKSDV++ G+++ E TG++P D + L+ LK + G V P + + S
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFD---ANNQGALI--LKIIRG-------VFPPVSQ-MYS 226
Query: 394 KALKRVLLVALRCVDPDATKRP 415
+ L +++ +C+ D +RP
Sbjct: 227 QQLAQLI---DQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 66/198 (33%), Positives = 113/198 (57%), Gaps = 12/198 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G G +G V+ G+ + +VA+K L ++ +++F+ EV+ + R+RHK+L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C G ++ E ++ G+L +L G V V+ L +++ A+G+AYL E
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLE---E 122
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+HRD+ + NIL+ +V+DFGLA+L+ E Y+++ + + APE A G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 333 NEKSDVYSFGILIMEIIT 350
+ KSDV+SFGIL+ E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 89/277 (32%), Positives = 130/277 (46%), Gaps = 39/277 (14%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G V+ G + TKVAVK L G E F E +++ ++RH LV+L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
E +V EY+ G+L +L G L + M + A+G+AYL +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMAYLES---RNYIH 126
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEK 335
RD+ + NIL+ +++DFGLA+L+ E T R F + APE A G K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 336 SDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-----KLPK 389
SDV+SFGIL+ EI+T GR P Y G N EV++ ++P+
Sbjct: 185 SDVWSFGILLTEIVTYGRVP--YP---GMTN--------------REVLEQVERGYRMPR 225
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P L+ L+C D D +RP ++ LE
Sbjct: 226 PPNCPEELYDLM--LQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-29
Identities = 83/289 (28%), Positives = 145/289 (50%), Gaps = 34/289 (11%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKVEVE 199
E S + ++ VIG G +G V+RGIL + VA+K L G EK+ F E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++G+ H N++RL G + M++ EY++NG LD++L G+ S + ++ G
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRG 115
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVMG 317
A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T+
Sbjct: 116 IAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377
+ APE SDV+SFGI++ E+++ RP +++ + +K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFG-----ERPYWDMSNHEVMKAINDGF 227
Query: 378 KSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+LP M A+ +++ L+C D +RP+ ++++L+
Sbjct: 228 --------RLPAPMDCPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 29/288 (10%)
Query: 146 LEAATSGLCEENVIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV 204
+ S L EENVI G G Y+G + +G + VK + + E +G++
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKL 740
Query: 205 RHKNLVRLLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
+H N+V+L+G C +GAY L++EY++ NL + L L+W+ R I +G AK
Sbjct: 741 QHPNIVKLIGLCRSEKGAY--LIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAK 791
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L +LH P VV ++ I++D + + L LLC++ T+ + YV
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYV 845
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN--LVDWLKTMVGSRKSE 380
APE T + EKSD+Y FG++++E++TG++P D + V+ +V+W + +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLD 902
Query: 381 EVVDPKLPKMPAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+DP + + + V+ +AL C D T RP V+ LE+
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 78/270 (28%), Positives = 133/270 (49%), Gaps = 37/270 (13%)
Query: 158 VIGEGGYGIVYRGI---LSDGTK--VAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+G+ + K VA+K L +A KE E V+ V H ++VR
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + L+ + + G L ++ ++G L W +++ AKG++YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYA 327
E ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
+ KSDV+S+G+ + E++T G +P + V+ + ++ K E +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGA------KPYEGIPAVE-IPDLL--EKGE-----R 229
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPK 416
LP+ P V +V ++C DA RP
Sbjct: 230 LPQPPICTI--DVYMVLVKCWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 74/273 (27%), Positives = 120/273 (43%), Gaps = 41/273 (15%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
IGEG G VY+ + G +VA+K + R Q ++ E+ ++ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW-DIRMN------IILGTAKGL 264
+ G +V EY+D G+L D+ +T +RMN + +GL
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLT--------DI--ITQNFVRMNEPQIAYVCREVLQGL 129
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
YLH V+HRD+KS NILL + + +++DFG A L E+S + V GT ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 325 EYACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383
E K D++S GI+ +E+ G P + P L+ + +
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-P---------LRALF------LIT 229
Query: 384 DPKLPKMPASKALKRVLLVAL-RCVDPDATKRP 415
+P + + L +C+ D KRP
Sbjct: 230 TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 68/268 (25%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 158 VIGEGGYGIVYRGILS-DGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG- 214
V+G+G G+VY+ G A+K + ++ + K+ E++ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI---ILGTAKGLAYLHEGL 271
+ EG +V EY+D G+L L VG + + I IL KGL YLH
Sbjct: 68 FYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPE---PVLAYIARQIL---KGLDYLHTKR 119
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS----ERSYVTTRVMGTFGYVAPEYA 327
++HRD+K SN+L++ + +++DFG++K+L + ++V GT Y++PE
Sbjct: 120 --HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERI 172
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
+ +D++S G+ ++E G+ P + P G+ + + ++ + P L
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFP--FL-PPGQPSFFELMQAICDGPP------PSL 223
Query: 388 PKMPASKALKRVLLVALRCVDPDATKRP 415
P S + + C+ D KRP
Sbjct: 224 PAEEFSPEFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 63/207 (30%), Positives = 110/207 (53%), Gaps = 9/207 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E +V+ ++ H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+ LV+E++++G L +L G S T + + L +G+AYL V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETL---LGMCLDVCEGMAYLESS---NVIHR 124
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + ++ +T + +PE + KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 339 YSFGILIMEIIT-GRNPVDYSRPQGEV 364
+SFG+L+ E+ + G+ P + +R EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 70/213 (32%), Positives = 110/213 (51%), Gaps = 27/213 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKN 208
E VIG G +G V RG L K VA+K L G ++K+ F E ++G+ H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RL G + M++ EY++NG+LD++L + G + + ++ G A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYLS 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG------YV 322
E VHRD+ + NIL++ +VSDFGL++ L + TT+ G +
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWT 175
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
APE SDV+SFGI++ E+++ G P
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 67/199 (33%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G+ ++ T VAVK L + +F E +++ ++RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V E + G+L ++L G G L I M + A G+AYL +HR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLEA---QNYIHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D+ + N+L+ +V+DFGLA+++ E Y R F + APE A + KS
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI-KEDIY-EAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ EI+T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 82/279 (29%), Positives = 129/279 (46%), Gaps = 31/279 (11%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR 203
E E E V+G+G YGIVY LS ++A+K + + + E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK- 262
++H+N+V+ LG E + + E V G+L L G PL D II T +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG---PLK-DNEQTIIFYTKQI 117
Query: 263 --GLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTF 319
GL YLH+ ++VHRD+K N+L++ ++SDFG +K L T GT
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTL 173
Query: 320 GYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGS 376
Y+APE G +D++S G I+E+ TG+ P ++ PQ + V K
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---- 229
Query: 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
P++P+ +++A + LRC +PD KR
Sbjct: 230 -------HPEIPESLSAEAKNFI----LRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 28/210 (13%)
Query: 157 NVIGEGGYGIVYRG---ILSDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
+GEG +G V L D T +VAVK+L ++ Q +F+ E+E++ + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWL--HGDVGDVSPL---TWDIRMNIILGTAKG 263
+ G C + R L+ EY+ +G+L +L H D ++ L + I KG
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI--------CKG 121
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFG 320
+ YL + +HRD+ + NIL++ + ++SDFGLAK+L ++ Y + G F
Sbjct: 122 MDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
Y APE T + SDV+SFG+ + E+ T
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 30/272 (11%)
Query: 157 NVIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRL 212
+G G G+V + G +AVK + E K E++++ + +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 213 LGYC-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G G + + EY+D G+LD+ L +V P I I + KGL YLHE
Sbjct: 65 YGAFYNNGDISICM-EYMDGGSLDKILK-EVQGRIPE--RILGKIAVAVLKGLTYLHEKH 120
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
K++HRDVK SNIL++ + ++ DFG++ L + S T V GT Y+APE
Sbjct: 121 --KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFV-GTSSYMAPERIQGND 175
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
+ KSD++S G+ ++E+ TGR P + + L+ +V +E P+LP
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYP-PENDPPDGIFELLQYIV----NEP--PPRLPSGK 228
Query: 392 ASKALKRVLLVALRCVDPDATKRPK----MGH 419
S V L C+ D +RP + H
Sbjct: 229 FSPDF--QDFVNL-CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 159 IGEGGYGIVYRGIL------SDGTKVAVKNLL-NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+GEG +G VY+G L T VA+K L N + ++EF+ E E++ ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV-------SPLTWDIRMNIILG 259
LLG C + +++EY+ +G+L ++L H DVG S L ++I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT- 318
A G+ YL VHRD+ + N L+ ++SDFGL++ + S Y RV
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKS 186
Query: 319 ---FGYVAPEYACTGMLNEKSDVYSFGILIMEI 348
++ PE G +SD++SFG+++ EI
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 45/218 (20%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IGEG YG VY+ G VA+K + R + EKE F + E++++ ++RH N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 213 LGYCVE---GAYRMLVYEYVD---NGNLDQWLHGDVGDVSPLTWD-IR--MNIILGTAKG 263
G+ M V+EY+D G LD +V T I+ M +L +G
Sbjct: 64 KEIVTSKGKGSIYM-VFEYMDHDLTGLLD---SPEV----KFTESQIKCYMKQLL---EG 112
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
L YLH ++HRD+K SNIL++ +++DFGLA+ S T + T Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 324 PE-------YACTGMLNEKSDVYSFGILIMEIITGRNP 354
PE Y + D++S G ++ E+ G+
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 83/282 (29%), Positives = 130/282 (46%), Gaps = 36/282 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKN 208
E VIG G +G V RG L K VA+K L G EK +F E ++G+ H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ L G + M++ E+++NG LD +L + G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLS 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMG---TFGYVAP 324
E VHRD+ + NIL++ +VSDFGL++ L + S T T +G + AP
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383
E SDV+S+GI++ E+++ G P Q +N ++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------- 226
Query: 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
D +LP L+ L C D RPK G ++ L+
Sbjct: 227 DYRLPPPMDCPTALHQLM--LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 159 IGEGGYGIVYRGI--LSDGT--KVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V +G+ + G +VAVK L A +KEF E V+ ++ H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C MLV E G L ++L ++ A G+AYL
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACT 329
VHRD+ + N+LL + A++SDFG+++ L + Y G + + APE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 330 GMLNEKSDVYSFGILIMEIIT 350
G + KSDV+S+G+ + E +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
N IG G +G VY + L G +AVK + +N + KE E++V+ ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G V + EY G L++ L G + + L +GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH--- 118
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV---MGTFGYVAPEYACTG 330
+VHRD+K +NI LD ++ DFG A L + + + V GT Y+APE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 331 MLNEK---SDVYSFGILIMEIITGRNP 354
+D++S G +++E+ TG+ P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 9e-24
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLL---NNRGQAEKEFKV---EVEVIGRVRHKNLV 210
V+G+G YG VY G+ + G +AVK + +N AEKE++ EV+++ ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ LG C++ + E+V G++ L+ P+ I+ G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL----DGVAYLHNN 121
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-----SERSYVTTRVMGTFGYVAPE 325
VVHRD+K +N++L ++ DFG A+ L S + + GT ++APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNP 354
KSD++S G + E+ TG+ P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 76/268 (28%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
IG+G +G V + SDG + K + N + EK+ V EV ++ ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 214 GYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
++ + + L V EY + G+L Q + + + + I+ L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 272 EPK--VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+P V+HRD+K +NI LD N ++ DFGLAK+L + S+ T V GT Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
+EKSD++S G LI E+ P +R Q ++ ++ + K +
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLA--------------SKIKEGKFRR 229
Query: 390 MPA--SKALKRVLLVALRCVDPDATKRP 415
+P S L V+ ++ D KRP
Sbjct: 230 IPYRYSSELNEVI---KSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-23
Identities = 71/203 (34%), Positives = 113/203 (55%), Gaps = 20/203 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G V+ G + TKVA+K+L +G E F E ++ +++H LVRL Y V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 218 ---EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E Y ++ EY++NG+L +L G LT + +++ A+G+A++
Sbjct: 70 VTQEPIY--IITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KN 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGML 332
+HRD++++NIL+ +++DFGLA+L+ E + T R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 333 NEKSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+ EI+T GR P
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 51/231 (22%)
Query: 158 VIGEGGYGIVYRGIL-SDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRV-RHKNLVRL 212
+IGEG + V + A+K L + + K K+E EV+ R+ H +++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 213 LGYCV----EGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKGLAYL 267
Y E Y V EY NG L Q++ G + T I+L L YL
Sbjct: 68 --YYTFQDEENLY--FVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLA----LEYL 118
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM----------- 316
H ++HRD+K NILLD+ + +++DFG AK+L S + +
Sbjct: 119 HS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 317 --------GTFGYVAPEYACTGMLNEK-----SDVYSFGILIMEIITGRNP 354
GT YV+PE +LNEK SD+++ G +I +++TG+ P
Sbjct: 176 RRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 50/291 (17%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G+ T+VA+K + N E+ EF E V+ ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHG------DVGDVSPLTWDIRMNIILGTAKGLA 265
LLG G ++V E + G+L +L + + P T + + A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGYVA 323
YL K VHRD+ + N ++ ++ DFG+ + + E Y + + ++A
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
PE G+ KSDV+SFG+++ E+ T P Y QG N EEV
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQP--Y---QGLSN--------------EEV 230
Query: 383 VD-------PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+ LP+ K L+ + C + RP ++ L+
Sbjct: 231 LKFVIDGGHLDLPENCPDKLLE----LMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-23
Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 18/200 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+IGEG +G V +G + G KVAVKN+ + QA F E V+ ++ HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 217 V-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ G Y +V E + GNL +L + + ++ + L A+G+ YL K+
Sbjct: 69 LHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLES---KKL 121
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
VHRD+ + NIL+ A+VSDFGLA++ +++ + APE + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKL--PVKWTAPEALKHKKFSSK 177
Query: 336 SDVYSFGILIMEIIT-GRNP 354
SDV+S+G+L+ E+ + GR P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 12/199 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHR 126
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +V+DFGLA+L+ E + T R F + APE A G KS
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 337 DVYSFGILIMEIIT-GRNP 354
DV+SFGIL+ E+ T GR P
Sbjct: 185 DVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 37/281 (13%)
Query: 151 SGLCEENVIGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQ-AEKEFKVEVEVIGR 203
S L E +G G +G V+ +GI +G + V VK L + + + EF+ E+++ +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-----PLTWDIRMNIIL 258
+ HKN+VRLLG C E ++ EY D G+L Q+L PL+ ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A G+ +L + VHRD+ + N L+ Q +VS L+K + + Y +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
++APE + KSDV+SFG+L+ E+ T QGE+
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGELPF--------YGLS 223
Query: 379 SEEVVDP----KLPKMPASKALKRVLLVALRCVDPDATKRP 415
EEV++ KL R+ + RC + RP
Sbjct: 224 DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 86/281 (30%), Positives = 137/281 (48%), Gaps = 36/281 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKN 208
E VIG G +G V G L K VA+K L G EK+ F E ++G+ H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ L G + M+V EY++NG+LD +L G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLS 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVMGTFGYVAPEY 326
+ VHRD+ + NIL++ +VSDFGL+++L E +Y T + APE
Sbjct: 124 ---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDY-SRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
SDV+S+GI++ E+++ Y RP E++ D +K + EE
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAI------EE--GY 226
Query: 386 KLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+LP M AL +++ L C D +RPK ++ +L+
Sbjct: 227 RLPAPMDCPAALHQLM---LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 33/275 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
IG+G +G VY+G+L T+VAVK + K F E E++ + H N+V+L+G CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
+ +V E V G+L +L LT + + L A G+ Y LE K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEY----LESKNCI 115
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPEYACTGML 332
HRD+ + N L+ ++SDFG+++ E + T G + APE G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
+SDV+S+GIL+ E + G+ ++++ E ++ +MPA
Sbjct: 173 TSESDVWSYGILLWETFSL----------GDTPYPGM-----SNQQTRERIESGY-RMPA 216
Query: 393 SKAL-KRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+ + + + L+C D RP + + L+
Sbjct: 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 22/216 (10%)
Query: 158 VIGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
+GEG +G V+ G D VAVK L A K+F+ E E++ +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HG--------DVGDVSPLTWDIRMNIILGT 260
+ G C EG ++V+EY+++G+L+++L HG + LT + I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTF 319
A G+ YL VHRD+ + N L+ ++ DFG+++ + + Y V M
Sbjct: 132 ASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE +SDV+SFG+++ EI T G+ P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 48/297 (16%)
Query: 158 VIGEGGYGIVYRGI------LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLV 210
+GEG +G V + + T VAVK L N +E ++ E ++ +V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------------HGDVGDVSPLTW 250
+L G C + +L+ EY G+L +L + D D LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
++ ++G+ YL E K+VHRD+ + N+L+ ++SDFGL++ + E SY
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 311 VT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVD 368
V ++ ++A E + +SDV+SFG+L+ EI+T G NP P+ L +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLFN 240
Query: 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
LKT + E S+ + ++ L C + KRP + LE
Sbjct: 241 LLKTGYRMERPEN----------CSEEMYNLM---LTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 31/221 (14%)
Query: 157 NVIGEGGYGIVYRG----ILSDGT---KVAVKNLLNNRG---QAEKEFKVEVEVIGRVRH 206
N +G G +G VY G IL G+ +VAVK L +G Q +KEF E ++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKG 263
N+V+LLG C+ + ++ E ++ G+L +L + LT ++I L AKG
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
YL + +HRD+ + N L+ D ++ DFGLA+ + Y R G
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172
Query: 319 ----FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE G +SDV+SFG+L+ EI+T G+ P
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 157 NVIGEGGYGIVY----RGILSDGTK--VAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNL 209
+G G +G VY RG D + VAVK L + Q E +F +E ++ + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAY 266
VRL+G E R ++ E + G+L +L + S LT + AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAKLLCSERSY-VTTRVMGTFGYV 322
L E +HRD+ + N LL + RV +DFG+A+ + Y R M ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
PE G+ K+DV+SFG+L+ EI + G P
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 9e-22
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG-Y 215
+GEG YG VY+ I G VA+K + + +E E+ ++ + +V+ G Y
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHE 269
+V EY G+ V D+ +T + + I+ T KGL YLH
Sbjct: 68 FKNTDL-WIVMEYCGAGS--------VSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
K +HRD+K+ NILL+ + A+++DFG++ L + T V+GT ++APE
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQE 173
Query: 330 GMLNEKSDVYSFGILIMEIITGRNP 354
N K+D++S GI +E+ G+ P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---------FKVEVEVIGRVRHK 207
+IG G +G VY G+ S G +AVK + A + E+ ++ ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+ LG ++ + + EYV G++ L+ L +R N + KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-----LLCSERSYVTTRVMGTFGYV 322
H ++HRD+K +NIL+D + ++SDFG++K L ++ + + G+ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE K+D++S G L++E++TG++P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 71/211 (33%), Positives = 107/211 (50%), Gaps = 12/211 (5%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH 206
E L +G G +G V+ G + TKVAVK L E F E +++ ++RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
LV+L E +V EY+ G+L +L G+ L +++ A G+AY
Sbjct: 61 DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAY 117
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAP 324
+ +HRD++S+NIL+ +++DFGLA+L+ E + T R F + AP
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
E A G KSDV+SFGIL+ E++T GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVRLL 213
+GEG YG+VY+ G VA+K + + E+ E+ ++ ++H N+V+LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+EY D +L ++L G +SP I+ +I+ +GLAY H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL--IK-SIMYQLLRGLAYCHSH--- 117
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTGML 332
+++HRD+K NIL++R +++DFGLA+ R+Y T V+ T Y APE +L
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEI----LL 171
Query: 333 NEKS-----DVYSFGILIMEIITGR 352
K D++S G + E+ITG+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAE-KEFKV-EVEVIGRVRHKNLVRLLG 214
V+GEG YG+V + G VA+K + + K+ + EV+V+ ++RH+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+EYV+ L + L G + P +R I + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDA--VRS-YIWQLLQAIAYCHSH---N 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPE-YACTGML 332
++HRD+K NIL+ ++ DFG A+ L S +T V T Y APE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNY 179
Query: 333 NEKSDVYSFGILIMEIITGR 352
+ DV++ G ++ E++ G
Sbjct: 180 GKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 43/281 (15%)
Query: 159 IGEGGYGIVYRG----ILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G+V RG VAVK L +++ +F E ++ + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT--WDIRMNIILGTAKGLAYLHEGL 271
G V M+V E G+L L D ++ D + I A G+ YL
Sbjct: 63 G-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES-- 115
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERSYVTT---RVMGTFGYVAPEYA 327
+ +HRD+ + NILL ++ DFGL + L +E YV +V F + APE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE--EVVD 384
T + SDV+ FG+ + E+ T G P W G S+ + +D
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP--------------W----AGLSGSQILKKID 214
Query: 385 PKLPKMPASKAL-KRVLLVALRCVDPDATKRPKMGHVIHML 424
+ ++ +A + + V L+C + RP + L
Sbjct: 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAE---KEFKVEVEVIGRVRHKNLVRL 212
+G G +G VY G+ L DG AVK +L ++ + K+ + E+ ++ +++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
LG E + E V G+L + L + GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-ACTGM 331
VHRD+K +NIL+D +++DFG+AK + G+ ++APE A G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGG 178
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+D++S G ++E+ TG+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
+G+G YG VY+ LSD A+K + L + Q E+E V E+ ++ V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++G +V EY G+L + + + I + +GL LHE K+
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+KS+NILL ++ D G++K+L + +GT Y+APE + K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVWKGRPYSYK 181
Query: 336 SDVYSFGILIMEIITGRNP 354
SD++S G L+ E+ T P
Sbjct: 182 SDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 81/296 (27%), Positives = 126/296 (42%), Gaps = 59/296 (19%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRH-KNL 209
L + IG G +G V + + GT +AVK + + +K ++++V+ R +
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 210 VRLLG---------YCVE------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM 254
V+ G C+E + VYE V + + +I
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPE--------------EILG 110
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
I + T K L YL E L K++HRDVK SNILLDR N ++ DFG++ L S TR
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTR 166
Query: 315 VMGTFGYVAPEYACTGMLNE---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371
G Y+APE + +SDV+S GI + E+ TG+ P ++ D L
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----KWNSVFDQLT 221
Query: 372 TMVGSRKSEEVVDPKLPKMPASKALKR----VLLVALRCVDPDATKRPKMGHVIHM 423
+VV P + S+ + V + L C+ D +KRPK ++
Sbjct: 222 ---------QVVKGDPPILSNSEEREFSPSFVNFINL-CLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 39/279 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRH---KNLVRL 212
+IG G YG VYRG + G VA+K + L+ + + EV ++ ++R N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G ++G ++ EY + G++ + P+ II L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-- 120
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-M 331
V+HRD+K++NIL+ N ++ DFG+A LL S +T V GT ++APE G
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
+ K+D++S GI I E+ TG P YS VD + M+ KS+ P+L
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP--YSD-------VDAFRAMMLIPKSKP---PRLEDNG 226
Query: 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430
SK L+ VA C+D + +R L A++LL
Sbjct: 227 YSKLLRE--FVAA-CLDEEPKER---------LSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 78/214 (36%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 216 CVE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
VE G Y +V EY+ G+L +L V L D + L + + YL
Sbjct: 68 IVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VHRD+ + N+L+ A+VSDFGL K S + V T APE
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEV 364
+ KSDV+SFGIL+ EI + GR P Y R P +V
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE--KEFKVEVEVIGRVRHKNL 209
+ E + +GEG G V + L + + + + K+ E+E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 210 VRLLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIILGTAKGLAY 266
V+ G ++ + + EY + G+LD ++ V + + I KGL+Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
LH K++HRD+K SNILL R+ ++ DFG++ L + S T GT Y+APE
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFT-GTSFYMAPER 174
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPV--DYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384
+ SDV+S G+ ++E+ R P + P G + L+ ++ M + E+ D
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKD 230
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPK 416
+ S+ K + +C++ D T+RP
Sbjct: 231 EPGNGIKWSEEFKDFI---KQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 9e-21
Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 32/271 (11%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLL---NNRGQAEK---EFKVEVEVIGRVRHKNL 209
+G G + Y R + + GT +AVK + N + E+ + E+ ++ R+ H ++
Sbjct: 7 QLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+R+LG E ++ L E++ G++ L + +N +GL+YLHE
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 270 GLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVAPE 325
+++HRDVK +N+L+D R++DFG A L ++ + +++GT ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
DV+S G +I+E+ T + P + + + L+ + + + E + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPK 416
L V LRC++ RP
Sbjct: 239 GLRD------------VTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 9e-21
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDV---------SPLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG + LT + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFG 320
G+ YL L VHRD+ + N L+ + ++ DFG+++ + S Y V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE +SD++SFG+++ EI T G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V+ G VA+K ++ +E +F E +V+ ++ H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA----KGLAYLHEGLEPK 274
+V EY+ NG L +L G + +L + + YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESN---G 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
+HRD+ + N L+ +VSDFGLA+ + ++ + + PE +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 335 KSDVYSFGILIMEIIT-GRNPVD 356
KSDV+SFG+L+ E+ + G+ P +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G YG VY+ ++ G VA+K + G + + E+ ++ RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ +V EY G+L G PL+ + T KGLAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHE---TGK 122
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA---CTGML 332
+HRD+K +NILL + +++DFG++ L + + + + GT ++APE A G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
+ K D+++ GI +E+ + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++ +G G YG VY G+ VAVK L + +EF E V+ ++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
C ++ E++ GNL +L + + + + + + + YL +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---N 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGML 332
+HRD+ + N L+ +V+DFGL++L+ + +Y T F + APE
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTY-TAHAGAKFPIKWTAPESLAYNKF 182
Query: 333 NEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV++FG+L+ EI T G +P
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 76/221 (34%), Positives = 106/221 (47%), Gaps = 40/221 (18%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGY 215
VIGEG YG VY+ G VA+K +++ E+E K E ++ + H N+ Y
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATF--Y 69
Query: 216 CVEGAYRMLVYEYVDNGNLDQ-WL------HGDVGDV--------SPLTWDIRMNIILGT 260
GA+ + GN DQ WL G V D+ L + I+ T
Sbjct: 70 ---GAF----IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS--DFGLAKLLCSERSYVTTRVMGT 318
+GLAYLHE KV+HRD+K NILL + NA V DFG++ L S T + GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTK--NAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176
Query: 319 FGYVAPEY-ACTGMLNE----KSDVYSFGILIMEIITGRNP 354
++APE AC + +SDV+S GI +E+ G+ P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G ++ TKVAVK L + F E ++ ++H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ EY+ G+L +L D G + P D I A+G+AY+ +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAYIER---KNYI 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNE 334
HRD++++N+L+ +++DFGLA+++ E + T R F + APE G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 335 KSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+ EI+T G+ P
Sbjct: 184 KSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 85/271 (31%), Positives = 136/271 (50%), Gaps = 37/271 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKV----AVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+GI + +G V A+K L G +A EF E ++ + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + LV + + +G L ++H ++G L W +++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYA 327
E ++VHRD+ + N+L+ + +++DFGLA+LL E+ Y ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
+SDV+S+G+ I E++T G P D P E+ D L+ K E +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIP--DLLE------KGE-----R 229
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKM 417
LP+ P V +V ++C DA RPK
Sbjct: 230 LPQPPICTI--DVYMVMVKCWMIDADSRPKF 258
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 70/270 (25%), Positives = 128/270 (47%), Gaps = 23/270 (8%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
E IG+G + +VY+ I L DG VA+K + + + + K E++++ ++ H N++
Sbjct: 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVI 65
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ L +E +V E D G+L + + + + L ++H
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS- 124
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+++HRD+K +N+ + ++ D GL + S+ + + V GT Y++PE
Sbjct: 125 --KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
N KSD++S G L+ E+ ++P ++NL K K E+ P LP
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCK------KIEKCDYPPLPAD 231
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHV 420
S+ L+ LV+ RC++PD KRP + +V
Sbjct: 232 HYSEELRD--LVS-RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 7e-20
Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 37/269 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTK----VAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
++G G +G V++GI + +G VA+K + + G Q +E + +G + H +VR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYLH 268
LLG C GA LV + G+L + + P L W +++ AKG+ YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-SERSYVTTRVMGTFGYVAPEYA 327
E ++VHR++ + NILL +++DFG+A LL ++ Y + ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
G +SDV+S+G+ + E+++ G P RP +L++ K E + P+
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---------KGERLAQPQ 234
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRP 415
+ + V +V ++C D RP
Sbjct: 235 ICTID-------VYMVMVKCWMIDENVRP 256
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-20
Identities = 68/273 (24%), Positives = 128/273 (46%), Gaps = 31/273 (11%)
Query: 158 VIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRL 212
V+G+G +G +YR D + V K + N +EKE + E+ ++ ++H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ ++ ++ EY + G L + G + + + ++Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY--LFQIVSAVSYIHKA-- 120
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM- 331
++HRD+K+ NI L + ++ DFG++K+L SE S T V+GT Y++PE C G+
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPEL-CQGVK 177
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
N KSD+++ G ++ E++T + D + P +NLV +K + G+
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNP---LNLV--VKIVQGNYTPV--------VSV 224
Query: 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
S L ++ + D KRP V+
Sbjct: 225 YSSELISLV---HSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 8e-20
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 159 IGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F E E++ ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---------SPLTWDIRMNIILGTAKG 263
G CVEG ++V+EY+ +G+L+++L D + LT ++I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYV 322
+ YL VHRD+ + N L+ ++ DFG+++ + S Y V M ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
PE +SDV+S G+++ EI T G+ P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVR 211
IG+G +G VY+ I VA+K + + +AE E + E++ + + R + +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G ++G+ ++ EY G+ D+ L I+ GL YLHE
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSC-----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+HRD+K++NILL + + +++DFG++ L S S T V GT ++APE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+EK+D++S GI +E+ G P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 159 IGEGGYGIVY--RGILSDGT---KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V R + KV K + R + E E ++ R+ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKLH 59
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK--------GL 264
Y + ++ LV EY G L + H A+ L
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGEL--FSH----------LSKEGRFSEERARFYAAEIVLAL 106
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
YLH +++RD+K NILLD + +++DFGLAK L SE S T GT Y+AP
Sbjct: 107 EYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAP 162
Query: 325 EYACTGMLNEK-----SDVYSFGILIMEIITGRNPVDYSRPQGEV 364
E +L K D +S G+L+ E++TG+ P Y+ + E+
Sbjct: 163 E-----VLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 81/277 (29%), Positives = 128/277 (46%), Gaps = 45/277 (16%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
VIG G +VY I L + KVA+K + L + E + EV+ + + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 215 YCVEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLE 272
V G LV Y+ G+ LD I ++ KGL YLH G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD--EAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-----CSERSYVTTRVMGTFGYVAPE-- 325
+HRD+K+ NILL + +++DFG++ L + + T +GT ++APE
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT--FVGTPCWMAPEVM 178
Query: 326 -----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR-PQGEVNLVDWLKTMVGSRKS 379
Y + K+D++SFGI +E+ TG P YS+ P +V + T+ S
Sbjct: 179 EQVHGY------DFKADIWSFGITAIELATGAAP--YSKYPPMKV----LMLTLQNDPPS 226
Query: 380 -EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
E D K SK+ ++ +++L C+ D +KRP
Sbjct: 227 LETGADYK----KYSKSFRK--MISL-CLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 82/271 (30%), Positives = 130/271 (47%), Gaps = 30/271 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + TKVA+K L E F E +++ ++RH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V E++ G+L +L GD L +++ A G+AY+ +HR
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGMLNEKS 336
D++++NIL+ +++DFGLA+L+ E + T R F + APE A G KS
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 337 DVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 395
DV+SFGIL+ E++T GR P G VN R+ E V+ + +MP +
Sbjct: 185 DVWSFGILLTELVTKGRVPY-----PGMVN-----------REVLEQVE-RGYRMPCPQG 227
Query: 396 LKRVLLVALR-CVDPDATKRPKMGHVIHMLE 425
L ++ C D +RP ++ LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 26/216 (12%)
Query: 159 IGEGGYGIVYRGILS--DGTK-VAVKNLLN--NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V +G+ K VAVK L N N + E E V+ ++ + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C E MLV E + G L+++L H +++ L + M G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 362
+ KSDV+SFG+L+ E + G+ P Y +G
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 18/204 (8%)
Query: 158 VIGEGGYG--IVYRGILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+GEG +G ++ + + SD K A+K + L A ++ + E ++ +++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP----LTWDIRMNIILGTAKGLAYLHEG 270
+ +V EY D G+L Q + G + P L W ++M + G+ ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE- 118
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+V+HRD+KS NI L + ++ DFG A+LL S +Y T V GT YV PE
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
N KSD++S G ++ E+ T ++P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G G +G V+ + TKVAVK + E F E V+ ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 69
Query: 216 CV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E Y ++ E++ G+L +L D G PL I + + A+G+A++ +
Sbjct: 70 VTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQ---RN 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYACTGML 332
+HRD++++NIL+ +++DFGLA+++ E + T R F + APE G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 333 NEKSDVYSFGILIMEIIT-GRNP 354
KSDV+SFGIL+MEI+T GR P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL-GYC 216
+G+G +G VY+ G A K + + ++F VE++++ +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E +L+ E+ D G LD + + LT + + L +LH KV+
Sbjct: 73 YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-ACTGM---- 331
HRD+K+ NILL + +++DFG++ S T + GT ++APE AC
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+ K+D++S GI ++E+ P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 5e-19
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 26/216 (12%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLG 214
+G G +G V +G+ K VA+K L N ++ + E E E++ ++ + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRMNIILGTAKGLAYLHE 269
C E MLV E G L+++L G V +V L + M G+ YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM--------GMKYLEG 113
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD+ + N+LL Q A++SDFGL+K L ++ SY R G + + APE
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 362
+ +SDV+S+GI + E + G+ P Y + +G
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP--YKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 23/194 (11%)
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
E++D G+LD P+ +I I + +GL YL+ +++HRD+K SNIL
Sbjct: 83 EFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNIL 136
Query: 287 LDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIM 346
++ + ++ DFG++ L + S T V GT Y++PE G KSDV+S GI I+
Sbjct: 137 VNSRGQIKLCDFGVSGELIN--SIADTFV-GTSTYMSPERIQGGKYTVKSDVWSLGISII 193
Query: 347 EIITGRNPVDYSR-----PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 401
E+ G+ P +S + ++D L +++V P++P+S + +
Sbjct: 194 ELALGKFPFAFSNIDDDGQDDPMGILDLL---------QQIVQEPPPRLPSSDFPEDLRD 244
Query: 402 VALRCVDPDATKRP 415
C+ D T+RP
Sbjct: 245 FVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 8e-19
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 8/197 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V+ G KVA+K + N +E++F E +V+ ++ H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V E+++NG L +L G +S D+ +++ +G+ YL +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDV 338
D+ + N L+ +VSDFG+ + + + ++ + PE + KSDV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 339 YSFGILIMEIIT-GRNP 354
+SFG+L+ E+ T G+ P
Sbjct: 185 WSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVRLL 213
IGEG YG+VY+ G VA+K + + E++++ + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+E++D +L + + L + + + +GLA+ H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GML 332
++HRD+K N+L++ + +++DFGLA+ S T V+ T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 333 NEKSDVYSFGILIMEIITGR 352
+ D++S G + E+++ R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 48/277 (17%)
Query: 173 SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR--MLVYEYVD 230
+ G VAVK L ++ + ++F+ E+E++ ++H N+V+ G C R LV EY+
Sbjct: 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 231 NGNLDQWL--HGDVGDVSPL---TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285
G+L +L H + D L I KG+ YL + VHRD+ + NI
Sbjct: 91 YGSLRDYLQKHRERLDHRKLLLYASQI--------CKGMEYLGS---KRYVHRDLATRNI 139
Query: 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEYACTGMLNEKSDVYSFG 342
L++ + ++ DFGL K+L ++ Y R G F Y APE + SDV+SFG
Sbjct: 140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFG 198
Query: 343 ILIMEIITGRN-----PVDYSRPQGE--------VNLVDWLKTMVGSRKSEEVVDPKLPK 389
+++ E+ T + P ++ R G +L++ LK R LP
Sbjct: 199 VVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--NGR---------LPA 247
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P A + + C + D ++RP + +EA
Sbjct: 248 PPGCPA--EIYAIMKECWNNDPSQRPSFSELALQVEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 158 VIGEGGYGIVYRG-----ILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
+G G +G V SD KVAVK L +E+E E++++ + H+N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V LLG C G +++ EY G+L +L + D+ ++ AKG+A+L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDL-LSFSYQVAKGMAFLAS 159
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVAPEY 326
+HRD+ + N+LL ++ DFGLA+ + ++ +YV R+ ++APE
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ +SDV+S+GIL+ EI + G NP P V+ + G R ++ P
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPY----PGMPVDSKFYKLIKEGYRMAQPEHAP 270
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ + C D D KRP ++ ++
Sbjct: 271 -----------AEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 41/224 (18%)
Query: 159 IGEGGYGIVYR----GILS--DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
IG+G +G V++ G+L T VAVK L + +F+ E ++ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDV------GDVSPLTWDIR 253
LLG C G L++EY+ G+L+++L H + PL+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-------CS 306
+ I A G+AYL E K VHRD+ + N L+ +++DFGL++ + S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
E + R M PE +SDV+++G+++ EI +
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 159 IGEGGYGIVYRG------ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F+ E E++ ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGD----VGDVSP------LTWDIRMNIILGT 260
G C +G ++V+EY+ +G+L+++L HG + D P L ++I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTF 319
A G+ YL VHRD+ + N L+ ++ DFG+++ + S Y V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE +SDV+SFG+++ EI T G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 64/226 (28%), Positives = 112/226 (49%), Gaps = 25/226 (11%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLN-NRGQAEKEFKVEV 198
EL + EE +GE +G +Y+G L VA+K L + N Q EF+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDVSPLTWDIR 253
++ + H N+V LLG + +++EY++ G+L ++L H DVG S ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 254 --------MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
++I + A G+ YL VH+D+ + NIL+ Q + ++SD GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 306 SERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
S Y V + + ++ PE G + SD++SFG+++ EI +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 65/276 (23%), Positives = 125/276 (45%), Gaps = 43/276 (15%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLG 214
V+G G +GIV+ K+ + + + E + E +V+ + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKGLAYLHEGLE 272
+E M+V EY G L +++ + + I+L L ++H L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA----LHHVHTKL- 121
Query: 273 PKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
++HRD+K+ NILLD+ ++ DFG++K+L S+ T V+GT Y++PE
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKP 177
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM------VGSRKSEEVVDP 385
N+KSD+++ G ++ E+ + + + + V LK M + R S ++
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALV-----LKIMSGTFAPISDRYSPDL--- 229
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
R L++++ +DP KRP++ ++
Sbjct: 230 ------------RQLILSMLNLDPS--KRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 156 ENVIGEGGYGIVYRGILS-DGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
E+VIGEG +G V R ++ DG K+ A+K L + + ++F E+EV+ ++ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNIIL 258
LLG C Y + EY GNL +L + G S LT +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A G+ YL E + +HRD+ + N+L+ ++++DFGL++ E YV + MG
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMGR 179
Query: 319 FG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++A E + KSDV+SFG+L+ EI++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLG 214
N IG G G VY+ I G A+K + N ++ E+E++ V H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
++ E++D G+L+ D ++ + I G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI--------LSGIAYLHR---RH 188
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
+VHRD+K SN+L++ N +++DFG++++L + V GT Y++PE T LN
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTD-LNH 246
Query: 335 ------KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
D++S G+ I+E GR P R QG DW M S P
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QG-----DWASLMCAICMS----QPPEA 296
Query: 389 KMPASKALKRVLLVALRCVDPDATKRP 415
AS+ + + C+ + KR
Sbjct: 297 PATASREFRHFI---SCCLQREPAKRW 320
|
Length = 353 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 158 VIGEGGYGIVYRGILS--DGT--KVAVKNL-LNNRGQAE-KEFKVEVEVIGRVRHKNLVR 211
++GEG +G V G LS DG+ KVAVK + L+ +E +EF E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 212 LLGYCVEGAYR------MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM--NIILGTAKG 263
L+G C E + M++ ++ +G+L +L P ++ ++ A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-FGYV 322
+ YL +HRD+ + N +L V+DFGL+K + S Y R+ ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
A E + KSDV++FG+ + EI T G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 40/273 (14%)
Query: 157 NVIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
VIG+G +G VY G L SDG K+ AVK+L + + + E+ F E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 211 RLLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 60 SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSETHN--PTVKDL-IGFGLQVAKGMEYL- 114
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPE 325
K VHRD+ + N +LD + +V+DFGLA+ + + Y G ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---SEEV 382
T KSDV+SFG+L+ E++T P P +V+ D ++ R+ E
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRLLQPEYC 227
Query: 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
DP M L C P RP
Sbjct: 228 PDPLYEVM-------------LSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 81/275 (29%), Positives = 136/275 (49%), Gaps = 37/275 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTK----VAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+G+ + +G K VA+K L +A KE E V+ V + ++ R
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYA 327
E ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
+ +SDV+S+G+ + E++T G P D P E++ + K E +
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE-----R 229
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
LP+ P V ++ ++C DA RPK +I
Sbjct: 230 LPQPPICTI--DVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 58/281 (20%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRH-KNLVRLL 213
+G G YG+V + + GT +AVK + +N++ Q K +++++ R V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ--KRLLMDLDISMRSVDCPYTVTFY 66
Query: 214 GYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVS-----PLTWDIRMNI---ILG----- 259
G EG D W+ +V D S +D + I ILG
Sbjct: 67 GALFREG---------------DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS 111
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
K L YLH L V+HRDVK SN+L++R ++ DFG++ L S T G
Sbjct: 112 IVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCK 167
Query: 320 GYVAPEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375
Y+APE + + KSDV+S GI ++E+ TGR P D W KT
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SW-KTPFQ 215
Query: 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK 416
K +VV+ P++PA K +C+ + +RP
Sbjct: 216 QLK--QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG +GIV++ G VA+K + R G + E++ + +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKGLAYLHEGLEPK 274
G+ +LV EY+ + L + D PL + + KG+AY+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
++HRD+K +N+L+ +++DFGLA+L E + + + T Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEKEFK---VEVEVIGRV-RHKN 208
+GEG +G V + + VAVK L ++ EK+ E+E++ + +HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 77
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---------VGDVSP---LTWDIRMNI 256
++ LLG C + +V EY +GNL +L P LT ++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ +L K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFG+L+ EI T
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 64/260 (24%), Positives = 120/260 (46%), Gaps = 26/260 (10%)
Query: 178 VAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + A +F E++++ R+++ N++RLLG CV ++ EY++NG+L+Q
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 237 WLH--------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+L ++ ++ + + + A G+ YL VHRD+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 289 RQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIME 347
+ +++DFG+++ L S Y + R + ++A E G SDV++FG+ + E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 348 IITGRNPVDYSRPQGEV---NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVAL 404
+ T YS E N ++ + + ++ + P P+ V + +
Sbjct: 224 MFTLCKEQPYSLLSDEQVIENTGEFFRN-----QGRQIYLSQTPLCPSP-----VFKLMM 273
Query: 405 RCVDPDATKRPKMGHVIHML 424
RC D RP + H L
Sbjct: 274 RCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 84/296 (28%), Positives = 137/296 (46%), Gaps = 47/296 (15%)
Query: 158 VIGEGGYGIVYRGI-LSDGTK----VAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+GI + DG VA+K L N +A KE E V+ V + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + LV + + G L ++ +G L W +++ AKG++YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYA 327
E ++VHRD+ + N+L+ + +++DFGLA+LL E Y ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
+SDV+S+G+ + E++T G P D P E+ D L+ G R
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIP--DLLEK--GER--------- 229
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPS 442
LP+ P V ++ ++C D+ RP+ ++ R+ R+PS
Sbjct: 230 LPQPPICT--IDVYMIMVKCWMIDSECRPRFRELVDEFS----------RMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE----------FKVEVEVIGRVRH 206
+IG+G YG VY + ++ G +AVK + A + + E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
N+V+ LG+ Y + EYV G++ L +G + +GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGL 121
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY---VTTRVMGTFGY 321
AYLH ++HRD+K+ N+L+D ++SDFG++K S+ Y + G+ +
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSVFW 176
Query: 322 VAPEYACTGM--LNEKSDVYSFGILIMEIITGRNP 354
+APE + + K D++S G +++E+ GR P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY I ++ G +VA+K + N + Q +KE + E+ V+ +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS NILL + +++DFG + E+S +T V GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 337 DVYSFGILIMEIITGRNP 354
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 43/290 (14%)
Query: 158 VIGEGGYG--IVYR-GILSDGTK--VAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVR 211
V+GEG +G +Y +DGT VAVK L GQ +K E+ ++ + H+N+V+
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 212 LLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C E + L+ EYV G+L +L +++ L + +G+AYLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHS 125
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYVAPEY 326
+HRD+ + N+LLD ++ DFGLAK + Y R G F Y A E
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP-----------QGEVNLVDWLKTMVG 375
+ SDV+SFG+ + E++T + P QG++ +V ++ +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS--KQSPPKKFEEMIGPKQGQMTVVRLIELL-- 237
Query: 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ + PK + V ++ C + +A RP +I +L+
Sbjct: 238 -ERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 55/182 (30%), Positives = 94/182 (51%), Gaps = 12/182 (6%)
Query: 178 VAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + A ++F EV+++ R+ N+ RLLG C ++ EY++NG+L+Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 237 WLH-------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
+L G + L++ + + A G+ YL VHRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165
Query: 290 QWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEI 348
+ +++DFG+++ L S Y V R ++A E G KSDV++FG+ + EI
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 349 IT 350
+T
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 14/216 (6%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE-FKVEVE 199
EL+ + + E ++G G +G + RG L +K VA+ L ++ F E
Sbjct: 1 ELDNKSIKI--ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
+G+ H N+VRL G G M+V EY+ NG LD +L G + M ++ G
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPG 115
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
A G+ YL E VH+ + + +L++ ++S F + SE Y T
Sbjct: 116 LASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ APE + SDV+SFGI++ E+++ G P
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNL-LNNRGQAEKEF-KVEVEVIGRVRHKNLVRLLG 214
IGEG +G +Y SD +K + L EKE K EV ++ +++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVG----DVSPLTWDIRMNIILGTAKGLAYLHEG 270
E +V EY D G+L + ++ G + L+W +++++ GL ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD- 119
Query: 271 LEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
K++HRD+KS NI L + A++ DFG+A+ L T +GT Y++PE
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQN 176
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVD 356
N K+D++S G ++ E+ T ++P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 27/220 (12%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVS--PLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI T G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 43/219 (19%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G YG+V + G KVA+K + N + A++ + E++++ +RH+N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64
Query: 213 L-------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
L Y +V E ++ +L + + PLT D + +GL
Sbjct: 65 LDILRPPSPEDFNDVY--IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLK 117
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTRVMGT 318
YLH V+HRD+K SNIL++ + ++ DFGLA+ + + YV TR
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW--- 171
Query: 319 FGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
Y APE +L+ D++S G + E++T +
Sbjct: 172 --YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-17
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ ++ H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ NG L +L P + + +G+AYL + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLES---KQFIHR 124
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEYACTGMLNEK 335
D+ + N L+D Q +VSDFGL++ + + Y ++ +G+ + PE + K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS--VGSKFPVRWSPPEVLLYSKFSSK 181
Query: 336 SDVYSFGILIMEIIT-GRNPVD 356
SDV++FG+L+ E+ + G+ P +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 26/214 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDVSP-----------LTWDIRMNIIL 258
LLG C Y L EY +GNL +L V + P L+ ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ + YV + MG
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGR 184
Query: 319 FG--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++A E + SDV+S+G+L+ EI++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLVR 211
+VIGEG +G V + + DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNIILG 259
LLG C Y L EY +GNL +L S L+ ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ + YV + MG
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRL 173
Query: 320 G--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++A E + SDV+S+G+L+ EI++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 9e-17
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 50/224 (22%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--------EVEVIGRV-RHKN 208
+G+G +G VY G VA+K + +K+F EV+ + ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V+L E V+EY++ GNL Q + G P + + +II +GLA++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH 116
Query: 269 E-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER---SYVTTRVMGTFGYVAP 324
+ G HRD+K N+L+ +++DFGLA+ + S YV+TR Y AP
Sbjct: 117 KHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAP 167
Query: 325 EYACTGML------NEKSDVYSFGILIMEIIT------GRNPVD 356
E +L + D+++ G ++ E+ T G + +D
Sbjct: 168 E-----ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 50/182 (27%), Positives = 97/182 (53%), Gaps = 12/182 (6%)
Query: 178 VAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + + A +F E++++ R++ N++RLL C+ ++ EY++NG+L+Q
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 237 WL-------HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
+L + DV +++ + + A G+ YL VHRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 290 QWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEI 348
+ +++DFG+++ L S Y + R + +++ E G SDV++FG+ + EI
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 349 IT 350
+T
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG GIV S G +VAVK + + R Q +E EV ++ +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V E+++ G L D+ + + + + L K L++LH V+
Sbjct: 86 LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYACTGMLN 333
HRD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 334 EKSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 159 IGEGGYGIVYRGIL----SDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IGEG +G + IL DG + +K N+ + +E + EV V+ ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
E +V +Y + G+L + ++ G D ++ + L ++H+
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD--- 119
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
K++HRD+KS NI L + ++ DFG+A++L S T +GT Y++PE
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPY 178
Query: 333 NEKSDVYSFGILIMEIIT 350
N KSD+++ G ++ E+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 1e-16
Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G V+ I ++ G +VA+K + N + Q +KE + E+ V+ +++ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + + R + + L +LH +V+
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS N+LL + +++DFG + E+S +T V GT ++APE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 337 DVYSFGILIMEIITGRNP 354
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 68/274 (24%), Positives = 128/274 (46%), Gaps = 25/274 (9%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
E IG G + VYR L DG VA+K +L++ +A + E++++ ++ H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNV 64
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++ +E +V E D G+L + + + + L ++H
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+V+HRD+K +N+ + ++ D GL + S ++ ++GT Y++PE
Sbjct: 125 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHE 180
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
N KSD++S G L+ E+ ++P Y ++NL K K E+ P LP
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCK------KIEQCDYPPLPS 230
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423
S+ L++++ + C++PD KRP + +V +
Sbjct: 231 DHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVR---HK 207
E IGEG YG VY+ L+ G VA+K + L+ G + E+ ++ ++ H
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHP 61
Query: 208 NLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGT 260
N+VRLL C LV+E+VD +L +L G + P I+ +++
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPP--ETIK-DLMRQL 116
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320
+G+ +LH ++VHRD+K NIL+ +++DFGLA++ E + T V+ T
Sbjct: 117 LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLW 171
Query: 321 YVAPE------YACTGMLNEKSDVYSFGILIMEI 348
Y APE YA D++S G + E+
Sbjct: 172 YRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY I ++ G +VA+K + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS NILL + +++DFG + E+S +T V GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 337 DVYSFGILIMEIITGRNP 354
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 159 IGEGGYGIVYRGILSDGT---KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V G L+ KVAVK + + R + E +F E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 213 LGYCVEGAYR------MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGT--AKG 263
+G C++ +++ ++ +G+L +L + +GD P +M + T A G
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD-CPQYLPTQMLVKFMTDIASG 124
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-FGYV 322
+ YL +HRD+ + N +L+ N V+DFGL+K + + Y R+ ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
A E + KSDV+SFG+ + EI T G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH ++HRD+K NILLD Q + ++DF +A + + + T+ GT GY+
Sbjct: 112 ALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS-GTPGYM 166
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 359
APE C + D +S G+ E + G+ P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 70/250 (28%), Positives = 122/250 (48%), Gaps = 17/250 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + +V A+K + + E E + E+ V+ + + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 217 VEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++G ++ EY+ G+ LD G + T ++ KGL YLH K
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLHS---EKK 122
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+K++N+LL Q + +++DFG+A L + T V GT ++APE + K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 336 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK--TMVG--SRKSEEVVDPKLPKMP 391
+D++S GI +E+ G P P + L+ T+ G S+ +E +D L K P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241
Query: 392 ASKALKRVLL 401
+ + + LL
Sbjct: 242 SFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+KS NILL + +++DFG + E+S + ++GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
D++S GI+ +E+I G P P + L + + + E+ +P+ A+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE-----KLSAI 245
Query: 397 KRVLLVALRCVDPDATKR 414
R L RC+D D KR
Sbjct: 246 FRDFLN--RCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 19/251 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLLGY 215
IG+G +G VY+GI + TK V + + +AE E + E+ V+ + + R G
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 216 CVEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
++G ++ EY+ G+ LD G PL I+ KGL YLH +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHS---ER 121
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
+HRD+K++N+LL Q + +++DFG+A L + T V GT ++APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKSEEVVDPKLPKM 390
K+D++S GI +E+ G P P + L+ + T+ G S+ +E V+ L K
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240
Query: 391 PASKALKRVLL 401
P + + LL
Sbjct: 241 PRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
N IGEG YGIVYR + G VA+K + R E++ + E+ ++ +RH N+V
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKG 263
L V LV EY + D+ + +P + ++L +G
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQ---------DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
L YLHE ++HRD+K SN+LL + +++DFGLA+ +T +V+ T Y A
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176
Query: 324 PEYACTGMLNEKS--DVYSFGILIMEIITGR 352
PE G + D+++ G ++ E++ +
Sbjct: 177 PEL-LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV------EVEVIGRVRHKNLVR 211
IGEG YG+VY+ G VA+K + R + E E V E+ ++ + H N+VR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LL LV+E++D LD + D ++ L + + + +G+AY H
Sbjct: 63 LLDVVHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPE----- 325
+V+HRD+K N+L+DR+ +++DFGLA+ R+Y T V+ T Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGS 174
Query: 326 -YACTGMLNEKSDVYSFGILIMEIITGR 352
T + D++S G + E++ R
Sbjct: 175 RQYSTPV-----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 68/272 (25%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
E IG G + VYR L D VA+K + +A ++ E++++ ++ H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +E +V E D G+L Q + + + + ++H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-- 124
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K +N+ + ++ D GL + S+ + + V GT Y++PE
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 182
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
N KSD++S G L+ E+ ++P Y D + +K E+ P LP
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPF-YG---------DKMNLFSLCQKIEQCDYPPLPTEH 232
Query: 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423
S+ L+ LV++ C+ PD +RP +G+V +
Sbjct: 233 YSEKLRE--LVSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVK--NLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRL 212
+G+G +G VY D G ++AVK + + +KE + E++++ ++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G + + EY+ G++ L +G LT + +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN 123
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGTFGYVAPEYA 327
+VHRD+K +NIL D N ++ DFG +K L CS + + + V GT +++PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVI 179
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
K+DV+S G ++E++T + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 74/284 (26%), Positives = 134/284 (47%), Gaps = 44/284 (15%)
Query: 152 GLCEENVIGEGGYGIV----YRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVR 205
C V+G+G YG V +R +DG + +K NL N + K + E +++ +++
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 206 HKNLVRLLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSP----LTWDIRMNIILG 259
H N+V EG +L V + + G+L L G + P + W +++
Sbjct: 58 HPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI----- 111
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
A L YLHE ++HRD+K+ N+ L R +V D G+A++L ++ +T ++GT
Sbjct: 112 -AMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTP 166
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
Y++PE N KSDV++ G + E+ T ++ N D + ++V
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA---------FNAKD-MNSLV----- 211
Query: 380 EEVVDPKLPKMPASKALKRV-LLVALRCVDPDATKRPKMGHVIH 422
+++ KLP MP + + L+ + P+ KRP + ++
Sbjct: 212 YRIIEGKLPPMPKDYSPELGELIATMLSKRPE--KRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 32/279 (11%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKV-----EVEVIG-RVR 205
+G G +G VY+ + ++ V N + + E++ + EV +I ++R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H N+VR +E +V + ++ L + + T + NI + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
YLH+ E ++VHRD+ +NI+L ++DFGLAK S +T+ V+GT Y PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTS-VVGTILYSCPE 183
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
EK+DV++FG ++ ++ T P YS N++ L T ++V+
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT-LQPPFYS-----TNMLS-LAT--------KIVEA 228
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424
+P + V V C+ PDA RP + V M+
Sbjct: 229 VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--------EVEVIGRVRHKNL 209
+GEG Y +VY+ G VA+K + KE K E++++ ++H N+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGE---RKEAKDGINFTALREIKLLQELKHPNI 64
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ LL + LV+E+++ +L++ + ++P DI+ + +L T +GL YLH
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLEYLHS 120
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE--YA 327
++HRD+K +N+L+ +++DFGLA+ S +T +V+ T Y APE +
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFG 176
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNP 354
D++S G + E++ R P
Sbjct: 177 AR-HYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G VY R + ++ VA+K + + Q+ ++++ EV + ++RH N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV--SPLTWDIRMNIILGTAKGLAYLHEGL 271
G + LV EY D+ +V PL I G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSA------SDILEVHKKPLQEVEIAAICHGALQGLAYLHS-- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-- 329
+ +HRD+K+ NILL +++DFG A L+ S+V GT ++APE
Sbjct: 134 -HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187
Query: 330 -GMLNEKSDVYSFGILIMEIITGRNP 354
G + K DV+S GI +E+ + P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
++G+G +G V++G L D T VAVK + Q K +F E ++ + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E V G+ +L + L + L A G+AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-FGYVAPEYACTGMLNEK 335
HRD+ + N L+ ++SDFG+++ + Y ++ + + APE G + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 336 SDVYSFGILIMEIIT 350
SDV+S+GIL+ E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/229 (27%), Positives = 112/229 (48%), Gaps = 31/229 (13%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGT------KVAVKNLLNN-RGQAEKEFKVE 197
E+ +T EE +GE +G VY+G L VA+K L + G +EFK E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV------- 245
+ R++H N+V LLG + +++ Y + +L ++L H DVG
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
S L ++I+ A G+ +L VVH+D+ + N+L+ + N ++SD GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 306 SERSYVTTRVMGT----FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+ Y ++MG +++PE G + SD++S+G+++ E+ +
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 69/233 (29%), Positives = 105/233 (45%), Gaps = 76/233 (32%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVR-HKNLVR 211
+G+G YGIV++ I D VA+K + + N A++ F+ E+ + + H N+V+
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 212 LLGYCVEGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI----------- 256
LL V A LV+EY++ D+ V IR NI
Sbjct: 72 LLN--VIKAENDKDIYLVFEYMET---------DLHAV------IRANILEDVHKRYIMY 114
Query: 257 -ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS------ 309
+L K L Y+H G V+HRD+K SNILL+ +++DFGLA+ L
Sbjct: 115 QLL---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 310 ---YVTTRVMGTFGYVAPE-------YACTGMLNEKSDVYSFGILIMEIITGR 352
YV TR Y APE Y G+ D++S G ++ E++ G+
Sbjct: 169 LTDYVATR-----WYRAPEILLGSTRYT-KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV------------EVEVIGRVRH 206
+GEG Y VY+G +N A KE + E+ ++ ++H
Sbjct: 8 LGEGTYATVYKG----------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
+N+VRL MLV+EY+D +L +++ HG G + P T +L KG+
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGI 113
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
A+ HE +V+HRD+K N+L++++ +++DFGLA+ + + V+ T Y AP
Sbjct: 114 AFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAP 169
Query: 325 EYACTGMLNEKS-DVYSFGILIMEIITGR 352
+ S D++S G ++ E+ITGR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 159 IGEGGYGIVY------RGILSDGTKVAVKNLL-NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+GEG +G V G + G +VAVK+L + G + K E+E++ + H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 212 LLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C E L+ E++ +G+L ++L + ++ ++ + KG+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ---QLKYAVQICKGMDYLGS 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT---RVMGTFGYVAPEY 326
+ VHRD+ + N+L++ + ++ DFGL K + +++ Y T F Y APE
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT 350
SDV+SFG+ + E++T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 34/276 (12%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V+ G L +D T VAVK+ K +F E ++ + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
+ +V E V G+ +L + P +++ ++ + A E LE K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE----GP---RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT----FGYVAPEYACTGM 331
+HRD+ + N L+ + ++SDFG+++ E V G + APE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 332 LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ +SDV+SFGIL+ E + G P Y+ + ++++ E ++ +
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVP--YAN--------------LSNQQTREAIEQGVRLP 216
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
V + RC + D +RP V L++
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
I +G YG V+ S G A+K + + + Q + + E +++ + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD-QVLTERDILSQAQSPYVVKLY 59
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y +G + LV EY+ G+L L +V L D+ I L YLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN-- 112
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-------TTRVMGTFGYVAPE 325
++HRD+K NIL+D + +++DFGL+K+ R R++GT Y+APE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 326 YACTGMLNE----KSDVYSFGILIMEIITGRNP 354
+L + D +S G ++ E + G P
Sbjct: 172 V----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAE--KEFKVEVEVIGRVRHKNLVRLLG 214
++GEG YG+V + + G VA+K L + K E+ ++ ++RH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+VD+ LD G I+ +G+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL----RGIEFCHSH---N 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE----RSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K NIL+ + ++ DFG A+ L + YV TR Y APE
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLVGD 175
Query: 331 MLNEKS-DVYSFGILIMEIITGRNP 354
++ D+++ G L+ E++TG P
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG-EP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLG-- 214
IG+G YG VY+ DG+ AVK +L+ ++E + E ++ + H N+V+ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 215 ----YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
V G LV E + G++ + + G + L + I+ G GL +LH
Sbjct: 89 YKADKLV-GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-ACT 329
+++HRDVK +NILL + ++ DFG++ L S R T V GT ++APE AC
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 203
Query: 330 GM----LNEKSDVYSFGILIMEIITGRNPV 355
+ + DV+S GI +E+ G P+
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV------EVEVIGRVRHKNLVR 211
IGEG YG+V++ + G VA+K + ++E + + E+ ++ +++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 212 LLGYCVEGAYRMLVYEYVDN---GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
L+ LV+EY D+ L++ G + + II T + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+ +HRDVK NIL+ +Q ++ DFG A++L T V T Y APE
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLV 173
Query: 329 TGM-LNEKSDVYSFGILIMEIITG 351
DV++ G + E++TG
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 66/250 (26%), Positives = 120/250 (48%), Gaps = 17/250 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V++GI + KV +++ +AE E + E+ V+ + + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ ++ EY+ G+ D+ + PL I+ KGL YLH K
Sbjct: 71 YLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHS---EKK 122
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+K++N+LL +++DFG+A L ++ +GT ++APE + K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 336 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLV--DWLKTMVG--SRKSEEVVDPKLPKMP 391
+D++S GI +E+ G P P + L+ + T+ G S+ +E V+ L K P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241
Query: 392 ASKALKRVLL 401
+ + + LL
Sbjct: 242 SFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 31/212 (14%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G YGIV S+ KVA+K N +NR A++ + E++++ + H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 215 YCVEGAYRM------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ +R +VYE +D LH + L+ D + +GL Y+H
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
V+HRD+K SN+LL+ + ++ DFGLA+ + ++T V+ T Y APE
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL-- 179
Query: 329 TGMLNEKS-----DVYSFGILIMEIITGRNPV 355
+LN DV+S G + E++ GR P+
Sbjct: 180 --LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 159 IGEGGYGIVYR----GILSD----GTKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V R GI VAVK L +N + + E+E++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVS--PLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V L++ ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL + +HRD+ + N+L+ +++DFGLA+ + Y T+
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
++APE + +SDV+SFGIL+ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 159 IGEGGYGIVYRGILS--DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGY 215
IG+G YG V++ +L+ +G+K AVK +L+ ++E + E ++ + H N+V+ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 216 -----CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G LV E + G++ + G + + I I+ GL +LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-ACT 329
K +HRDVK +NILL + ++ DFG++ L S R T V GT ++APE AC
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 199
Query: 330 GML----NEKSDVYSFGILIMEIITGRNPV 355
L + + DV+S GI +E+ G P+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 65/234 (27%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
+GEG +G VY+ + G VA+K +L EK+ F + E++++ +++H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP----------------LTW-DIRMN 255
+ + E D + G V V+P LT I+
Sbjct: 73 ID---------MAVERPDK---SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK-C 119
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL----------- 304
+L +G+ YLHE ++HRD+K++NIL+D Q +++DFGLA+
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 305 -CSERSYVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
R Y T ++ T Y PE +L E+ D++ G + E+ T R
Sbjct: 177 GGGTRKY--TNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 153 LCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVR 205
+ E +G+G +G+VY +G++ D T+VA+K + E+ EF E V+
Sbjct: 10 MSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 67
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWDIRMNIILG 259
++VRLLG +G +++ E + G+L +L ++ +P + + +
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + + E Y G
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLL 183
Query: 320 G--YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+++PE G+ SDV+SFG+++ EI T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ ++G G G VY+ L +AVK + L+ + +K+ E+E++ + ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 214 G-YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G + VE + E++D G+LD ++ + + + I + KGL YL L
Sbjct: 66 GAFFVENRISICT-EFMDGGSLD--VYRKIPE------HVLGRIAVAVVKGLTYLW-SL- 114
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
K++HRDVK SN+L++ + ++ DFG++ L + S T V GT Y+APE
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--SIAKTYV-GTNAYMAPERISGEQY 170
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
SDV+S GI ME+ GR P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 39/213 (18%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G GG+G V + S A+K + GQ ++ E E++ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIILGTAKG--------- 263
+ Y ++ EY G L W I R +
Sbjct: 60 RTFKDKKYIYMLMEYCLGGEL---------------WTILRDRGLFDEYTARFYIACVVL 104
Query: 264 -LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
YLH +++RD+K N+LLD ++ DFG AK L ++++ GT Y
Sbjct: 105 AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEY 158
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
VAPE + D +S GIL+ E++TGR P
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 51/189 (26%), Positives = 96/189 (50%), Gaps = 20/189 (10%)
Query: 178 VAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + + A +F EV+++ R++ N++RLLG CV+ ++ EY++NG+L+Q
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 237 WLH---------------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK 281
+L + +++ +++ L A G+ YL VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 282 SSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYS 340
+ N L+ +++DFG+++ L + Y + R + ++A E G SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 341 FGILIMEII 349
FG+ + EI+
Sbjct: 226 FGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 75/246 (30%), Positives = 121/246 (49%), Gaps = 39/246 (15%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG G YG+V I G KVA+K + + A++ + E++++ +H N++ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIR 70
Query: 214 G-YCVEGAYRMLVYEYVD--NGNLDQWLHGDVGDVSPLTWD-IR--MNIILGTAKGLAYL 267
GA VY +D +L +H D PLT + IR + +L +GL Y+
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQLL---RGLKYI 123
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS---ERSYVTTRVMGTFGYVAP 324
H V+HRD+K SN+L++ R+ DFG+A+ L S E Y T + T Y AP
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 325 EYACTGMLNEKS---DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK---TMVGSRK 378
E + L E + D++S G + E++ GR + + N V LK +++GS
Sbjct: 181 ELLLS--LPEYTTAIDMWSVGCIFAEML-GRRQLFPGK-----NYVHQLKLILSVLGS-P 231
Query: 379 SEEVVD 384
SEEV++
Sbjct: 232 SEEVLN 237
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + + RMN + L K L+ LH
Sbjct: 88 VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLKALSVLHA-- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR---VMGTFGYVAPEYAC 328
V+HRD+KS +ILL ++SDFG C++ S R ++GT ++APE
Sbjct: 135 -QGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPELIS 189
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G VY+G+ ++ VAVK N + +E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+G E +V E G L +L + D++ L + LAYL
Sbjct: 73 IGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALAYLES- 125
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ L E Y ++ ++APE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 331 MLNEKSDVYSFGILIMEIIT-GRNP 354
SDV+ FG+ + EI+ G P
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 29/266 (10%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG-Y 215
+G+G YG VY+ + G +A+K + +++ + +E++++ + +V G +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+EGA M + EY+D G+LD+ L+ + D+ I KGL +L E E +
Sbjct: 69 FIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE- 334
+HRDVK +N+L++ ++ DFG++ L S T + G Y+APE +G N+
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGGPNQN 181
Query: 335 -----KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
+SDV+S G+ I+E+ GR P P+ N+ L +V DP P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFAQLSAIVDG-------DP--PT 229
Query: 390 MPASKALKRVLLVALRCVDPDATKRP 415
+P+ + VA C++ +RP
Sbjct: 230 LPSGYSDDAQDFVAK-CLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 41/220 (18%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IGEG YG VY+ D G VA+K + R EKE F + E++++ ++ H+N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 211 RLLGYCVE-----------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
L + GA+ LV+EY+D+ +L L + S M +L
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAF-YLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLL- 126
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTTRVMG 317
+GL Y H+ +HRD+K SNILL+ + +++DFGLA+L SE R Y T +V+
Sbjct: 127 --EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY-TNKVI- 179
Query: 318 TFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
T Y PE +L E+ DV+S G ++ E+ T +
Sbjct: 180 TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVA 323
YL+ K VHRD+ + N ++ + ++ DFG+ + + E Y G ++A
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT 350
PE G+ SD++SFG+++ EI +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRL 212
IGEG YG+VY+ G VA+K + R E E E+ ++ + H N+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII----LGTAKGLAYLH 268
L LV+E++ + +L +++ D SPL+ I + +I +GLA+ H
Sbjct: 65 LDVIHTENKLYLVFEFL-HQDLKKFM-----DASPLS-GIPLPLIKSYLFQLLQGLAFCH 117
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYA 327
+V+HRD+K N+L++ + +++DFGLA+ R+Y T + T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 172
Query: 328 C-TGMLNEKSDVYSFGILIMEIITGR 352
+ D++S G + E++T R
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 72/261 (27%), Positives = 112/261 (42%), Gaps = 32/261 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+GG+G V + K+ A K L R + E+ E +++ +V + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 215 YCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y E + LV ++ G+L + G+ G II G L +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
++V+RD+K N+LLD N R+SD GLA L + R GT GY+APE +
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRA-GTPGYMAPEVLQGEV 170
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK-- 389
+ D ++ G + E+I GR+P R + E + LK V + P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF---RQRKEKVEKEELKRRT---LEMAV---EYPDKF 221
Query: 390 MPASKALKRVLLVALRCVDPD 410
P +K L LL DP+
Sbjct: 222 SPEAKDLCEALL----QKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 27/244 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVA---VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLG 214
IG G +G V G G A VK L + E+ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW-DIRMNIILGTAKGLAYLHEGLEP 273
C+E +LV E+ G+L +L + G V+ + D+ + A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-FGYVAPEYA----- 327
+H D+ N L + ++ D+GLA E Y+T ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 328 --CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+KS+++S G+ + E+ T +P +++ LK +V + D
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLKQVVREQ------DI 228
Query: 386 KLPK 389
KLPK
Sbjct: 229 KLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ + TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L L++ ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y TT
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI T G +P
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 159 IGEGGYGIVYR----GILSD----GTKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D VAVK L ++ + + E+E++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D + LT+ ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRV 315
A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y TT
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI T G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 50/277 (18%)
Query: 159 IGEGGYGIVYRGIL---SDGTKVA----VKNLLNNRGQAEK---EFKVEVEVIGRVRHKN 208
+G+G + +Y+G+L SD V V +L G + F ++ ++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LV+L G CV M V EYV G LD +LH + +VS L W ++++ A L YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVS-LHW--KLDVAKQLASALHYLE 118
Query: 269 EGLEPKVVHRDVKSSNILLDR-------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+ K+VH +V NIL+ R ++SD G+ + S R R+ +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI----PW 170
Query: 322 VAPEYACTGM--LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
+APE G L +D +SFG ++EI + G P L T+ S K
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP---------------LSTLSSSEK 215
Query: 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
D MP L ++ +C D TKRP
Sbjct: 216 ERFYQDQHRLPMPDCAELANLI---NQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 175 GTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLGYCVEGAYRML-VYEYVD 230
G +VA+K L + + E + F+ E + R+ H N+V LL + V+EYV
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL--- 287
L + L D G + M +L LA H +VHRD+K NI++
Sbjct: 63 GRTLREVLAAD-GALPAGETGRLMLQVL---DALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 288 DRQWNARVSDFGLAKLLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 341
+ +A+V DFG+ LL R TT V+GT Y APE + SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 342 GILIMEIITGR----------------NPVDYSRPQ 361
G++ +E +TG+ +PVD S P
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 73/264 (27%), Positives = 113/264 (42%), Gaps = 42/264 (15%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G VY R + + VA+K + + Q+ ++++ EV + ++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLH 268
G + LV EY G D+ PL + G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
++HRDVK+ NILL ++ DFG A ++ +V GT ++APE
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 329 T---GMLNEKSDVYSFGILIMEIITGRNPVD--------YSRPQGEVNLVDWLKTMVGSR 377
G + K DV+S GI +E+ + P+ Y Q E L++ S
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---LQSGHWSE 241
Query: 378 KSEEVVDPKLPKMPASKALKRVLL 401
VD L K+P + VLL
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 25/202 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLG-YC 216
+G+G +G VY+ + +A ++ + + E E + VE+E++ H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 217 VEGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+G +++ E+ G +D L D G P I++ I + L YLH K+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKI 131
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTTRVMGTFGYVAPEYA-CTG 330
+HRD+K+ N+LL + +++DFG++ K L S++ GT ++APE C
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 331 M----LNEKSDVYSFGILIMEI 348
M + K+D++S GI ++E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 54/284 (19%), Positives = 118/284 (41%), Gaps = 49/284 (17%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-------EVEVIGRVRHKNLV 210
+I E +Y+GI + +V ++ + K KV E++ + R+ N++
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTF----KKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 211 RLLGY----CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
++ G+ + L+ EY G L + L + L++ ++++ + KGL
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYN 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY----- 321
L++ ++++ S + L+ + ++ GL K+L S + M F Y
Sbjct: 138 LYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLND 194
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
+ EY K D+YS G+++ EI TG+ P + + + ++ ++ +
Sbjct: 195 IFSEY------TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD-------LIINKNNSL 241
Query: 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ P +K ++ C D+ KRP + +++ L
Sbjct: 242 KLPLDCPLE-----IKCIV---EACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV G +VAVK + + Q + EV ++ H+N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIH 141
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGYVAPEYACTGMLNEK 335
RD+KS +ILL ++SDFG + E V R ++GT ++APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 336 SDVYSFGILIMEIITGRNP 354
D++S GI+++E+I G P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ IGEG YG+V G KVA+K + ++ ++ + E++++ R +H+N++ +L
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGIL 69
Query: 214 GYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ +V E ++ L+ + L+ D + +GL Y+H
Sbjct: 70 DIIRPPSFESFNDVYIVQELMETD-----LY-KLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-------SYVTTRVMGTFGY 321
V+HRD+K SN+LL+ + ++ DFGLA++ E YV TR Y
Sbjct: 124 SA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR-----WY 175
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
APE MLN K D++S G ++ E+++ R
Sbjct: 176 RAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
IGEG YG V++ VA+K + L++ + + E+ ++ ++HKN+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY D +L ++ GD+ P M +L KGLA+ H V
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHS---HNV 120
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
+HRD+K N+L+++ +++DFGLA+ R Y V T Y P+ L
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 178
Query: 335 KS-DVYSFGILIMEIITGRNPV 355
S D++S G + E+ P+
Sbjct: 179 TSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 63/272 (23%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVR 211
IG+G +G V+ R + VA+K +L EKE F + E++++ ++H+N+V
Sbjct: 20 IGQGTFGEVFKARHKKT-KQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVN 75
Query: 212 LLGYCVEGA-----YR---MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK- 262
L+ C A Y+ LV+E+ ++ D++ L + + L K
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH------------DLAGLLSNKNVKFTLSEIKK 123
Query: 263 -------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC----SERSYV 311
GL Y+H K++HRD+K++NIL+ + +++DFGLA+ S+ +
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 312 TTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV-DYSRPQGEVN 365
T RV+ T Y PE +L E+ D++ G ++ E+ T R+P+ + Q ++
Sbjct: 181 TNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLT 234
Query: 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALK 397
L+ L GS E V P + K+ K ++
Sbjct: 235 LISQL---CGSITPE--VWPGVDKLELFKKME 261
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLGY 215
IGEG GIV R S G +VAVK +++ R Q +E VI R +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHS-GRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ G ++ E++ G L D+ + L + + + L YLH V
Sbjct: 87 YLVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHS---QGV 138
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTR--VMGTFGYVAPEYACTGML 332
+HRD+KS +ILL ++SDFG C++ S V R ++GT ++APE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRTPY 194
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
+ D++S GI+++E++ G P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 6e-13
Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLVR 211
++G+G +G VY D G ++A K + + E +V E++++ ++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 212 LLGYCVEGAYRMLV--YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G + A + L EY+ G++ L LT + +G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGTFGYVAPEY 326
+ +VHRD+K +NIL D N ++ DFG +K L C + + + V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEV 180
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNP 354
K+DV+S G ++E++T + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 7e-13
Identities = 67/262 (25%), Positives = 119/262 (45%), Gaps = 27/262 (10%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
++G G YG VY+G ++A +++ G E+E K E+ ++ + H+N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 217 VEGA------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++ LV E+ G++ + G+ W I +GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLSHLHQH 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-AC- 328
KV+HRD+K N+LL ++ DFG++ L T +GT ++APE AC
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 186
Query: 329 ---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-----DWLKTMVGSRKSE 380
+ KSD++S GI +E+ G P+ P + L+ LK+ S+K +
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 246
Query: 381 EVVDPKLPK----MPASKALKR 398
++ L K P ++ L +
Sbjct: 247 SFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 9e-13
Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM-- 254
E ++ +RH LV L G + + LV EYV G L L P R
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYA 107
Query: 255 -NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++L L YLH +V+RD+K N+LLD +++DFG AK + R+Y
Sbjct: 108 AQVVLA----LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC 159
Query: 314 RVMGTFGYVAPEYACTGMLNE---KS-DVYSFGILIMEIITGRNP 354
GT Y+APE +L++ K+ D ++ GILI E++ G P
Sbjct: 160 ---GTPEYLAPEI----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 40/222 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
N I EG YG+VYR G VA+K L + EKE F + E+ ++ +++H N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIV 67
Query: 211 RL----LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTA 261
+ +G ++ Y +V EYV++ D+ + P ++L
Sbjct: 68 TVKEVVVGSNLDKIY--MVMEYVEH---------DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
G+A+LH+ ++HRD+K+SN+LL+ + ++ DFGLA+ S T V+ T Y
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 322 VAPE-YACTGMLNEKSDVYSFGILIMEIIT------GRNPVD 356
APE + D++S G + E++T G++ +D
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 50/218 (22%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE-------------VIGRVR 205
IGEG YG+VY+ ++ + N A K+ ++E E ++ ++
Sbjct: 10 IGEGTYGVVYKA----------RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
Query: 206 HKNLVRL--LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP-LTWDIRM--NIILGT 260
H N+VRL + + + Y LV+EY+D LD H D SP + R+ +
Sbjct: 60 HGNIVRLQDVVHSEKRLY--LVFEYLD---LDLKKHMDS---SPDFAKNPRLIKTYLYQI 111
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRVMGTF 319
+G+AY H +V+HRD+K N+L+DR+ NA +++DFGLA+ T V+ T
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TL 167
Query: 320 GYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
Y APE +L + D++S G + E++ +
Sbjct: 168 WYRAPEI----LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+GG+G V + + G A K L R + EK +E E++ +V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 215 YCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN-IILGTAK---GLAYLHE 269
Y E + LV ++ G+L ++ +VG+ + M +I +A+ G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIY-NVGERG-----LEMERVIHYSAQITCGILHLHS 113
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+V+RD+K N+LLD Q N R+SD GLA L ++ T+ GT GY+APE
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKE 168
Query: 330 GMLNEKSDVYSFGILIMEIITGRNP 354
+ D ++ G I E++ GR P
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLVR 211
++G+G +G VY +D G ++AVK + + E +V E++++ + H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 212 LLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G + R L E++ G++ L LT ++ +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGTFGYVAPEY 326
+ +VHRD+K +NIL D N ++ DFG +K L C + + + V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEV 180
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNP 354
K+D++S G ++E++T + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
V+G G YG VY+G ++A +++ E+E K+E+ ++ + H+N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 217 VEGA------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++ + LV E+ G++ + G+ L D I +GLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA--LKEDWIAYICREILRGLAHLHAH 140
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-ACT 329
KV+HRD+K N+LL ++ DFG++ L T +GT ++APE AC
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 196
Query: 330 ----GMLNEKSDVYSFGILIMEIITGRNPV 355
+ +SD++S GI +E+ G P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 40/129 (31%), Positives = 73/129 (56%), Gaps = 9/129 (6%)
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
E++D G+LDQ L + + +I + + +GLAYL E + +++HRDVK SNIL
Sbjct: 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136
Query: 287 LDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIM 346
++ + ++ DFG++ L + +GT Y++PE + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 347 EIITGRNPV 355
E+ GR P+
Sbjct: 194 ELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 75/273 (27%), Positives = 116/273 (42%), Gaps = 50/273 (18%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G G YG V+ R + T KV K L + + + + E V+ VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNG----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+ L Y + ++ L+ +YV G +L Q + +V + +I + L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL--------AL 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
+LH+ +V+RD+K NILLD + + ++DFGL+K SE T GT Y+AP
Sbjct: 119 EHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 325 EYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383
E + K+ D +S GILI E++TG +P T+ G R ++ V
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPF----------------TLEGERNTQSEV 219
Query: 384 -------DPKLPKMPASKALKRVLLVALRCVDP 409
DP P + LL L DP
Sbjct: 220 SRRILKCDPPFP--SFIGPEAQDLLHKLLRKDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G GIV + G VAVK L N+ A++ ++ E+ ++ V HKN++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 215 YCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLAYL 267
E LV E +D NL Q +H ++ RM+ +L G+ +L
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHE-------RMSYLLYQMLCGIKHL 139
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAP 324
H ++HRD+K SNI++ ++ DFGLA+ C+ YV TR Y AP
Sbjct: 140 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAP 191
Query: 325 EYACTGMLNEKSDVYSFGILIMEIITG 351
E E D++S G ++ E++ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 67/240 (27%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR------------GQAEKEFKV--EVEVI 201
+GEG YG V + G VA+K + G F E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------ 255
++H+N++ L+ VEG + LV + + D+ V + IR+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKV--VDRKIRLTESQVKC 123
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--------CSE 307
I+L GL LH+ +HRD+ +NI ++ + +++DFGLA+ S+
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 308 RSY------VTTRVMGTFGYVAPE---------YACTGMLNEKSDVYSFGILIMEIITGR 352
+T++V+ T Y APE +A D++S G + E++TG+
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--------DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 76/309 (24%), Positives = 130/309 (42%), Gaps = 32/309 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ + + L L + + E++V+ +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRDVK SNIL++ + ++ DFG++ L + +GT Y++PE + +S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
D++S G+ ++E+ GR P+ + E+ L+ +SE P+ P P S
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRPPGRPLSS-- 240
Query: 397 KRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEENRDFARKV 456
PD+ RP M + E D + + + PS +G E +DF K
Sbjct: 241 ----------YGPDS--RPPMA----IFELLDYIVNEPPP--KLPSGVFGAEFQDFVNKC 282
Query: 457 GDKQLGEGA 465
K E A
Sbjct: 283 LIKNPAERA 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
E RH LV L C + + V EY G+L +H DV P ++
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVV 111
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER---SYVTTR 314
LG L YLHE K+V+RD+K N+LLD + +++DFG LC E T+
Sbjct: 112 LG----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG----LCKEGMGFGDRTST 160
Query: 315 VMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
GT ++APE +L E S D + G+LI E++ G +P
Sbjct: 161 FCGTPEFLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 43/131 (32%), Positives = 71/131 (54%), Gaps = 13/131 (9%)
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
E++D G+LDQ L + +I I + +GL YL E + K++HRDVK SNIL
Sbjct: 79 EHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 287 LDRQWNARVSDFGLAKLLCSE--RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGIL 344
++ + ++ DFG++ L S+V TR Y++PE +SD++S G+
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 345 IMEIITGRNPV 355
++E+ GR P+
Sbjct: 188 LVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVR---HKN 208
IGEG YG V+ R + + G VA+K + R Q +E EV V+ + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 209 LVRLLGYC-VEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
+VRL C V R LV+E+VD +L +L V + T I+ +++ +G
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIK-DMMFQLLRG 122
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
L +LH +VVHRD+K NIL+ +++DFGLA++ + T V+ T Y A
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRA 177
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355
PE D++S G + E+ R P+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 5e-12
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G VY R + ++ VA+K + + Q+ ++++ EV+ + R++H N +
Sbjct: 33 IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLH 268
G + LV EY G D+ PL I G +GLAYLH
Sbjct: 92 GCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
++HRD+K+ NILL +++DFG A + S+V GT ++APE
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 329 T---GMLNEKSDVYSFGILIMEIITGRNPV 355
G + K DV+S GI +E+ + P+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 51/212 (24%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 157 NVIGEGGYGIVYRGILSDGT-----KVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLV 210
+++ EG +G ++ GIL D +V VK + ++ + + + E ++ + H+N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNIILGTAKGLA 265
+L C+E G ++Y Y++ GNL +L G+ + L+ +++ + A G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL------C-SERSYVTTRVMGT 318
YLH+ V+H+D+ + N ++D + +++D L++ L C + + M
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM-- 186
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
A E + SDV+SFG+L+ E++T
Sbjct: 187 ----ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 8/112 (7%)
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
P+ DI + + K L YL E + V+HRDVK SNILLD N ++ DFG++ L
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167
Query: 307 ERSYVTTRVMGTFGYVAPEY----ACTGMLNEKSDVYSFGILIMEIITGRNP 354
++ TR G Y+APE + ++DV+S GI ++E+ TG+ P
Sbjct: 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLVR 211
++G G +G VY +D G ++AVK + + E +V E++++ +RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 212 LLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G + + L EY+ G++ L LT ++ +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---LLCSERSYVTTRVMGTFGYVAPEY 326
+ +VHRD+K +NIL D N ++ DFG +K +C + + + V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEV 180
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNP 354
K+DV+S ++E++T + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVE 197
T+ EL + L + +G G YG V I G KVA+K L + A++ ++ E
Sbjct: 9 TVWELPERYTSLKQ---VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-E 64
Query: 198 VEVIGRVRHKNLVRLLGYCVEGA--------YRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
+ ++ ++H+N++ LL Y ++ Y D L +G PL+
Sbjct: 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-------LQKIMG--HPLS 115
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
D ++ GL Y+H ++HRD+K N+ ++ ++ DFGLA+ +E +
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172
Query: 310 -YVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGR 352
YV TR Y APE M N+ D++S G ++ E++TG+
Sbjct: 173 GYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 70/284 (24%), Positives = 128/284 (45%), Gaps = 53/284 (18%)
Query: 159 IGEGGYGIVYRGI---LSDG-----TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G + +++GI + D T+V +K L + + F ++ ++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G CV G ++V EYV G+LD +L + ++ ++W L AK LA+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAKQLAWALHF 115
Query: 271 LEPK-VVHRDVKSSNILLDRQWNA--------RVSDFGLAKLLCSERSYVTTRVMGTFGY 321
LE K + H +V + N+LL R+ + ++SD G++ + + + R+ +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-KEILLERI----PW 170
Query: 322 VAPEYAC---TGMLNEKSDVYSFGILIMEIITGRN-PVDYSRPQGEVNLVDWLKTMVGSR 377
V PE C L+ +D +SFG + EI +G + P+ Q +
Sbjct: 171 VPPE--CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---------------K 213
Query: 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
K + D ++PA K + L+ +C+D + RP +I
Sbjct: 214 KLQFYEDRH--QLPAPKWTELANLIN-QCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY+ L G AVK + G + E+ ++ +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ EY G+L H PL+ + T +GLAYLH + +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 278 RDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTTRVMGTFGYVAPEYAC---TG 330
RD+K +NILL + +++DFG+A + +S++ GT ++APE A G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPEVAAVEKNG 184
Query: 331 MLNEKSDVYSFGILIMEIITGRNPV 355
N+ D+++ GI +E+ + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 158 VIGEGGYGIVY----RGILSDGT----KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G G YG V+ G G KV K + + + + + E +V+ VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNG----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+ L Y + ++ L+ +YV+ G +L Q H +V +I + L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVL--------AL 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
+LH+ +++RD+K NILLD + + ++DFGL+K +E GT Y+AP
Sbjct: 119 DHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 325 EYACTGML--NEKSDVYSFGILIMEIITGRNP 354
E G ++ D +S G+L E++TG +P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 84 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 139
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y APE
Sbjct: 140 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 331 M-LNEKSDVYSFGILIMEIITGR 352
M N+ D++S G ++ E++TGR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 53/201 (26%), Positives = 102/201 (50%), Gaps = 23/201 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLL-GYC 216
+G+G +G VY+ + +A +++ + + E E + VE++++ H N+V+LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E +L+ E+ G +D + + PLT + T + L YLHE K++
Sbjct: 73 YENNLWILI-EFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
HRD+K+ NIL + +++DFG++ + + S++ GT ++APE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETS 180
Query: 333 NE-----KSDVYSFGILIMEI 348
+ K+DV+S GI ++E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ + EV ++ R+ H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKGLA 265
+ C LV+E+VD Q L + V P L + +++ +GL
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+LH +VHRD+K NIL+ +++DFGLA++ + + T V+ T Y APE
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPE 177
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPV 355
D++S G + E+ R P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
IG G +G VY S + VAVK + + Q ++++ EV+ + +++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLHE 269
++ LV EY G D+ PL I G +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
++HRD+K+ NILL +++DFG A S+V GT ++APE
Sbjct: 140 H---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILA 191
Query: 330 ---GMLNEKSDVYSFGILIMEIITGRNPV 355
G + K DV+S GI +E+ + P+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 12/154 (7%)
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ +L Y LV EY++ G+ + + L D I G+ L
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASL----IKTLGGLPEDWAKQYIAEVVLGVEDL 113
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H+ ++HRD+K N+L+D+ + +++DFGL S + +GT Y+APE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGL-----SRNGLENKKFVGTPDYLAPETI 165
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361
++ SD +S G +I E + G P P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 28/204 (13%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G+V R L+ G VA+K ++ A++ ++ E++++ +RH+N++ L
Sbjct: 18 VGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75
Query: 214 GYCV---EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ E Y V E + +L + L PL + +GL Y+H
Sbjct: 76 DIFISPLEDIY--FVTELLGT-DLHRLL-----TSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACT 329
VVHRD+K SNIL++ + ++ DFGLA++ + + YV+TR Y APE T
Sbjct: 128 ---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLT 179
Query: 330 GM-LNEKSDVYSFGILIMEIITGR 352
+ + D++S G + E++ G+
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 52/219 (23%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRL 212
IGEG YG+VY+G G VA+K + R ++E+E E+ ++ ++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ + L++E++ +D + D + + +YL++ L+
Sbjct: 65 QDVLMQESRLYLIFEFLS---MDLKKYLD---------SLPKGQYMDAELVKSYLYQILQ 112
Query: 273 P-------KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-----VTTRVMGTFG 320
+V+HRD+K N+L+D + +++DFGLA R++ V T + T
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVVTLW 166
Query: 321 YVAPE-------YACTGMLNEKSDVYSFGILIMEIITGR 352
Y APE Y+ D++S G + E+ T +
Sbjct: 167 YRAPEVLLGSPRYST------PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 57/170 (33%), Positives = 88/170 (51%), Gaps = 15/170 (8%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGD 244
R + E+ E V+ V H ++RL + E R L + EYV G L +L + G
Sbjct: 41 RLKQEQHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGR 97
Query: 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
S T + I+ L YLH E +V+RD+K NILLD++ + +++DFG AK L
Sbjct: 98 FSNSTGLFYASEIVC---ALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+R++ + GT Y+APE + N+ D ++ GILI E++ G P
Sbjct: 152 -RDRTWT---LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 79/320 (24%), Positives = 137/320 (42%), Gaps = 53/320 (16%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+ VIG+G YG+V I G KVA+K ++ + A + + E++++ +RH ++V
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + + R YV ++ LH + LT + + + L Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA- 122
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-------RSYVTTRVMGTFGYVAP 324
V HRD+K NIL + ++ DFGLA++ ++ YV TR Y AP
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-----WYRAP 175
Query: 325 EYACTGMLNEKS---DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
E C ++ + D++S G + E++TG+ P+ + V+ +D + ++G+ E
Sbjct: 176 EL-CGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGK--NVVHQLDLITDLLGTPSPET 231
Query: 382 V--------------VDPKLP-----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422
+ + K P K P + L LL L DP RP +
Sbjct: 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPK--DRPTAEEALA 289
Query: 423 MLEADDLLFRDERRIGREPS 442
D F+ ++ REPS
Sbjct: 290 -----DPYFKGLAKVEREPS 304
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 31/158 (19%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTTRVM-GTF 319
GL +LHE +++RD+K N+LLD + + +++DFG +C E VTT GT
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFG----MCKEGILGGVTTSTFCGTP 160
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
Y+APE D ++ G+L+ E++ G++P + E L S
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELFQ-------SILE 210
Query: 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
+EV P+ A LK L TK P+
Sbjct: 211 DEVRYPRWLSKEAKSILKSFL-----------TKNPEK 237
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
+G+GG+G V + + G A K L R + K ++ VE ++ +V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 215 YCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEG 270
Y + + LV ++ G+L ++ +V + +P + R TA+ GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRA--CFYTAQIISGLEHLHQR 116
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++++RD+K N+LLD N R+SD GLA L +S T GT G++APE
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGE 172
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363
+ D ++ G+ + E+I R P R +GE
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPF---RARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 159 IGEGGYGIVYRGILSDG---TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G +G V G ++ G +V VK L + Q + +F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLH----GDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
C E +LV E+ G+L +L ++ P T RM + A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLHLHKN 119
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYA-- 327
+H D+ N LL ++ D+GL+ E YVT ++ ++APE
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 328 CTGML-----NEKSDVYSFGILIMEI 348
G L ++S+V+S G+ I E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 27/234 (11%)
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
+E ++ V H +++R+ V GA +V + + +L +L PL D +
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR---PLPIDQALI 161
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I +GL YLH +++HRDVK+ NI ++ + D G A+ +++ +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT---------GRNPVDYSRPQGEVNL 366
GT APE N K+D++S GI++ E++ P +Y + +L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK-SCHSHL 275
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420
+ + T+ +V + P+ P S+ L R + T+ P V
Sbjct: 276 LKIISTL-------KVHPEEFPRDPGSR-LVRGFIEYASLERQPYTRYPCFQRV 321
|
Length = 357 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 13/213 (6%)
Query: 159 IGEGGYGIVYRG--ILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+GEG Y V++G L++ VA+K + L + A EV ++ ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY+D +L Q++ D G++ + ++++ + +GLAY H KV
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMD-DCGNIMSMH-NVKI-FLYQILRGLAYCHR---RKV 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-TGMLNE 334
+HRD+K N+L++ + +++DFGLA+ + V+ T Y P+ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
+ D++ G + E+ +GR S + E++L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 158 VIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V++ G KV K + + K E ++ V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAK------ 262
V L+ G L+ EY+ G L L R I + TA
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLE-------------REGIFMEDTACFYLSEI 109
Query: 263 --GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320
L +LH+ +++RD+K NILLD Q + +++DFGL K E + VT GT
Sbjct: 110 SLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIE 165
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
Y+APE + D +S G L+ +++TG P
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IG G YG VY+ ++ G A+K + G+ + E+ ++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ E+ G+L H PL+ + T +GL YLH + +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 278 RDVKSSNILLDRQWNARVSDFG----LAKLLCSERSYVTTRVMGTFGYVAPEYACT---G 330
RD+K +NILL + +++DFG + + +S++ GT ++APE A G
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMAPEVAAVERKG 184
Query: 331 MLNEKSDVYSFGILIMEIITGRNPV 355
N+ D+++ GI +E+ + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFG 320
GL +LH +V+RD+K NILLD + +++DFG+ K +L + T GT
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPD 161
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
Y+APE N D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 32/92 (34%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
GL +LH+ +++RD+K N+LLD+ + +++DFG+ K + +T GT Y+
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYI 163
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE NE D +SFG+L+ E++ G++P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 159 IGEGGYGIVYRG--ILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+GEG Y VY+G L+D VA+K + L + A EV ++ ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY+D +L Q+L D G+ + ++++ + +GL Y H KV
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLD-DCGNSINMH-NVKL-FLFQLLRGLNYCHR---RKV 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM-LNE 334
+HRD+K N+L++ + +++DFGLA+ + V+ T Y P+ +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 335 KSDVYSFGILIMEIITGR 352
+ D++ G + E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
GL ++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNP 354
APE G+ + S D +S G ++ +++ G +P
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 7/89 (7%)
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
YLH +++RD+K N+LLD + + +V+DFG AK + +R++ + GT Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPE 185
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ + D ++ G+L+ E I G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 39/212 (18%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V + G KVA+K L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 215 YCVEGAYRMLVYEYVDNGNLDQW---------LHGDVGDV---SPLTWDIRMNIILGTAK 262
+ + +LD++ + D+G + L+ D ++ K
Sbjct: 82 V------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGY 321
GL Y+H ++HRD+K N+ ++ ++ DFGLA+ SE + YV TR Y
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WY 181
Query: 322 VAPEYACTGM-LNEKSDVYSFGILIMEIITGR 352
APE M + D++S G ++ E++TG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 159 IGEGGYGIVYRGILSDGTKVA---VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLG 214
IG G +G V + T VA VK L N E+ EF + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 215 YCVEGAYRMLVYEYVDNGNL------DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
CVE +LV+EY + G+L +QW + + L RM + A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN-SQLLLLQ---RMACEI--AAGVTHMH 116
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--RVMGTFGYVAPEY 326
+ +H D+ N L +V D+G+ E Y+ T ++APE
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172
Query: 327 ACT---GML----NEKSDVYSFGILIMEI 348
G++ + S+V++ G+ + E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 28/259 (10%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLL 213
V+G+GG+G V + + G A K L R + K + E +++ +V + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
Y E + LV ++ G+L ++ G+ G I G L LH+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQ- 120
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++V+RD+K NILLD + R+SD GLA + E + RV GT GY+APE
Sbjct: 121 --ERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYMAPEVVKNE 176
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
D ++ G L+ E+I G++P + + + V+ L V SE+
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKF-------S 229
Query: 391 PASKALKRVLLVALRCVDP 409
P +++L ++LL C DP
Sbjct: 230 PDARSLCKMLL----CKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 10/99 (10%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-G 317
A GL +LH +++RD+K N++LD + + +++DFG +C E + TTR G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFG----MCKENIFGGKTTRTFCG 163
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
T Y+APE + D ++FG+L+ E++ G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 40/232 (17%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNL-------LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+GGYG V+ D G VA+K + LN + E +++ + + LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV----RHVLTERDILTTTKSEWLV 64
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+LL + Y L EYV G+ L+ G + + + M + L Y
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY-- 122
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+HRD+K N L+D + +++DFGL+K + +Y + V+G+ Y+APE
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANS-VVGSPDYMAPE--- 168
Query: 329 TGMLNEKS-----DVYSFGILIMEIITGRNPVDYSRPQGEV--NLVDWLKTM 373
+L K D +S G ++ E + G P S P E NL W +T+
Sbjct: 169 --VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 7/93 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
GL ++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 323 APEYACTGMLNEKS-DVYSFGILIMEIITGRNP 354
APE G + S D +S G ++ +++ G +P
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 157 NVIGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
N+IG G +G+VY I D + KVA+K +L + +E + + + H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 216 CVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII----LGTAKG 263
++ +V E++ Q +H + + + + ++ +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAK-LLCSER--SYVTTRVMGTF 319
LAY+H + HRD+K N+L+D ++ DFG AK LL +R SY+ +R
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---- 235
Query: 320 GYVAPEYACTGMLNEKS--DVYSFGILIMEIITG 351
Y APE G N + D++S G +I E+I G
Sbjct: 236 -YRAPELM-LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 66/274 (24%)
Query: 159 IGEGGYGIV----YRGILSDGTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVR-HKNLV 210
+G+G YGIV S+ VA+K N+ + + A++ + E++++ R HKN+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNIT 65
Query: 211 RL--LGYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
L + G + L +YE + +L Q + PLT + I GL Y+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYI 121
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---------RSYVTTRVMGT 318
H V+HRD+K N+L++ ++ DFGLA+ SE YV TR
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATR---- 173
Query: 319 FGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV----DYSRPQGEVNLVDW 369
Y APE ML+ +S DV+S G ++ E++ GR PV DY ++N +
Sbjct: 174 -WYRAPEI----MLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD---QLNQI-- 222
Query: 370 LKTM----------VGSRKSEEVVD--PKLPKMP 391
L+ + +GS K++ + P +PK P
Sbjct: 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKP 256
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 73/287 (25%), Positives = 128/287 (44%), Gaps = 39/287 (13%)
Query: 158 VIGEGGYGIVYRGIL--SDGT--KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
++G+G +G V L DG+ KVAVK L + + E EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVI 64
Query: 211 RLLGYCVEGAYR------MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIR--MNIILGTA 261
+L+G + + M++ ++ +G+L +L +G+ P T ++ + ++ A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRFMIDIA 123
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG-TFG 320
G+ YL +HRD+ + N +L+ V+DFGL+K + S Y
Sbjct: 124 SGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
++A E + SDV++FG+ + EI+T G+ P Y+ G N + + G+R
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YA---GVENSEIYNYLIKGNRL- 234
Query: 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
K P L+ V + +C P+ RP H+ LE
Sbjct: 235 ---------KQPP-DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 10/99 (10%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-G 317
+ GL +LH +++RD+K N++LD + + +++DFG +C E VTTR G
Sbjct: 111 SVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFG----MCKEHMVDGVTTRTFCG 163
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
T Y+APE + D +++G+L+ E++ G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 159 IGEGGYGIVYRGILSDGT--KVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
+G G +G V + VA+K ++ +K+ E +++ + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLH------GDVGDVSPLTWDIRMNIILGTAKGLAYL 267
G + +Y LV E+V G +L DVG A + +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--------------YAAQIVLI 143
Query: 268 HEGLEP-KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
E L+ +V+RD+K N+LLD+ +++DFG AK++ R+Y + GT Y+APE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYT---LCGTPEYIAPEI 199
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360
+ +D ++ GI I EI+ G P + P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G G YG V+ R + + KV K + + + + + E +V+ +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNG----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+ L Y + ++ L+ +Y++ G +L Q +V + +I + L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL--------AL 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
+LH+ +++RD+K NILLD + ++DFGL+K + GT Y+AP
Sbjct: 119 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 325 EYACTGML--NEKSDVYSFGILIMEIITGRNP 354
+ G ++ D +S G+L+ E++TG +P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 68/216 (31%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 158 VIGEGGYGIVYRGILS-DGTKVAVKNL-----LNNRGQAEKEFKVEVEVIGR-VRHKNLV 210
VIG+G +G V DG AVK L LN + Q K E V+ + V+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLV 59
Query: 211 RLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI-ILGTAKGLAYLH 268
L Y + ++ V ++V+ G L L + P R A L YLH
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLH 113
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+V+RD+K NILLD Q + ++DFGL K ++ S TT GT Y+APE
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIR 169
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 364
+ D + G ++ E++ G P Y R E+
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 18/97 (18%)
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFG 320
+GL Y+H ++HRD+K SNI ++ ++ DFGLA+ E + YV TR
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 321 YVAPEYACTGMLN-----EKSDVYSFGILIMEIITGR 352
Y APE MLN + D++S G ++ E++TG+
Sbjct: 181 YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 158 VIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGR-VRHKNLVRL 212
VIG+G +G V SDG+ AVK L + + + E V+ + ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + A ++ V +YV+ G L L + + P + A + YLH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV----ASAIGYLHS-- 114
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+++RD+K NILLD Q + ++DFGL K E T+ GT Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 364
+ D + G ++ E++ G P YSR ++
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF-YSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEG Y V++G VA+K + L + A EV ++ ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
LV+EY+D+ +L Q+L +S I M +L +GL+Y H+ K++
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHK---RKIL 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-TGMLNEK 335
HRD+K N+L++ + +++DFGLA+ + V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 336 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
D++ G ++ E+ TGR S + E++L+
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
GL LH ++V+RD+K NILLD + R+SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYM 168
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE D + G LI E+I G++P
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYV 322
L +H ++HRD+KS+NILL ++ DFG +K+ + S R GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
APE ++K+D++S G+L+ E++T + P D + ++ KT+ G
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH-----KTLAGR------ 261
Query: 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423
DP LP P+ + ++ AL DP +RP +++M
Sbjct: 262 YDP-LP--PSISPEMQEIVTALLSSDPK--RRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 69/216 (31%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK---VEVEV-IGRVRHKNLVRL 212
VIG+G +G V +DG AVK L +KE K E V + V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + A ++ V +YV+ G L L + P I A L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI----ASALGYLHS-- 114
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAPEYAC 328
+++RD+K NILLD Q + ++DFG LC E S T+ GT Y+APE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFG----LCKEGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 364
+ D + G ++ E++ G P YSR E+
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 158 VIGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
IG G GIV Y + G VA+K L N A++ ++ E+ ++ V HKN++
Sbjct: 23 PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 212 LLGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGL 264
LL E LV E +D NL Q + D L + RM+ +L G+
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHE-RMSYLLYQMLCGI 131
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGY 321
+LH ++HRD+K SNI++ ++ DFGLA+ + YV TR Y
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 183
Query: 322 VAPEYACTGM-LNEKSDVYSFGILIMEIITGR 352
APE GM E D++S G ++ E+I G
Sbjct: 184 RAPE-VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 73/290 (25%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIG---------------- 202
+G G +Y GIL+ + ++ EKE KV ++V+
Sbjct: 3 LGRGTRTQIYAGILNYK-----DDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57
Query: 203 --RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT 260
+V HK++V L G CV ++V E+V+ G LD ++H LT + +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQL 114
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-------NARVSDFG-----LAKLLCSER 308
A L+YL + +VH +V + NILL R+ ++SD G L++ C ER
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER 171
Query: 309 SYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 365
++APE C + L+ +D +SFG + EI GE+
Sbjct: 172 ----------IPWIAPE--CVEDSKNLSIAADKWSFGTTLWEICY----------NGEIP 209
Query: 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
L D KT+ + K + P+ K L ++ C++ D +RP
Sbjct: 210 LKD--KTL--AEKERFYEGQCMLVTPSCKELADLM---THCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGR-VRHKNLVRL 212
VIG+G +G V ++ AVK L + + EK E V+ + V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + A ++ V +Y++ G L L + + P I A L YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS-- 114
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+RD+K NILLD Q + ++DFGL K E + T+ GT Y+APE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 364
+ D + G ++ E++ G P YSR E+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT------ 329
VHRD+K N+L+DR + +++DFG A L + + + +GT Y+APE T
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 330 GMLNEKSDVYSFGILIMEIITGRNP 354
G + D +S G++ E+I GR+P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 37/92 (40%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
GL LH V+RD+K NILLD + R+SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYM 168
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE D + G LI E+I G++P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 30/177 (16%)
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +V H +L + G CV G+ ++V E+V++G LD L + G V P+ W ++ +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAW--KITVAQQ 125
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-------RVSDFGLAKLLCSERSYVT 312
A L+YL + +VH +V + NILL R A ++SD G++ S V
Sbjct: 126 LASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE 182
Query: 313 TRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEI-------ITGRNPVDYSR 359
++APE C L+ +D +SFG ++EI + R P + R
Sbjct: 183 -----RIPWIAPE--CVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 34/81 (41%), Positives = 47/81 (58%), Gaps = 2/81 (2%)
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
++V+RD+K NILLD + + R+SD GLA + E V RV GT GY+APE
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYMAPEVINNEKYT 179
Query: 334 EKSDVYSFGILIMEIITGRNP 354
D + G LI E+I G++P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 49/197 (24%)
Query: 159 IGEGGYGIVYRGIL---SDGTKVAVKNLLNNRGQAEKEFKV--------EVEVIGRVRHK 207
IG G YG VY+ DG + A+K + +KE E+ ++ ++H+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 208 NLVRLLGYCVEGAYRM--LVYEYVDNGNLDQW----LHGDVGDVS-------PLTWDIRM 254
N+V L+ +E A + L+++Y ++ D W H VS L W I +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLWQI-L 118
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKLLCS--ER 308
N G+ YLH V+HRD+K +NIL+ + R + D GLA+L + +
Sbjct: 119 N-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 309 SYVTTRVMGTFGYVAPE 325
V+ T Y APE
Sbjct: 169 LADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 10/99 (10%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-G 317
A GL +LH +++RD+K N++LD + + +++DFG +C E + VTT+ G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENMWDGVTTKTFCG 163
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
T Y+APE + D ++FG+L+ E++ G+ P +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 82 LNVFTP---QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 331 MLNEKSDVYSFGILIMEII------TGRNPVD 356
E D++S G ++ E++ GR+ +D
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 62/261 (23%)
Query: 158 VIGEGGYGIVY--RGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
VIG G +G V+ R + KV K+ + R Q + E +++ +V+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAK--------G 263
+ + LV EY+ G+L + IR ++ TA+
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETARFYIAELVLA 113
Query: 264 LAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-----------------LLC 305
L +H+ G +HRD+K NIL+D + +++DFGL K LL
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 306 SERSYVTTR-----------VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ V R +GT Y+APE + D +S G+++ E++ G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 355 VDYSRPQGEVN-LVDWLKTMV 374
Q N +++W +++
Sbjct: 230 FYSDTLQETYNKIINWKESLR 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 38/116 (32%), Positives = 62/116 (53%), Gaps = 11/116 (9%)
Query: 244 DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
D PL D + A+G+ +L +HRDV + N+LL A++ DFGLA+
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARD 261
Query: 304 LCSERSYVTTRVMGT----FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ ++ +YV V G ++APE + +SDV+S+GIL+ EI + G++P
Sbjct: 262 IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRV 204
AATS L E +GEG Y VY+GI +G VA+K +++ + + F E ++ +
Sbjct: 3 AATSYLNLEK-LGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGL 60
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+H N+V L V+EY+ +L Q++ G + P + M +L +GL
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL---RGL 116
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
AY+H ++HRD+K N+L+ +++DFGLA+ ++ V+ T Y P
Sbjct: 117 AYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPP 172
Query: 325 EYACTGMLNEKS--DVYSFGILIMEIITGR 352
+ G + S D++ G + +E++ G+
Sbjct: 173 D-VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 29/157 (18%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV------------EVEVIGRVR 205
+GEG Y VY+G ++ L + A KE ++ E ++ ++
Sbjct: 12 KLGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H N+V L LV+EY+D +L Q++ G +S + + +L +GLA
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
Y H+ +V+HRD+K N+L+ + +++DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 158 VIGEGGYGIVY--RGILSD------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V+ R I KV K L R + K+E +++ V H +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT--KMERDILAEVNHPFI 60
Query: 210 VRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
V+L + EG L+ +++ G+L L +V T + + A L +LH
Sbjct: 61 VKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLH 115
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
L +++RD+K NILLD + + +++DFGL+K GT Y+APE
Sbjct: 116 -SL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVN 171
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
+ +D +SFG+L+ E++TG P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM---GTF 319
GL +LH +++RD+K N++LDR + +++DFG +C E + R GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG----MCKENVFGDNRASTFCGTP 160
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
Y+APE D +SFG+L+ E++ G++P
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 30/190 (15%)
Query: 174 DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL-GY------C-VEGAYRMLV 225
KV VK K E++++ + H+ ++ L+ Y C V Y+ +
Sbjct: 118 QRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172
Query: 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285
+ YVD PL + + I + LAYLH ++HRDVK+ NI
Sbjct: 173 FTYVDR-------------SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENI 216
Query: 286 LLDRQWNARVSDFGLA-KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGIL 344
LD NA + DFG A KL + GT +PE K+D++S G++
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276
Query: 345 IMEIITGRNP 354
+ E+
Sbjct: 277 LFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 158 VIGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAE-KEFKV-EVEVIGRVRHKNLVRLLG 214
V+GEG YG+V + + + VA+K ++ E KE + E++++ ++ +N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+EYV+ N+ + L V P + + I K + + H+
Sbjct: 68 AFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHKN---D 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
+VHRD+K N+L+ ++ DFG A+ L + T + T Y +PE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 335 KSDVYSFGILIMEIITGR 352
D++S G ++ E+ G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKN-LVR 211
IGEG YG VY+ + G VA+K R + ++E E+ ++ + +VR
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 212 LLGYCVEGAYR-------MLVYEYVDNGNLDQWLHGDV-GDVSPLTWDIRMNIILGTAKG 263
LL VE LV+EY+D+ +L +++ + G PL + + KG
Sbjct: 66 LL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSE-RSYVTTRVMGTFGY 321
+A+ H+ V+HRD+K N+L+D+Q +++D GL + +SY T + T Y
Sbjct: 123 VAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWY 177
Query: 322 VAPEYACTGMLNEKS-DVYSFGILIMEIITG 351
APE D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 MLNEKSDVYSFGILIMEIITGR 352
E D++S G ++ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V KVAVK L + A + ++ E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
E NL + D+ ++ L+ + +I +GL Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNL---MGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA- 137
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTG 330
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR Y APE
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNW 190
Query: 331 M-LNEKSDVYSFGILIMEIITGR 352
M N+ D++S G ++ E++ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
E V+ RH L L Y + R+ V EYV+ G L + H V + D
Sbjct: 45 ESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV--FSEDRTRF 99
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
L YLH G K+V+RD+K N++LD+ + +++DFGL K ++ + + T
Sbjct: 100 YGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-F 155
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
GT Y+APE D + G+++ E++ GR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGYC 216
+GEG Y VY+G K+ ++ + + F E ++ ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
LV+EYV + +L Q++ G + P + + +L +GL+Y+H+ ++
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---IL 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+K N+L+ +++DFGLA+ S S+ + + T Y P+ E S
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAK-SVPSHTYSNEVVTLWYRPPDVLLGS--TEYS 182
Query: 337 ---DVYSFGILIMEIITG 351
D++ G + +E+I G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
L LH+ V++RD+K NILLD Q + + DFGL KL + T GT Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLA 161
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
PE + D ++ G+L+ E++TG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 36/113 (31%), Positives = 60/113 (53%), Gaps = 9/113 (7%)
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
PLT + ++ A+G+ +L K +HRD+ + NILL ++ DFGLA+ +
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 306 SERSYV---TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ YV R+ ++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 225 KDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 36/233 (15%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLV 210
IG G +G+V+ R DG +VA+K + N N ++ F+ E++++ +H N++
Sbjct: 8 IGYGAFGVVWSVTDPR----DGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVL 62
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV----SPLTWD-IRMNI--ILGTAKG 263
L YV + + + D+ + PL+ D +++ + IL +G
Sbjct: 63 SALDILQPPHIDPFEEIYV----VTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RG 115
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYV 322
L YLH ++HRD+K N+L++ ++ DFGLA++ E ++T V+ + Y
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 323 APEYACTGMLNEKS--DVYSFGILIMEIITGRNPVDYSRPQGEVNLV-DWLKT 372
APE G + S D++S G + E++ R P +++L+ D L T
Sbjct: 172 APEI-LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT 223
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 26/189 (13%)
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
SPLT + + A+G+ +L K +HRD+ + NILL ++ DFGLA+ +
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 306 SERSYV---TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQ 361
+ YV + R+ ++APE + +SDV+SFG+L+ EI + G +P Y Q
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP--YPGVQ 281
Query: 362 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
LK R E A+ + R++ L C D +RP ++
Sbjct: 282 INEEFCQRLKDGTRMRAPEN----------ATPEIYRIM---LACWQGDPKERPTFSALV 328
Query: 422 HMLEADDLL 430
+L DLL
Sbjct: 329 EIL--GDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 24/253 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
VIG G Y V L ++ VK L N + + E V + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V EYV+ G+L H P + + A L YLHE
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHE--- 114
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAPEYACT 329
+++RD+K N+LLD + + +++D+G +C E T+ GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDY--SRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
D ++ G+L+ E++ GR+P D S + N D+L ++ + ++ P+
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRIPRS 227
Query: 388 PKMPASKALKRVL 400
+ A+ LK L
Sbjct: 228 LSVKAASVLKSFL 240
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 13/141 (9%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTF 319
L +LHE +++RD+K N+LLD + +++D+G +C E T+ GT
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYG----MCKEGLGPGDTTSTFCGTP 160
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379
Y+APE D ++ G+L+ E++ GR+P D ++N D+L ++ +
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP- 219
Query: 380 EEVVDPKLPKMPASKALKRVL 400
+ P+ + AS LK L
Sbjct: 220 --IRIPRFLSVKASHVLKGFL 238
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 15/166 (9%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
E V+ RH L L Y + R+ V EY + G L L +
Sbjct: 45 ESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTT 313
I+ L YLH VV+RD+K N++LD+ + +++DFGL K S
Sbjct: 104 IVSA----LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 153
Query: 314 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 359
GT Y+APE D + G+++ E++ GR P Y++
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 37/209 (17%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-------------EVEVIGRVR 205
+G+G +G VY ++ D VA + L + KE V E +++ ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERL-----KVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH--GDVGDVSP----LTWDIRMNIILG 259
H +V+ +E ++ EY + +LD L G W I++ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--- 117
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
G+ Y+H+ +++HRD+K+ NI L ++ DFG+++LL TT GT
Sbjct: 118 ---GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTP 169
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEI 348
Y++PE + KSD++S G ++ E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 175 GTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232
GT V V+ +L N + K + EV + RH N++ G++ ++ ++ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
+ + L + ++ + NI+ G +GL YLH+ +HR++K+S+IL+ +
Sbjct: 85 SANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG--D 137
Query: 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML---------------NEKSD 337
VS GL+ L R+ +V+ F P+++ T +L N KSD
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDF----PQFS-TSVLPWLSPELLRQDLYGYNVKSD 192
Query: 338 VYSFGILIMEIITGRNP-VDYSRPQ 361
+YS GI E+ TGR P D R Q
Sbjct: 193 IYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 12/112 (10%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFG 320
L +LHE +++RD+K N+LLD + + +++D+G +C E T+ GT
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG----MCKEGIRPGDTTSTFCGTPN 161
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDY--SRPQGEVNLVDWL 370
Y+APE D ++ G+L+ E++ GR+P D + N D+L
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 45/238 (18%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+GG G VY D +VA+K + L+ +K F E ++ + H +V +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 213 LGYCVEGA---YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--------MNIILGTA 261
C +G Y M Y++ L L V L+ ++ ++I
Sbjct: 68 YSICSDGDPVYYTM---PYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL-----------------L 304
+ Y+H V+HRD+K NILL + D+G A +
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 362
C + +++GT Y+APE +E +D+Y+ G+++ +++T P Y R +G
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKG 236
|
Length = 932 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 24/170 (14%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF- 319
A+G+ +L VHRD+ + N+LL + ++ DFGLA+ + + +YV+ TF
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301
Query: 320 --GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGS 376
++APE + SDV+S+GIL+ EI + G P P V+ + K G
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTFYNKIKSGY 357
Query: 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
R ++ A + V + ++C + + KRP H+ ++E+
Sbjct: 358 RMAK-----------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLGY 215
IG G +G V+ + ++ RG E+E +EV V+ ++HKN+VR +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 216 CVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE- 272
+ A + L + E+ D G+L + + + ++I LAY H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 273 ---PKVVHRDVKSSNILLDR----------QWN-------ARVSDFGLAKLLCSERSYVT 312
+V+HRD+K NI L Q N A++ DFGL+K + E +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MA 198
Query: 313 TRVMGTFGYVAPEYAC--TGMLNEKSDVYSFGILIMEIITGRNP 354
+GT Y +PE T ++KSD+++ G +I E+ +G+ P
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 13/96 (13%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
L +LH+ +V+RD+K NILLD + + DFGL+K ++ T GT Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLA 164
Query: 324 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
PE +L+EK D +S G+L+ E+ G +P
Sbjct: 165 PEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 48/223 (21%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G G+V+ + SD +VAVK ++ Q+ K E+++I R+ H N+V+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT----------WDIRMNIILGTA------ 261
VYE + D L DVG ++ L D+ + G
Sbjct: 67 -------VYEVLGPSGSD--LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 262 -------KGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERS---Y 310
+GL Y+H V+HRD+K +N+ ++ ++ DFGLA+++ S Y
Sbjct: 118 LFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 311 VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGR 352
++ ++ + Y +P + + D+++ G + E++TG+
Sbjct: 175 LSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 158 VIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
V+G+G +G V L G AVK L + + + + E ++ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V E+V+ G+L + I L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SALMFLHD--- 114
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTTRVM-GTFGYVAPEYACT 329
+++RD+K N+LLD + + +++DFG +C E + TT GT Y+APE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVD 356
+ D ++ G+L+ E++ G P +
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 246 SP-LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
SP L++ + A G+ +L VHRD+ + N+L+ ++ DFGLA+ +
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 305 CSERSYVTTRVMGTF---GYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRP 360
+ +Y++ TF ++APE + SDV+SFGIL+ EI T G P P
Sbjct: 290 MRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY----P 343
Query: 361 QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420
+ +N + G R ++ PA A + + +C + RP +
Sbjct: 344 ELPMNEQFYNAIKRGYRMAK----------PA-HASDEIYEIMQKCWEEKFEIRPDFSQL 392
Query: 421 IHMLE 425
+H++
Sbjct: 393 VHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT-- 318
AKG+++L +HRD+ + NILL ++ DFGLA+ + ++ +YV V G
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 319 --FGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVG 375
++APE + +SDV+S+GIL+ EI + G +P Y + +K G
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGMPVDSKFYKMIKE--G 333
Query: 376 SR-KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
R S E ++ + S C D D KRP ++ ++E
Sbjct: 334 YRMLSPECAPSEMYDIMKS------------CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH E VV+RD+K N++LD+ + +++DFGL K + + + T GT Y+
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 163
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE D + G+++ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 158 VIGEGGYGIVY---------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
+I G YG VY R + K+ +NL+ R Q ++ F VE +++ +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMK---KINKQNLIL-RNQIQQVF-VERDILTFAENPF 62
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + + +V EYV+ G+ L ++ L D+ T L YLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLH 118
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL-LCS-------------ERSYVTTR 314
+VHRD+K N+L+ + +++DFGL+K+ L S R ++ +
Sbjct: 119 N---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
V GT Y+APE + D ++ GI++ E + G P
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMG 317
AKG+ +L K +HRD+ + NILL ++ DFGLA+ + + YV R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++APE + +SDV+SFG+L+ EI + G +P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFG 320
L +LH V++RD+K NILLD + + +++DFG +C E TT GT
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG----MCKEGILNGVTTTTFCGTPD 161
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
Y+APE D ++ G+L+ E++ G+ P
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + + T GT Y+A
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
PE D + G+++ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVR-HKNLVRLLGY 215
IGEG + V + G A+K + + E+ + E++ + R+ H N++RL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL--- 63
Query: 216 CVEGAYR------MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+E + LV+E +D NL + + G + M +L K L ++H
Sbjct: 64 -IEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL---KSLDHMHR 118
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+ HRD+K NIL+ +++DFG + + S+ Y T + T Y APE T
Sbjct: 119 N---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLT 172
Query: 330 -GMLNEKSDVYSFGILIMEIIT------GRNPVD 356
G K D+++ G + EI++ G N +D
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 39/179 (21%), Positives = 79/179 (44%), Gaps = 19/179 (10%)
Query: 180 VKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL--------LGYCVEGAYRMLVYEYVDN 231
+ + +A + + E+ +GR+ H+N++++ Y + Y +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291
D W PL R I+ + Y+H+ K++HRD+K NI L+
Sbjct: 256 EAFD-WKD------RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304
Query: 292 NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350
+ DFG A ER +GT +PE E +D++S G++++++++
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY-----ACTG 330
VHRD+K N+LLD+ + R++DFG L ++ + + +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+ D +S G+ + E++ G P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEVEVIGRVRHKNLVRLL 213
VIG G +G V L + KV +LN ++ F+ E +V+ ++ +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWIT--- 64
Query: 214 GYCVEGAYRMLVYEYVDNGNL----DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
L Y + D NL D ++ GD+ LT + L YL E
Sbjct: 65 ---------TLHYAFQDENNLYLVMDYYVGGDL-----LTLLSKFEDRLPEDMARFYLAE 110
Query: 270 GL-------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
+ + VHRD+K NIL+D + R++DFG L + + ++ +GT Y+
Sbjct: 111 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 323 APEYACT-----GMLNEKSDVYSFGILIMEIITGRNP 354
+PE G + D +S G+ + E++ G P
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 44/197 (22%), Positives = 82/197 (41%), Gaps = 29/197 (14%)
Query: 175 GTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231
T VAVK + N ++++ K+ E+ +++H N++ + + + +V +
Sbjct: 25 NTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-EGLEPKVVHRDVKSSNILLDRQ 290
G+ + L + P I I+ L Y+H +G +HR VK+S+ILL
Sbjct: 84 GSCEDLLKTHFPEGLPELA-IA-FILKDVLNALDYIHSKGF----IHRSVKASHILLSGD 137
Query: 291 WNARVS-----------DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML--NEKSD 337
+S + +S + + + +++PE + NEKSD
Sbjct: 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKS--SVKNL---PWLSPEVLQQNLQGYNEKSD 192
Query: 338 VYSFGILIMEIITGRNP 354
+YS GI E+ G P
Sbjct: 193 IYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+ + YLHE +++HRD+K+ NI ++ + + DFG A C + G G
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA---CFPVDINANKYYGWAGT 246
Query: 322 VA---PEYACTGMLNEKSDVYSFGILIMEIITGRN 353
+A PE D++S GI++ E+ T +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 28/82 (34%), Positives = 47/82 (57%), Gaps = 1/82 (1%)
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGML 332
K++HRD+KS+NI L ++ DFG +K S V + GT Y+APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
++K+D++S G+++ E++T P
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 18/206 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEVEVIGRVRHKNLVRLL 213
VIG G +G V KV LL+ ++ F E +++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ Y +V EY+ G+L + DV P W TA+ + L
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----ARFYTAEVVLALDAIHS 160
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--- 329
+HRDVK N+LLD+ + +++DFG + E +GT Y++PE +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 330 -GMLNEKSDVYSFGILIMEIITGRNP 354
G + D +S G+ + E++ G P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 18/206 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEVEVIGRVRHKNLVRLL 213
VIG G +G V KV LL+ ++ F E +++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ Y +V EY+ G+L + DV P W TA+ + L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKW-----AKFYTAEVVLALDAIHS 160
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--- 329
++HRDVK N+LLD+ + +++DFG + +GT Y++PE +
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 330 -GMLNEKSDVYSFGILIMEIITGRNP 354
G + D +S G+ + E++ G P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 46/161 (28%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGL----------------------------------A 301
+HRD+K N+LLD + + ++SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361
+ R + +GT Y+APE N+ D +S G+++ E++ G P PQ
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 362 GEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 401
+++W +T+V P++P S+ K ++L
Sbjct: 243 ETYRKVMNWKETLVFP-----------PEVPISEKAKDLIL 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 60/283 (21%), Positives = 108/283 (38%), Gaps = 57/283 (20%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE----FKVEVEVIGRVRHKNLVRLL 213
VIG G +G V D V +L EKE + E +++ +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ L+ E++ G++ L LT + I T + +H+
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQ---L 120
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGL--------------------------------- 300
+HRD+K N+LLD + + ++SDFGL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 301 -AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 359
A+ R + +GT Y+APE N+ D +S G+++ E++ G P
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 360 PQGEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 401
PQ +++W +T++ P++P S+ K ++L
Sbjct: 241 PQETYKKVMNWKETLIFP-----------PEVPISEKAKDLIL 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 24/83 (28%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY----ACTGM 331
+HRDVK N+LLD+ + +++DFG + + +GT Y++PE G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+ D +S G+ + E++ G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-----G 330
VHRD+K N+LLD + R++DFG + + + ++ +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+ D +S G+ + E++ G P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 15/137 (10%)
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
L+ +Y+ +G+L L + L+ II + L LH+ ++H D+K
Sbjct: 86 LIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLE 138
Query: 284 NILLDR-QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS-DVYSF 341
N+L DR + + D+GL K++ + Y GT Y +PE G + S D ++
Sbjct: 139 NVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPE-KIKGHNYDVSFDWWAV 192
Query: 342 GILIMEIITGRNPVDYS 358
G+L E++TG++P
Sbjct: 193 GVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 51/219 (23%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 159 IGEGGYGIVYRGILSDGT---KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G YG VY+ DG + A+K + G + + E+ ++ ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 216 CVEGAYRM--LVYEYVDNG--NLDQWLHGDVGDVSPLTWDIRM--NIILGTAKGLAYLHE 269
+ + R L+++Y ++ ++ ++ + P+ M +++ G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 270 GLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVA 323
V+HRD+K +NIL+ + +++D G A+L S + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 324 PEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQ 361
PE K+ D+++ G + E++T P+ + R +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 52/219 (23%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G YG VY+ DG A+K + G + + E+ ++ ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 216 CVEGAYRM--LVYEYVDNG--NLDQWLHGDVGDVSPLTWDIRM--NIILGTAKGLAYLHE 269
+ A R L+++Y ++ ++ ++ + P+ M +++ G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 270 GLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVA 323
V+HRD+K +NIL+ + +++D G A+L S + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 324 PEYACTGMLNEKS-DVYSFGILIMEIITGRNPVDYSRPQ 361
PE K+ D+++ G + E++T P+ + R +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 61/235 (25%), Positives = 88/235 (37%), Gaps = 49/235 (20%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLVR 211
++G+G G V+ L K+ A+K L + K KV E E++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM---NIILGTAKGLAYLH 268
L Y LV +Y G L + L G R ++L L YLH
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAAEVLLA----LEYLH 120
Query: 269 -EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---------------- 311
G +V+RD+K NILL + +SDF L+K E V
Sbjct: 121 LLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 312 ---------TTRVM---GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ R GT Y+APE D ++ GIL+ E++ G P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 42/176 (23%), Positives = 71/176 (40%), Gaps = 33/176 (18%)
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH----GDVGDVSPLTWDIRMNIILGTAKG 263
N+V L Y V LV ++ + G L W H ++ + W M + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVALDA--- 100
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG----LAKLLCSERSYVTTRVMGTF 319
LH +V RD+ +NILLD + + +++ F + E +
Sbjct: 101 ---LHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE---AVENM---- 147
Query: 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG-----EVNLVDWL 370
Y APE E D +S G ++ E++TG+ V+ P G +N+ +W+
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 31/145 (21%), Positives = 58/145 (40%), Gaps = 47/145 (32%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGL---------------------------------AK 302
+HRD+K NIL+DR + +++DFGL A
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 303 LLCSERSYVTTR-------------VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 349
C +R R ++GT Y+APE + D +S G+++ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 350 TGRNPVDYSRP-QGEVNLVDWLKTM 373
G+ P P + ++ +++W ++
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 27/92 (29%), Positives = 37/92 (40%), Gaps = 9/92 (9%)
Query: 264 LAYLHEGLEP-KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
A + L + +HR KS NILL W+ + G E+S M
Sbjct: 20 WAVCLQCLGALRELHRQAKSGNILL--TWDGLLKLDGSVAFKTPEQSRPDPYFM------ 71
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE EK+D+YS GI + E + P
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 32/141 (22%), Positives = 56/141 (39%), Gaps = 43/141 (30%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGL----------------------------------- 300
+HRD+K NIL+DR + +++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 301 AKLLCSERSYVT--TRVM-----GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN 353
+L ER R + GT Y+APE + D +S G+++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 354 PVDYSRPQG-EVNLVDWLKTM 373
P P ++ +++W T+
Sbjct: 243 PFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 13/27 (48%), Positives = 20/27 (74%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+K N+LLD + + ++SDFGL
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 14/26 (53%), Positives = 21/26 (80%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLA 301
+HRD+K NIL+DR + ++SDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 484 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.02 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.82 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.79 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.15 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.02 | |
| PLN02236 | 344 | choline kinase | 96.98 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.97 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.51 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.15 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.0 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 95.96 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.96 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.95 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.89 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.87 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.62 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.59 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.57 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.54 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 95.51 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.12 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-56 Score=438.95 Aligned_cols=287 Identities=56% Similarity=0.970 Sum_probs=255.2
Q ss_pred CCccccHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeeccee
Q 011498 137 WGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216 (484)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 216 (484)
..+.|++.++..+|++|...+.||+|+||.||+|.+.+|..||||++.........+|..|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999998899999988665443155699999999999999999999999
Q ss_pred eeCC-eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 217 VEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 217 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
.+.+ +.+|||||+++|+|.++|+..... +++|..+++|+.++|+||+|||..+.+.|+||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999876433 8999999999999999999999998889999999999999999999999
Q ss_pred eeecccccccC-CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 296 SDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 296 ~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
+|||+++.... ........ .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+..+.++.+|.....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999976543 22211111 79999999999999999999999999999999999999988766666777999999999
Q ss_pred cCCCcccccCCCCC-CCChH-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 375 GSRKSEEVVDPKLP-KMPAS-KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 375 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......+++|+.+. ..... +...++..++.+|++.+|.+||+|.||+++|+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 88899999999987 44443 688889999999999999999999999999954
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=392.40 Aligned_cols=255 Identities=33% Similarity=0.533 Sum_probs=209.4
Q ss_pred CCcCceeccCCceEEEEEEECCCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCC-eeeEEEEec
Q 011498 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-YRMLVYEYV 229 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 229 (484)
+...+.||+|+||+||+|.|++...||||++..... ...++|.+|+.+|.+++|||||+|+|+|.+.. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 444566999999999999997444499999976432 22568999999999999999999999999987 789999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc-eeecCCCCCcEEEcCCC-cEEEeeecccccccCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE 307 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~ 307 (484)
++|+|.++|+.. ....+++..++.++.|||.||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999864 336799999999999999999999998 7 99999999999999997 9999999999876433
Q ss_pred Cceeecccccccccccccccc--cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYAC--TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
. ...+...||..|||||++. ...|+.|+||||||++||||+||+.||....+. ... .... ..
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~---~~v~---------~~ 261 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVA---SAVV---------VG 261 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHH---HHHH---------hc
Confidence 2 2233367999999999999 569999999999999999999999999866541 111 1111 11
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
..++..+..+...+..++.+||..||..||++.+|+..|+...
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1222222236667889999999999999999999999998643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=390.77 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=213.2
Q ss_pred CCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
+...+.||+|.||+||.|.++...+||+|.+... ....++|.+|+.+|++|+|+|||+++++|.....++|||||++.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3445689999999999999987779999988765 344578889999999999999999999999988999999999999
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 312 (484)
+|.+||+.. ....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...++.....
T Consensus 287 sLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 999999863 346688999999999999999999999 999999999999999999999999999996655544433
Q ss_pred cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
...--+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+.... ++...+-..
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~----------------le~GyRlp~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL----------------LERGYRLPR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH----------------HhccCcCCC
Confidence 33334668999999999999999999999999999999 9999886654322211 122222233
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+..++..+.+||..||..+|++|||++.+...|+..
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 445777899999999999999999999999888753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=364.65 Aligned_cols=249 Identities=27% Similarity=0.475 Sum_probs=208.1
Q ss_pred cCceeccCCceEEEEEEEC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeeeCC-eeeEEEEecCC
Q 011498 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-YRMLVYEYVDN 231 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~ 231 (484)
..+.||+|..|+||++.++ ++..+|+|.+... .....+++.+|+++++..+||+||++||.|+... ...|+||||.+
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3578999999999999986 4788999999544 4455678999999999999999999999999988 59999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|+++++.- ..+++...-.++.+|++||.|||+. .+|+||||||+|||++..|.+||||||.+..+... .
T Consensus 163 GSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 163 GSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999754 5699999999999999999999962 29999999999999999999999999999887554 4
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
...++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+ ......+.+. .+++...+..+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~---------~Iv~~ppP~lP 303 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLC---------AIVDEPPPRLP 303 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHH---------HHhcCCCCCCC
Confidence 5678899999999999999999999999999999999999999976421 1112222222 23332222222
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+..++..++..||++||.+||++.|+++
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2346778999999999999999999888865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=369.61 Aligned_cols=203 Identities=28% Similarity=0.533 Sum_probs=181.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
..+|...+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||.|++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356778888999999999999975 4789999999766 3455667888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC------CcEEEeeecc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ------WNARVSDFGL 300 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~Dfgl 300 (484)
|||.||+|.+||+.. ..+++..+..++.|||.||++||++ +||||||||.||||+.. ..+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999866 4799999999999999999999999 99999999999999765 5689999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCC
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~ 361 (484)
|+.+... ......+|++.|||||+++.+.|+.|+|+||+|++||+|++|+.||......
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9987533 2345679999999999999999999999999999999999999999866543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=384.31 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=209.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
..|...++||+|+|+.||.++. ..|+.||+|++.+. +....+...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588889999999999999997 78999999999653 2344566788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|+|.+++|..+++.+ .++++..+..+..||+.||.|||+. +|+|||||-.|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999844 6799999999999999999999999 999999999999999999999999999998764
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
+.. ...+.||||.|+|||++....++..+||||+||+||-||+|++||+...-.+..+.+ . ..+..
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I------k----~~~Y~--- 236 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI------K----LNEYS--- 236 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH------H----hcCcc---
Confidence 422 345679999999999999999999999999999999999999999855422221111 1 01111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
+ +......-.+||.++|++||.+|||+.+|+..
T Consensus 237 ~----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 M----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 11234456778889999999999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=365.45 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=206.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchh-------hHHHHHHHHHHHhccCCCceeeecceeeeCC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ-------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 220 (484)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.... ......+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788889999999999999984 46999999999654321 1234568999999999999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC---CcEEEee
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSD 297 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~D 297 (484)
..||||||++||+|.+++-.+ ..+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999765 4567777788999999999999999 99999999999999766 6799999
Q ss_pred ecccccccCCCceeecccccccccccccccccCC---CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM---LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
||+|+... ....+..+|||+.|.|||++.+.. +..++|+||+||+||-+|+|.+||....... .+. .
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----e-- 392 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----E-- 392 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----H--
Confidence 99999864 444577899999999999998765 3348899999999999999999998655332 111 1
Q ss_pred cCCCcccccCCCC--CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 375 GSRKSEEVVDPKL--PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 375 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
++..... .+....+..++.++|+.++|..||++|||+.|+++
T Consensus 393 ------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 ------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111111 12234556778899999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=351.90 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=209.3
Q ss_pred CCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecce-eeeCCe-eeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGY-CVEGAY-RMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~-~~~~~~-~~lv~ 226 (484)
+|.+.+.||+|.||+||++. ..+|..+|.|.+.... ....+++..|+.+|++|+|||||+++++ +.++.. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 35567789999999999998 4579999999886432 3445678889999999999999999994 444444 89999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc--eeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
|||.+|+|...++..+.....+++..+|+++.|++.||.++|.. .+. |+||||||.||+|+.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999987666667899999999999999999999984 235 899999999999999999999999999988
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
..... .....+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+ +.+.... +..
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~K---------I~q 242 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKK---------IEQ 242 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHH---------HHc
Confidence 65443 3455789999999999999999999999999999999999999998652 2222111 112
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
...++.+..-+...+..|+..|+.+||+.||+.-.++..+
T Consensus 243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 2334444566778899999999999999999954444443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=392.32 Aligned_cols=259 Identities=29% Similarity=0.498 Sum_probs=217.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
..+..+.+.||+|.||+||+|...+ ...||||.+++.... ...+|++|++++..++|||||+|+|+|..++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455667789999999999998532 357999999887765 778999999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCC------C----CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVG------D----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~ 292 (484)
++|+|||..|+|.+||+.+.. . ..+|+..+.+.|+.|||.||+||.++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999964321 1 23488999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccCCCceeec-ccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTT-RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL 370 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~ 370 (484)
|||+|||+++.+-..+.+... ...-..+||+||.+..++|+++||||||||+|||+++ |+.||.+...++.+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe----- 716 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE----- 716 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-----
Confidence 999999999987555544332 4445779999999999999999999999999999999 999998766443221
Q ss_pred hhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+..+ .+ ...+..++.++..||..||+.+|.+||+++||-..|+..
T Consensus 717 --~i~~g--------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 717 --CIRAG--------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred --HHHcC--------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 12222 22 234455777899999999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.32 Aligned_cols=267 Identities=27% Similarity=0.433 Sum_probs=219.1
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhh-HHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
+...+.+.+.++||+|-||.|.+|....+.+||||.++...... ..+|..|+++|.+|+||||+.|+|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34567788899999999999999999878999999998775544 47999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
+||+++|+|.+||..+.. ..+.-....+|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+-
T Consensus 614 ~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999986632 2245556778999999999999987 99999999999999999999999999998654
Q ss_pred CCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh--CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT--GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
.... ....+.+-+.+|||||.+..+++++++|||+||++|||+++ .+.||.....+ +.++....+......+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV 765 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee
Confidence 4443 34566777889999999999999999999999999999866 77888755432 233333333333222222
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+ ..+.-++..+.+++++||..|.++||++++|...|+..
T Consensus 766 l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 L------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred c------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 12234566788999999999999999999999988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=350.21 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=201.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.++||+|+||+||.++.+ +++.+|+|++.+..- ...+....|..+|..++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356888999999999999999965 488999999876542 2345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
+||+.||.|...|++. ..+++..+.-++.+|+.||.|||+. +|+||||||+|||||.+|+++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999855 5689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... ..+..+|||+.|||||++.+.+|+..+|+||||+++|||++|.+||...+.. .+........
T Consensus 177 ~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 177 KDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGK-------- 241 (357)
T ss_pred cCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCc--------
Confidence 433 2355689999999999999999999999999999999999999999865532 1112211111
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCC
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPK 416 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 416 (484)
++ ..+.-......+++.+.|..||++|..
T Consensus 242 -~~-~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 -LP-LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -CC-CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 10 111112345677778999999999964
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.52 Aligned_cols=268 Identities=22% Similarity=0.313 Sum_probs=210.9
Q ss_pred CCCcCceeccCCceEEEEEEECC-CCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.|+...++|+|+||.||+|+.++ |+.||||++....+ ...+-..+|+++|++++|+|+|.|+.+|.....+++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46667789999999999999764 99999999976543 3345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
|+. ++.+-|.... ..++...+.+++.|++.|+.|+|++ +++||||||+||||+.++.+||||||.|+.+.. .
T Consensus 83 ~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 83 CDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred cch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 988 6655565443 4588899999999999999999999 999999999999999999999999999998764 2
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh---------hhhhhcCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW---------LKTMVGSRK 378 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~---------~~~~~~~~~ 378 (484)
...-+..+.|.+|+|||.+.+ -.|...+||||+||++.||++|.+.|.+....+....+.. ..-+..+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 333455678999999999987 6899999999999999999999999988765444333211 111111122
Q ss_pred cccccCCCCCCCC-----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 379 SEEVVDPKLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 379 ~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...+.-|...... .+....-+++++..||+.||.+|++.++++..=-.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 2222222222211 123445788999999999999999999998754443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=358.39 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=215.3
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
.....+|.+++.||+|+|++|++|+. ..++.||||++.+.- ....+-...|-..|.+| .||.|++|+..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45567899999999999999999995 458999999885542 22234566788899999 89999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
+|+|+||+++|+|.++|++. +.+++.....++.+|+.||+|||++ |||||||||+|||||.++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999865 6799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCce----------e--ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh
Q 011498 302 KLLCSERSY----------V--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 302 ~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~ 369 (484)
+.+...... . ...++||..|.+||++.....++.+|+|+|||+||+|+.|.+||...++.-.. +.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF---qk 298 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF---QK 298 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH---HH
Confidence 887432211 1 14489999999999999999999999999999999999999999876643211 11
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcchhh
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRD 433 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 433 (484)
+.. ++=.++.. ..+...+|+.+.|..||.+|+|.++|-+........|++
T Consensus 299 I~~----------l~y~fp~~----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 299 IQA----------LDYEFPEG----FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHH----------hcccCCCC----CCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 111 11112222 224677888899999999999999998877665555554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=369.99 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=213.9
Q ss_pred cCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
....+.++||.|.||+||+|+++- ...||||.++.... ....+|..|+.+|.++.||||++|.|+........||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345677899999999999999753 35799999987654 4557899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
+|||++|+|+.||+.+. ..+++-+...++++||.||.||.+. ++|||||.++|||++.+..+|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999998765 3488889999999999999999998 99999999999999999999999999999875
Q ss_pred CCCceeeccccc--ccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERSYVTTRVMG--TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
++.....+..-| +.+|.|||.+...+++.++||||||++|||.++ |+.||-....++..+.+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI--------------- 847 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI--------------- 847 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH---------------
Confidence 544221221112 458999999999999999999999999999888 99998766654333222
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+...+-.++.+++..|.+|++.||++|..+||++.+|+..|+.
T Consensus 848 -e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 848 -EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred -HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 1123334455678889999999999999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.79 Aligned_cols=278 Identities=28% Similarity=0.441 Sum_probs=219.4
Q ss_pred cHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC
Q 011498 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219 (484)
Q Consensus 142 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 219 (484)
+..+++...+.+.+...||+|.||+||+|.|. | .||||.+.... .+..+.|++|+..+++-+|.||+-|.|+|..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34677777778888899999999999999996 3 49999997654 44567999999999999999999999999988
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
.. .||+.+|+|-+|+.+|+... ..+.....+.|+.|||+||.|||.+ +|||||||..||+|.+++.|||+|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 77 99999999999999998653 5688899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC-ceeeccccccccccccccccc---CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 300 LAKLLCSER-SYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 300 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
++.....-. .......-|...|||||+++. .+|++.+||||||+++|||+||..||........ .-+++
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmVG 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMVG 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEec
Confidence 996532211 111222347789999999974 4799999999999999999999999983332211 11222
Q ss_pred CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcchhhhcccCCC
Q 011498 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 440 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~~~~ 440 (484)
.+... +.+ ......+.+++.+|+..||..++++||.+.+|+..|+......++-.|...+
T Consensus 607 rG~l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~ 666 (678)
T KOG0193|consen 607 RGYLM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASE 666 (678)
T ss_pred ccccC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCc
Confidence 22111 111 1123446678899999999999999999999999998765544444444333
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=343.14 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=202.4
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC--eeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e 227 (484)
.++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|++++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 345567899999999999999754 8999999886654333667889999999999999999999855444 6899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeecccccccC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCS 306 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~ 306 (484)
|+++|+|.+++.+..+ .+++..+..+..||++||+|||++ ||+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999987632 699999999999999999999998 9999999999999999 79999999999987653
Q ss_pred --CCceeecccccccccccccccccCC-CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 307 --ERSYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 307 --~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
..........||+.|||||++..+. ...++|||||||++.||+||+.||... .....++....... .
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-----~ 240 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-----S 240 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-----C
Confidence 2222234567999999999998643 345999999999999999999999753 11111111111111 1
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.|.++ ........+++.+|+..||++|||+.++++...
T Consensus 241 ~P~ip----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 LPEIP----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCC----cccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 12222 234556778888999999999999999998553
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=356.77 Aligned_cols=245 Identities=28% Similarity=0.505 Sum_probs=204.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
..+.....+.||.|+.|.||+|+++ ++.||||+++.-+ ..+|+-|++|+||||+.|.|+|.....+||||||
T Consensus 122 PFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 122 PFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred CHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 3444455678999999999999997 7889999885433 2367789999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
|..|-|...|+.. .++.......|..+||.||.|||.+ .|||||||.-||||..+..+||+|||.++.....
T Consensus 194 Ca~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 194 CAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred cccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 9999999999855 5788889999999999999999998 9999999999999999999999999999876433
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
+ ....++||..|||||++.+.+.++|+|||||||||||||||..||..-+... +-| . ++ ...+.
T Consensus 266 S-TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw--G-VG--------sNsL~ 329 (904)
T KOG4721|consen 266 S-TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW--G-VG--------SNSLH 329 (904)
T ss_pred h-hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE--e-cc--------CCccc
Confidence 2 2445789999999999999999999999999999999999999997443211 101 0 11 11122
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
-..+..+++-+.-|+.+||+..|.+||++.+|+..|+
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 2334556777888999999999999999999999886
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=348.53 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=209.6
Q ss_pred cCCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 225 (484)
+.|...++||+|+||.||+|+ ..+|+.||+|+++.+. ........+||.+|++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667789999999999999 4579999999997665 34455677899999999999999999998876 689999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
+|||++ +|.-++.... -.+++.++..++.||+.||+|+|.+ +|+|||||.+|||||++|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999998 9999886532 4589999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc----
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE---- 380 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 380 (484)
.......+..+-|.+|+|||++.+. .|+.++|+||.||||.||++|++.|.+....+.+..+-.+..........
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 6665556667789999999998875 69999999999999999999999999877554444332221111111111
Q ss_pred ---cccCCCCCCC-C----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 ---EVVDPKLPKM-P----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ---~~~~~~~~~~-~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+.+..+-. . ........++|+..+|..||.+|.|+.++|.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111111100 0 0112345678888999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.17 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=211.7
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+.|.+.+.||.|..++||+|+. ..++.||||++.-+ +....+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5688889999999999999994 45799999999644 444468899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
|.+|++.+.++.... ..+++..+..|+.++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+....
T Consensus 106 Ma~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999986543 3489999999999999999999999 99999999999999999999999999886654332
Q ss_pred ce--ee-ccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 309 SY--VT-TRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 309 ~~--~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.. .. ..++||++|||||+++. ..|+.|+||||||++..||.+|..||....+...+ +..+.+... ...
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp--~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPP--TLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCC--Ccc
Confidence 11 12 55789999999999653 47999999999999999999999999876653211 111111110 000
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
...++........+.+.+++..||..||.+|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1122333344556789999999999999999999999873
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=350.26 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=204.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc----ch-hhHHHHHHHHHHHhccC-CCceeeecceeeeCCe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN----RG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAY 221 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 221 (484)
..++|.+.+.||+|+||+|+.|... ++..||+|.+... .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3567888999999999999999854 5899999966543 11 23456778999999998 9999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGL 300 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgl 300 (484)
.++||||+.||+|.+++... ..+.+..+..++.|++.|++|||++ +|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999863 5688899999999999999999999 99999999999999999 9999999999
Q ss_pred cccccCCCceeecccccccccccccccccCC-CC-cccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGM-LN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|..||...+.. ..... +...
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~k-i~~~- 238 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRK-IRKG- 238 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHH-HhcC-
Confidence 98764 2333456678999999999999877 86 7899999999999999999999863321 11111 1100
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+. .++.... ...+..|+.+||..||.+|+|+.+|+.
T Consensus 239 --~~---~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 --EF---KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --Cc---cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 01 1111111 456888899999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=345.12 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=206.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
..++|...+.||+|+||.||+|+-+ +|..+|+|++++..- ........|-.+|...++|+||+|+..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3568999999999999999999955 599999999976542 233557779999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||++||++..+|... ..|++..+..++.+.+.|++-||+. |+|||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999755 6799999999999999999999998 9999999999999999999999999999432
Q ss_pred cC----------------------CCce-----ee-------------------cccccccccccccccccCCCCcccce
Q 011498 305 CS----------------------ERSY-----VT-------------------TRVMGTFGYVAPEYACTGMLNEKSDV 338 (484)
Q Consensus 305 ~~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv 338 (484)
.. .... .. ...+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0000 00 02579999999999999999999999
Q ss_pred ecchhHHHHHHhCCCCCCCCCCCCccc-hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 339 YSFGILIMEIITGRNPVDYSRPQGEVN-LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 339 wslG~~l~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
||||||+||||.|.+||....+.+... ++.|-..+ ..........+-.+||.+|+. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l--------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG- 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL--------------KFPEEVDLSDEAKDLITRLLC-DPENRLG- 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc--------------cCCCcCcccHHHHHHHHHHhc-CHHHhcC-
Confidence 999999999999999999887754432 22332211 111112223567888889999 9999976
Q ss_pred HHHHHHHhcCCcc
Q 011498 418 GHVIHMLEADDLL 430 (484)
Q Consensus 418 ~evl~~L~~~~~~ 430 (484)
.-=++.++...++
T Consensus 436 ~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 436 SKGAEEIKKHPFF 448 (550)
T ss_pred cccHHHHhcCCcc
Confidence 2223334444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=349.84 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=211.7
Q ss_pred hcCCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
...|.....||+|+.|.||.+. ..+++.||||++...+....+-+.+|+.+|+..+|+|||.+++.|...+.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3467777899999999999998 446889999999777766677788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
++||+|.+.+... .+++.++..|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999998643 489999999999999999999999 99999999999999999999999999998876554
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. .....+||+.|||||++....|++++||||||++++||+-|++||-..++-....++ ... -.|.+
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------a~n-----g~P~l- 489 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATN-----GTPKL- 489 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------hhc-----CCCCc-
Confidence 4 355678999999999999999999999999999999999999999755443222111 111 11111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+++.+||+.|+++||++.|+|+
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 223345667888899999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=351.02 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=202.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeC-
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG- 219 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~- 219 (484)
..++|.+.+.||+|+||.||+|.+. .+..||+|++..... .....+..|+.++..+ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888999999999999999742 246799998865432 3345788899999999 899999999988764
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCC-------------------------------------------------------
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGD------------------------------------------------------- 244 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 244 (484)
...+++|||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4578999999999999999753210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce-eecccccccc
Q 011498 245 ---VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFG 320 (484)
Q Consensus 245 ---~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~ 320 (484)
..++++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23578889999999999999999998 9999999999999999999999999999865332221 1222345678
Q ss_pred cccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHH
Q 011498 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRV 399 (484)
Q Consensus 321 y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 399 (484)
|+|||++.+..++.++|||||||+||||++ |..||........ .. ... .... .... +......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~---~~~-~~~~-----~~~~----~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC---QRL-KDGT-----RMRA----PENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH---HHH-hcCC-----CCCC----CCCCCHHH
Confidence 999999999999999999999999999997 9999975432211 11 111 1110 0011 11234568
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 400 LLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 400 ~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+++.+||+.||++|||+.+|++.|+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=344.57 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=210.2
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch-hhHHHHHHHHHHHhccC-CCceeeecceeeeCC-eeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGA-YRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~lv 225 (484)
.++|...+.||.|+||.||+|+. ..|..||||+++..-. ..+..-.+|+..|++|+ |||||+|..++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 35677788999999999999994 4588999998865532 23334557999999998 999999999999887 99999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
||||+. +|+++++.+ ...+++..++.|+.||++||+|+|.+ |++|||+||+|||+..+..+||+|||+|+.+.
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999977 999999876 36799999999999999999999999 99999999999999988899999999999876
Q ss_pred CCCceeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc---
Q 011498 306 SERSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE--- 381 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 381 (484)
+... .+..+.|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++.|.+.++.++...+ ...++......
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI---c~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI---CEVLGTPDKDSWPE 236 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH---HHHhCCCccccchh
Confidence 5443 35567899999999775 678999999999999999999999999887654433222 22222111111
Q ss_pred ---------ccCCCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 382 ---------VVDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 382 ---------~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
+.-|...+.. ...+..+..+++.+|+..||.+|||++|.++.-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1112222111 112567788999999999999999999998854
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=311.92 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=215.5
Q ss_pred HhcCCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Cee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 222 (484)
..++|.+.+.||+|||+.||+++ ..++..||+|++.....+..+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35789999999999999999998 556889999999888877788899999999999999999999987643 348
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|++++|+..|+|.+.+......+..+++.+++.|+.+|++||++||+. .++++||||||.|||+.+++.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999988776777899999999999999999999998 4569999999999999999999999999997
Q ss_pred cccCCCce--------eecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhh
Q 011498 303 LLCSERSY--------VTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 303 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 371 (484)
...-.-.. .......|..|+|||.+. +...++++|||||||+||.|+.|..||+.....+.- +
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-l----- 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-L----- 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-E-----
Confidence 64211100 011234688999999885 456889999999999999999999999755432211 1
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...+..+.+.........+.+.+++.+|++.||.+||++.+++..++.
T Consensus 252 -------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 252 -------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111222233222233367789999999999999999999999998875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=373.16 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=213.5
Q ss_pred cCCCcCceeccCCceEEEEEEECC--CC----EEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD--GT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
.+.+..+.||+|.||.||.|...+ |. .||||.+.... .+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445567789999999999999653 33 49999997764 455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 224 LVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
|++|||++|+|..||++... ....++....+.++.|||+|+.||+++ ++|||||.++|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999986521 235688999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeccc-ccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 301 AKLLCSERSYVTTRV-MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 301 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
|+.+.....+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||......+... .....+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC-
Confidence 996544444433322 34568999999999999999999999999999999 999998665432111 011111
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
+-.++..++..+.++|..||+.+|++||++..|++.+....
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 22234456778999999999999999999999999887654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=312.87 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=208.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.+|...+.||+|.||.||+|+. ++|+.||||++.... ........+|++.|+.++|+||+.++++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3566778999999999999994 569999999996543 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|++. +|+..++... ..++...+..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 9999997653 5688999999999999999999999 9999999999999999999999999999988655
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc-------
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS------- 379 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 379 (484)
..... ..+-|.+|+|||.+.+ ..|+..+|+||.||++.||+-|.+-|.+.+.-+....+ -...+....
T Consensus 155 ~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I---f~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI---FRALGTPTPDQWPEMT 230 (318)
T ss_pred Ccccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH---HHHcCCCCcccCcccc
Confidence 44333 3368999999998886 46999999999999999999999888876543322221 111221111
Q ss_pred --------ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 380 --------EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 380 --------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
.....+.... ..+.+....++|+.+++..||.+|+|+.|.+++=
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 1111111111 2233455678999999999999999999998754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=349.28 Aligned_cols=259 Identities=31% Similarity=0.469 Sum_probs=208.9
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECC--C---CEEEEEEeccc---chhhHHHHHHHHHHHhccCCCceeeecceee
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGILSD--G---TKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~---~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 217 (484)
++...++....++||+|+||.||+|+++. + ..||||..... ......+|..|+++|+.++|||||+|||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34444566677899999999999999653 2 23899988752 3456688999999999999999999999999
Q ss_pred eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEee
Q 011498 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (484)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 297 (484)
...++++|||+|.||+|.++|+... ..++..+++.++.+.|.||+|||++ +++||||.++|+|++.++.+||+|
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999998764 2699999999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCceeecc-c-ccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhh
Q 011498 298 FGLAKLLCSERSYVTTR-V-MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~-~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
||+++.... +.... . --+..|+|||.+....|+.++|||||||++||+++ |..||....... +..++.
T Consensus 306 FGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~--- 376 (474)
T KOG0194|consen 306 FGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIV--- 376 (474)
T ss_pred cccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHH---
Confidence 999876431 11111 1 24568999999999999999999999999999999 888997665331 111110
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
. ...+...+...+..+..++.+||..||++||+|.+|.+.|+...
T Consensus 377 ~---------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 377 K---------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred h---------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 1 11111222244556778888999999999999999999998643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=317.69 Aligned_cols=236 Identities=26% Similarity=0.341 Sum_probs=198.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh---hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|...+.||.|+||.|.+++.+ +|..+|+|++...... ..+...+|..+|+.+.||+++++++.|.+...+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34677889999999999999965 4889999998765432 2345667999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||++||.|..+|++. ..+++..+..++.||+.||+|||+. +|++|||||+|||||.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999865 5699999999999999999999998 999999999999999999999999999998744
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. +...|||+.|+|||++...+|+.++|+|||||++|||+.|.+||...++.... +.++...
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY---------------~KI~~~~ 257 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY---------------EKILEGK 257 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH---------------HHHHhCc
Confidence 3 45679999999999999999999999999999999999999999876652111 1122222
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKR 414 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~R 414 (484)
+. .+.-....+.+|+.+.|+.|-.+|
T Consensus 258 v~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 VK--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 21 122233457777788889999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=343.02 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=207.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|.||.||+|+-+ +.+.||+|.+.+... ...+.+.+|+++++.++|||||.++++|++..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45777789999999999999855 478899998865532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+.| +|..+|..+ ..++++.+..++.+++.||.|||+. +|.|||+||.|||++.++++|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 999999866 5699999999999999999999999 9999999999999999999999999999987543
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
..+.+..-||+.|||||+..+..|+..+|+||+||+||||++|++||-... +.+.++... .||..
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~--------~d~v~ 218 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSIL--------KDPVK 218 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHh--------cCCCC
Confidence 335566789999999999999999999999999999999999999996432 111112111 11221
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
++......+..++...|.+||.+|.|..+++..
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 223556678888889999999999999998763
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=337.36 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=208.4
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.|+..+.||+|.||.||+|... .++.||+|++.-... ....++++|+.++..++++||.++|+.+..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4555678999999999999954 588999999965543 34578899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.||++.+.|+.. ..+.+..+.-++.++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 94 ~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999754 3447777788899999999999999 999999999999999999999999999988765444
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
. ...++||+.|||||++....|+.|+||||||++.+||++|.+|+....+..... ++....++
T Consensus 167 r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~PP 229 (467)
T KOG0201|consen 167 R-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSAPP 229 (467)
T ss_pred c-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCCCC
Confidence 3 367899999999999998899999999999999999999999998766532211 11222223
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+.+.+++..||+.||+.||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 333345667889999999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=332.62 Aligned_cols=245 Identities=20% Similarity=0.371 Sum_probs=197.6
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhh---HHHHHHHHHHHhccCCCceeeecceeee----CCeeeEEEEec
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVYEYV 229 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 229 (484)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999999 48899999986543322 4678899999999999999999999877 34678999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.+++... ..+++...+.++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999754 46889999999999999999999731 78899999999999999999999999988653322
Q ss_pred eeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .. ....... ..+..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~---~~i~~~~-----~~~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IY---DLIINKN-----NSLKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHhcC-----CCCCC
Confidence 23457899999999976 689999999999999999999999997543221 11 1111110 01111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+ ..+...+.+++.+||+.||++|||+++|++.|+..
T Consensus 244 ~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 P----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 12345688899999999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=328.26 Aligned_cols=278 Identities=27% Similarity=0.420 Sum_probs=211.0
Q ss_pred cCCCCCCCCccccCCCCccccHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHH
Q 011498 122 SFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVI 201 (484)
Q Consensus 122 s~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l 201 (484)
++|||++.|...+++.+++..+ .+.||+|.||+||+|.|+ |+.||||++... .++.+.+|.+++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L------------~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIY 257 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVL------------QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIY 257 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEE------------EEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHH
Confidence 4577887777777666665544 569999999999999997 899999988443 345666777777
Q ss_pred hc--cCCCceeeecceeeeC----CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC-----
Q 011498 202 GR--VRHKNLVRLLGYCVEG----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG----- 270 (484)
Q Consensus 202 ~~--l~H~niv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~----- 270 (484)
+. |+|+||+.|++.-..+ ..+|||++|.++|||+|||.. .+++....++++..+|.||+|||..
T Consensus 258 qTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTq 332 (513)
T KOG2052|consen 258 QTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQ 332 (513)
T ss_pred HHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCC
Confidence 65 5999999999876543 257999999999999999975 4689999999999999999999954
Q ss_pred CCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce---eecccccccccccccccccCC----CC--cccceecc
Q 011498 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY---VTTRVMGTFGYVAPEYACTGM----LN--EKSDVYSF 341 (484)
Q Consensus 271 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~--~~~Dvwsl 341 (484)
.+|.|.|||||+.|||+..++.+.|+|+|||......... ..+..+||.+|||||++.... +. ..+|||||
T Consensus 333 gKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYaf 412 (513)
T KOG2052|consen 333 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAF 412 (513)
T ss_pred CCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHH
Confidence 3789999999999999999999999999999876544222 234568999999999996532 11 37899999
Q ss_pred hhHHHHHHhC----------CCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC-ChHHHHHHHHHHHHhcCCCC
Q 011498 342 GILIMEIITG----------RNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPD 410 (484)
Q Consensus 342 G~~l~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~d 410 (484)
|++|||+.-. ++||....+.+. +..+ +. ...-.+-+.|.++.. ...+.+..+.++|..||..|
T Consensus 413 gLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s~ee-Mr----kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~N 486 (513)
T KOG2052|consen 413 GLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-SFEE-MR----KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYAN 486 (513)
T ss_pred HHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-CHHH-Hh----cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCC
Confidence 9999999753 356544332211 1111 11 111112233344332 34678899999999999999
Q ss_pred CCCCCCHHHHHHHHhc
Q 011498 411 ATKRPKMGHVIHMLEA 426 (484)
Q Consensus 411 p~~RPs~~evl~~L~~ 426 (484)
|.-|-|+--|-+.|..
T Consensus 487 p~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 487 PAARLTALRIKKTLAK 502 (513)
T ss_pred chhhhHHHHHHHHHHH
Confidence 9999999888887764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.22 Aligned_cols=263 Identities=25% Similarity=0.441 Sum_probs=203.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-----------------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRL 212 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l 212 (484)
.+|.+.+.||+|+||.||+|.+++ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999998532 2369999886543 3345678999999999999999999
Q ss_pred cceeeeCCeeeEEEEecCCCCHHHHhhcCC---------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceee
Q 011498 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDV---------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277 (484)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH 277 (484)
++++.+....++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999986432 1123578889999999999999999998 9999
Q ss_pred cCCCCCcEEEcCCCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh--CCCC
Q 011498 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT--GRNP 354 (484)
Q Consensus 278 ~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--G~~p 354 (484)
|||||+|||++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999765333221 2233446788999999988899999999999999999987 5567
Q ss_pred CCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 355 VDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
|...... ............... ... ... +..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~-~~~-~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGR-QVY-LFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccc-ccc-ccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7644322 112221111111100 000 001 1123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.81 Aligned_cols=247 Identities=22% Similarity=0.387 Sum_probs=207.1
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHH---HHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.+|.+.+.||+|.||+|-+|.. ..|+.||||.++++....++ .+.+|+++|+.|+||||+.++.+|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999984 67999999999887654444 5678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||..+|.|++|+..+ ..|++..+..++.||..|+.|+|.+ +++|||||.+|||||.|+++||+|||++.++..
T Consensus 133 EYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999865 5799999999999999999999999 999999999999999999999999999988754
Q ss_pred CCceeecccccccccccccccccCCCC-cccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. ....+||++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+-. .+ +..........|
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l-------vrQIs~GaYrEP 273 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL-------VRQISRGAYREP 273 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH-------HHHhhcccccCC
Confidence 33 35668999999999999998874 7899999999999999999999866421 11 111111122222
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
..+ ....-||.+||..||++|.|+.+|....
T Consensus 274 ~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ETP--------SDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCC--------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 222 1344577899999999999999997743
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.09 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=211.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCC-CEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecc-eeeeC------C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDG-TKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLG-YCVEG------A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~~~------~ 220 (484)
..++++.+.|.+|||+.||+|....+ ..||+|++..........+.+|+++|++|. |+|||.+++ ..... -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 46678889999999999999997665 999999998887778889999999999995 999999999 33321 3
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
+.+|+||||.||.|-++|+.+... .|++.++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 568999999999999999866443 399999999999999999999986 78899999999999999999999999999
Q ss_pred cccccCCC-cee-------eccccccccccccccc---ccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh
Q 011498 301 AKLLCSER-SYV-------TTRVMGTFGYVAPEYA---CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 301 a~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~ 369 (484)
+.-..... ... .-...-|+.|+|||.+ .+.++++|+|||+|||+||-|+....||+....-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 96532221 100 0112468999999966 4778999999999999999999999999865322
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.++.........+.+...|..||..||+.||++||++.+|+..+..
T Consensus 265 -----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 -----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 2334444444446788899999999999999999999999987753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=329.08 Aligned_cols=255 Identities=26% Similarity=0.411 Sum_probs=203.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||.||+|.++ .+..||+|.+..... .....+..|+.++..++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999853 356899998876532 334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997542 4689999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
............++..|+|||++.+..++.++|||||||++||+++ |..||....... .. .... ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~---~~~~-~~~----- 225 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VI---KAVE-DGF----- 225 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH---HHHH-CCC-----
Confidence 2222111222335678999999999999999999999999999875 999997543221 11 1111 110
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... .+..++..+.+++.+||+.+|.+||++.+|++.|..
T Consensus 226 ~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 RLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 001 112244568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=328.62 Aligned_cols=250 Identities=23% Similarity=0.270 Sum_probs=199.2
Q ss_pred CCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56678999999999999986 4689999998864422 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998886432 23589999999999999999999998 99999999999999999999999999997653322
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
......||..|+|||++.+..++.++|||||||++|||++|+.||.......... .+...... . .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~--------~--~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKE--------D--Q 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhc--------c--c
Confidence 1234568999999999999999999999999999999999999997654321111 01110000 0 0
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
..........+.+|+.+||+.||.+||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111223456888999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.53 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=201.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 223 (484)
..++|.+.++||+|.||+|+++..+ +++.+|||.+++.. ....+..+.|.+++... +||.++.++.+|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467999999999999999999976 47899999997764 23445677788888777 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+.||++..+.+. ..+++..+..++..|+.||+|||++ +|||||||-+|||||.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 99999999995544432 4589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
... ....+.++|||+.|+|||++.+..|+..+|+|||||+|||||.|..||.+.+..+.. +.+.. -
T Consensus 518 ~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F---dsI~~----------d 583 (694)
T KOG0694|consen 518 GMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF---DSIVN----------D 583 (694)
T ss_pred cCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHhc----------C
Confidence 532 223577899999999999999999999999999999999999999999876643221 11110 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
+ ..++..+..+...++.+.|..||++|..+
T Consensus 584 ~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 11233345667788889999999999776
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=335.33 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=195.0
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
+.||+|+||.||++..+ +|+.||+|++.... ......+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 58899999886542 223346778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 312 (484)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 999999754 4689999999999999999999998 999999999999999999999999999875322211 23
Q ss_pred cccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCCh
Q 011498 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392 (484)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (484)
...+||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ..... . +..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~---~~~~~-~------~~~~p---- 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELILM-E------EIRFP---- 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH---HHHHc-C------CCCCC----
Confidence 3456999999999999999999999999999999999999999643321 111 11110 0 01111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 011498 393 SKALKRVLLVALRCVDPDATKRP-----KMGHVIH 422 (484)
Q Consensus 393 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 422 (484)
......+.+++.+||..||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12345678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.46 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=203.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||+|++..... .....+..|+.++..++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 478999999865421 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.++++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999754 4588999999999999999999998 999999999999999999999999999976533
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
......||+.|+|||++.+..++.++|||||||++|||++|..||......+.... +.. ... ....+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~---i~~---~~~--~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN---LKY---WKE--TLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH---HHh---ccc--cccCCC
Confidence 23345689999999999999999999999999999999999999975543211110 000 000 000011
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
. ..........+.+++.+||..+|.+||++.++++.-
T Consensus 222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 1 000112345678889999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.00 Aligned_cols=259 Identities=31% Similarity=0.568 Sum_probs=209.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
..+...+.||+|+||.||+|+. .++..||||++....... ..|++.+++++|||||+++++|.+....++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 3466778999999999999996 468899999886443221 23578899999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.++++ .++|..+..++.|++.||+|||..+.++|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999995 37899999999999999999996656699999999999999999888875 6655432211
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
....+|..|+|||++.+..++.++|||||||++|||+||+.||.... ........|.............+++.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence 12357899999999999999999999999999999999999995432 22334556655544444445556665533
Q ss_pred --CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 390 --MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 390 --~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
....+...++.+++.+||+.||++||||.||++.|+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 23345667889999999999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=343.73 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=202.8
Q ss_pred hcCCCcCceeccCCceEEEEEEE------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
.++|.+.+.||+|+||.||+|++ ..+..||||++.... ......+.+|+.++..+ +||||++++++|.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35688889999999999999974 235689999886443 23345788899999999 89999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCC----------------------------------------------------------
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG---------------------------------------------------------- 243 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 243 (484)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999964321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 244 -------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 244 -------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 012578899999999999999999998 9999999999999999999999999999765433221
Q ss_pred -eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 311 -VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 311 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
......++..|+|||++.+..++.++|||||||++|||++ |..||....... .....+. ... .+..+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~-----~~~~~ 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGY-----RMLSP 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCc-----cCCCC
Confidence 1122334567999999999999999999999999999998 899986543211 1111111 110 00011
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......+.+|+.+||+.||++||++.+|++.|+.
T Consensus 340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=342.56 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=204.6
Q ss_pred CCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
-|..++.||.|+.|.|-+|++ .+|+.+|||++.... ......+.+|+-+|+.+.|||++++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 356678999999999999995 469999999986552 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|.|++||-.+ +++++..+.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-..
T Consensus 93 yv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred ecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 99999999999755 5799999999999999999999998 999999999999999999999999999976433
Q ss_pred CceeecccccccccccccccccCCCC-cccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.......||++.|.+||++++.+|+ .++||||+|||||.||||+.||+..+ +...+.. +..+.
T Consensus 165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlK-V~~G~-------- 228 (786)
T KOG0588|consen 165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLK-VQRGV-------- 228 (786)
T ss_pred -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHH-HHcCc--------
Confidence 2334557899999999999999886 68999999999999999999998443 2211111 11111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
...+.....+..+|+.+|+..||++|.|++||++.-
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 111233445677888899999999999999999843
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.09 Aligned_cols=251 Identities=25% Similarity=0.442 Sum_probs=202.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||++.++++..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999999878889999875432 334678889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.++++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999997542 3588999999999999999999998 9999999999999999999999999998765333222
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+. ... ....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~---~~~---~~~~~---- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMIS---RGF---RLYRP---- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---CCC---CCCCC----
Confidence 2222335668999999988899999999999999999999 99999754322 1111111 100 00111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
......+.+++.+||+.||++||++.++++.|
T Consensus 224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.37 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=201.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||.||+|+.+ ++..||+|++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999976 47889999886542 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|++++.|..+.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776554322 4588999999999999999999998 9999999999999999999999999999876433
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh---------hhhhhcCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW---------LKTMVGSRK 378 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~---------~~~~~~~~~ 378 (484)
.........|++.|+|||++.+..++.++|||||||++|||++|++||......+....... .........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 22223345689999999999988999999999999999999999999976543221111000 000000000
Q ss_pred cccccCCCCCC------CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPK------MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+.... .........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000010000 001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=324.46 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=206.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|...++..||+|.+.... ...+.+..|+.+++.++|+||+++++++......+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688889999999999999998888899999876433 235678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.++++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999997542 24588899999999999999999998 9999999999999999999999999999876433222
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||++....++.++|||||||++|+|+| |..||....... ....+. . .. ..+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~---~-~~----~~~~--- 225 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ---R-GY----RMPR--- 225 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH---c-CC----CCCC---
Confidence 2223345678999999988889999999999999999998 999997543221 111111 0 00 0011
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.......+.+++.+||..||++||++++|++.|++
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 --MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11233568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.56 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=198.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+..|+.+++.++||||+++++++.+....++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 47899999886432 123456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+.+|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999754 4588899999999999999999998 999999999999999999999999999986533
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.. ....||+.|+|||++.+..++.++|||||||++|||++|..||....+.. ...... ... ..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~-~~~------~~ 233 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKIL-AGR------LK 233 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHh-cCC------cC
Confidence 22 23468999999999999999999999999999999999999996543211 111111 110 01
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
++.. ....+.+++.+||+.||.+||+ +++++.
T Consensus 234 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 2345788999999999999997 566654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.18 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=199.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999975 58899999885432 123456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999754 4688999999999999999999998 999999999999999999999999999976533
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. .....|++.|+|||++.+..++.++|||||||++|||++|..||....... ....... .. ..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~~-~~------~~ 216 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKILA-GK------LE 216 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CC------cC
Confidence 2 223468999999999999899999999999999999999999997543211 1111111 00 01
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 423 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 423 (484)
++. .....+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111 12345788999999999999995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=341.29 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=202.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... ......+..|+.+++.+ +|+||++++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 356888999999999999999842 23579999986543 23345688899999999 89999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCC----------------------------------------------------------
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG---------------------------------------------------------- 243 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 243 (484)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce-eecc
Q 011498 244 --------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTR 314 (484)
Q Consensus 244 --------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 314 (484)
...++++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 113478889999999999999999998 9999999999999999999999999999765332211 1222
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 393 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (484)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. ...... ..+..+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~-----~~~~~~~---- 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG-----YQMSRPD---- 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc-----cCccCCC----
Confidence 335668999999998899999999999999999998 9999975432211 11 111110 0111111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 394 KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 394 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 123568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.01 Aligned_cols=252 Identities=26% Similarity=0.300 Sum_probs=198.0
Q ss_pred CCCcCceeccCCceEEEEEEE----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCee
Q 011498 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 222 (484)
+|.+.+.||+|+||.||+++. .++..||+|++.... ......+..|+.++..+ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999985 257899999886432 22335677899999999 599999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999999654 4588999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
..............||+.|+|||++.+. .++.++|||||||++|||+||..||......... .........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc------
Confidence 6543333233345799999999998765 4789999999999999999999999754322111 111111110
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
.++.++. .....+.+++.+||+.||++|| +++++++.
T Consensus 226 -~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1122221 2334578889999999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=332.67 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=203.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||++... ++..||+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67888999999999999999975 47889999886543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++|+|.+++... ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 85 MDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999754 35889999999999999999999751 6999999999999999999999999998765322
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC--C--------
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR--K-------- 378 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~-------- 378 (484)
......|+..|+|||++.+..++.++|||||||++|||+||+.||....... +...+....... .
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1233568999999999999999999999999999999999999996433211 000000000000 0
Q ss_pred ------------------------cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 379 ------------------------SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 379 ------------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
...+.....+..........+.+++.+||+.||++|||+.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000001111112244578899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.14 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=205.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++||||+++++++......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998777889999886543 23567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997543 34689999999999999999999998 999999999999999999999999999987643221
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
........+..|+|||++.+..++.++||||||+++|||+| |+.||....... .. .... ... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~---~~~~-~~~---------~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL---QQVD-QGY---------R 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH---HHHH-cCC---------C
Confidence 11111223457999999998899999999999999999999 999997543211 11 1111 100 0
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..........+.+++.+||+.||++||++.+|++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01111234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.94 Aligned_cols=255 Identities=27% Similarity=0.476 Sum_probs=209.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
..+|.+.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688889999999999999998888999999987666555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.++++... ...+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999997542 24689999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
......++..|+|||.+....++.++||||||+++|+|++ |+.||....... .. ..... ...
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~---~~~~~----------~~~ 222 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VY---DQITA----------GYR 222 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HH---HHHHh----------CCc
Confidence 1223345678999999988899999999999999999998 899997544211 11 11110 000
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...+..+...+.+++.+||+.||++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11112334568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=325.03 Aligned_cols=257 Identities=28% Similarity=0.497 Sum_probs=205.6
Q ss_pred cCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
.+|.+.+.||+|+||.||+|.... ...|++|.+.... ......+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778899999999999998643 2579999886543 234467889999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC
Q 011498 224 LVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999975321 114588899999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhh
Q 011498 292 NARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 292 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~ 369 (484)
.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999976533221 12233456788999999988899999999999999999998 999987544321 1111
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+.... ....+..++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 239 ----i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 111123345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=324.98 Aligned_cols=256 Identities=26% Similarity=0.473 Sum_probs=205.4
Q ss_pred cCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
.+|.+.+.||+|+||.||+|...+ +..||+|.+...... ....+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 468999988665443 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 224 LVYEYVDNGNLDQWLHGDV----------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
++|||+++++|.++++... .....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997542 1234578999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhh
Q 011498 294 RVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 371 (484)
||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 9999999875432221 11223345778999999999999999999999999999999 999986543221 111111
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.... ...+......+.+++.+||+.||++||++.||++.|+
T Consensus 239 ----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ----QGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1110 0111223456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=348.76 Aligned_cols=252 Identities=20% Similarity=0.295 Sum_probs=203.8
Q ss_pred CCCcCceeccCCceEEEEEEEC-C-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-D-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3777889999999999999854 3 5778888775555555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.++|+.......++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999875443445789999999999999999999998 999999999999999999999999999987643322
Q ss_pred -eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 -YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..... .. ..+ .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~-~~----~~~-~- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY-GK----YDP-F- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CC----CCC-C-
Confidence 1234457999999999999999999999999999999999999999643321 11111111 00 000 1
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+......+.+++.+||..||++||++.+++.
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1123356888999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=321.04 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=202.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577788999999999999998777779999876433 334678899999999999999999999998888999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999997542 3589999999999999999999998 9999999999999999999999999998765433322
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|++||.+.+..++.++|||||||++|||++ |..||....... ....+ ..... ...+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~---~~~~~------~~~~- 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV---SQGLR------LYRP- 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH---hcCCC------CCCC-
Confidence 2222335678999999988889999999999999999999 999987544211 11111 10000 0011
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
......+.+++.+||+.||.+||++.+|++.|+
T Consensus 224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112456888999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=329.98 Aligned_cols=239 Identities=22% Similarity=0.265 Sum_probs=191.8
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 47889999886432 23345677899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 9999754 4589999999999999999999998 999999999999999999999999999875432221 2334
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..||+.|+|||++.+..++.++|||||||++|||++|..||..... ........... ..+ +..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~-------~~~----~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP-------LRF----PDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC-------CCC----CCc
Confidence 5799999999999999999999999999999999999999975432 11111111100 011 112
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+.+++.+||+.||.+||++..+.+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 3356788899999999999986544333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=303.57 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=207.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+++.||+|.||.||.|+.+ ++-.||+|++.+.. ......+.+|+++-+.|+||||+++|++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56888999999999999999964 57789999997654 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||..+|+|+..|.... ...+++.....+..|+|.||.|+|.. +|+||||||+|+|++..+.+||+|||.+....
T Consensus 102 Eya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999998543 25588888999999999999999998 99999999999999999999999999997643
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.......|||..|.+||...+..++..+|+|++|++.||++.|.+||+.....+... .+.. -++.+|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk---rI~k-------~~~~~p- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK---RIRK-------VDLKFP- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH---HHHH-------ccccCC-
Confidence 334556789999999999999999999999999999999999999998665221111 1110 111111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........+++.+|+..+|.+|.+..|++.
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 233456788999999999999999999876
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=338.28 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=195.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ......+..|+++++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999964 48899999885432 123456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999999754 4588899999999999999999998 999999999999999999999999999743210
Q ss_pred C------------------------------------------CceeecccccccccccccccccCCCCcccceecchhH
Q 011498 307 E------------------------------------------RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGIL 344 (484)
Q Consensus 307 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 344 (484)
. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0000123469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC---CHHHHH
Q 011498 345 IMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP---KMGHVI 421 (484)
Q Consensus 345 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl 421 (484)
+|||++|+.||....+.... ........ ....+. .......+.+++.+|+ .+|.+|+ ++.+++
T Consensus 234 lyell~G~~Pf~~~~~~~~~------~~i~~~~~--~~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQ------LKVINWET--TLHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHHHHH------HHHhccCc--cccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999999765432111 11110000 000011 1112334566666765 4999999 888887
Q ss_pred HH
Q 011498 422 HM 423 (484)
Q Consensus 422 ~~ 423 (484)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=331.48 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=195.7
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
+.||+|+||.||++... ++..||+|++.... ......+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999964 58899999986542 223456778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 312 (484)
+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 999998654 4689999999999999999999998 999999999999999999999999999875422211 22
Q ss_pred cccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCCh
Q 011498 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392 (484)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (484)
...+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....... . ...++.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~-~------~~~~p~--- 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM-E------DIKFPR--- 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhcc-C------CccCCC---
Confidence 34579999999999999999999999999999999999999997543211 1111100 0 111111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 393 SKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 393 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
.....+.+++.+||..||++|| ++.++++.
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 -TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2334678888999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.63 Aligned_cols=241 Identities=26% Similarity=0.378 Sum_probs=193.6
Q ss_pred ceeccCCceEEEEEEE----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+.||+|+||.||+++. ..++.||+|.+.... ......+..|+.+++.++||||+++++++..+...|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 247889999886532 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++|+|.+++... ..+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999999754 4578888999999999999999998 99999999999999999999999999987543222
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..++
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~-------~~~~ 220 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGK-------LNLP 220 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-------CCCC
Confidence 2 233456899999999999888999999999999999999999999754321 1111111110 0111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 422 (484)
. .....+.+++.+||+.||++|| ++.++++
T Consensus 221 ~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 P----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 1234678899999999999999 7777766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=337.67 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=217.8
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 144 RELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 144 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
+.++-...+.+..++||-|.||.||.|+|+. .-.||||.++.+.. ...+|..|..+|+.++|||+|+|+|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555556677788999999999999999875 56799998876553 457899999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|||+|||.+|+|.+||+.. +...++....+.++.||+.||+||..+ ++|||||.++|+|+.++..+|++|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999876 345677788899999999999999998 99999999999999999999999999999
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
++..+...-....--...|.|||-+....++.|+|||+|||+|||+.| |..||.+.+..... .
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY----------------~ 477 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------G 477 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH----------------H
Confidence 987655433333334568999999999999999999999999999999 98898755422111 1
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
++....+-..+..|+..+.+||+.||+.+|.+||++.||-+.+|.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 122222233345577789999999999999999999999988874
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=333.56 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=203.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+..|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999975 58899999986532 133456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999754 4689999999999999999999998 999999999999999999999999999976543
Q ss_pred CC----------------------------ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCC
Q 011498 307 ER----------------------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYS 358 (484)
Q Consensus 307 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~ 358 (484)
.. ........||+.|+|||++.+..++.++|||||||+||||++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11123356899999999999999999999999999999999999999755
Q ss_pred CCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHH
Q 011498 359 RPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIHML 424 (484)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~L 424 (484)
.... ......... .....+.. ......+.+++.+|+. ||.+||+ ++++++..
T Consensus 234 ~~~~------~~~~i~~~~--~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 234 TLQE------TYNKIINWK--ESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CHHH------HHHHHhccC--CcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 4211 111111100 00001111 1134568888889997 9999999 99998853
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=321.33 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=204.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|.+.+.||+|+||.||+|.++ .+..||+|.+.... .....+.+|+++++.++||||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999965 47889999876443 33467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ...+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999996542 24589999999999999999999998 999999999999999999999999999976543322
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +....... . ..+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~-~-----~~~~~- 226 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEK-G-----YRMER- 226 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHC-C-----CCCCC-
Confidence 22222234568999999999999999999999999999998 99998754321 11111111 0 01111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+......+.+++.+||+.||++||++.++++.|++
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 12234568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.68 Aligned_cols=260 Identities=22% Similarity=0.379 Sum_probs=208.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|+.. ++..||||.+... .......+..|+.+++.++||||+++++++......+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999964 6889999987542 2233457888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999864433345688999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|..||...... ...+..... . ..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~-~--------~~ 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIE-Q--------CD 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHh-c--------CC
Confidence 221 122345888999999998888999999999999999999999998643221 111111111 0 01
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+..........+.+++.+||+.+|++||++.+|++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11222233456788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=331.03 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=194.8
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
+.||+|+||.||++... +|..||+|.+.... ......+..|+.+++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 58899999986542 223346678999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 312 (484)
+|..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 999988654 4689999999999999999999998 999999999999999999999999999875322211 22
Q ss_pred cccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCCh
Q 011498 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392 (484)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (484)
....||+.|+|||++.+..++.++|||||||++|||++|..||....... . ....... ...++.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~~~~~-------~~~~p~--- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---FELILME-------EIRFPR--- 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHhcC-------CCCCCC---
Confidence 33568999999999999999999999999999999999999997543211 1 1111100 011111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 393 SKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 393 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
.....+.+++.+||+.||.+|| ++.++++.
T Consensus 217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 -TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2345678899999999999998 78887763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=333.78 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=198.8
Q ss_pred cCCCcCceeccCCceEEEEEEECC--CCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD--GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||.||+|.+++ +..||+|.+.... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998643 3589999885432 22345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999754 4588999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.. . ...... .. .
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~---~~~i~~-~~------~ 245 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---I---YQKILE-GI------I 245 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---H---HHHHhc-CC------C
Confidence 22 223568999999999998889999999999999999999999997543211 0 111110 00 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
..+. .....+.+++.+||+.||++|+ +++++++.
T Consensus 246 ~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111 1234577888999999999995 78888764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=333.56 Aligned_cols=252 Identities=18% Similarity=0.287 Sum_probs=195.4
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.|...+.||+|+||+||+|+.. ++..||+|++.... ......+..|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778889999999999999864 57899999986532 2334568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999999754 4588999999999999999999998 9999999999999999999999999997532100
Q ss_pred Cc----------------------------------------------eeecccccccccccccccccCCCCcccceecc
Q 011498 308 RS----------------------------------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 341 (484)
Q Consensus 308 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 341 (484)
.. ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998899999999999
Q ss_pred hhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHh--cCCCCCCCCCCHHH
Q 011498 342 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALR--CVDPDATKRPKMGH 419 (484)
Q Consensus 342 G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPs~~e 419 (484)
||++|||+||..||......... ........ .. ..+. .......+.+++.+ |+..+|..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~--~~---~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWEN--TL---HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH------HHHHcccc--cc---CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999999755432110 01110000 00 1111 11123345566666 66777778999999
Q ss_pred HHHH
Q 011498 420 VIHM 423 (484)
Q Consensus 420 vl~~ 423 (484)
|+..
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.77 Aligned_cols=248 Identities=32% Similarity=0.579 Sum_probs=193.0
Q ss_pred CceeccCCceEEEEEEEC-----CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 156 ENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+.||.|.||.||+|.+. .+..|+||.+..... ...+.+.+|++.+++++||||++++|++......++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999986 256899999965433 34678999999999999999999999999888899999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.++|+.. ....+++..++.|+.||+.||.|||++ +++|+||+++||+++.++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999876 235689999999999999999999998 999999999999999999999999999987632222
Q ss_pred -eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 310 -YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 310 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
...........|+|||.+....++.++||||||+++|||++ |+.||...... +..... .....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~~-~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEKL-KQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHHH-HTTEE--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccc-ccccc--------
Confidence 22233456778999999999889999999999999999999 78888644221 111111 11110
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
......+...+.+++.+||..||++|||+.+|++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011122345688899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.91 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=198.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999975 58899999986432 223356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999999754 4589999999999999999999998 999999999999999999999999999875422
Q ss_pred CCce-------------------------------------eecccccccccccccccccCCCCcccceecchhHHHHHH
Q 011498 307 ERSY-------------------------------------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEII 349 (484)
Q Consensus 307 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 349 (484)
.... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHH
Q 011498 350 TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---MGHVIHM 423 (484)
Q Consensus 350 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~ 423 (484)
+|..||........ ......... ... .+. .......+.+++.+|+. +|.+|++ +.++++.
T Consensus 234 ~G~~Pf~~~~~~~~------~~~i~~~~~--~~~---~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQET------YRKIINWKE--TLQ---FPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHH------HHHHHcCCC--ccC---CCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999975542211 111111000 000 111 11123456778888886 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.80 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=200.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++... ++..||+|.+..... .....+..|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999965 588999999865432 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.++++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997542 3689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeecccccccccccccccc------cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYAC------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
..........||+.|+|||++. ...++.++|||||||++|||++|..||....... ..........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~-- 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQR-- 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCC--
Confidence 4333333456899999999986 4567899999999999999999999997543211 1111111110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. ..+. .......+.+++..||. ||.+||++++++.
T Consensus 227 -~~--~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 -FL--KFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -cc--CCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 0111 11233457788889998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.26 Aligned_cols=261 Identities=21% Similarity=0.331 Sum_probs=199.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||+|..+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 57899999886443 22345677899999999999999999999998899999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.+ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 9999886442 3578899999999999999999998 99999999999999999999999999987643222
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC-----------
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS----------- 376 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 376 (484)
. ......+++.|+|||++.+ ..++.++|||||||++|||+||++||......+..... ......
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI---FRLLGTPTEETWPGITS 233 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHHhhcccc
Confidence 1 1233467899999998865 56899999999999999999999999765432221111 110000
Q ss_pred -CCcccccCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 -RKSEEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 -~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........+....... ........+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000111111110000 112345788999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=318.60 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=200.9
Q ss_pred CCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+|++.+.||+|+||.||++.++++..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477788999999999999998777789999875432 2345688899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999997543 3589999999999999999999998 99999999999999999999999999987654322211
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+. .. .....+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~-----~~~~~~-- 223 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVS----AG-----YRLYRP-- 223 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHH----cC-----CcCCCC--
Confidence 112223457999999998899999999999999999999 899997543221 111110 00 011111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
......+.+++.+||..+|++|||+.+|++.|
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 --KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.56 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=204.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccch-hhHHHHHHHHHHHhccC-CCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~ 221 (484)
.++|.+.+.||+|+||.||+|++.. +..||||++..... ...+.+..|+.+++.+. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678889999999999999998531 34699999865433 33467889999999995 9999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCC----------------------------------------------------------
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG---------------------------------------------------------- 243 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 243 (484)
.|+||||+++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999864311
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC
Q 011498 244 ----------------------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289 (484)
Q Consensus 244 ----------------------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~ 289 (484)
....+++..++.++.|++.||.|||+. +|+|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 013478888999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchh
Q 011498 290 QWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLV 367 (484)
Q Consensus 290 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~ 367 (484)
++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 999999999999765332221 1222346778999999998899999999999999999997 9999875432111 00
Q ss_pred hhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...... ............+.+++.+||+.||++||++.+|.+.|+.
T Consensus 351 ----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 351 ----NKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred ----HHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 111110 0001112344578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=328.57 Aligned_cols=200 Identities=26% Similarity=0.409 Sum_probs=174.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++||||++++++|.+....++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999976 47889999876542 3344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999754 45889999999999999999999741 7999999999999999999999999998755322
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYS 358 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~ 358 (484)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123346899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.68 Aligned_cols=258 Identities=26% Similarity=0.476 Sum_probs=206.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|.+.+.||+|+||.||++... ++..+|+|.+..........+..|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999842 245689998876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 225 VYEYVDNGNLDQWLHGDV---------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999997432 1223589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhh
Q 011498 296 SDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
+|||++......... ......++..|+|||++.+..++.++|||||||++|+|+| |..||....... .. ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~---~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI---ECI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHH
Confidence 999999765332211 1223345778999999998899999999999999999999 999986544221 11 111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
..... ...+. .....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 236 -~~~~~-----~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 236 -TQGRV-----LQRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred -HcCCc-----CCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11110 01111 1234688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=310.76 Aligned_cols=259 Identities=23% Similarity=0.310 Sum_probs=201.6
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh--hHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEEEE
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVYE 227 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 227 (484)
|...+.|++|+||.||+|+.+ +++.||+|+++..... ..-.-.+|+.+|.+++|||||.+..+.... +.+|||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 555678999999999999964 5889999999765432 223456799999999999999999887743 46899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
||++ +|..+|.... .++...++.-+..|++.|++|||++ .|+|||||++|+|++..|.+||+|||+|+.+.+.
T Consensus 158 ~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9998 9999997653 5788899999999999999999999 9999999999999999999999999999988655
Q ss_pred CceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC---ccccc
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---SEEVV 383 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 383 (484)
. ...+..+-|.+|+|||++.+. .|+++.|+||+|||+.||+++++.|.+...-+..+.+ ....+... ...+.
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I---f~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI---FKLLGTPSEAIWPGYS 306 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH---HHHhCCCccccCCCcc
Confidence 3 345667889999999988865 6999999999999999999999999877654433332 22222110 00000
Q ss_pred CC------CCCCCCh--------HH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DP------KLPKMPA--------SK-ALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~------~~~~~~~--------~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. .++..+. .. ....=++|+...|..||.+|.|+.|-|+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 0011111 00 2245567778899999999999999877
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=316.61 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=202.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 46788899999999999999988888899998865433 34678899999999999999999998754 56799999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.++++... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999997542 24589999999999999999999998 9999999999999999999999999999765433222
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||++.+..++.++||||||+++|||++ |..||...... ... ...... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~---~~~~~~----------~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVL---EQVERG----------YRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHcC----------CCC
Confidence 1222335668999999988889999999999999999999 89999654321 111 111110 001
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.........+.+++.+||..||++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.69 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=191.5
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
|...+.||+|+||.||+|++. +++.||||.+..... .....+.+|+++++.++|+||+++++++......++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999965 588999999865433 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986532 356777889999999999999998 999999999999999999999999999986533221
Q ss_pred eeccccccccccccccccc-----CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 311 VTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+. ..... .
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~-~-------- 291 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAICM-S-------- 291 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhc-c--------
Confidence 2234568999999998743 23456899999999999999999999743322111111 11000 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............+.+++.+||+.||++|||+.||++
T Consensus 292 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 292 -QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111223456889999999999999999999987
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=324.79 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=189.6
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhc-cCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|... ++..||+|.+.... ......+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 47889999886542 1223344556666665 4899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999998754 4588999999999999999999998 99999999999999999999999999997543222 22
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ......... .+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-------~~~~~~-- 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILND-------RPHFPR-- 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-------CCCCCC--
Confidence 33457999999999999989999999999999999999999999754321 111111110 111111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMG-HVIH 422 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~ 422 (484)
.....+.+++.+||+.||.+||++. ++++
T Consensus 218 --~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 --WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1334577888999999999999975 4433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=317.03 Aligned_cols=254 Identities=30% Similarity=0.502 Sum_probs=204.0
Q ss_pred cCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|++.+.||+|+||.||+|.+.. ...||+|.+.... ......|..|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468888999999999999999743 3579999886543 33456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+|+||||+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999997543 3689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 306 SERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 306 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+. ... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~----~ 226 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVE----DGY----R 226 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCC----C
Confidence 2221 11222335678999999998899999999999999999998 99998643321 1111111 000 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+ ....+...+.+++.+||+.||++||++.+|++.|+.
T Consensus 227 ~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=330.50 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=214.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC---C--CEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD---G--TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~---~--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
.....+..+.||.|.||.||+|.+.+ | -.||||..+.++. ...+.|..|..+|+.++|||||+|+|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34455666789999999999999643 2 3589999987543 446789999999999999999999999987 468
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|||||.++.|.|..||+.+. ..++......++.||+.||+|||+. .+|||||..+|||+...--+||+|||+++
T Consensus 466 WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 99999999999999998764 4688889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
.+.++..+..+...-+..|||||.+....++.++|||.|||++||++. |..||.+-...+..-.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~--------------- 604 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH--------------- 604 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE---------------
Confidence 998777766665556779999999999999999999999999999998 9999987654432211
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+...-+...++.|+..|..|+.+||..||.+||.+.+|...|...
T Consensus 605 -iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 605 -IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred -ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 111222333445667889999999999999999999999888653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=329.29 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=210.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCe-eeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY-RMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 226 (484)
++|...+++|+|+||.++.++++ ++..|++|.+.-... ...+....|+.++++++|||||.+.+.|+.++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778889999999999999865 477899998865542 233467789999999999999999999998887 99999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
+||+||+|.+.|...+ ..-++++.+..|+.|++.|+.|||++ .|+|||||+.||+++.++.+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998764 45689999999999999999999988 999999999999999999999999999998866
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... .....+||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|...+...- +.-+.. .
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i~ki~~-------------~ 221 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---ILKINR-------------G 221 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---HHHHhh-------------c
Confidence 542 24457899999999999999999999999999999999999999987654321 111110 1
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.-...+..+...+..++..|+..+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122233456678889999999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=321.38 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=202.3
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--------------hhHHHHHHHHHHHhccCCCce
Q 011498 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------------QAEKEFKVEVEVIGRVRHKNL 209 (484)
Q Consensus 145 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------------~~~~~~~~e~~~l~~l~H~ni 209 (484)
+-....+.|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33445678999999999999999999954 588999999854321 112467889999999999999
Q ss_pred eeecceeeeC--CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 210 VRLLGYCVEG--AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 210 v~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
|+|+.+..+. +.+|||+|||..|.+...-. ....+.+.++++++.+++.||+|||.+ ||+||||||+|+||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl 243 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL 243 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence 9999998764 57899999999988765321 222399999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecccccccCC----CceeecccccccccccccccccCC----CCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 288 DRQWNARVSDFGLAKLLCSE----RSYVTTRVMGTFGYVAPEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
+++|++||+|||.+...... ........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 99999999999999866322 111223468999999999887643 3568999999999999999999997543
Q ss_pred CCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 360 PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
..+ +. ..++...+......+....+.+|++++|++||++|.+..+|....
T Consensus 324 ~~~---l~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ELE---LF------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHH---HH------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 211 11 122222333333335667889999999999999999998886644
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.72 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=201.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
..++|.+.+.||+|+||.||++... ++..||+|.+.... ......+..|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567889999999999999999965 57899999885432 2233457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998643 478888999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCceeecccccccccccccccccC----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
............||+.|+|||++.+. .++.++|||||||++|||++|..||....... ..........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~-- 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKN-- 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCC--
Confidence 43332223345799999999988653 47899999999999999999999997544211 1111111100
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHM 423 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 423 (484)
.. ..+ ........+.+++.+||+.+|.+ ||++.+++..
T Consensus 265 ~~---~~~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SL---TFP--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cC---CCC--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 011 11123456788889999999988 9999999774
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=327.23 Aligned_cols=242 Identities=22% Similarity=0.295 Sum_probs=194.3
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
+.||+|+||.||++... ++..||+|.+.... ......+..|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 58899999886532 223356677999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
+|.+++... ..+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 999998644 468999999999999999999996 6 999999999999999999999999999875432221 1
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||+||..||....... .. .... .. ...++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~---~~i~-~~------~~~~p~-- 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---ELIL-ME------EIRFPR-- 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HH---HHHh-cC------CCCCCC--
Confidence 233569999999999999999999999999999999999999997543211 11 1110 00 011111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
.....+.+++.+||+.||++|+ ++.++++.
T Consensus 218 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 --TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1234678889999999999997 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=316.75 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=202.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
.+|.+.+.||+|+||.||+|.+.++..||+|++..... ....+..|+.+++.++||||+++++++.. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46888999999999999999987777899998865332 34578889999999999999999998754 55799999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999997542 24578999999999999999999998 9999999999999999999999999999765433322
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||+..+..++.++|||||||++|||+| |..||........ . ..... . ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~---~~~~~-~---------~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L---DQVER-G---------YRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H---HHHhc-C---------CCC
Confidence 2222346678999999988899999999999999999999 8889865432211 1 11100 0 001
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.........+.+++.+||+.||++||++.++++.|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.47 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=193.3
Q ss_pred CCCcCceeccCCceEEEEEEEC--CCCEEEEEEecccch--hhHHHHHHHHHHHhcc---CCCceeeecceeee-----C
Q 011498 152 GLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVE-----G 219 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~ 219 (484)
+|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999863 467899998864332 2233455677666655 69999999999852 3
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 46899999996 59999986542 24589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC-
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK- 378 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 378 (484)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|.+||......+. ...+........
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCCh
Confidence 99765432 123345689999999999888999999999999999999999999976543211 111111110000
Q ss_pred --c-------ccccCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 --S-------EEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 --~-------~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. .....+. ..... ......+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCC-CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000 00000 123356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=332.35 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=200.3
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCC
Q 011498 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (484)
Q Consensus 145 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 220 (484)
.+....++|.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33444678999999999999999999975 47889999885422 223456778999999999999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999999643 478889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccccC----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
+...............||+.|+|||++.+. .++.++|||||||+||||++|..||....... ........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~ 262 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDH 262 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhC
Confidence 987643332223456799999999998754 37889999999999999999999997543211 11111111
Q ss_pred CCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 011498 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHM 423 (484)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 423 (484)
... ..++ ........+.+++..|+..++.+ ||++.++++.
T Consensus 263 ~~~-----~~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNS-----LNFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Ccc-----cCCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0111 11123445677788888755543 8999998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.23 Aligned_cols=258 Identities=23% Similarity=0.423 Sum_probs=202.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 221 (484)
.+++|++.+.||+|+||.||+|.+. .+..||+|.+.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999853 24679999875432 2334568889999999999999999999999899
Q ss_pred eeEEEEecCCCCHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGD------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
.++||||+++|+|.++++..... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999653211 23467889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhh
Q 011498 296 SDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
+|||++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~---~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VL---RFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HHH
Confidence 9999987553322211 112345778999999998899999999999999999999 788986543221 11 111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
. ..... .. .......+.+++.+||+.||++|||+.|+++.|+
T Consensus 235 ~-~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 M-EGGLL-----DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred H-cCCcC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1 11000 01 1123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=324.95 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=200.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|...+.||+|+||.||+|.+. ++. .||+|.+.... .....++..|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999864 233 48999886543 34456788999999999999999999999875 5689
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
++||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997542 3588999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
....... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ... ...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~--~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE--RL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCCC--CC
Confidence 4332221 122234668999999999999999999999999999998 999997543211 111 111110 00
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
..+ ..+...+.+++.+||..||++||++.+|+..|...
T Consensus 231 ---~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 ---PQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred ---CCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011 11234688899999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.21 Aligned_cols=238 Identities=24% Similarity=0.320 Sum_probs=191.9
Q ss_pred ceeccCCceEEEEEEE----CCCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
+.||+|+||.||++.. .+|..||+|++..... .....+..|++++++++||||+++++++.+....|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999998865432 223456779999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999999654 4589999999999999999999998 999999999999999999999999999876533221
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... . ...... .. ..++
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~---~~~i~~-~~------~~~p-- 218 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---T---MTMILK-AK------LGMP-- 218 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---H---HHHHHc-CC------CCCC--
Confidence 2334578999999999998889999999999999999999999997543211 1 111110 00 0111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGH 419 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~e 419 (484)
......+.+++.+||+.||++||++.+
T Consensus 219 --~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 --QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 123346788899999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.76 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=206.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999843 245688998876665556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc
Q 011498 225 VYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~ 292 (484)
||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999975321 123488999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhh
Q 011498 293 ARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL 370 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~ 370 (484)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||+| |..||....... ..+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence 99999999976543221 11233456788999999999999999999999999999999 999986543221 111
Q ss_pred hhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.. ...... . .....+..+.+++.+||+.||++||++.+|+++|++.
T Consensus 237 -~~-~~~~~~-----~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 237 -CI-TQGRVL-----E----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -HH-hCCCCC-----C----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11 111100 0 1112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=316.77 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=199.2
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC-----eeeEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-----YRMLV 225 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv 225 (484)
.|...+++|.|+||.||+|... ++..||||++..+.... .+|+.+|+++.|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3555789999999999999964 46899999997776433 24888999999999999999887432 33589
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLL 304 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgla~~~ 304 (484)
|||++. +|.++++........++...+.-+..||.+||.|||.. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999988 99999985433345677777888999999999999998 99999999999999976 89999999999987
Q ss_pred cCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc----
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS---- 379 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 379 (484)
....... ....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+....+....+ ....+....
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI---ik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI---IKVLGTPTREDIK 251 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH---HHHhCCCCHHHHh
Confidence 6544332 23457789999998864 6999999999999999999999999886543322221 111111110
Q ss_pred ------ccccCCCCCCC-----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 380 ------EEVVDPKLPKM-----PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 380 ------~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.+...|.+... .......+..+++.++|..+|.+|.++.|++..=-
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 11122222222 22334567889999999999999999999987443
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=315.25 Aligned_cols=259 Identities=23% Similarity=0.402 Sum_probs=207.3
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++.. .++..++||.+.... .....++..|+.+++.++||||+++++++......+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4577788999999999999995 468899999875432 223457888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433345689999999999999999999998 999999999999999999999999999876533
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ........ ... .
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~------~~~---~ 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI------EQC---D 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh------hcC---C
Confidence 222 122346888999999999888999999999999999999999998643321 11111110 011 1
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+..........+.+++.+||..||++|||+.+|++.++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111222345678899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=312.14 Aligned_cols=260 Identities=24% Similarity=0.419 Sum_probs=209.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +|..||+|.+.... ......+..|++++++++|+||+++++++......+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 68999999885322 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999975443445689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... ......++..|+|||.+.+..++.++|||||||++|+|++|..||..... +......... ...
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~---------~~~ 224 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE---------KCD 224 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhh---------cCC
Confidence 221 12234588899999999888899999999999999999999999864331 1111111110 001
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+..+.......+.+++.+||..+|++|||+.+|++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11112223455788999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=331.84 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=195.0
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Ceee
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~ 223 (484)
+|.+.+.||+|+||.||+|... ++..||||++.... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999964 58899999886432 23345688899999999999999999988643 2479
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 5999998644 4589999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCc--eeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC---
Q 011498 304 LCSERS--YVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS--- 376 (484)
Q Consensus 304 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 376 (484)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||++||.......... .+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD---LITDLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCCH
Confidence 432211 11234568999999999865 678999999999999999999999997543211110 00000000
Q ss_pred --------CCcccc---cCCCCCCCCh---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 --------RKSEEV---VDPKLPKMPA---SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 --------~~~~~~---~~~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...... +....+.... ......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0000000000 012345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=331.56 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=174.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+..|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999999999999865 47899999886532 223356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999754 4689999999999999999999998 999999999999999999999999999875422
Q ss_pred CCc----------------------------------eeecccccccccccccccccCCCCcccceecchhHHHHHHhCC
Q 011498 307 ERS----------------------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR 352 (484)
Q Consensus 307 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~ 352 (484)
... ......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 100 0012347999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 011498 353 NPVDYSR 359 (484)
Q Consensus 353 ~p~~~~~ 359 (484)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=312.49 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=198.2
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHH
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 235 (484)
+.||+|+||.||+|...++..||+|.+..... .....+..|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999998865543 33456888999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeeccc
Q 011498 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315 (484)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 315 (484)
+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9986542 3578999999999999999999998 999999999999999999999999999875432221111222
Q ss_pred ccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 316 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
.++..|+|||++.+..++.++||||||+++|+|++ |..||....... .. .. ..... ... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~---~~-~~~~~-----~~~----~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR---EQ-VEKGY-----RMS----CPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH---HH-HHcCC-----CCC----CCCC
Confidence 34567999999998899999999999999999999 999997543211 11 11 10110 001 1112
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
....+.+++.+||..+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=315.48 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=204.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||+|..+++..||+|.+..... ....+..|+.+++.++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356888899999999999999988889999998865443 3457888999999999999999999874 45689999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999986543 24689999999999999999999998 999999999999999999999999999976543222
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......++..|+|||++....++.++||||||+++|||++ |+.||....... ... .... . .....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~-~-----~~~~~- 224 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQ---NLER-G-----YRMPR- 224 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHH---HHHc-C-----CCCCC-
Confidence 22222345678999999988889999999999999999999 999997543211 111 1110 0 00011
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.......+.+++.+||+.||++||++++++..|+.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ---PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11233468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=318.92 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=201.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-----CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee--CCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~ 223 (484)
..|.+.+.||+|+||.||++..+ ++..||+|.+..........+..|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999853 478899999876665556788999999999999999999998754 34678
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999996532 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcee--ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCC------cc---chhhhhhh
Q 011498 304 LCSERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG------EV---NLVDWLKT 372 (484)
Q Consensus 304 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~------~~---~~~~~~~~ 372 (484)
........ .....++..|+|||++.+..++.++|||||||++|||++|..|+......- .. .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64332211 111223456999999988889999999999999999999877654321100 00 00000000
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+...............+.+++.+||..+|++|||+.+|++.|+..
T Consensus 238 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 ---------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0110111111122345688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=319.11 Aligned_cols=257 Identities=26% Similarity=0.446 Sum_probs=202.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|.+.+.||+|+||.||+|.+ ..+..|++|.+.... ......+..|+.+++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999984 245789999886433 3344678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC
Q 011498 225 VYEYVDNGNLDQWLHGDVG-------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
+|||+++++|.+++..... ....+++...+.++.|++.||.|||++ +++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123578899999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhh
Q 011498 292 NARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 292 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~ 369 (484)
.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence 999999999976533221 11222345678999999988889999999999999999999 99998654321 1111
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
........ .. +..+...+.+++.+||+.||++||++.+|++.|..
T Consensus 238 ---~~~~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ---MVRKRQLL-----PC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111100 01 11234568889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.74 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=194.8
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||++... ++..||+|.+.... ......+..|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999965 57899999986542 22335577899999888 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 9999988644 4689999999999999999999998 99999999999999999999999999987432211 12
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCC--ccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG--EVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....... .....++......... ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCC
Confidence 334578999999999999999999999999999999999999997443221 1111122222111111 11111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPK------MGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs------~~evl~ 422 (484)
.....+.+++.+||+.||.+||+ ++++++
T Consensus 227 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 ----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12345788999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=317.78 Aligned_cols=247 Identities=23% Similarity=0.283 Sum_probs=194.2
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEecccchh---hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
||+|+||+||++... +++.||+|.+...... ....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 5889999988654322 234567899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++.........+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988854433445689999999999999999999998 999999999999999999999999999976543322 1233
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... +..... ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~---------~~~~~~--~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR---------ILNDSV--TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh---------hcccCC--CCccc
Confidence 56899999999999999999999999999999999999999754321110 010010 001000 11122
Q ss_pred HHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 011498 395 ALKRVLLVALRCVDPDATKRP-----KMGHVIH 422 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 422 (484)
....+.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 445688899999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.71 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=204.8
Q ss_pred HHhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC----
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA---- 220 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 220 (484)
...++|.+.+.||+|+||+||+|.. .+++.||||.+.... ......+..|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 468999999886542 334456788999999999999999988775432
Q ss_pred ----eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEe
Q 011498 221 ----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 221 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 36799999999999999976544556799999999999999999999998 99999999999999999999999
Q ss_pred eecccccccCCC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 297 DFGLAKLLCSER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 297 Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
|||+++...... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+.....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhc
Confidence 999997654321 12233457999999999999999999999999999999999999999754321 11111111
Q ss_pred CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.. .+ .+ +......+.+++.+||+.||.+||++.+++..
T Consensus 260 -~~----~~-~~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 -GR----YD-PL----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -CC----CC-CC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 01 11 11234568889999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=331.70 Aligned_cols=259 Identities=18% Similarity=0.271 Sum_probs=197.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
..+|.+.+.||+|+||.||++... +++.||+|... ...+.+|+++++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999964 57899999643 23467799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+. ++|..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 6899888654 4588999999999999999999998 99999999999999999999999999997543322
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCC-Ccc---chhhhhhhhhcCCC------
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ-GEV---NLVDWLKTMVGSRK------ 378 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~-~~~---~~~~~~~~~~~~~~------ 378 (484)
........||+.|+|||++.+..++.++|||||||++|||+||..||-..... ... .....+....+...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22233457999999999999999999999999999999999999876432211 000 00000000000000
Q ss_pred ----cc---------cccCCCCCCC--ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 ----SE---------EVVDPKLPKM--PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ----~~---------~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. ....+..... ........+.+|+.+||+.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0000000000 11123557889999999999999999999986
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=323.63 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=191.9
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHH---hccCCCceeeecceeeeCCeeeEE
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVI---GRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+..|+.++ +.++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999865 58899999986432 12234566665554 566899999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|..+++. ..+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988853 3589999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... .....+|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ......... .
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~-------~ 218 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDE-------V 218 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-------C
Confidence 2221 2334578999999999999999999999999999999999999997543211 111111100 1
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
..+ ......+.+++.+||+.||.+||+ +.++++
T Consensus 219 ~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111 123346788999999999999995 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=312.15 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=203.0
Q ss_pred CCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchh---hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.|...+.||+|.-|+||++..++ +..+|+|++.+..-. ...+.+.|-+||+.++||.++.||+.|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45556789999999999999875 578999998665432 23456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
||+||+|..+++.+.+ ..+++..+..++.+|+.||+|||.. |||+|||||+||||-++|++.|+||.|+......
T Consensus 158 yCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999987644 5699999999999999999999988 9999999999999999999999999887442100
Q ss_pred --------------------------------C-c----------------------eeecccccccccccccccccCCC
Q 011498 308 --------------------------------R-S----------------------YVTTRVMGTFGYVAPEYACTGML 332 (484)
Q Consensus 308 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 332 (484)
. . .....++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 00123579999999999999999
Q ss_pred CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCC
Q 011498 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDAT 412 (484)
Q Consensus 333 ~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~ 412 (484)
+.++|+|+||++|||||.|..||.+.+..+.. .+ ++-..+...........+.+||.+.|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl--~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL--RN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH--HH-------------HhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999877654322 11 1111121222224566789999999999999
Q ss_pred CCCC----HHHHHH
Q 011498 413 KRPK----MGHVIH 422 (484)
Q Consensus 413 ~RPs----~~evl~ 422 (484)
+|.. ++||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9999 555544
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=313.07 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=196.0
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 58899999876443 33456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee-c
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-T 313 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 313 (484)
.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99996432 4588999999999999999999998 999999999999999999999999999875432211111 1
Q ss_pred ccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCCh
Q 011498 314 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392 (484)
Q Consensus 314 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (484)
....+..|+|||.+.+..++.++|||||||++|||++ |..||....... . ...... ..+....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~----~~~~~~---------~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---T----REAIEQ---------GVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---H----HHHHHc---------CCCCCCc
Confidence 1123456999999998899999999999999999998 888886443211 0 111100 0011111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 393 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 393 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
......+.+++.+||+.||++|||+.+|+++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 223456888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=332.97 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=192.4
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.|...+.||+|+||.||+|... +++.||+|.+.... ......+..|+.+++.++||||+++++++.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999964 57899999886532 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999999754 4588899999999999999999998 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------ceeecccccccccccccccccCCCCcccceecc
Q 011498 308 R----------------------------------------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSF 341 (484)
Q Consensus 308 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 341 (484)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122468999999999999999999999999
Q ss_pred hhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC---HH
Q 011498 342 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---MG 418 (484)
Q Consensus 342 G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~ 418 (484)
||+||||++|+.||....+... ........ ................+++.+++ .||.+|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLET------QMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHH------HHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999999975543211 11111000 00000111112334556666654 59999997 77
Q ss_pred HHHH
Q 011498 419 HVIH 422 (484)
Q Consensus 419 evl~ 422 (484)
+++.
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.52 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=192.8
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|.+++..+ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 47899999886542 22334566788888866 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|..++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 9999998654 4588999999999999999999998 999999999999999999999999999875432222 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........ . ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~---~~~i~~~~----~---~~p~-- 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---L---FESILHDD----V---LYPV-- 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---H---HHHHHcCC----C---CCCC--
Confidence 334568999999999999999999999999999999999999997554221 1 11111110 0 1111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCC-------CHHHHHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRP-------KMGHVIHM 423 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RP-------s~~evl~~ 423 (484)
.....+.+++.+||+.||++|| +++++++.
T Consensus 218 --~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 --WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1234678889999999999999 67777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=316.43 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=200.0
Q ss_pred CcCceeccCCceEEEEEEE-----CCCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEE
Q 011498 154 CEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLV 225 (484)
Q Consensus 154 ~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 225 (484)
...+.||+|+||+||++.+ .++..||+|.+..... .....+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7778999999999988763 2467899998865432 3456788899999999999999999988753 357899
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999643 489999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 306 SERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 306 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
..... ......++..|+|||.+.+..++.++||||||+++|||+||..||...... .....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence 32211 111223566799999998888999999999999999999999998643321 000010000000000011111
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+.......+......+.+++.+||+.||++|||+++|++.|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111223446788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=332.96 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=196.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++... +++.||||++.... ......+..|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999864 58899999886532 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999754 4588999999999999999999998 999999999999999999999999999863311
Q ss_pred CCc------------e----------------------------------eecccccccccccccccccCCCCcccceec
Q 011498 307 ERS------------Y----------------------------------VTTRVMGTFGYVAPEYACTGMLNEKSDVYS 340 (484)
Q Consensus 307 ~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 340 (484)
... . .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0 001246899999999999999999999999
Q ss_pred chhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCC---CCH
Q 011498 341 FGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR---PKM 417 (484)
Q Consensus 341 lG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~ 417 (484)
|||+||||+||..||........ ......... .+ .++. .......+.+++.+|+. +|.+| +++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~--~~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET------YRKIINWRE--TL---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH------HHHHHccCC--cc---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999975442111 111111000 00 0111 11123457788889997 66665 599
Q ss_pred HHHHHHH
Q 011498 418 GHVIHML 424 (484)
Q Consensus 418 ~evl~~L 424 (484)
.+++..-
T Consensus 300 ~~~l~hp 306 (377)
T cd05629 300 HEIKSHP 306 (377)
T ss_pred HHHhcCC
Confidence 8888743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=320.01 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=204.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 220 (484)
..++|...+.||+|+||.||++.+.. ...+|+|.+.... ......+..|+.++.++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34568888999999999999998642 3579999886543 23345688899999999 8999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
..+++|||+++|+|.++++... .....+++..++.++.|++.||.|||+. +|+|+||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999996431 2345689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccch
Q 011498 289 RQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNL 366 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~ 366 (484)
.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 99999999999998654322211 122234568999999988999999999999999999998 9999865432111
Q ss_pred hhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
. .... ... ....+......+.+++.+||+.||++|||+.+|++.|++
T Consensus 244 ~---~~~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 244 F---KLLK-EGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred H---HHHH-cCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 1 1111 100 001111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=322.84 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=192.3
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCC-CceeeecceeeeCCeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 226 (484)
+|.+.+.||+|+||.||+|..+ ++..||+|++.... ......+..|..++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999965 46789999886542 2334567778899998866 56888999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998654 4588999999999999999999998 999999999999999999999999999865322
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .. ...... ...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~---~~i~~~-------~~~ 219 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF---QSIMEH-------NVS 219 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHHHcC-------CCC
Confidence 111 2234568999999999999999999999999999999999999997543211 11 111110 011
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
.+. .....+.+++.+||..||.+|++.
T Consensus 220 ~~~----~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPK----SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111 233467889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=319.22 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=194.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ......+..|+.++..++|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999965 48899999886422 223356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999653 24588999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccc-----CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc
Confidence 33222233468999999999863 45788999999999999999999999754321 11111111111000
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCC--CCCCCCCHHHHHHH
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDP--DATKRPKMGHVIHM 423 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dp~~RPs~~evl~~ 423 (484)
++.. .......+.+++.+|+.. ++..||++.++++.
T Consensus 229 -----~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -----FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----CCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1110 011234566667676654 44448898888775
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.78 Aligned_cols=236 Identities=22% Similarity=0.335 Sum_probs=189.6
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|+.+ +++.||+|.+.... ......+..|..++..+ +||||+++++++......|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 47899999886532 22334566788888776 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 9999998754 4588999999999999999999998 999999999999999999999999999875422221 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~----~---~~~--- 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDE----V---VYP--- 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCC----C---CCC---
Confidence 33457999999999999999999999999999999999999999754321 1111111100 0 111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
......+.+++.+||+.||.+||++
T Consensus 217 -~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 -TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1133467889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=313.23 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=201.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4577788999999999999998777789999876443 234678889999999999999999998754 56789999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.++++... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999997542 24578999999999999999999998 9999999999999999999999999999765433222
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||...+..++.++||||||+++|||+| |..||....... ...++ ... ..+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~------~~~---- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV---ERG------YRM---- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HcC------CCC----
Confidence 1222345678999999988889999999999999999999 999997543211 11111 100 000
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.........+.+++.+||..||++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.29 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=190.5
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||++..+ +++.||+|.+.... ......+..|+.++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 47899999886542 22334577788888776 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 9999988654 4689999999999999999999998 999999999999999999999999999875322211 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCC--ccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG--EVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....||..|+|||++.+..++.++|||||||++|||++|..||....... ......++........ ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCCC
Confidence 334578999999999999999999999999999999999999996432211 1111122221111111 01111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
.....+.+++.+||+.||.+||++
T Consensus 227 ----~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 ----SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 233457789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=308.98 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=201.5
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCc-eeeecceeeeCC------ee
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGA------YR 222 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~~ 222 (484)
|...++||+|+||+||+|+.+ +|+.||+|+++-... .......+|+.+++.++|+| |++|++++.+.. .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 444557999999999999954 688999999976544 23455677999999999999 999999999877 78
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++|+||+.. +|..++.........++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence 999999977 99999976543223567788999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC---
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK--- 378 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 378 (484)
...-... ..+..++|.+|+|||++.+. .|++..||||+||++.||+++++.|.+....+.. ..+-...+...
T Consensus 169 a~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql---~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 169 AFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL---FRIFRLLGTPNEKD 244 (323)
T ss_pred HhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHHHcCCCCccC
Confidence 6542222 23456789999999999876 7999999999999999999999999877642221 11111111110
Q ss_pred ccc---ccC--CCCCCCC-h----HHH---HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 379 SEE---VVD--PKLPKMP-A----SKA---LKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 379 ~~~---~~~--~~~~~~~-~----~~~---~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
... ..+ ...+... . ... .....+++.+||+.+|.+|.|++..+.+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 000 0111111 1 111 1367888999999999999999999885
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.44 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=200.0
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
+|...+.||+|+||+||++... +++.||+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999964 588999998865322 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999886432 24589999999999999999999998 9999999999999999999999999998765332
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. .....|+..|+|||++.+..++.++|||||||++|||++|..||......... ..+...... .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~----------~ 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE----------D 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh----------c
Confidence 21 22346899999999999889999999999999999999999999754322111 111111100 0
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
...........+.+++.+||..||.+|| ++.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111223445688899999999999999 77787664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=319.60 Aligned_cols=263 Identities=19% Similarity=0.294 Sum_probs=197.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999975 588999998864432 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+. ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 58888886532 4588899999999999999999998 9999999999999999999999999998754322
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc------
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE------ 380 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 380 (484)
.. ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||....... .....+..........
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 21 1233468899999998865 458899999999999999999999997543210 1111111100000000
Q ss_pred --cccCCC-C---CCCChH------HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 --EVVDPK-L---PKMPAS------KALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 --~~~~~~-~---~~~~~~------~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+. . ...... .....+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0 000000 01245778999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=327.60 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=201.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeC-C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG-A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~ 220 (484)
.++|.+.+.||+|+||.||+|... .++.||+|++..... .....+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888999999999999999742 246899998865432 2335677899999999 899999999988754 5
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCC--------------------------------------------------------
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGD-------------------------------------------------------- 244 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 244 (484)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998643210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee-ecccccccccc
Q 011498 245 -VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYV 322 (484)
Q Consensus 245 -~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ 322 (484)
...+++..+..++.||+.||+|||++ +|+||||||.|||++.++.+||+|||++..+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999998 99999999999999999999999999998754332211 22234567899
Q ss_pred cccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHH
Q 011498 323 APEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLL 401 (484)
Q Consensus 323 aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 401 (484)
|||++.+..++.++|||||||+||||++ |..||......+. + ......... ...+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~---------~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRRLKEGTR---------MRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHHHhccCC---------CCCCccCCHHHHH
Confidence 9999999999999999999999999998 9999975432211 1 111111100 0011123456889
Q ss_pred HHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 402 VALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 402 l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
++.+||+.+|++||++.||++.|+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.20 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=202.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|.+.+.||+|+||.||+|+. .++..||+|++..........+..|+.+++.++||||+++++++......++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5688899999999999999996 457889999886555445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.++++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998643 4688999999999999999999998 999999999999999999999999999986532221
Q ss_pred eeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
......++..|+|||.+. ...++.++|||||||++|||++|..||....+....... . . .....+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~-~---~~~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------S-K---SNFQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------e-c---CCCCCCC
Confidence 122346888999999874 345788999999999999999999998644322111000 0 0 0001111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
.. ........+.+++.+||..||++||++++|++.|
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 1112345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=325.01 Aligned_cols=246 Identities=25% Similarity=0.299 Sum_probs=191.3
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVE-VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||+||+|... +|+.||+|++..... .....+..|.. +++.++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 588999998864321 12233444444 56778999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 9999998754 4688999999999999999999998 99999999999999999999999999987542222 12
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... +......... ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-------~~~~~-- 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKP-------LRLKP-- 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC-------CCCCC--
Confidence 33456899999999999999999999999999999999999999754321 1111111100 01111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.....+.+++.+||+.||.+||++.+.+..+...
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 218 --NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred --CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1244678899999999999999986444333333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=329.70 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=203.4
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeee
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 218 (484)
+.++....++|.+.+.||+|+||.||++..+ +++.||+|.+.... ......+..|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556789999999999999999999975 47889999885422 2233457789999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
....++||||+++|+|.++++.. .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999999643 478888999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCceeecccccccccccccccccC----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|++...............||+.|+|||++... .++.++|||||||++|||++|..||...... .......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 99987644333233456799999999998754 3789999999999999999999999754321 1111111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHh
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHMLE 425 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~L~ 425 (484)
....... ++ ........+.+++.+||..++.+ ||++++|++..-
T Consensus 261 ~~~~~~~-----~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 NHKNSLT-----FP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCccc-----CC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1110000 11 11123456778888999844433 789999988653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=323.98 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=192.4
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 226 (484)
+|.+.+.||+|+||.||+|... ++..||+|.+..... .....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777889999999999999975 467999998865432 2233456677777777 6899999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999998654 4588999999999999999999998 999999999999999999999999999875422
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ... ..... .. ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~---~~i~~-~~------~~ 219 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---QSIME-HN------VA 219 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH---HHHHh-CC------CC
Confidence 221 233457899999999999999999999999999999999999999754321 111 11111 00 01
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
.+ ......+.+++.+||+.||.+|++.
T Consensus 220 ~p----~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YP----KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC----CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11 1234567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.47 Aligned_cols=237 Identities=24% Similarity=0.305 Sum_probs=186.6
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHH-HHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEV-EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|+.. ++..||+|.+..... .....+..|. .+++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 578999998864321 2223444454 467888999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|..++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence 9999988643 4578889999999999999999998 999999999999999999999999999875322221 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ......... . ..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~-~------~~~~--- 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHK-P------LQLP--- 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcC-C------CCCC---
Confidence 33456899999999999989999999999999999999999999754311 111111110 0 0111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMG 418 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~ 418 (484)
......+.+++.+||+.||.+||+..
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 -GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12234678889999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.90 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=190.3
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|..+ +|..||+|.+.... ......+..|..++... +||||+++++++.+....|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 47899999886542 12234556677777654 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 9999998754 4588999999999999999999998 99999999999999999999999999987432211 12
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ..... ..+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~---~~~~~-------~~~~~~~-- 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF---ESIRV-------DTPHYPR-- 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHh-------CCCCCCC--
Confidence 33457899999999999999999999999999999999999999754321 111 11110 0111111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMG-HVI 421 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl 421 (484)
.....+.+++.+||+.||++||++. +++
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 --WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234677889999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=316.47 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=202.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
+++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999999753 4678999876443 33446788899999999999999999999998899
Q ss_pred eEEEEecCCCCHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC---cEEEe
Q 011498 223 MLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVS 296 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~ 296 (484)
++||||+++++|.+++..... ....+++..++.++.||+.||+|||+. +++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999965421 123589999999999999999999998 999999999999998754 59999
Q ss_pred eecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhh
Q 011498 297 DFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 297 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||....... .. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~---~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM---EFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HHHH
Confidence 999998653222111 112234568999999998999999999999999999997 999997544321 11 1111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.... ...+......+.+++.+||+.||++||++.+|++.|+
T Consensus 236 ~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 0111223456888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=309.50 Aligned_cols=267 Identities=27% Similarity=0.368 Sum_probs=204.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEec--ccchhhHHHHHHHHHHHhccCCCceeeecceeee-----CCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-----GAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~ 221 (484)
...|...+.||+|+||.|+.+..+ +|..||||++. .......++..+|+.+|+.++|+||+.+++++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555688999999999999964 58999999997 3344455677789999999999999999998865 346
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.|+|+|+|+. +|...++.. ..++..++..++.|++.||.|+|+. +|+||||||.|+|++.+..+||+|||+|
T Consensus 101 vYiV~elMet-DL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHHhh-HHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 7999999955 999999755 4599999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCC-Cceeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh-------
Q 011498 302 KLLCSE-RSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT------- 372 (484)
Q Consensus 302 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~------- 372 (484)
+..... .....+..+-|.+|.|||++. ...|+.+.||||.||+|.||++|++.|.+.+......++..+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987432 222345667899999999775 56899999999999999999999999988765443333211100
Q ss_pred -hhcCCCccccc--CCCCCCCChH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 373 -MVGSRKSEEVV--DPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 373 -~~~~~~~~~~~--~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
.+........+ .|..+..+.. .....-++|+.+||..||.+|+|++|.+..-
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 00000000000 1111111111 2234567788899999999999999998744
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=317.00 Aligned_cols=256 Identities=25% Similarity=0.441 Sum_probs=203.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|...+.||+|+||.||++... ++..+++|.+..........+..|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999999742 355789998876666666789999999999999999999999999899999
Q ss_pred EEEecCCCCHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 225 VYEYVDNGNLDQWLHGDVG-----------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
+|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999975421 113588999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhh
Q 011498 294 RVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 371 (484)
||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |.+||........ . .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I---E 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H---H
Confidence 9999999875533221 11222335678999999999999999999999999999998 9999864432211 1 1
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
....... ... +......+.+++.+||+.||++||++.+|++.|+
T Consensus 236 ~~~~~~~------~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQGRE------LER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCcc------CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1110000 011 1123346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=313.27 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=205.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||+|..+++..||+|.+.... ....++..|+.+++.++|+||+++++++......+++|||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998878889999886543 33467889999999999999999999999888999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999997642 24589999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
........+..|+|||.+.+..++.++||||||+++|+|+| |+.||....... .. ....... ....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~~~~~~------~~~~- 225 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VL---EQVERGY------RMPR- 225 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHcCC------CCCC-
Confidence 11222234568999999998889999999999999999999 999996443211 11 1111100 0001
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+......+.+++.+||+.||++||+++++++.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11124568889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.44 Aligned_cols=256 Identities=28% Similarity=0.464 Sum_probs=201.9
Q ss_pred CCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
+|.+.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 135688888765443 334678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCC--------------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCc
Q 011498 225 VYEYVDNGNLDQWLHGDV--------------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~N 284 (484)
+|||+.+|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 1124588999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCC
Q 011498 285 ILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 362 (484)
Q Consensus 285 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~ 362 (484)
|++++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997653322211 122345678999999988889999999999999999999 999996543221
Q ss_pred ccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 363 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+.+. .... .... .+......+.+++.+||+.||++||++.+|++.|++
T Consensus 238 ---~~~~----~~~~-----~~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 238 ---LFNL----LKTG-----YRME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred ---HHHH----HhCC-----CCCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1111 1111 0011 112234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=331.37 Aligned_cols=260 Identities=24% Similarity=0.420 Sum_probs=203.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccch-hhHHHHHHHHHHHhccC-CCceeeecceeeeCC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGA 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~ 220 (484)
..++|.+.+.||+|+||.||+|++.+ +..||+|++..... .....+..|+.++..+. ||||++++++|....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 34567778999999999999998642 35799999975432 23356888999999997 999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCC---------------------------------------------------------
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVG--------------------------------------------------------- 243 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 243 (484)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999965321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEE
Q 011498 244 -------------------------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (484)
Q Consensus 244 -------------------------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIl 286 (484)
....+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 113467788899999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCcc
Q 011498 287 LDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEV 364 (484)
Q Consensus 287 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~ 364 (484)
++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999976432221 11223456788999999998889999999999999999998 8899864432111
Q ss_pred chhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 365 NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......... .+.. +......+.+++.+||..+|++||++.+|++.|+.
T Consensus 351 -----~~~~~~~~~-----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 351 -----FYNAIKRGY-----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred -----HHHHHHcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111110 0011 11234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.57 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=200.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-----hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-----QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|...+.||+|++|.||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999864 588999998864321 123568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
++||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998754 4588999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCceee--cccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSYVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
........ ....++..|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~----- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQP----- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccC-----
Confidence 32211111 234578899999999998899999999999999999999999864322110 01100000
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..+.+ +......+.+++.+||..+|.+|||+.++++.
T Consensus 224 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111 12234568889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=320.23 Aligned_cols=244 Identities=24% Similarity=0.321 Sum_probs=193.1
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||+||+|... ++..||+|++..... .....+..|+.++.++ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 478899999875432 2335577889988888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 9999988644 4589999999999999999999998 999999999999999999999999999875322211 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
....+||+.|+|||++.+..++.++|||||||+||||++|..||............++......... ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~-- 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPR-- 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCC--
Confidence 3345799999999999999999999999999999999999999975443322222222222211110 01111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMG 418 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~ 418 (484)
.....+.+++.+||+.||.+|+++.
T Consensus 225 --~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 --FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1234577888999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=312.10 Aligned_cols=263 Identities=29% Similarity=0.459 Sum_probs=196.5
Q ss_pred CcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhc--cCCCceeeecceeeeCC----eeeEEEE
Q 011498 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEGA----YRMLVYE 227 (484)
Q Consensus 154 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~e 227 (484)
...++||+|.||.||+|.+. ++.||||++.. +..+.|+.|-++.+. ++|+||++|+++-.... .++||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 33468999999999999996 69999998843 345677888777776 48999999999876554 7899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC------CCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL------EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
|.+.|+|.+||+.+ .++|....+++.-+++||+|||+.. +++|+|||||++||||.+++++.|+|||+|
T Consensus 289 fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999865 5999999999999999999999753 778999999999999999999999999999
Q ss_pred ccccCCCc-eeecccccccccccccccccCC-CC-----cccceecchhHHHHHHhCCCCCCCCCCCCcc----------
Q 011498 302 KLLCSERS-YVTTRVMGTFGYVAPEYACTGM-LN-----EKSDVYSFGILIMEIITGRNPVDYSRPQGEV---------- 364 (484)
Q Consensus 302 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~~l~elltG~~p~~~~~~~~~~---------- 364 (484)
..+..... ......+||.+|||||++.+.. +. .+.||||+|.|||||++...-+.. .+..+.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVGN 442 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhcC
Confidence 88754322 1233478999999999997642 22 378999999999999996544421 111111
Q ss_pred -chhhhhhhhhcCCCcccccCCCCCCCC-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcc
Q 011498 365 -NLVDWLKTMVGSRKSEEVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430 (484)
Q Consensus 365 -~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 430 (484)
.-.+.++..+-..+ ..|.++... ....+..+.+.+..||+.||+.|.|+.=|-+.+.+..-+
T Consensus 443 hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11111222221111 112222211 113456788888999999999999998887777654433
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=321.92 Aligned_cols=241 Identities=23% Similarity=0.342 Sum_probs=190.6
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhc-cCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||+||+|... ++..||+|.+.... ......+..|..++.. ++||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 47889999886542 1223445567777775 4999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 9999999753 4588999999999999999999998 999999999999999999999999999875322211 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ... .... . ..+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~---~~i~-~------~~~~~~~-- 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELF---QSIR-M------DNPCYPR-- 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-h------CCCCCCc--
Confidence 23456899999999999999999999999999999999999999754321 111 1110 0 0111111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMG-HVIH 422 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~ 422 (484)
.....+.+++.+||+.||++||++. ++++
T Consensus 218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 --WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1334577889999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.24 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=197.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCC----EEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|.+.+.||+|+||.||+|.+. ++. .+++|.+..... ....++..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35777889999999999999964 344 478887754332 233567788889999999999999998764 45788
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
++||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +++|+||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997542 4689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....+.. ..+. ..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~--~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGE--RL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC--cC
Confidence 33221 12223446778999999998899999999999999999998 999997554321 1111 11110 01
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..+ . .+...+.+++.+||..||++|||+.|+++.|..
T Consensus 231 ~~~---~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 AQP---Q----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCC---C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111 1 123457788899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.56 Aligned_cols=249 Identities=24% Similarity=0.296 Sum_probs=194.0
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVE-VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||+||+|... +|+.||+|++..... .....+..|.. +++.++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999964 588999998865421 22234445544 56778999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 9999988644 4689999999999999999999998 999999999999999999999999999875322211 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|+|||++.+..++.++|||||||++|||++|..||....... ........ . ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~-~------~~~~~-- 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHK-P------LVLRP-- 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcC-C------ccCCC--
Confidence 234568999999999999999999999999999999999999997543211 11111110 0 01111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcc
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 430 (484)
.....+.+++.+||..||.+||++.+.+..+....++
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 1234577888999999999999997666655554433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.06 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=198.1
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
||+|+||.||++..+ +|..||+|.+..... .....+..|+++++.++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 589999998854321 2234556699999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 99886432 24588999999999999999999998 99999999999999999999999999987654322 2233
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..|+..|+|||++.+..++.++|||||||++|||++|..||....... ........... ..... ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~---------~~~~~-~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE---------DEVKF-EHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc---------ccccc-cccc
Confidence 468999999999998889999999999999999999999997543211 11111111110 01100 0112
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcc
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 430 (484)
....+.+++.+||+.||++||+++|+++.+....++
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 344688899999999999999998887666655444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.02 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=200.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC-C--CEEEEEEeccc-chhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-G--TKVAVKNLLNN-RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~--~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||.||+|..++ + ..+++|.+... .....+.+..|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998753 3 24788877643 233456788899999999 799999999999998899999
Q ss_pred EEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 226 YEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
|||+++++|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhh
Q 011498 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~ 372 (484)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEK 230 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence 99999998642111 11111123457999999988889999999999999999998 999997543221 1111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... . ..... +..+...+.+++.+||+.||.+||++++|++.|+..
T Consensus 231 ~~~-~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 231 LPQ-G-----YRMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred Hhc-C-----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 110 0 00111 112345688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.02 Aligned_cols=245 Identities=28% Similarity=0.450 Sum_probs=194.8
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 158 VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
.||+|+||.||+|.++ ++..+|+|++.... ....+.+..|+.+++.++||||+++++++.. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 46789999885443 2345678899999999999999999998864 4678999999999
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee-
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV- 311 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 311 (484)
+|.+++... ..+++..++.++.|++.||+|||++ +++|+||||.||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999644 3588999999999999999999998 99999999999999999999999999998764333211
Q ss_pred -ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 312 -TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 312 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....++..|+|||.+....++.++|||||||++|||++ |..||...... ..... ...... +..+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----i~~~~~-----~~~~- 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM----IESGER-----MECP- 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCCC-----CCCC-
Confidence 112234578999999988889999999999999999998 99999754322 11111 111110 1111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......+.+++.+||+.||++||++.+|.+.|++
T Consensus 221 ---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 ---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=319.60 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=196.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+++.. ++..||+|.+.... ......+..|+.++..++|+||+++++++.+....|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999965 47889999886432 222345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997532 3588999999999999999999998 999999999999999999999999999976644
Q ss_pred CCceeeccccccccccccccccc-----CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... +...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~-- 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEER-- 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCc--
Confidence 33333334569999999998865 56889999999999999999999999754321 111111111000
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHM 423 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~ 423 (484)
. .++.. .......+.+++.+|+..++.+ |++++++++.
T Consensus 227 ~---~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 F---QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c---cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 01110 1123456777888888865544 4678777664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=329.88 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=203.3
Q ss_pred CCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccC-C-----CceeeecceeeeCCeeeE
Q 011498 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-H-----KNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 224 (484)
+|.+.++||+|+||+|-+|.. ++++.||||+++....- ..+-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 678899999999999999985 45899999988766543 445566999999996 4 389999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC--CcEEEeeecccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ--WNARVSDFGLAK 302 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfgla~ 302 (484)
|+|.+.. +|+++|+.+ ....++...+..++.||+.||.+||.. +|||+||||+||||.+. ..+||+|||+++
T Consensus 266 VfELL~~-NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhhh-hHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999976 999999876 456699999999999999999999988 99999999999999654 379999999998
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh----------
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT---------- 372 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~---------- 372 (484)
...... . ..+.+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+....+..+..
T Consensus 340 ~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 340 FESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 754322 1 45678899999999999999999999999999999999999988775543322211000
Q ss_pred -----hhcC-C------Cccc-----------------ccCCCCC-C------CChHHHHHHHHHHHHhcCCCCCCCCCC
Q 011498 373 -----MVGS-R------KSEE-----------------VVDPKLP-K------MPASKALKRVLLVALRCVDPDATKRPK 416 (484)
Q Consensus 373 -----~~~~-~------~~~~-----------------~~~~~~~-~------~~~~~~~~~l~~l~~~cl~~dp~~RPs 416 (484)
+... . .... ..+...+ . ......-+.+.+++.+||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0000 0 0000 0010111 0 011123466899999999999999999
Q ss_pred HHHHHHH
Q 011498 417 MGHVIHM 423 (484)
Q Consensus 417 ~~evl~~ 423 (484)
..+.++.
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999873
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=308.77 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=203.2
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|++|.||+|..+ ++..|++|.+... .......+..|+.+++.++||||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 5889999988543 234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 25689999999999999999999998 99999999999999999999999999988654332
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.. .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...... ... .... .. ..
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~-~~--------~~- 218 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI---LKII-RG--------VF- 218 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-cC--------CC-
Confidence 22 23346888999999999999999999999999999999999999754421 111 1111 00 01
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..........+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111134457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=315.06 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=204.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3568888999999999999998642 3679999886443 23345788899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCC------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEe
Q 011498 223 MLVYEYVDNGNLDQWLHGDVG------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999965322 123578899999999999999999998 99999999999999999999999
Q ss_pred eecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhh
Q 011498 297 DFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 297 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||....... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh---
Confidence 99998765433221 1223446788999999988889999999999999999998 999986543221 111111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
... .+..+ ......+.+++.+||+.+|++|||+.+|+..|+
T Consensus 236 -~~~-----~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG-----HLDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC-----CCCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 110 01111 112457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=311.27 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=199.5
Q ss_pred CCcCceeccCCceEEEEEEECC----CCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCe-----
Q 011498 153 LCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----- 221 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 221 (484)
|.+.+.||+|+||.||+|.... +..||+|++.... ......+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 3679999886543 2334578889999999999999999998876544
Q ss_pred -eeEEEEecCCCCHHHHhhcCC--CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 222 -RMLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 222 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
.+++|||+++|+|..++.... .....+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 1224689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 299 GLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 299 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
|+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...... ...+ .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~---~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYD---YLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHcC
Confidence 9998654332211 111234678999999988899999999999999999999 89998654321 1111 11111
Q ss_pred CCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
. .... +......+.+++.+||+.||++|||+.+|++.|++
T Consensus 232 ~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 N------RLKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred C------CCCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0111 12234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=312.21 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=196.9
Q ss_pred CCcCceeccCCceEEEEEEECCC-C--EEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC------Ce
Q 011498 153 LCEENVIGEGGYGIVYRGILSDG-T--KVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------AY 221 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~~-~--~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 221 (484)
|.+.+.||+|+||.||+|.+.+. . .||+|.+.... ......+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34568899999999999997543 2 68999875432 33456788899999999999999999987532 24
Q ss_pred eeEEEEecCCCCHHHHhhcCC--CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 222 RMLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 1234589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 300 LAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 300 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
++.......... .....+++.|++||++.+..++.++|||||||++|||++ |..||...... ... .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---~~-~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY---DY-LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HH-HHcC
Confidence 998764332211 122245678999999999999999999999999999999 88998753321 111 11 1111
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... .. .......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 231 ~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL-----KQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC-----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 100 01 11234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=317.29 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=201.0
Q ss_pred CCcCceeccCCceEEEEEEECC------CCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 153 LCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
|.+.+.||+|+||.||+|...+ +..||+|++..... .....+..|+.++..++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 5556789999999999998632 46899998875433 2345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 226 YEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
+||+.+++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||.||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 99999999999985321 1123578889999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhh
Q 011498 294 RVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 371 (484)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ++..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~ 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVIE 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 9999999876533221 11223345778999999988889999999999999999998 88888654321 1111
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... .... ......+...+.+++.+||+.+|.+||++++|+..|+.
T Consensus 238 ~i~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR-NRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-cCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 1110 01112344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.43 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=203.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||++...++..+++|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788899999999999999998777889999876443 334678889999999999999999999887 6789999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999997542 24578899999999999999999998 999999999999999999999999999876543222
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......++..|+|||++....++.++|+|||||++|+|+| |..||...... ....++. ... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~----~----- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE----RGY----R----- 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----CCC----C-----
Confidence 22222335677999999988889999999999999999999 99999754321 1111111 110 0
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..........+.+++.+||+.||++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00112234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=321.06 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=210.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchh---hHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 224 (484)
...|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+.+. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3567778899999999999999765 999999999765442 3468889999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC----CcEEEeeecc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ----WNARVSDFGL 300 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfgl 300 (484)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. ||+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999755 289999999999999999999998 99999999999999543 4799999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .+...
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~--- 253 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG--- 253 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC---
Confidence 998765 444667899999999999999999999999999999999999999998765432211 01111
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+..+.............+++..|+..||.+|+|+.++++
T Consensus 254 ---~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 ---DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 112233333445667888899999999999999999998
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=321.72 Aligned_cols=241 Identities=22% Similarity=0.327 Sum_probs=193.0
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||+||+|... ++..||+|.+.... ......+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 47899999986542 22334566788888877 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|..++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 9999998754 3689999999999999999999998 999999999999999999999999999865322221 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
....+|++.|+|||++.+..++.++|||||||++|+|++|..||...... .......... ...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~-------~~~~--- 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDE-------VRYP--- 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC-------CCCC---
Confidence 23356899999999999999999999999999999999999999744321 1111111100 0111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKM-----GHVIH 422 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~ 422 (484)
......+.+++.+||..||.+||++ .++++
T Consensus 217 -~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 -RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1233467889999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=322.95 Aligned_cols=247 Identities=24% Similarity=0.278 Sum_probs=191.8
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHH-HHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEV-EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|+.. ++..||+|++..... .....+..|. .+++.++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 467899998864321 2223334443 456778999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 9999999754 3577888899999999999999998 999999999999999999999999999875432221 2
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........ . ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~-~------~~~~--- 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNK-P------LQLK--- 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhC-C------cCCC---
Confidence 334579999999999999999999999999999999999999997543211 11111110 0 0011
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
......+.+++.+||+.||.+||++.+.+..+.+..
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 217 -PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred -CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 123346788889999999999999886655555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=314.86 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=202.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|+..+.||+|+||.||+|... ++..|++|.+..........+..|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46888889999999999999864 57899999887655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998642 478899999999999999999998 999999999999999999999999999876533221
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... . ...... .+.+
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~----~~~~~~------~~~~-- 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIATNG------TPEL-- 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H----HHhcCC------CCCC--
Confidence 122346888999999998888999999999999999999999999754432111 0 000000 0011
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+......+.+++.+||..||++||++.+|+.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112234456888999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=316.43 Aligned_cols=263 Identities=25% Similarity=0.447 Sum_probs=200.9
Q ss_pred cCCCcCceeccCCceEEEEEEECC---------------CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecc
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD---------------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLG 214 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~ 214 (484)
.+|.+.+.||+|+||.||++...+ ...||+|.+.... ......+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987542 1258999886543 233457889999999999999999999
Q ss_pred eeeeCCeeeEEEEecCCCCHHHHhhcCC--------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEE
Q 011498 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDV--------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (484)
Q Consensus 215 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIl 286 (484)
++......++||||+.+++|.+++.... .....+++..++.++.|++.||+|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999986431 1123478899999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh--CCCCCCCCCCCCc
Q 011498 287 LDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT--GRNPVDYSRPQGE 363 (484)
Q Consensus 287 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--G~~p~~~~~~~~~ 363 (484)
++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 999999999999999765332211 1222345678999999988899999999999999999998 667776443211
Q ss_pred cchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 364 VNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
............... ... .. ....+..+.+++.+||+.||++||++.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~~~-~~~-~~----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQGRQ-IYL-SQ----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhcccc-ccC-CC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111100000 000 00 1112347999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.84 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=199.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCC--EEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGT--KVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||.||+|.++ ++. .+++|.+.... ......+.+|+.++.++ +||||+++++++......++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888899999999999999965 343 45777765432 23446788899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc
Q 011498 225 VYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~ 292 (484)
||||+++++|.++++.... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975421 123588999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 371 (484)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+ ...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 234 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHH
Confidence 9999999986421111 1111234567999999988889999999999999999998 999996543221 111
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.... . ............+.+++.+||+.+|++||++.+++..|+.
T Consensus 235 ~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 235 KLPQ-G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHhc-C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1110 0 0000111123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=336.45 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=193.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC--------C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--------A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~ 220 (484)
..+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999964 57899999885543 2334699999999999999999887532 2
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeec
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFG 299 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg 299 (484)
.+++||||+++ +|.+++.........+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999985 78887764333446789999999999999999999998 999999999999999664 79999999
Q ss_pred ccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
+++....... .....||+.|+|||++.+ ..++.++|||||||+||||+||.+||......... ... ....+...
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~i-~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL--VRI-IQVLGTPT 291 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH-HHHhCCCC
Confidence 9986543222 223468999999998865 46899999999999999999999999765432111 111 11000000
Q ss_pred ----------cccccCCCCCC-----CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 379 ----------SEEVVDPKLPK-----MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 379 ----------~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
...+.-+.... ..+......+.+|+.+||..||.+|||+.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000011100 0111123568899999999999999999999863
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.04 Aligned_cols=258 Identities=23% Similarity=0.400 Sum_probs=205.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeee-CCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~ 222 (484)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......+..|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999765 6789999886543 3335678889999999999999999998876 4678
Q ss_pred eEEEEecCCCCHHHHhhcCCCC----CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGD----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999654221 25689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 299 GLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 299 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
|+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||....+. ....++. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---DG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH---cC
Confidence 999865433221 1122345678999999988889999999999999999999 99999754322 1111111 10
Q ss_pred CCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
. .......+...+.+++.+||..||++|||+.+|++.|+.
T Consensus 236 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 236 Y----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred C----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0 000111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.40 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=198.6
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC-----eee
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-----YRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 223 (484)
+|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677889999999999999964 68999999885432 233457888999999999999999999998766 789
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 4888887543 4689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc-
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE- 381 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 381 (484)
.............++..|+|||++.+. .++.++|||||||++|||++|+.||....+...... +....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~~~~~ 229 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPSLEAM 229 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCHHHH
Confidence 543333233344678999999998764 579999999999999999999999976543221111 111111000000
Q ss_pred ----------cc-CCCCCC------CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 382 ----------VV-DPKLPK------MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 382 ----------~~-~~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
+. .+..+. .........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000000 0011124567889999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=314.45 Aligned_cols=263 Identities=25% Similarity=0.441 Sum_probs=202.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-----------------CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-----------------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRL 212 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l 212 (484)
++|++.+.||+|+||.||++.+. ++..||+|.+.... ......+..|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998643 23468999886543 3345678999999999999999999
Q ss_pred cceeeeCCeeeEEEEecCCCCHHHHhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcE
Q 011498 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVG-------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285 (484)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NI 285 (484)
++++......+++|||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999975421 123478889999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh--CCCCCCCCCCCC
Q 011498 286 LLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT--GRNPVDYSRPQG 362 (484)
Q Consensus 286 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--G~~p~~~~~~~~ 362 (484)
+++.++.++|+|||++..+...... ......++..|++||...++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999765332211 1222334678999999888889999999999999999998 778886443221
Q ss_pred ccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 363 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
. ............ .....+. +..+...+.+++.+||+.||.+||++.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111111111100 0001111 1123357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=308.29 Aligned_cols=249 Identities=32% Similarity=0.466 Sum_probs=203.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|... |+.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+....++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46788899999999999999885 78999999876544 45678889999999999999999999998889999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.++++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999997542 23689999999999999999999998 999999999999999999999999999976532211
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
....+..|+|||++....++.++||||||+++|||++ |..||...... .+...+. ... ....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~-----~~~~-- 220 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVE----KGY-----RMEA-- 220 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----cCC-----CCCC--
Confidence 2234567999999988889999999999999999998 99998644321 1111111 110 0011
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+......+.+++.+||..+|++||++.+++++|++
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 --PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11234568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=309.28 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=197.6
Q ss_pred CCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+..|+.++++++||||+++++++......++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999985 457899999886542 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999997653 367888999999999999999998 99999999999999999999999999997653221
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCcc-chhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-NLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.....++..|+|||++.+..++.++|||||||++|+|++|..||......... ............. .+.+
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~- 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL- 220 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC-
Confidence 23356899999999999989999999999999999999999999654322111 1111111111000 0111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
........+.+++.+||+.||++||+++++++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111233468889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=317.34 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=203.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 222 (484)
++|.+.+.||+|+||.||++... .+..||+|.+.... ......+..|+.+++++ +||||+++++++......
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888899999999999999742 24579999886543 33346788999999999 899999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
+++|||+.+|+|.++++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975422 3489999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ .. ......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~----~~~~~~--- 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY----KLIKEG--- 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH----HHHHcC---
Confidence 65433221 1222345678999999999999999999999999999998 9999875432211 11 111111
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
............+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0000111123468889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=309.37 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=189.5
Q ss_pred ceeccCCceEEEEEEECC-------------CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 157 NVIGEGGYGIVYRGILSD-------------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
+.||+|+||.||+|++.. ...|++|.+..........+..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2258899876655555567888999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc-------EEEe
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-------ARVS 296 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~-------~kl~ 296 (484)
++|||+++|+|..++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999986432 4589999999999999999999998 9999999999999987654 8999
Q ss_pred eecccccccCCCceeecccccccccccccccc-cCCCCcccceecchhHHHHHH-hCCCCCCCCCCCCccchhhhhhhhh
Q 011498 297 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEII-TGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 297 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||........ ....
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence 99998654322 2235788899999886 567899999999999999998 58888864332111 0111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
... ... .......+.+|+.+||+.||++||++.+|++.|+
T Consensus 223 ~~~---------~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ---------CML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC---------ccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 000 0112346888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=309.17 Aligned_cols=252 Identities=27% Similarity=0.504 Sum_probs=202.1
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
.+|++.+.||+|+||.||++.+.++..+|+|.+.... .....+..|+++++.++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577788999999999999998778899999875433 234578899999999999999999999999899999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999997542 3578999999999999999999998 9999999999999999999999999998765333222
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........ . .....+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~-~--~~~~~~~--- 224 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINA-G--FRLYKPR--- 224 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHhC-C--CCCCCCC---
Confidence 1222335678999999988899999999999999999998 99998643321 11111110 0 0111111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.....+.+++.+||+.+|++|||+.++++.|.
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.43 Aligned_cols=246 Identities=26% Similarity=0.449 Sum_probs=193.8
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 158 VIGEGGYGIVYRGILS---DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
.||+|+||.||+|.+. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 345699998865533 334678899999999999999999998864 46799999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee-
Q 011498 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT- 312 (484)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 312 (484)
|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999997432 4689999999999999999999998 999999999999999999999999999976533322111
Q ss_pred -cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 313 -TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 313 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .. . ...... .+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~---~-~~~~~~-----~~~~--- 219 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM---S-FIEQGK-----RLDC--- 219 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH---H-HHHCCC-----CCCC---
Confidence 11223568999999988889999999999999999997 999997543221 11 1 111110 0111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+..+...+.+++.+||..||++||++.+|.+.|+.
T Consensus 220 -~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 -PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 12234568889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.70 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=202.4
Q ss_pred cCCCcCceeccCCceEEEEEEECC--------CCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 220 (484)
++|.+.+.||+|+||.||++...+ ...+|+|.+.... ......+..|+.+++.+ +||||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 568899999999999999998531 3469999886543 23345688899999999 7999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999975422 123588999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccch
Q 011498 289 RQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNL 366 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~ 366 (484)
.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----- 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----
Confidence 99999999999987653221111 111224568999999998899999999999999999998 88898643321
Q ss_pred hhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+..... .... ....+......+.+++.+||..+|++||++.+|++.|+..
T Consensus 250 -~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 -ELFKLL-KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -HHHHHH-HcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 1110 0011122345788899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.18 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=200.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||++... ++..+|+|.+... .......+..|+++++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 35888899999999999999965 4778899987644 233445688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.++++.. ..+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999754 45889999999999999999999731 89999999999999999999999999987543221
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc---------
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS--------- 379 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 379 (484)
.....++..|+|||++.+..++.++|||||||++|+|++|..||............ .........
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF---GRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh---cCccccccccCCcccccC
Confidence 23356889999999998888999999999999999999999998644322111100 000000000
Q ss_pred ---------------ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 ---------------EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ---------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
........+..+.......+.+++.+||..||++|||+.+|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000011111134568899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=310.27 Aligned_cols=254 Identities=28% Similarity=0.508 Sum_probs=201.9
Q ss_pred cCCCcCceeccCCceEEEEEEECC-C---CEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-G---TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|+..+.||+|+||.||+|.... + ..+++|.+.... ......+..|+++++.++||||+++++++......++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999999652 3 379999886543 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.++++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999997532 4589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCceee--cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERSYVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
....... .....+..|+|||++.+..++.++|||||||++|||++ |..||...... ....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~-~~----- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIN-DG----- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHh-cC-----
Confidence 3221111 11123457999999988889999999999999999998 99999644321 1111111 10
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
............+.+++.+||..||++||++.+|++.|+.
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0001111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=312.32 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=204.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-----------------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVR 211 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~ 211 (484)
..+|.+.+.||+|+||.||+|.... +..||+|.+.... ......+..|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568889999999999999998642 2458999887553 334567889999999999999999
Q ss_pred ecceeeeCCeeeEEEEecCCCCHHHHhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCc
Q 011498 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVG-------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (484)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~N 284 (484)
+++++..+...+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999998999999999999999999975431 123689999999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh--CCCCCCCCCCC
Q 011498 285 ILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT--GRNPVDYSRPQ 361 (484)
Q Consensus 285 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--G~~p~~~~~~~ 361 (484)
|+++.++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876533221 12233456778999999988889999999999999999998 67777543321
Q ss_pred CccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 362 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
................ ...+ .....+..+.+++.+||+.||++|||+.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQ-IYLP-----RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhcccccccc-ccCC-----CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111110000 0000 11123357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=322.90 Aligned_cols=244 Identities=30% Similarity=0.478 Sum_probs=203.4
Q ss_pred eeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHHH
Q 011498 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 236 (484)
+||+|.||+||-|+..+ ...+|||.+........+.+..|+.+.+.++|.|||+++|.|..++.+-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999654 56799999987777777889999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCC--CHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-CCCcEEEeeecccccccCCCceeec
Q 011498 237 WLHGDVGDVSPL--TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTT 313 (484)
Q Consensus 237 ~l~~~~~~~~~l--~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~ 313 (484)
+|+..- .++ ++...-.+..||++||.|||++ .|||||||-+|||++ -.|.+||+|||.++.+..-.. .+.
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TE 734 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTE 734 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccc
Confidence 998654 455 7777888999999999999999 999999999999996 579999999999987744332 355
Q ss_pred ccccccccccccccccC--CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 314 RVMGTFGYVAPEYACTG--MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 314 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.+.||..|||||++..+ .|..++|||||||++.||.||++||-....... .+..-+. -+..+..
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm------yKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM------YKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc------eecCCCC
Confidence 67899999999999765 589999999999999999999999964432110 1111111 1122344
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.+...+...++++|+.+||.+||++++++.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 5667788899999999999999999998876
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.89 Aligned_cols=203 Identities=24% Similarity=0.349 Sum_probs=174.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|...+.||+|+||.||++..+ ++..||+|++.... ......+..|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35788899999999999999965 58899999886432 223456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999999754 4589999999999999999999998 999999999999999999999999999865422
Q ss_pred CCc----------------------------------eeecccccccccccccccccCCCCcccceecchhHHHHHHhCC
Q 011498 307 ERS----------------------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR 352 (484)
Q Consensus 307 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~ 352 (484)
... ......+||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0011346999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 011498 353 NPVDYSRP 360 (484)
Q Consensus 353 ~p~~~~~~ 360 (484)
.||....+
T Consensus 234 ~Pf~~~~~ 241 (360)
T cd05627 234 PPFCSETP 241 (360)
T ss_pred CCCCCCCH
Confidence 99976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=306.34 Aligned_cols=250 Identities=31% Similarity=0.502 Sum_probs=202.7
Q ss_pred ceeccCCceEEEEEEECC----CCEEEEEEecccchhh-HHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|.... +..|++|.+....... ...+..|++++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 7789999887654433 57888999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 232 GNLDQWLHGDVGD-----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 232 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
++|.+++...... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764221 36789999999999999999999998 999999999999999999999999999987644
Q ss_pred CCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 307 ERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 307 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
... .......++..|+|||.+....++.++||||||+++|||++ |..||...... ... ..... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~-~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVL---EYLRK-G------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHc-C-------
Confidence 321 11233457889999999988899999999999999999999 69999765321 111 11111 0
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.....+......+.+++.+||+.||++|||+.++++.|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001111223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=307.11 Aligned_cols=247 Identities=27% Similarity=0.445 Sum_probs=196.0
Q ss_pred ceeccCCceEEEEEEECC----CCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|.+.. +..||+|.+..... ...+.+..|+.+++.+.||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999998532 26899998875543 345678899999999999999999998764 467999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999754 3689999999999999999999998 99999999999999999999999999998664332221
Q ss_pred ecc--cccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 312 TTR--VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 312 ~~~--~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
... ..++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....++.. .. .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~----~~--~------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES----GE--R------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----CC--c-------
Confidence 111 123467999999998899999999999999999998 99999754321 11111111 10 0
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...+......+.+++.+||+.||++||++.+|++.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011112335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=314.77 Aligned_cols=260 Identities=25% Similarity=0.445 Sum_probs=203.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 221 (484)
..++|.+.+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678899999999999999997542 45799998754432 233467889999999999999999999999889
Q ss_pred eeEEEEecCCCCHHHHhhcCCC------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
.++||||+++|+|.++++.... ....+.+..+..++.|++.||.|||++ +++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 124457788899999999999999998 9999999999999999999999
Q ss_pred eeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhh
Q 011498 296 SDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence 9999987653322211 122235678999999998899999999999999999999 78888643321 111111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
..... +..+ ......+.+++.+||+.||++|||+.++++.|+..
T Consensus 235 ~~~~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGGY------LDQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCCC------CCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11100 0011 12235788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.29 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=192.2
Q ss_pred eeccCCceEEEEEEECC---CCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 158 VIGEGGYGIVYRGILSD---GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 35799998865443 334578889999999999999999999999888999999999999
Q ss_pred HHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee-
Q 011498 234 LDQWLHGDVG-DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV- 311 (484)
Q Consensus 234 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 311 (484)
|.++++.... .....++..+..++.|++.||+|||+. +++|+||||+||+++.++++||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432 223467778889999999999999998 99999999999999999999999999987543322211
Q ss_pred ecccccccccccccccccC-------CCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 312 TTRVMGTFGYVAPEYACTG-------MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||.......... ...........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-------YTVREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-------HHhhcccCCCC
Confidence 1234567889999988642 35789999999999999997 999997544321110 00011111122
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
++.+... ....+.+++..|| .+|++|||+++|++.|+
T Consensus 232 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 2334677888998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=306.21 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=201.4
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+|.+.+.||+|+||.||++... ++..||+|.+... .....+.+..|+.+++.++|+||+++++++.+....+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999965 5889999988543 2334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999986532 24578999999999999999999998 999999999999999999999999999876543222
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||...... ....... ..... .+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~-----~~-- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVC-QGSYK-----PL-- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHh-cCCCC-----CC--
Confidence 223356888999999998888999999999999999999999999743321 1111110 11000 01
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
+......+.+++.+||+.||++||++.+|+..
T Consensus 221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11233468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=309.40 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=202.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-C---CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-D---GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.+|.+.+.||+|+||.||+|.+. + +..+|+|.+.... ......+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45778899999999999999863 2 3379999886543 33446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997542 3588999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCceee--cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERSYVT--TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
....... ....++..|+|||++.+..++.++|||||||++||+++ |..||......+ ....+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~---~~~----- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE---EGY----- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh---CCC-----
Confidence 3322111 11223567999999998899999999999999999887 999987543221 111111 000
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
. . ......+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 227 -~--~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 -R--L--PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -c--C--CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0 0111234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=311.29 Aligned_cols=239 Identities=25% Similarity=0.424 Sum_probs=188.0
Q ss_pred eeccCCceEEEEEEECC-------------------------CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeee
Q 011498 158 VIGEGGYGIVYRGILSD-------------------------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l 212 (484)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588998865555555678889999999999999999
Q ss_pred cceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-
Q 011498 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW- 291 (484)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~- 291 (484)
++++......++||||+++|+|..++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999986432 4588999999999999999999998 999999999999997643
Q ss_pred ------cEEEeeecccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHH-hCCCCCCCCCCCCc
Q 011498 292 ------NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEII-TGRNPVDYSRPQGE 363 (484)
Q Consensus 292 ------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell-tG~~p~~~~~~~~~ 363 (484)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987643221 12346788999998865 56899999999999999995 69999875443211
Q ss_pred cchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 364 VNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
. .... .. ...+. .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 231 ~---~~~~----~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E---RFYE----KK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HHHH----hc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1100 00 01111 11235888999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=306.66 Aligned_cols=248 Identities=33% Similarity=0.427 Sum_probs=199.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceee-eCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~ 229 (484)
.+|.+.+.||+|+||.||++... |..||+|.+.... ..+.+..|+.+++.++|+|++++++++. .....+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999875 7889999885443 3457888999999999999999999765 456789999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.++++... ...+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999997543 24588999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+...... ... .+.
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~-~~~-----~~~-- 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVE-KGY-----KMD-- 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHh-cCC-----CCC--
Confidence 12234568999999998899999999999999999998 9999864322 11111111 110 011
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
....+...+.+++.+||+.||++|||+.++++.|+.
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112234568889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=295.23 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=207.7
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhcc-CCCceeeeccee
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~l~~~~ 216 (484)
.....+|...+.||.|..+.|-++.++ +|..+|+|++..... ...++-..|+.+|+++ .||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 445677888999999999999998865 578899998853221 1224455699999998 799999999999
Q ss_pred eeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEe
Q 011498 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
+.+...++|+|.|+.|.|.|+|... .++++.....|+.|+..|++|||.+ +||||||||+|||+|++.++||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence 9999999999999999999999755 5799999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCceeeccccccccccccccccc------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhh
Q 011498 297 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 370 (484)
Q Consensus 297 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~ 370 (484)
|||.++.+.... .....|||++|+|||.+.. ..|+..+|+|++||+||-|+.|.+||-.... + .+
T Consensus 166 DFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m--lM 236 (411)
T KOG0599|consen 166 DFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M--LM 236 (411)
T ss_pred ccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H--HH
Confidence 999999875433 4566899999999998853 4688899999999999999999999965431 1 11
Q ss_pred hhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..++.++.. .+......+......+|+.+||+.||.+|.|++|.|..
T Consensus 237 LR~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 237 LRMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 122222211 12233344566678899999999999999999999874
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=315.96 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=203.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeC
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 219 (484)
..+|.+.+.||+|+||.||+|.+. ++..||+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356788899999999999999742 23479999876543 33456788999999999 899999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
...+++|||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +++|+||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999975421 123578889999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccc
Q 011498 288 DRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~ 365 (484)
+.++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 999999999999998654322211 222335678999999988899999999999999999998 88888644321
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+.......... ......+...+.+++.+||..+|.+||++.+|++.|+..
T Consensus 247 --~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 247 --ELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred --HHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 11111111100 001122345688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.93 Aligned_cols=242 Identities=22% Similarity=0.314 Sum_probs=192.3
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 226 (484)
+|.+.+.||+|+||.||+|... ++..||+|++.... ......+..|..++..+. |++|+++++++.+....|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999965 58899999886542 223345677888888885 577888999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998654 4589999999999999999999998 999999999999999999999999999875432
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ....... ..
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~~~~-------~~ 219 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELF---QSIMEHN-------VS 219 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCC-------CC
Confidence 221 223456899999999999989999999999999999999999999754321 111 1111100 01
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMG 418 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 418 (484)
.+ ......+.+++.+||+.||.+|++..
T Consensus 220 ~p----~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 YP----KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CC----ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11 12234678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=308.44 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=201.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCC----CEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.+|.+.+.||+|+||.||+|.+.+. ..|++|...... ....+.+..|+.+++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999986432 468999886554 3445688999999999999999999998875 457899
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997542 3589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
...........++..|+|||.+....++.++||||||+++|||++ |..||....... ....+. ... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~----~~~-----~ 226 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRIE----NGE-----R 226 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH----cCC-----c
Confidence 433222222334568999999988889999999999999999997 999997554221 111111 000 0
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... ...+...+.+++.+||..+|++|||+.++++.|++
T Consensus 227 ~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 227 LPM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011 11234568889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=304.66 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=203.5
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|+..+.||+|+||.||+|.+.+ +..|++|.+..... ...+.+|+++++.++||||+++++++......|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888999999999999999765 78999998865433 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999996432 5689999999999999999999998 999999999999999999999999999987643321
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||++.+..++.++||||||+++|+|++|+.||....+...... .... ..+..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNK-----PPPTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccC-----CCCCC--
Confidence 12234578899999999988999999999999999999999999975443211100 0000 00000
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+++.+||+.||++|||+.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223456888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.59 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=194.0
Q ss_pred ceeccCCceEEEEEEECC-CC--EEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSD-GT--KVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|..++ +. .+++|.+.... ......+..|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 46888776433 33446788899999999 899999999999999899999999999
Q ss_pred CCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 232 GNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 232 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975421 123578999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||......+ .........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~- 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQGY- 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHhCCC-
Confidence 985321111 1111223567999999988899999999999999999997 999996543211 111111100
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...........+.+++.+||..||.+|||+.+++..|+.
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 000111233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=309.29 Aligned_cols=253 Identities=30% Similarity=0.502 Sum_probs=200.0
Q ss_pred CCCcCceeccCCceEEEEEEECC-C---CEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD-G---TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.|.+.+.||+|+||.||+|.+.. + ..||+|.+.... ......|..|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999999653 2 369999886542 334568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999997542 3588999999999999999999998 999999999999999999999999999876533
Q ss_pred CCcee--ecccc--cccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 307 ERSYV--TTRVM--GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 307 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
..... ..... .+..|+|||++.+..++.++|||||||++|||++ |..||...... ....++.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~----~---- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ----D---- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc----C----
Confidence 22111 11111 2357999999998999999999999999999987 99998654321 11111110 0
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.. . .....++..+.+++.+||..+|++||++.+|+..|+.
T Consensus 228 -~~--~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 228 -YR--L--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred -Cc--C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00 0 0111234567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=309.92 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=203.6
Q ss_pred cCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
++|...+.||+|+||.||+|+.+. ...|++|.+...... ....+..|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 467788899999999999999642 457999987654443 4567899999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
+||||+++|+|.++++...... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997553221 2689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~---~~-~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN---RL-QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH---HH-HcC
Confidence 9987543333222233456778999999988889999999999999999999 888986433211 111 11 000
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.. ...........+.+++.+||+.||++||++.+++..|.
T Consensus 235 ~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 00011123456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=303.67 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=198.6
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHH
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 235 (484)
++||+|+||.||++...++..|++|.+...... ....+..|+++++.++|+||+++++++......++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877899999988655433 4567889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee-cc
Q 011498 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TR 314 (484)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 314 (484)
+++.... ..+++..++.++.+++.||.|||++ +++|+||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9996542 3578999999999999999999998 999999999999999999999999999876532211111 11
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 393 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (484)
...+..|+|||.+.+..++.++|||||||++|||+| |..||........ ...+. .. .....+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~~~~~----~~---------~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---RERIE----SG---------YRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---HHHHh----cC---------CCCCCCc
Confidence 223567999999988899999999999999999999 8888865543211 11110 00 0011112
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 394 KALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 394 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.....+.+++.+||..+|++|||+.||++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 23457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=316.24 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=202.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeC
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 219 (484)
..+|.+.+.||+|+||.||++... ....+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356888899999999999999742 23468999876543 33446788899999999 699999999999998
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
...+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 899999999999999999975321 124588999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccc
Q 011498 288 DRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~ 365 (484)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999997654322111 111224467999999998899999999999999999999 889986543221
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... . ...... ... .......+.+++.+||..||++|||+.++++.|+..
T Consensus 245 ~~~---~-~~~~~~-----~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 LFK---L-LREGHR-----MDK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHH---H-HHcCCC-----CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 1 111100 011 112334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=305.97 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=199.0
Q ss_pred ceeccCCceEEEEEEECC--C--CEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSD--G--TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+..|+.++++++||||+++++++.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 2 3699998877655 556789999999999999999999999988 888999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce-
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY- 310 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 310 (484)
++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976532 4689999999999999999999998 9999999999999999999999999999876432211
Q ss_pred -eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 311 -VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 311 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
......++..|+|||++.+..++.++|||||||++|||++ |..||....... .......... ..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~-------~~- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGE-------RL- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC-------cC-
Confidence 1122346778999999998899999999999999999999 999986443211 1111110000 00
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.11 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=203.1
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|.+.+.||+|+||.||++.. .++..||+|.+..........+..|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788889999999999999996 468999999987655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999864 2478899999999999999999998 999999999999999999999999999876533322
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+....... . ... .+. .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~-~~~-----~~~--~ 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A-TNG-----TPE--L 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------c-cCC-----CCC--C
Confidence 122346888999999999888999999999999999999999999754432111000 0 000 000 0
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+......+.+++.+||..||++||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112223455788899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=310.37 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=199.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|...+.||+|+||.||+|.+. ++. .||+|.+.... ......+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 45778899999999999999853 343 48999886543 33456788899999999999999999998764 4689
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
+|||+++|+|.++++... ..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999997542 4589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....++. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~---- 228 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KGE---- 228 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCC----
Confidence 4332211 112234678999999998899999999999999999998 99998654321 1111111 100
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...........+.+++.+||..||++||++.++++.|+..
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0001112345688999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=310.68 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=199.9
Q ss_pred CCCcCceeccCCceEEEEEEEC-----CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeC--Ceee
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 223 (484)
.|.+.+.||+|+||.||++.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4667789999999999999842 47789999886543 33446789999999999999999999998875 5678
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999996542 3589999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCC---------CCccchhhhhhh
Q 011498 304 LCSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP---------QGEVNLVDWLKT 372 (484)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~---------~~~~~~~~~~~~ 372 (484)
....... ......++..|+|||++.+..++.++|||||||++|||+|+..|...... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432221 12234567789999999888899999999999999999998766432110 000001111110
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..... ...........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 239 -~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 -LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred -HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 00000 001112245578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.52 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=201.2
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++......++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445666777789999999999999964 477899998876665666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCC--CHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeeccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPL--TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLA 301 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla 301 (484)
++||+++++|.+++.... ..+ ++..++.++.||+.||+|||+. +|+|+||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999997542 234 7888899999999999999998 9999999999999986 678999999998
Q ss_pred ccccCCCceeecccccccccccccccccC--CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTG--MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
........ ......++..|+|||++... .++.++||||||+++|+|++|..||........ ..+.....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~----- 227 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF----- 227 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh-----
Confidence 76533222 12234578899999998654 378999999999999999999999864322111 00000000
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+.+ +......+.+++.+||+.+|.+|||+.+|+.
T Consensus 228 --~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 --KIHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --ccCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001111 1223456888999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.70 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=199.9
Q ss_pred CCCcCceeccCCceEEEEEEECCCCEEEEEEecccch------hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
+|...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999987889999998854321 2234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999654 3578999999999999999999998 99999999999999999999999999987642
Q ss_pred CCC-----ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 306 SER-----SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 306 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
... ........++..|+|||++.+..++.++|||||||++|+|++|..||......... ..... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~----~ 223 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGA----H 223 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhh----c
Confidence 211 11122345888999999999888999999999999999999999999644321110 00000 0
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+.++ ......+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 RGLMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCCCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111121 123456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=312.49 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=203.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
.++|.+.+.||+|+||.||++... ++..||+|.+.... ......+..|+.+++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888899999999999999863 35789999886543 33456788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCC------------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCc
Q 011498 223 MLVYEYVDNGNLDQWLHGDV------------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~N 284 (484)
+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999996431 1123578899999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCC
Q 011498 285 ILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQG 362 (484)
Q Consensus 285 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~ 362 (484)
|+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999998754322211 1112234667999999988899999999999999999998 88888643321
Q ss_pred ccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 363 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+...... .... . ..+......+.+++.+||+.||++|||+.||++.|+.
T Consensus 240 -----~~~~~~~-~~~~--------~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYYVR-DGNV--------L-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHh-cCCC--------C-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 1110 0 0111234568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.00 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=204.1
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceee-
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCV- 217 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~- 217 (484)
+.++.+..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 345566667889999999999999999999864 47899999875432 2345677899999999 7999999999884
Q ss_pred ----eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 218 ----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 218 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34568999999999999998865433345688999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCceeeccccccccccccccccc-----CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh
Q 011498 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~ 368 (484)
||+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....+....
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~---- 238 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---- 238 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH----
Confidence 9999999876543221 1223468999999998753 45788999999999999999999998754321110
Q ss_pred hhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.... ........+ +......+.+++.+||+.||++|||+.||++.
T Consensus 239 --~~~~-~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 --FKIP-RNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hhcc-ccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 000000111 11123468889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=307.20 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=200.6
Q ss_pred CCCcCceeccCCceEEEEEEECC--CCEEEEEEecccc----------hhhHHHHHHHHHHHhc-cCCCceeeecceeee
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD--GTKVAVKNLLNNR----------GQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVE 218 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~ 218 (484)
+|++.+.||+|+||.||+|..+. +..+|+|.+.... .....++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777899999999999999764 6789999875321 2233456678887765 699999999999999
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEee
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSD 297 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~D 297 (484)
....+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986433334568999999999999999999996 5 899999999999999999999999
Q ss_pred ecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
||++....... ......++..|++||.+.+..++.++||||||+++|+|++|+.||...... ....... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~-~- 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIV-E- 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHh-h-
Confidence 99998654432 223456888999999999888999999999999999999999998643211 1111111 0
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
..............+.+++.+||+.||++||++.||..+++
T Consensus 228 -------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 -------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111123356888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.13 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=195.2
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++..+. +..||+|.+.... ......+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999999764 6789999885422 222345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.++++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997532 3588999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~-- 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKER-- 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcc--
Confidence 3332233457999999999886 346889999999999999999999999754321 111111111100
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCC--CCCCHHHHHHH
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDAT--KRPKMGHVIHM 423 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~--~RPs~~evl~~ 423 (484)
. ..+. ........+.+++.+|+..++. .|+++.++++.
T Consensus 227 ~---~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 F---QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c---cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0111 1112344567777787755444 47898888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=326.71 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=204.7
Q ss_pred cCceeccCCceEEEEEEECC--C--CEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 155 EENVIGEGGYGIVYRGILSD--G--TKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
..++||+|.||.|++|.|.. | ..||||.+...... ...+|.+|+.+|.+|+|||+++|||+..+ ....+|||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 35689999999999999864 3 36999999877654 56899999999999999999999999988 6788999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC-
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER- 308 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~- 308 (484)
+.|+|.+.|++ .....+.......++.|||.||.||..+ ++|||||..+|+||-....+||+||||.+.+....
T Consensus 193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999987 3446688888899999999999999999 99999999999999999999999999999875443
Q ss_pred ceeecc-cccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 309 SYVTTR-VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 309 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.+.+.. .--...|+|||.+....++.++|||+|||+||||+| |+.||-+......+. .+|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----------------~iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----------------NIDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH----------------hcccc
Confidence 333322 223557999999999999999999999999999999 999997665432211 12222
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
-+-..+..|.+.+.++++.||..+|++|||+..|.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 222334457889999999999999999999999974
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=309.45 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=197.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeC------C
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG------A 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~------~ 220 (484)
+++.|...+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++..+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566788889999999999999865 47889999885443 3345678899999998 799999999998753 4
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..+++|||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 5789999999999999997542 24688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
+........ ......|+..|+|||++. ...++.++|||||||++|||++|..||....+.... .. ..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~--~~ 229 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FL--IP 229 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HH--Hh
Confidence 876532221 223456889999999886 345888999999999999999999999643321110 00 00
Q ss_pred CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .+.. ........+.+++.+||..||.+|||+.+|++
T Consensus 230 ~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 0111 11123346888999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=320.08 Aligned_cols=262 Identities=25% Similarity=0.310 Sum_probs=195.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 220 (484)
.++|...+.||+|+||.||++... +|..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467999999999999999999864 48899999886432 233456778999999999999999999986543
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|+||||+.+ +|.+.++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 67776642 378888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccc------------hhh
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN------------LVD 368 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~------------~~~ 368 (484)
+....... ......||..|+|||++.+..++.++|||||||++|+|+||+.||...+...... ...
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 97543221 2233568999999999999999999999999999999999999997553211000 000
Q ss_pred ----hhhhhhcCCC------cccccCCC-CCC--CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 369 ----WLKTMVGSRK------SEEVVDPK-LPK--MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 369 ----~~~~~~~~~~------~~~~~~~~-~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.......... ..+..... .+. .........+.+++.+||..||++|||+.|++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 00000000 000 0001123467889999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.26 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=197.6
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||+|+||.||++... +++.||+|.+.... ......+..|+.+++.++|+||+++++.+.+....++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999965 57899999885432 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999986432 23588999999999999999999998 99999999999999999999999999987653322
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ........ .. ...
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~~-----~~-~~~- 224 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKE-----VQ-EEY- 224 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhhh-----hh-hhc-
Confidence 1 123468999999999999999999999999999999999999997543211100 00111000 00 001
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
.......+.+++.+||+.||++||| ++|+++
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ---SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1123345788999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=318.14 Aligned_cols=246 Identities=24% Similarity=0.263 Sum_probs=186.1
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEecccchh---hHHHHHHHHHHHhcc---CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
||+|+||+||+|... ++..||+|++...... ....+..|..++... +||||+++++++......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 5889999988543211 122344455666554 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 9999998754 4589999999999999999999998 999999999999999999999999999875422221 2
Q ss_pred ecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
....+||..|+|||++.+. .++.++|||||||++|||+||..||...... ........ .. ..++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~-~~------~~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAF-GK------VRFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHc-CC------CCCCC-
Confidence 3345699999999998754 5899999999999999999999999654321 11111110 00 01111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
......+.+++.+||+.||.+||++.+.+..+....
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 112345778889999999999996444333333333
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.57 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=200.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+.|.+.+.||+|+||.||+|.... +..|++|.+..........+..|+.+++.++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 567788899999999999999754 7899999987666566678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|..++.... ..+++..++.++.|++.+|.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998875432 3589999999999999999999998 999999999999999999999999999865422211
Q ss_pred eeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 310 YVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
......++..|+|||++. ...++.++|||||||++|||++|..||....... ......... .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~------~ 232 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE------P 232 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcCC------C
Confidence 122345788999999885 3457889999999999999999999986543211 111111000 0
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.. .........+.+++.+||..||++||++.+|++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 111223446888999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.76 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=193.9
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|.+.+.||+|+||.||+|.+.. ++.||||.... ..+.+|++++++++|+|||++++++......++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 468899999999999999999754 78899995422 23567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
. ++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 5 69999886432 3689999999999999999999998 999999999999999999999999999976533221
Q ss_pred e-eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCC-CccchhhhhhhhhcCCCc--ccc---
Q 011498 310 Y-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ-GEVNLVDWLKTMVGSRKS--EEV--- 382 (484)
Q Consensus 310 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~--- 382 (484)
. ......||..|+|||++.+..++.++|||||||+||||++|..|+-..... ........+...+..... ...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 122356999999999999999999999999999999999987654322111 101110101111100000 000
Q ss_pred ----------------cCCCCCCCCh---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 383 ----------------VDPKLPKMPA---SKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 383 ----------------~~~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..+....... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 0122357789999999999999999999873
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.79 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=197.3
Q ss_pred CCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
|++.+.||+|+||.||+|.... +..+++|.+..........+..|+++++.++||||+++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556789999999999999754 678889988665555567788899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
++|..++... ..++++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988643 24689999999999999999999998 999999999999999999999999999876432221 1
Q ss_pred ecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 312 TTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.....++..|+|||++. +..++.++|||||||++|||++|.+||........ ......... +.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~------~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEP------PT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcCC------CC
Confidence 23346889999999874 34578899999999999999999999975432110 111110000 00
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ..+......+.+++.+||+.||++||++.++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011123456888999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=307.33 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=199.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||.||+|... ++..||+|.+..........+.+|+.+++.++||||+++++++......+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35666778999999999999864 58899999886655444556788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999998654 4689999999999999999999998 999999999999999999999999999876533221
Q ss_pred eeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
......|+..|+|||++. ...++.++|||||||++|+|++|..||....+..... ...... ...+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~~~~----~~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTKSN----FQPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhhccC----CCCCc
Confidence 223356899999999874 4568899999999999999999999986443221110 000000 00111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .......+.+++.+||..||++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 110 0112345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=341.54 Aligned_cols=259 Identities=21% Similarity=0.310 Sum_probs=201.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999965 48899999986542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 227 EYVDNGNLDQWLHGDVG-------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
||++||+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123456778899999999999999998 99999999999999999999999999
Q ss_pred ccccccCCC-----------------ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCC
Q 011498 300 LAKLLCSER-----------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 362 (484)
Q Consensus 300 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~ 362 (484)
++....... .......+||+.|+|||++.+..++.++|||||||++|||+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 997652110 001123569999999999999999999999999999999999999997533211
Q ss_pred ccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhc
Q 011498 363 EVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEA 426 (484)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~ 426 (484)
.. .. ....++.. .......+..+.+++.+||..||++|| +++++++.|+.
T Consensus 239 i~-~~------------~~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 IS-YR------------DVILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hh-hh------------hhccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00 00011100 011123345678899999999999995 56667666654
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=319.39 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=199.3
Q ss_pred hcCCCcCceeccCCceEEEEEEE------CCCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeC-C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG-A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~ 220 (484)
.++|.+.+.||+|+||.||+|.+ .+++.||||.+..... .....+..|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999974 2467899999865432 3345688899999999 789999999988654 4
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCC--------------------------------------------------------
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGD-------------------------------------------------------- 244 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 244 (484)
..+++|||+++|+|.++++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998643210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce-eecccc
Q 011498 245 -------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVM 316 (484)
Q Consensus 245 -------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~ 316 (484)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12467888899999999999999998 9999999999999999999999999999765322211 112233
Q ss_pred cccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHH
Q 011498 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 395 (484)
Q Consensus 317 gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (484)
++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ........ ...+. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~-----~~~~~----~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTR-----MRAPD----YT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCC-----CCCCC----CC
Confidence 5677999999988899999999999999999997 9999865432111 11 11111100 01111 12
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 396 LKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 396 ~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2458889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.91 Aligned_cols=260 Identities=24% Similarity=0.345 Sum_probs=192.7
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhcc---CCCceeeecceeee-----CC
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVE-----GA 220 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~ 220 (484)
+|.+.+.||+|+||.||+|... +++.||+|.+..... .....+..|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999965 588999998864322 2223455677766655 79999999998864 24
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..+++|||+.+ +|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999985 8999886542 24589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc-
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS- 379 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 379 (484)
+....... ......+|..|+|||++.+..++.++|||||||++|||++|.+||......+.. .. +.........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~--~~-~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GK-IFDLIGLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH--HH-HHHHhCCCChh
Confidence 97654322 123346889999999999889999999999999999999999999654322111 00 1110000000
Q ss_pred ---------ccccCCCCCC---CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 ---------EEVVDPKLPK---MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ---------~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.....+.... .........+.+++.+||+.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=315.24 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=197.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|...+.||+|+||.||+|+.+ ++..||+|.+..... .....+.+|+.+++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999865 578899998864432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 976 8988886442 3578899999999999999999998 99999999999999999999999999987543222
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhh---------hhhhcCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL---------KTMVGSRK 378 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~---------~~~~~~~~ 378 (484)
. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||......+........ ........
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1 1223457899999998865 56899999999999999999999999765432221111000 00000000
Q ss_pred cccccCCCCCCC----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....-.+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 00113346788999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.45 Aligned_cols=246 Identities=24% Similarity=0.283 Sum_probs=193.9
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|+..+.||+|+||+||++... +++.||+|.+..... .....+..|+++++.++|+||+++++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556688999999999999864 588999998855422 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999886432 24689999999999999999999998 99999999999999999999999999987643222
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. .....|+..|+|||++.+..++.++|+|||||++|||++|..||......... .. +....... ....
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~-~~~~~~~~------~~~~- 224 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EE-VDRRVLET------EEVY- 224 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHhhhcc------cccc-
Confidence 1 22346899999999999889999999999999999999999999754321111 00 11100000 0011
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMG 418 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 418 (484)
.......+.+++.+||+.||++||++.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ---CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 112334578889999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=317.44 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=202.8
Q ss_pred cCCCcCceeccCCceEEEEEEECC--------CCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 220 (484)
.+|.+.+.||+|+||.||+|.... +..||+|.+.... ......+..|+.+++++ +||||++++++|....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999997421 2368999776443 23356788999999999 8999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
..+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999975321 224588899999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccCCCcee-ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccch
Q 011498 289 RQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNL 366 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~ 366 (484)
.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 99999999999997653322111 112234567999999999999999999999999999999 88888654321
Q ss_pred hhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
+....... .. ...........+.+++.+||+.+|++||++.+|++.|+...
T Consensus 244 -~~~~~~~~-~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 -ELFKLLKE-GH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -HHHHHHHc-CC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11111111 10 00111123456889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.49 Aligned_cols=192 Identities=25% Similarity=0.369 Sum_probs=163.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
...+|.+.+.||+|+||.||+|... ++..||+|..... ....|+.+++.++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999975 3678999964332 22458899999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+. ++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 138 ~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 58999886432 4689999999999999999999998 9999999999999999999999999998753222
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPV 355 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~ 355 (484)
. ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 123356899999999999999999999999999999999954443
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.61 Aligned_cols=238 Identities=27% Similarity=0.483 Sum_probs=189.6
Q ss_pred ceeccCCceEEEEEEECCCC-----------EEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 157 NVIGEGGYGIVYRGILSDGT-----------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999976432 5788876544333 6788899999999999999999999988 778999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-------cEEEeee
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-------NARVSDF 298 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~kl~Df 298 (484)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+|+||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999997543 2688999999999999999999998 999999999999999887 7999999
Q ss_pred cccccccCCCceeecccccccccccccccccC--CCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhc
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACTG--MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
|++..... .....++..|+|||++... .++.++|||||||++|||++ |..||......... .+.. .
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~~---~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFYQ---D 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHHh---c
Confidence 99876533 1223466789999998876 78999999999999999999 57777654322111 1100 0
Q ss_pred CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.. ..+. .. ...+.+++.+||..||.+|||+.+|++.|+
T Consensus 222 ~~--------~~~~-~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH--------RLPM-PD---CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--------CCCC-CC---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0000 00 156889999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=306.08 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=201.5
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+|...+.||.|+||.||+|... +++.||+|.+.... ......+..|+.+++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777789999999999999965 57899999886543 334467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999643 689999999999999999999998 999999999999999999999999999987643321
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||++.+..++.++||||||+++|+|+||..||....+... . .. .... ..+.+..
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~---~~-~~~~-----~~~~~~~ 220 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---L---FL-IPKN-----NPPSLEG 220 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---H---HH-hhhc-----CCCCCcc
Confidence 22334688899999999988899999999999999999999999975432111 0 00 0000 1111111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. .....+.+++.+||..||++|||++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 13446888999999999999999999977
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.99 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=202.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|...+.||.|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999985 468899999886655555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998642 488999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||.+.+..++.++|||||||++|+|++|..||....+.... ..... ... +.+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~-~~~-----~~~-- 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT-NGT-----PEL-- 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-cCC-----ccc--
Confidence 122346888999999999888999999999999999999999999754432111 00000 000 000
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+++.+||..||++||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011223446888899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=304.47 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=202.3
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.|...+.||.|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3556678999999999999975 47899999886443 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.+++.. .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999864 3478899999999999999999998 999999999999999999999999999976543322
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||++.+..++.++|+|||||++|||+||..||....+...... .....+.
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcCCCC
Confidence 12234578899999999888899999999999999999999999975443211100 0011112
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.........+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233456778899999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.45 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=198.7
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh---------hHHHHHHHHHHHhccCCCceeeecceeeeCCe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 221 (484)
+|.+...||+|+||.||+|... ++..||+|.+...... ..+.+..|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5789999988543221 22568889999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999754 4588899999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCc-----eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 302 KLLCSERS-----YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 302 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... .+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-- 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIG-- 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHh--
Confidence 76642211 01122457889999999998889999999999999999999999997543211 001100
Q ss_pred CCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+.++ ......+.+++.+||+.||.+||++.+|++
T Consensus 226 ----~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ----ENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----ccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111221 223456888999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=301.92 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=204.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||.|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999964 47889999887665556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999986532 4588999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeecccccccccccccccccC---CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTG---MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
......++..|+|||.+.+. .++.++||||||+++|||+||..||....+.... .. .... ....+.
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~-~~~~---~~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FL-ISKS---NFPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhc---cCCCcc
Confidence 12334678899999998776 8899999999999999999999999754322111 00 0000 000001
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..........+.+++.+||..||.+|||+.+|+.
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1112334567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.19 Aligned_cols=248 Identities=29% Similarity=0.473 Sum_probs=190.9
Q ss_pred ceeccCCceEEEEEEECC----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeee-CCeeeEEEEecC
Q 011498 157 NVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVYEYVD 230 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~ 230 (484)
+.||+|+||.||+|.+.+ ...||+|.+.... ......+..|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998532 3579999875432 3345678889999999999999999998764 456789999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++.... ..+.+..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997542 3467788899999999999999998 9999999999999999999999999999765332111
Q ss_pred e---ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 311 V---TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 311 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...... ... ....... .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~---~~~~~~~------~~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT---VYLLQGR------RLL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HHHhcCC------CCC
Confidence 1 112345678999999988899999999999999999999 56666543211 111 1111100 000
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
. +...+..+.+++.+||..+|++||++.+|++.|++
T Consensus 223 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 Q----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1 11123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.60 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=198.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEC---CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
..+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|+.+++.++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3568999987543 23457999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|++. ++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 166 e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9996 5899988432 5689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc-----
Q 011498 307 ERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE----- 380 (484)
Q Consensus 307 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 380 (484)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 322 12234579999999999999999999999999999999999999997654322111111111111000000
Q ss_pred ------------cccCCCCCCCC---hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 381 ------------EVVDPKLPKMP---ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 381 ------------~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
....+...... .......+.+++.+||..||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00123457788999999999999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=309.94 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=208.1
Q ss_pred CCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchh--hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
-|...+.||+|.|+.|-+|++ -+|.+||||++.+.+-. ....+.+|++.|+.++|||||+||.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 356667899999999999983 46999999999765432 234677799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-CCCcEEEeeecccccccCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfgla~~~~~~ 307 (484)
-.+|+|++||-+.. ..+++....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||+|||++..+...
T Consensus 99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999996543 4699999999999999999999998 899999999999875 4588999999999876443
Q ss_pred CceeecccccccccccccccccCCCC-cccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. .....||+..|-|||++.+..|+ +++||||||||||.|++|++||+..+..+.+..+ +|
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mD-- 233 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MD-- 233 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hc--
Confidence 3 45667999999999999998887 5899999999999999999999877654433221 22
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhcC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH--MLEAD 427 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~ 427 (484)
..-..+.....++.+||..||..||.+|.+.++|.. +|+..
T Consensus 234 CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 234 CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 112234556778999999999999999999999875 44443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=303.73 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=190.4
Q ss_pred eeccCCceEEEEEEECCC---CEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 158 VIGEGGYGIVYRGILSDG---TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
.||+|+||.||+|...++ ..+++|.+.... ......+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985433 346677665443 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC-ceee
Q 011498 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-SYVT 312 (484)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~ 312 (484)
|.++++.........++..++.++.||+.||+|||+. +++|+||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976543345577778889999999999999998 99999999999999999999999999986432211 1112
Q ss_pred ccccccccccccccccc-------CCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 313 TRVMGTFGYVAPEYACT-------GMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 313 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
....++..|+|||++.. ..++.++|||||||++|||++ |..||...... +....... .......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh-hcccccCC
Confidence 23467889999998743 245789999999999999997 57787543321 11111111 11122233
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
+.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333322 2345677888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.08 Aligned_cols=240 Identities=24% Similarity=0.423 Sum_probs=189.3
Q ss_pred ceeccCCceEEEEEEECC--------CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 157 NVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+.||+|+||.||+|.... ...|++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 234888877655445556788899999999999999999999998899999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc--------EEEeeecc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------ARVSDFGL 300 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~Dfgl 300 (484)
+.+|+|.++++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997543 3588999999999999999999998 9999999999999987765 69999998
Q ss_pred cccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCC-CCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGR-NPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||....+.... . ....
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~------~-~~~~-- 220 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL------Q-FYED-- 220 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH------H-HHHc--
Confidence 8654321 22457889999999976 45899999999999999999984 565533221110 0 0000
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
...++. .....+.+++.+||+.||++|||+++|++.|+
T Consensus 221 -----~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----RHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----cccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111 12246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.61 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=203.2
Q ss_pred CCCcCceeccCCceEEEEEEEC-----CCCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeee--CCeee
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~ 223 (484)
.|.+.+.||+|+||.||++.+. ++..||+|.+...... ....+..|+++++.+.||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999864 3678999988765443 46789999999999999999999999887 55789
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
++|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999997543 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcee--ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCcc--------chhhhhhhh
Q 011498 304 LCSERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--------NLVDWLKTM 373 (484)
Q Consensus 304 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 373 (484)
........ .....++..|++||.+.+..++.++||||||+++|||+||..|+......... .....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 64322211 11223456799999998889999999999999999999999998643221100 001111111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.. ..........+...+.+++.+||+.||++|||+.+|+++|+..
T Consensus 239 ~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LK---------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HH---------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 1111111122345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=301.15 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=203.3
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|+..+.||+|+||.||.++.. ++..+++|.+.... ......+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999999854 58899999875432 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997542 24689999999999999999999998 99999999999999999999999999997654333
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. ......+++.|+|||.+.+..++.++||||||+++|||++|..||....... ...... .. ...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~--------~~~ 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV-QG--------NYT 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cC--------CCC
Confidence 2 2234568999999999988889999999999999999999999996543211 111111 11 111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
. ........+.+++.+||..||.+||++.++++.+
T Consensus 220 ~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 P-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 1123345688899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.46 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=204.6
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeee
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 218 (484)
+++.++..++++|.+.+.||+|+||.||++... ++..+|+|.+.... .....+..|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455666677889999999999999999999964 58899999885432 2345677889999988 89999999999875
Q ss_pred C-----CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 219 G-----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 219 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
. ...++||||+++++|.++++........+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 357999999999999999875433345689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCceeecccccccccccccccccC-----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh
Q 011498 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~ 368 (484)
||+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.||....+... +.
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~- 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF- 243 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH-
Confidence 9999999876533221 12234578899999987543 368899999999999999999999975432111 11
Q ss_pred hhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .... +.+. ........+.+++.+||+.||++||++.++++
T Consensus 244 ---~~~-~~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 ---KIP-RNPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HHh-cCCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 0000 0110 11223456889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.25 Aligned_cols=250 Identities=28% Similarity=0.495 Sum_probs=196.3
Q ss_pred eeccCCceEEEEEEECC-------CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 158 VIGEGGYGIVYRGILSD-------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998643 2578999875543 234567888999999999999999999999989999999999
Q ss_pred CCCCHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-----cEEEeeeccc
Q 011498 230 DNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-----NARVSDFGLA 301 (484)
Q Consensus 230 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~Dfgla 301 (484)
++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999975321 124478899999999999999999998 999999999999999877 8999999998
Q ss_pred ccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 302 KLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 302 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
......... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... .....+ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~-- 229 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----TAG-- 229 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----hcC--
Confidence 765322211 1122345678999999999999999999999999999998 99998644321 111111 000
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
............+.+++.+||..+|.+||++.+|++.|++
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0011112234578899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=307.74 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=204.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||+||++... ++..||+|.+.... ......+..|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45667789999999999999965 57889999876543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++... ..+++..+..++.+++.||.|||+. .+++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999998653 4689999999999999999999963 289999999999999999999999999986542211
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCc-----cchhhhhhhhhcCCCccccc
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE-----VNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 383 (484)
.....|+..|+|||++.+..++.++|||||||++|+|+||..||......+. ....++......
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 227 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-------- 227 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh--------
Confidence 2234689999999999888999999999999999999999999975543211 111122221111
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
...+..........+.+++.+||+.||++|||+.||++..
T Consensus 228 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 228 -EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111111222455688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.79 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=196.5
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|++|.||+|+.. ++..||+|.+.... ......+..|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999975 58899999885432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
++ ++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58999886532 224689999999999999999999998 99999999999999999999999999987553222
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC-----------
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS----------- 376 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 376 (484)
. ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||......... ..........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhh
Confidence 1 1223356889999998865 45789999999999999999999999754321110 0000000000
Q ss_pred C----CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 R----KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 ~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. .......... .........++.+++.+||+.||++|||+.+|++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000000 0001113456778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.05 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=198.7
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECC-CCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeee--CCee
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYR 222 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~ 222 (484)
....+|.+.+.||+|+||+||+|.... +..||+|.+... .......|..|+.+++.++|||||+++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345689999999999999999999754 678899987543 22344678889999999999999999998865 3568
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC----CCceeecCCCCCcEEEcC---------
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL----EPKVVHRDVKSSNILLDR--------- 289 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~----~~~ivH~dlkp~NIll~~--------- 289 (484)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.. ..+|+|+||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999764434457999999999999999999999841 125999999999999964
Q ss_pred --------CCcEEEeeecccccccCCCceeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 290 --------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 290 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+||..||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999997653322 1234568999999999864 458999999999999999999999996433
Q ss_pred CCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 360 PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ....+.... .. +.++. ......+.+|+..||..+|.+||++.|++.
T Consensus 248 ~-----~~qli~~lk-~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-----FSQLISELK-RG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-----HHHHHHHHh-cC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2 111111111 10 11111 112356888999999999999999999984
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=306.69 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=198.4
Q ss_pred CCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHH--HHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEK--EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~--~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
|++.+.||+|+||+||++.... +..||+|.+......... ....|+.+++.++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999764 568999998766543322 3455999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 999999999732 4689999999999999999999998 99999999999999999999999999997642 222
Q ss_pred eeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......++..|+|||++. +..++.++||||||+++|+|++|..||............ ....... ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~----~~~~~~- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILKRP----LPSSSQ- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHHTH----HHHHTT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhccccc----cccccc-
Confidence 2344556899999999998 888999999999999999999999999755211111111 1100000 000000
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........+.+++.+||+.||++||++.++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001267899999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.82 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=198.6
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
|...+.||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 444567999999999999864 47789999876443 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++.. ..+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999853 3588999999999999999999998 999999999999999999999999999876543221
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
......++..|+|||++.+..++.++|||||||++|||+||..||....+.... .. ... .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~---------~~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-IPK---------NSPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-hhc---------CCCCC
Confidence 122345788999999999889999999999999999999999998644322110 00 000 00111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
........+.+++.+||+.+|++||++.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112344568899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.83 Aligned_cols=198 Identities=23% Similarity=0.379 Sum_probs=161.3
Q ss_pred CceeccCCceEEEEEEEC---CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee--CCeeeEEEEecC
Q 011498 156 ENVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVYEYVD 230 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 230 (484)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999864 45789999885442 23456789999999999999999998864 456789999996
Q ss_pred CCCHHHHhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE----cCCCcEEEeeeccc
Q 011498 231 NGNLDQWLHGDV-----GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLA 301 (484)
Q Consensus 231 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfgla 301 (484)
+ +|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 8988875321 1223588999999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCc--eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 302 KLLCSERS--YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 302 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87543221 12234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=311.21 Aligned_cols=260 Identities=18% Similarity=0.232 Sum_probs=192.6
Q ss_pred CceeccC--CceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 156 ENVIGEG--GYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 156 ~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
.++||+| +|++||++..+ +|+.||+|++.... ......+..|+.+++.++||||+++++++..+...++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 68999999864 58899999986542 2334567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999996542 23588999999999999999999998 9999999999999999999999999865433211110
Q ss_pred ------eeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc-------
Q 011498 311 ------VTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG------- 375 (484)
Q Consensus 311 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~------- 375 (484)
......++..|+|||++.+ ..++.++|||||||++|||++|..||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccc
Confidence 0112346778999999875 4689999999999999999999999975332110 0000000000
Q ss_pred -------CCC-----cccccC------------CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 -------SRK-----SEEVVD------------PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 -------~~~-----~~~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .....+ ..............+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000000 00000111223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=303.84 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=189.4
Q ss_pred eeccCCceEEEEEEECC---CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 158 VIGEGGYGIVYRGILSD---GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888775443 2334578889999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCC-CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee-
Q 011498 234 LDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV- 311 (484)
Q Consensus 234 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 311 (484)
|.+++...... ....++...+.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 23356788899999999999999998 99999999999999999999999999986543222111
Q ss_pred eccccccccccccccccc-------CCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 312 TTRVMGTFGYVAPEYACT-------GMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....... . ....... ....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVRE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhhc-cCccCC
Confidence 122345678999998743 356889999999999999999 788886443211 1 1111111 111122
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.+.+. ......+.+++..|| .||++|||+++|++.|.
T Consensus 232 ~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222 223345666777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=304.44 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=198.7
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+|.+.+.||+|+||.||++.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999975 68899999886542 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|..+++... ....+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999987532 124689999999999999999999963 289999999999999999999999999987653221
Q ss_pred eeecccccccccccccccccC------CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 310 YVTTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ...+.. +.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~---------~~ 223 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSA---------IV 223 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHH---------Hh
Confidence 2234578899999988544 358899999999999999999999965432111 111111 11
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... +..........+.+++.+||..+|++||++.+++.
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 100 11112235567888999999999999999998876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=300.81 Aligned_cols=251 Identities=29% Similarity=0.517 Sum_probs=200.6
Q ss_pred CCcCceeccCCceEEEEEEECC-----CCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
+++.+.||+|+||.||++.+.+ +..||+|.+...... ....+..|+.++..++|+||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999999754 378999998665433 5678889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999975421 1289999999999999999999998 999999999999999999999999999987644
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
..........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ..... ... .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~---~~~~~-~~~-----~ 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVL---EYLKK-GYR-----L 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHhc-CCC-----C
Confidence 32222212336789999999988889999999999999999999 88888653211 111 11111 100 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
.. .......+.+++.+||+.||++|||+.++++.|
T Consensus 224 ~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 111445688899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.68 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=197.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||+|..+ ++..||+|.+.... ......+..|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999865 57899999886443 22334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 49999886542 3578999999999999999999998 99999999999999999999999999987543222
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh---------hhhhhhcCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD---------WLKTMVGSRK 378 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~---------~~~~~~~~~~ 378 (484)
. ......+++.|+|||.+.+ ..++.++|||||||++|||+||++||......+...... ..........
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1 1222356889999998865 458889999999999999999999997554321110000 0000000000
Q ss_pred cccccCCCCCCC----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000111000 01123446788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.68 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=201.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||.||++.+. ++..||+|.+..........+..|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45777889999999999999975 57899999887665556678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999986532 4589999999999999999999998 999999999999999999999999999876533221
Q ss_pred eeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 310 YVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
......++..|+|||.+. ...++.++||||||+++|||++|..||....... ......... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~------~ 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSE------P 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcCC------C
Confidence 123345889999999875 3457789999999999999999999997543211 111111000 0
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.+. .+......+.+++.+||+.||.+||++.+|++
T Consensus 226 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1110 11123346788999999999999999999977
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.23 Aligned_cols=263 Identities=24% Similarity=0.264 Sum_probs=197.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC------
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------ 219 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 219 (484)
..++|...+.||+|+||.||++... .+..||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3568999999999999999999864 47899999886532 23345677899999999999999999988643
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...++||||+.+ +|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346999999976 77777752 478889999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh------------
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV------------ 367 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~------------ 367 (484)
+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 997653321 223456899999999999999999999999999999999999999754321110000
Q ss_pred ----hhhhhhhcCC-CcccccCCC------CC--CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 368 ----DWLKTMVGSR-KSEEVVDPK------LP--KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 368 ----~~~~~~~~~~-~~~~~~~~~------~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.......... .......+. .+ ..........+.+++.+||..||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 000000000 00 00111123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=300.28 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=199.5
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee-CCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 227 (484)
+|++.+.||+|++|.||++..+ ++..||+|++.... ....+.+..|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999965 47889999885432 2334568889999999999999999998764 446789999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997542 24689999999999999999999998 9999999999999999999999999999766432
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........ .. +
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~-~~--------~ 219 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIE-GK--------L 219 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-cC--------C
Confidence 22 223456889999999999999999999999999999999999998743311 11111111 10 1
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..........+.+++.+||+.||++||++.++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111234457889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.69 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=192.9
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC------CCceeeeccee
Q 011498 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR------HKNLVRLLGYC 216 (484)
Q Consensus 144 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~~~ 216 (484)
+++...+.+|.+.+.||+|+||+||+|... .+..||||++.... .....+..|+.++..++ |.+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456788999999999999999999864 47889999885432 22344556777776664 45688999988
Q ss_pred eeC-CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCC---
Q 011498 217 VEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQW--- 291 (484)
Q Consensus 217 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~--- 291 (484)
... .+.|+|||++ +++|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5788999988 67999988654 468999999999999999999996 5 999999999999998765
Q ss_pred -------------cEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCC
Q 011498 292 -------------NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYS 358 (484)
Q Consensus 292 -------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~ 358 (484)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||+||||+||+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998754321 223467999999999999999999999999999999999999999765
Q ss_pred CCCCccchhhhhhh-----hhc---CCCcccc------cCCCCCC---------CC--hHHHHHHHHHHHHhcCCCCCCC
Q 011498 359 RPQGEVNLVDWLKT-----MVG---SRKSEEV------VDPKLPK---------MP--ASKALKRVLLVALRCVDPDATK 413 (484)
Q Consensus 359 ~~~~~~~~~~~~~~-----~~~---~~~~~~~------~~~~~~~---------~~--~~~~~~~l~~l~~~cl~~dp~~ 413 (484)
...+....+..... +.. ......+ +.+.... .. .......+.+|+.+||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 43221111110000 000 0000000 0000000 00 0011245779999999999999
Q ss_pred CCCHHHHHH
Q 011498 414 RPKMGHVIH 422 (484)
Q Consensus 414 RPs~~evl~ 422 (484)
|||++|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999986
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=301.83 Aligned_cols=247 Identities=31% Similarity=0.461 Sum_probs=197.9
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
.+|.+.+.||+|+||.||++.. .+..||+|.+.... ....+.+|+.+++.++||||+++++++... ..+++|||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999986 47889999885432 345788899999999999999999998764 4799999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999997542 24588999999999999999999998 9999999999999999999999999998754221
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......+..|+|||.+.+..++.++|+|||||++|||++ |..||....... .... ..... ..
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~-~~~~~---------~~ 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKEC-VEKGY---------RM 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHH-HhCCC---------CC
Confidence 111234567999999988899999999999999999998 999997544221 1111 11110 01
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.........+.+++.+||+.+|++||++++|+..|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=304.84 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=202.1
Q ss_pred cHHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeee-
Q 011498 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE- 218 (484)
Q Consensus 142 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~- 218 (484)
++.++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45666667788999999999999999999964 57889999875443 2335678899999988 79999999999863
Q ss_pred -----CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 219 -----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 219 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
....+++|||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +++|+||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 457799999999999999997543 24578888999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCceeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh
Q 011498 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~ 368 (484)
+|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|..||....+......
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-- 237 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-- 237 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence 9999999876532211 123346888999999875 34688899999999999999999999965432211100
Q ss_pred hhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ................+.+++.+||+.||.+||++.||++
T Consensus 238 ----~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ----I---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----H---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000111111223456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.10 Aligned_cols=252 Identities=24% Similarity=0.441 Sum_probs=200.5
Q ss_pred CCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch------hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
+|...+.||+|+||.||++.. .++..||+|.+..... .....+..|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999985 4688999998864331 134678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeeccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKL 303 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~ 303 (484)
||||+++++|.+++... .++++..++.++.|++.||.|||++ +++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999999754 4688999999999999999999998 999999999999998775 599999999876
Q ss_pred ccCCCc---eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 304 LCSERS---YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 304 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||........... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~------ 224 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIA------ 224 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHh------
Confidence 643211 112234678899999999888899999999999999999999999964432211111 11000
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........+......+.+++.+||..||++||++.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 ---SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000111222334567888999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.49 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=199.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++.|.+.+.||+|.|+.||++... +|+.+|+|.+... .....+++.+|+.+.+.|+||||++|.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356677779999999999999854 5888999977433 2335578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeeccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKL 303 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfgla~~ 303 (484)
|++.|++|..-+-.+ .-.++..+-..+.||+++|.|+|.+ +|||||+||.|+||.. ..-+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999997665433 3467777888999999999999999 9999999999999943 34589999999998
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
+. ........+|||.|||||++...+|+..+|||+.||+||-||.|.+||.+.+.. .+.+.+. ... .
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~----~g~----y 229 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIK----AGA----Y 229 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHh----ccc----c
Confidence 76 333455678999999999999999999999999999999999999999764322 1111111 000 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..++...+...+.-.+|+.+||..||.+|.|+.|.|+
T Consensus 230 --d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 --DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1112122233445677888999999999999998875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.02 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=196.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC------C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 220 (484)
.++|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467899999999999999999864 47889999886532 23345677899999999999999999987643 3
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|+||||+.+ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999975 78877752 378889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh---------hh--
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV---------DW-- 369 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~---------~~-- 369 (484)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...........+ ++
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 97653321 223456899999999999999999999999999999999999999755422111000 00
Q ss_pred -----hhhhhcCCC-cc-----cccCCC-CC--CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 370 -----LKTMVGSRK-SE-----EVVDPK-LP--KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 370 -----~~~~~~~~~-~~-----~~~~~~-~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
......... .. ...... .+ ..........+.+++.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00 000000 00 00011123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.31 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=199.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35788899999999999999976 48899999886443 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|..++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888876533 3589999999999999999999998 9999999999999999999999999999876433
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh-hh----h---hhhc-CC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD-WL----K---TMVG-SR 377 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~-~~----~---~~~~-~~ 377 (484)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|..||......+...... .. . .... ..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 21 1223457889999998875 568899999999999999999999997554321110000 00 0 0000 00
Q ss_pred CcccccCCCCCCCC-----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 KSEEVVDPKLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+...... .......+.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000011100000 0122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=306.02 Aligned_cols=264 Identities=24% Similarity=0.344 Sum_probs=200.5
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+..|+++++.++|+||+++++++......+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999976 47899999886432 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
++++.+..++... ..+++..++.++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9987776665432 4589999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhh---------hhhhcCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL---------KTMVGSRK 378 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~---------~~~~~~~~ 378 (484)
........++..|+|||++.+. .++.++||||||+++|+|++|..||......+........ ..+.....
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2223345678899999999887 8899999999999999999999999754322111000000 00000000
Q ss_pred cc--cccCCCCC----CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SE--EVVDPKLP----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~--~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. +....... ..........+.+++.+||..||++||++++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 0011123567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=308.16 Aligned_cols=257 Identities=23% Similarity=0.258 Sum_probs=201.6
Q ss_pred CCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchh---hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
+|...+.||+|+||.||+|...+ +..||+|.+...... ....+..|+++++.++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57788899999999999999754 889999988654322 34568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999997542 24689999999999999999999998 9999999999999999999999999998654221
Q ss_pred Cce----------------------------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 308 RSY----------------------------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 308 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1112467889999999998889999999999999999999999997544
Q ss_pred CCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 360 PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
.... ..... ...............+.+++.+||..||++|||....++.+...+
T Consensus 237 ~~~~------~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 237 RDET------FSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred hHHH------HHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 2211 11111 111111111114567899999999999999999444444444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=299.04 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=199.3
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
+|...+.||+|+||+||+|... ++..|++|.+.... ....+.+..|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 68899999885433 22446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999754 4588999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCceeecccccccccccccccccCC-CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
... ......++..|++||.+.... ++.++|+||||+++|+|++|..||....... ...........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~----- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL----- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-----
Confidence 332 123356888999999987766 8999999999999999999999996543111 11111100000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.+ +......+.+++.+||+.+|.+||++.+++.
T Consensus 221 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111 1123456788899999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=297.27 Aligned_cols=256 Identities=28% Similarity=0.403 Sum_probs=204.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+..|+.+++.++|+||+++++.+......+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888899999999999999964 57889999886443 33457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.++++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975421 24589999999999999999999998 99999999999999999999999999987664432
Q ss_pred ce---eecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 309 SY---VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 309 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.. ......++..|+|||++... .++.++|+|||||++|+|++|+.||........ ... .... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQN------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcC------CC
Confidence 21 22334688999999998776 789999999999999999999999975443211 111 1100 01
Q ss_pred CCCCCCC-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+...... .......+.+++.+||..||++||++.+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111 1234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=300.59 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=202.8
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+|+..+.||+|+||.||++..+ +++.|++|.+.... ......+.+|+++++.++||||+++++++......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999976 57899999886653 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999997542 568899999999999999999999 7 99999999999999999999999999987653222
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+.+...... ..+
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~---------~~~ 222 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE---------PPP 222 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC---------CCC
Confidence 1 11568889999999998899999999999999999999999996543211 1112222211111 111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..........+.+++.+||..||++|||+.+++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111124556889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=299.54 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=201.8
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee--CCeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 226 (484)
+|.+.+.||.|+||.||++... ++..||+|.+.... ......+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999854 57889999886432 2334568889999999999999999998764 45679999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhh-----cCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-----EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-----~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
||+++++|.+++.........+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444567999999999999999999999 66 9999999999999999999999999999
Q ss_pred ccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
......... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..... .....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~--- 226 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASK----IKEGK--- 226 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHH----HhcCC---
Confidence 876443321 23346889999999999888999999999999999999999999754311 11111 11110
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.+. .+......+.+++.+||+.+|++||++.+|++.
T Consensus 227 --~~~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 --FRR----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCC----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011 122344578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=301.09 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=200.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCC------
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA------ 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~------ 220 (484)
++++|.+.+.||+|+||.||+|..+ ++..+++|.+..... ....+..|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999975 478899998765443 346788999999999 7999999999997644
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..++||||+++++|.++++........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 47999999999999999875432345789999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeeccccccccccccccccc-----CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
+........ ......++..|+|||++.. ..++.++|||||||+||+|++|..||........ ......
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~ 232 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFKIPR 232 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHHhhc
Confidence 876533221 1233458889999998753 3477899999999999999999999964322111 111110
Q ss_pred CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. .+.+ .........+.+++.+||..||++|||+.+|++
T Consensus 233 -~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 -NP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 0111 112224567889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=303.26 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=200.5
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CC----EEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GT----KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|.+.+.||+|+||.||+|.+++ |. .+|+|.+..... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457778899999999999998643 32 589998765543 344678889999999999999999999987 67899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
+|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999997542 3589999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCCceee-cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSYVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
........ ....++..|+|||.+....++.++|+||||+++||+++ |..||....... +.. ... ... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~-~~~--~~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD---LLE-KGE--RL 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH---HHh-CCC--CC
Confidence 43322111 11223568999999988899999999999999999999 999997543221 111 111 110 00
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
..+. .+...+.+++.+||..||.+||++.++++.|+..
T Consensus 231 ---~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ---PQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---CCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111 1234578889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=298.96 Aligned_cols=249 Identities=21% Similarity=0.358 Sum_probs=200.9
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|++.+.||+|+||.||++... ++..||+|.+... ......++.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 5789999988643 223345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999987542 23578999999999999999999998 99999999999999999999999999997653322
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...... +........ ..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~---------~~- 218 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRG---------SY- 218 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcC---------CC-
Confidence 1 122345788999999999888999999999999999999999998643211 111111110 00
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+......+.+++.+||+.+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0111223456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=299.66 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=201.2
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 227 (484)
+|...+.||.|++|.||++... ++..+|+|.+..... .....+.+|+++++.++||||++++++|... ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999975 478899998865432 3456788999999999999999999998653 46899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999998865333345688999999999999999999998 9999999999999999999999999998754322
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
. .....++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....+........ ....+.+ ..
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~-~~ 232 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNM-PNPELKD-EP 232 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcC-Cchhhcc-CC
Confidence 1 123457889999999999999999999999999999999999997653211 1111111111110 0000100 00
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+++.+||..||++|||+.||++
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 --GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.62 Aligned_cols=249 Identities=23% Similarity=0.389 Sum_probs=193.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhccCCCceeeecceeeeC--Cee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 222 (484)
.+|...+.||+|+||.||+|... ++..|++|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999864 58899999885432 12335688899999999999999999988753 567
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
+++|||+++++|.+++... ..+++...+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999999754 3588999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCC--ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSER--SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~----- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIAT----- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhc-----
Confidence 543211 111123457889999999998889999999999999999999999997442211 1111110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+.++ ......+..++ +||..+|++||+++||++
T Consensus 224 ~~~~~~~~----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 QPTNPQLP----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCCc----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00111221 22234455555 788899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.25 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=195.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhccCCCceeeecceeeeC--Cee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 222 (484)
.+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999965 48899999875322 12235788899999999999999999988763 467
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
+++|||+++++|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999999744 3578889999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCc--eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSERS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... . ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~----- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIAT----- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhc-----
Confidence 5432111 11223458889999999988889999999999999999999999996432111 0 011100
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+ .....+......+.+++.+|+. +|++||++++|++
T Consensus 224 ---~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 ---QP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 1111223345567788888985 9999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=305.29 Aligned_cols=264 Identities=24% Similarity=0.389 Sum_probs=198.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|...+.||+|+||.||+|.++ ++..||+|.+..... ...+.+..|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35778899999999999999975 488999998754332 234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|..+.... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999998877543 3489999999999999999999998 9999999999999999999999999998765433
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccc-hhhh-------hhhhhcCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN-LVDW-------LKTMVGSRK 378 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~-~~~~-------~~~~~~~~~ 378 (484)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|.+||.......... ...+ .........
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 22 2233457889999998875 457889999999999999999999986443211000 0000 000000000
Q ss_pred -cccccCCCCCCC-----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 -SEEVVDPKLPKM-----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 -~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+..... ........+.+++.+||+.||++||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000111000 01123466889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=296.42 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=205.3
Q ss_pred CCCcCceeccCCceEEEEEEECC-CCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+|.+.+.||+|++|.||+|.... +..|++|++..... .....+..|+..+..++|+||+++++++......++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57788999999999999999764 89999998866543 44578889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
++++|.+++... ..+++..++.++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999754 568999999999999999999999 8 99999999999999999999999999988664332
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.. .....++..|+|||.+.+..++.++|+||||+++|+|+||..||............. ..... ..+...
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~------~~~~~~ 224 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AICDG------PPPSLP 224 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHhcC------CCCCCC
Confidence 21 223457889999999998899999999999999999999999997654311111111 11110 001111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+.+++.+||..+|++||++.++++
T Consensus 225 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 ---AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1114457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.57 Aligned_cols=196 Identities=23% Similarity=0.379 Sum_probs=159.9
Q ss_pred ceeccCCceEEEEEEECC---CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee--CCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~~ 231 (484)
..||+|+||.||+|..++ +..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999999653 4689999886443 23457789999999999999999999854 4577999999975
Q ss_pred CCHHHHhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE----cCCCcEEEeeecccc
Q 011498 232 GNLDQWLHGDV-----GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAK 302 (484)
Q Consensus 232 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfgla~ 302 (484)
+|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 8888875321 1223588999999999999999999998 99999999999999 556789999999998
Q ss_pred cccCCCce--eeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCC
Q 011498 303 LLCSERSY--VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYS 358 (484)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~ 358 (484)
........ ......+|+.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 65432211 1233568999999998876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.14 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=202.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||.||++... ++..|++|.+........+.+..|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56888899999999999999854 57889999886554444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998643 478899999999999999999998 999999999999999999999999998876543322
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......+++.|+|||.+....++.++||||||+++|+|++|..||............ . ..+....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~--------~~~~~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A--------TNGTPEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------h--------cCCCCCC
Confidence 122346888999999998888999999999999999999999999755432211100 0 0000011
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.........+.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234568889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.06 Aligned_cols=251 Identities=29% Similarity=0.444 Sum_probs=200.3
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|...+.||+|+||.||+|... ++..|++|.+..... .....+..|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999864 588999999865544 2567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999999753 3578899999999999999999998 99999999999999999999999999998764332
Q ss_pred ceee---cccccccccccccccccCC---CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 309 SYVT---TRVMGTFGYVAPEYACTGM---LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 309 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
.... ....++..|+|||++.+.. ++.++||||||+++|+|++|..||....... ... .. ... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~---~~-~~~-----~ 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIM---FH-VGA-----G 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHH---HH-Hhc-----C
Confidence 2111 1245788999999998766 8899999999999999999999996443110 000 00 000 0
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+.++.. ......+.+++.+||+.||++||++.+++.
T Consensus 223 ~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 122456778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.54 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=197.5
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch----------hhHHHHHHHHHHHhccCCCceeeecceeeeCC
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG----------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 220 (484)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999854 588999998753211 11246778999999999999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..++||||+++++|.++++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999754 4688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCce-eecccccccccccccccccCC--CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 301 AKLLCSERSY-VTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 301 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
+......... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||...... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~- 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNK- 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhcc-
Confidence 8764322111 122345788999999987654 889999999999999999999998633211 101111000
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ..+.++..........+.+++.+||..||++||++.+|++
T Consensus 228 ~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 R----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred c----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0 0111111111224567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=297.86 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=206.8
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
|.+..+||+|+||.||++.++ .|..+|||.+.... ..+++..|+.+|.+++.|++|++||.+.....+|+|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 445568999999999999965 58999999886543 457788899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|++.+.++.+. .++++..+..++...+.||+|||.. .-+|||||+.||||+.+|.+||+|||.+-.+.+.- ..
T Consensus 113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 99999997653 6899999999999999999999988 88999999999999999999999999997764432 23
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....||+.|||||++..-.|+.++||||||++..||.-|++||....+-...-. +. ..|......
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IP-------T~PPPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IP-------TKPPPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------cc-------CCCCCCCCC
Confidence 4567899999999999999999999999999999999999999975543211100 00 011111122
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
+..-...+-+++.+||.++|++|-|+.++++.
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 34456778999999999999999999988874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=305.66 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=200.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++... .+..|++|.+..... .....+..|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999975 468899998865432 23356778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999654 4589999999999999999999998 999999999999999999999999998864210
Q ss_pred CC--------------ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 307 ER--------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 307 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|..||...... +....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 00 00111235778899999998889999999999999999999999999644321 11111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.... ....+... ......+.+++.+||+.||++||++.++.+.|+.
T Consensus 228 ~~~~----~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISD----DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhc----ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1100 01111111 1234467899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=326.95 Aligned_cols=268 Identities=18% Similarity=0.252 Sum_probs=189.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC--CCEEEEE------------------EecccchhhHHHHHHHHHHHhccCCCc
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD--GTKVAVK------------------NLLNNRGQAEKEFKVEVEVIGRVRHKN 208 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~e~~~l~~l~H~n 208 (484)
...+|.+.+.||+|+||+||+|.++. +..+++| .+. ........+.+|+.+++.++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 11223456788999999999999
Q ss_pred eeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVG-DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
|+++++++......|++++++.+ +|.+++..... .........+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 99999999999999999999954 88887754321 112234566788999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCC-CCCCCCCCCccch
Q 011498 288 DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN-PVDYSRPQGEVNL 366 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~-p~~~~~~~~~~~~ 366 (484)
+.++.+||+|||++..+............||..|+|||++.+..++.++|||||||+||||++|.. |+..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998765443333344679999999999999999999999999999999999875 4443222111111
Q ss_pred hhhhhhhhcCCCcccccCC--------------CCCCCC-----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 367 VDWLKTMVGSRKSEEVVDP--------------KLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
...+... .. ...++.+. ..+... .......+.+++.+||+.||.+|||+.|++..
T Consensus 381 ~~~~~~~-~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSL-SV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhc-cc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111100 00 00000000 000000 00112346677889999999999999999873
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.85 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=194.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHH-HhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEV-IGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||.||++..+ +|..||+|++..... .....+..|+.. ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999975 589999998865432 233445556654 566799999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|++ |+|.+++.........+++..++.++.|++.||+|||++ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 589888865433446789999999999999999999974 28999999999999999999999999998765332
Q ss_pred Cceeeccccccccccccccccc----CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... . +.+..... ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~~------~~ 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVVE------EP 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHHh------cC
Confidence 1 1223457889999998864 45788999999999999999999998632211 0 00111100 01
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+.+ +.......+.+++.+||..+|++||++.+|++
T Consensus 225 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11123456889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=306.47 Aligned_cols=254 Identities=30% Similarity=0.483 Sum_probs=197.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCC----EEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|...+.||+|+||.||+|.+. ++. .||+|.+..... .....+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999864 343 578888765432 3344688899999999999999999998764 4678
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999987542 3588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...++. ... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~--~~ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLE----KGE--RL 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCC--CC
Confidence 432221 1122335678999999998999999999999999999998 899986543211 111111 110 00
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.. ...+...+.+++.+||..||++||++.++++.|...
T Consensus 231 ---~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ---PQ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 111234678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=318.58 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=204.3
Q ss_pred cCceeccCCceEEEEEEEC-CC----CEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 155 EENVIGEGGYGIVYRGILS-DG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~-~~----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
..++||+|+||+||+|.|- .| -+||+|++..... ....++..|+..|.+++|||+++|+|+|.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 3578999999999999962 23 4799998876643 45678999999999999999999999999876 7899999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
++.|+|.+|++.++ ..+..+..+.|..|||+||.|||.+ +++||||.++|||+..-..+||.|||+++....+.
T Consensus 779 mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999998754 5688889999999999999999998 99999999999999999999999999999876544
Q ss_pred ceeecc-cccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 309 SYVTTR-VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 309 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
...... ..-.+.|||=|.+....|+.++|||||||++||++| |..|+......+.-++ +...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl----------------le~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL----------------LEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH----------------Hhcc
Confidence 332222 223568999999999999999999999999999999 9999876553322111 1122
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.+-..++.+...+..++.+||..|+..||+++++.....
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 223334456678899999999999999999999987664
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.77 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=194.4
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeC-----
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG----- 219 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----- 219 (484)
...++|...+.||+|+||.||+|... ++..||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 578999998865422 2335677899999999999999999988643
Q ss_pred -CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 220 -AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 220 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
...|++++++ +++|.++++. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 7799988753 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+.......
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~ 235 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTP 235 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCC
Confidence 999865332 233568999999999876 5689999999999999999999999975432110 00000000000
Q ss_pred C-----------cccccC--CCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 K-----------SEEVVD--PKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ~-----------~~~~~~--~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ...... +..+.... ......+.+++.+||+.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000000 00000000 011234678999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.15 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=200.9
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|+||.||+|... +|..||+|++.... ......+..|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999964 58899999886543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+ +++|.+++.... .++++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987542 5689999999999999999999998 99999999999999999999999999998764433
Q ss_pred ceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC----------
Q 011498 309 SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---------- 377 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 377 (484)
........++..|+|||.+.+. .++.++|||||||++|||+||.+||........ ...........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccC
Confidence 2122334688999999988654 468999999999999999999888865432111 11111100000
Q ss_pred --CcccccCCCCCCC----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 378 --KSEEVVDPKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 378 --~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
....+..+..... ........+.+++.+||+.||++||++++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 001234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=305.72 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=197.1
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
...||+|+||.||++... ++..||||.+..........+..|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 357999999999999864 5789999988665555566788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++.. ..+++..++.++.||+.||.|||+. +++||||||+||++++++.++|+|||++........ ....
T Consensus 107 ~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 107 TDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 998853 3488999999999999999999998 999999999999999999999999999875432221 1233
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..++..|+|||.+.+..++.++||||||+++|||++|..||........ . .... ....+.... ...
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~---~~~~------~~~~~~~~~--~~~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---M---RRIR------DNLPPRVKD--SHK 243 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHH------hcCCCcccc--ccc
Confidence 4688999999999888899999999999999999999999975432111 1 1100 011111111 112
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
....+..++.+||..||.+|||+++|++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 33457788889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.61 Aligned_cols=247 Identities=27% Similarity=0.450 Sum_probs=198.1
Q ss_pred CCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhccC---CCceeeecceeeeCCeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 226 (484)
.|...+.||+|+||.||+|.+ .++..||+|.+.... ......+..|+.+++.++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366678899999999999996 458899999886542 334467888999999986 999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.++++.. .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998642 588999999999999999999998 999999999999999999999999999987644
Q ss_pred CCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||........... . .....+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~-----~~~~~~ 220 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------I-----PKSKPP 220 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------c-----ccCCCC
Confidence 332 2233468889999998865 4578999999999999999999999975432211100 0 000111
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+.. ......+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 113456888999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.39 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=199.2
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|...+.||+|+||.||++... ++..+|+|.+.... ......+..|+.+++.++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999999999999864 57889999886542 23356788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecccccccCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSE 307 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgla~~~~~~ 307 (484)
+++++|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||||+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997542 24589999999999999999999998 99999999999999865 46899999999865432
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... .. ..... .... .+
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~---~~~~~-~~~~-----~~ 221 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LV---LKIMS-GTFA-----PI 221 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HH---HHHHh-cCCC-----CC
Confidence 21 223457889999999998889999999999999999999999997543221 11 11100 0000 01
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+.+++.+||..||++|||+.+++.
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=305.16 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=198.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEeccc--chhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 226 (484)
...|++.++||+||.++||++...+.+.||+|++... ..+...-|..|+.+|.+| .|.+||.|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3568888999999999999999887888998877443 345567899999999999 5999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||-+. +|..+|+.... ....| .++.+..|++.++.++|++ ||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 440 E~Gd~-DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecccc-cHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99866 99999986542 22234 7888999999999999999 9999999999999976 4899999999988765
Q ss_pred CC-ceeecccccccccccccccccCC-----------CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 307 ER-SYVTTRVMGTFGYVAPEYACTGM-----------LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 307 ~~-~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
+. .-.....+||+.||+||.+.... .++++||||||||||+|+.|++||.... +.. .
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~---a--- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI---A--- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH---H---
Confidence 43 33445678999999999885332 5679999999999999999999997332 111 1
Q ss_pred cCCCcccccCCCC----CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 375 GSRKSEEVVDPKL----PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 375 ~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
++..+.+|.- +..... .++.+++..||..||.+||++.++|+.
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHhhcCCCccccccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1223444421 222221 228899999999999999999999873
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=304.80 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=196.7
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
...||+|+||.||++... ++..||+|.+..........+.+|+.++..++||||+++++++......+++|||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 347999999999999864 5889999988654444456788899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 998753 3488999999999999999999998 999999999999999999999999999875533221 1233
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..++..|+|||++.+..++.++|||||||++|||++|+.||....+.. .. ..... .. .+.. .....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~---~~~~~-~~-----~~~~--~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM---KRLRD-SP-----PPKL--KNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHhc-cC-----CCCc--cccCC
Confidence 568899999999988889999999999999999999999997443211 11 11100 00 0000 00112
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
....+.+++.+||+.||++||++.+|++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 23457888999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=298.91 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=197.4
Q ss_pred CCcCceeccCCceEEEEEEEC----CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC------
Q 011498 153 LCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 220 (484)
|.+.+.||+|+||.||+|.+. .+..||+|.+.... ....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 36789999886543 334567888999999999999999999886532
Q ss_pred eeeEEEEecCCCCHHHHhhcCC--CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 1223578899999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 299 GLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 299 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |.+||...... ....+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cC
Confidence 999865332211 1122335678999999988889999999999999999999 88998754321 1111111 10
Q ss_pred CCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.. ... .......+.+++.+||+.+|++||++.+|++.|++
T Consensus 232 ~~------~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NR------LKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred Cc------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00 001 11234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.76 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=198.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++... +++.||+|.+.... ......+..|+++++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999965 57899999886532 223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999754 4689999999999999999999998 999999999999999999999999999987543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ........ . ...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~------~~~ 216 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILE-G------KVR 216 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-C------Ccc
Confidence 3 23346889999999998888999999999999999999999999644311 10111110 0 011
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 422 (484)
++. .....+.+++.+||..||.+|| +++++++
T Consensus 217 ~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 FPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111 1235678899999999999998 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=302.08 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=198.3
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
+|...+.||+|+||.||+|... +++.||+|.+...... ....+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999965 5889999998654322 345567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+ +|+|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997542 3689999999999999999999998 99999999999999999999999999997664
Q ss_pred CCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC-------
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR------- 377 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------- 377 (484)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+. ...........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhh
Confidence 3322 1222346788999998854 4678999999999999999999888865442211 11000000000
Q ss_pred --CcccccCCCCCCC-----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 --KSEEVVDPKLPKM-----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 --~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............. ........+.+++.+||+.||++|||+.||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000 01123467889999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=298.25 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=195.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|...+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999975 578999998865432 2234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 9999887542 3688999999999999999999998 99999999999999999999999999986542221
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC----------
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---------- 377 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 377 (484)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++|..||....... .............
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhh
Confidence 11 122346788999998865 458899999999999999999999996543110 0000000000000
Q ss_pred --CcccccCCCCCCCC------hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 --KSEEVVDPKLPKMP------ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 --~~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+...... .......+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000000 0001246778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=296.31 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=198.5
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556778999999999999864 57899999875433 2334678889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999864 3588999999999999999999998 999999999999999999999999999876543221
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... .... ..... .+.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~--- 221 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IPKNN-----PPTL--- 221 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-HhcCC-----CCCC---
Confidence 1223457889999999988889999999999999999999999996433211 1111 00000 0111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 -EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12234568889999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=298.32 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=203.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++.|...+.||+|+||.||+|.++ ++..|++|.+..... ....+..|+++++.++|+||+++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3456777789999999999999976 588999998865544 45678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999997652 3689999999999999999999998 9999999999999999999999999988755332
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. ......++..|++||.+.+..++.++||||||+++|+|++|..||....+... ..... ..... ..
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~-----~~ 236 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLIT-TKGIP-----PL 236 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCC-----CC
Confidence 21 12234578899999999888899999999999999999999999864432110 00000 00000 00
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+++.+||+.+|.+||++.+|+.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111123456888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.94 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=197.1
Q ss_pred CCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||.|+||.||.|+. .+.+.||||++..... +...++..|+..|.+++|||++.+.|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 33445699999999999995 4678899999865433 3346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
|-| +-.|++.-.. .++.+..+..|..+.+.||+|||+. +.||||||+.||||++.|.|||+|||.+....+.
T Consensus 108 ClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 966 8777775432 5789999999999999999999998 9999999999999999999999999999876543
Q ss_pred ceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 309 SYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
..++|||.|||||++. .+.|+-++||||||++-.||.-.++|+-..+.-.. . ..+...-.|
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---L---------YHIAQNesP 243 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---------YHIAQNESP 243 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---H---------HHHHhcCCC
Confidence 3478999999999885 57899999999999999999999999754331110 0 011111223
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.+. ..+-...+..++..||++=|.+|||.+++++.
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 333 23344567788889999999999999988764
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.03 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=194.2
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|+||.||+|... +|..||+|.+.... ......+..|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999975 58899999886432 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.+ +|.+++.... ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 8888876432 4589999999999999999999998 99999999999999999999999999987653322
Q ss_pred ceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC------ccc
Q 011498 309 SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK------SEE 381 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 381 (484)
. ......++..|+|||++.+. .++.++|||||||++|||+||..|+....... .....+........ ...
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence 1 12234578899999988764 47899999999999999999988864322110 00000000000000 000
Q ss_pred ccC----CCCCCC-----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 382 VVD----PKLPKM-----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 382 ~~~----~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+ +..+.. ........+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000000 01123456788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=295.52 Aligned_cols=247 Identities=23% Similarity=0.294 Sum_probs=200.5
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
+|.+.+.||.|+||.||+|... ++..||+|.+.... ....+.+..|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777889999999999999975 58899999886543 2345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+.+++|.+++... .++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999754 4688999999999999999999998 9999999999999999999999999998765433
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..+....... ..+..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~------~~~~~ 221 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET------ADVLY 221 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc------ccccC
Confidence 2 1233458889999999988889999999999999999999999997654321 1111111110 00111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCH--HHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKM--GHVI 421 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~--~evl 421 (484)
+......+.+++.+||+.||.+||++ +|++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 ----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11233678889999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=303.95 Aligned_cols=266 Identities=21% Similarity=0.315 Sum_probs=197.5
Q ss_pred CCCcCceeccCCceEEEEEEECC---CCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeC--Ceee
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD---GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 223 (484)
+|.+.+.||+|+||.||+|.... +..||+|.+.... ......+..|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 46778899999999999999753 7899999987643 33345677899999999999999999999987 7899
Q ss_pred EEEEecCCCCHHHHhhcCCCC-CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC----CCcEEEeee
Q 011498 224 LVYEYVDNGNLDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSDF 298 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Df 298 (484)
+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 787777543222 23689999999999999999999998 9999999999999999 899999999
Q ss_pred cccccccCCCc--eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCcc-------chhh
Q 011498 299 GLAKLLCSERS--YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-------NLVD 368 (484)
Q Consensus 299 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~-------~~~~ 368 (484)
|++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986533221 11233467889999998766 45899999999999999999999999765433200 0000
Q ss_pred hhhhhhcCC------------Cccc----ccCCCCCCCChH-------HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 369 WLKTMVGSR------------KSEE----VVDPKLPKMPAS-------KALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 369 ~~~~~~~~~------------~~~~----~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+ ...... .... ......+..... .....+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 000000 0000 000001100000 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.14 Aligned_cols=243 Identities=23% Similarity=0.419 Sum_probs=191.6
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEe--cc--cchhhHHHHHHHHHHHhccCCCceeeecceeeeCCe--eeEEEEe
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNL--LN--NRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY--RMLVYEY 228 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l--~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~ 228 (484)
..+||+|+|-+||+|... +|..||--.+ .+ ......+.|..|+.+|+.|+||||+++|+++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 458999999999999864 4666663222 11 123345789999999999999999999999987654 7789999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecccccccCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSE 307 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgla~~~~~~ 307 (484)
+..|+|..|+++. ..++...+..|++||++||.|||++ .|+|+|||||-+||+|+.+ |.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999865 5688899999999999999999998 8999999999999999865 89999999999886443
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
. .....|||.|||||+.. ..|++.+||||||++|+||+|+..||........ ..+... ....
T Consensus 200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~---------SGiK 261 (632)
T KOG0584|consen 200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVT---------SGIK 261 (632)
T ss_pred c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHH---------cCCC
Confidence 3 23368999999999885 8899999999999999999999999976553221 111111 1111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
|.....-....+.++|.+|+.. ..+|||+.|+|.
T Consensus 262 P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111111123578888999999 999999999987
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.37 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=199.4
Q ss_pred CCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
|.+...||.|+||+||+|..++ +-..|.|.+.........+|..|+++|+.+.||+||+|++.|+..+.+||+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3344569999999999999775 334567777666666778899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|-+...+-.- ...|.+.++.-++.|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+....... ..
T Consensus 114 GAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QK 186 (1187)
T ss_pred chHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-hh
Confidence 9998887543 25799999999999999999999999 99999999999999999999999999986542221 12
Q ss_pred ecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 312 TTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
...+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|-...++. ..+... .... .|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKi-aKSe-----PPT 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSE-----PPT 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHH-hhcC-----CCc
Confidence 34578999999999875 457999999999999999999999997644331 111111 0110 011
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
+ ..+..-...+.+++.+||..||..||++.++++.-
T Consensus 255 L--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 255 L--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred c--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 1 12233445688888999999999999999998843
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=299.58 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=195.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
..|...+.||+|+||.||+|... +++.||+|.+.... ......+..|+.+++.++||||++++++|.+....++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999965 58899999885432 233356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 58877775432 3589999999999999999999998 999999999999999999999999999875432
Q ss_pred CCceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
. ....++..|+|||++. ...++.++||||||+++|||+||..||........ ...... .
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~-~------ 229 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-N------ 229 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhc-C------
Confidence 2 2245788999999874 45688999999999999999999999864432110 000000 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..+..........+.+++.+||+.||++||++.+|+..
T Consensus 230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01111122345678899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=289.49 Aligned_cols=249 Identities=25% Similarity=0.437 Sum_probs=203.4
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
+|...+.||+|++|.||++... ++..+++|++..........+.+|+.+++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999975 588999999876655556788899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++.... ..+++..+..++.|++.||.|||.. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987542 4689999999999999999999998 999999999999999999999999999877644332
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
.....++..|++||.+.+..++.++||||||+++|+|++|..||........ . .... .... +....
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~-~~~~-----~~~~~- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---L---FKIA-TNGP-----PGLRN- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---H---HHHH-hcCC-----CCcCc-
Confidence 2345688899999999888899999999999999999999999875432111 1 0100 0000 01111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+.+++.+||+.||++|||+.++++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456888999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=291.84 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=194.6
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
||.|+||.||++... ++..||+|.+..... ...+.+..|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 388999998865432 3346788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999754 3588999999999999999999998 99999999999999999999999999998764432 1223
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..++..|++||.+.+..++.++|+||||+++|+|++|..||....... ......... .......+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK---------GNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc---------cCCCCCCCcc
Confidence 467889999999988889999999999999999999999997554211 111111110 0000111112
Q ss_pred HHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 395 ALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
....+.+++.+||..||++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2457889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=297.35 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=195.6
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|...+.||.|+||.||+|... ++..||||.+.... ......+..|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999865 58899999886433 22335788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+. ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 58999886542 24689999999999999999999998 99999999999999999999999999987653322
Q ss_pred ceeecccccccccccccccccCC-CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc------cc
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS------EE 381 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 381 (484)
. ......++..|+|||++.+.. ++.++|||||||++|||+||+.||....... ........ ...... ..
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRT-LGTPDEVVWPGVTS 230 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHH-hCCCChhhhhhhhH
Confidence 1 122234678999999886644 6889999999999999999999997543211 11111100 000000 00
Q ss_pred c-----cCCCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 382 V-----VDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 382 ~-----~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+ .-+...... .......+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 000000000 0112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=296.87 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=198.6
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
|...+.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++||||+++++++......++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999864 5789999988655444556688899999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
++|.+++.. ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999999864 3488999999999999999999998 999999999999999999999999998875533221 1
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....|+..|+|||.+.+..++.++|||||||++|||++|..||....+. ......... ..+....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~------~~~~~~~-- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN------LPPKLKN-- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc------CCCCCcc--
Confidence 23346889999999998888999999999999999999999998643321 111111110 0011110
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1113356889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.92 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=194.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
+++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467888999999999999999864 588999998865432 223466789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+. ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 68887775432 3577888999999999999999998 9999999999999999999999999998754322
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC----------
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS---------- 376 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 376 (484)
... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||.......+ ...........
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhh
Confidence 211 223357889999999875 4588899999999999999999999975432110 00000000000
Q ss_pred ---CCcccccCCCCCCCC-----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 ---RKSEEVVDPKLPKMP-----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 ---~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...........+... .......+.+++.+|+..||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0011345778889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=293.31 Aligned_cols=249 Identities=22% Similarity=0.389 Sum_probs=198.8
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|+||.||++..+ +|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999975 47889999885432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeecccccccCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE 307 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~ 307 (484)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997542 23579999999999999999999998 999999999999999885 4699999998765432
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. ......|+..|+|||++.+..++.++|+||||+++|||++|..||..... ..+....... ...+ .
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-----~~~~-~ 222 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG-----YFAP-I 222 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc-----cCCC-C
Confidence 21 12234588899999999888899999999999999999999999864332 1111111111 0111 1
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+.+++.+||..+|++|||+.+|++
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1123346888999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=297.33 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=197.2
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEEEE
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVYE 227 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 227 (484)
|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+..|+.+++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999976 47899999997653 33345688899999999999999999999987 78999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8998886442 4689999999999999999999998 9999999999999999999999999999876443
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC---Cccc--
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---KSEE-- 381 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 381 (484)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||.......... .+....... ....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccc
Confidence 3222233456788999997764 467899999999999999999999997554321111 111100000 0000
Q ss_pred ------ccCCC--CC----CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 382 ------VVDPK--LP----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 382 ------~~~~~--~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+. .. ......+...+.+++.+||+.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 00 0000012567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.87 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=205.0
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||.|+||.||++... ++..|++|++..... .....+..|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999975 588999998865432 4456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.........+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999976543346799999999999999999999998 99999999999999999999999999997654432
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......+++.|+|||.+....++.++|+||||+++|+|++|..||...... ........ .. .+.++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~-----~~~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK-GQ-----YPPIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc-CC-----CCCCC
Confidence 2233356888999999998888999999999999999999999998654321 11111111 00 01111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. .....+.+++.+||..+|++|||+.++++
T Consensus 225 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 S----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 23456888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=297.84 Aligned_cols=264 Identities=24% Similarity=0.308 Sum_probs=196.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv 225 (484)
++|.+.+.||+|+||.||+|..+ ++..+++|.+..... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778889999999999999976 478899998864432 2234567799999999999999999999877 789999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+.+ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 9999886542 3689999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh----------hhh--hh
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWL--KT 372 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~----------~~~--~~ 372 (484)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||............ .|. ..
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 4321 12234578899999988654 4689999999999999999999999754422111000 000 00
Q ss_pred hh--cCCCcccccCCCCCCCChHH-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 MV--GSRKSEEVVDPKLPKMPASK-ALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 ~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+. ............+....... ....+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000000000011111111 2456788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=294.50 Aligned_cols=252 Identities=25% Similarity=0.289 Sum_probs=194.2
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
||+|+||+||++... +|+.||+|.+.... ......+..|+++++.++||||+++++++......|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 58899999886432 12234567799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 999975432 4689999999999999999999998 99999999999999999999999999987653321 1223
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..++..|+|||++.+..++.++|||||||++|+|++|+.||.......... .+.... .. .+...+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~----~~------~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRT----LE------MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcc----cc------ccccCCcc
Confidence 457889999999988889999999999999999999999997544311110 000000 00 00011112
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHhcCCcc
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGH-VIHMLEADDLL 430 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~e-vl~~L~~~~~~ 430 (484)
....+.+++.+||+.||++||++++ .+..|....++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 3456888999999999999995555 44444444433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=295.11 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=195.6
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
|.+.+.||.|++|.||+|... +|..||+|++.... ......+..|+++++.++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999864 68999999886543 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
. ++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 699999875432 4689999999999999999999998 999999999999999999999999999976532221
Q ss_pred eeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC--------Ccc
Q 011498 310 YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR--------KSE 380 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 380 (484)
. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||........ +........... ...
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223468899999987654 578999999999999999999999975432111 111000000000 000
Q ss_pred ccc--CCCCC----CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVV--DPKLP----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~--~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... -+... ..........+.+++.+||+.||.+|||+++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00000 0001123356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=297.73 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=195.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe-----
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY----- 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~----- 221 (484)
++|...+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999965 588999998754432 2235678899999999 46999999999887655
Q ss_pred eeEEEEecCCCCHHHHhhcCCCC-CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeec
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFG 299 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg 299 (484)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 899888654322 35689999999999999999999998 9999999999999998 8899999999
Q ss_pred ccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... .... .......
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIF-KLLGTPT 232 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHH-HHhCCCC
Confidence 98765322111 122346788999998865 45799999999999999999999999754321110 0000 0000000
Q ss_pred cc---c---cc----CCCCCC----CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SE---E---VV----DPKLPK----MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~---~---~~----~~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. . .. -+.... .........+.+++.+||..||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0 00 000000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=290.75 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=203.1
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|+||.||++..+ ++..+++|.+.... ......+..|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999864 57899999886432 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|.||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999976433346789999999999999999999998 9999999999999999999999999999776443
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||....... .. ...... ..+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~----~~~~~~--------~~~ 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR----YKVQRG--------KYP 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhcC--------CCC
Confidence 1223457889999999999899999999999999999999999997543211 11 111111 111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+++.+||..+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111245567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.12 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=186.4
Q ss_pred eeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHH---HhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 158 VIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEV---IGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
.||+|+||.||++... ++..||+|.+..... .....+..|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 588999998865422 112233344433 334479999999999999899999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999998754 4589999999999999999999998 99999999999999999999999999987543221
Q ss_pred eecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....|+..|+|||.+. +..++.++|||||||++|||++|..||.......... +..... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~------~~~~~~-- 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------TVNVEL-- 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhh------cCCcCC--
Confidence 12346899999999886 4568999999999999999999999997543221111 111100 011111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHML 424 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~L 424 (484)
+......+.+++.+||+.||.+|| +++++++..
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 122345688889999999999999 588887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=323.73 Aligned_cols=263 Identities=29% Similarity=0.471 Sum_probs=211.7
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECC--------CCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecce
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGY 215 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~ 215 (484)
++...+++.+.+.||+|.||.|++|.... ...||||.+..... ...+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 44445566677799999999999998431 34799999876644 3457899999999999 79999999999
Q ss_pred eeeCCeeeEEEEecCCCCHHHHhhcCC---CC-------C--CCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCC
Q 011498 216 CVEGAYRMLVYEYVDNGNLDQWLHGDV---GD-------V--SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283 (484)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~ 283 (484)
|......++|+||+.+|+|.+||+... .. . ..++....+.++.|||.|++||++. +++||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999998664 00 0 2488999999999999999999998 9999999999
Q ss_pred cEEEcCCCcEEEeeecccccccCCCceeeccccc--ccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCC
Q 011498 284 NILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG--TFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRP 360 (484)
Q Consensus 284 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~ 360 (484)
|||+..+..+||+|||+++.......+......+ ...|||||.+....|+.++||||||++||||+| |..||.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999765555444333333 446999999999999999999999999999999 9999975321
Q ss_pred CCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 361 QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.. ++.+++. . ..+...+..+..++.+++..||+.+|++||++.++.+.++.
T Consensus 528 ~~--~l~~~l~----~---------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 528 TE--ELLEFLK----E---------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HH--HHHHHHh----c---------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11 1121111 1 11222233456678899999999999999999999999987
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.41 Aligned_cols=264 Identities=26% Similarity=0.357 Sum_probs=197.2
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC----
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA---- 220 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~---- 220 (484)
...++|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34577889999999999999999975 47899999886432 223356778999999999999999999987654
Q ss_pred ------eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEE
Q 011498 221 ------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (484)
Q Consensus 221 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 294 (484)
..++|+||+++ +|..++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 787777643 24689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhh
Q 011498 295 VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 295 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||......... ..+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~---~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL---ELISRL 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHH
Confidence 99999997654332211222345778999998764 45789999999999999999999999754321111 111111
Q ss_pred hcCCCc---ccc--------cCC------CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 374 VGSRKS---EEV--------VDP------KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 374 ~~~~~~---~~~--------~~~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...... ..+ .++ .... ........+.+++.+||+.||++||++.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110000 000 000 0000 00112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=295.97 Aligned_cols=255 Identities=29% Similarity=0.403 Sum_probs=193.6
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|...+.||+|+||.||++... ++..||+|.+.... ......+..|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999965 47899999886543 234567888999999995 99999999999998899999999
Q ss_pred cCCCCHHHHhhcC-CCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 229 VDNGNLDQWLHGD-VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 229 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
+.. +|.++.... ......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 865 665543211 01125689999999999999999999963 28999999999999999999999999999765332
Q ss_pred CceeecccccccccccccccccC---CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTG---MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.. .....++..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+..... ...
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~------~~~ 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK------GDP 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC------CCC
Confidence 21 2233578899999998765 68999999999999999999999997443 11111111110 001
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.+...........+.+++.+||+.||++|||+++|+.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12222222234557889999999999999999999977
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=286.00 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=203.0
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 226 (484)
+|...+.||+|++|.||+|... ++..|++|.+..... ...+.+..|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999976 588999998865542 4457888999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999754 3789999999999999999999998 999999999999999999999999999987644
Q ss_pred CCce-eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ......++..|++||.+.+...+.++||||||+++|+|++|..||..... ......... ..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~---------~~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIG---------SS 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhcc---------cc
Confidence 3221 12334688899999999888899999999999999999999999975541 111111100 00
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+......+.+++.+|+..||++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111111223567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=297.35 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=194.8
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||+|+||.||+++.. ++..||+|.+.... ......+..|+++++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556778999999999999964 57899999886432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.+ +|.+++.... .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 975 8888775432 4589999999999999999999998 999999999999999999999999998865432
Q ss_pred ceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 309 SYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.....++..|+|||++. .+.++.++|||||||++|||++|..||........ ...... .
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~---------~ 239 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ---------N 239 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHh---------c
Confidence 12345788999999874 45689999999999999999999999864321110 011110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
..+..........+.+++.+||+.+|.+||++.+|++.+.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1111112223456888999999999999999999998553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=291.56 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=196.3
Q ss_pred eccCCceEEEEEEECC-CCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
||+|+||.||+++... |+.|++|.+..... .....+..|+++++.++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999998865433 3446788899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc-----
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS----- 309 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~----- 309 (484)
.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999754 3689999999999999999999998 999999999999999999999999999876433211
Q ss_pred --eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 310 --YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 310 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.......++..|++||......++.++||||||+++|+|++|..||....... ....... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~--------~~ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN-G--------KI 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-C--------Cc
Confidence 12233457889999999988889999999999999999999999997544221 1111111 0 00
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...........+.+++.+||+.+|.+|||+..+.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000011124568899999999999999999666666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=293.35 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=197.9
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+|...+.||.|++|.||+|+.. +|..||+|.+..... .....+..|+.+++.++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777889999999999999975 588999998865432 23456677999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++ +|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8999886543 234689999999999999999999998 999999999999999999999999999976533211
Q ss_pred eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh-hh--------hhhhhcCCCc
Q 011498 310 YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-DW--------LKTMVGSRKS 379 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~-~~--------~~~~~~~~~~ 379 (484)
......++..|++||++.+ ..++.++|||||||++|+|++|..||......+..... .. .......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL--- 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC---
Confidence 1122356889999998865 45789999999999999999999999765432111100 00 0000000
Q ss_pred ccccCCCCCCC-------ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 EEVVDPKLPKM-------PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. .....+.. ........+.+++.+||+.||.+||++.+|++
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PE-YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ch-hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00001000 01123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.48 Aligned_cols=261 Identities=25% Similarity=0.281 Sum_probs=196.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeC------C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 220 (484)
.++|...+.||+|+||.||+|... ++..||+|.+... .......+..|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467888999999999999999964 5889999988543 223345677899999999999999999988643 3
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|+||||+.+ +|.+.+.. .++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 56999999965 88888753 278889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccch------------hh
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL------------VD 368 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~------------~~ 368 (484)
+........ .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....... ..
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 986533221 2334578899999999999999999999999999999999999975432111000 00
Q ss_pred h----hhhhhcCCC------cccccC----CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 369 W----LKTMVGSRK------SEEVVD----PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 369 ~----~~~~~~~~~------~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ......... ..+... +.............+.+++.+||+.||++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000000000 000000 00001111234556789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.83 Aligned_cols=289 Identities=21% Similarity=0.263 Sum_probs=222.8
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhccCCCceeeecceeee
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 218 (484)
..++....++|.+.++||+|+||.|..++.+ .++.||+|++.+. +.....-|..|-.+|.--+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566666789999999999999999999975 4788999988662 23344568889999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
..++|+||||++||+|..+|.+. ..+++..+..++..|+.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999754 3699999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCceeecccccccccccccccc----c-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhh
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYAC----T-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
|.+-.+..+....+...+|||.|++||++. + +.|++.+|+||+||++|||+.|..||..... ++.....
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHH
Confidence 999888777766677789999999999985 2 5689999999999999999999999974432 2211111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHhcCCcchhhhcc--cCCCCCCCCCcc
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK---MGHVIHMLEADDLLFRDERR--IGREPSNSYGEE 448 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~L~~~~~~~~~~~~--~~~~~~~~~~~~ 448 (484)
........ +| ...+......+||.+.+. +|+.|.. ++++-.........|+.-+. .+..|.-+....
T Consensus 294 m~hk~~l~-----FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~D 365 (1317)
T KOG0612|consen 294 MNHKESLS-----FP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDD 365 (1317)
T ss_pred hchhhhcC-----CC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCc
Confidence 11111111 11 112234445555554443 7888877 99987766655555543333 334455444444
Q ss_pred chhH
Q 011498 449 NRDF 452 (484)
Q Consensus 449 ~~~~ 452 (484)
..+|
T Consensus 366 TsnF 369 (1317)
T KOG0612|consen 366 TSNF 369 (1317)
T ss_pred cccc
Confidence 4444
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=289.11 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=188.1
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHH-hccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVI-GRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 578999998865432 1222344454443 445899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
++|.++++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999754 4588999999999999999999998 999999999999999999999999999875432
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....... ... ..+...
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~------~~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILS-RRI------NWPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHh-ccc------CCCCcc
Confidence 223457889999999988889999999999999999999999996443211 1111110 000 001111
Q ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 392 ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 392 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
...+...+.+++.+||+.||++||++.++.+.|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1123456889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=292.62 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=194.9
Q ss_pred CCCcCceeccCCceEEEEEEE----CCCCEEEEEEecccch----hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCee
Q 011498 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRG----QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 222 (484)
+|++.+.||+|+||.||++.. .+|..||+|.+..... ...+.+..|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 3578999998865322 2345678899999999 699999999999998899
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999999754 4588899999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCceeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
..............|+..|+|||.+.. ..++.++||||||+++|+|++|..||....... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~---- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc----
Confidence 654332222234568899999998875 347889999999999999999999996433211 111111111100
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 422 (484)
.+.. +......+.+++.+||+.||++|| ++.+++.
T Consensus 228 ---~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ---EPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111 112345678899999999999997 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=292.50 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=192.5
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeC--CeeeEEEE
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG--AYRMLVYE 227 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~lv~e 227 (484)
|.+.+.||+|+||.||+|... ++..||+|++.... .........|+.++.++ +|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999964 57899999886542 22223445688888888 499999999999987 88999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+. |+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 48888886532 4689999999999999999999998 9999999999999999 99999999999865432
Q ss_pred Cceeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC----------
Q 011498 308 RSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS---------- 376 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 376 (484)
.. .....++..|+|||++. +..++.++|||||||++|||++|..||...+..+ .........+.
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 22 12345788999999764 4567889999999999999999999997654321 11111111100
Q ss_pred -CCcccccCCCCCCC----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 -RKSEEVVDPKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 -~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........+..... ........+.+++.+||++||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 01134577999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=304.65 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=195.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Cee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 222 (484)
+++|.+.+.||+|+||.||+|... +|..||+|.+... .......+..|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467889999999999999999864 5889999988643 223445678899999999999999999987644 357
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++++||+.+ +|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 88888753 3589999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCce--eeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 303 LLCSERSY--VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 65332211 1123468899999998654 568999999999999999999999996543211 00001110000000
Q ss_pred ---ccccC----------CCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 ---EEVVD----------PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ---~~~~~----------~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..+.+ +...... .......+.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000000 01124568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=289.36 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=209.7
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccchhh-HHHHHHHHHHHhccCCCceeeecce
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
..++.....++....++-+|.||.||+|.|.+ .+.|-+|.+.....+. ...+..|..++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45566666778888899999999999997653 3456777776654433 3567778888888999999999999
Q ss_pred eee-CCeeeEEEEecCCCCHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC
Q 011498 216 CVE-GAYRMLVYEYVDNGNLDQWLHGDV----GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290 (484)
Q Consensus 216 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~ 290 (484)
+.+ ....++++.+..-|+|..||...+ .....++..+...++.|++.|++|||.. +++|.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 875 456789999999999999997322 2345677788899999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccCCCceee-cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhh
Q 011498 291 WNARVSDFGLAKLLCSERSYVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 291 ~~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~ 368 (484)
.++||+|-.+++.+...+.... .....+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-+|.+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---- 508 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---- 508 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----
Confidence 9999999999987655443322 22345678999999999999999999999999999999 99999766553221
Q ss_pred hhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.++.. ..+-..+-.++.+++.++.-||..+|++||+++|++.-|.+
T Consensus 509 ---~ylkd---------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 ---HYLKD---------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---HHHhc---------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11111 11122334467789999999999999999999999987753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=292.89 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=199.2
Q ss_pred CCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccc----hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCee
Q 011498 152 GLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 222 (484)
+|.+.+.||+|+||.||++... ++..||||.+.... ......+..|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999842 46789999886432 22335678899999999 699999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998643 4588999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCceeecccccccccccccccccCC--CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
..............++..|+|||.+.+.. .+.++||||||+++|||++|..||........ ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~---- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS---- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc----
Confidence 65433322223345888999999987654 78899999999999999999999964332111 11111111110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+..+. .....+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 ---~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ---KPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111111 133457888999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=286.16 Aligned_cols=247 Identities=27% Similarity=0.460 Sum_probs=201.5
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+|.+.+.||+|++|.||++... ++..|++|.+..... .....+..|++++.+++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 578999998866543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999999754 4689999999999999999999998 99999999999999999999999999998764433
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.. .....++..|+|||...+..++.++|||+||+++|+|++|..||...... ... ..... . ..+.+
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~-~-----~~~~~- 219 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AAL-FRIVQ-D-----DHPPL- 219 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHH-HHHhc-c-----CCCCC-
Confidence 21 23345788999999998888899999999999999999999998643311 100 11110 0 00111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+......+.+++.+||..+|++||++.+++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1123456888999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.52 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=195.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 224 (484)
.++|.+.+.||+|+||.||+|... +|..||+|.+..... .....+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999975 588999998864322 2223456799999999999999999998765 46899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 8988886532 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC-----
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK----- 378 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 378 (484)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||.......... .+........
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD---LIIQLLGTPNESIWP 234 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChhhch
Confidence 43321 1222345788999998865 568899999999999999999999997554322111 1111100000
Q ss_pred -------cccccCCCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 -------SEEVVDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 -------~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+..+... .......+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000 0112456778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=285.59 Aligned_cols=242 Identities=25% Similarity=0.276 Sum_probs=195.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhH---HHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
-++|.+.++||+|.||+|-+++-+ .++.||+|++++.-.... ..-..|-++|+..+||.+..|...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 457888999999999999999854 588999999877643322 2344588899999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||..||.|.-.|... ..+++.....+-..|+.||.|||++ +||+||||.+|.|||.+|++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999988754 4688888899999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. ...+..+|||+.|+|||++....|..++|+|.+||+||||++|+.||...+......++ .. -+-
T Consensus 320 ~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---l~----------ed~ 385 (516)
T KOG0690|consen 320 KY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---LM----------EDL 385 (516)
T ss_pred cc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---Hh----------hhc
Confidence 32 33467789999999999999999999999999999999999999999755433222111 10 111
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCC
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPK 416 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 416 (484)
+++.. ...+-..|+...|.+||.+|..
T Consensus 386 kFPr~----ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 386 KFPRT----LSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred cCCcc----CCHHHHHHHHHHhhcChHhhcC
Confidence 22222 2233455666788999999953
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=303.30 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=196.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Ce
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 221 (484)
..+|.+.+.||+|+||.||+|... ++..||||.+... .......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999864 5889999988643 222345677899999999999999999988654 34
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.+++|||+. ++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 6899988643 4689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC----
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS---- 376 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 376 (484)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.......... .+....+.
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK---LITELLGSPSEE 231 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCChH
Confidence 8653322 12233457889999998764 468999999999999999999999997543211100 00000000
Q ss_pred -------CCcccccC--CCCCC----CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 377 -------RKSEEVVD--PKLPK----MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 377 -------~~~~~~~~--~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
......+. +.... .........+.+++.+||+.||++|||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 00000 0011244668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=296.54 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=191.7
Q ss_pred eeccC--CceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 158 VIGEG--GYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 158 ~Lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
.||+| +||+||++... +|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|......++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999964 68999999886432 233467888999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee-
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV- 311 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 311 (484)
+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999976422 3588999999999999999999998 99999999999999999999999998654322111100
Q ss_pred -----ecccccccccccccccccC--CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh------------
Q 011498 312 -----TTRVMGTFGYVAPEYACTG--MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT------------ 372 (484)
Q Consensus 312 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~------------ 372 (484)
.....++..|+|||++.+. .++.++|||||||++|||++|..||........ .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 0112345679999998763 578999999999999999999999975432110 0000000
Q ss_pred --------------------hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 --------------------MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...........+..+...........+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000111111222223345678899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=292.05 Aligned_cols=259 Identities=23% Similarity=0.305 Sum_probs=198.8
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
|...+.||+|++|.||+|... +++.+++|.+..... .....+..|+.+++.++|+||+++++++......+++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999864 588999998865432 23467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++ +|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 76 8988886532 4689999999999999999999998 99999999999999999999999999997664433
Q ss_pred eeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC---Cccccc--
Q 011498 310 YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---KSEEVV-- 383 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 383 (484)
.......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+.... ........ ......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhh
Confidence 112234578889999998776 789999999999999999999999975442111100 00000000 000000
Q ss_pred -------CCCCC----CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 -------DPKLP----KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 -------~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+... ..........+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0111234577899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=287.10 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=195.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHhccCCCceeeecceeeeC--Cee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-----RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 222 (484)
.+|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+++++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999964 5889999987432 123345788899999999999999999998764 457
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998744 3578899999999999999999998 99999999999999999999999999997
Q ss_pred cccCCC--ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSER--SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
...... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||....... .+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~------ 222 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIA------ 222 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHH------
Confidence 653211 111123458889999999998889999999999999999999999996432111 011110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+...+......+.+++.+||. +|..||++.+++.
T Consensus 223 ---~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 ---TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0011111223344568888899999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=293.77 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=195.2
Q ss_pred ceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHH
Q 011498 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 235 (484)
..||+|+||.||++..+ ++..||+|++..........+..|+.+++.++|+||+++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999874 58899999886554445567888999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeeccc
Q 011498 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315 (484)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 315 (484)
+++.. ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 98753 2478999999999999999999998 999999999999999999999999998876533221 12234
Q ss_pred ccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHH
Q 011498 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 395 (484)
Q Consensus 316 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (484)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....+.. ...+.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~~~---------~~~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRD---------NLPPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---------hCCcccCC--cccC
Confidence 58889999999988889999999999999999999999987543211 1111110 00111111 1112
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 396 LKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 396 ~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+.+++.+||+.||.+||++.+|+.
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 345778889999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.44 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=197.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeee----CCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~ 223 (484)
.+|.+.+.||+|+||.||+|... ++..||+|++..... .....+..|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999964 588999998865422 334567789999999999999999998763 34679
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 5999998643 4589999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCce---eeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC--
Q 011498 304 LCSERSY---VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR-- 377 (484)
Q Consensus 304 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 377 (484)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChh
Confidence 5332211 1223468889999998765 46899999999999999999999999755432111 1111110000
Q ss_pred ---------CcccccC--CCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 378 ---------KSEEVVD--PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 378 ---------~~~~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
......+ +...... .......+.+++.+||+.||++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000 0000000 01235678999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.24 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=202.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhh--HHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQA--EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
...|.+.+.||+|.|++|.++++. .+..||||.+.+..... ...+.+|+++|+.++|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456888899999999999999954 58899999887665332 244778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+.+|.+++||.++ ....+..+..++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999865 3455688889999999999999999 999999999999999999999999999988753
Q ss_pred CCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.......+|++.|.|||++.+..| .+.+|+||+|++||-|+.|..||++.....-.. ..+..
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~g 270 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRG 270 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheee
Confidence 334556789999999999998776 479999999999999999999998655321110 00111
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.++- +.-...++.+++.++|-.+|.+|+++++|.+
T Consensus 271 k~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 271 KYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eecc--cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1110 1112234667788999999999999999976
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=292.89 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=194.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|...+.||+|++|.||+|..+ +++.||+|.+..... .....+..|+++++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 588999998854322 233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeecccccccC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCS 306 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~ 306 (484)
|++ ++|.+++.... ...+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 48888876442 23467888899999999999999998 9999999999999985 55799999999976432
Q ss_pred CCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc---
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV--- 382 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 382 (484)
... ......+++.|+|||++.+ ..++.++|||||||++|+|+||..||......+.... ........ ....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~-~~~~~~~ 230 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTP-NEETWPG 230 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCC-Chhhccc
Confidence 211 1223356889999998865 4578999999999999999999999975433211100 00000000 0000
Q ss_pred ---------cCCCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 ---------VDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ---------~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+..+... .......+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 1122345788999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=293.73 Aligned_cols=258 Identities=18% Similarity=0.220 Sum_probs=190.7
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
+.+|.|+++.||++.. ++..||+|++... .......+..|+.+++.++|+||+++++++......+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455556666666555 5899999998654 334456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc-----
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS----- 309 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~----- 309 (484)
.+++..... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999975422 3588999999999999999999998 999999999999999999999999998865432211
Q ss_pred -eeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhh----hc-------
Q 011498 310 -YVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM----VG------- 375 (484)
Q Consensus 310 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~----~~------- 375 (484)
.......++..|+|||++.. ..++.++|||||||++|||++|..||........ ..+..... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhh
Confidence 11122346778999999865 4588999999999999999999999975432110 00000000 00
Q ss_pred CCCccc----ccCCC----CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRKSEE----VVDPK----LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~~~----~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...... ..++. ............+.+++.+||..||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 00000 111112234467888999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.07 Aligned_cols=258 Identities=17% Similarity=0.213 Sum_probs=183.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCC----CEEEEEEecccchhh--H---------HHHHHHHHHHhccCCCceeeecce
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNRGQA--E---------KEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~~--~---------~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
++|.+.+.||+|+||.||+|.+.++ ..+|+|......... + .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788899999999999999997543 456666432222111 0 112223345566789999999997
Q ss_pred eeeCC----eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC
Q 011498 216 CVEGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 216 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
+.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 76543 34678887754 777766532 2357888899999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccCCCc------eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccc
Q 011498 292 NARVSDFGLAKLLCSERS------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 365 (484)
Q Consensus 292 ~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~ 365 (484)
.++|+|||+++....... .......||+.|+|||++.+..++.++|||||||+||||++|..||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~- 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL- 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH-
Confidence 999999999976532211 1112246999999999999999999999999999999999999999865322211
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
....... ....+..+... .....+.+.+++..|+..+|++||++.+|++.++
T Consensus 243 -~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 -IHAAKCD----FIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -HHHhHHH----HHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1100000 00011111111 1112456888899999999999999999998763
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.92 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=199.6
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC-----eee
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-----YRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 223 (484)
+|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+..|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778889999999999999975 48899999886543 334567888999999999999999999998765 789
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
++|||+.+ +|.+++... ..+++..++.++.|++.||+|||+. +++|+||||.||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999985 899988644 3789999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCc--eeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC---
Q 011498 304 LCSERS--YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR--- 377 (484)
Q Consensus 304 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 377 (484)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... +.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChh
Confidence 644321 112334578899999999887 899999999999999999999999976543211100 00000000
Q ss_pred --------CcccccC---CCCCC---CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 --------KSEEVVD---PKLPK---MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 --------~~~~~~~---~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.....+. ..... .........+.+++.+||+.||++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000 00000 001113456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=285.32 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=191.9
Q ss_pred HHHHHHHhcCCCcCcee--ccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeee
Q 011498 143 LRELEAATSGLCEENVI--GEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~L--g~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 218 (484)
..+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 33444455677777776 99999999999864 578899998754321111 22222222 79999999999999
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEee
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSD 297 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~D 297 (484)
....++||||+++++|.++++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999999754 3689999999999999999999998 999999999999999998 999999
Q ss_pred ecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
||++....... ...++..|+|||++.+..++.++||||||+++|||++|..||...... ......+....
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---- 223 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ---- 223 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh----
Confidence 99987653221 235788999999999889999999999999999999999999744322 22222221111
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIH 422 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~ 422 (484)
.... .........+.+++.+||+.||.+||+ ++++++
T Consensus 224 ------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ------QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 011134456888999999999999996 688874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=295.58 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=193.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC-------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------- 220 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------- 220 (484)
++|...+.||+|+||.||+|... ++..||+|.+.... ......+..|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56888999999999999999965 58899999885432 222345667999999999999999999987654
Q ss_pred -eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 221 -YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 221 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999975 8888886432 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCce---eecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 300 LAKLLCSERSY---VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 300 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
++......... ......++..|+|||.+.+. .++.++||||||+++|||+||..||..............+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99765332211 11234577889999988654 478899999999999999999999975543221111111100000
Q ss_pred CCCc-----ccccCC-CCCCCC---------hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRKS-----EEVVDP-KLPKMP---------ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~-----~~~~~~-~~~~~~---------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... ....+. ..+... .......+.+++.+||..||++|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000000 000000 0001245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.19 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=195.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhcc-CCCceeeecceeeeC--Ceee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG--AYRM 223 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~ 223 (484)
.++|.+.+.||+|+||.||+|... ++..+|+|++... .......+..|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456888889999999999999975 5789999988543 222334577799999999 999999999998653 4679
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+.+ +|.+++... .+.+..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999974 999988643 578889999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCc----eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh---------
Q 011498 304 LCSERS----YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW--------- 369 (484)
Q Consensus 304 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~--------- 369 (484)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 12233468889999998754 5688999999999999999999999975432211100000
Q ss_pred ---hhhhhcCCCcccccCCCCC--CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 370 ---LKTMVGSRKSEEVVDPKLP--KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 370 ---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
+.................. ..........+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000000 00011134568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.93 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=186.0
Q ss_pred eeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHH---HHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 158 VIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEV---EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~---~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
.||+|+||.||++... +++.||+|.+..... .....+..|. .+++...||||+++++++......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 578999998865421 1112233333 34444689999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999998643 4689999999999999999999998 99999999999999999999999999987553221
Q ss_pred eecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....|+..|+|||++.++ .++.++|||||||++|||++|..||............ ... ....+.++.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~------~~~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT------LTMAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHh------hccCCCCCC
Confidence 2234689999999998754 6899999999999999999999999755322111110 000 001111221
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 422 (484)
.....+.+++.+||..||.+|| ++.++++
T Consensus 221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1245688888999999999999 8889876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=291.34 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=199.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||.||++... ++..||+|.+.... ......+..|+.+++.++ ||||+++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999975 58899999886532 233467788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999754 3699999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCc-------------------eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccch
Q 011498 306 SERS-------------------YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366 (484)
Q Consensus 306 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~ 366 (484)
.... .......++..|+|||.+....++.++||||||++++++++|..||....... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---T 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---H
Confidence 3221 11223457889999999988889999999999999999999999997544211 1
Q ss_pred hhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHH
Q 011498 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM----GHVIH 422 (484)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~----~evl~ 422 (484)
. ..... .. ...+......+.+++.+||+.||.+||++ +++++
T Consensus 231 ~---~~~~~-------~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 F---QKILK-------LE----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---HHHHh-------cC----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 11110 00 01111224568899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=286.64 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=194.0
Q ss_pred CCcCceeccCCceEEEEEEECC-CCEEEEEEecccch--hhHHHHHHHHHHHhcc---CCCceeeecceeeeCCe-----
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAY----- 221 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~----- 221 (484)
|.+.+.||+|+||.||+|.++. +..||+|++..... .....+..|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567899999999999999864 88999999864322 2234566677766655 69999999999988776
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 89998865422 3589999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc--
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS-- 379 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 379 (484)
........ .....++..|+|||++.+..++.++|||||||++|||++|.+||......+. ..............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhc
Confidence 76543321 2233578899999999998999999999999999999999999875442211 11111100000000
Q ss_pred -------ccccCCCCC---CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 -------EEVVDPKLP---KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 -------~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......... ..........+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0111233467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.45 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=193.7
Q ss_pred CceeccCCceEEEEEEE-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCC------eeeEEEE
Q 011498 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------YRMLVYE 227 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~e 227 (484)
.+.||+|+||.||+|++ ..|+.||||.+.... ....+...+|+++|++++|+|||+++++-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 45799999999999995 469999999887643 234567888999999999999999999866543 5689999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc--CCC--cEEEeeeccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQW--NARVSDFGLAKL 303 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~Dfgla~~ 303 (484)
||.+|||...|+... +...|++...+.++.+++.||.|||++ +|+||||||.||++- .+| --||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999998653 446699999999999999999999998 999999999999994 223 369999999998
Q ss_pred ccCCCceeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC-----
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR----- 377 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 377 (484)
+.++. ....++||..|++||++. .+.|+..+|.|||||++|+.+||..||..........-+.|........
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 86544 456688999999999998 4889999999999999999999999997654332211122211111100
Q ss_pred -------CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC
Q 011498 378 -------KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415 (484)
Q Consensus 378 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 415 (484)
...--..-..+..........+-..+..+|..||++|.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11000000112233344555666777778888999998
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=275.16 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=192.5
Q ss_pred cCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEecCC
Q 011498 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+...||.|+.|.|++++++ .|...|||.+..... +..+.+...++++.+.+ .|.||+.+|+|..+...++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3456999999999999976 478999999876543 44466777777777664 89999999999999999999999854
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
-++.+|+.-. .++++..+-++...+++||.||.+++ +|+|||+||+|||+|+.|++||||||++-.+.+...
T Consensus 176 -C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 176 -CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred -HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 5566665432 56899888899999999999998764 999999999999999999999999999987654433
Q ss_pred ecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 312 TTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.++..|-+.|||||.+. ...|+.++||||||+.|+||.||..||...+.+ ..... ....+ ..|.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~lt---kvln~------ePP~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLT---KVLNE------EPPLLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHH---HHHhc------CCCCCC
Confidence 34456889999999885 346899999999999999999999999865421 11111 11111 012222
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .....+.+++..||.+|+.+||...++++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 211 14567888889999999999999888876
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=286.39 Aligned_cols=261 Identities=25% Similarity=0.329 Sum_probs=195.2
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEec
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
|.+.+.||+|+||.||+|... ++..|++|++..... .......+|+..+++++ |+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556789999999999999975 478899998865432 22334556889999998 999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
+|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999987543 24689999999999999999999998 999999999999999999999999999976543222
Q ss_pred eeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh----------hhhhhhhcCCC
Q 011498 310 YVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTMVGSRK 378 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~----------~~~~~~~~~~~ 378 (484)
.....++..|+|||++. ...++.++|+||||+++|||++|++||......+..... .|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22345788999999875 456889999999999999999999999755432111000 00000000000
Q ss_pred cccccCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..... +....... ......+.+++.+||+.||++|||++|++.
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRF-PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccc-cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 00000000 011356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=293.08 Aligned_cols=249 Identities=24% Similarity=0.287 Sum_probs=200.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.+.|..-++||+|+||.||-+..+ +|..||.|++.+.. ...+....+|-.+|.+++.+.||.+-..|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356788899999999999999854 58999999885543 23344566789999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
+..|.||+|.-.|.+... ..+++..++.++.+|+.||++||.. +||+|||||+|||||+.|+++|+|+|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999988865532 5699999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||......... +.+.....+
T Consensus 339 ~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~--------- 404 (591)
T KOG0986|consen 339 EGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLE--------- 404 (591)
T ss_pred CCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhc---------
Confidence 5443 23348999999999999999999999999999999999999999755432111 111111111
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMG 418 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 418 (484)
.+...+....++...|+...|..||.+|....
T Consensus 405 -~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 -DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11122234455677777788899999997654
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=291.38 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=192.6
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||.||+|.+++ +..||||.+.... ......+..|+.++.+. .||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999865 8899999986543 23344566677766666 59999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+.+ +|.+++.... ..+++..+..++.|++.||+|||+. .+++|+||+|+||++++++.+||+|||++......
T Consensus 95 ~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 7877775432 3689999999999999999999962 18999999999999999999999999998765332
Q ss_pred CceeecccccccccccccccccCC----CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... .
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~---- 236 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-P---- 236 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-C----
Confidence 22 12234778999999987553 788999999999999999999999643211 11111111110 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
+..+. .......+.+++.+||..||++||++.+++..
T Consensus 237 -~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 01234568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=285.80 Aligned_cols=250 Identities=19% Similarity=0.297 Sum_probs=194.7
Q ss_pred CCCcCceeccCCceEEEEEEECC-CCEEEEEEeccc-----chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNN-----RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
+|.+.+.||+|+||.||++.... +..+++|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999998653 344555554321 122334566789999999999999999999998899999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875433446799999999999999999999998 9999999999999986 469999999987653
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......... .
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~---------~ 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE---------G 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc---------C
Confidence 3221 22334578899999999888899999999999999999999999863321 111111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ...........+.+++.+||..||++||++.++++
T Consensus 221 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 P-TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C-CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 11112334567888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.59 Aligned_cols=243 Identities=26% Similarity=0.385 Sum_probs=191.5
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||+|+||.||+|+.. ++..|++|.+..... .....+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445577999999999999864 588999998864322 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+. |+|.+++.... .++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 58888876432 4589999999999999999999998 999999999999999999999999998864321
Q ss_pred ceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 309 SYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||......... .......
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-------- 236 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND-------- 236 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC--------
Confidence 22346888999999874 456889999999999999999999998654321111 1111000
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+..........+.+++.+||+.+|.+||++.+++.
T Consensus 237 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 -SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111122345788999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=276.45 Aligned_cols=206 Identities=22% Similarity=0.353 Sum_probs=172.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-----CCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeee-CCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~ 221 (484)
...|.....||+|+||.||+|+-++ ...+|+|++...+. .......+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468888999999999999996332 23799999876543 234567789999999999999999999987 778
Q ss_pred eeEEEEecCCCCHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC----CcEEEe
Q 011498 222 RMLVYEYVDNGNLDQWLHGDV-GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ----WNARVS 296 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~ 296 (484)
.++++||.++ +|+..|+-.. .....++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999998 9999886432 2235789999999999999999999999 89999999999999877 899999
Q ss_pred eecccccccCCCc--eeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 297 DFGLAKLLCSERS--YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 297 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
|||+++.+.+.-. ......+-|.+|+|||++.+. .|+.+.|||+.||++.||+|-++.|....
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999998754321 223456789999999998875 69999999999999999999998886543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=290.32 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=192.7
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||+|+||.||+|... ++..+++|.+... ......++..|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555678999999999999965 4788999988542 223345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+. |+|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 96 58888775432 4588999999999999999999998 9999999999999999999999999998765322
Q ss_pred ceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 309 SYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
....++..|+|||.+. ...++.++|||||||++|+|++|..||....... ...... ..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~-~~-------- 229 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QN-------- 229 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHh-hc--------
Confidence 2345788999999874 3568889999999999999999999986432111 001000 00
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
..+..........+.+++.+||..+|++||++.+|+...
T Consensus 230 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 011111223445688899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=292.62 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=193.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCC------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 220 (484)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467889999999999999999965 578999998854322 22345678999999999999999999875433
Q ss_pred --eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 221 --YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 221 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
..++||||+.+ +|...+... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999975 787777543 24689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCcee----------eccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh
Q 011498 299 GLAKLLCSERSYV----------TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367 (484)
Q Consensus 299 gla~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~ 367 (484)
|++.......... .....+++.|+|||.+.+ ..++.++|||||||++|||++|++||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9997653221110 122356788999998765 45889999999999999999999999754432111110
Q ss_pred hhhhhhhcC---------CCccc----ccCCCCCCCC---hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 368 DWLKTMVGS---------RKSEE----VVDPKLPKMP---ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 368 ~~~~~~~~~---------~~~~~----~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...... ..... ......+... .......+.+++.+||..||.+|||+.+++.
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 ---FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ---HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 00000 0001111100 0112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.97 Aligned_cols=272 Identities=24% Similarity=0.318 Sum_probs=201.2
Q ss_pred ccccHHHHHHHhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecce
Q 011498 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
+.....++...+++|.+.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 4556677788889999999999999999999985 468899999886532 2234567789999999999999999998
Q ss_pred eeeC------CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC
Q 011498 216 CVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289 (484)
Q Consensus 216 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~ 289 (484)
+... ...+++++++ +++|.++++. ..+++..++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence 8643 2357788877 7799988853 2488999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh
Q 011498 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 290 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~ 368 (484)
++.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 156 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 156 DCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999998764321 223457889999998866 568899999999999999999999996543211100000
Q ss_pred h--------hhhhhcCCCccccc--CCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 369 W--------LKTMVGSRKSEEVV--DPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 369 ~--------~~~~~~~~~~~~~~--~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
. +............. .+..+.... ......+.+++.+||+.||.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00000000000000 000000000 0123467899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=297.57 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=191.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 220 (484)
..+|...+.||+|+||.||+|... +|..||+|++.... ......+..|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378888999999999999999964 58999999886432 223356788999999999999999999987542
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999965 7877653 3488999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhh--------h
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL--------K 371 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~--------~ 371 (484)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............... .
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 8754321 123457888999998876 46889999999999999999999999754321111000000 0
Q ss_pred hhhcCCCcccccC--CCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 372 TMVGSRKSEEVVD--PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 372 ~~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............. +..+... .......+.+++.+||+.||++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000000 0000000 0112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=293.40 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=192.1
Q ss_pred cCceeccCCceEEEEEEEC-CCCEEEEEEecccchhh--------------HHHHHHHHHHHhccCCCceeeecceeeeC
Q 011498 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQA--------------EKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 219 (484)
+.+.||+|+||.||+|... +++.||+|.+....... ...+..|+++++.++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3467999999999999965 58899999885432211 12467899999999999999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...+++|||+. |+|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence 99999999997 5999998643 4588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCC-------------ceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccc
Q 011498 300 LAKLLCSER-------------SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 365 (484)
Q Consensus 300 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~ 365 (484)
++....... ........++..|+|||.+.+. .++.++|||||||++|||+||..||......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-- 242 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-- 242 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 997654110 0111123467889999988764 478999999999999999999999976543211
Q ss_pred hhhhhhhhhcCCCcc---c--------ccCCCCCCC---ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 366 LVDWLKTMVGSRKSE---E--------VVDPKLPKM---PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~---~--------~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+.......... . ......+.. ........+.+++.+||+.||++||++++++.
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 -LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111100000 0 000000000 00112456889999999999999999999986
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=284.38 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=197.3
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
|...+.||+|+||.||+|+.. +++.||+|.+.... ......+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999975 48999999887653 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.+ +|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 84 9999997542 3589999999999999999999998 999999999999999999999999999876543222
Q ss_pred eeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC---------C-
Q 011498 310 YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR---------K- 378 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~- 378 (484)
......++..|+|||.+.+. .++.++|||||||++|||++|..||......+.. ..+....... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHHhhccc
Confidence 12233467789999998766 7899999999999999999999999754421111 0000000000 0
Q ss_pred --cccccCCCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 --SEEVVDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 --~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..... +...... .......+.+++.+||..||++||++.+|+.
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 0000000 0112456899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.01 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=198.4
Q ss_pred hcCCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
+-++....+||.|.||.||.|. ..+|+..|+|.+.-.. ......+.+|+.++..++|||+|+.+|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3356667889999999999999 4568999999775432 233457788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|||++|+|.+.+... ...++.....+..|++.|++|||+. |||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999643 3356666677889999999999999 999999999999999999999999999988755
Q ss_pred CCcee---ecccccccccccccccccC---CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhh-hcCCCc
Q 011498 307 ERSYV---TTRVMGTFGYVAPEYACTG---MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM-VGSRKS 379 (484)
Q Consensus 307 ~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 379 (484)
..... .....||+.|||||++.+. +...+.||||+|||+.||+||+.||...+. +|...+ ++.+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~g-- 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAG-- 1457 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhcc--
Confidence 43221 2345799999999999753 466799999999999999999999975542 121111 1111
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
-.|.++. .....=.+++..||..||..|.++.|+++.
T Consensus 1458 ---h~Pq~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 ---HKPQIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---CCCCCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1122222 255566778889999999999998888764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=278.86 Aligned_cols=236 Identities=26% Similarity=0.338 Sum_probs=191.6
Q ss_pred eccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
||+|+||.||++... +++.+++|.+..... .....+..|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 488999998865432 2345788899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999754 3589999999999999999999998 99999999999999999999999999987654322 12334
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
..++..|++||...+...+.++|+||||+++|+|++|..||...... ........ . ...++. .
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~------~~~~~~----~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYEKILK-D------PLRFPE----F 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhc-C------CCCCCC----C
Confidence 56788999999998888999999999999999999999999644321 11111111 0 011111 1
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHH
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGH 419 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~e 419 (484)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=297.37 Aligned_cols=262 Identities=21% Similarity=0.319 Sum_probs=192.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC----------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG---------- 219 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---------- 219 (484)
.+|.+.+.||.|+||.||+|... ++..||+|.+........+.+..|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888899999999999999964 5889999988665555567788899999999999999999876643
Q ss_pred ----CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEE
Q 011498 220 ----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNAR 294 (484)
Q Consensus 220 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~k 294 (484)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 499988853 2588999999999999999999998 9999999999999974 56789
Q ss_pred EeeecccccccCCCce--eeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh--
Q 011498 295 VSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW-- 369 (484)
Q Consensus 295 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~-- 369 (484)
|+|||++......... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||....+.........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998765322111 1122357889999997654 5688999999999999999999999975442111100000
Q ss_pred -------hhhhhcCCCccccc-CCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 370 -------LKTMVGSRKSEEVV-DPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 370 -------~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....... ...... ......... ......+.+++.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 000000 000000000 123356888999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=291.28 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=195.9
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee-CCee
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYR 222 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~ 222 (484)
...+++|.+.+.||+|+||.||++... ++..||+|++.... ......+..|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999855 68899999885432 2234667789999999999999999999875 4578
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
+++|||+ +++|.++++. .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 5699988863 2478888889999999999999998 99999999999999999999999999987
Q ss_pred cccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh---------hhhhh
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV---------DWLKT 372 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~---------~~~~~ 372 (484)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|+||..||............ ++...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54221 122457889999998765 56899999999999999999999999754321110000 00000
Q ss_pred hhcCCCcccccCCCCC-CCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 MVGSRKSEEVVDPKLP-KMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~-~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............-... ..+. ......+.+++.+||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 0000 112357889999999999999999998866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.45 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=182.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeee----------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE---------- 218 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------- 218 (484)
.+|+..+.||+||||.||+++.+ ||+.||||++.-.. ......+.+|+.++++|+|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 34556678999999999999965 79999999996543 3334567889999999999999998642110
Q ss_pred -------------------------------------------------------C------------------------
Q 011498 219 -------------------------------------------------------G------------------------ 219 (484)
Q Consensus 219 -------------------------------------------------------~------------------------ 219 (484)
+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc
Q 011498 220 ------------------------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269 (484)
Q Consensus 220 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~ 269 (484)
..+||-||||+.-+|.++++.+.-. -.....++++.+|+.||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHHh
Confidence 1236789999987777777654211 1466789999999999999999
Q ss_pred CCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc-----------------CCCceeecccccccccccccccccC--
Q 011498 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-----------------SERSYVTTRVMGTFGYVAPEYACTG-- 330 (484)
Q Consensus 270 ~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~-- 330 (484)
. |||||||||.||+||.+..|||+|||+++... .......+..+||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998721 0011123456899999999999754
Q ss_pred -CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC--ChHHHHHHHHHHHHhcC
Q 011498 331 -MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM--PASKALKRVLLVALRCV 407 (484)
Q Consensus 331 -~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl 407 (484)
.|+.|+|+||||+||+||+. ||...- +.... +.. +-++.++.. ...+....=..++.+++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~i---L~~---------LR~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASI---LTN---------LRKGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchH--HHHHH---HHh---------cccCCCCCCcccccccchHHHHHHHHHh
Confidence 49999999999999999986 454211 11111 111 112222221 12223334556788999
Q ss_pred CCCCCCCCCHHHHHH
Q 011498 408 DPDATKRPKMGHVIH 422 (484)
Q Consensus 408 ~~dp~~RPs~~evl~ 422 (484)
+.||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=281.51 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=203.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCC--C----ceeeecceeeeCCe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH--K----NLVRLLGYCVEGAY 221 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~~~~~~~~~ 221 (484)
.+.+|.+...+|+|.||.|-.+... .+..||||+++. -....+..+.|++++.++.+ | -+|.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999854 368899997643 33344566679999999942 3 37888899999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC------------
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR------------ 289 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~------------ 289 (484)
.|||+|.+ |-|++++|..+ +..+++..++..++.|++.+++|||+. +++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999999 56999999765 557899999999999999999999998 9999999999999921
Q ss_pred --------CCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCC
Q 011498 290 --------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361 (484)
Q Consensus 290 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~ 361 (484)
+..++|+|||.|+...... ...+.|..|.|||++.+.+++.++||||+||||+|+.||...|......
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3458999999998754333 4467899999999999999999999999999999999999999866543
Q ss_pred CccchhhhhhhhhcCCC-------------------------cccccCCCCC----CCChHHHHHHHHHHHHhcCCCCCC
Q 011498 362 GEVNLVDWLKTMVGSRK-------------------------SEEVVDPKLP----KMPASKALKRVLLVALRCVDPDAT 412 (484)
Q Consensus 362 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~ 412 (484)
+.+.+.+.+........ ...+.++..+ -.....+..+|++|+.++|..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 33322221111000000 0111111111 012334567799999999999999
Q ss_pred CCCCHHHHHHH
Q 011498 413 KRPKMGHVIHM 423 (484)
Q Consensus 413 ~RPs~~evl~~ 423 (484)
+|+|+.|+++.
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=266.04 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=196.8
Q ss_pred HhcCCCcC-ceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeee----CCe
Q 011498 149 ATSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE----GAY 221 (484)
Q Consensus 149 ~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~ 221 (484)
.+++|.+. ++||-|-.|+|..+..+ +++++|+|++.+.. ...+|+++.-.. .|||||.++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35566554 57999999999999865 58899999886543 234466655444 69999999999874 346
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeee
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDF 298 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Df 298 (484)
+.+|||.++||.|++.++.+. ...+++.++-.|..||+.|+.|||+. +|.||||||+|+|... |..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 789999999999999998763 35699999999999999999999998 9999999999999964 456899999
Q ss_pred cccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
|.|+...... .....+-|+.|.|||++...+|+...|+||+||++|-||+|.+||-...-. .+.--++..+..+.
T Consensus 209 GFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gq 283 (400)
T KOG0604|consen 209 GFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQ 283 (400)
T ss_pred ccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccC
Confidence 9998754322 244567899999999999999999999999999999999999999644321 11111111111110
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
-.++........+...+++...|..+|.+|.|+++++.
T Consensus 284 ------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 12344445566778888999999999999999999876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=291.39 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=190.2
Q ss_pred CCCcCceeccCCceEEEEEEEC-C--CCEEEEEEecccc--hhhHHHHHHHHHHHhcc-CCCceeeecceeeeC----Ce
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-D--GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG----AY 221 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~ 221 (484)
+|.+.+.||+|+||.||++... . +..||+|.+.... ....+.+..|+.+++.+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999965 3 6789999886432 22345677899999999 599999999875432 35
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889886 5999988643 4689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCc---eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccch---------hh
Q 011498 302 KLLCSERS---YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL---------VD 368 (484)
Q Consensus 302 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~---------~~ 368 (484)
........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||........... .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 76543221 11233468899999998765 5689999999999999999999999975432110000 00
Q ss_pred hhhhhhcCC------CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 369 WLKTMVGSR------KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 369 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+........ .........+.. ........+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 000000000000 00112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=294.98 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=195.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCe----
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY---- 221 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~---- 221 (484)
..++|.+.+.||+|+||.||+|... ++..||+|++.... ......+..|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999975 47899999886432 2233567789999999999999999998876554
Q ss_pred --eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 222 --RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 222 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 5699999864 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC--
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS-- 376 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 376 (484)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .+......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~---~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK---RIMNLVGTPD 236 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHhcCCCC
Confidence 99765332 223457889999998865 467899999999999999999999997544321110 00000000
Q ss_pred ---------CCcccccC--CCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 ---------RKSEEVVD--PKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 ---------~~~~~~~~--~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+. +...... .......+.+++.+||+.||++|||+.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000 0000000 0112457889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=286.62 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=193.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC-----
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----- 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----- 220 (484)
..++|...+.||+|+||.||++... ++..||||++.... ......+..|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999854 68899999885432 223456778999999999999999999987543
Q ss_pred -eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 221 -YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 221 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 6799988853 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccch---------hhh
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL---------VDW 369 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~---------~~~ 369 (484)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........... ..+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 98765322 123457889999998875 4588999999999999999999999975432110000 000
Q ss_pred hhhhhcCCCcccccC--CCCCCC----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 370 LKTMVGSRKSEEVVD--PKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... .......... +..... ........+.+++.+|+..||++|||+.+++.
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0000000000 000000 00122345789999999999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=280.64 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=194.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccch---hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 224 (484)
..+|.+..+||+|+||+|.++.-++ .+.||||+++++-. ...+--..|-++|+.. +-|.++.++.+|++-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4568889999999999999998654 56799998876532 2222234467777776 57899999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+.||+|--.++.- ..+.+..+..++..||-||-|||++ ||++||||.+||+||.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999998888754 4577778899999999999999999 9999999999999999999999999999864
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.-. ...+..++||+.|+|||++...+|...+|+|||||+||||+.|++||++.+..+ +...+ .+
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~aI------------~e 564 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQAI------------ME 564 (683)
T ss_pred ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH------------HH
Confidence 322 223566899999999999999999999999999999999999999998766432 21111 11
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPK 416 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 416 (484)
.. -.++....++...++...|.+.|.+|..
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11 1223345566778888889999999954
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.28 Aligned_cols=145 Identities=25% Similarity=0.375 Sum_probs=129.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+..|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999976 58899999886532 223457888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
||+.+++|.+++... ..+++..++.++.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999753 3588899999999999999999998 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=271.74 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=191.5
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhc-cCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGR-VRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
...||.|.||+|++-.++ .|+..|||+++.... ...+++..|.+...+ -+.||||+++|.+..++..|+.||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 446999999999998875 589999999977654 445677778875555 4799999999999999999999999965
Q ss_pred CHHHHhhcC-CCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 233 NLDQWLHGD-VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 233 sL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
||..+.+.- ......+++...-.|....+.||.||... ..|+|||+||+|||||..|.+||||||++-.+... .-
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence 776654310 01224588888888888999999999875 49999999999999999999999999998765332 22
Q ss_pred eccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.+..+|-..|||||.+.. ..|+.++||||||++|||+.||+.|+...+ +..+.+...+...... +. ..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~-l~----~~ 293 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPI-LL----FD 293 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCe-ec----Cc
Confidence 334568889999998853 459999999999999999999999997543 2333333222211111 10 11
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.........+..++.-|+.+|-..||++.+++++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1122355678889999999999999999888663
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.81 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=209.6
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeee--
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE-- 218 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-- 218 (484)
++.+...++.|.+.+.||.|.+|.||+++. ++++.+|+|++.... ...+++..|.++++.+ .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 333444567788899999999999999994 468889999775443 3345677788888887 79999999999873
Q ss_pred ---CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 219 ---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 219 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
++.+|||||||.+||..|++++.. ...+.|..+..|+..++.||.+||.+ .++|||||-.|||++.++.+||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 568899999999999999998765 56799999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccCCCceeecccccccccccccccccC-----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhh
Q 011498 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 370 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~ 370 (484)
+|||++..+..... .....+||+.|||||++... .|+..+|+||||++..||--|.+|+...-+...+-.+
T Consensus 165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--- 240 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 240 (953)
T ss_pred eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---
Confidence 99999987755433 24557899999999998643 4778999999999999999999999766543211000
Q ss_pred hhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.-.|......+..-.+++.++|..||.+|.++||++.++++
T Consensus 241 -----------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 -----------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00112222234556788999999999999999999988876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=270.58 Aligned_cols=220 Identities=20% Similarity=0.188 Sum_probs=175.3
Q ss_pred CCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhc
Q 011498 162 GGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG 240 (484)
Q Consensus 162 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 240 (484)
|.||.||++... +++.||+|.+.... .+..|...+....||||+++++++......+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 58899999986543 223344555556799999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccccccc
Q 011498 241 DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320 (484)
Q Consensus 241 ~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 320 (484)
. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 4 3589999999999999999999998 9999999999999999999999999987655332 122345678
Q ss_pred cccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHH
Q 011498 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 400 (484)
Q Consensus 321 y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 400 (484)
|+|||.+.+..++.++||||+|+++|||++|..|+........ ......++ ......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~~~----~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTLNIP----EWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccccCCc----ccCCHHHH
Confidence 9999999888899999999999999999999988753221100 00000111 12334678
Q ss_pred HHHHhcCCCCCCCCCCHH
Q 011498 401 LVALRCVDPDATKRPKMG 418 (484)
Q Consensus 401 ~l~~~cl~~dp~~RPs~~ 418 (484)
+++.+||+.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=265.37 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=200.3
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCC
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 220 (484)
+.++-..|+ +.||+|+|+.|-.++ ..+|..||||++.+..........+|++++..+ .|+||+.|+++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 555555554 579999999999988 667999999999877767777888899999998 6999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc---EEEee
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSD 297 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~D 297 (484)
..|||||.+.||+|...|+++ .-+++..+.++..+|+.||.|||++ ||.||||||+|||-..... +||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence 999999999999999999866 4689999999999999999999999 9999999999999976544 79999
Q ss_pred ecccccccC--CCc----eeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCC----
Q 011498 298 FGLAKLLCS--ERS----YVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG---- 362 (484)
Q Consensus 298 fgla~~~~~--~~~----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~---- 362 (484)
|.+..-... +-+ ......+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.-..+
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 987743211 111 1123457899999999763 2368999999999999999999999997653211
Q ss_pred --cc--chhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 363 --EV--NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 363 --~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+. .-.+.+-.-+.++. - .++.........+-.+++...+..|+.+|.++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGk-Y-----eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGK-Y-----EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccC-C-----cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 00111111111111 1 1222223334455667777888899999999988876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=286.94 Aligned_cols=239 Identities=25% Similarity=0.276 Sum_probs=190.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 227 (484)
+..|.+...+|.|+|+.|-.+... +++..++|++..... +..+|+.++... +||||+++.+++.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888888999999999999854 578899998866522 223356555554 89999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE-cCCCcEEEeeecccccccC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-DRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~Dfgla~~~~~ 306 (484)
++.|+-|.+.+.... .....+..|+.+|+.|+.|||.+ |++||||||+|||+ ++.++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999888776432 22267778999999999999998 99999999999999 5889999999999987654
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. ....+-|..|.|||++....|++++||||||++||+||+|+.||.....+ .++. ..+.. +.
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~--------~~ 530 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQM--------PK 530 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcC--------Cc
Confidence 4 23346788999999999999999999999999999999999999865533 1111 11111 11
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..........+|+.+||+.||.+||++.++..
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11234455677888999999999999999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=292.49 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=194.7
Q ss_pred CCcCceeccCCceE-EEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecC
Q 011498 153 LCEENVIGEGGYGI-VYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
|...+.+|.|+.|+ ||+|.+. |+.||||++.... ..-..+|+.+|+.- +|||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34456799999875 7999996 8899999885543 34556799999887 79999999999999999999999997
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---C--CcEEEeeeccccccc
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---Q--WNARVSDFGLAKLLC 305 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~Dfgla~~~~ 305 (484)
. +|.+++...............+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6 99999976411111122134577889999999999997 9999999999999975 2 578999999999886
Q ss_pred CCCcee--ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... .....||-+|+|||++....-+.++|||||||++|+.++ |..||......+ .++.. ++..+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~------~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT------GNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc------Cccceee-
Confidence 554433 345679999999999999888889999999999999999 599997554221 11110 1111110
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcchhhhccc
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRI 437 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~ 437 (484)
+... .++ .-.+||.+|+++||..||++.+|+. .+++|+.+.+.
T Consensus 735 ----L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~----HPlFW~~ekrL 777 (903)
T KOG1027|consen 735 ----LEPL--PDC--EAKDLISRMLNPDPQLRPSATDVLN----HPLFWDSEKRL 777 (903)
T ss_pred ----eccC--chH--HHHHHHHHhcCCCcccCCCHHHHhC----CCccCChHHHH
Confidence 1111 111 5678888999999999999999975 56677776654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=242.93 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=196.9
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
|.-.++||+|.||+||+|+.. .++.||+|+++-+. ........+|+.+++.++|.|||+++++...+..+.+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444568999999999999954 58899999886543 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.. +|..|..... ..+....+..++.|+++||.|+|++ ++.||||||.|.||+.+|++|++|||+++.+.-.-.
T Consensus 84 dq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 65 8988886543 4588889999999999999999998 999999999999999999999999999987754332
Q ss_pred eeecccccccccccccccccC-CCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCC---cccccC
Q 011498 310 YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRK---SEEVVD 384 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 384 (484)
. ....+-|.+|.+|.++.+. -|++..|+||.||++.|+.. |.+.|.+.+..+....+-|+.....+.. ...+.|
T Consensus 157 c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2 2334678999999999875 58999999999999999987 8888877654433322222222211111 111111
Q ss_pred CCCCCCCh---------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 385 PKLPKMPA---------SKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 385 ~~~~~~~~---------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
-..-+..+ +.....=.+++.+.+.-+|.+|.++++.++.
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111 1112223456667778899999999888763
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=274.48 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=197.2
Q ss_pred CCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccch-------hhHHHHHHHHHHHhccCCCceeeecceee-eCCee
Q 011498 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-------QAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYR 222 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~ 222 (484)
+|-...+||+|+|+.||+|. +...+-||||+-..++. ...+...+|.++.+.|.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 46666789999999999997 44578899996543322 12245667999999999999999999986 55678
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeec
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFG 299 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg 299 (484)
|-|+|||+|.+|.-||+.+ ..+++..+..|+.||+.||.||... +++|+|-||||.||||-+ .|.+||+|||
T Consensus 544 CTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 8999999999999999866 5689999999999999999999986 889999999999999954 4789999999
Q ss_pred ccccccCCCce------eecccccccccccccccccC----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh
Q 011498 300 LAKLLCSERSY------VTTRVMGTFGYVAPEYACTG----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 300 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~ 369 (484)
+++.+..+... .+....||.+|++||++.-+ +++.|+||||.||++|..+.|+.||.....+... .+.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hhh
Confidence 99988654322 34556899999999987533 5788999999999999999999999865432211 100
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcchhhh
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 434 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~ 434 (484)
...+... ++ .++.. +-...+...+|.+||...-++|....++ -.+..+.+..
T Consensus 697 -NTIlkAt---EV---qFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qL----A~dpyllPh~ 748 (775)
T KOG1151|consen 697 -NTILKAT---EV---QFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQL----ACDPYLLPHI 748 (775)
T ss_pred -hchhcce---ec---cCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHH----ccCccccchh
Confidence 0011111 11 11111 1123345677889999999999885554 4455554433
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.23 Aligned_cols=204 Identities=23% Similarity=0.361 Sum_probs=172.3
Q ss_pred CCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||-|+||+|.++.. ++...||.|.+++... ......+.|-+||+.-..+-||+||..|.+.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 55667899999999999984 4466799998866542 2234567789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc--cC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CS 306 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~--~~ 306 (484)
++||++-.+|-.. .-+.+..+..++.++..|+++.|.. |+|||||||+|||||.+|++||+||||+.-+ ..
T Consensus 711 IPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999998654 4688889999999999999999988 9999999999999999999999999998532 10
Q ss_pred C-Ccee--------------------------------------ecccccccccccccccccCCCCcccceecchhHHHH
Q 011498 307 E-RSYV--------------------------------------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIME 347 (484)
Q Consensus 307 ~-~~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e 347 (484)
+ ..+. ....+||+.|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 0000 012579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCc
Q 011498 348 IITGRNPVDYSRPQGE 363 (484)
Q Consensus 348 lltG~~p~~~~~~~~~ 363 (484)
|+.|+.||-...+.+.
T Consensus 864 m~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhCCCCccCCCCCcc
Confidence 9999999988776543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=278.78 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=198.3
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
.++||.|.||+||-|+++ +|+.||||++.+.+ ...+..+.+|+.+|..+.||.||.|.-.|++.+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999964 69999999986543 344577889999999999999999999999999999999999775
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC---CcEEEeeecccccccCCCc
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~ 309 (484)
-|...|.... ..+++.....+..||+.||.|||.+ +|+|+||||+||||... ..+||||||.|+.+....
T Consensus 649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 5555555433 5689999999999999999999999 99999999999999643 579999999999875432
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....+||+.|+|||++.++.|+..-|+||.||++|--|+|..||..... +.+.++. ..++ .+.
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQN-------AaFM---yPp 785 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQN-------AAFM---YPP 785 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhc-------cccc---cCC
Confidence 34557899999999999999999999999999999999999999974431 1111111 1111 233
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+..+....-++||...|+..-.+|-|...-+.
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 445556667788888999999999999877655
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=292.93 Aligned_cols=262 Identities=19% Similarity=0.235 Sum_probs=170.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC-----CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecce------ee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY------CV 217 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~~ 217 (484)
..++|.+.+.||+|+||.||+|++.+ +..||+|++...... +.+..+ .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999753 689999987543211 111111 1122223333333222 23
Q ss_pred eCCeeeEEEEecCCCCHHHHhhcCCCC----------------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCC
Q 011498 218 EGAYRMLVYEYVDNGNLDQWLHGDVGD----------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK 281 (484)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlk 281 (484)
.....++||||+.+++|.++++..... ........+..++.||+.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 456789999999999999998643210 01112344567999999999999998 99999999
Q ss_pred CCcEEEcC-CCcEEEeeecccccccCCCceeecccccccccccccccccC----------------------CCCcccce
Q 011498 282 SSNILLDR-QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG----------------------MLNEKSDV 338 (484)
Q Consensus 282 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 338 (484)
|+|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986644433344556789999999965322 24456799
Q ss_pred ecchhHHHHHHhCCCCCCCCCC-------CCccchhhhhhhhhcCCCcccccCCCCCC--CChHHHHHHHHHHHHhcCCC
Q 011498 339 YSFGILIMEIITGRNPVDYSRP-------QGEVNLVDWLKTMVGSRKSEEVVDPKLPK--MPASKALKRVLLVALRCVDP 409 (484)
Q Consensus 339 wslG~~l~elltG~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~ 409 (484)
|||||+||||+++..++..... ........|...... . ..+.+.. ...........+|+.+||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-R-----ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-c-----cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999997766432100 000011111111000 0 0000000 00000112345799999999
Q ss_pred CCCCCCCHHHHHHH
Q 011498 410 DATKRPKMGHVIHM 423 (484)
Q Consensus 410 dp~~RPs~~evl~~ 423 (484)
||++|||+.++++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999873
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=260.54 Aligned_cols=237 Identities=27% Similarity=0.401 Sum_probs=192.5
Q ss_pred CceEEEEEEECC-CCEEEEEEecccchhh-HHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhc
Q 011498 163 GYGIVYRGILSD-GTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG 240 (484)
Q Consensus 163 ~~g~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 240 (484)
+||.||+|...+ +..+++|++....... .+.+..|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999987655444 67889999999999999999999999999999999999999999999975
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccccccc
Q 011498 241 DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320 (484)
Q Consensus 241 ~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 320 (484)
.. .+++..++.++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 42 388999999999999999999998 99999999999999999999999999998764432 2334567889
Q ss_pred cccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChH-HHHHHH
Q 011498 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS-KALKRV 399 (484)
Q Consensus 321 y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 399 (484)
|++||.+....++.++|||+||+++|+|++|..||...... ....+... .. ........ .....+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~----~~--------~~~~~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG----KP--------KPPFPPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh----cc--------CCCCccccccCCHHH
Confidence 99999998888999999999999999999999998653211 11111111 00 00000000 034578
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHH
Q 011498 400 LLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 400 ~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+++.+||..||++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 88999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.60 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=180.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-----------------CCCCEEEEEEecccchhhHHH--------------HHHH
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGIL-----------------SDGTKVAVKNLLNNRGQAEKE--------------FKVE 197 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~e 197 (484)
..++|.+.++||+|+||.||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 235679999986543322222 3346
Q ss_pred HHHHhccCCCce-----eeecceeee--------CCeeeEEEEecCCCCHHHHhhcCCCC--------------------
Q 011498 198 VEVIGRVRHKNL-----VRLLGYCVE--------GAYRMLVYEYVDNGNLDQWLHGDVGD-------------------- 244 (484)
Q Consensus 198 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------- 244 (484)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++|+...+.
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 677787753 34679999999999999999753211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccccccccccc
Q 011498 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324 (484)
Q Consensus 245 ~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP 324 (484)
...+++..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999998 999999999999999999999999999976533222112223357899999
Q ss_pred cccccCCC----------------------CcccceecchhHHHHHHhCCC-CCCCCCCCC-c-----cchhhhhhhhhc
Q 011498 325 EYACTGML----------------------NEKSDVYSFGILIMEIITGRN-PVDYSRPQG-E-----VNLVDWLKTMVG 375 (484)
Q Consensus 325 E~~~~~~~----------------------~~~~DvwslG~~l~elltG~~-p~~~~~~~~-~-----~~~~~~~~~~~~ 375 (484)
|.+..... ..+.||||+||++|+|++|.. ||....... + .....|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 98754321 235799999999999999875 664321100 0 01111110 00
Q ss_pred CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCC---CCCCCHHHHHH
Q 011498 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDA---TKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPs~~evl~ 422 (484)
... ..............+++.++|..+| .+|+|++|+++
T Consensus 458 ~~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000 0011112233457778888888765 68999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=260.23 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=193.9
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeee--------CCe
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--------GAY 221 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~ 221 (484)
|.-..+||+|.||+||+|+.+ .|++||+|++... +........+|+++|..++|+|++.++..|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 334467999999999999965 4778898876442 22233455669999999999999999998853 235
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
+|+||++|++ +|..+|.+.. ..++...+..++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 7999999998 9999986543 4588889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCcee---eccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 302 KLLCSERSYV---TTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 302 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
+.+....... .+..+-|.+|++||.+.+ ..|+++.|||+.||+|.||+|+.+-+.....+....++..+..-....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7664332221 123356999999998875 579999999999999999999999998776555444443221111100
Q ss_pred C--------c-ccccCCCCCCCChH---HHH------HHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 378 K--------S-EEVVDPKLPKMPAS---KAL------KRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 378 ~--------~-~~~~~~~~~~~~~~---~~~------~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
. + +.+-.+.++..... +.. ..-.+|+.+++..||.+|+++.+++..-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0 0 00000101111111 111 1445677788999999999999997644
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=277.66 Aligned_cols=250 Identities=24% Similarity=0.284 Sum_probs=201.7
Q ss_pred cCCCcCceeccCCceEEEEEEECCCC-EEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGT-KVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~-~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.++.....||-|+||.|=++..++.. .+|+|.+++... ...+....|-.+|..++.|.||++|-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555567999999999999876433 388888765432 23345667889999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|-|-||.|+..|+.+ ..+.......++..+++|++|||.+ +||+|||||+|++||.+|-+||.|||.|+.+..
T Consensus 500 EaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999865 4677888888999999999999999 999999999999999999999999999998865
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.. .+-.+|||+.|.|||++.+...+.++|.||||+++|||+||.+||...++....+++-.-. +.
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi--------d~----- 637 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI--------DK----- 637 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh--------hh-----
Confidence 44 3566899999999999999999999999999999999999999999887655444331100 00
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHML 424 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~L 424 (484)
...+....+.-.+|+++.+..+|.+|.. +.+|-+.-
T Consensus 638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 1112233445666777778899999976 66665543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=256.40 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=193.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 224 (484)
..+|...++||+|+|++|.+++++ +.+.||+|++++. ..+..+-.+.|-.+...- +||.+|.+..+|.+...+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 356888899999999999999964 5778999988654 233344455566666555 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
|.||++||+|--.++.. ..++++.+..+...|+.||.|||++ ||++||||.+|||||..|++||+|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999998887654 5699999999999999999999999 9999999999999999999999999999864
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCC-CccchhhhhhhhhcCCCccccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ-GEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.. ....+..++||+.|.|||++.+..|...+|+|+|||+|+||+.|+.||+.-..+ .+.+..+++-..+-+.. +
T Consensus 402 l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq---i- 476 (593)
T KOG0695|consen 402 LG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ---I- 476 (593)
T ss_pred CC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---c-
Confidence 33 333467789999999999999999999999999999999999999999754321 22233333322221111 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPK 416 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 416 (484)
.++.. ..-+...++..-|++||.+|..
T Consensus 477 --riprs----lsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 --RIPRS----LSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --cccce----eehhhHHHHHHhhcCCcHHhcC
Confidence 11111 1122334555778999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=237.04 Aligned_cols=208 Identities=28% Similarity=0.413 Sum_probs=170.6
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCee
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 222 (484)
++...+.+.....||+|++|.|-+-++ .+|...|+|++...-. +..+....|+++..+. .+|.+|.|+|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444445566667899999999877774 3689999999976533 3445677788876665 799999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+.||.|.. ||..|-+.-......+++...-+|+..+..||.|||++. .++|||+||+||||+.+|++|+||||++-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999976 898887654445678999999999999999999999874 99999999999999999999999999997
Q ss_pred cccCCCceeeccccccccccccccccc----CCCCcccceecchhHHHHHHhCCCCCCCC
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACT----GMLNEKSDVYSFGILIMEIITGRNPVDYS 358 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~elltG~~p~~~~ 358 (484)
.+.+.-. .+-..|-..|||||.+.. ..|+-++||||||+++.||.+++.||+..
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 7644322 122357778999998753 37999999999999999999999999744
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=260.47 Aligned_cols=272 Identities=22% Similarity=0.209 Sum_probs=206.2
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC------CCceeeec
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR------HKNLVRLL 213 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~ 213 (484)
|.+.--+....+|.+....|+|-|++|.+|... .|..||||++..+.. ..+.=..|+++|++|+ --|+++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 444444555678988899999999999999854 378999998876543 3445566999999995 24899999
Q ss_pred ceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-Cc
Q 011498 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WN 292 (484)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~ 292 (484)
-.|....++|||+|-+.- +|.+.|+... ....|....+..++.|+..||..|... +|+|.||||+|||+++. ..
T Consensus 501 r~F~hknHLClVFE~Lsl-NLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLSL-NLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhhhc-hHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 999999999999999854 9999998654 335588899999999999999999987 99999999999999876 46
Q ss_pred EEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
+||||||.|........ +...-+..|.|||++.+..|+...|+||.||+||||.||+..|.+......+.+..-++.
T Consensus 576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 79999999987644332 222345679999999999999999999999999999999999987765433222111000
Q ss_pred -----hhcCC------------------------C---cccccCC------------CCCCCChHHHHHHHHHHHHhcCC
Q 011498 373 -----MVGSR------------------------K---SEEVVDP------------KLPKMPASKALKRVLLVALRCVD 408 (484)
Q Consensus 373 -----~~~~~------------------------~---~~~~~~~------------~~~~~~~~~~~~~l~~l~~~cl~ 408 (484)
++..+ . +-..+.| .+ +.........|.+|+.+||.
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~-~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL-PDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC-CchhHHHHHHHHHHHHHHhc
Confidence 00000 0 0001111 11 12233456778899999999
Q ss_pred CCCCCCCCHHHHHH
Q 011498 409 PDATKRPKMGHVIH 422 (484)
Q Consensus 409 ~dp~~RPs~~evl~ 422 (484)
.||++|.|..+.|+
T Consensus 732 LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 732 LDPEKRITVNQALK 745 (752)
T ss_pred cChhhcCCHHHHhc
Confidence 99999999998876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=245.56 Aligned_cols=264 Identities=21% Similarity=0.327 Sum_probs=200.1
Q ss_pred CCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Ceee
Q 011498 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~ 223 (484)
+....+.||-|+||.||.++. ++|+.||+|++..-. -...+.+-+|+.+|..++|.|++..++...-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344567899999999999985 468999999885432 23346777899999999999999999876543 2467
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+++|.+.. +|...+-. ...++...+.-+..||++||.|||+. +|.||||||.|.|++.|..+||||||+++.
T Consensus 134 V~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 88888865 77776643 35688888999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC-----
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR----- 377 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 377 (484)
...+....++..+-|..|.|||++++. .|+.+.||||.||++.||+..+..|...++....+++.- +.+..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd---LLGTPs~EaM 282 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID---LLGTPSQEAM 282 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH---HhCCCcHHHH
Confidence 777666667777889999999999875 699999999999999999999999988777655444321 11111
Q ss_pred ------CcccccC-----CCCCCC----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 378 ------KSEEVVD-----PKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 378 ------~~~~~~~-----~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
....++. |.++.. .+...-..-+.+..+++.+||++|.+.++.+..+..
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1111111 111100 001112234456668899999999999988876643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=248.76 Aligned_cols=131 Identities=24% Similarity=0.329 Sum_probs=110.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-----C---Cceeeecceeee---
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----H---KNLVRLLGYCVE--- 218 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~--- 218 (484)
.+|.+.++||.|.|++||+|... +.+.||+|+++..... .+....||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999854 4678999988655433 344556999999883 3 479999999974
Q ss_pred -CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 219 -GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 219 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
+.++|||+|++ |.+|..+|... ....++...+.+|+.||+.||.|||..| +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999999 66999999765 4466999999999999999999999986 99999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=232.04 Aligned_cols=210 Identities=34% Similarity=0.595 Sum_probs=182.1
Q ss_pred eccCCceEEEEEEECC-CCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHHH
Q 011498 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 236 (484)
||+|.+|.||++...+ +..+++|.+...... ....+.+|+..++.+.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999988665432 34678899999999999999999999999899999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeecccccccCCCceeeccc
Q 011498 237 WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERSYVTTRV 315 (484)
Q Consensus 237 ~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 315 (484)
++.... ..+++..++.++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 997542 3588999999999999999999998 9999999999999999 89999999999976543321 12234
Q ss_pred ccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHH
Q 011498 316 MGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394 (484)
Q Consensus 316 ~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (484)
.+...|++||.+... .++.+.|+|+||+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999998877 888999999999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 395 ALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 395 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..+.+++.+|++.||++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357888899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=231.42 Aligned_cols=199 Identities=31% Similarity=0.478 Sum_probs=172.4
Q ss_pred CCcCceeccCCceEEEEEEECC-CCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
|.+.+.||+|++|.||++...+ +..+++|.+...... ....+..|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999865 789999998766544 56788899999999999999999999999889999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++..... .+++..++.++.+++.++.|||+. +++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999975421 178999999999999999999998 9999999999999999999999999999876443211
Q ss_pred eeccccccccccccccc-ccCCCCcccceecchhHHHHHHhCCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIITGRNPVDY 357 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltG~~p~~~ 357 (484)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=251.93 Aligned_cols=197 Identities=25% Similarity=0.391 Sum_probs=168.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhH--------HHHHHHHHHHhccC---CCceeeecceee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAE--------KEFKVEVEVIGRVR---HKNLVRLLGYCV 217 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~--------~~~~~e~~~l~~l~---H~niv~l~~~~~ 217 (484)
..+|+..+.||+|+||.|++|.++. ...|+||.+.+.+.... -..-.|+.+|+.++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468888999999999999999764 56799998876543211 12345999999997 999999999999
Q ss_pred eCCeeeEEEEec-CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEe
Q 011498 218 EGAYRMLVYEYV-DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 218 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
+++.+||+||-. ++.+|++++.-. +.+++..+..|+.||+.|+++||++ +|||||||-+||.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 999999999975 467999999754 5689999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCceeecccccccccccccccccCCCC-cccceecchhHHHHHHhCCCCCC
Q 011498 297 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVD 356 (484)
Q Consensus 297 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltG~~p~~ 356 (484)
|||.+....+.. ...++||..|.|||++.+.+|- ..-|||++|++||-++..+.||-
T Consensus 713 dfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998764443 2346899999999999988764 56899999999999999888874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=224.23 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=189.4
Q ss_pred hcCCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCC--eeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGA--YRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lv 225 (484)
.++|.+.+.+|+|.+++||.|. ..++++++||.++.- ..+.+++|+.+|..|. ||||++|+++..+.. ...+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4578888899999999999998 456889999988543 3467888999999996 999999999987653 56799
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLL 304 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgla~~~ 304 (484)
+||+.+.+...+. ++++...+..++.+++.||.|+|+. ||+|||+||.|++||.. ..++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998877765 4577788899999999999999999 99999999999999965 56999999999887
Q ss_pred cCCCceeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCC-CCCCccchhh------hhhhhhcC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYS-RPQGEVNLVD------WLKTMVGS 376 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~-~~~~~~~~~~------~~~~~~~~ 376 (484)
.....+ .-.+.+..|.-||++- ...|+..-|+|||||+|..|+..+.||-.. +..+.+..+. .+...+..
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 544332 2224566789999876 467899999999999999999998887433 2222211110 00111100
Q ss_pred CC------ccccc--------CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 RK------SEEVV--------DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 ~~------~~~~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
-. ...++ ...+......-...+.++++.+.|..|-++|+|++|.+.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00 00000 011111111112245677888999999999999999865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=225.04 Aligned_cols=254 Identities=19% Similarity=0.315 Sum_probs=185.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecce-eeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGY-CVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~-~~~~~~~~lv~ 226 (484)
.+.|.+.+.||+|.||.+-++.++. .+.+++|-+.... ...++|.+|...--.| .|.||+.-|++ |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3578888999999999999999875 5678889764433 3457888887654445 68999998875 55667778999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc--CCCcEEEeeecccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKLL 304 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfgla~~~ 304 (484)
||++.|+|.+-+.. ..+.+.....++.|+++||.|+|++ ++||||||.+||||- +.-++||||||+.+..
T Consensus 102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999997754 3478888999999999999999999 999999999999993 3348999999998765
Q ss_pred cCCCceeecccccccccccccccccC-----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
+..- .....+..|.+||..... ..++.+|||.||+++|.++||++||+... .......+|..-..+.
T Consensus 174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk--- 245 (378)
T KOG1345|consen 174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRK--- 245 (378)
T ss_pred Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhccc---
Confidence 3321 222345679999976432 35678999999999999999999998433 2222333333222111
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.+.++..+. ......+.+..+-+.++|++|-...++.++..
T Consensus 246 ----~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 246 ----NPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ----CccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 112222111 12334556667889999999977777766554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=233.19 Aligned_cols=261 Identities=25% Similarity=0.276 Sum_probs=190.7
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC------Ce
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------AY 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~ 221 (484)
.+|...+.+|.|.- .|.-+-. -.+++||+|++.... ....+...+|+.++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888887 4544442 247899999885432 23345677799999999999999999998743 35
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.|+||||+.. +|...+.. .++-.....++.|++.|++|||+. +|+||||||+||++..+..+||.|||++
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 6899999965 99888863 366677889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh--------------
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-------------- 367 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~-------------- 367 (484)
+.-... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|.+...-+....+
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 864322 3566678899999999999989999999999999999999999998755422211110
Q ss_pred --hhhhhhhcCC-------CcccccCCCCCCCC--hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 368 --DWLKTMVGSR-------KSEEVVDPKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 368 --~~~~~~~~~~-------~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
.....+.... ....+.|..++... .........+++.+||..||++|.+++++|..-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0011111100 00111121111111 112234567788899999999999999998743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=250.71 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=200.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.....+|.|+||.||+++.. .++..|+|+++-.......-.+.|+-+++..+|||||.++|.+...+..|+.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 56778889999999999999954 58899999998777777777888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.+|+|.+.-+.. .++++.++...++....||+|||+. +-+|||||-.|||+++.|.+|++|||.+-.+...-
T Consensus 95 gggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 95 GGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred CCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 999999977644 6799999999999999999999998 99999999999999999999999999987654322
Q ss_pred eeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 310 YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.....+.||+.|||||+.. .+.|...+|||++|+...|+---++|....-+.... .-+.. ...+|.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l------~LmTk-----S~~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL------FLMTK-----SGFQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH------HHhhc-----cCCCCC
Confidence 2244578999999999774 578999999999999999997777764332221111 01110 111111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
-.. ....-...+.++++.|+.++|.+||+++-++.
T Consensus 236 ~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 01112345778888999999999999876654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=265.97 Aligned_cols=195 Identities=17% Similarity=0.236 Sum_probs=138.5
Q ss_pred ccCC-Cceeeeccee-------eeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc
Q 011498 203 RVRH-KNLVRLLGYC-------VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274 (484)
Q Consensus 203 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ 274 (484)
.++| +||++++++| .....+++++||+ +++|.++|+.. ...+++..++.++.||+.||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3455 5888888877 2334567788987 55999999643 24589999999999999999999998 9
Q ss_pred eeecCCCCCcEEEcCCC-------------------cEEEeeecccccccCCC---------------ceeecccccccc
Q 011498 275 VVHRDVKSSNILLDRQW-------------------NARVSDFGLAKLLCSER---------------SYVTTRVMGTFG 320 (484)
Q Consensus 275 ivH~dlkp~NIll~~~~-------------------~~kl~Dfgla~~~~~~~---------------~~~~~~~~gt~~ 320 (484)
|+||||||+||||+..+ .+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 45566666654321100 000112357889
Q ss_pred cccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHH
Q 011498 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 400 (484)
Q Consensus 321 y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 400 (484)
|+|||++.+..++.++|||||||+||||++|.+|+.... ... ..... ....+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~---~~~~~-----~~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM---SSLRH-----RVLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH---HHHHH-----hhcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999988865221 001 01000 0111111 11123456
Q ss_pred HHHHhcCCCCCCCCCCHHHHHH
Q 011498 401 LVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 401 ~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.++.+||.+||.+||++.||++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7888999999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=222.91 Aligned_cols=266 Identities=21% Similarity=0.324 Sum_probs=194.5
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
......|...++||+|.|+.||++.+. .+..||+|.+.... ....+..|+++|..+ .+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334567888999999999999999843 36789999885443 235678899999998 69999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGL 300 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgl 300 (484)
..+|+||+++....+++. .++...+..+++.+..||.++|.+ |||||||||.|+|.+.. +.-.|.|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 999999999999999884 467888999999999999999999 99999999999999854 5679999999
Q ss_pred ccccc-----------------C----------------CCceee----------cccccccccccccccccC-CCCccc
Q 011498 301 AKLLC-----------------S----------------ERSYVT----------TRVMGTFGYVAPEYACTG-MLNEKS 336 (484)
Q Consensus 301 a~~~~-----------------~----------------~~~~~~----------~~~~gt~~y~aPE~~~~~-~~~~~~ 336 (484)
+.... . ...+.. ....||++|.|||++... .-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97210 0 000000 114699999999988754 578899
Q ss_pred ceecchhHHHHHHhCCCCCCCCCCCCccchhhhh-----------hhhhcC------CC---cc------cccC-CCC--
Q 011498 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL-----------KTMVGS------RK---SE------EVVD-PKL-- 387 (484)
Q Consensus 337 DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~------~~---~~------~~~~-~~~-- 387 (484)
||||.|||++-++++..||-..... ...+.+.+ ....+. .. .. +-++ ..+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred ceeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 9999999999999999998544321 11111110 000000 00 00 0000 000
Q ss_pred ------CC-CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 388 ------PK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 388 ------~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.. .........+++++.+|+..||.+|.|+++.|+.--
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 00 011112336888999999999999999999988543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=207.02 Aligned_cols=166 Identities=23% Similarity=0.212 Sum_probs=125.3
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.++++.+. ..+++..++.++.|++.||+|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997532 4699999999999999999999987 5 999999999999999 99987653322
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCC
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (484)
..||+.|+|||++.+..++.++|||||||++|||+||..||........ .+..+..... . .++.. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~-~------~~~~~-~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMP-A------DDPRD-RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhc-c------CCccc-ccc
Confidence 2588999999999999999999999999999999999999964432110 1111111100 0 00000 011
Q ss_pred hHHHHH--HHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 392 ASKALK--RVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 392 ~~~~~~--~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...... .+.+++.+||..||.+||++.++++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 222233 68999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=207.57 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=188.4
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
..+|.+...|+.|+|+|+ |..+++|++... .....++|..|.-.|+.+.||||+.+++.|....++.++..|++.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346889999999999997 455666766433 33445789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeec
Q 011498 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313 (484)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 313 (484)
|+..|++.. .-.++..++.+++.++++|++|||+. .+-|.---|.+..|++|++.+++|+- +-.++ +....
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEV 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----eeecc
Confidence 999998653 23467778999999999999999986 45555667999999999999888742 11111 11122
Q ss_pred ccccccccccccccccCCCC---cccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 314 RVMGTFGYVAPEYACTGMLN---EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 314 ~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
.....+.|++||.+...+-+ .++|+|||+++||||.|.+.||....+-+--- .+....++..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccccc
Confidence 23457889999999876543 47999999999999999999998665432110 1111223333
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.++.....+.+|+.-|++.||.+||.+..|+-.||.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 344455678888889999999999999999988874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=214.14 Aligned_cols=173 Identities=21% Similarity=0.238 Sum_probs=131.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC--CCCEEEEEEeccc-----chhhHHHHHHHHHHHhccCCCceee-ecceeeeCC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNN-----RGQAEKEFKVEVEVIGRVRHKNLVR-LLGYCVEGA 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~ 220 (484)
..++|...+.||+|+||+||+|.++ +++.||||++... .......|.+|+++++.++|+|+++ ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3467889999999999999999864 4777899987533 1223457899999999999999985 4432 4
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCC-CCCcEEEcCCCcEEEeeec
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV-KSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg 299 (484)
..|+||||++|++|.. +.. .. ...++.|++.+|.|||++ ||+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5799999999999973 211 11 146788999999999998 9999999 9999999999999999999
Q ss_pred ccccccCCCce-e------ecccccccccccccccccCC------CCccccee
Q 011498 300 LAKLLCSERSY-V------TTRVMGTFGYVAPEYACTGM------LNEKSDVY 339 (484)
Q Consensus 300 la~~~~~~~~~-~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 339 (484)
+++.+...... . .....+++.|+|||++.... .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99876432210 0 13456888899999886432 33446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=208.66 Aligned_cols=257 Identities=17% Similarity=0.233 Sum_probs=190.6
Q ss_pred CCCcCceeccCCceEEEEEEECCC--CEEEEEEecccchhhHHHHHHHHHHHhccCC----Cceeeeccee-eeCCeeeE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSDG--TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH----KNLVRLLGYC-VEGAYRML 224 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~l 224 (484)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999996543 4788887765433333367778888888863 5889999888 57778899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-----CcEEEeeec
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-----WNARVSDFG 299 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~Dfg 299 (484)
||+.+ |.+|.++..... ...++..+++.++.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 779999886553 35689999999999999999999998 99999999999999765 469999999
Q ss_pred ccc--cccCCCce----e---ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhh
Q 011498 300 LAK--LLCSERSY----V---TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL 370 (484)
Q Consensus 300 la~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~ 370 (484)
+++ ........ . .....||..|.++....+...+.+.|+||++.++.|++.|..||............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~--- 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF--- 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---
Confidence 998 43222111 0 12345999999999999999999999999999999999999999765433221111
Q ss_pred hhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... ........ .....+.. +.++...+-..+...+|....+...|..
T Consensus 250 ~~~----~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 250 EKD----PRKLLTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHH----hhhhcccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 110 00011110 11112223 3344444446899999999999888654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=189.75 Aligned_cols=200 Identities=21% Similarity=0.312 Sum_probs=167.7
Q ss_pred CCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEec
Q 011498 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.|.+.++||+|.||.++.|+ +-+++.||||.-. ......++..|.+..+.| ..++|..++-+...+.+..||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 58889999999999999998 4468999999432 222234566788888888 5689999999888888899999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-----CcEEEeeecccccc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-----WNARVSDFGLAKLL 304 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~Dfgla~~~ 304 (484)
|.||+|++.-. ...++...+..++.|++.-++|+|++ .+|+|||||+|+||... ..+.|+|||+|+..
T Consensus 107 -GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 77999987543 25689999999999999999999999 99999999999999643 45899999999987
Q ss_pred cCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCC
Q 011498 305 CSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360 (484)
Q Consensus 305 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~ 360 (484)
.+.... ......||.+||+-....+.+-+.+.|+=|||-++++.|-|..||.+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 544322 12346799999999999999999999999999999999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-22 Score=196.08 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=196.5
Q ss_pred CCcCceeccCCceEEEEEEECCCCEEEEEEecccchh---hHHHHHHHHHHHhccCCC-ceeeecceeeeCCeeeEEEEe
Q 011498 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHK-NLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 228 (484)
|...+.||.|+||.||++... ..+++|.+...... ....+..|+.++..+.|+ +++++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999986 78899988655432 367888999999999888 799999999777778999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeecccccccCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE 307 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~ 307 (484)
+.+++|.+++...... ..+.......+..|++.++.|+|.. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777644211 3688899999999999999999998 999999999999999988 7999999999855433
Q ss_pred Cce-----eeccccccccccccccccc---CCCCcccceecchhHHHHHHhCCCCCCCCCCC-CccchhhhhhhhhcCCC
Q 011498 308 RSY-----VTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ-GEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 308 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 378 (484)
... ......|+..|++||.+.+ ..++...|+|++|++++++++|..||...... ........+.. ..
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cC
Confidence 221 2355679999999999987 57899999999999999999999997654421 00111111111 00
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.. .................+.+++..|+..+|..|.+..+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000001000002223467788889999999999998887664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-24 Score=222.39 Aligned_cols=253 Identities=23% Similarity=0.259 Sum_probs=185.3
Q ss_pred CcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhH----HHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAE----KEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 154 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~----~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.....+|.|.+|.|+..... .....+.|..... ..... ..+..|+.+-..+.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999977776632 2333344432210 11111 12555777778889999999888887766666669
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|||++ +|+.++... ..+....+..++.|+..|+.|||+. ||.|||||++|++++.++.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999998654 3577888889999999999999998 999999999999999999999999999976543
Q ss_pred CCc---eeecccccccccccccccccCCCCc-ccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 307 ERS---YVTTRVMGTFGYVAPEYACTGMLNE-KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 307 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
... ......+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......+... ..... ....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~---~~~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNY---SDQR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcc---cccc
Confidence 222 3455678999999999999999887 6899999999999999999997665433211 00000 0000
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
-...-+......+..+...++.++|+.||.+|.|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111111223345667888999999999999999999976
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=181.78 Aligned_cols=255 Identities=19% Similarity=0.227 Sum_probs=190.3
Q ss_pred hcCCCcCceeccCCceEEEEEE-ECCCCEEEEEEecccchhhHHHHHHHHHHHhccCC-CceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 227 (484)
..+|...+.||.|+||.+|.|. ..+|..||||.-.... ....+..|..+...|++ ..|..+..+..+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678999999999999999998 5679999999654332 23456678889998865 688888889999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC---CcEEEeeecccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLL 304 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfgla~~~ 304 (484)
.+ |.+|.++++-.. ..++..+++-++-|++.-++|+|.+ +++||||||+|.|..-+ ..+.++|||+++..
T Consensus 92 LL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99 779999886432 4588889999999999999999999 99999999999999654 46899999999876
Q ss_pred cCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 305 CSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 305 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
.+.... ......||.+|.+--...+..-+.+.|+-|+|.+|.++.-|..||++.........-+.+.+......
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 443221 12346799999998888788889999999999999999999999998765443333332222221111
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
++.+.. ..+.++...+.-|-..--++-|....+.+
T Consensus 245 ie~LC~---------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 245 IEVLCK---------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred HHHHhC---------CCcHHHHHHHHHHhhcCCCCCCcHHHHHH
Confidence 111111 12234455555666666777777655443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=220.16 Aligned_cols=251 Identities=22% Similarity=0.216 Sum_probs=183.6
Q ss_pred CCCcCceeccCCceEEEEEEECCCCEEEEEEecccc-hhhHHHHHHHHHH--HhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR-GQAEKEFKVEVEV--IGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++...+.||.+.|=+|.+|+++.|. |+||++.+.. ....+.|.++++- ...++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999998887 8999886654 3334455544433 4445899999999888888888999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc--cC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CS 306 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~--~~ 306 (484)
..+ +|+|.|..+ +-+...+.+.|+.|++.||..+|.. ||+|||||.+||||+.-+-+.|+||...+.. ..
T Consensus 103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 987 999998644 5577888889999999999999998 9999999999999999989999999876542 22
Q ss_pred CCceee----cccccccccccccccccC----------C-CCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhh
Q 011498 307 ERSYVT----TRVMGTFGYVAPEYACTG----------M-LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL 370 (484)
Q Consensus 307 ~~~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~ 370 (484)
++...- .....-.+|+|||.+... . .+++-||||+||++.||++ |.+||.... .+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------L~ 245 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------LL 245 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------HH
Confidence 211111 111234589999977432 1 6788999999999999999 899996321 11
Q ss_pred hhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...-+.....+.+-..+.. ..+.++++.|++.||++|.++++.|+.-.+.
T Consensus 246 aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1000000000001011111 2478889999999999999999999975443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=185.28 Aligned_cols=172 Identities=13% Similarity=0.151 Sum_probs=134.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHH---------HHHHHHHHhccCCCceeeecceeeeC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---------FKVEVEVIGRVRHKNLVRLLGYCVEG 219 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~e~~~l~~l~H~niv~l~~~~~~~ 219 (484)
...+|...++||.|+||.||+... ++..+|||.+.......... +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 47789999986554332222 67899999999999999999886643
Q ss_pred --------CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC
Q 011498 220 --------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 220 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
...+++|||++|.+|.++.. ++. ....+++.+|..||.. |++|||+||.||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999988742 222 2456899999999998 999999999999999988
Q ss_pred cEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh
Q 011498 292 NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350 (484)
Q Consensus 292 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 350 (484)
++|+|||........... ..++....++.++|+|+||+++..+..
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999987654221110 013345557789999999999877643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=178.91 Aligned_cols=139 Identities=17% Similarity=0.164 Sum_probs=107.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhh--------------------------HHHHHHHHHHHhccCCCce
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA--------------------------EKEFKVEVEVIGRVRHKNL 209 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~e~~~l~~l~H~ni 209 (484)
...||+|+||.||+|...+|+.||||+++...... ......|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998789999999986542210 0122348899999988776
Q ss_pred eeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhh-hcCCCCceeecCCCCCcEEEc
Q 011498 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL-HEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~~ivH~dlkp~NIll~ 288 (484)
.....+.. ...+|||||++++++...+... ..++......++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 2238999999998776543222 3588899999999999999999 687 999999999999998
Q ss_pred CCCcEEEeeecccccc
Q 011498 289 RQWNARVSDFGLAKLL 304 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~ 304 (484)
+ +.++|+|||++...
T Consensus 153 ~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 D-GKLYIIDVSQSVEH 167 (190)
T ss_pred C-CcEEEEEccccccC
Confidence 4 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=203.96 Aligned_cols=238 Identities=24% Similarity=0.274 Sum_probs=183.4
Q ss_pred eeccCCceEEEEEE----ECCCCEEEEEEecccchhh--HHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEecC
Q 011498 158 VIGEGGYGIVYRGI----LSDGTKVAVKNLLNNRGQA--EKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~----~~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
.+|+|.||.|+++. .+.|..+|.|.+++..... ......|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 2336778888776543211 113445667777785 9999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|.|...+... ..+.+.....+...++.+++++|+. +++|||+|++||+++.+|++++.|||+++........
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 99999988654 4567777788888999999999998 9999999999999999999999999999876443322
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
|||..|||||++. .....+|.||||++++||+||..||.. +.+..+. .....
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il-----------~~~~~ 205 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRIL-----------KAELE 205 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHh-----------hhccC
Confidence 8999999999998 678899999999999999999999975 1111111 11123
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhcCCcc
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMG-HVIHMLEADDLL 430 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~~L~~~~~~ 430 (484)
.+.+.......++..++..+|.+|--.. +.+..+.+..++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~ 246 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFF 246 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchh
Confidence 3444555666777788899999997663 444545444433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=193.22 Aligned_cols=216 Identities=28% Similarity=0.492 Sum_probs=162.1
Q ss_pred HhccCCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCC
Q 011498 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (484)
Q Consensus 201 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dl 280 (484)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.....+..+|+.||+|||.. +-..|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 35689999999999999999999999999999999999763 25688999999999999999999986 23399999
Q ss_pred CCCcEEEcCCCcEEEeeecccccccCC-CceeecccccccccccccccccCC-------CCcccceecchhHHHHHHhCC
Q 011498 281 KSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTGM-------LNEKSDVYSFGILIMEIITGR 352 (484)
Q Consensus 281 kp~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~~l~elltG~ 352 (484)
++.|+++|..+.+||+|||+....... ............-|.|||.+.... .+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998776421 001111122345799999987642 467899999999999999999
Q ss_pred CCCCCCCCCCcc-chhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 353 NPVDYSRPQGEV-NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 353 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
.||......... .++..+.. .....+.|.+.... +....+..++.+||..+|+.||++++|-..++...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999865433221 12222111 11112222222111 34446889999999999999999999988887544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=171.90 Aligned_cols=139 Identities=19% Similarity=0.174 Sum_probs=110.0
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchh--------------------------hHHHHHHHHHHHhccCCCce
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ--------------------------AEKEFKVEVEVIGRVRHKNL 209 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~e~~~l~~l~H~ni 209 (484)
...||+|+||.||+|...+|+.||||++...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998754211 01224578899999999987
Q ss_pred eeecceeeeCCeeeEEEEecCCCCHHHH-hhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEE
Q 011498 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQW-LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll 287 (484)
.....+... ..++||||++++++... +.. ..++......++.|++.++.+||+ . ||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 544443333 24899999998865433 322 346788899999999999999999 7 99999999999999
Q ss_pred cCCCcEEEeeeccccccc
Q 011498 288 DRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~ 305 (484)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=167.73 Aligned_cols=186 Identities=17% Similarity=0.082 Sum_probs=137.8
Q ss_pred cCceeccCCceEEEEEEECCCCEEEEEEecccchh----hHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEec
Q 011498 155 EENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ----AEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+...|++|+||+||.+.- .+.+++.+.+...... ....+.+|+++|+++. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346899999999997766 5788887777554331 1235788999999995 5889999886 3469999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCC-CCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV-KSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
.|.+|...+.. ....++.|++.+|.++|++ ||+|||| ||.|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998754321 1135778999999999999 9999999 7999999999999999999998543322
Q ss_pred ce----e--------ecccccccccccccccccC-CCC-cccceecchhHHHHHHhCCCCCCCCC
Q 011498 309 SY----V--------TTRVMGTFGYVAPEYACTG-MLN-EKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 309 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
.. . ......++.|++|+...-. ..+ ...++++-|+-+|.++|+..+.-...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 0112256677777744321 233 56788999999999999988765443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=178.59 Aligned_cols=196 Identities=27% Similarity=0.322 Sum_probs=136.7
Q ss_pred CCCceeeecceeeeC---------------------------CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHH
Q 011498 205 RHKNLVRLLGYCVEG---------------------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257 (484)
Q Consensus 205 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 257 (484)
+|||||++.++|.+. ..+|+||.-++. +|..|+-.+ ..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 599999999877532 235899999877 999999643 35566677789
Q ss_pred HHHHHHHHhhhcCCCCceeecCCCCCcEEE--cCC--CcEEEeeecccccccCCC---cee--ecccccccccccccccc
Q 011498 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILL--DRQ--WNARVSDFGLAKLLCSER---SYV--TTRVMGTFGYVAPEYAC 328 (484)
Q Consensus 258 ~~ia~al~~LH~~~~~~ivH~dlkp~NIll--~~~--~~~kl~Dfgla~~~~~~~---~~~--~~~~~gt~~y~aPE~~~ 328 (484)
.|+++|+.|||.+ ||.|||+|++|||| |++ ..+.|+|||++.--.... .+. .-..-|....||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999998 99999999999999 333 357899999875322211 000 11123777899999886
Q ss_pred cCC------CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHH
Q 011498 329 TGM------LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLV 402 (484)
Q Consensus 329 ~~~------~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 402 (484)
..+ .-.|+|.|+.|.+.||+++...||-... +..+. ....++.--|.++. .+...+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~--------~r~Yqe~qLPalp~----~vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLD--------TRTYQESQLPALPS----RVPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheec--------hhhhhhhhCCCCcc----cCChHHHHH
Confidence 432 1248999999999999999999996522 11111 11112222233333 233457788
Q ss_pred HHhcCCCCCCCCCCHHHHHHHH
Q 011498 403 ALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 403 ~~~cl~~dp~~RPs~~evl~~L 424 (484)
+...|+.||++|++..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 8889999999999976554444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=200.65 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=187.5
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC---CCceeeecceeeeCC
Q 011498 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGA 220 (484)
Q Consensus 144 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~ 220 (484)
.+++.....|.+.+.||+|+||+||+|...+|+.||+|.-..... .+|..-.+++.+|+ -+.|..+..++...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344455668888999999999999999988899999997655442 34444445555555 345666666666777
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-------CCCcE
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-------RQWNA 293 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-------~~~~~ 293 (484)
..+||+||.+.|+|.++++.. ..++|..++.++.|++.-++.||.. +|||+||||+|.||. ++..+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 789999999999999999843 5689999999999999999999998 999999999999993 24468
Q ss_pred EEeeecccccccC-CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 294 RVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 294 kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
+|+|||.+..+.- .........++|-.+-.+|...+..++..+|.|.|+.+++-||.|+.-- ..
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~------------- 905 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VK------------- 905 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hc-------------
Confidence 9999999965432 2222344567888999999999999999999999999999999997431 00
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+ ....++..++.....+.+..++.+++ +.|-..=|...++...++.+
T Consensus 906 ---~g-~~~~~~~~~~Ry~~~~~W~~~F~~lL---N~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 906 ---NG-SSWMVKTNFPRYWKRDMWNKFFDLLL---NPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ---CC-cceeccccchhhhhHHHHHHHHHHHh---CcCcccchhHHHHHHHHHHH
Confidence 00 00112222444455667777777665 44444447788887777653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=175.48 Aligned_cols=233 Identities=21% Similarity=0.324 Sum_probs=147.1
Q ss_pred CCcCceeccCCceEEEEEEECC-CCEEEEEEecccch---hhHHHHHHHHHHHhccCC----------Cceeeecce---
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRH----------KNLVRLLGY--- 215 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H----------~niv~l~~~--- 215 (484)
+...+.||.|+++.||.+++.. |+.+|+|....... ...+.+++|.-.+..+.+ -.++..++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3446789999999999999764 89999998854332 234566666655554322 122222221
Q ss_pred ------eeeCC--------eeeEEEEecCCCCHHHHhh---cCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeec
Q 011498 216 ------CVEGA--------YRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278 (484)
Q Consensus 216 ------~~~~~--------~~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~ 278 (484)
+.... ..+++|+-+.+ +|.+++. ........+....++.+..|+++.+++||.. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11111 23678888854 8888754 2211122344556677889999999999999 99999
Q ss_pred CCCCCcEEEcCCCcEEEeeecccccccCCCceeeccccccccccccccccc--------CCCCcccceecchhHHHHHHh
Q 011498 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--------GMLNEKSDVYSFGILIMEIIT 350 (484)
Q Consensus 279 dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~ellt 350 (484)
||+|+|++++.+|.++|+||+....... .... ...+..|.+||.... -.++.+.|.|+||+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987765322 1111 234577999996643 247889999999999999999
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCC
Q 011498 351 GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 414 (484)
Q Consensus 351 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 414 (484)
|..||....+...... .+ ..+. ..++.+..|+..+|+.||++|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986543221110 11 1222 566778899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=164.22 Aligned_cols=137 Identities=19% Similarity=0.266 Sum_probs=105.9
Q ss_pred CCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-----CCCceeeecceeeeCC---e-ee
Q 011498 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-----RHKNLVRLLGYCVEGA---Y-RM 223 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~-~~ 223 (484)
+...+.||+|+||.||. +......+||++........+.+.+|+.+++.+ .||||++++|+++++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 433233479988665444557789999999999 5799999999998863 3 33
Q ss_pred EEEEe--cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH-HhhhcCCCCceeecCCCCCcEEEcC----CCcEEEe
Q 011498 224 LVYEY--VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL-AYLHEGLEPKVVHRDVKSSNILLDR----QWNARVS 296 (484)
Q Consensus 224 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al-~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~ 296 (484)
+|+|| +.+|+|.+++++. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5679999999642 24444 35677888777 999999 9999999999999974 3479999
Q ss_pred eeccc
Q 011498 297 DFGLA 301 (484)
Q Consensus 297 Dfgla 301 (484)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=162.58 Aligned_cols=141 Identities=17% Similarity=0.150 Sum_probs=109.7
Q ss_pred CCCcCceeccCCceEEEEEE--ECCCCEEEEEEecccchh------------------------hHHHHHHHHHHHhccC
Q 011498 152 GLCEENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ------------------------AEKEFKVEVEVIGRVR 205 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l~ 205 (484)
.|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 457999999988643210 1123567999999997
Q ss_pred CC--ceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc-eeecCCCC
Q 011498 206 HK--NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKS 282 (484)
Q Consensus 206 H~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~-ivH~dlkp 282 (484)
+. .+.+++++ ...++||||+.+++|..++... ..+.......++.|++.++.+||+. + ++|+||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 33444432 2348999999998887654222 2355566788999999999999998 9 99999999
Q ss_pred CcEEEcCCCcEEEeeecccccc
Q 011498 283 SNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 283 ~NIll~~~~~~kl~Dfgla~~~ 304 (484)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-18 Score=157.63 Aligned_cols=134 Identities=22% Similarity=0.368 Sum_probs=112.8
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchh--------hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ--------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+.||+|++|.||+|.+ +|..+++|........ ....+..|+.++..+.|++++....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999998 5788999976543211 123577899999999999988877777777788999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
++|++|.+++... .. .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998643 12 7788999999999999998 999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=153.19 Aligned_cols=144 Identities=18% Similarity=0.134 Sum_probs=111.1
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchh----------------------hHHHHHHHHHHHh
Q 011498 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ----------------------AEKEFKVEVEVIG 202 (484)
Q Consensus 145 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~e~~~l~ 202 (484)
++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444447778999999999999999888999999987543210 1123567888888
Q ss_pred ccCCCc--eeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCC
Q 011498 203 RVRHKN--LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (484)
Q Consensus 203 ~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dl 280 (484)
.+.|++ ++..++ ....++||||+++++|...... .....++.+++.++.++|+. +++|+||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 887774 444443 2345899999999998765421 23467888999999999998 9999999
Q ss_pred CCCcEEEcCCCcEEEeeeccccccc
Q 011498 281 KSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 281 kp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
||.||+++.++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.6e-18 Score=153.94 Aligned_cols=130 Identities=23% Similarity=0.384 Sum_probs=106.2
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEecccch--------hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.||+|+||.||+|.+ ++..|++|....... .....+..|++++..+.|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 478899998653221 11245778999999999887665555566666779999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875321 0 7889999999999998 999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-19 Score=176.45 Aligned_cols=174 Identities=21% Similarity=0.369 Sum_probs=130.3
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
++||.|++|...+|.+||..+. .....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997543 33557788899999999999999 5 899999999999999999999999999
Q ss_pred cccccCCC-----ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhh
Q 011498 301 AKLLCSER-----SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 301 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
........ ....+...||..||+||.+.+..|+.++||||||++|+|+++ -..+++-..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------------- 467 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------------- 467 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------------
Confidence 97764433 223456789999999999999999999999999999999998 333332111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev 420 (484)
....+-+..+++....+.+. =..++.+++.+.|.+||++.++
T Consensus 468 ---t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 ---TLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---hhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence 11112222233222222222 2346668999999999954443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=175.56 Aligned_cols=137 Identities=21% Similarity=0.338 Sum_probs=111.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEeccc--ch------hhHHHHHHHHHHHhccCCCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 221 (484)
...|...+.||+|+||.||+|.+.+. .+++|+.... .. .....+..|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999998644 4444433211 11 123467889999999999999988888777777
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999884 3467899999999999998 99999999999999 5678999999998
Q ss_pred cc
Q 011498 302 KL 303 (484)
Q Consensus 302 ~~ 303 (484)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.3e-19 Score=184.29 Aligned_cols=209 Identities=22% Similarity=0.317 Sum_probs=142.0
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|...++|..|+||.||..+++. .+.+|+| +.+... +.+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-------------------
Confidence 567788999999999999998764 5677875 322211 1100 22222233322
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC-
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER- 308 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~- 308 (484)
|+-...++.- .+++... +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 136 --gDc~tllk~~----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKNI----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcccC----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 4555555432 3444332 6799999998 99999999999999999999999999987532110
Q ss_pred -------------ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 309 -------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 309 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
.......+||+.|+|||++....|...+|+|++|+|+||.+.|+.||.+..+++....+ ...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---isd-- 273 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---ISD-- 273 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---hhh--
Confidence 11123468999999999999999999999999999999999999999887664322111 100
Q ss_pred CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 376 SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
.+.-+. .......+..+++.+.|+.+|..|--.
T Consensus 274 -----~i~wpE----~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 274 -----DIEWPE----EDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred -----hccccc----cCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 000000 012233456777778889999999443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-16 Score=140.12 Aligned_cols=135 Identities=22% Similarity=0.242 Sum_probs=95.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhH--HH----------------------HHHHHHHHhccCCCc--e
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE--KE----------------------FKVEVEVIGRVRHKN--L 209 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~--~~----------------------~~~e~~~l~~l~H~n--i 209 (484)
.+.||+|+||+||+|...+++.||||++........ .. ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987899999998865432111 11 123555555553332 3
Q ss_pred eeecceeeeCCeeeEEEEecCCCCHHH-HhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEE
Q 011498 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll 287 (484)
.+.+++ ...+++|||++++.+.. .+.... .. .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 24589999999954422 121110 01 5577899999999999998 7 99999999999999
Q ss_pred cCCCcEEEeeecccccc
Q 011498 288 DRQWNARVSDFGLAKLL 304 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~ 304 (484)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=132.56 Aligned_cols=134 Identities=19% Similarity=0.185 Sum_probs=112.5
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCC--CceeeecceeeeCCeeeEEEEecCCCC
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH--KNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .+++++++++...+..+++|||+.++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999864 7899998755433 4578889999999976 589999988887788999999999876
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+..+ +......++.+++.+|++||.....+++|+|++|.||++++.+.++++|||.+..
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4556678899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.1e-15 Score=140.45 Aligned_cols=135 Identities=21% Similarity=0.279 Sum_probs=104.8
Q ss_pred ceec-cCCceEEEEEEECCCCEEEEEEecccc-------------hhhHHHHHHHHHHHhccCCCce--eeecceeeeCC
Q 011498 157 NVIG-EGGYGIVYRGILSDGTKVAVKNLLNNR-------------GQAEKEFKVEVEVIGRVRHKNL--VRLLGYCVEGA 220 (484)
Q Consensus 157 ~~Lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~~ 220 (484)
..|| .|+.|+||.+... +..++||.+.... ......+.+|+.++..+.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4788 8999999999885 7789999774311 1223467789999999998775 67777654322
Q ss_pred ----eeeEEEEecCC-CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 221 ----YRMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 221 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
..++|||+++| .+|.+++... .++.. .+.+|+.+|.+||+. ||+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22599999997 6999988542 34443 356889999999999 9999999999999999889999
Q ss_pred eeecccccc
Q 011498 296 SDFGLAKLL 304 (484)
Q Consensus 296 ~Dfgla~~~ 304 (484)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.4e-17 Score=170.38 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=183.0
Q ss_pred CCCcCceeccCCceEEEEEEECC--CCEEEEEEecccc--hhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD--GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 226 (484)
.|.+.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-+.+. |+|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35556679999999998877533 3456666554332 222234445777777776 999999999999999999999
Q ss_pred EecCCCCHHHHh-hcCCCCCCCCCHHHHHHHHHHHHHHHHhhh-cCCCCceeecCCCCCcEEEcCCC-cEEEeeeccccc
Q 011498 227 EYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLH-EGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKL 303 (484)
Q Consensus 227 e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~ 303 (484)
+|..++++.+.+ +... ...+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||++..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 4321 23455566778999999999999 76 999999999999999999 999999999987
Q ss_pred ccC--CCceeeccccc-ccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 304 LCS--ERSYVTTRVMG-TFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 304 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
+.. .........+| ++.|.|||...+. ...+..|+||.|+++.-+++|..|+........ ....|....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~------ 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK------ 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc------
Confidence 655 23333445678 9999999999884 556789999999999999999999876543321 111121110
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev 420 (484)
................+++.+++..+|..|.+.+++
T Consensus 248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred -----cccccCccccCChhhhhcccccccCCchhccccccc
Confidence 000011122233346667778999999999997666
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-14 Score=135.66 Aligned_cols=201 Identities=18% Similarity=0.276 Sum_probs=141.3
Q ss_pred HHhccCCCceeeecceeeeCC-----eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc
Q 011498 200 VIGRVRHKNLVRLLGYCVEGA-----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274 (484)
Q Consensus 200 ~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ 274 (484)
-|-.+.|.|||+++.++.+.. ...+++||++.|+|..+|++.......+......+|+.||..||.|||+. .|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344567999999999886543 46889999999999999987766677788888899999999999999995 899
Q ss_pred eeecCCCCCcEEEcCCCcEEEeeecccccccC----CCceeecccccccccccccccccCCCCcccceecchhHHHHHHh
Q 011498 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCS----ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350 (484)
Q Consensus 275 ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 350 (484)
|+|+++.-+.|++..++-+|+.- +....... ..........+-++|.+||.-.....+.++|||+||...+||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999998888742 11111100 00001112235678999998777778889999999999999988
Q ss_pred CCCCCCCCCC--CCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 351 GRNPVDYSRP--QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 351 G~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
|..--..... ..+.+.... ....-++. =..++.+|++..|..||+|.+++..
T Consensus 278 lEiq~tnseS~~~~ee~ia~~---------i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV---------IIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhhh---------eeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 7654221111 001111000 00000111 1234568999999999999987653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.2e-14 Score=142.41 Aligned_cols=141 Identities=22% Similarity=0.228 Sum_probs=98.9
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhH----------------------------------------HHHH
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE----------------------------------------KEFK 195 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~ 195 (484)
.+.||.|++|+||+|++++|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421100 1244
Q ss_pred HHHHHHhcc----CCCceeeecceee-eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHH-HHHhhhc
Q 011498 196 VEVEVIGRV----RHKNLVRLLGYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-GLAYLHE 269 (484)
Q Consensus 196 ~e~~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-al~~LH~ 269 (484)
.|...+.++ +|.+-+.+-.++. .....++||||++|++|.++...... ... ...++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence 455555554 2333333333332 23456899999999999887653211 122 2345555555 4677888
Q ss_pred CCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 270 ~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
. |++|+|++|.||+++.++.++++|||++..+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.9e-13 Score=136.40 Aligned_cols=247 Identities=21% Similarity=0.246 Sum_probs=176.0
Q ss_pred CCCcCceecc--CCceEEEEEEE---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeee
Q 011498 152 GLCEENVIGE--GGYGIVYRGIL---SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 152 ~~~~~~~Lg~--G~~g~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 223 (484)
.+.+.+.+|. |.+|.||.+.. .++..+|+|+-+... ......=.+|+...+++ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455678999 99999999986 347789998632221 12222333455556666 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHH----HHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeee
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK----GLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDF 298 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Df 298 (484)
+-+|+|. .+|..+.+... ..++....+..+.+... ||.++|.. +++|.|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999996 58888876542 33666777777888877 99999998 99999999999999999 88999999
Q ss_pred cccccccCCCce----eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 299 GLAKLLCSERSY----VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 299 gla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|+...+...... ......|...|++||.. .+.++...|+|++|.++.+..++..+....... .|...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~-- 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQL-- 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccccc--
Confidence 999887554311 12233678899999987 556788999999999999999876654332111 11110
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.. .++...-......+...+..+++.+|-.|++.+.+..
T Consensus 339 r~~--------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQG--------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc--------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 0111111112234555788999999999999777654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.4e-13 Score=140.19 Aligned_cols=145 Identities=17% Similarity=0.126 Sum_probs=94.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchh----------------------------------hHH--
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQ----------------------------------AEK-- 192 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~----------------------------------~~~-- 192 (484)
...|.. +.||.|++|+||+|++++ |+.||||+++..... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999987 999999999754211 011
Q ss_pred ----HHHHHHHHHhccC----CCceeeecceeee-CCeeeEEEEecCCCCHHHH--hhcCCCCCCCCCHHHHHHHHHHHH
Q 011498 193 ----EFKVEVEVIGRVR----HKNLVRLLGYCVE-GAYRMLVYEYVDNGNLDQW--LHGDVGDVSPLTWDIRMNIILGTA 261 (484)
Q Consensus 193 ----~~~~e~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~ia 261 (484)
++..|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.+.++ +.........+....+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1333444333332 3333333333332 3456899999999999874 322211111233333444445543
Q ss_pred HHHHhhhcCCCCceeecCCCCCcEEEcCCC----cEEEeeeccccccc
Q 011498 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFGLAKLLC 305 (484)
Q Consensus 262 ~al~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfgla~~~~ 305 (484)
.. |++|+|+||.||+++.++ .++++|||+...+.
T Consensus 278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 23 999999999999999888 99999999997664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.9e-12 Score=113.95 Aligned_cols=130 Identities=19% Similarity=0.132 Sum_probs=94.7
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCcee-eecceeeeCCeeeEEEEecCCCCHH
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV-RLLGYCVEGAYRMLVYEYVDNGNLD 235 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gsL~ 235 (484)
+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999875 77899997654432 223467788888888655544 444443 33458999999998775
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC--CCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+.. . ....++.+++.+|+.||... ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 0 11345678999999999872 12369999999999999 56899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.2e-12 Score=127.58 Aligned_cols=165 Identities=20% Similarity=0.237 Sum_probs=123.7
Q ss_pred CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHH
Q 011498 173 SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI 252 (484)
Q Consensus 173 ~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~ 252 (484)
.++.+|.|...............+-++.|+.++||||+++++.++.....|||+|-+. -|..+++. +....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~ 105 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEE 105 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHH
Confidence 3577888887765555444556677889999999999999999999999999999985 67777754 33555
Q ss_pred HHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccccccccccccccccCCC
Q 011498 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332 (484)
Q Consensus 253 ~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 332 (484)
+..-+.||+.||.|||+.+ +++|++|.-..|+++..|+.||++|.++........ .......--.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6667899999999999654 999999999999999999999999988765422211 001111122355665442222
Q ss_pred CcccceecchhHHHHHHhC
Q 011498 333 NEKSDVYSFGILIMEIITG 351 (484)
Q Consensus 333 ~~~~DvwslG~~l~elltG 351 (484)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=105.05 Aligned_cols=136 Identities=16% Similarity=0.165 Sum_probs=96.9
Q ss_pred ceeccCCceEEEEEEECC-------CCEEEEEEecccch----------------------hhHHHHH----HHHHHHhc
Q 011498 157 NVIGEGGYGIVYRGILSD-------GTKVAVKNLLNNRG----------------------QAEKEFK----VEVEVIGR 203 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~----------------------~~~~~~~----~e~~~l~~ 203 (484)
..||.|--+.||.|...+ +..+|||+.+.... .....+. .|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899997743210 0112222 68888888
Q ss_pred cCC--CceeeecceeeeCCeeeEEEEecCCCCHHH-HhhcCCCCCCCCCHHHHHHHHHHHHHHHHhh-hcCCCCceeecC
Q 011498 204 VRH--KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYL-HEGLEPKVVHRD 279 (484)
Q Consensus 204 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~~ivH~d 279 (484)
+.. -++++++++ ...++||||+.+..+.. .++. ..++......+..+++.+|..| |.. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 843 456666654 35689999997654422 2221 1244456677889999999999 777 999999
Q ss_pred CCCCcEEEcCCCcEEEeeeccccccc
Q 011498 280 VKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 280 lkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|++.||++++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 579999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-10 Score=100.77 Aligned_cols=130 Identities=24% Similarity=0.393 Sum_probs=98.3
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEecccc---h-----hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR---G-----QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+++|+-+.+|.+.+. |.++++|.-.... + -......+|+.++.+++--.|...+=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999886 5557777432221 1 11234567999999886555554444556667778999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+|-.|.+++... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888643 245677777788899998 999999999999998875 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.1e-11 Score=123.01 Aligned_cols=246 Identities=20% Similarity=0.211 Sum_probs=170.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC--CCCEEEEEEecccchhhHHHH--HHHHHHHhcc-CCCceeeecceeeeCCeee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNNRGQAEKEF--KVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~--~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 223 (484)
-+.+|.....||.|.|+.|+....+ ++..|++|.+.+.......+. ..|+.+...+ .|.++++.+..+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3456788889999999999998743 578899998866543322221 2255555555 5888998888777777788
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAK 302 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgla~ 302 (484)
+--|||+++++...+. ....+....++.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||+..
T Consensus 343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 9999999998877662 224567778899999999999999988 99999999999999886 788999999886
Q ss_pred cccCCCceeecccccccccc--cccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSERSYVTTRVMGTFGYV--APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
.+.... ......-++. +++......+-.+.|+++||.-+.+.+++..--... .+|.
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~---------- 473 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSL---------- 473 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccce----------
Confidence 432111 1111223344 555556677889999999999999999986432211 1111
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
.+.....+..... ...+..+...+..+++..||.+.++....+
T Consensus 474 ~i~~~~~p~~~~~--~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 TIRSGDTPNLPGL--KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred eeecccccCCCch--HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111111111111 134455555677999999999888766544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.7e-10 Score=111.83 Aligned_cols=169 Identities=19% Similarity=0.289 Sum_probs=128.7
Q ss_pred ceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceee----eCCeeeEEEEecCC-CCHHHH
Q 011498 164 YGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV----EGAYRMLVYEYVDN-GNLDQW 237 (484)
Q Consensus 164 ~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 237 (484)
-.+.|++.. .+|..|++|++..++.........-+++++++.|+|+|+|..+|. .+..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357788874 479999999995554433323334567899999999999999887 34567999999987 678776
Q ss_pred hhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 238 LHGDV-----------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 238 l~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
--... .....+++...|.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+.+|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 53221 1234578899999999999999999998 999999999999999999999999988766533
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN 353 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~ 353 (484)
+.. |.+.. -.+-|.=.||.+++.|.||..
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 321 11111 236788899999999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-10 Score=107.21 Aligned_cols=142 Identities=22% Similarity=0.270 Sum_probs=106.6
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccch-hhHHHHHHHHHHHhccCC--CceeeecceeeeCC---eeeEEEEecC
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRH--KNLVRLLGYCVEGA---YRMLVYEYVD 230 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~~ 230 (484)
+.|+.|.++.||++...+|..+++|....... .....+..|.++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987668899997754332 134567889999999865 34566777766532 5689999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC---------------------------------------
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--------------------------------------- 271 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--------------------------------------- 271 (484)
|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888775421 23566677777778888888777421
Q ss_pred --------------CCceeecCCCCCcEEEcC--CCcEEEeeeccccc
Q 011498 272 --------------EPKVVHRDVKSSNILLDR--QWNARVSDFGLAKL 303 (484)
Q Consensus 272 --------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfgla~~ 303 (484)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.9e-10 Score=98.49 Aligned_cols=142 Identities=20% Similarity=0.298 Sum_probs=104.2
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccc--------hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--------GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
..+|-+|+-+.|+++.+. |+.++||.-.... .-.....++|++++.++.--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 457889999999999996 8888888543221 1123467789999998865454444445666666789999
Q ss_pred ecCC-CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC---cEEEeeeccccc
Q 011498 228 YVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKL 303 (484)
Q Consensus 228 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfgla~~ 303 (484)
|++| -++.+|+..... ..........++..|-..+.-||.+ +|+|+||..+||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 478888865422 1222233367888999999999999 999999999999996554 458999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4e-11 Score=127.22 Aligned_cols=246 Identities=20% Similarity=0.216 Sum_probs=160.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
+.+.+.+-+-+|.++.++.+.-. .|...++|...... ....+....+-.++-..++|.++...--+.-....+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34445556778888888876632 23223333221111 111111111222222234576776665555667889999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc-
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC- 305 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~- 305 (484)
+|+.+++|...|+... ..+..........+..+++|||.. .+.|+|++|.|+++..+++.+++|||......
T Consensus 884 ~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999998653 455555566777788899999987 79999999999999999999999998432211
Q ss_pred -----CC--C----------------------ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCC
Q 011498 306 -----SE--R----------------------SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356 (484)
Q Consensus 306 -----~~--~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~ 356 (484)
.. . ........+|+.|.+||.+.+......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 0 001123568999999999999999999999999999999999999998
Q ss_pred CCCCCCccchhhhhhhhhcCCCcccccCCCCCCC-ChHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 011498 357 YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMG 418 (484)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 418 (484)
...++..... +.....++. ...+......+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~~f~n---------------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFEN---------------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhhhc---------------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 7766532211 111111111 1122234456666677889999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=95.93 Aligned_cols=125 Identities=26% Similarity=0.314 Sum_probs=80.7
Q ss_pred EEEEEEECCCCEEEEEEecccch--------------------------hhHHHHHHHHHHHhccCCC--ceeeecceee
Q 011498 166 IVYRGILSDGTKVAVKNLLNNRG--------------------------QAEKEFKVEVEVIGRVRHK--NLVRLLGYCV 217 (484)
Q Consensus 166 ~Vy~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~e~~~l~~l~H~--niv~l~~~~~ 217 (484)
.||.|...+|..+|||..+.... .......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999997743210 0123466799999999765 466666442
Q ss_pred eCCeeeEEEEecC--CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHh-hhcCCCCceeecCCCCCcEEEcCCCcEE
Q 011498 218 EGAYRMLVYEYVD--NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY-LHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (484)
Q Consensus 218 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~-LH~~~~~~ivH~dlkp~NIll~~~~~~k 294 (484)
..+|||||+. |..+..+.... ++......++.+++..+.. +|.. ||+|+||.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 54454433211 1123345567777775555 4677 99999999999999988 999
Q ss_pred Eeeecccccc
Q 011498 295 VSDFGLAKLL 304 (484)
Q Consensus 295 l~Dfgla~~~ 304 (484)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-08 Score=96.34 Aligned_cols=141 Identities=16% Similarity=0.106 Sum_probs=99.4
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchh-----------hHHHHHHHHHHHhccCCCc--eeeecceeee-----
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ-----------AEKEFKVEVEVIGRVRHKN--LVRLLGYCVE----- 218 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~----- 218 (484)
+.+-......|++..+ +|+.|.||........ ....+.+|...+.++...+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777777 4788999976433211 1113677888888874333 3344555543
Q ss_pred CCeeeEEEEecCCC-CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-------C
Q 011498 219 GAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-------Q 290 (484)
Q Consensus 219 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-------~ 290 (484)
....++|||++++. +|.+++.... ..+.+......++.+++..+.-||+. ||+|+||+++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 8999985321 13455667788999999999999999 9999999999999975 4
Q ss_pred CcEEEeeeccccc
Q 011498 291 WNARVSDFGLAKL 303 (484)
Q Consensus 291 ~~~kl~Dfgla~~ 303 (484)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8e-08 Score=93.32 Aligned_cols=262 Identities=16% Similarity=0.151 Sum_probs=157.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeeccee------eeCC-eeeEEEE
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC------VEGA-YRMLVYE 227 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~------~~~~-~~~lv~e 227 (484)
...||+|+-+.+|-.--- +.. +.|+............ +..|... .||-+-.-+.+= -+.. ..-++|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 457999999999875321 223 4476665544333322 2233333 566433312111 1122 2557888
Q ss_pred ecCCC-CHHHHhhc--CCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 228 YVDNG-NLDQWLHG--DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 228 ~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
.+++. -..++++. +........|...++.+..++.+.+-||.. |.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 87764 23333321 223456689999999999999999999998 9999999999999999999999985443322
Q ss_pred cCCCceeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhC-CCCCCCCCCCCcc--chh-hhhhh-hh
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITG-RNPVDYSRPQGEV--NLV-DWLKT-MV 374 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG-~~p~~~~~~~~~~--~~~-~~~~~-~~ 374 (484)
.+.......+|...|.+||.-. +-.-+...|.|.||+++++++.| +.||.+....... ... ..... +.
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 1222233356889999999654 33457789999999999999885 9999765321110 000 00000 00
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCC--CCCCCCCHHHHHHHHhcC
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDP--DATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dp~~RPs~~evl~~L~~~ 427 (484)
.......-..+.....+..-....+..+..+|+.. ++.-|||++..+..|...
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00011111111111222233344555566678754 367899999998877653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.9e-10 Score=112.65 Aligned_cols=161 Identities=19% Similarity=0.256 Sum_probs=108.5
Q ss_pred HHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeec--------cccccccccccccccc
Q 011498 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--------RVMGTFGYVAPEYACT 329 (484)
Q Consensus 258 ~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~ 329 (484)
.+++.|+.|+|.. +++||++|.|++|.++.++..||+.|+.+........+... -......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999964 79999999999999999999999999987654331111111 1124567999999999
Q ss_pred CCCCcccceecchhHHHHHH-hCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCC
Q 011498 330 GMLNEKSDVYSFGILIMEII-TGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVD 408 (484)
Q Consensus 330 ~~~~~~~DvwslG~~l~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 408 (484)
...+.++|+||+||++|.+. .|+.-+............ ...+..-........+.++.+-+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHhc
Confidence 88899999999999999998 466555543321111110 0001011111123445567777778899
Q ss_pred CCCCCCCCHHHHHHHHhcCCcchhh
Q 011498 409 PDATKRPKMGHVIHMLEADDLLFRD 433 (484)
Q Consensus 409 ~dp~~RPs~~evl~~L~~~~~~~~~ 433 (484)
.++..||++.++.......+...+.
T Consensus 251 ~~~~~rp~~~~l~~~~ff~D~~~~a 275 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSIPFFSDPGLKA 275 (700)
T ss_pred CCcccCcchhhhhcccccCCchhhh
Confidence 9999999888877655554444333
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.6e-08 Score=92.01 Aligned_cols=136 Identities=23% Similarity=0.209 Sum_probs=93.0
Q ss_pred CCCcCceeccCCceEEEEEEECCCCEEEEEEecccchh----------------------hHHHHHHHHHHHhccCCC--
Q 011498 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ----------------------AEKEFKVEVEVIGRVRHK-- 207 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~e~~~l~~l~H~-- 207 (484)
-..+...||-|--+.||.|....|.++|||.=+..... .....++|.+.|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34566789999999999999988999999954221110 122456788888888544
Q ss_pred ceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 208 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
.+.+.+++ +...+||||++|-.|...- +.....-.++..|+.-+.-+-.. |++|+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 66666655 4458999999986665432 11112222333333333333344 99999999999999
Q ss_pred cCCCcEEEeeeccccc
Q 011498 288 DRQWNARVSDFGLAKL 303 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~ 303 (484)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999965543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.1e-07 Score=81.63 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=102.3
Q ss_pred eccCCceEEEEEEECCCCEEEEEEecccc------hhhHHHHHHHHHHHhccCCC--ceeeecceeeeC----CeeeEEE
Q 011498 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNR------GQAEKEFKVEVEVIGRVRHK--NLVRLLGYCVEG----AYRMLVY 226 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~----~~~~lv~ 226 (484)
-|+||.+.|++..+. |..+=+|+-.... +.....|.+|+..|..+..- .+.++....... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999998875 5578888764221 23456899999999988532 244444222211 1347999
Q ss_pred EecCC-CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc--EEEeeeccccc
Q 011498 227 EYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKL 303 (484)
Q Consensus 227 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfgla~~ 303 (484)
|-+.+ -+|.+++.+. ...+.+...+..++.+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 5899988643 224567778889999999999999999 9999999999999986666 99999976653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-07 Score=98.00 Aligned_cols=140 Identities=19% Similarity=0.203 Sum_probs=89.6
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhh----------------------------------------HHHHHH
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA----------------------------------------EKEFKV 196 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~~~ 196 (484)
+.|+.++-|+||+|++++|+.||||+.+..-... +-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999886643210 011333
Q ss_pred HHHHHhccC-----CCceeeecceee-eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC
Q 011498 197 EVEVIGRVR-----HKNLVRLLGYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270 (484)
Q Consensus 197 e~~~l~~l~-----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~ 270 (484)
|...+.+++ .+++ ++=.+|. -.....|+|||++|-.+.+...-.. ..++...+.....++.--.-+-|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHHhc--
Confidence 444444431 2222 2222332 2455689999999988888742211 12333333222222221122223
Q ss_pred CCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 271 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|++|.|..|.||+++.++.+.+.|||+.....
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.9e-07 Score=85.80 Aligned_cols=106 Identities=22% Similarity=0.221 Sum_probs=81.8
Q ss_pred HHHHHHHHHHhccCC--CceeeecceeeeCC----eeeEEEEecCC-CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 011498 192 KEFKVEVEVIGRVRH--KNLVRLLGYCVEGA----YRMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264 (484)
Q Consensus 192 ~~~~~e~~~l~~l~H--~niv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al 264 (484)
....+|...+..+.. =.+++.+++.+... ..++|+|++++ .+|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 356667777777643 23455666665432 34899999998 48999987532 255667788999999999
Q ss_pred HhhhcCCCCceeecCCCCCcEEEcCCC---cEEEeeecccccc
Q 011498 265 AYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKLL 304 (484)
Q Consensus 265 ~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfgla~~~ 304 (484)
+-||+. ||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.1e-06 Score=77.67 Aligned_cols=153 Identities=21% Similarity=0.229 Sum_probs=97.3
Q ss_pred ccHHHHHHHhcCCCcCceec---cCCceEEEEEEECCCCEEEEEEecccchhhHH------------------------H
Q 011498 141 YTLRELEAATSGLCEENVIG---EGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK------------------------E 193 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg---~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~------------------------~ 193 (484)
.++..+....++..+....| .|--+.||+|...++..+|||+.........+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 55666776666666666555 56667899999878999999988543321110 1
Q ss_pred HHHHHHHHhccC--CCceeeecceeeeCCeeeEEEEecCCCCH-HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC
Q 011498 194 FKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270 (484)
Q Consensus 194 ~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~ 270 (484)
...|+.-|.++. +=.+.+.+++. ...|||||+....+ .-.|+ ..++.......+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 223555555542 22333344332 23799999965311 11111 12233335666777777777777652
Q ss_pred CCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 271 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
.++||+||+.-|||+. ++.+.|+|||-+....
T Consensus 186 --a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 --AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 2999999999999999 7799999999887543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.5e-06 Score=78.43 Aligned_cols=140 Identities=19% Similarity=0.186 Sum_probs=84.0
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCc--eeeecceeeeCCeeeEEEEecCCCC-
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN--LVRLLGYCVEGAYRMLVYEYVDNGN- 233 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 233 (484)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 25567888665432 2345677999998885433 4677777777777889999999863
Q ss_pred HHHH---------------------hhcCCCCCCCCCHHHHHHHHHH----------HHH-HHHhhhcC-CCCceeecCC
Q 011498 234 LDQW---------------------LHGDVGDVSPLTWDIRMNIILG----------TAK-GLAYLHEG-LEPKVVHRDV 280 (484)
Q Consensus 234 L~~~---------------------l~~~~~~~~~l~~~~~~~i~~~----------ia~-al~~LH~~-~~~~ivH~dl 280 (484)
+... ||.-......+... ...+..+ +.. ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11110011111100 0001000 001 11222211 1346789999
Q ss_pred CCCcEEEcCCCcEEEeeeccccc
Q 011498 281 KSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 281 kp~NIll~~~~~~kl~Dfgla~~ 303 (484)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999987753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.9e-06 Score=75.58 Aligned_cols=137 Identities=15% Similarity=0.164 Sum_probs=91.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHH---------HHHHHHhccCC---Cceeeeccee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK---------VEVEVIGRVRH---KNLVRLLGYC 216 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~---------~e~~~l~~l~H---~niv~l~~~~ 216 (484)
...+|...+++-......|.+...+ |..+++|..+......++.|. +.+..+.++.. -.+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3567888888887777888887775 788999977654333222222 23333333322 2333333333
Q ss_pred ee-----CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC
Q 011498 217 VE-----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 217 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
+. ....+++|||++|..|.++.. ++. .+...++.++.-||.. |++|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence 22 234568999999988876532 222 2445677789999998 999999999999999664
Q ss_pred cEEEeeecccc
Q 011498 292 NARVSDFGLAK 302 (484)
Q Consensus 292 ~~kl~Dfgla~ 302 (484)
++++||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 8999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.8e-06 Score=88.84 Aligned_cols=137 Identities=20% Similarity=0.239 Sum_probs=88.9
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhh-------------------------------------HHHHHHHHH
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA-------------------------------------EKEFKVEVE 199 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~e~~ 199 (484)
+.||.-+.|+||+|++++|+.||||+-+..-... +-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999876542210 012334444
Q ss_pred HHhcc----CCCc------eeeecceeeeCCeeeEEEEecCCCCHHHH--hhcCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 011498 200 VIGRV----RHKN------LVRLLGYCVEGAYRMLVYEYVDNGNLDQW--LHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267 (484)
Q Consensus 200 ~l~~l----~H~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~ia~al~~L 267 (484)
-..+. .|-+ |.+++-.+ .....|+|||++|..+.|. |.+. .++...+..-+.+...-+-+-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-----GISPHDILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-----CCCHHHHHHHHHHHHHHHHHh
Confidence 33332 3444 33333322 2356899999999877554 3332 244444443333333223333
Q ss_pred hcCCCCceeecCCCCCcEEEcC----CCcEEEeeeccccccc
Q 011498 268 HEGLEPKVVHRDVKSSNILLDR----QWNARVSDFGLAKLLC 305 (484)
Q Consensus 268 H~~~~~~ivH~dlkp~NIll~~----~~~~kl~Dfgla~~~~ 305 (484)
| |++|+|-.|.||++.. ++.+.+-|||+.....
T Consensus 320 ~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 T-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred c-----CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3 8999999999999984 6789999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.3e-05 Score=74.63 Aligned_cols=143 Identities=23% Similarity=0.279 Sum_probs=83.0
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC--ceeeecceeee---CCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLLGYCVE---GAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~---~~~~~lv~e~~~~ 231 (484)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999976 68999976544 3456677788888877432 35566664433 3346899999999
Q ss_pred CCHHH----------------Hh---hcCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHhhhc-
Q 011498 232 GNLDQ----------------WL---HGDVGDVSPLTWDI---------RMNI------------ILGTAK-GLAYLHE- 269 (484)
Q Consensus 232 gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-al~~LH~- 269 (484)
..+.. .+ +.......+..... .... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 11111111111111 0000 011222 2333332
Q ss_pred ---CCCCceeecCCCCCcEEEc-CCCcEEEeeecccc
Q 011498 270 ---GLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAK 302 (484)
Q Consensus 270 ---~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfgla~ 302 (484)
.....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 56666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.4e-07 Score=94.49 Aligned_cols=182 Identities=18% Similarity=0.170 Sum_probs=128.2
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCc-eeeecceeeeCCeeeEEEEecCCC-CH
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEYVDNG-NL 234 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL 234 (484)
+-+++|+++++++.+-.-.+....+.+... .....++++|.+++||| .+..++-+..+...++.++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 347899999999987432233334544322 34455888999999999 777777777778889999999887 22
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 314 (484)
...... ....+..-+...+...-.+++++||+. .=+|+| ||+..+ +..+..||+....+.... ....
T Consensus 323 ~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 323 ALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 221110 001122333344556667789999975 458888 887766 478999999887654332 3445
Q ss_pred cccccccccccccccCCCCcccceecchhHHHHHHhCCCCCC
Q 011498 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356 (484)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~ 356 (484)
..+++.|+|||+.....+..+.|+|++|+--.+|--|.+|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 679999999999999999999999999987777777776653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.5e-05 Score=73.74 Aligned_cols=140 Identities=18% Similarity=0.116 Sum_probs=83.5
Q ss_pred eccCCc-eEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEecCCCCHHH
Q 011498 159 IGEGGY-GIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236 (484)
Q Consensus 159 Lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 236 (484)
|..|.+ ..||+.... +..+.+|...... ...+..|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 789999765 4778888664332 234566888888773 4446677777776667899999999977754
Q ss_pred Hh-------------------hcCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHhhhc----CC
Q 011498 237 WL-------------------HGDVGDVSPLTWD--IRMNIIL--------------------GTAKGLAYLHE----GL 271 (484)
Q Consensus 237 ~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~ia~al~~LH~----~~ 271 (484)
.. +.-.....++... ..+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 1111001111100 0000000 01111222211 11
Q ss_pred CCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 272 ~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3569999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.4e-05 Score=67.67 Aligned_cols=129 Identities=21% Similarity=0.302 Sum_probs=89.4
Q ss_pred cCceeccCCceEEEEEEECCCCEEEEEEecccc----------------hhhHHHHHHHHHHHhccC------CCceeee
Q 011498 155 EENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR----------------GQAEKEFKVEVEVIGRVR------HKNLVRL 212 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~e~~~l~~l~------H~niv~l 212 (484)
....||+|+.=.||. +.++...+||+..... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999987 4445667889886655 112344555655544444 7899999
Q ss_pred cceeeeCCeeeEEEEecCC------CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEE
Q 011498 213 LGYCVEGAYRMLVYEYVDN------GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (484)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIl 286 (484)
+|+.+++.-.-+|+|.+.+ -+|.+++... .++. ...+.+. .-..||-+. .|+.+||+|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEE
Confidence 9999999888899998754 3688888543 2444 3333333 345566666 8999999999999
Q ss_pred EcCCC----cEEEee
Q 011498 287 LDRQW----NARVSD 297 (484)
Q Consensus 287 l~~~~----~~kl~D 297 (484)
+.... .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 95432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.4e-05 Score=84.74 Aligned_cols=78 Identities=13% Similarity=0.293 Sum_probs=56.4
Q ss_pred CceeccCCceEEEEEEECCC---CEEEEEEecccch-hhHHHHHHHHHHHhccC-CCce--eeecceeeeC---CeeeEE
Q 011498 156 ENVIGEGGYGIVYRGILSDG---TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNL--VRLLGYCVEG---AYRMLV 225 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv 225 (484)
.+.|+.|.+..+|+....++ ..+++|+...... .....+.+|+++++.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999887653 4678886543221 22346788999999985 6665 7778887764 357899
Q ss_pred EEecCCCC
Q 011498 226 YEYVDNGN 233 (484)
Q Consensus 226 ~e~~~~gs 233 (484)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.9e-05 Score=71.17 Aligned_cols=104 Identities=21% Similarity=0.246 Sum_probs=80.7
Q ss_pred HHHHHHhccCC-CceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc
Q 011498 196 VEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274 (484)
Q Consensus 196 ~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ 274 (484)
.|.-++..+.+ +++++++|+|-. +++.||...+++...-. ........+|..+.+|+.++++.+.+|+....-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47778888866 699999999943 67999998776643200 0001134689999999999999999999854335
Q ss_pred eeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 275 ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
+.-.|++++|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.2e-05 Score=67.33 Aligned_cols=126 Identities=18% Similarity=0.293 Sum_probs=85.0
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCcee-eecceeeeCCeeeEEEEecCCCCH
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV-RLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
.+.|++|++|.||+|.+. |..+|+|+-+.+. ....+..|++++..+.-.++- +++.+..+ ++.|||+.|-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence 467999999999999997 5688999665443 356788899999988765544 34444332 456999999888
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCC--CcEEEcCCCcEEEeeeccccc
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS--SNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp--~NIll~~~~~~kl~Dfgla~~ 303 (484)
.+.-.. ....+.. .++..---|-.. ||-|+.|.- .||++.+ +.+.|+||..|..
T Consensus 100 ~~~~~~-------~~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG-------GDRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhc-------ccHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 775431 1222333 334442233333 899999875 3555555 4899999998874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0002 Score=69.58 Aligned_cols=76 Identities=12% Similarity=0.052 Sum_probs=55.1
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCC---CceeeecceeeeC---CeeeEEEEec
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH---KNLVRLLGYCVEG---AYRMLVYEYV 229 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~---~~~~lv~e~~ 229 (484)
.+.||.|..+.||+....++ .+++|.... ......+..|...++.+.- -.+.++++++... +..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 45799999999999877555 466775432 1123577889988888842 3677888877543 5679999999
Q ss_pred CCCCH
Q 011498 230 DNGNL 234 (484)
Q Consensus 230 ~~gsL 234 (484)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00021 Score=64.36 Aligned_cols=125 Identities=26% Similarity=0.414 Sum_probs=88.8
Q ss_pred cCCCcCceeccCCc-eEEEEEEECCCCEEEEEEecc---cc--------h----------hhHHHHHHHHHHHhccC---
Q 011498 151 SGLCEENVIGEGGY-GIVYRGILSDGTKVAVKNLLN---NR--------G----------QAEKEFKVEVEVIGRVR--- 205 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~-g~Vy~~~~~~~~~vavK~l~~---~~--------~----------~~~~~~~~e~~~l~~l~--- 205 (484)
.++...+.||.|.- |.||+++.. |..||+|.+.. .. . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 999999995 78999998321 00 0 11235778888777763
Q ss_pred CCce--eeecceeeeCC------------------eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 011498 206 HKNL--VRLLGYCVEGA------------------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265 (484)
Q Consensus 206 H~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~ 265 (484)
+.++ |+.+||..-.. ...||.||++... .+. ..-+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 5566 89999874220 1246777776522 122 233456667788
Q ss_pred hhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 266 ~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.+|.. ||+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89988 9999999999987 4589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00015 Score=68.07 Aligned_cols=73 Identities=16% Similarity=0.270 Sum_probs=44.3
Q ss_pred ceeccCCce-EEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC---ceeeecceeeeC---CeeeEEEEec
Q 011498 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK---NLVRLLGYCVEG---AYRMLVYEYV 229 (484)
Q Consensus 157 ~~Lg~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~---~~~~lv~e~~ 229 (484)
+.|+.|+.. .||+. +..+++|..... .....+..|.+++..+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 58875 345777854332 2344688899888877432 234444433322 2348899999
Q ss_pred CCCCHH
Q 011498 230 DNGNLD 235 (484)
Q Consensus 230 ~~gsL~ 235 (484)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 986653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00027 Score=66.15 Aligned_cols=73 Identities=14% Similarity=0.114 Sum_probs=46.8
Q ss_pred ceeccCCceEEEEEEECC--CCEEEEEEecccchhhHHHHHHHHHHHhccCCCc-eeeecceeeeCCeeeEEEEecCCCC
Q 011498 157 NVIGEGGYGIVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
+.|..|-...+|+....+ +..|++|....... ..-+...|+.+++.+...+ .+++++.+. ..++|||++|-+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778889999998764 57899996643322 1123346888888874333 344444332 248999999866
Q ss_pred H
Q 011498 234 L 234 (484)
Q Consensus 234 L 234 (484)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00013 Score=69.42 Aligned_cols=139 Identities=15% Similarity=0.112 Sum_probs=77.8
Q ss_pred eccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCce-eeecceeeeCCeeeEEEEecCCCCHHHH
Q 011498 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDNGNLDQW 237 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~ 237 (484)
+..|-.+.+|+... ++..+++|..........-+...|..+++.+....+ .+++..+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677889999875 467888986543322211235668888888854333 33443322 3689999998665321
Q ss_pred -----------------hhcCCCCCCCCCHHHH-HHHHHHH---------HHHHHhhhcC-----CCCceeecCCCCCcE
Q 011498 238 -----------------LHGDVGDVSPLTWDIR-MNIILGT---------AKGLAYLHEG-----LEPKVVHRDVKSSNI 285 (484)
Q Consensus 238 -----------------l~~~~~~~~~l~~~~~-~~i~~~i---------a~al~~LH~~-----~~~~ivH~dlkp~NI 285 (484)
||.......+++.... ..+..++ ...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1221111122222211 1111111 1111111111 133689999999999
Q ss_pred EEcCCCcEEEeeeccccc
Q 011498 286 LLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 286 ll~~~~~~kl~Dfgla~~ 303 (484)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.71 E-value=6.4e-05 Score=82.14 Aligned_cols=197 Identities=19% Similarity=0.238 Sum_probs=136.3
Q ss_pred HHHHHHHHHhccCCCceeeecceeeeCCe----eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 011498 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAY----RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268 (484)
Q Consensus 193 ~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH 268 (484)
....|+..+.++.|+|++.++.+...... ..+..+++..-++...+..- ..++....+.+..++..||.|+|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence 34457778888899999999988765432 23567888888888887643 56888999999999999999999
Q ss_pred cCCCCceeecCCCCC---cEEEcCCCcEEEe--eecccccccCCCceeecccccccccccccccccCCCCc--ccceecc
Q 011498 269 EGLEPKVVHRDVKSS---NILLDRQWNARVS--DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE--KSDVYSF 341 (484)
Q Consensus 269 ~~~~~~ivH~dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dvwsl 341 (484)
.. ...|.-|..+ +--.+.++.+.++ ||+........... ....-+..|.+||......++. ..|+|++
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHH
Confidence 87 5555555555 5555666777777 88887765433221 1223455688888877665554 4799999
Q ss_pred hhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 011498 342 GILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421 (484)
Q Consensus 342 G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl 421 (484)
|.++..+..|..+-...... ..+ ++.... ..+.+...+|+..++++|++..+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~------------------~~~----l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP------------------VSL----LDVLST----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccch------------------hhh----hccccc----hhhhhhhhhhcchhhhhccchhhhh
Confidence 99999999986553321100 000 111111 1456667799999999999999998
Q ss_pred HHH
Q 011498 422 HML 424 (484)
Q Consensus 422 ~~L 424 (484)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00062 Score=66.21 Aligned_cols=143 Identities=18% Similarity=0.188 Sum_probs=82.9
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC--ceeeecce------eeeCCeeeEEEE
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLLGY------CVEGAYRMLVYE 227 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~------~~~~~~~~lv~e 227 (484)
.+.|..|....+|+....+ ..+++|.... ........|+.++..+.+. .+++++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3457778778999988754 4688897654 2234556677777777432 24444432 123445689999
Q ss_pred ecCCCCHHH----H----------hhcCC----C---CCCCCCHHHHH----------HHHHHHHHHHHhhhc----CCC
Q 011498 228 YVDNGNLDQ----W----------LHGDV----G---DVSPLTWDIRM----------NIILGTAKGLAYLHE----GLE 272 (484)
Q Consensus 228 ~~~~gsL~~----~----------l~~~~----~---~~~~l~~~~~~----------~i~~~ia~al~~LH~----~~~ 272 (484)
|++|..+.. . ||... . ......|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999866422 0 11100 0 00111221111 011112333444442 123
Q ss_pred CceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 273 ~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0014 Score=65.84 Aligned_cols=75 Identities=20% Similarity=0.305 Sum_probs=52.4
Q ss_pred ceeccCCceEEEEEEECCC-CEEEEEEeccc-----c--hhhHHHHHHHHHHHhccC---CCceeeecceeeeCCeeeEE
Q 011498 157 NVIGEGGYGIVYRGILSDG-TKVAVKNLLNN-----R--GQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~-~~vavK~l~~~-----~--~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv 225 (484)
+.||.|.+..||++...+| +.|+||.-... . ......+..|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998776 48999974311 1 123455666777777762 2456777766 33557899
Q ss_pred EEecCCCC
Q 011498 226 YEYVDNGN 233 (484)
Q Consensus 226 ~e~~~~gs 233 (484)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.003 Score=62.09 Aligned_cols=142 Identities=16% Similarity=0.179 Sum_probs=75.1
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC-----CCceeeec-c--eeeeCCeeeEEEEe
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----HKNLVRLL-G--YCVEGAYRMLVYEY 228 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lv~e~ 228 (484)
+.|+.|....+|+....+| .+++|+.. .. .......|+.++..|. .|.+++-. | +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~--~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RL--TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-cC--ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999987655 68889764 21 1223333445554442 23333211 1 12234567899999
Q ss_pred cCCCCHH-----------HH---hhcCCCC-------CCCCCH-HHHHH------------HHHH-HHHHHHhhhc----
Q 011498 229 VDNGNLD-----------QW---LHGDVGD-------VSPLTW-DIRMN------------IILG-TAKGLAYLHE---- 269 (484)
Q Consensus 229 ~~~gsL~-----------~~---l~~~~~~-------~~~l~~-~~~~~------------i~~~-ia~al~~LH~---- 269 (484)
++|..+. .. +|..... ...+.| ..... ...+ +...+..+..
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9986431 11 1111000 011111 11111 1111 1112223321
Q ss_pred CCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 270 ~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
....+++|+|+.+.||+++++...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 124589999999999999977556899998775
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0048 Score=60.36 Aligned_cols=144 Identities=17% Similarity=0.168 Sum_probs=79.9
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC--ceeeeccee------eeCCeeeEEEE
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLLGYC------VEGAYRMLVYE 227 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~------~~~~~~~lv~e 227 (484)
.+.++.|....+|+....+| .+++|....... ......|++++..|... .+++++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34567777789999887544 678887644321 23344556666666321 234444321 22456789999
Q ss_pred ecCCCCHH-----H------H---hhcCCCCC--------CCCCHHHHH------------HHHHHHHHHHHhhhc----
Q 011498 228 YVDNGNLD-----Q------W---LHGDVGDV--------SPLTWDIRM------------NIILGTAKGLAYLHE---- 269 (484)
Q Consensus 228 ~~~~gsL~-----~------~---l~~~~~~~--------~~l~~~~~~------------~i~~~ia~al~~LH~---- 269 (484)
|++|..+. . . +|...... ..-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 1 1 12111000 001111110 001122334555532
Q ss_pred CCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 270 ~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
....+++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224589999999999999998777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0012 Score=64.44 Aligned_cols=141 Identities=25% Similarity=0.282 Sum_probs=81.2
Q ss_pred ceeccCCceEEEEEEECC-------CCEEEEEEecccchhhHHHHHHHHHHHhccCCCc-eeeecceeeeCCeeeEEEEe
Q 011498 157 NVIGEGGYGIVYRGILSD-------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~ 228 (484)
+.|..|-...+|+....+ +..+++|...... ....+...|..++..+...+ ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 346667778999988654 4789999764433 22234566777777774322 3345555432 468999
Q ss_pred cCCCCHHHH-----------------hhcCCCCC-----CCC--CHHHHHH--------------------------HHH
Q 011498 229 VDNGNLDQW-----------------LHGDVGDV-----SPL--TWDIRMN--------------------------IIL 258 (484)
Q Consensus 229 ~~~gsL~~~-----------------l~~~~~~~-----~~l--~~~~~~~--------------------------i~~ 258 (484)
++|..+... ||...... ... -+..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765431 11111110 011 1111111 111
Q ss_pred HHHHHHHhhhc------CCCCceeecCCCCCcEEEcCC----CcEEEeeecccc
Q 011498 259 GTAKGLAYLHE------GLEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAK 302 (484)
Q Consensus 259 ~ia~al~~LH~------~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfgla~ 302 (484)
.+...+.+|-. .....++|+|+.+.||+++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334431 234579999999999999985 789999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00048 Score=65.76 Aligned_cols=134 Identities=18% Similarity=0.099 Sum_probs=87.8
Q ss_pred CCCcCceeccCCceEEEEEEECCCCEEEEEEecccch----------------h------hHHHHHHHHHHHhccC-CC-
Q 011498 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG----------------Q------AEKEFKVEVEVIGRVR-HK- 207 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~----------------~------~~~~~~~e~~~l~~l~-H~- 207 (484)
-+.+.+.||-|--+.||.+...+|++.++|.-+-.+. . ..-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3566789999999999999998899999883311110 0 0112445777777773 32
Q ss_pred ceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 208 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
-+.+.+++ ...++|||++.+-.|...-+- .+...+.. .+..-+.-|..+ |+||+|..--||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~---~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLYD---DLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHHH---HHHHHHHHHHHc---CceecccchheeEE
Confidence 24444443 455899999988777654321 12222222 222233344444 99999999999999
Q ss_pred cCCCcEEEeeecccc
Q 011498 288 DRQWNARVSDFGLAK 302 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~ 302 (484)
++++.++++||--..
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999996544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0067 Score=58.45 Aligned_cols=73 Identities=18% Similarity=0.228 Sum_probs=46.4
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc---CCCceeeecceeeeCCeeeEEEEecCCC
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
.+.++.|....+|+.. .++..+.||.-. ......|..|.+-|+.| .--.+++++++....+..+|||||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999987 457889999664 22334577787777777 3446778888888777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0083 Score=59.64 Aligned_cols=140 Identities=21% Similarity=0.238 Sum_probs=79.0
Q ss_pred eeccCCceEEEEEEECC-----CCEEEEEEecccchhhHHHHHHHHHHHhccCCCce-eeecceeeeCCeeeEEEEecCC
Q 011498 158 VIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~ 231 (484)
.|-.|-...+|+..+.+ +..|++|..-...... -+...|..+++.+..-++ .++++.+... .|++|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45457788999987542 3678999765443222 233568888887743333 3455555332 58999987
Q ss_pred CCHHHH-----------------hhcCC--CCCCCCCHHHHHHHHHHH-----------------HHHHHh----hhc-C
Q 011498 232 GNLDQW-----------------LHGDV--GDVSPLTWDIRMNIILGT-----------------AKGLAY----LHE-G 270 (484)
Q Consensus 232 gsL~~~-----------------l~~~~--~~~~~l~~~~~~~i~~~i-----------------a~al~~----LH~-~ 270 (484)
.+|... +|... .......+.....+..++ ...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665321 12111 011112233333332221 111111 221 1
Q ss_pred CCCceeecCCCCCcEEEcC-CCcEEEeeecccc
Q 011498 271 LEPKVVHRDVKSSNILLDR-QWNARVSDFGLAK 302 (484)
Q Consensus 271 ~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla~ 302 (484)
....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2347899999999999986 4679999998765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0092 Score=58.00 Aligned_cols=145 Identities=21% Similarity=0.188 Sum_probs=79.8
Q ss_pred eeccCCceEEEEEEECCCCEEEEEEecc--cchhhHHHHHHHHHHHhccCC--CceeeecceeeeCC--eeeEEEEecCC
Q 011498 158 VIGEGGYGIVYRGILSDGTKVAVKNLLN--NRGQAEKEFKVEVEVIGRVRH--KNLVRLLGYCVEGA--YRMLVYEYVDN 231 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~--~~~lv~e~~~~ 231 (484)
.+..|..-.+|..... +++++++ ... ..........+|+.+|+.+.- --+...++.|.++. ..|.||+|++|
T Consensus 32 ~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 32 EISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 3433444445554443 7778888 321 222334556678888887632 23455667777665 67999999988
Q ss_pred CCHHHH------------------hh---cCCC-----CCC--CCCHHHHHHHHHH--------------HHHHHHhhhc
Q 011498 232 GNLDQW------------------LH---GDVG-----DVS--PLTWDIRMNIILG--------------TAKGLAYLHE 269 (484)
Q Consensus 232 gsL~~~------------------l~---~~~~-----~~~--~l~~~~~~~i~~~--------------ia~al~~LH~ 269 (484)
..+.+. |. .-.. ... .....+...+..+ ...-..+|+.
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 432221 11 0000 000 0000011111111 1112334433
Q ss_pred CC-----CCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 270 GL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 270 ~~-----~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
+. .+.++|+|+.+.||+++++.-+=+.||+++...
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 21 347999999999999999888999999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.91 E-value=9.7e-05 Score=82.64 Aligned_cols=159 Identities=12% Similarity=-0.012 Sum_probs=114.2
Q ss_pred HHHHHhccCCCceeeecceee--eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC--C
Q 011498 197 EVEVIGRVRHKNLVRLLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--E 272 (484)
Q Consensus 197 e~~~l~~l~H~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~ 272 (484)
|...++...|+++.....-.. +..+.+..++|+.+|.+.+.|-+.......+....+.....+...+..-+|... .
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 444555567888776655443 234568999999999999998655444455554444434344345555544432 2
Q ss_pred CceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCC
Q 011498 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR 352 (484)
Q Consensus 273 ~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~ 352 (484)
.-.+|++||+.|.+|..+-++|+.++|+.+...+ .....+...+++.|++|+....-.++.++|+|..|+.+|+..-|.
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 2368999999999999999999999999983322 222234456788899999998888999999999999999998888
Q ss_pred CCCC
Q 011498 353 NPVD 356 (484)
Q Consensus 353 ~p~~ 356 (484)
.+|-
T Consensus 1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred HHHH
Confidence 7763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.012 Score=56.44 Aligned_cols=31 Identities=29% Similarity=0.459 Sum_probs=25.8
Q ss_pred CceeecCCCCCcEEEcCCCc-EEEeeeccccc
Q 011498 273 PKVVHRDVKSSNILLDRQWN-ARVSDFGLAKL 303 (484)
Q Consensus 273 ~~ivH~dlkp~NIll~~~~~-~kl~Dfgla~~ 303 (484)
+.++|+|+++.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.012 Score=57.42 Aligned_cols=139 Identities=16% Similarity=0.163 Sum_probs=89.0
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccc------hh-------------------hH-HHHHHHHHHHhccCCCce
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR------GQ-------------------AE-KEFKVEVEVIGRVRHKNL 209 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~------~~-------------------~~-~~~~~e~~~l~~l~H~ni 209 (484)
...|..|--+-||.+...+|..+|||+++.+. .. .. .-...|++-|++++.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34577788889999998899999999763211 00 00 112346666666654443
Q ss_pred eeecceeeeCCeeeEEEEecCCCCH-HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 210 VRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
.-.--+... ...|||+|+..... .-.|+ .-.++...+..+-.|++.-|.-|.+.| ++||.||.--|+|+-
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 221111111 23689999954211 11121 134666667777778888888887665 999999999999986
Q ss_pred CCCcEEEeeecccccc
Q 011498 289 RQWNARVSDFGLAKLL 304 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~ 304 (484)
+ |.+.|+|.+-+...
T Consensus 300 d-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEH 314 (520)
T ss_pred C-CEEEEEEccccccC
Confidence 6 48999998877543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.029 Score=54.80 Aligned_cols=29 Identities=31% Similarity=0.373 Sum_probs=25.4
Q ss_pred CceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 273 ~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999998 578999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.068 Score=52.50 Aligned_cols=140 Identities=22% Similarity=0.307 Sum_probs=79.6
Q ss_pred eccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC---CCc---eeeecce----eeeCCeeeEEEEe
Q 011498 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKN---LVRLLGY----CVEGAYRMLVYEY 228 (484)
Q Consensus 159 Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---H~n---iv~l~~~----~~~~~~~~lv~e~ 228 (484)
|.+ .-..+|+....+|.. ++|..... ....++..|+..+..+. .+- +..+-|- .......+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789998876665 88877654 34455666777776662 221 2222221 1112367789999
Q ss_pred cCCCCHHH-H--------------hh----c----CCCCCCCCCHHH-------------HHHHHHHHHHHHHhhhcC--
Q 011498 229 VDNGNLDQ-W--------------LH----G----DVGDVSPLTWDI-------------RMNIILGTAKGLAYLHEG-- 270 (484)
Q Consensus 229 ~~~gsL~~-~--------------l~----~----~~~~~~~l~~~~-------------~~~i~~~ia~al~~LH~~-- 270 (484)
++|..+.. . |+ + +........|.. ......++...+..+...
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99977762 1 11 0 111112233431 011223333344444332
Q ss_pred --CCCc---eeecCCCCCcEEEcCCCc-EEEeeecccc
Q 011498 271 --LEPK---VVHRDVKSSNILLDRQWN-ARVSDFGLAK 302 (484)
Q Consensus 271 --~~~~---ivH~dlkp~NIll~~~~~-~kl~Dfgla~ 302 (484)
.... +||+|+.|.||+++.+.. +-++||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 899999999999999875 8899998765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.032 Score=55.12 Aligned_cols=141 Identities=16% Similarity=0.220 Sum_probs=77.1
Q ss_pred ceeccCCceEEEEEEECC----CCEEEEEEecccchhhHHHHHHHHHHHhccCCCce-eeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.|..|=...+|+....+ +..|++|..-..... .-+...|..+++.+..-++ +++++++. .. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345557778899987543 237899976544332 2234567888888754444 34555553 22 58899877
Q ss_pred CCHHH--H---------------hhcCCCC--CCCCCHHHHHHHHHHH----------------------HH---HHH-h
Q 011498 232 GNLDQ--W---------------LHGDVGD--VSPLTWDIRMNIILGT----------------------AK---GLA-Y 266 (484)
Q Consensus 232 gsL~~--~---------------l~~~~~~--~~~l~~~~~~~i~~~i----------------------a~---al~-~ 266 (484)
-.|.. + +|..... ..+-.|.....+..++ .. .+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 55421 0 1221101 1111233322222221 11 111 1
Q ss_pred hhc-CCCCceeecCCCCCcEEEcC-CCcEEEeeecccc
Q 011498 267 LHE-GLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAK 302 (484)
Q Consensus 267 LH~-~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla~ 302 (484)
+.. ....-++|+|+.+.|||+++ ++.++++||..+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111 11235799999999999975 4689999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.17 Score=51.02 Aligned_cols=72 Identities=13% Similarity=0.221 Sum_probs=47.7
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccch-------hhHHHHHHHHHHHhccC---CCceeeecceeeeCCeeeEEE
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-------QAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 226 (484)
+.||.|....||+.... +..++||.-..... .....-..|...|+.+. ..++++++.++.+ ..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 56899999999998874 55688996541110 12223333566665553 3478888888774 457899
Q ss_pred EecCC
Q 011498 227 EYVDN 231 (484)
Q Consensus 227 e~~~~ 231 (484)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99977
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.006 Score=49.98 Aligned_cols=33 Identities=21% Similarity=0.264 Sum_probs=16.9
Q ss_pred CchHHHHHHHHHHHHHHHHHHHH-HHHHhhhccc
Q 011498 21 GLRLWVVIGILLGSLIVLALFLL-SLCLTSRRKK 53 (484)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~li~~-~~~~~~rr~~ 53 (484)
+|+...+++|++|+++.++++++ ++|+.+|++|
T Consensus 60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~K 93 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRK 93 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS-
T ss_pred CccccceeehhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 44666677777776666543333 3333444433
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.044 Score=49.88 Aligned_cols=150 Identities=17% Similarity=0.162 Sum_probs=87.8
Q ss_pred CCceEEEEEEECCCCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhc
Q 011498 162 GGYGIVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG 240 (484)
Q Consensus 162 G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 240 (484)
++..+.-.++.+-|. ..+|++....-. ...-|..+.++++++. .|+++..- +.-..-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 344555555444333 455666443322 3456777888888765 57777732 23344589999854111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccccccc
Q 011498 241 DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320 (484)
Q Consensus 241 ~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 320 (484)
.. ..++.-=+.+|.-.|+. ..+.+|+|..|+||+=|..|.+||.|-+.-.. . +..
T Consensus 142 -------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~-----------~V~ 196 (308)
T PF07387_consen 142 -------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N-----------QVN 196 (308)
T ss_pred -------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h-----------eee
Confidence 11 11221113567788865 56899999999999999999999999764321 1 111
Q ss_pred cccccccccCCCCcccceecchhHHHHHHh
Q 011498 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT 350 (484)
Q Consensus 321 y~aPE~~~~~~~~~~~DvwslG~~l~ellt 350 (484)
|.--| ....+.++.+-+|=.-++++..
T Consensus 197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~ 223 (308)
T PF07387_consen 197 MVNIE---YESLTQEAEVKVFVKSCLKLVE 223 (308)
T ss_pred EEeee---ccccChHHHHHHHHHHHHHHHH
Confidence 22211 2234566666666666666655
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.025 Score=51.95 Aligned_cols=29 Identities=28% Similarity=0.519 Sum_probs=20.7
Q ss_pred ceeecCCCCCcEEE-cCCCcEEEeeecccc
Q 011498 274 KVVHRDVKSSNILL-DRQWNARVSDFGLAK 302 (484)
Q Consensus 274 ~ivH~dlkp~NIll-~~~~~~kl~Dfgla~ 302 (484)
.++|+||.+.|||+ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 67899999999999 888899999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.0036 Score=63.41 Aligned_cols=48 Identities=17% Similarity=0.246 Sum_probs=37.3
Q ss_pred HHHHHHHHHhccCCCceeeecceeeeC-CeeeEEEEecCCCCHHHHhhcC
Q 011498 193 EFKVEVEVIGRVRHKNLVRLLGYCVEG-AYRMLVYEYVDNGNLDQWLHGD 241 (484)
Q Consensus 193 ~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~ 241 (484)
.+.-...+++.+.|+|+...+++.... ....+|||++. .||++++..+
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~ 76 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG 76 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence 444566788999999999999887643 45678999995 5999998654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.15 Score=58.18 Aligned_cols=143 Identities=20% Similarity=0.296 Sum_probs=77.8
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-------CCCceeeec-ce----eee-CC--e
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-------RHKNLVRLL-GY----CVE-GA--Y 221 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-------~H~niv~l~-~~----~~~-~~--~ 221 (484)
+.|+ |..-.+|+....+|..+++|+....... .....+..++..| .-|.+++-. |- ... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 4567889998877889999988654332 2233334444433 234444433 11 111 12 4
Q ss_pred eeEEEEecCCCCHHHH-----------------hhc------CCCCCCCCCHHH-----------------HHHHHHHHH
Q 011498 222 RMLVYEYVDNGNLDQW-----------------LHG------DVGDVSPLTWDI-----------------RMNIILGTA 261 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~-----------------l~~------~~~~~~~l~~~~-----------------~~~i~~~ia 261 (484)
.+.+++|++|..|.+. |+. .......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5778999999777551 110 011111222221 112222222
Q ss_pred HHHH-----hhhcCCCCceeecCCCCCcEEEcCCC--cEE-Eeeeccccc
Q 011498 262 KGLA-----YLHEGLEPKVVHRDVKSSNILLDRQW--NAR-VSDFGLAKL 303 (484)
Q Consensus 262 ~al~-----~LH~~~~~~ivH~dlkp~NIll~~~~--~~k-l~Dfgla~~ 303 (484)
..+. .|. ....++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 121 2244799999999999999875 555 999998754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.081 Score=51.74 Aligned_cols=32 Identities=22% Similarity=0.308 Sum_probs=28.3
Q ss_pred CCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 272 ~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
..+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44799999999999999998999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.15 Score=50.48 Aligned_cols=73 Identities=16% Similarity=0.256 Sum_probs=45.7
Q ss_pred eeccCCceEEEEEEECCC-CEEEEEEecc-------cchhhHHHHHHHHHHHhccC--CC-ceeeecceeeeCCeeeEEE
Q 011498 158 VIGEGGYGIVYRGILSDG-TKVAVKNLLN-------NRGQAEKEFKVEVEVIGRVR--HK-NLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~e~~~l~~l~--H~-niv~l~~~~~~~~~~~lv~ 226 (484)
.||.|....||++...+| ..|+||.-.. .-.....+...|...|.... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478999999999997654 5799995421 11223344455777776652 24 34444433 445567899
Q ss_pred EecCCC
Q 011498 227 EYVDNG 232 (484)
Q Consensus 227 e~~~~g 232 (484)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.12 Score=51.95 Aligned_cols=74 Identities=16% Similarity=0.310 Sum_probs=44.0
Q ss_pred ceeccCCceEEEEEEECCC--CE-----EEEEEecccchhhHHHHHHHHHHHhccCCCc-eeeecceeeeCCeeeEEEEe
Q 011498 157 NVIGEGGYGIVYRGILSDG--TK-----VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~--~~-----vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~ 228 (484)
+.|..|-...+|++...++ .. |.++. ........-+-..|+.+++.+...+ -.++++.+.. ++++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 3455577899999976433 22 33332 2222222223456888888885444 4455555542 689999
Q ss_pred cCCCCHH
Q 011498 229 VDNGNLD 235 (484)
Q Consensus 229 ~~~gsL~ 235 (484)
++|-+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.32 Score=47.98 Aligned_cols=71 Identities=17% Similarity=0.139 Sum_probs=42.6
Q ss_pred CCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC--ceeeec---c--eeeeCCeeeEEEEecCCCC
Q 011498 162 GGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLL---G--YCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 162 G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~---~--~~~~~~~~~lv~e~~~~gs 233 (484)
+.-..||+....++..+++|...... ....++..|++.+..|... .++... | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 44578999988778889999764332 2344555677766665311 122211 2 2223456788999998754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.043 Score=53.62 Aligned_cols=72 Identities=21% Similarity=0.279 Sum_probs=55.3
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|++|++. |++|.- + ....+.+.+.++++-+.-+.-+..+ ...-|||+.-.||||+ +|++.|+||-+
T Consensus 300 y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 446666665 334432 1 3356888999999888877777765 3889999999999999 89999999999
Q ss_pred cccc
Q 011498 301 AKLL 304 (484)
Q Consensus 301 a~~~ 304 (484)
++.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9854
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.03 Score=35.04 Aligned_cols=23 Identities=13% Similarity=0.570 Sum_probs=9.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH
Q 011498 24 LWVVIGILLGSLIVLALFLLSLC 46 (484)
Q Consensus 24 ~~~~i~i~~g~~~~l~li~~~~~ 46 (484)
+.+++|+++|.+++++.+++.+|
T Consensus 6 IaIIv~V~vg~~iiii~~~~YaC 28 (38)
T PF02439_consen 6 IAIIVAVVVGMAIIIICMFYYAC 28 (38)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHH
Confidence 34444444444444333333333
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.27 Score=45.22 Aligned_cols=75 Identities=17% Similarity=0.202 Sum_probs=51.5
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc---CCCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
+.+.-|..-..|.... +..++-||+- .......|..|+.-|..| +--++.+++.+.....+.|+||||++-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455566666666655 3567888843 223345677777666655 34567788888888899999999999866
Q ss_pred HH
Q 011498 234 LD 235 (484)
Q Consensus 234 L~ 235 (484)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 484 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-68 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-66 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = 0.0
Identities = 137/314 (43%), Positives = 201/314 (64%), Gaps = 4/314 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEV HLG + ++LREL+ A+ +N++G GG+G VY+G L+DGT VAVK L R Q
Sbjct: 10 PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ 68
Query: 190 A-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
E +F+ EVE+I H+NL+RL G+C+ R+LVY Y+ NG++ L PL
Sbjct: 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
W R I LG+A+GLAYLH+ +PK++HRDVK++NILLD ++ A V DFGLAKL+ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE--VNL 366
++VTT V GT G++APEY TG +EK+DV+ +G++++E+ITG+ D +R + V L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+DW+K ++ +K E +VD L + +++++ VAL C +RPKM V+ MLE
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
Query: 427 DDLLFRDERRIGRE 440
D L R E E
Sbjct: 309 DGLAERWEEWQKEE 322
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 482 bits (1243), Expect = e-171
Identities = 113/320 (35%), Positives = 182/320 (56%), Gaps = 11/320 (3%)
Query: 107 SSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGI 166
S S+ T S + ++ L +LE AT+ + +IG G +G
Sbjct: 2 GSKYSKATNSI-------NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGK 54
Query: 167 VYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226
VY+G+L DG KVA+K Q +EF+ E+E + RH +LV L+G+C E +L+Y
Sbjct: 55 VYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
+Y++NGNL + L+G ++W+ R+ I +G A+GL YLH ++HRDVKS NIL
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINIL 171
Query: 287 LDRQWNARVSDFGLAKL-LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILI 345
LD + +++DFG++K ++++++T V GT GY+ PEY G L EKSDVYSFG+++
Sbjct: 172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231
Query: 346 MEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALR 405
E++ R+ + S P+ VNL +W + + E++VDP L ++L++ A++
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK 291
Query: 406 CVDPDATKRPKMGHVIHMLE 425
C+ + RP MG V+ LE
Sbjct: 292 CLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-138
Identities = 105/299 (35%), Positives = 169/299 (56%), Gaps = 21/299 (7%)
Query: 139 RWYTLRELEAATSG------LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR----G 188
++ EL+ T+ N +GEGG+G+VY+G + + T VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 189 QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
+ +++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE- 307
+W +R I G A G+ +LH E +HRD+KS+NILLD + A++SDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
++ +T+R++GT Y+APE G + KSD+YSFG++++EIITG VD R L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244
Query: 368 DWLKTMVGSRKS-EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
D + + K+ E+ +D K+ S +++ + VA +C+ KRP + V +L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 9e-96
Identities = 75/322 (23%), Positives = 132/322 (40%), Gaps = 30/322 (9%)
Query: 128 VGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR 187
+G H G L + L V G +G V++ L VAVK + +
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQ 58
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----RMLVYEYVDNGNLDQWLHGDVG 243
+ + + EV + ++H+N+++ +G G L+ + + G+L +L
Sbjct: 59 DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--- 115
Query: 244 DVSPLTWDIRMNIILGTAKGLAYLHE-------GLEPKVVHRDVKSSNILLDRQWNARVS 296
+ ++W+ +I A+GLAYLHE G +P + HRD+KS N+LL A ++
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 297 DFGLAKLLCSERSYV-TTRVMGTFGYVAPEYACTGMLNE-----KSDVYSFGILIMEIIT 350
DFGLA + +S T +GT Y+APE + + + D+Y+ G+++ E+ +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 351 GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV-----DPKLPK-MPASKALKRVLLVAL 404
D + + + + +EVV P L + +
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 405 RCVDPDATKRPKMGHVIHMLEA 426
C D DA R G V +
Sbjct: 294 ECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-68
Identities = 81/343 (23%), Positives = 125/343 (36%), Gaps = 51/343 (14%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IG 202
E L +IG G YG VY+G L D VAVK + F E + +
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62
Query: 203 RVRHKNLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
+ H N+ R + +LV EY NG+L ++L W +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLA 117
Query: 258 LGTAKGLAYLHE------GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS----- 306
+GLAYLH +P + HRD+ S N+L+ +SDFGL+ L
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 307 --ERSYVTTRVMGTFGYVAPEYA-------CTGMLNEKSDVYSFGILIMEIITGRNPVDY 357
E +GT Y+APE ++ D+Y+ G++ EI +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 358 SRPQGEVNLVDWLKTMVGSRKSEE-----VVD----PKLPK--MPASKALKRVLLVALRC 406
E + +T VG+ + E V PK P+ S A++ + C
Sbjct: 238 GESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 407 VDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEEN 449
D DA R + +L+ ER P+ + +
Sbjct: 296 WDQDAEARLTAQXAEERMA--ELMMIWERNKSVSPTAHHHHHH 336
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-67
Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 23/300 (7%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR-- 187
P +L + +++ L + IG G +G V+R G+ VAVK L+
Sbjct: 16 PTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH 74
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
+ EF EV ++ R+RH N+V +G + +V EY+ G+L + LH G
Sbjct: 75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ 133
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
L R+++ AKG+ YLH P +VHR++KS N+L+D+++ +V DFGL++L +
Sbjct: 134 LDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-AS 191
Query: 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNL 366
+ GT ++APE NEKSDVYSFG+++ E+ T + P + + Q
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----- 246
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
V R ++P+ + + ++ C + KRP ++ +L
Sbjct: 247 VVAAVGFKCKR-------LEIPR-NLNPQVAAII---EGCWTNEPWKRPSFATIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-64
Identities = 80/276 (28%), Positives = 131/276 (47%), Gaps = 29/276 (10%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+ E V+G G +G+V + VA+K + + K F VE+ + RV H N+V+L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKL 66
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G C+ LV EY + G+L LHG + T M+ L ++G+AYLH
Sbjct: 67 YGACLNPVC--LVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 273 PKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
++HRD+K N+LL ++ DFG A + + T G+ ++APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSN 179
Query: 332 LNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK- 389
+EK DV+S+GI++ E+IT R P + P + G+R P L K
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----VHNGTR-------PPLIKN 228
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+P K ++ ++ RC D ++RP M ++ ++
Sbjct: 229 LP--KPIESLM---TRCWSKDPSQRPSMEEIVKIMT 259
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-63
Identities = 62/282 (21%), Positives = 115/282 (40%), Gaps = 34/282 (12%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLV 210
L + E G +++G G + VK L + ++F E + H N++
Sbjct: 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 211 RLLGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+LG C + L+ ++ G+L LH + + L A+G+A+LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH 128
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE--- 325
LEP + + S ++++D AR+S + S+ + M +VAPE
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWVAPEALQ 181
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384
+D++SF +L+ E++T P D S + + + G R
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGLR------- 229
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P +P S + +++ C++ D KRPK ++ +LE
Sbjct: 230 PTIPP-GISPHVSKLM---KICMNEDPAKRPKFDMIVPILEK 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-63
Identities = 78/289 (26%), Positives = 138/289 (47%), Gaps = 42/289 (14%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLL----NNRGQAEKEFKVEVEVIGRVRHKN 208
L E +IG GG+G VYR G +VAVK + Q + + E ++ ++H N
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ L G C++ LV E+ G L++ L G + DI +N + A+G+ YLH
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLH 122
Query: 269 EGLEPKVVHRDVKSSNILLDR--------QWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320
+ ++HRD+KSSNIL+ + +++DFGLA+ R+ + G +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYA 179
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380
++APE M ++ SDV+S+G+L+ E++TG P + + + G +
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--F-------------RGIDGLAVAY 224
Query: 381 EVVDPKL-PKMPAS--KALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
V KL +P++ + +++ C +PD RP +++ L
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLM---EDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 9e-63
Identities = 81/293 (27%), Positives = 143/293 (48%), Gaps = 46/293 (15%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE-------KEFKVEVEVIGRV 204
+ E IG+GG+G+V++G + D + VA+K+L+ + E +EF+ EV ++ +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
H N+V+L G +V E+V G+L L P+ W +++ ++L A G+
Sbjct: 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGI 135
Query: 265 AYLHEGLEPKVVHRDVKSSNILLD-----RQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
Y+ P +VHRD++S NI L A+V+DFGL++ + + + ++G F
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNF 190
Query: 320 GYVAPE--YACTGMLNEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNLVDWLKTMV-- 374
++APE A EK+D YSF +++ I+TG P +YS + + ++ +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREE 245
Query: 375 GSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
G R P +P+ P L+ V+ C D KRP +++ L
Sbjct: 246 GLR-------PTIPEDCP--PRLRNVI---ELCWSGDPKKRPHFSYIVKELSE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-62
Identities = 78/312 (25%), Positives = 125/312 (40%), Gaps = 40/312 (12%)
Query: 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+G+G +G + G + +K L+ + ++ F EV+V+ + H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + EY+ G L + W R++ A G+AYLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR-------------VMGTFGY 321
++HRD+ S N L+ N V+DFGLA+L+ E++ V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 322 VAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381
+APE +EK DV+SFGI++ EII N P+ TM
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR----------TMDFGLNVRG 238
Query: 382 VVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 440
+D P P S + +RC D D KRP + H LE R
Sbjct: 239 FLDRYCPPNCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLET----LRMHLAGHLP 289
Query: 441 PSNSYGEENRDF 452
+ +R F
Sbjct: 290 LGPQLEQLDRGF 301
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-60
Identities = 68/323 (21%), Positives = 118/323 (36%), Gaps = 44/323 (13%)
Query: 124 GSGSVGPEVSHLGWGRW-----YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKV 178
G +S + R L+E + L +IG+G +G VY G +V
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EV 58
Query: 179 AVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
A++ + R K FK EV + RH+N+V +G C+ + ++ L
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 237 WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296
+ L + I KG+ YLH ++H+D+KS N+ D ++
Sbjct: 119 VVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVIT 171
Query: 297 DFGLAKL----LCSERSYVTTRVMGTFGYVAPEYACTGML---------NEKSDVYSFGI 343
DFGL + R G ++APE ++ SDV++ G
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 344 LIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVA 403
+ E+ P + + + G + P L ++ K + +L
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQMGT-----GMK-------PNLSQIGMGKEISDIL--- 276
Query: 404 LRCVDPDATKRPKMGHVIHMLEA 426
L C + +RP ++ MLE
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-58
Identities = 79/311 (25%), Positives = 133/311 (42%), Gaps = 38/311 (12%)
Query: 125 SGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLL 184
S W E + IG G +G VY+G VAVK L
Sbjct: 4 GHHHHHHGSRDAADDW------EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLN 55
Query: 185 NNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDV 242
Q + FK EV V+ + RH N++ +GY +V ++ + +L LH
Sbjct: 56 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASE 114
Query: 243 GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++I TA+G+ YLH ++HRD+KS+NI L ++ DFGLA
Sbjct: 115 T---KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 303 LLCS-ERSYVTTRVMGTFGYVAPE---YACTGMLNEKSDVYSFGILIMEIITGRNP-VDY 357
S+ ++ G+ ++APE + + +SDVY+FGI++ E++TG+ P +
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
Query: 358 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS--KALKRVLLVALRCVDPDATKRP 415
+ + +V GS P L K+ ++ K +KR++ C+ +RP
Sbjct: 229 NNRDQIIEMVGR-----GSLS------PDLSKVRSNCPKRMKRLM---AECLKKKRDERP 274
Query: 416 KMGHVIHMLEA 426
++ +E
Sbjct: 275 SFPRILAEIEE 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-58
Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 44/303 (14%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLV 210
+ +G+G YG V+RG G VAVK + EK + E E+ +RH+N++
Sbjct: 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENIL 65
Query: 211 RLLGYCVEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ + + L+ Y + G+L +L ++ L + I+L A GLA+
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAH 120
Query: 267 LHEGLE-----PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM---GT 318
LH + P + HRD+KS NIL+ + ++D GLA + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 319 FGYVAPE------YACTGMLNEKSDVYSFGILIMEIITGRNPV----DYSRP-QGEVNLV 367
Y+APE ++ D+++FG+++ E+ DY P V
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 368 DWLKTMVGSRKSEEVVDPKL-PKMPASKALKRVL--LVAL--RCVDPDATKRPKMGHVIH 422
+ M V + P +P L L L C + + R +
Sbjct: 241 PSFEDMRKV-----VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 423 MLE 425
L
Sbjct: 296 TLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-56
Identities = 74/333 (22%), Positives = 128/333 (38%), Gaps = 48/333 (14%)
Query: 119 ETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKV 178
++ S GSGS P + ++++ IG+G YG V+ G G KV
Sbjct: 17 QSQSSGSGSGLPLLVQ-----RTIAKQIQ-------MVKQIGKGRYGEVWMGKW-RGEKV 63
Query: 179 AVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLVRLLGYCVEGAYR----MLVYEYVDNG 232
AVK E + E E+ +RH+N++ + ++G L+ +Y +NG
Sbjct: 64 AVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-----GLEPKVVHRDVKSSNILL 287
+L +L + L + + + GL +LH +P + HRD+KS NIL+
Sbjct: 121 SLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 288 DRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVAPE------YACTGMLNEKSDV 338
+ ++D GLA S+ + +GT Y+ PE +D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 339 YSFGILIMEIITGRNPV----DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
YSFG+++ E+ +Y P ++ D + + + P P +S
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295
Query: 395 ALKRVLLVAL--RCVDPDATKRPKMGHVIHMLE 425
R + L C + R V L
Sbjct: 296 ECLRQ-MGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-55
Identities = 77/351 (21%), Positives = 140/351 (39%), Gaps = 62/351 (17%)
Query: 108 SGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIV 167
S + + + GSGS P + R + + IG+G +G V
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQ-----RTIARTIV-------LQESIGKGRFGEV 58
Query: 168 YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLVRLLGYCVEGAYR--- 222
+RG G +VAVK + E+ + E E+ +RH+N++ + +
Sbjct: 59 WRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114
Query: 223 -MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE-----PKVV 276
LV +Y ++G+L +L+ +T + + + L TA GLA+LH + P +
Sbjct: 115 LWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVAPEYACTGML- 332
HRD+KS NIL+ + ++D GLA S +GT Y+APE +L
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-----VLD 224
Query: 333 ----------NEKSDVYSFGILIMEIITGRNPV----DYSRP-QGEVNL---VDWLKTMV 374
+++D+Y+ G++ EI + DY P V V+ ++ +V
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+K + + A + + +++ C + R + L
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIM---RECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-43
Identities = 68/293 (23%), Positives = 122/293 (41%), Gaps = 47/293 (16%)
Query: 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG G +G V+ G L +D T VAVK+ + +F E ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G C + +V E V G+ +L + L + ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGM 331
+HRD+ + N L+ + ++SDFG+++ ++ Y + + APE G
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 332 LNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD------ 384
+ +SDV+SFGIL+ E + G +P Y N ++ +
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--Y---PNLSN--------------QQTREFVEKGG 332
Query: 385 --PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 435
P P A+ R++ +C + +RP + L++ + + R
Sbjct: 333 RLPCPELCPD--AVFRLM---EQCWAYEPGQRPSFSTIYQELQS---IRKRHR 377
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-40
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 50/305 (16%)
Query: 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++ +G G YG VY G+ VAVK L +EF E V+ ++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
C ++ E++ GNL +L ++ + + + + + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGML 332
+HR++ + N L+ +V+DFGL++L+ T F APE
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-----K 386
+ KSDV++FG+L+ EI T G +P Y G +V + +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSP--Y---PGIDL--------------SQVYELLEKDYR 437
Query: 387 LPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSY 445
+ + + + ++ C + + RP + E + +E S S
Sbjct: 438 MERPEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFE----------TMFQESSISD 484
Query: 446 GEENR 450
E
Sbjct: 485 EVEKE 489
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 67/308 (21%), Positives = 127/308 (41%), Gaps = 33/308 (10%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ +G+G +G V + G VAVK L ++ +++F+ E++++ + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ G + LV EY+ +G L +L + + KG+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL---LLYSSQICKGMEYLG 144
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEY 326
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G + APE
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ + +SDV+SFG+++ E+ T S + + +++
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CS---PSAEFLRMMGCERDVPALSRLLEL 256
Query: 386 -----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGR 439
+LP PA + ++ C P RP + L+ L+ R
Sbjct: 257 LEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDM---LWSGSRGCET 310
Query: 440 EPSNSYGE 447
++ E
Sbjct: 311 HAFTAHPE 318
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-40
Identities = 72/314 (22%), Positives = 129/314 (41%), Gaps = 49/314 (15%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
P + LG+G W E++ L +G G +G+V G VA+K +
Sbjct: 9 PSTAGLGYGSW----EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSM 61
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
+E EF E +V+ + H+ LV+L G C + ++ EY+ NG L +L
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ 121
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+ + + + YL + +HRD+ + N L++ Q +VSDFGL++ +
Sbjct: 122 ---LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDD 173
Query: 310 YVTTRVMGTFGY--VAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNL 366
T+ V F PE + KSD+++FG+L+ EI + G+ P Y + N
Sbjct: 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--Y---ERFTN- 227
Query: 367 VDWLKTMVGSRKSEEVVDP-----KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHV 420
E + +L + AS+ + ++ C A +RP +
Sbjct: 228 -------------SETAEHIAQGLRLYRPHLASEKVYTIM---YSCWHEKADERPTFKIL 271
Query: 421 IHMLEADDLLFRDE 434
+ + + +E
Sbjct: 272 LSNILD---VMDEE 282
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
V+G G +G VY+G+ VA+K L +A KE E V+ V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
RLLG C+ L+ + + G L ++ ++ +N + AKG+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
++VHRD+ + N+L+ + +++DFGLAKLL +E G ++A E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY-SRPQGEVNLVDWLKTMVGSRKSEEVVD 384
+ +SDV+S+G+ + E++T G P Y P E+ L+ G R
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEI--SSILEK--GER------- 237
Query: 385 PKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 436
LP+ P + + ++ +C DA RPK +I + RD +R
Sbjct: 238 --LPQPPICTIDVYMIM---RKCWMIDADSRPKFRELIIEFSK---MARDPQR 282
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 12/202 (5%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
C+E A LV E++++G L +L G + T + + L +G+AYL E V
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLE---EACV 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGMLN 333
+HRD+ + N L+ +VSDFG+ + + T+ F +PE +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 334 EKSDVYSFGILIMEIIT-GRNP 354
KSDV+SFG+L+ E+ + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 82/302 (27%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G+G +G V+ G + T+VA+K L + + F E +V+ ++RH+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E +V EY+ G+L +L G+ G L +++ A G+AY+
Sbjct: 248 VSEEPI-YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
VHRD++++NIL+ +V+DFGLA+L+ + APE A G K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 336 SDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-----KLPK 389
SDV+SFGIL+ E+ T GR P Y G VN EV+D ++P
Sbjct: 362 SDVWSFGILLTELTTKGRVP--Y---PGMVN--------------REVLDQVERGYRMPC 402
Query: 390 MP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEE 448
P ++L ++ +C + +RP ++ LE Y
Sbjct: 403 PPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE----------DYFTSTEPQYQPG 449
Query: 449 NR 450
Sbjct: 450 EN 451
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 85/285 (29%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V G G KVAVK + + F E V+ ++RH NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 216 CVEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
VE +V EY+ G+L +L S L D + L + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NN 309
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGML 332
VHRD+ + N+L+ A+VSDFGL + +T+ G APE
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKF 363
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ KSDV+SFGIL+ EI + GR P Y R P +V V ++ G + +
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV--VPRVEK--GYK---------MDAP 408
Query: 391 P-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 434
A+ V+ C DA RP + LE + E
Sbjct: 409 DGCPPAVYDVM---KNCWHLDAATRPTFLQLREQLEH---IRTHE 447
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-39
Identities = 82/302 (27%), Positives = 132/302 (43%), Gaps = 46/302 (15%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G+G +G V+ G + T+VA+K L + + F E +V+ ++RH+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E +V EY+ G+L +L G+ G L +++ A G+AY+
Sbjct: 331 VSEEPI-YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
VHRD++++NIL+ +V+DFGLA+L+ + APE A G K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 336 SDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-----KLPK 389
SDV+SFGIL+ E+ T GR P Y G VN EV+D ++P
Sbjct: 445 SDVWSFGILLTELTTKGRVP--Y---PGMVN--------------REVLDQVERGYRMPC 485
Query: 390 MP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEE 448
P ++L ++ +C + +RP ++ LE Y
Sbjct: 486 PPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLE----------DYFTSTEPQYQPG 532
Query: 449 NR 450
Sbjct: 533 EN 534
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G+V G VAVK + +E EF E + + ++ H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
C + +V EY+ NG L +L + P + + +G+A+L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ---LLEMCYDVCEGMAFLE---SHQF 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGMLN 333
+HRD+ + N L+DR +VSDFG+ + + + V F APE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 334 EKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-----KL 387
KSDV++FGIL+ E+ + G+ P Y N EVV +L
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP--Y---DLYTN--------------SEVVLKVSQGHRL 224
Query: 388 PKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 435
+ AS + +++ C KRP ++ +E L ++
Sbjct: 225 YRPHLASDTIYQIM---YSCWHELPEKRPTFQQLLSSIEP---LREKDK 267
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 65/280 (23%), Positives = 111/280 (39%), Gaps = 32/280 (11%)
Query: 156 ENVIGEGGYGIVYRGIL----SDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKN 208
+G+G +G+V RG VAVK L + ++ +A +F EV + + H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
L+RL G + +V E G+L L G T + A+G+ YL
Sbjct: 83 LIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGT---LSRYAVQVAEGMGYLE 138
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEY 326
+ +HRD+ + N+LL + ++ DFGL + L + + + APE
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
T + SD + FG+ + E+ T G+ P ++ +D G R
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----KEGER-------- 243
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
LP+ + + V ++C RP + L
Sbjct: 244 -LPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 65/290 (22%), Positives = 126/290 (43%), Gaps = 29/290 (10%)
Query: 153 LCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRH 206
L +GEG +G V + G +VAVK+L G + K E+E++ + H
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 207 KNLVRLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+N+V+ G C E L+ E++ +G+L ++L + ++ ++ + KG+
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGM 139
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYV 322
YL + VHRD+ + N+L++ + ++ DFGL K + +++ Y T + +
Sbjct: 140 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
APE SDV+SFG+ + E++T + + M +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM----TVTRL 252
Query: 383 VDP-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
V+ +LP P + +++ +C + + R ++I EA
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 85/285 (29%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V G G KVAVK + + F E V+ ++RH NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 216 CVEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
VE +V EY+ G+L +L S L D + L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NN 137
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGML 332
VHRD+ + N+L+ A+VSDFGL + +T+ G APE
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ KSDV+SFGIL+ EI + GR P Y R P +V V ++ G + +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV--VPRVEK--GYK---------MDAP 236
Query: 391 P-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDE 434
A+ V+ C DA RP + LE + E
Sbjct: 237 DGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLEH---IKTHE 275
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 60/286 (20%), Positives = 123/286 (43%), Gaps = 27/286 (9%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G +G V + G VAVK L ++ + ++F+ E+E++ ++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLG 131
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEY 326
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + + G + APE
Sbjct: 132 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP- 385
+ SDV+SFG+++ E+ T + S+ + G +++
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 386 ----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+LP+ + ++ C + + +RP + ++
Sbjct: 246 KNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 76/275 (27%), Positives = 130/275 (47%), Gaps = 32/275 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G G +G V+ + TKVAVK + + + F E V+ ++H LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ ++ E++ G+L +L D G S ++ A+G+A++ +
Sbjct: 252 VTKEPI-YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNY 305
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGMLN 333
+HRD++++NIL+ +++DFGLA+++ + Y T R F APE G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEY-TAREGAKFPIKWTAPEAINFGSFT 363
Query: 334 EKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
KSDV+SFGIL+MEI+T GR P Y EV + L+ G R +P+
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV--IRALER--GYR---------MPRPE 408
Query: 392 -ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ L ++ +RC +RP ++ +L+
Sbjct: 409 NCPEELYNIM---MRCWKNRPEERPTFEYIQSVLD 440
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 69/304 (22%), Positives = 114/304 (37%), Gaps = 56/304 (18%)
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEF 194
GR+ IG G + VY+G+ +VA + F
Sbjct: 25 GRFLKFDIE------------IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 72
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRM----LVYEYVDNGNLDQWL--HGDVGDVSPL 248
K E E++ ++H N+VR LV E + +G L +L +
Sbjct: 73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VM 126
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSE 307
+ + KGL +LH P ++HRD+K NI + + ++ D GLA L
Sbjct: 127 KIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--R 183
Query: 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
S+ V+GT ++APE +E DVY+FG+ ++E+ T P YS N
Sbjct: 184 ASFAKA-VIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YS---ECQNAA 236
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427
+ + + V K+ A +K ++ C+ + +R
Sbjct: 237 QIYRRV-----TSGVKPASFDKV-AIPEVKEII---EGCIRQNKDERYS---------IK 278
Query: 428 DLLF 431
DLL
Sbjct: 279 DLLN 282
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 154 CEENVIGEGGYGIVYRGILSDG---TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNL 209
+ +G G +G V +G+ VA+K L +E E +++ ++ + +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VRL+G C A MLV E G L ++L G ++ ++ + G+ YL E
Sbjct: 73 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKYLEE 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD+ + N+LL + A++SDFGL+K L ++ SY T R G + + APE
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ +SDV+S+G+ + E ++ G+ P
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 42/293 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
V+G G +G V++G+ V +K + + G Q+ + + IG + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VRLLG C + LV +Y+ G+L + G + P +N + AKG+ YL E
Sbjct: 78 VRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
+VHR++ + N+LL +V+DFG+A LL + + ++A E
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY-SRPQGEVNLVDWLKTMVGSRKSEEVVD 384
G +SDV+S+G+ + E++T G P Y EV D L+ G R
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAEV--PDLLEK--GER------- 235
Query: 385 PKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 436
L + + + V+ ++C D RP + + + RD R
Sbjct: 236 --LAQPQICTIDVYMVM---VKCWMIDENIRPTFKELANEFTR---MARDPPR 280
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 45/303 (14%)
Query: 156 ENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E +IG G G V G L VA+K L + ++ +F E ++G+ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL G G M+V EY++NG+LD +L G + + + ++ G G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGMRYLS-- 168
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYAC 328
+ VHRD+ + N+L+D +VSDFGL+++L + T G APE
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 329 TGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-- 385
+ SDV+SFG+++ E++ G P Y N +V+
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP--Y---WNMTN--------------RDVISSVE 268
Query: 386 ---KLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREP 441
+LP AL +++ L C D +RP+ ++ +L+A L R +
Sbjct: 269 EGYRLPAPMGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVLDA---LIRSPESLRATA 322
Query: 442 SNS 444
+ S
Sbjct: 323 TVS 325
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 82/312 (26%), Positives = 134/312 (42%), Gaps = 35/312 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
+ V+G G +G V G L +K VA+K L + ++ +F E ++G+ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL G + M+V EY++NG+LD +L T + ++ G A G+ YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLS-- 164
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYAC 328
+ VHRD+ + NIL++ +VSDFGL ++L + T G +PE
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 329 TGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
SDV+S+GI++ E+++ G P Y N G R L
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP--Y---WEMSNQDVIKAVDEGYR---------L 269
Query: 388 PKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYG 446
P AL +++ L C D RPK ++ +L+ L R+ + S +
Sbjct: 270 PPPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK---LIRNPGSLKIITSAAAR 323
Query: 447 EENRDFARKVGD 458
N + D
Sbjct: 324 PSNLLLDQSNVD 335
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 155 EENVIGEGGYGIVYRGIL---SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G VAVK L N + E E V+ ++ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VR++G C ++ MLV E + G L+++L + + + ++ + G+ YL E
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEYA 327
VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G + + APE
Sbjct: 136 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ KSDV+SFG+L+ E + G+ P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 50/302 (16%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ ++ EY++NG+L +L G LT + +++ A+G+A++ E
Sbjct: 77 VTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGMLN 333
+HRD++++NIL+ + +++DFGLA+L+ + Y T R F APE G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFT 188
Query: 334 EKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP-----KL 387
KSDV+SFGIL+ EI+T GR P Y G N EV+ ++
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP--Y---PGMTN--------------PEVIQNLERGYRM 229
Query: 388 PKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYG 446
+ + L +++ C RP ++ +LE Y
Sbjct: 230 VRPDNCPEELYQLM---RLCWKERPEDRPTFDYLRSVLE----------DFFTATEGQYQ 276
Query: 447 EE 448
+
Sbjct: 277 PQ 278
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 62/263 (23%), Positives = 114/263 (43%), Gaps = 23/263 (8%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
IG G + VYR L DG VA+K + + + + E++++ ++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+E +V E D G+L + + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML- 332
+V+HRD+K +N+ + ++ D GL + S+ + + V GT Y++PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE-RIHENGY 213
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
N KSD++S G L+ E+ ++P Y +L K P LP
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC--KKIEQCDY-------PPLPSDHY 263
Query: 393 SKALKRVLLVALRCVDPDATKRP 415
S+ L++++ C++PD KRP
Sbjct: 264 SEELRQLV---NMCINPDPEKRP 283
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 42/305 (13%)
Query: 156 ENVIGEGGYGIVYRGILSDG-TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++ +G G YG VY G+ VAVK L +EF E V+ ++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
C ++ E++ GNL +L ++ + + + + + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYACTGML 332
+HRD+ + N L+ +V+DFGL++L+ T F APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 333 NEKSDVYSFGILIMEIIT-GRNPVDYSR-PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ KSDV++FG+L+ EI T G +P Y +V + L+ R + +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQV--YELLEK--DYR---------MERP 234
Query: 391 P-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGREPSNSYGEEN 449
+ + ++ C + + RP + E + +E S S E
Sbjct: 235 EGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFE----------TMFQESSISDEVEK 281
Query: 450 RDFAR 454
R
Sbjct: 282 ELGKR 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 61/286 (21%), Positives = 123/286 (43%), Gaps = 27/286 (9%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G +G V + G VAVK L ++ + ++F+ E+E++ ++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLG 162
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPEY 326
+ +HRD+ + NIL++ + ++ DFGL K+L ++ Y + G + APE
Sbjct: 163 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP- 385
+ SDV+SFG+++ E+ T + S+ + G +++
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 386 ----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+LP+ + ++ C + + +RP + ++
Sbjct: 277 KNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 319
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 35/288 (12%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEGG+ V L DG A+K +L + Q +E + E ++ H N++RL+
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 215 YCVEGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
YC+ L+ + G L + + LT D + ++LG +GL +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM--------GTFGYV 322
HRD+K +NILL + + D G C + T Y
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 323 APE----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
APE + +++E++DV+S G ++ ++ G P D +G+ L
Sbjct: 211 APELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---LAVQNQLS- 265
Query: 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
P+ P+ S AL ++L + VDP +RP + ++ LEA
Sbjct: 266 -----IPQSPRH--SSALWQLLNSMMT-VDPH--QRPHIPLLLSQLEA 303
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 86/307 (28%), Positives = 139/307 (45%), Gaps = 41/307 (13%)
Query: 156 ENVIGEGGYGIVYRGILSDGT-----KVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNL 209
+ VIG G +G VY+G+L + VA+K L + ++ +F E ++G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+RL G + M++ EY++NG LD++L G+ S L + ++ G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAGMKYLA- 164
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEYA 327
VHRD+ + NIL++ +VSDFGL+++L + T G APE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 328 CTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
SDV+SFGI++ E++T G P Y N G R
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP--Y---WELSNHEVMKAINDGFR--------- 268
Query: 387 LPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA--------DDLLFRDERRI 437
LP A+ +++ ++C + +RPK ++ +L+ L D R
Sbjct: 269 LPTPMDCPSAIYQLM---MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVS 325
Query: 438 GREPSNS 444
R PS S
Sbjct: 326 IRLPSTS 332
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-37
Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
+GEG +G V G VAVK L + G Q +K E++++ + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 210 VRLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
++ G C + LV EYV G+L +L ++ L + +G+AYL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF--GYVAPE 325
H +HRD+ + N+LLD ++ DFGLAK + Y R G + APE
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 326 YACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384
SDV+SFG+ + E++T + E+ + G + +
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-----GQMTVLRLTE 262
Query: 385 P-----KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+LP+ + ++ C + +A+ RP ++I +L+
Sbjct: 263 LLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKT 307
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 44/297 (14%)
Query: 156 ENVIGEGGYGIVYRGIL----SDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
++GEG +G VY G+ + VAVK + +++F E ++ + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L + + LT + L K +AYL
Sbjct: 77 KLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLES- 131
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
VHRD+ NIL+ ++ DFGL++ + E Y + +++PE
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 331 MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP---- 385
SDV+ F + + EI++ G+ P + N ++V+
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP--F---FWLEN--------------KDVIGVLEKG 230
Query: 386 -KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRIGRE 440
+LPK L ++ RC D D + RP+ ++ L +++ E+ I E
Sbjct: 231 DRLPKPDLCPPVLYTLM---TRCWDYDPSDRPRFTELVCSLSD---VYQMEKDIAME 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 40/293 (13%)
Query: 156 ENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
V+G G +G VY+G+ VA+K L +A KE E V+ V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
RLLG C+ L+ + + G L ++ ++ +N + AKG+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYVAPEY 326
++VHRD+ + N+L+ + +++DFGLAKLL +E G ++A E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY-SRPQGEVNLVDWLKTMVGSRKSEEVVD 384
+ +SDV+S+G+ + E++T G P Y P E+ L+ G R
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEI--SSILEK--GER------- 237
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRI 437
LP+ P V ++ ++C DA RPK +I + RD +R
Sbjct: 238 --LPQPPI--CTIDVYMIMVKCWMIDADSRPKFRELIIEFSK---MARDPQRY 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEF-KVEVEVIGRVRHKNLVRLLG 214
IGEG +G DG + +K + ++ E+E + EV V+ ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E +V +Y + G+L + ++ G D ++ + L ++H+ K
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML-N 333
++HRD+KS NI L + ++ DFG+A++L S + GT Y++PE C N
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPE-ICENKPYN 203
Query: 334 EKSDVYSFGILIMEIITGRNP 354
KSD+++ G ++ E+ T ++
Sbjct: 204 NKSDIWALGCVLYELCTLKHA 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 153 LCEENVIGEGGYGIVYRGILSDG---TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKN 208
L + +G G +G V +G+ VA+K L +E E +++ ++ +
Sbjct: 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+VRL+G C A MLV E G L ++L G ++ ++ + G+ YL
Sbjct: 398 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKYLE 453
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY--VAPEY 326
E VHR++ + N+LL + A++SDFGL+K L ++ SY T R G + APE
Sbjct: 454 E---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 327 ACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ +SDV+S+G+ + E ++ G+ P
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 159 IGEGGYGIVYRG---ILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G GG VY IL KVA+K + + + K F+ EV ++ H+N+V +
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ E LV EY++ L +++ PL+ D +N G+ + H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
++VHRD+K NIL+D ++ DFG+AK L T V+GT Y +PE A
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
+E +D+YS GI++ E++ G P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
+G G +G VY G +S +VAVK L + ++ +F +E +I + H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLA 265
+VR +G ++ R ++ E + G+L +L S L +++ A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAKLLCSERSYVTTRVMGTFG-- 320
YL E +HRD+ + N LL RV DFG+A+ + SY
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 210
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
++ PE G+ K+D +SFG+L+ EI + G P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 153 LCEENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHK 207
+ VIG+G +G+VY G D + A+K+L + F E ++ + H
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 208 NLVRLLGYCVEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
N++ L+G + ++ Y+ +G+L Q++ + + ++ L A+G+ Y
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEY 139
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV---A 323
L E K VHRD+ + N +LD + +V+DFGLA+ + Y + V A
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSE 380
E T KSDV+SFG+L+ E++T G P Y + L +L G R
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP--Y---RHIDPFDLTHFLAQ--GRR--- 246
Query: 381 EVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
LP+ +L +V+ +C + D RP ++ +E
Sbjct: 247 ------LPQPEYCPDSLYQVM---QQCWEADPAVRPTFRVLVGEVEQ 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 157 NVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNL 209
+G+G +G+VY G+ T+VA+K + E+ EF E V+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL------HGDVGDVSPLTWDIRMNIILGTAKG 263
VRLLG +G +++ E + G+L +L + ++P + + + A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV- 322
+AYL+ K VHRD+ + N ++ + ++ DFG+ + + Y G G +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 323 ----APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+PE G+ SDV+SFG+++ EI T P
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-35
Identities = 63/293 (21%), Positives = 114/293 (38%), Gaps = 44/293 (15%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
IGEG +G V++GI VA+K ++F E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L + + + + LAYL
Sbjct: 80 KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAYLES- 134
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 331 MLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP---- 385
SDV+ FG+ + EI+ G P + QG N +V+
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP--F---QGVKN--------------NDVIGRIENG 233
Query: 386 -KLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERR 436
+LP P L ++ +C D ++RP+ + L + +E+
Sbjct: 234 ERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST---ILEEEKA 280
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
+ +GEG +G V+ + VAVK L A ++F+ E E++ ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------HGDVGDVSPLTWDIRMNIIL 258
VR G C EG ++V+EY+ +G+L+++L G+ PL + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A G+ YL VHRD+ + N L+ + ++ DFG+++ + S Y +G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGG 218
Query: 319 FGYV-----APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ PE +SDV+SFG+++ EI T G+ P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE--G 270
++ L V EY + G+L + + L + + ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
V+HRD+K +N+ LD + N ++ DFGLA++L + S+ T V GT Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPE-QMNR 190
Query: 331 ML-NEKSDVYSFGILIMEIITGRNP 354
M NEKSD++S G L+ E+ P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
+G G +G VY G +S +VAVK L + ++ +F +E +I + H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLA 265
+VR +G ++ R ++ E + G+L +L S L +++ A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAKLLCSERSYVTTRVMGTFGYV 322
YL E +HRD+ + N LL RV DFG+A+ + Y G +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAML 248
Query: 323 -----APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
PE G+ K+D +SFG+L+ EI + G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 156 ENVIGEGGYGIVYRGIL--------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK 207
+G+G + +++G+ T+V +K L + F ++ ++ HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+LV G CV G +LV E+V G+LD +L + ++ L ++ + A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW---KLEVAKQLAAAMHFL 129
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNAR--------VSDFGLAKLLCSERSYVTTRVMGTF 319
E ++H +V + NILL R+ + + +SD G++ + + + R+
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184
Query: 320 GYVAPE-YACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
PE LN +D +SFG + EI + G P
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
VIG G +G VY G L D AVK+L E +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 211 RLLGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ ++V Y+ +G+L ++ + + + + L AKG+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLAS 146
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG------YVA 323
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y V G ++A
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSE 380
E T KSDV+SFG+L+ E++T G P Y + +L G R
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PDVNTFDITVYLLQ--GRR--- 250
Query: 381 EVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
L + L V+ L+C P A RP ++ + A
Sbjct: 251 ------LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEK-EFKVEVEVIGRVRHKNL 209
++GEG +G V G L KVAVK + L+N Q E EF E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 210 VRLLGYCVEG-----AYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK 262
+RLLG C+E M++ ++ G+L +L + + ++ A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV------- 315
G+ YL +HRD+ + N +L V+DFGL+K + S Y R+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ A E + KSDV++FG+ + EI T G P
Sbjct: 216 I------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 156 ENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
+ +GEG +G V+ D VAVK L + A K+F+ E E++ ++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMNII 257
V+ G C +G ++V+EY+ +G+L+++L L ++I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT---- 313
A G+ YL VHRD+ + N L+ ++ DFG+++ + S Y
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 314 ---RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
R M PE +SDV+SFG+++ EI T G+ P
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 156 ENVIGEGGYGIVYRGILSDG---TKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + + A+K + + + +F E+EV+ ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMNIIL 258
LLG C Y L EY +GNL +L S L+ ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT----- 313
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ + YV
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 314 --RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
R M A E + SDV+S+G+L+ EI++ G P
Sbjct: 204 PVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 31/221 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEKE-FKVEVEVIGRVRHKNL 209
++G+G +G V L KVAVK L + ++ E F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 210 VRLLGYCVEG------AYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTA 261
+L+G + M++ ++ +G+L +L + L + ++ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV------ 315
G+ YL +HRD+ + N +L V+DFGL++ + S Y
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 316 -MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ A E + SDV++FG+ + EI+T G+ P
Sbjct: 205 WL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 58/301 (19%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKN 208
+GE +G VY+G L VA+K L + G +EF+ E + R++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMNI 256
+V LLG + +++ Y +G+L ++L D S L +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--- 313
+ A G+ YL VVH+D+ + N+L+ + N ++SD GL + + + Y
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 314 ----RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--L 366
R M APE G + SD++S+G+++ E+ + G P Y G N +
Sbjct: 191 LLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--Y---CGYSNQDV 239
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
V+ ++ LP + ++ + C + ++RP+ + L
Sbjct: 240 VEMIRN--RQV---------LPCPDDCPAWVYALM---IECWNEFPSRRPRFKDIHSRLR 285
Query: 426 A 426
A
Sbjct: 286 A 286
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 60/286 (20%), Positives = 113/286 (39%), Gaps = 53/286 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G GG+G+V+ D A+K + L NR A ++ EV+ + ++ H +VR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 216 CVEG---------AYRMLVY---EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
+E + ++ +Y + NL W++G + + ++I L A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEA 130
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM------- 316
+ +LH ++HRD+K SNI +V DFGL + + T
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 317 ----GTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371
GT Y++PE G + K D++S G+++ E++ ++ V L
Sbjct: 188 TGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERVRTLT 238
Query: 372 TMVGSRKSEEVVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRP 415
+V + K P + ++ + P +RP
Sbjct: 239 ---------DVRNLKFPPLFTQKYPCEYVMV---QDMLSPSPMERP 272
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-34
Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 13/205 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
IGEG +G V++GI VA+K ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L + + + + LAYL
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQLSTALAYLES- 509
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 331 MLNEKSDVYSFGILIMEIIT-GRNP 354
SDV+ FG+ + EI+ G P
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 51/277 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+IG GG+G V++ DG +K + N +AE+E V+ + ++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72
Query: 216 CVEGAYRM----------------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
Y + E+ D G L+QW+ G L + + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQ 130
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
KG+ Y+H K+++RD+K SNI L ++ DFGL L + TR GT
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGTL 185
Query: 320 GYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
Y++PE + ++ D+Y+ G+++ E++ +
Sbjct: 186 RYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF----------- 228
Query: 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
++ D + + K K +L + + RP
Sbjct: 229 -TDLRDGIISDIF-DKKEKTLL---QKLLSKKPEDRP 260
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 80/280 (28%), Positives = 127/280 (45%), Gaps = 38/280 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G YGIVY G LS+ ++A+K + + + E+ + ++HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E + + E V G+L L G + +GL YLH+ ++V
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPL-KDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 277 HRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE---YACTGML 332
HRD+K N+L++ ++SDFG +K L T GT Y+APE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG-Y 202
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM--VGSRKSEEVVDPKLPKM 390
+ +D++S G I+E+ TG+ P + L + M VG K P++P+
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP--FY------ELGEPQAAMFKVGMFKVH----PEIPE- 249
Query: 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430
S K + L+C +PD KR A+DLL
Sbjct: 250 SMSAEAKAFI---LKCFEPDPDKRA---------CANDLL 277
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 42/286 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
VIG G +G VY G L D AVK+L E +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 211 RLLGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ ++V Y+ +G+L ++ + + + + L AKG+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLAS 210
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV-----AP 324
K VHRD+ + N +LD ++ +V+DFGLA+ + ++ + + T + A
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMAL 265
Query: 325 EYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSEE 381
E T KSDV+SFG+L+ E++T G P Y + +L G R
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PDVNTFDITVYLLQ--GRR---- 314
Query: 382 VVDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
L + L V+ L+C P A RP ++ + A
Sbjct: 315 -----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 352
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 47/206 (22%), Positives = 81/206 (39%), Gaps = 17/206 (8%)
Query: 156 ENVIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKE----FKVEVEVIGRVRHKN 208
++G GG G VY + VA+K L++ ++ + E GR++ +
Sbjct: 39 RRLVGRGGMGDVYEAEDTVR--ERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + + + ++ +L L PL + I+ L H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
HRDVK NIL+ A + DFG+A E+ +GT Y+APE
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNP 354
++D+Y+ ++ E +TG P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 70/288 (24%), Positives = 114/288 (39%), Gaps = 54/288 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G +G V + D A+K + + + EV ++ + H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 217 VEGAYRM-------------LVYEYVDNGNLDQWLH-GDVGDVSPLTWDIRMNIILGTAK 262
+E + + EY +NG L +H ++ W + I+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA--- 128
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV----------- 311
L+Y+H ++HRD+K NI +D N ++ DFGLAK + +
Sbjct: 129 -LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 312 ---TTRVMGTFGYVAPE-YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367
T+ + GT YVA E TG NEK D+YS GI+ E+I + V
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTGMERV 235
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
+ LK + R P K K+++ +D D KRP
Sbjct: 236 NILKKL---RSVSIEFPPDFDD-NKMKVEKKII---RLLIDHDPNKRP 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 156 ENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-R 205
+GEG +G V VAVK L ++ + + + E+E++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNL------------DQWLHGDVGDVSPLTWDIR 253
HKN++ LLG C + ++ EY GNL + + +T+
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++ A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y T
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 314 RV-------MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
M APE + +SDV+SFG+L+ EI T G +P
Sbjct: 217 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 67/234 (28%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
+GEG +G V + T VAVK L N +E + E V+ +V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------------HGDVGDVSPL 248
+++L G C + +L+ EY G+L +L D D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
T ++ ++G+ YL E K+VHRD+ + NIL+ ++SDFGL++ + E
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 309 SYVTT-------RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
SYV + M A E + +SDV+SFG+L+ EI+T G NP
Sbjct: 205 SYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 84/380 (22%), Positives = 146/380 (38%), Gaps = 62/380 (16%)
Query: 81 HHPAPVPEIQVDIGK---IEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGW 137
HH + P + K + +V S +SS + T T S + P ++ +
Sbjct: 8 HHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSE 67
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQ 189
+ E L +GEG +G V VAVK L ++ +
Sbjct: 68 YELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 190 AEK-EFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL------------D 235
+ + E+E++ + +HKN++ LLG C + ++ EY GNL +
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
+ +T+ ++ A+G+ YL K +HRD+ + N+L+ ++
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKI 244
Query: 296 SDFGLAKLLCSERSYVTTRV-------MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEI 348
+DFGLA+ + + Y T M APE + +SDV+SFG+L+ EI
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 349 IT-GRNPVDYSRPQGEVN--LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALR 405
T G +P Y G L LK G R + K + ++
Sbjct: 299 FTLGGSP--Y---PGIPVEELFKLLKE--GHR---------MDKPA--NCTNELYMMMRD 340
Query: 406 CVDPDATKRPKMGHVIHMLE 425
C ++RP ++ L+
Sbjct: 341 CWHAVPSQRPTFKQLVEDLD 360
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 56/292 (19%), Positives = 108/292 (36%), Gaps = 65/292 (22%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRV-RHKNLV 210
E IG G +G V++ + DG A+K G +++ + EV + +H ++V
Sbjct: 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
R E + ++ EY + G+L + + +S +++L +GL Y+H
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132
Query: 271 LEPKVVHRDVKSSNILLDR-------------------QWNARVSDFGLAKLLCSERSYV 311
+VH D+K SNI + R + ++ D G + S +
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 312 TTRVMGTFGYVAPEYACTGMLNE------KSDVYSFGILIMEIITGRNPVDYSRPQGEVN 365
G ++A E +L E K+D+++ + ++
Sbjct: 192 -----GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236
Query: 366 LVDWLKTMVGSRKSEEVVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRP 415
W + G +LP++P S+ +L + PD +RP
Sbjct: 237 ---WHEIRQG----------RLPRIPQVLSQEFTELL---KVMIHPDPERRP 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 68/262 (25%), Positives = 99/262 (37%), Gaps = 32/262 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRV-RHKNLVRLL 213
+G G YG V++ DG AVK RG ++ K+ EV +V +H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
EG L E +L Q G + L + T LA+LH
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCE-AWG--ASLPEAQVWGYLRDTLLALAHLHS---Q 176
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+VH DVK +NI L + ++ DFGL L + G Y+APE G
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYG 233
Query: 334 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 393
+DV+S G+ I+E+ W + G + P+ S
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGE--------GWQQLRQG------YLPPEFTA-GLS 278
Query: 394 KALKRVLLVALRCVDPDATKRP 415
L+ VL + ++PD R
Sbjct: 279 SELRSVL---VMMLEPDPKLRA 297
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 159 IGEGGYGIVYRG---ILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G GG V+ VAVK L L F+ E + + H +V +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 213 LGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
G +V EYVD L +H P+T + +I + L + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH 133
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--RVMGTFGYVAPEY 326
+ ++HRDVK +NI++ +V DFG+A+ + + VT V+GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNP 354
A ++ +SDVYS G ++ E++TG P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 156 ENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHK 207
+G G +G V KVAVK L + EK E++++ + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL----------HGDVGDVSPLTWDIRMNII 257
N+V LLG C G +++ EY G+L +L S + ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT---- 313
A+G+A+L +HRDV + N+LL A++ DFGLA+ + ++ +Y+
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 314 ---RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ M APE + +SDV+S+GIL+ EI + G NP
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 156 ENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHK 207
+G G +G V VAVK L + E+ E++V+ + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------HGDVGDVSPLTWDIR 253
N+V LLG C G +++ EY G+L +L D L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++ AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 314 -------RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ M APE + +SDV+S+GI + E+ + G +P
Sbjct: 205 GNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-32
Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 55/299 (18%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHKN 208
+G G +G V + VAVK L +E E++++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 209 LVRLLGYC-VEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMN 255
+V LLG C G M++ E+ GNL +L + LT + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT-- 313
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 314 -----RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLV 367
+ M APE + +SDV+SFG+L+ EI + G +P Y + +
Sbjct: 210 ARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFC 261
Query: 368 DWLKTMVGSRKSEEVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
LK G+R + + + + + L C + ++RP ++ L
Sbjct: 262 RRLKE--GTR---------MRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 40/232 (17%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
IGEG +G V++ T VAVK L + +F+ E ++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------------HGDVGDVSPL 248
+V+LLG C G L++EY+ G+L+++L PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
+ ++ I A G+AYL E K VHRD+ + N L+ +++DFGL++ + S
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 309 SYVTTRVMGTFGYV-----APEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
Y + PE +SDV+++G+++ EI + G P
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 39/229 (17%)
Query: 156 ENVIGEGGYGIVYRGIL--------SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-R 205
+GEG +G V + TKVAVK L ++ + + + E+E++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIR 253
HKN++ LLG C + ++ EY GNL ++L + L+
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++ A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 314 -------RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+ M APE + +SDV+SFG+L+ EI T G +P
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 44/234 (18%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHK 207
V+G G +G V +VAVK L +E+ E++++ ++ H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-------------------HGDVGDVSPL 248
N+V LLG C L++EY G+L +L + D++ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
T++ + AKG+ +L VHRD+ + N+L+ ++ DFGLA+ + S+
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 309 SYVTT-------RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNP 354
+YV + M APE G+ KSDV+S+GIL+ EI + G NP
Sbjct: 227 NYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 51/267 (19%), Positives = 94/267 (35%), Gaps = 49/267 (18%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLL 213
I GG G +Y + +G V +K L+++ + E + + V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 214 GYCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ +V EYV +L + L + +L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+V+ D+K NI+L + ++ D G + S + GT G+ APE
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIV- 249
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388
+D+Y+ G + + + G + P
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------LPEDDP 289
Query: 389 KMPASKALKRVLLVALRCVDPDATKRP 415
+ + R+L R +DPD +R
Sbjct: 290 VLKTYDSYGRLL---RRAIDPDPRQRF 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 39/362 (10%), Positives = 85/362 (23%), Gaps = 62/362 (17%)
Query: 89 IQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWG-RWYTLRELE 147
++ + + E + + + E A + + S L G R L E
Sbjct: 11 MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE-- 68
Query: 148 AATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGR 203
+ G +V+ + A+K N + R
Sbjct: 69 ----------PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 204 VRHKNLVRLLGYC--------------------------VEGAYRMLVYEYV--DNGNLD 235
+ ++ A +L+ D L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
L + + A L +VH N+ + +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLML 235
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC--TGMLNEKSDVYSFGILIMEIITGRN 353
D + + Y E+ T + + G+ I +
Sbjct: 236 GDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
Query: 354 PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK 413
P P + W + + ++ + +P +K ++ R ++ D +
Sbjct: 292 PFGLVTPGIK---GSWKRPSLRVPGTDSLAFGSCTPLPD--FVKTLI---GRFLNFDRRR 343
Query: 414 RP 415
R
Sbjct: 344 RL 345
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 65/271 (23%), Positives = 110/271 (40%), Gaps = 26/271 (9%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGR-VRHKNL 209
L +G G YG+V + + G +AVK + Q +K +++++ R V
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V G + E +D +LD++ + + DI I + K L +LH
Sbjct: 69 VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE---- 325
+ V+HRDVK SN+L++ ++ DFG++ L G Y+APE
Sbjct: 128 --KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINP 183
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
+ KSD++S GI ++E+ R P Y LK +V P
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQ---LKQVVEEP------SP 232
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPK 416
+LP S + +C+ ++ +RP
Sbjct: 233 QLPADKFSAEFVD--FTS-QCLKKNSKERPT 260
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 46/230 (20%)
Query: 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVE 197
W T + +G G +G V+R G + AVK + + E E
Sbjct: 58 HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN 255
+ + +V L G EG + + E ++ G+L Q + G L D +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG------CLPEDRALY 154
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTR 314
+ +GL YLH +++H DVK+ N+LL A + DFG A L + +
Sbjct: 155 YLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 315 ----VMGTFGYVAPE------YACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ GT ++APE + K D++S +++ ++ G +P
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPC------DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV G +VAVK + + Q + EV ++ +H N+V + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G ++ E++ G L D+ L + + + LAYLH V+H
Sbjct: 113 VGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIH 164
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSD 337
RD+KS +ILL ++SDFG + + + V GT ++APE + + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVD 223
Query: 338 VYSFGILIMEIITGRNP 354
++S GI+++E++ G P
Sbjct: 224 IWSLGIMVIEMVDGEPP 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IG+G G VY + ++ G +VA++ + + ++ E+ V+ ++ N+V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V EY+ G+L DV + + + + L +LH +V+H
Sbjct: 88 VGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSD 337
RD+KS NILL + +++DFG + E+S +T V GT ++APE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 338 VYSFGILIMEIITGRNP 354
++S GI+ +E+I G P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V++GI VA+K + + E E + E+ V+ + + + G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ ++ EY+ G+ D+ + PL I+ KGL YLH K
Sbjct: 89 YLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE---KK 140
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+K++N+LL +++DFG+A L + T +GT ++APE + K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSK 199
Query: 336 SDVYSFGILIMEIITGRNP 354
+D++S GI +E+ G P
Sbjct: 200 ADIWSLGITAIELARGEPP 218
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 57/275 (20%), Positives = 110/275 (40%), Gaps = 39/275 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNL--VRL 212
IG GG V++ + A+K NL Q ++ E+ + +++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + Y +V E N +L+ WL + R + + + +H+
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPE------ 325
+VH D+K +N L+ ++ DFG+A + S V +GT Y+ PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 326 -----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380
++ KSDV+S G ++ + G+ P + + +++ + +
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKL--------HAIID 235
Query: 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
+ + P +P K L+ VL C+ D +R
Sbjct: 236 PNHEIEFPDIP-EKDLQDVL---KCCLKRDPKQRI 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 11/243 (4%)
Query: 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ + +G G G+V++ G +A K + L + + E++V+ +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G + E++D G+LDQ L + I + + KGL YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE- 149
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ K++HRDVK SNIL++ + ++ DFG++ L S + V GT Y++PE
Sbjct: 150 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGT 205
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ +SD++S G+ ++E+ GR P+ + + + P P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 391 PAS 393
Sbjct: 266 KFG 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 59/275 (21%), Positives = 109/275 (39%), Gaps = 39/275 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNL--VRL 212
IG GG V++ + A+K NL Q ++ E+ + +++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + Y +V E N +L+ WL + R + + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPE------ 325
+VH D+K +N L+ ++ DFG+A + S V +GT Y+ PE
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 326 -----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380
++ KSDV+S G ++ + G+ P +N + L ++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPN--- 256
Query: 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
+ + P +P K L+ VL C+ D +R
Sbjct: 257 --HEIEFPDIP-EKDLQDVL---KCCLKRDPKQRI 285
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY +A+K L L G + + EVE+ +RH N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHS-- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+LL +++DFG + S R GT Y+ PE M
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLPPEMIEGRM 183
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+EK D++S G+L E + G+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 39/275 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNL--VRL 212
IG GG V++ + A+K NL Q ++ E+ + +++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + Y +V E N +L+ WL + R + + + +H+
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPE------ 325
+VH D+K +N L+ ++ DFG+A + S V +G Y+ PE
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 326 -----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380
++ KSDV+S G ++ + G+ P + + +++ + +
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKL--------HAIID 282
Query: 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP 415
+ + P +P K L+ VL C+ D +R
Sbjct: 283 PNHEIEFPDIP-EKDLQDVL---KCCLKRDPKQRI 313
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 25/227 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G V+RG G A+K N ++ + + + E EV+ ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 215 Y--CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+++L+ E+ G+L L + + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 273 PKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+VHR++K NI+ D Q +++DFG A+ L + + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTEEYLHPDMYE 188
Query: 329 TGML--------NEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNL 366
+L D++S G+ TG P + P+ +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 75/274 (27%), Positives = 117/274 (42%), Gaps = 28/274 (10%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGR-VRHKNL 209
L + IG G YG V + + G +AVK + + +K+ ++++V+ R +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+ G + E + + + + +I I L T K L +L E
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE---- 325
K++HRD+K SNILLDR N ++ DFG++ L S TR G Y+APE
Sbjct: 144 --NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDP 199
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
A + +SDV+S GI + E+ TGR P Y + + + T V P
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVFDQL----TQVVKGDP-----P 248
Query: 386 KLPKMPA---SKALKRVLLVALRCVDPDATKRPK 416
+L S + V C+ D +KRPK
Sbjct: 249 QLSNSEEREFSPSFIN--FVN-LCLTKDESKRPK 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 46/204 (22%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G +G VY+ G A K + + +++ VE+E++ H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ E+ G +D + LT + + L +LH ++
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML--- 332
+HRD+K+ N+L+ + + R++DFG++ + +GT ++APE +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMKDT 197
Query: 333 --NEKSDVYSFGILIMEIITGRNP 354
+ K+D++S GI ++E+ P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPP 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 34/276 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLL-NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++V+G G G + + D VAVK +L A++E ++ E H N++R
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIRYFC 85
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ ++ + E L +++ D + L + ++ T GLA+LH
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQ--KDFAHLGLEPI-TLLQQTTSGLAHLH---SLN 138
Query: 275 VVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGYVAPEY- 326
+VHRD+K NIL+ + A +SDFGL K L R + R V GT G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 327 --ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384
C D++S G + +I+ + Q + N+ +D
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----------LLGACSLD 248
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420
P+ + L+ + + D KRP HV
Sbjct: 249 CLHPEKHEDVIARE--LIE-KMIAMDPQKRPSAKHV 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-27
Identities = 67/286 (23%), Positives = 106/286 (37%), Gaps = 40/286 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLL-- 213
+G GG+G V R I G +VA+K +E + +E++++ ++ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+L EY + G+L ++L+ + L ++ + L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNAR---VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
+++HRD+K NI+L + D G AK L + T V GT Y+APE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQYLAPEL 194
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS---------- 376
D +SFG L E ITG P V W +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFL-----PNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 377 -----RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
+ S + P + L+R L L +R
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM-WHQ--RQRGTD 292
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 25/227 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G V+RG G A+K N ++ + + + E EV+ ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 215 Y--CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+++L+ E+ G+L L + + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 273 PKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+VHR++K NI+ D Q +++DFG A+ L + + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTEEYLHPDMYE 188
Query: 329 TGML--------NEKSDVYSFGILIMEIITGRNP-VDYSRPQGEVNL 366
+L D++S G+ TG P + P+ +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 4e-27
Identities = 34/235 (14%), Positives = 64/235 (27%), Gaps = 41/235 (17%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGRVR-------- 205
V+G+ G V A K+ K EV + +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 206 -----------------HKNLVRLLG----YCVEGAYRMLVYEYVDNGNLDQWLHGDVGD 244
K ++R+ V + + + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
L R+ + L + LA LH +VH ++ +I+LD++ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 305 CSERSYVTTRVMGTFGYVAPE-----YACTGMLNEKSDVYSFGILIMEIITGRNP 354
+ R A ++ D ++ G+ I I P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG VY+ I G VA+K + +E E+ ++ + ++V+ G
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ +V EY G++ + LT D I+ T KGL YLH +
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---R 145
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
+HRD+K+ NILL+ + +A+++DFG+A L + T + GT ++APE N
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204
Query: 335 KSDVYSFGILIMEIITGRNP 354
+D++S GI +E+ G+ P
Sbjct: 205 VADIWSLGITAIEMAEGKPP 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 63/330 (19%), Positives = 122/330 (36%), Gaps = 51/330 (15%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
V+ EGG+ VY + G + A+K LL+N + + EV + ++ H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 214 GYCV-------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G L+ + G L ++L + PL+ D + I T + + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM---------- 316
+H +P ++HRD+K N+LL Q ++ DFG A + Y +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 317 -GTFGYVAPE----YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371
T Y PE Y+ + EK D+++ G ++ + ++P + L+
Sbjct: 211 NTTPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHPFEDGAK---------LR 260
Query: 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLF 431
+ G P ++ + + +R + V+H L+
Sbjct: 261 IVNGKYS-----IPPHDTQ--YTVFHSLI---RAMLQVNPEERLSIAEVVHQLQE----I 306
Query: 432 RDERRI-GREPSNSYGEENRDFARKVGDKQ 460
R + + P E+N + +
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 18/205 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ + A K +LL Q EK +E+ + + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + LT + G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+ L+ ++ DFGLA + + + GT Y+APE
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 332 LNEKSDVYSFGILIMEIITGRNPVD 356
+ + DV+S G ++ ++ G+ P +
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G + VYR + G +VA+K + G ++ + EV++ +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
Y + Y LV E NG ++++L V P + + + + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHS---H 131
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
++HRD+ SN+LL R N +++DFGLA L T + GT Y++PE A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHG 190
Query: 334 EKSDVYSFGILIMEIITGRNP 354
+SDV+S G + ++ GR P
Sbjct: 191 LESDVWSLGCMFYTLLIGRPP 211
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLG- 214
++G G YG VY+G + G A+K +++ G E+E K E+ ++ + H+N+ G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 215 YCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ + M LV E+ G++ + G+ L + I +GL++LH+
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--TLKEEWIAYICREILRGLSHLHQ 147
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE-YAC 328
KV+HRD+K N+LL ++ DFG++ L T +GT ++APE AC
Sbjct: 148 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIAC 203
Query: 329 TGML----NEKSDVYSFGILIMEIITGRNP 354
+ KSD++S GI +E+ G P
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 37/276 (13%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGR-VRHKNL 209
L +G G G V++ G +AVK + + + K ++++V+ + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+ G + + E + P+ I + + K L YL E
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE 142
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE---- 325
+ V+HRDVK SNILLD + ++ DFG++ L R G Y+APE
Sbjct: 143 --KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDP 198
Query: 326 -YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384
+ ++DV+S GI ++E+ TG+ P Y + + ++ +V+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDFEVL------------TKVLQ 244
Query: 385 PKLPKMPA----SKALKRVLLVALRCVDPDATKRPK 416
+ P +P S + V C+ D KRPK
Sbjct: 245 EEPPLLPGHMGFSGDFQS--FVK-DCLTKDHRKRPK 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 47/211 (22%), Positives = 72/211 (34%), Gaps = 18/211 (8%)
Query: 157 NVIGEG--GYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG+G V G V V+ NL + + E+ V H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ +V ++ G+ + D + I+ G K L Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM- 147
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV------APE 325
VHR VK+S+IL+ +S + S V +PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 326 YACTGML--NEKSDVYSFGILIMEIITGRNP 354
+ + KSD+YS GI E+ G P
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGY 215
VIG G +V KVA+K + + Q + E++ + + H N+V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 216 CVEGAYRMLVYEYVDNGNL----DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
V LV + + G++ + L I+ +GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF-G---YVAPE-- 325
+HRDVK+ NILL + +++DFG++ L + +V TF G ++APE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 326 -----YACTGMLNEKSDVYSFGILIMEIITGRNP 354
Y + K+D++SFGI +E+ TG P
Sbjct: 199 EQVRGY------DFKADIWSFGITAIELATGAAP 226
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/298 (22%), Positives = 110/298 (36%), Gaps = 57/298 (19%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLG 214
E ++G G G V G VAVK +L + +E++++ H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYC 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM-NIILGTAKGLAYLHEGL 271
+ + E N NL + + L + +++ A G+A+LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 272 EPKVVHRDVKSSNILLD-------------RQWNARVSDFGLAKLLCSERSYVTTRVM-- 316
K++HRD+K NIL+ +SDFGL K L S +S T +
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 317 -GTFGYVAPE-------YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV- 367
GT G+ APE L D++S G + I++ + E N++
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 368 -----DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420
D +K + E D L++ + +D D KRP V
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATD----------------LIS-QMIDHDPLKRPTAMKV 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 43/221 (19%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVK-----------------NLLNNRGQAEKEFKVEVEV 200
+ +G + + D A+K N + +FK E+++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNI 256
I ++++ + G ++YEY++N ++ ++ D + + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
I +Y+H + HRDVK SNIL+D+ ++SDFG ++ + ++ +
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS--R 211
Query: 317 GTFGYVAPEYACTGML---NEKSDVYSFGILIMEIITGRNP 354
GT+ ++ PE + K D++S GI + + P
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 42/290 (14%), Positives = 93/290 (32%), Gaps = 46/290 (15%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEKEFKVE 197
E + + + +++GEG + VY D K +K + EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114
Query: 198 VEVIGRVR---HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIR 253
+++ R++ ++ + +LV E G L + + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-----------DRQWNARVSDFGLAK 302
++ + + +H+ +++H D+K N +L D + D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 303 LL--CSERSYVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNPV 355
+ + + T + T G+ E ML+ K D + + ++ G
Sbjct: 232 DMKLFPKGTIFTAKC-ETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM- 284
Query: 356 DYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL-----PKMPASKALKRVL 400
GE + + E L +P+ L++ L
Sbjct: 285 KVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ + A K +LL Q EK +E+ + + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + LT + G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHR-- 159
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
+V+HRD+K N+ L+ ++ DFGLA + + + GT Y+APE
Sbjct: 160 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217
Query: 332 LNEKSDVYSFGILIMEIITGRNP 354
+ + DV+S G ++ ++ G+ P
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G+G +G VY + +A+K L L G E + + E+E+ +RH N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
Y + L+ E+ G L + L HG + A L Y HE
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHE- 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
KV+HRD+K N+L+ + +++DFG + S R + GT Y+ PE
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGK 187
Query: 331 MLNEKSDVYSFGILIMEIITGRNP 354
+EK D++ G+L E + G P
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVRL 212
IG G +G VY + + VA+K + + Q+ ++ EV + ++RH N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G + LV EY D PL + G +GLAYLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--- 329
++HRDVK+ NILL ++ DFG A ++ S+V GT ++APE
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDE 227
Query: 330 GMLNEKSDVYSFGILIMEIITGRNP 354
G + K DV+S GI +E+ + P
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPP 252
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 35/214 (16%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLR 113
Query: 214 GY------CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ + Y LV +YV + + L + + LAY+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSER---SYVTTRVMGTFGYVA 323
H + HRD+K N+LLD ++ DFG AK L SY+ +R Y A
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 224
Query: 324 PEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
PE + DV+S G ++ E++ G+
Sbjct: 225 PEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL- 213
VIG G +G+V++ L + +VA+K +L +K FK E++++ V+H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 214 -----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
G + + LV EYV + + + + + + LAY+H
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSER---SYVTTRVMGTFGYVAP 324
+ HRD+K N+LLD ++ DFG AK+L + SY+ +R Y AP
Sbjct: 159 SI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAP 210
Query: 325 EYACTGMLNEKS-----DVYSFGILIMEIITGR 352
E + + D++S G ++ E++ G+
Sbjct: 211 EL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 31/215 (14%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
E + G+G +G V G G VA+K ++ + +E + ++ + + H N+V+L
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQ- 85
Query: 215 YCV--------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
Y +V EYV + L + + + + +
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSER---SYVTTRVMGTFGYV 322
LH V HRD+K N+L++ ++ DFG AK L +Y+ +R Y
Sbjct: 145 LHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YR 198
Query: 323 APEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
APE + + D++S G + E++ G
Sbjct: 199 APEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 36/241 (14%), Positives = 68/241 (28%), Gaps = 52/241 (21%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGRVR-------- 205
V+G+ G V A K+ K EV + +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 206 -----------------HKNLVRLLG----YCVEGAYRMLVYEYVDNGNLDQWLHGDVGD 244
K ++R+ V + + + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
L R+ + L + LA LH +VH ++ +I+LD++ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 305 CSERSYVTTRVMGTFGYVAPEYACT-----------GMLNEKSDVYSFGILIMEIITGRN 353
R + G+ PE ++ D ++ G++I I
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 354 P 354
P
Sbjct: 312 P 312
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V + A+K + + + EV V+ + H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ + LV E G L + + D + + + +L G+ YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLS---GVTYLH 153
Query: 269 EGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
+ +VHRD+K N+LL ++ +A ++ DFGL+ + E +GT Y+APE
Sbjct: 154 KH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE 208
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNP 354
+EK DV+S G+++ ++ G P
Sbjct: 209 -VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 41/220 (18%), Positives = 77/220 (35%), Gaps = 46/220 (20%)
Query: 215 YCVEGAYRMLVY---EYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYLH 268
+ ++ +Y + NL W++ + I + I + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH 181
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-----------TRVMG 317
++HRD+K SNI +V DFGL + + T T +G
Sbjct: 182 S---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377
T Y++PE + K D++S G+++ E++ + M R
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----------------QMERVR 281
Query: 378 KSEEVVDPKLPKMPA--SKALKRVLLVALRCVDPDATKRP 415
+V + K P + ++ + P T+RP
Sbjct: 282 IITDVRNLKFPLLFTQKYPQEHMMV---QDMLSPSPTERP 318
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 2/76 (2%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G GG+G+V+ D A+K + L NR A ++ EV+ + ++ H +VR
Sbjct: 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 213 LGYCVEGAYRMLVYEY 228
+E E
Sbjct: 70 FNAWLETPPEKWQEEM 85
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 41/223 (18%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK-------------NLLNNRGQAEKEFKVEVEVI 201
+G G YG V + ++ A+K + N + +E E+ ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRM 254
+ H N+++L + Y LV E+ + G L + + D ++ M
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI--------M 152
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYV 311
IL G+ YLH+ +VHRD+K NILL ++ ++ DFGL+ + Y
Sbjct: 153 KQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYK 204
Query: 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+GT Y+APE NEK DV+S G+++ ++ G P
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ V+G+G +G V G + AVK + + E EV+++ ++ H N++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIM 89
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKG 263
+L + + Y LV E G L + D + + +L G
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--------IRQVLS---G 138
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 320
+ Y+H+ K+VHRD+K N+LL + +A R+ DFGL+ E S +GT
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAY 193
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
Y+APE G +EK DV+S G+++ +++G P
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 53/209 (25%), Positives = 107/209 (51%), Gaps = 26/209 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVR 211
+G G Y VY+G+ + G VA+K + + +E+ E+ ++ ++H+N+VR
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
L LV+E++DN +L +++ L ++ +GLA+ HE
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYAC 328
K++HRD+K N+L++++ ++ DFGLA+ ++ ++ V+ T Y AP+
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLWYRAPDV-- 179
Query: 329 TGMLNEKS-----DVYSFGILIMEIITGR 352
++ ++ D++S G ++ E+ITG+
Sbjct: 180 --LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG+G + +V R I G + AVK ++ G + ++ K E + ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 212 LLGYCVEGAYRMLVYEYVDNGNL-DQWL-HGDVG------DVSPLTWDIRMNIILGTAKG 263
LL +V+E++D +L + + D G S M IL +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----MRQIL---EA 142
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFG 320
L Y H+ ++HRDVK +LL ++ +A V FG+A L RV GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 321 YVAPEYACTGMLNEKSDVYSFGIL 344
++APE + DV+ G++
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVR 211
+GEG YG+VY+ S G VA+K + R AE E E+ ++ + H N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L+ LV+E+++ +L + L + + I + +L +G+A+ H+
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH- 138
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTG 330
+++HRD+K N+L++ +++DFGLA+ RSY T V+ T Y AP+
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPDV---- 190
Query: 331 MLNEKS-----DVYSFGILIMEIITGR 352
++ K D++S G + E+ITG+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IGEG YG V++ VA+K + R + E E+ ++ ++HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL LV+E+ D +L ++ GD+ P + +L KGL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR 120
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACT 329
V+HRD+K N+L++R ++++FGLA+ R Y + V+ T Y P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPPDV--- 172
Query: 330 GMLNEKS-----DVYSFGILIMEIITGRNP 354
+ K D++S G + E+ P
Sbjct: 173 -LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IGEG YG+V++ G VA+K + K E+ ++ +++H NLV
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL LV+EY D+ + L V ++ +I T + + + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHL--VK-SITWQTLQAVNFCHKH 121
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+HRDVK NIL+ + ++ DFG A+LL Y V T Y +PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPEL---- 173
Query: 331 MLNEKS-----DVYSFGILIMEIITGR 352
++ + DV++ G + E+++G
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 40/217 (18%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
++G+G +G V + + AVK N + + + EVE++ ++ H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLA 265
+ + +V E G L + D + + + G+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--------IKQVFS---GIT 135
Query: 266 YLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
Y+H+ +VHRD+K NILL ++ + ++ DFGL+ +++ +GT Y+
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYI 190
Query: 323 APE-----YACTGMLNEKSDVYSFGILIMEIITGRNP 354
APE Y +EK DV+S G+++ +++G P
Sbjct: 191 APEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 5e-21
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+G G + V+ G A+K + + + + E+ V+ +++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHE 269
+ LV + V G L + + G D S + + + YLHE
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRIL-ERGVYTEKDASLVIQQV--------LSAVKYLHE 124
Query: 270 GLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
+VHRD+K N+L + N+++ +DFGL+K+ + ++T GT GYVAPE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYVAPEV 178
Query: 327 ACTGMLNEKSDVYSFGILIMEI 348
++ D +S G+ I I
Sbjct: 179 LAQKPYSKAVDCWSIGV-ITYI 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEV------EV-----IGRV 204
IG G YG VY+ G VA+K++ R + EV +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 205 RHKNLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
H N+VRL+ C LV+E+VD +L +L D L + +++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQ 128
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+GL +LH +VHRD+K NIL+ +++DFGLA++ + + T V+ T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TL 183
Query: 320 GYVAPE------YACTGMLNEKSDVYSFGILIMEIITGR 352
Y APE YA D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 2e-20
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 27/207 (13%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVR 211
IGEG YG+VY+ + G A+K + R + E E E+ ++ ++H N+V+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +LV+E++D +L + L G + +T + +L G+AY H+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR- 119
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTG 330
+V+HRD+K N+L++R+ +++DFGLA+ R Y T ++ T Y AP+
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDV---- 171
Query: 331 MLNEKS-----DVYSFGILIMEIITGR 352
++ K D++S G + E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
++GEG YG+V + G VA+K + + K E++++ ++RH+NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF---LESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL C + LV+E+VD+ + L + ++ + G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQV--VQ-KYLFQIINGIGFCHSH 143
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K NIL+ + ++ DFG A+ L + V T Y APE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPEL---- 195
Query: 331 MLNEKS-----DVYSFGILIMEIITGR 352
++ + DV++ G L+ E+ G
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 34/207 (16%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKE----FKVEVEVIGRVRHKN 208
+G G G V KVA++ E + + E+E++ ++ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG--DVSPLTWDIRMNIILGTAKGL 264
++++ + Y +V E ++ G L + + + + + +
Sbjct: 202 IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--------LLAV 252
Query: 265 AYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
YLHE ++HRD+K N+LL + +++DFG +K+L E S + T GT Y
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTY 307
Query: 322 VAPE---YACTGMLNEKSDVYSFG-IL 344
+APE T N D +S G IL
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 58/230 (25%), Positives = 88/230 (38%), Gaps = 58/230 (25%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
++GEG YG V + + AVK L E K E++++ R+RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 213 LGYCV----EGAYRMLVYEYVDNGN---LDQWLHGDVGDVSPLTWDIRMN---------- 255
V E +V EY G LD R
Sbjct: 72 --VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------------RFPVCQAHGYFCQ 117
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER--SYVTT 313
+I GL YLH +VH+D+K N+LL ++S G+A+ L T
Sbjct: 118 LID----GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 314 RVMGTFGYVAPEYACTGMLNE-------KSDVYSFGILIMEIITGRNPVD 356
G+ + PE + N K D++S G+ + I TG P +
Sbjct: 171 -SQGSPAFQPPE-----IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLG 214
IG G Y + R I + + AVK + ++ ++ E+E++ R +H N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKD 83
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHE 269
+G Y +V E + G L + + S + + I K + YLH
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTI--------TKTVEYLHA 134
Query: 270 GLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
VVHRD+K SNIL D N R+ DFG AK L +E + T T +VAPE
Sbjct: 135 Q---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190
Query: 326 YACTGMLNEKS-----DVYSFGIL--IM 346
+L + D++S G+L M
Sbjct: 191 -----VLERQGYDAACDIWSLGVLLYTM 213
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
+GEG YG VY+ I VA+K + R + E+E EV ++ ++H+N++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L L++EY +N +L +++ ++ + + + G+ + H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHS- 150
Query: 271 LEPKVVHRDVKSSNILLDRQWNAR-----VSDFGLAKLLCSE-RSYVTTRVMGTFGYVAP 324
+ +HRD+K N+LL + + DFGLA+ R + T ++ T Y P
Sbjct: 151 --RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRPP 206
Query: 325 EYACTGMLNEKS-----DVYSFGILIMEIITGR 352
E +L + D++S + E++
Sbjct: 207 EI----LLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 21/195 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V+R + + G K + + K E+ ++ ++ H L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 217 VEGAYRMLVYEYVDNGNL-DQWLHGDVG----DVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ +L+ E++ G L D+ D +V M GL ++HE
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMHEH- 168
Query: 272 EPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+VH D+K NI+ + + + V DFGLA L + T + APE
Sbjct: 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 224
Query: 330 GMLNEKSDVYSFGIL 344
+ +D+++ G+L
Sbjct: 225 EPVGFYTDMWAIGVL 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 6e-20
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
V+G GG+G V+ + K+ A K L R + K + VE +++ +V + +V L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN-----IILGTAKGLAYL 267
Y E + LV ++ G++ ++ D R I+ G L +L
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSG----LEHL 305
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H+ +++RD+K N+LLD N R+SD GLA L + ++ GT G++APE
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE-- 359
Query: 328 CTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+L + D ++ G+ + E+I R P
Sbjct: 360 ---LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+ + ++G G +G V++ + G K+A K ++ RG +KE K E+ V+ ++ H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT-WDIR--MNIILGTAKGLAYL 267
+L +LV EYVD G L + + + LT D M I G+ ++
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICE---GIRHM 203
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
H+ ++H D+K NIL + ++ DFGLA+ GT ++APE
Sbjct: 204 HQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPE 258
Query: 326 YACTGMLNEKSDVYSFGIL 344
++ +D++S G++
Sbjct: 259 VVNYDFVSFPTDMWSVGVI 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 35/195 (17%), Positives = 84/195 (43%), Gaps = 22/195 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +GIV+R + S K + +G + K E+ ++ RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 217 VEGAYRMLVYEYVDNGNL-DQWLHGDVG----DVSPLTWDIRMNIILGTAKGLAYLHEGL 271
++++E++ ++ ++ ++ ++ + + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVC---EALQFLHSH- 121
Query: 272 EPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+ H D++ NI+ + ++ + +FG A+ L ++ + Y APE
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQH 177
Query: 330 GMLNEKSDVYSFGIL 344
+++ +D++S G L
Sbjct: 178 DVVSTATDMWSLGTL 192
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+ S G + +K + +R Q E + E+EV+ + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ +V E + G L + + L+ ++ LAY H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 276 VHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VH+D+K NIL D ++ ++ DFGLA+ L + T GT Y+APE +
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAA-GTALYMAPE-VFKRDV 202
Query: 333 NEKSDVYSFGILIMEI 348
K D++S G+ +M
Sbjct: 203 TFKCDIWSAGV-VMYF 217
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 41/212 (19%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYC 216
+G G Y V+ I +++ KV VK L + +K+ K E++++ +R N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 217 VEGAYRMLVY--EYVDNGNLDQWLHGDVGDVSPLT-WDIR--MNIILGTAKGLAYLHEGL 271
+ R E+V+N + Q LT +DIR M IL K L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHSM- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSY---VTTRVMGTFGYVAPEYA 327
++HRDVK N+++D + R+ D+GLA+ + Y V +R + PE
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPEL- 201
Query: 328 CTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+++ + D++S G ++ +I + P
Sbjct: 202 ---LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 57/212 (26%), Positives = 109/212 (51%), Gaps = 33/212 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV----EVEVIGRVRHKNLV 210
+ +GEG + VY+ + VA+K + L +R +A+ E++++ + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLH 268
LL + LV+++++ +L+ + + ++P I+ M + L +GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS--HIKAYMLMTL---QGLEYLH 129
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPE-- 325
+ ++HRD+K +N+LLD +++DFGLAK S R+Y T +V+ T Y APE
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV-TRWYRAPELL 184
Query: 326 -----YACTGMLNEKSDVYSFGILIMEIITGR 352
Y G+ D+++ G ++ E++
Sbjct: 185 FGARMYG-VGV-----DMWAVGCILAELLLRV 210
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 29/209 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-------NLLNNRGQAEKEFKV--EVEVIGRV-RH 206
++G G +V R I + AVK + E EV+++ +V H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
N+++L + LV++ + G L D + + L+ I+ + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFD-----YLTEKVTLSEKETRKIMRALLEVIC 138
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE 325
LH+ +VHRD+K NILLD N +++DFG + L + GT Y+APE
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVC-GTPSYLAPE 193
Query: 326 ------YACTGMLNEKSDVYSFGILIMEI 348
++ D++S G+ IM
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGV-IMYT 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 50/225 (22%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKV--EVEVIGRVRHK--N 208
++G GG+G VY GI +SD VA+K + +++ G+ +V EV ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IIL 258
++RLL + +L+ E + D+ D +T + ++
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV-------QDLFDF--ITERGALQEELARSFFWQVL- 159
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMG 317
+ + + H V+HRD+K NIL+D + ++ DFG LL + + T G
Sbjct: 160 ---EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-G 210
Query: 318 TFGYVAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 356
T Y PE + + V+S GIL+ +++ G P +
Sbjct: 211 TRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 60/299 (20%), Positives = 119/299 (39%), Gaps = 72/299 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK------------------------NLLNNRGQAEKE 193
IG+G YG+V +D T A+K
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 194 FKV--EVEVIGRVRHKNLVRLLGYCV-EGAYR---MLVYEYVDNGNL-DQWLHGDVGDVS 246
+V E+ ++ ++ H N+V+L V + +V+E V+ G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------ 132
Query: 247 PLTWDIRMN----IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
PL+ D +I G+ YLH K++HRD+K SN+L+ + +++DFG++
Sbjct: 133 PLSEDQARFYFQDLIK----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNE----KSDVYSFGILIMEIITGRNPVDYS 358
+ ++ V GT ++APE + + DV++ G+ + + G+ P
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-- 241
Query: 359 RPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
+ ++ + KS+ + P P + ++ LK L+ + +P+ R +
Sbjct: 242 ----DERIMCLHSKI----KSQALEFPDQPDI--AEDLKD-LITRMLDKNPE--SRIVV 287
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 29/204 (14%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A + + ++ + E + ++H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLAYL 267
E + L+++ V G L + + D + IL + +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--------IQQILE---AVLHC 126
Query: 268 HEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
H+ VVHR++K N+LL + A V +DFGLA + E+ GT GY++P
Sbjct: 127 HQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182
Query: 325 EYACTGMLNEKSDVYSFGILIMEI 348
E + D+++ G+ I+ I
Sbjct: 183 EVLRKDPYGKPVDLWACGV-ILYI 205
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ +++YE++ G L + + + + ++ D + + KGL ++HE
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 275 VVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VH D+K NI+ + + + DFGL L + V GT + APE A +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTT-GTAEFAAPEVAEGKPV 333
Query: 333 NEKSDVYSFGILIMEIITGRNP 354
+D++S G+L +++G +P
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSP 355
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 28/204 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKE----FKVEVEVIGRVRHKN 208
+G G G V KVA+K E + + E+E++ ++ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
++++ + Y +V E ++ G L D V L + YL
Sbjct: 77 IIKIKNFFDAEDY-YIVLELMEGGELFD-----KVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 268 HEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
HE ++HRD+K N+LL Q +++DFG +K+L E S + T GT Y+AP
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTYLAP 185
Query: 325 E---YACTGMLNEKSDVYSFG-IL 344
E T N D +S G IL
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 39/207 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V + + A K + + FK E+E++ + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 217 VEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ LV E G L + + D + M +L +AY H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI--------MKDVL---SAVAYCHK 124
Query: 270 GLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE- 325
V HRD+K N L ++ DFGLA + T+V GT YV+P+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKV-GTPYYVSPQV 179
Query: 326 ----YACTGMLNEKSDVYSFGILIMEI 348
Y + D +S G+ +M +
Sbjct: 180 LEGLY------GPECDEWSAGV-MMYV 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 48/246 (19%), Positives = 93/246 (37%), Gaps = 67/246 (27%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
+G G +GIV + G + A+K +L + +K E++++ + H N+++L+
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLV 66
Query: 214 GYCVEGAYRM--------------------------------------LVYEYVDNGNLD 235
Y ++ EYV + L
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNAR 294
+ L + + ++ I + + ++H + HRD+K N+L++ + +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLK 182
Query: 295 VSDFGLAKLLCSER---SYVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIM 346
+ DFG AK L +Y+ +R Y APE ML D++S G +
Sbjct: 183 LCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSIDLWSIGCVFG 233
Query: 347 EIITGR 352
E+I G+
Sbjct: 234 ELILGK 239
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 25/195 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G IVYR A+K L + +K + E+ V+ R+ H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV E V G L + + G D + I + +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIV-EKGYYSERDAADAVKQI--------LEAVAYLHEN- 167
Query: 272 EPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
+VHRD+K N+L +A + +DFGL+K++ E + V GT GY APE
Sbjct: 168 --GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILR 223
Query: 329 TGMLNEKSDVYSFGI 343
+ D++S GI
Sbjct: 224 GCAYGPEVDMWSVGI 238
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 28/202 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+G G + IV + S G + A K +R +E + EV ++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDV---GDVSPLTWDIRMNIILGTAKGLAY 266
L +L+ E V G L D + + + + IL G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNY 130
Query: 267 LHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
LH K+ H D+K NI+L D+ ++ DFGLA + + GT +V
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIF-GTPEFV 185
Query: 323 APEYACTGMLNEKSDVYSFGIL 344
APE L ++D++S G++
Sbjct: 186 APEIVNYEPLGLEADMWSIGVI 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K + + A K+ E + +++H N+VRL
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 215 YCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFE-----DIVAREFYSEADASHCIQQILESIAYCHSN--- 124
Query: 274 KVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+VHR++K N+LL + A V +DFGLA ++ GT GY++PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGYLSPEVLKKD 182
Query: 331 MLNEKSDVYSFG-IL 344
++ D+++ G IL
Sbjct: 183 PYSKPVDIWACGVIL 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 30/204 (14%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
+ +GEG + I + + AVK + E + E+ + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYL 267
+ + LV E ++ G L ++ + S + + ++++
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKL--------VSAVSHM 122
Query: 268 HEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
H+ VVHRD+K N+L D N ++ DFG A+L + + T T Y AP
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAP 178
Query: 325 EYACTGMLNEKSDVYSFGIL--IM 346
E +E D++S G++ M
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTM 202
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGY 215
+GEG YG V + VAVK +++ + + + E+ + + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 216 CVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMN----------IILGTAKGL 264
EG + L EY G L D+ + DI M ++ G +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPDAQRFFHQLMAG----V 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--YVTTRVMGTFGYV 322
YLH + HRD+K N+LLD + N ++SDFGLA + + GT YV
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 323 APE-YACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
APE E DV+S GI++ ++ G P D
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 41/209 (19%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + + AVK + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ + +V E G L + D + + + G+ Y+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--------IKQVFS---GITYM 137
Query: 268 HEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
H+ +VHRD+K NILL ++ + ++ DFGL+ + + + R+ GT Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRI-GTAYYIAP 192
Query: 325 E-----YACTGMLNEKSDVYSFGILIMEI 348
E Y +EK DV+S G+ I+ I
Sbjct: 193 EVLRGTY------DEKCDVWSAGV-ILYI 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 51/221 (23%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGY 215
IG+G + V + G +VA+K + + K+ EV ++ + H N+V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 216 CVEGAYRM--LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILGTA 261
V + L+ EY G + +L HG RM I+
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVS--- 125
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+ Y H+ ++VHRD+K+ N+LLD N +++DFG + + + G Y
Sbjct: 126 -AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLDAFC-GAPPY 179
Query: 322 VAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 356
APE + K DV+S G+++ +++G P D
Sbjct: 180 AAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 157 NVIGEGGYGIVYRG--ILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEV---IGRVRH 206
IGEG YG V++ + + G VA+K + R Q +E + EV V + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 207 KNLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
N+VRL C LV+E+VD +L +L D + + +++
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLL 130
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+GL +LH +VVHRD+K NIL+ +++DFGLA++ + + T+ V+ T Y
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLWY 185
Query: 322 VAPE------YACTGMLNEKSDVYSFGILIMEIITGR 352
APE YA T + D++S G + E+ +
Sbjct: 186 RAPEVLLQSSYA-TPV-----DLWSVGCIFAEMFRRK 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 54/247 (21%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
IG+G YG+V I A+K + + + K EV ++ ++ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 212 LLGYCVEGAYRMLVYEYVDNGNL-----------DQWLHGDVGDVSPLTWDIRMNIILGT 260
L + Y LV E G+L DV +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 261 AK-------------------------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
+ L YLH + HRD+K N L + +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 296 --SDFGLAKLL----CSERSYVTTRVMGTFGYVAPE--YACTGMLNEKSDVYSFGILIME 347
DFGL+K E +TT+ GT +VAPE K D +S G+L+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 348 IITGRNP 354
++ G P
Sbjct: 269 LLMGAVP 275
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVR 211
+ +GEG Y VY+G VA+K + R + E+ EV ++ ++H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L LV+EY+D +L Q+L ++ + + +L +GLAY H
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR-- 118
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTG 330
KV+HRD+K N+L++ + +++DFGLA+ ++Y V+ T Y P+
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYRPPDI---- 171
Query: 331 MLNEKS-----DVYSFGILIMEIITGR 352
+L D++ G + E+ TGR
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 36/267 (13%), Positives = 70/267 (26%), Gaps = 61/267 (22%)
Query: 158 VIGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVR 211
G ++ + D +VA+ + + +E + R+ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-G 270
+L A ++V E++ G+L + + + + A H G
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
V S + VS G L +
Sbjct: 150 ----VALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA----- 179
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL--P 388
N + D+ G + ++ R P L + + ++P
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGL-----APAERDTAGQPIEPADIDR 230
Query: 389 KMPASKALKRVLLVALRCVDPDATKRP 415
+P + VA R V D R
Sbjct: 231 DIPFQ-----ISAVAARSVQGDGGIRS 252
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 46/223 (20%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IG+G +G V++ G KVA+K + + EKE F + E++++ ++H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79
Query: 211 RLLGYCVEGAYRM--------LVYEYVDN---GNLDQWLHGDVGDVSPLTWDIRMNIILG 259
L+ C A LV+++ ++ G L + V T ++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLV----KFTLSEIKRVMQM 132
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-----CSERSYVTTR 314
GL Y+H K++HRD+K++N+L+ R +++DFGLA+ Y T R
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNR 188
Query: 315 VMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
V+ T Y PE +L E+ D++ G ++ E+ T
Sbjct: 189 VV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 42/222 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKV--EVEVIGRVR----H 206
++G+GG+G V+ G L+D +VA+K N + EV ++ +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------I 256
++RLL + MLV E D+ D +T + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA-------QDLFDY--ITEKGPLGEGPSRCFFGQV 148
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRV 315
+ + + H VVHRD+K NIL+D + ++ DFG LL T
Sbjct: 149 VAA----IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD 199
Query: 316 MGTFGYVAPEY-ACTGMLNEKSDVYSFGILIMEIITGRNPVD 356
GT Y PE+ + + V+S GIL+ +++ G P +
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 57/307 (18%), Positives = 113/307 (36%), Gaps = 54/307 (17%)
Query: 59 QQQQSKQILNTPPISKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTGSAC 118
+++ ++I + P +++E + Q E + + + E+ S
Sbjct: 19 RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78
Query: 119 ETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTK 177
+ E Y ++ VIG G +V R + + G +
Sbjct: 79 PEDELPDWAAAKEFYQK-----YDPKD------------VIGRGVSSVVRRCVHRATGHE 121
Query: 178 VAVK--------NLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEY 228
AVK + + + E ++ +V H +++ L+ ++ LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 229 VDNGNL-DQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
+ G L D + + + M +L + +++LH +VHRD+K
Sbjct: 182 MRKGELFDYLT--EKVALSEKETRSI-----MRSLL---EAVSFLHAN---NIVHRDLKP 228
Query: 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPE------YACTGMLNEKS 336
NILLD R+SDFG + L + GT GY+APE ++
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHL-EPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 337 DVYSFGI 343
D+++ G+
Sbjct: 287 DLWACGV 293
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 28/203 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+G G + IV + G + A K L ++R +E + EV ++ +RH N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDV---GDVSPLTWDIRMNIILGTAKGLAY 266
L +L+ E V G L D + + + + IL G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHY 123
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA----RVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
LH ++ H D+K NI+L + ++ DFG+A + + + + GT +V
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFV 178
Query: 323 APEYACTGMLNEKSDVYSFGILI 345
APE L ++D++S G++
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 28/202 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+G G + IV + S G + A K +R +E + EV ++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDV----GDVSPLTWDIRMNIILGTAKGLAY 266
L +L+ E V G L +L + + + IL G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNY 130
Query: 267 LHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
LH K+ H D+K NI+L D+ ++ DFGLA + + + GT +V
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFV 185
Query: 323 APEYACTGMLNEKSDVYSFGIL 344
APE L ++D++S G++
Sbjct: 186 APEIVNYEPLGLEADMWSIGVI 207
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 54/221 (24%), Positives = 85/221 (38%), Gaps = 44/221 (19%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE--FKV---------EVEVIGRVRH 206
I G YG V G+ S+G VA+K + N E+ ++ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 207 KNLVRLL-------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
N++ L + Y LV E + +L Q +H ++ +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLY--LVTELMRT-DLAQVIHDQR---IVISPQHIQYFMYH 142
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVM 316
GL LHE VVHRD+ NILL + + DF LA+ ++ + YVT R
Sbjct: 143 ILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW- 198
Query: 317 GTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
Y APE ++ K D++S G ++ E+ +
Sbjct: 199 ----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K + + + ++ + E + +++H N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 215 YCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFE-----DIVAREFYSEADASHCIQQILESIAYCHSN--- 147
Query: 274 KVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+VHR++K N+LL + A V +DFGLA + ++ GT GY++PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFA-GTPGYLSPEVLKKD 205
Query: 331 MLNEKSDVYSFGILIMEI 348
++ D+++ G+ I+ I
Sbjct: 206 PYSKPVDIWACGV-ILYI 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEK-EFKV--EVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + + +A + E+ + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMN----------IILGTAKG 263
+ EG + L EY G L D+ + DI M ++ G
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPDAQRFFHQLMAG---- 117
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--YVTTRVMGTFGY 321
+ YLH + HRD+K N+LLD + N ++SDFGLA + + GT Y
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173
Query: 322 VAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 356
VAPE +L + DV+S GI++ ++ G P D
Sbjct: 174 VAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 48/220 (21%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
++GEG + V ++ A+K L E + E +V+ R+ H V+L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN-------------IILGT 260
+ Y NG L +++ ++ I+
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVSA- 142
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTF 319
L YLH ++HRD+K NILL+ + +++DFG AK+L E GT
Sbjct: 143 ---LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 320 GYVAPEYACTGMLNEK-----SDVYSFGILIMEIITGRNP 354
YV+PE +L EK SD+++ G +I +++ G P
Sbjct: 197 QYVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
V+G+GG+G V + K+ A K L R + K E +++ +V + +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM-----NIILGTAKGLAYL 267
Y E + LV ++ G+L ++ P R I G L L
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCG----LEDL 302
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H ++V+RD+K NILLD + R+SD GLA + E + RV GT GY+APE
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYMAPE-- 355
Query: 328 CTGMLNEKS-----DVYSFGILIMEIITGRNP 354
++ + D ++ G L+ E+I G++P
Sbjct: 356 ---VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 26/200 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRH-KNLVRLL 213
+G G + +V + I S G + A K L R + ++ E+ V+ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYL 267
+ +L+ EY G + L DV L + IL G+ YL
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYYL 147
Query: 268 HEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
H+ +VH D+K NILL + DFG+++ + +MGT Y+AP
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAP 202
Query: 325 EYACTGMLNEKSDVYSFGIL 344
E + +D+++ GI+
Sbjct: 203 EILNYDPITTATDMWNIGII 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 54/223 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V G G KVAVK + + K K E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKL- 76
Query: 214 GYCVEGAYRM--LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILG 259
Y V +V EYV G L ++ HG R+ I+
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL-- 121
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ Y H VVHRD+K N+LLD NA+++DFGL+ ++ T+ G+
Sbjct: 122 --SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSP 174
Query: 320 GYVAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 356
Y APE +++ + D++S G+++ ++ G P D
Sbjct: 175 NYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKN 208
+G G + +V + S G + A K ++R +E + EV ++ ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDV---GDVSPLTWDIRMNIILGTAKGL 264
++ L +L+ E V G L D + + + + IL G+
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GV 127
Query: 265 AYLHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFG 320
YLH ++ H D+K NI+L DR ++ DFGLA + + + GT
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPE 182
Query: 321 YVAPEYACTGMLNEKSDVYSFGIL 344
+VAPE L ++D++S G++
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 28/186 (15%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
E+V+GEG + V I L + AVK + G EVE++ + + H+N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLH 268
+ E LV+E + G++ +H + S + D+ A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDV--------ASALDFLH 128
Query: 269 EGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLL--CSERSYVTTRVM----GTF 319
+ HRD+K NIL + ++ DF L + + S ++T + G+
Sbjct: 129 N---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 320 GYVAPE 325
Y+APE
Sbjct: 186 EYMAPE 191
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV + VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 213 LG-YCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
L + + + +V E +D NL Q + L + ++ G+ +
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVA 323
LH ++HRD+K SNI++ ++ DFGLA+ + YV TR Y A
Sbjct: 143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRA 194
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGR 352
PE E D++S G ++ E+I G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 48/223 (21%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--------NLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
+G G +G V+ + +V VK + +E+ ++ RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IILG 259
+++L + LV E +G D+ + R++ ++
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-------LDLFAF--IDRHPRLDEPLASYIFRQLVSA 142
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ YL ++HRD+K NI++ + ++ DFG A L T GT
Sbjct: 143 ----VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTI 193
Query: 320 GYVAPEYACTGMLNEKS------DVYSFGILIMEIITGRNPVD 356
Y APE +L +++S G+ + ++ NP
Sbjct: 194 EYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 213 LG-YCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
L + + LV E +D NL Q + L + ++ G+ +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKH 179
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYVA 323
LH ++HRD+K SNI++ ++ DFGLA+ + YV TR Y A
Sbjct: 180 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRA 231
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGR 352
PE E D++S G ++ E++ +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 40/214 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V I G KVA+K L + A++ ++ E+ ++ ++H+N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 88
Query: 213 L--------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
L Y LV ++ +L + + + + ++ KGL
Sbjct: 89 LDVFTPASSLRNFYDFY--LVMPFMQT-DLQKIMG------LKFSEEKIQYLVYQMLKGL 139
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVA 323
Y+H VVHRD+K N+ ++ ++ DFGLA+ +E + YV TR Y A
Sbjct: 140 KYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRA 191
Query: 324 PEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
PE +L+ D++S G ++ E++TG+
Sbjct: 192 PEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKN---LV 210
+IG GG+G VY +D K+ A+K L R + ++ E ++ V + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 211 RLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ Y ++ + + ++ G+L L IILG L ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMHN 310
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
VV+RD+K +NILLD + R+SD GLA ++ + V GT GY+APE
Sbjct: 311 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQK 364
Query: 330 GMLNEKS-DVYSFGILIMEIITGRNP 354
G+ + S D +S G ++ +++ G +P
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 47/221 (21%), Positives = 89/221 (40%), Gaps = 43/221 (19%)
Query: 159 IGEGGYGIVYRGI---LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV------RHKNL 209
+G G YG VY+ D A+K + + + + + +H N+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80
Query: 210 VRLLGYCVEGAYR--MLVYEYVDN---GNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKG 263
+ L + A R L+++Y ++ + L + +++ G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKLLCSE-RSY--VTTRVM 316
+ YLH V+HRD+K +NIL+ + R ++D G A+L S + + V+
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 317 GTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
TF Y APE +L + D+++ G + E++T
Sbjct: 198 -TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V + G KVA+K L + A++ ++ E+ ++ +RH+N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGL 89
Query: 213 L--------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
L Y LV ++ +L + + + L D ++ KGL
Sbjct: 90 LDVFTPDETLDDFTDFY--LVMPFMGT-DLGKLMKHE-----KLGEDRIQFLVYQMLKGL 141
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVA 323
Y+H ++HRD+K N+ ++ ++ DFGLA+ SE + YV TR Y A
Sbjct: 142 RYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRA 193
Query: 324 PEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
PE +LN D++S G ++ E+ITG+
Sbjct: 194 PEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 54/223 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V G G KVAVK + + K + E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKL- 81
Query: 214 GYCVEGAYRM--LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILG 259
Y V +V EYV G L ++ +G R++ I+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDEKESRRLFQQIL-- 126
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
G+ Y H VVHRD+K N+LLD NA+++DFGL+ ++ T+ G+
Sbjct: 127 --SGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSP 179
Query: 320 GYVAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 356
Y APE +++ + D++S G+++ ++ G P D
Sbjct: 180 NYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 35/208 (16%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLL 213
+ V+G G G V G K A+K LL + + + EV+ + ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDS----PKARQEVDHHWQASGGPHIVCIL 88
Query: 214 GYCVEGAYRM----LVYEYVDNGNL-DQWL-HGDVG----DVSPLTWDIRMNIILGTAKG 263
+ ++ E ++ G L + GD + + + DI
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI--------GTA 140
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 320
+ +LH + HRDVK N+L ++ +A +++DFG AK ++ + T T
Sbjct: 141 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPY 194
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEI 348
YVAPE ++ D++S G+ IM I
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGV-IMYI 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+ +G G YG V + G +VAVK L + A++ ++ E+ ++ ++H+N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 213 L--------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
L Y LV + +L+ + LT D +I +GL
Sbjct: 94 LDVFTPARSLEEFNDVY--LVTHLMGA-DLNNIVKC-----QKLTDDHVQFLIYQILRGL 145
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVA 323
Y+H ++HRD+K SN+ ++ ++ DFGLA+ E + YV TR Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRA 197
Query: 324 PEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
PE MLN D++S G ++ E++TGR
Sbjct: 198 PEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 52/221 (23%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGY 215
IG G +G+ VAVK + RG A E V E+ +RH N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEV 84
Query: 216 CVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILGTAKG 263
+ + ++ EY G L + + G R + ++ G
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS----G 128
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQW--NARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++Y H ++ HRD+K N LLD ++ DFG +K S + V GT Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAY 183
Query: 322 VAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 356
+APE +L + +DV+S G+ + ++ G P +
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 48/224 (21%), Positives = 101/224 (45%), Gaps = 48/224 (21%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL-- 213
+G GG G+V+ + +D +VA+K + L + + + E+++I R+ H N+V++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 214 -----GYCVEGAYRM-------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
+ + +V EY++ +L L PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-----GPLLEEHARLFMYQLL 130
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERS-------YVTT 313
+GL Y+H V+HRD+K +N+ ++ + ++ DFGLA+++ S + T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 314 RVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
+ Y +P +L+ + D+++ G + E++TG+
Sbjct: 188 K-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 38/210 (18%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRV-RHKNLVR 211
V+G G G V + K A+K L + K EVE+ R + ++VR
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 119
Query: 212 LLGYCVEGAYRM----LVYEYVDNGNL-DQWL-HGDVG----DVSPLTWDIRMNIILGTA 261
++ +V E +D G L + GD + S + I
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI--------G 171
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGT 318
+ + YLH + HRDVK N+L ++ NA +++DFG AK S S T T
Sbjct: 172 EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYT 226
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEI 348
YVAPE ++ D++S G+ IM I
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGV-IMYI 255
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 55/223 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+GEG +G V KVA+K LL + + E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKL- 74
Query: 214 GYCVEGAYRM--LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILG 259
Y V +V EY G L ++ RM II
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKK------------RMTEDEGRRFFQQII-- 118
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ Y H K+VHRD+K N+LLD N +++DFGL+ ++ T+ G+
Sbjct: 119 --CAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSP 171
Query: 320 GYVAPEYACTGMLNEK------SDVYSFGILIMEIITGRNPVD 356
Y APE ++N K DV+S GI++ ++ GR P D
Sbjct: 172 NYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN--NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ IGEG YG+V + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 214 GYCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + ++ +L + L L+ D + +GL Y+H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH 145
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTRVMGTFGY 321
V+HRD+K SN+LL+ + ++ DFGLA++ + YV TR Y
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR-----WY 197
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
APE MLN K D++S G ++ E+++ R
Sbjct: 198 RAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 50/224 (22%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL- 213
++GEG YG+V G VA+K + A + + E++++ +H+N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 214 ------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
Y ++ E + +L + + L+ D I T + + L
Sbjct: 77 IQRPDSFENFNEVY--IIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--------------YVTT 313
H V+HRD+K SN+L++ + +V DFGLA+++ + +V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 314 RVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
R Y APE ML DV+S G ++ E+ R
Sbjct: 186 R-----WYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YL +++HRD+K NILLD + ++DF +A +L E T + GT Y+
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYM 181
Query: 323 APEYACTGMLNEKS--------DVYSFGILIMEIITGRNP 354
APE M + + D +S G+ E++ GR P
Sbjct: 182 APE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 27/213 (12%)
Query: 158 VIGEGGYGIVY--RGILSDGT---KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
VIG G + V + + K+ K + RG+ F+ E +V+ + + +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQL 126
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM---NIILGTAKGLAYLH 268
+ + + LV EY G+L L G+ P R I++ + +H
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFYLAEIVMA----IDSVH 179
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
VHRD+K NILLDR + R++DFG L ++ + + +GT Y++PE
Sbjct: 180 RL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 329 TGMLNEKSDVY-------SFGILIMEIITGRNP 354
+ Y + G+ E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 49/250 (19%), Positives = 93/250 (37%), Gaps = 63/250 (25%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+IG G YG V + VA+K +L + ++ + E+ ++ R+ H ++V++L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVL 118
Query: 214 G-YCVEGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ + +V E D D LT ++ G+ Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD---SD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS------------------- 309
++HRD+K +N L+++ + +V DFGLA+ + +
Sbjct: 174 SA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 310 ------------YVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
+V TR Y APE +L +++ DV+S G + E++
Sbjct: 231 PHTKNLKRQLTGHVVTR-----WYRAPEL----ILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 353 NPVDYSRPQG 362
Sbjct: 282 KENVAYHADR 291
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 70/344 (20%), Positives = 112/344 (32%), Gaps = 93/344 (27%)
Query: 156 ENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVE----------- 197
+G G +G V + VAVK L +E + E
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 198 --VEVIGRV--------------RHKNLVRLL--------GYCVEGAYRMLVYEYVDNGN 233
V ++G + NL L Y +GA +YV
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 234 LDQWLHGDVG-----------------------------DVSPLTWDIRMNIILGTAKGL 264
+D D LT + + AKG+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYVA 323
+L K +HRD+ + NILL + ++ DFGLA+ + + YV ++A
Sbjct: 207 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
PE + +SDV+SFG+L+ EI + G +P Y + + LK G+R
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRRLKE--GTR----- 314
Query: 383 VDPKLPKMPA-SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
M A + L C + ++RP ++ L
Sbjct: 315 -------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 52/239 (21%), Positives = 98/239 (41%), Gaps = 62/239 (25%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+IG G YG VY + VA+K + + ++ + E+ ++ R++ ++RL
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLY 91
Query: 214 -------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y +V E D+ +L + + LT + I+ G +
Sbjct: 92 DLIIPDDLLKFDELY--IVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLGENF 144
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS----------------- 309
+HE ++HRD+K +N LL++ + +V DFGLA+ + SE+
Sbjct: 145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 310 ---------YVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+V TR Y APE +L +++ D++S G + E++
Sbjct: 202 KNLKKQLTSHVVTR-----WYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 4e-14
Identities = 49/320 (15%), Positives = 94/320 (29%), Gaps = 90/320 (28%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVK--------NLLNNRGQAEKEFKVEVEV---------I 201
IGEG +G V++ I D T VA+K + + + +E E+ +
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 202 GRVRHKNLVRLLG-YCVEGAY-----------------------------RMLVYEYVDN 231
R + + L +CV+G+Y +V E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 232 GN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
G L+Q + +I+ LA + HRD+ N+LL +
Sbjct: 147 GIDLEQMRT------KLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKT 198
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP--EYACTGMLNEKSDVYSFGILIMEI 348
++ K + + G +Y + + + V+ + ++
Sbjct: 199 SLKKLHYTLNGKSST----------IPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248
Query: 349 ITGR--------------NPVDYSRPQGEVNLVDWL----KTMVGSRKSEEVVDPKLPKM 390
TG N + N++ WL M+ + + K
Sbjct: 249 FTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQMTFKTKCNTPAMKQ 307
Query: 391 PAS--KALKRVLLVALRCVD 408
+ R +L D
Sbjct: 308 IKRKIQEFHRTMLNFSSATD 327
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
++G+G +G V + A+K L A+ E E V+ RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + R+ V EY + G L L + I+ L YLH
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYLHSEKN 269
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYVAPEYACTGM 331
VV+RD+K N++LD+ + +++DFGL K + + T + GT Y+APE +
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPE-----V 320
Query: 332 LNEKS-----DVYSFGILIMEIITGRNP 354
L + D + G+++ E++ GR P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 60/235 (25%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVR-HKNLVR 211
+G+G YGIV++ I G VAVK + + N A++ F+ E+ ++ + H+N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVN 73
Query: 212 LLGYCV----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
LL Y LV++Y++ +L + + L + ++ K + YL
Sbjct: 74 LLNVLRADNDRDVY--LVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYL 125
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS------------------ 309
H G ++HRD+K SNILL+ + + +V+DFGL++ + R
Sbjct: 126 HSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 310 -------YVTTRVMGTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGR 352
YV TR Y APE +L D++S G ++ EI+ G+
Sbjct: 183 DQPILTDYVATR-----WYRAPEI----LLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 8e-14
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 52/222 (23%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V+ + I KV K L R + K+E +++ V H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPFI 88
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IIL 258
V+L Y + ++ L+ +++ G+L L +V + L
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELAL 137
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-G 317
L +LH +++RD+K NILLD + + +++DFGL+K G
Sbjct: 138 A----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCG 188
Query: 318 TFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
T Y+APE ++N + D +SFG+L+ E++TG P
Sbjct: 189 TVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 37/217 (17%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLL 213
VIG G +G V L + KV A+K L E F+ E +V+ K + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL--GTAK-------- 262
Y + + LV +Y G+L LT + L A+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDL-------------LTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
+ +H+ VHRD+K NIL+D + R++DFG L + + ++ +GT Y+
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 323 APE-----YACTGMLNEKSDVYSFGILIMEIITGRNP 354
+PE G + D +S G+ + E++ G P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 36/215 (16%)
Query: 158 VIGEGGYGIVY--RGILSDGT---KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
VIG G +G V R + K+ K + R + F E +++ +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQL 134
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK--------G 263
Y + + +V EY+ G+L + ++ A+
Sbjct: 135 F-YAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDVPEKWARFYTAEVVLA 180
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
L +H +HRDVK N+LLD+ + +++DFG + E +GT Y++
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 324 PE----YACTGMLNEKSDVYSFGILIMEIITGRNP 354
PE G + D +S G+ + E++ G P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 46/218 (21%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
++G+G +G V + A+K L A+ E E V+ RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IILGTAK 262
Y + R+ V EY + G L + H L+ + I+
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFTEERARFYGAEIVSA--- 117
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGY 321
L YLH VV+RD+K N++LD+ + +++DFGL K S+ + T + GT Y
Sbjct: 118 -LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 171
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+APE +L + D + G+++ E++ GR P
Sbjct: 172 LAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 52/223 (23%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V+ R + T KV K ++ + K E ++ V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM-----------NII 257
V L+ Y + ++ L+ EY+ G L L + + I
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLERE-----------GIFMEDTACFYLAEIS 131
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM- 316
+ L +LH+ +++RD+K NI+L+ Q + +++DFGL K + + T
Sbjct: 132 MA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFC 182
Query: 317 GTFGYVAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
GT Y+APE +L D +S G L+ +++TG P
Sbjct: 183 GTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 45/216 (20%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
+G G +G V + A+K L + K+ E ++ V LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IILGTAKG 263
+ + +V EYV G + + H L R + I+L
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEM--FSH--------LRRIGRFSEPHARFYAAQIVLT---- 153
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
YLH +++RD+K N+L+D+Q +V+DFG AK T + GT +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALA 206
Query: 324 PEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
PE ++ K D ++ G+LI E+ G P
Sbjct: 207 PE-----IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 61/317 (19%), Positives = 117/317 (36%), Gaps = 37/317 (11%)
Query: 56 HLQQQQQSKQILNTPPISKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTG 115
+ + + +S I E+ + + E+ F+ S G
Sbjct: 244 EIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEY---FNVPVPPEGSEGNE 300
Query: 116 SACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEEN-----VIGEGGYGIVYRG 170
+ G + + + + + V+G+G +G V
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLS 360
Query: 171 ILSDGTKV-AVKNL----LNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM- 223
++ AVK L + E VE V+ + L +L C + R+
Sbjct: 361 ERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALPGKPPFLTQLH-SCFQTMDRLY 418
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
V EYV+ G+L + P I +G L +L +++RD+K
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQSK---GIIYRDLKLD 471
Query: 284 NILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGYVAPEYACTGMLNEKS-----D 337
N++LD + + +++DFG+ K + TT+ GT Y+APE ++ + D
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPE-----IIAYQPYGKSVD 524
Query: 338 VYSFGILIMEIITGRNP 354
++FG+L+ E++ G+ P
Sbjct: 525 WWAFGVLLYEMLAGQAP 541
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 16/98 (16%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGY 321
L YLH +V+RD+K NILLD Q + ++DFGL K S TT GT Y
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEY 205
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+APE +L+++ D + G ++ E++ G P
Sbjct: 206 LAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 15/99 (15%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L +LH+ +++RD+K NILLD + ++DFGL+K ++ + GT Y+
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 323 APEYACTGMLNEKS-------DVYSFGILIMEIITGRNP 354
AP+ ++ D +S G+L+ E++TG +P
Sbjct: 228 APD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 16/98 (16%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGY 321
L +LH+ +++RD+K N+LLD + + +++DFG+ K TT GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDY 190
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+APE +L E D ++ G+L+ E++ G P
Sbjct: 191 IAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 16/98 (16%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGY 321
GL +LH +V+RD+K NILLD+ + +++DFG+ K + T GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDY 184
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+APE +L + D +SFG+L+ E++ G++P
Sbjct: 185 IAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 17/97 (17%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322
L YLH +++RD+K NILLD+ + +++DFG AK VT + GT Y+
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYI 170
Query: 323 APEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
APE +++ K D +SFGILI E++ G P
Sbjct: 171 APE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGY 321
L YLHE +++RD+K N+LLD + + +++D+G+ K TT GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNY 176
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+APE +L + D ++ G+L+ E++ GR+P
Sbjct: 177 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 16/98 (16%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGY 321
GL +L +++RD+K N++LD + + +++DFG+ K + TT+ GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDY 187
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+APE ++ + D ++FG+L+ E++ G+ P
Sbjct: 188 IAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GTFGY 321
L YLHE +++RD+K N+LLD + + +++D+G+ K TT GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNY 219
Query: 322 VAPEYACTGMLNEKS-----DVYSFGILIMEIITGRNP 354
+APE +L + D ++ G+L+ E++ GR+P
Sbjct: 220 IAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGY 215
V+G G G V + K A+K L + + + EVE+ R + ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 216 C----VEGAYRMLVYEYVDNGNL-DQWL-HGDVG----DVSPLTWDIRMNIILGTAKGLA 265
++V E +D G L + GD + S + I + +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI--------GEAIQ 131
Query: 266 YLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAK 302
YLH + HRDVK N+L ++ NA +++DFG AK
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 47/226 (20%), Positives = 87/226 (38%), Gaps = 50/226 (22%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNN---RGQAEKEFKV-------EVEVIGRVRH 206
+G G + V+ + + T VA+K + + AE E K+ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 207 KNLVRLLGY----CVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGT 260
++++LL + G + ++V+E V NL + + G I ++LG
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLG- 143
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDR------QWNARVSDFGLAKLLCSERSYVTTR 314
L Y+H ++H D+K N+L++ +++D G A C + T
Sbjct: 144 ---LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNS 195
Query: 315 VMGTFGYVAPE--------YACTGMLNEKSDVYSFGILIMEIITGR 352
+ Y +PE D++S LI E+ITG
Sbjct: 196 IQTRE-YRSPEVLLGAPWGCGA--------DIWSTACLIFELITGD 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 35/155 (22%), Positives = 66/155 (42%), Gaps = 24/155 (15%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G + G L VA+K + + Q E++ ++ + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQVYYF 73
Query: 216 CVEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLE 272
G Y +V E + G +L+ D+ D+ T+ ++ +++ + Y+H
Sbjct: 74 GPCGKYNAMVLELL--GPSLE-----DLFDLCDRTFSLKTVLMIAIQLISRMEYVHS--- 123
Query: 273 PKVVHRDVKSSNILLDRQWNARVS-----DFGLAK 302
+++RDVK N L+ R N DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 4e-08
Identities = 66/472 (13%), Positives = 139/472 (29%), Gaps = 123/472 (26%)
Query: 54 HNHL-----QQQQQSKQIL--NTPPISK--EIQEIVHHPAPV---PEIQVDIGKIEHRVV 101
H+H+ + Q Q K IL + +++ P + EI I + V
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID-HIIMSKDAVS 62
Query: 102 FSDR-----ASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEE 156
+ R S E F + L + + S +
Sbjct: 63 GTLRLFWTLLSKQEE-------MVQKFVEEVLRINYKFL-MSPI---KTEQRQPSMMTRM 111
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVR-HKNLVRLLG 214
Y I R L + +V K N +R Q + + + + +R KN++
Sbjct: 112 -------Y-IEQRDRLYNDNQVFAK--YNVSRLQPYLKLR---QALLELRPAKNVL---- 154
Query: 215 YCVEGAYRM-------LVYEYVDNGNLDQ-------WLHGDVGDV-SP------------ 247
++G + + + + + WL ++ + SP
Sbjct: 155 --IDG---VLGSGKTWVALDVCLSYKVQCKMDFKIFWL--NLKNCNSPETVLEMLQKLLY 207
Query: 248 ---LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD-FGLAKL 303
W R + + + L + + ++ ++L NA+ + F L+
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS-- 265
Query: 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVY----SFGILIMEIITGRNPVDYSR 359
C + +TTR +++ L+ S +L+ P D R
Sbjct: 266 -C--KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK--YLDCRPQDLPR 320
Query: 360 PQGEVNLVDWLK-TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG 418
EV + + +++ + + K L ++ +L ++P +
Sbjct: 321 ---EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR----- 372
Query: 419 HVIHMLEADDL-LFRDERRIGREPS--------NSYGEENRDFARKVGDKQL 461
M + L +F I P+ + + K+ L
Sbjct: 373 ---KMFD--RLSVFPPSAHI---PTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 34/154 (22%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKN--LLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG +G+++ G L + +VA+K ++ Q E++ + G + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNVYYF 74
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLEP 273
EG + +LV + + +L+ D+ D+ + ++ + + +HE
Sbjct: 75 GQEGLHNVLVIDLLGP-SLE-----DLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 125
Query: 274 KVVHRDVKSSNILLDRQWNAR-----VSDFGLAK 302
+V+RD+K N L+ R + V DFG+ K
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 42/215 (19%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHK------ 207
VIG+G +G V + VA+K + N QA E+ ++ +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 208 NLVRLLGY-------C-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
N++ +L C M +YE + + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF-----------QGFSLPLVRKFAHS 208
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA--RVSDFGLAKLLCSERSYVTTRVMG 317
+ L LH+ +++H D+K NILL +Q + +V DFG + C E V T +
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQS 262
Query: 318 TFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR 352
F Y APE D++S G ++ E++TG
Sbjct: 263 RF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 58/225 (25%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRH------ 206
++IG+G +G V + + VA+K + N QA ++EV ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 207 KNLVRLLGY-------CVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNII 257
+V L + C LV+E + NL L G LT +
Sbjct: 116 YYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA--RVSDFGLAKLLCSERSYVTTRV 315
L +L E ++H D+K NILL + ++ DFG + C + +
Sbjct: 168 TA----LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYI 219
Query: 316 MGTFGYVAPE--------YACTGMLNEKSDVYSFGILIMEIITGR 352
F Y +PE A D++S G +++E+ TG
Sbjct: 220 QSRF-YRSPEVLLGMPYDLAI--------DMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 22/153 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G +Y G ++ G +VA+K + Q E K+ + G V + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV---GIPTIRWC 73
Query: 216 CVEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLE 272
EG Y ++V E + G +L+ D+ + + ++ ++L + Y+H
Sbjct: 74 GAEGDYNVMVMELL--GPSLE-----DLFNFCSRKFSLKTVLLLADQMISRIEYIHS--- 123
Query: 273 PKVVHRDVKSSNILLDRQWNA---RVSDFGLAK 302
+HRDVK N L+ + DFGLAK
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 33/167 (19%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVA---VKNLLNNRGQAEKEFKVE-----VEVIGRVRHKNL 209
IG GG+G++Y + K A VK G E K + I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 210 VRLLG-----YC-----VEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLT-WDIRMNII 257
+ LG +YR +V E + G +L Q + G G T + + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDL-QKISGQNGTFKKSTVLQLGIRML 161
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAK 302
L Y+HE + VH D+K++N+LL + +V +D+GL+
Sbjct: 162 ----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 37/152 (24%), Positives = 66/152 (43%), Gaps = 20/152 (13%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G +Y G + +VA+K N+ Q E K+ + G + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG---GTGIPNVRWF 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLEP 273
VEG Y +LV + + +L+ D+ + ++ ++L + ++H
Sbjct: 72 GVEGDYNVLVMDLLGP-SLE-----DLFNFCSRKLSLKTVLMLADQMINRVEFVH---SK 122
Query: 274 KVVHRDVKSSNILLDRQWNAR---VSDFGLAK 302
+HRD+K N L+ A + DFGLAK
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 30/174 (17%), Positives = 59/174 (33%), Gaps = 44/174 (25%)
Query: 159 IGEGGYGIVYRGI---------LSDGTKVAVK-NLLNNRGQAEKEF------KVEVEVIG 202
GI+Y K ++K + + R E+ F ++V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 203 RVRHKNLV---RLLGY-CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++ L+ +G+ + YR LV L + L + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPS---------LGRSLQSA--LDVSPKHVLSE 158
Query: 259 GTAKGLA--------YLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAK 302
+ +A +LHE + VH +V + NI +D + ++V + +G A
Sbjct: 159 RSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 38/178 (21%), Positives = 69/178 (38%), Gaps = 34/178 (19%)
Query: 159 IGEGGYGIVYRGILSDGT------KVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHK 207
IG+GG+G +Y ++ VK ++ G E K + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 208 NLVRLLG----------YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
++ LG +YR ++ + L + + + + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR-----FGSDLQ-KIYEANAKRFSRKTVLQ 156
Query: 258 LGT--AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYV 311
L L Y+HE + VH D+K+SN+LL+ + +V D+GLA C E +
Sbjct: 157 LSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 48/256 (18%), Positives = 86/256 (33%), Gaps = 72/256 (28%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--------HKNL 209
+G G + V+ + VA+K + + E E+ ++ VR + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 210 VRLLGY-CVEGAYRM---LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
V+LL + G +V+E V +L +W+ + L II +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII--KSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 266 YLHEGLEPKVVHRDVKSSNILL-------------------------------------- 287
YLH + +++H D+K NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 288 -----------DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
+ +++D G A C + T + T Y + E N +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQ-TRQYRSLEVLIGSGYNTPA 274
Query: 337 DVYSFGILIMEIITGR 352
D++S + E+ TG
Sbjct: 275 DIWSTACMAFELATGD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 48/244 (19%), Positives = 79/244 (32%), Gaps = 84/244 (34%)
Query: 158 VIGEGGYGIVYRGI--LSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHK----- 207
+GEG +G V + ++VA+K + N R A ++E+ V+ +++ K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 208 -NLVRLLGY-------C-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
V + + C +E++ N P ++
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF-----------QPYPLPHVRHMAY 130
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-------------------RVSDFG 299
L +LHE ++ H D+K NIL RV+DFG
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 300 LAKLLCSER----SYVTTRVMGTFGYVAPE--------YACTGMLNEKSDVYSFGILIME 347
A + + V TR Y PE C DV+S G ++ E
Sbjct: 188 SA---TFDHEHHTTIVATRH-----YRPPEVILELGWAQPC--------DVWSIGCILFE 231
Query: 348 IITG 351
G
Sbjct: 232 YYRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 484 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.14 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.89 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.75 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.59 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.5 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.62 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 94.5 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 93.81 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 91.94 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.44 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 91.08 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.64 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.56 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 88.58 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 86.21 | |
| 1q55_A | 880 | EP-cadherin, C-cadherin; trans interaction, desmos | 83.02 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.47 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 81.75 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 81.2 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=441.35 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=212.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999864 367899999987776677889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 225 VYEYVDNGNLDQWLHGDV---------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
|||||++|+|.++|+... .....++|..++.++.||+.||+|||++ +|+||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 2345799999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhh
Q 011498 296 SDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
+|||+++........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+...+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~-- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECIT-- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH--
Confidence 999999876443332 2334569999999999999999999999999999999999 99999755422 1111111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
. ... +..+ ..++..+.+|+.+||+.||++|||+++|++.|+.
T Consensus 245 -~-~~~-----~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 245 -Q-GRV-----LQRP----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp -H-TCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -c-CCC-----CCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 110 1111 2244578899999999999999999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=441.60 Aligned_cols=257 Identities=27% Similarity=0.467 Sum_probs=206.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|.+.+.||+|+||+||+|+++ ++..||||++........++|.+|+++|++++|||||+++|+|.+....||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999975 367899999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 225 VYEYVDNGNLDQWLHGDVG-----------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
|||||++|+|.++|+.... ...+++|..++.|+.||+.||+|||++ +|+||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999976432 224699999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhh
Q 011498 294 RVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 371 (484)
||+|||+++....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+...+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHHHH
Confidence 9999999987643322 23345679999999999999999999999999999999999 99999754321 1111111
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... .+..+ ..++..+.+|+.+||+.||++|||++||++.|+.
T Consensus 275 ---~g~------~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 275 ---QGR------ELERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp ---HTC------CCCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred ---cCC------CCCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111 11122 2234568899999999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=437.67 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=210.3
Q ss_pred CCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++.+.+.||+|+||+||+|.+. +++.||||++..... ...++|.+|+.++++++|||||+++|+|.+....+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556788999999999999973 367899999965433 345789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc
Q 011498 225 VYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~ 292 (484)
|||||++|+|.++|+.... ....++|..++.++.|||.||+|||++ +|+||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965321 124689999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccCCC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhh
Q 011498 293 ARVSDFGLAKLLCSER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWL 370 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~ 370 (484)
+||+|||+++...... ........||+.|||||++.++.|+.++|||||||+||||+| |..||...... .+...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~- 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEM- 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHH-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHH-
Confidence 9999999998764332 223445679999999999999999999999999999999999 89999765422 12211
Q ss_pred hhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 371 KTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+..... +. .+..++..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 260 ---i~~~~~-----~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 ---IRNRQV-----LP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHcCCC-----CC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 11 1223455788999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=426.66 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=202.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.+++.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467888999999999999999975 35999988643 23445789999999999999999999998865 56899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
||++|+|.++|+... ..+++..++.|+.|||.||+|||++ +|+||||||+||||+.++++||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999997542 4699999999999999999999998 9999999999999999999999999999876432
Q ss_pred C-ceeeccccccccccccccccc---CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 308 R-SYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 308 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
. .......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||....... .+....... ..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~----~~ 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRG----YA 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTT----CC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC----CC
Confidence 2 223445689999999999864 468999999999999999999999997544221 111111111 11
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.|.++ .....++..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 256 ~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 256 SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 1122345578899999999999999999999998874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=430.30 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=208.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
..|...+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999975 58999999997655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
+||+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....+||+.|||||++.+..|+.++|||||||+||||+||++||...... .....+. .. ..+.+
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~---~~------~~~~~-- 290 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR---DN------LPPRL-- 290 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH---HS------SCCCC--
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHH---cC------CCCCC--
Confidence 345578999999999999999999999999999999999999999754321 1111111 10 11111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+|+.+||..||++|||++|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234557889999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=431.90 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=202.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999975 58999999996543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
||+||+|.++|+... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997542 24578999999999999999999999 9999999999999999999999999999876332
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.. +.+....... . +.+
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~-----~-~~~ 245 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIISGS-----F-PPV 245 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC-----C-CCC
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCC-----C-CCC
Confidence 1 1234567999999999999999999999999999999999999999754321 1111111111 0 111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+ ......+.+|+.+||+.||++|||++|+++
T Consensus 246 ~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 S----LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 123456888999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=424.65 Aligned_cols=250 Identities=20% Similarity=0.227 Sum_probs=202.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+.|.+.+.||+|+||+||+|+++ +|+.||||++..... ..+|+.+++.++|||||++++++.+...+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45677789999999999999975 589999999965432 235999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeecccccccCCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSER 308 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 308 (484)
+||+|.++|+.. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++ ++||+|||+|+......
T Consensus 133 ~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999764 4699999999999999999999998 999999999999999987 69999999998764332
Q ss_pred ce----eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 309 SY----VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 309 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.. .....+||+.|||||++.+..|+.++|||||||+||||+||++||......... ..+. ......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~---~~~~~~---- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIA---SEPPPI---- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHH---HSCCGG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHH---cCCCCc----
Confidence 11 123357999999999999999999999999999999999999999765543221 1111 111000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..+ +..+...+.+++.+||+.||.+|||+.||++.|..
T Consensus 276 ~~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 REI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 011 12234568889999999999999999999988764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=414.36 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=195.8
Q ss_pred CcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee----CCeeeEEE
Q 011498 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVY 226 (484)
Q Consensus 154 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 226 (484)
.+.+.||+|+||+||+|.+. ++..||+|++.... ....+.|.+|+.++++++|||||+++++|.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44568999999999999975 48899999986543 3345679999999999999999999999875 34679999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeeccccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLC 305 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla~~~~ 305 (484)
|||++|+|.++|+.. ..+++..+..++.||+.||+|||++ .++|+||||||+||||+. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999764 4699999999999999999999998 223999999999999984 7899999999998643
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ...... +....
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~-i~~~~------- 246 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR-VTSGV------- 246 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH-HTTTC-------
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHH-HHcCC-------
Confidence 22 2345689999999998864 6999999999999999999999999644321 111111 11111
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+...+......+.+|+.+||..||++|||++|+++
T Consensus 247 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 -KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111122345888999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-55 Score=420.82 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=210.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999965 58999999986532 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|||+||+|.++|+.. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999764 4699999999999999999999999 999999999999999999999999999987653
Q ss_pred CC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .......+||+.|||||++.+..|+.++|||||||+||||+||++||...+.. .+. ....... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~---~~i~~~~-------~ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIF---AKIIKLE-------Y 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTC-------C
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCC-------C
Confidence 32 23345678999999999999999999999999999999999999999754321 111 1111110 1
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHhcCCcc
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH--MLEADDLL 430 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~--~L~~~~~~ 430 (484)
.++. .....+.+|+.+||..||++|||++|++. .|....++
T Consensus 252 ~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F 294 (311)
T 4aw0_A 252 DFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294 (311)
T ss_dssp CCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred CCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCc
Confidence 1221 22346788999999999999999998742 34444443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=419.60 Aligned_cols=265 Identities=25% Similarity=0.349 Sum_probs=202.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC----eeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+++ |+.||||++..... ....+..|+..+.+++|||||+++++|.++. .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 34677889999999999999985 89999999854432 2223445666677889999999999998653 579999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC-----CCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG-----LEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
|||++|+|.++|+.. +++|..+++++.|++.||+|||++ ..++|+||||||+||||+.++++||+|||++
T Consensus 81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999754 589999999999999999999975 2458999999999999999999999999999
Q ss_pred ccccCCCce---eecccccccccccccccccC------CCCcccceecchhHHHHHHhCCCCCCCCCCCCcc--------
Q 011498 302 KLLCSERSY---VTTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV-------- 364 (484)
Q Consensus 302 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~-------- 364 (484)
+........ .....+||+.|||||++.+. .++.++|||||||+||||+||.+||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543322 12345799999999998764 4678999999999999999999887644321110
Q ss_pred chhhhhhhhhcCCCcccccCCCCCCC-ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 365 NLVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.....+.... .....+|.++.. ...+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus 236 ~~~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chHHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0011111111 112223333332 234567789999999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=428.67 Aligned_cols=268 Identities=25% Similarity=0.396 Sum_probs=216.7
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccch-hhHHHHHHHHHHHhccCC-Cceeee
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRH-KNLVRL 212 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H-~niv~l 212 (484)
+...+++...++|.+.+.||+|+||+||+|.+.. ++.||||++..... ...+.|.+|+.+|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455666677889999999999999999999653 25799999976543 345679999999999965 899999
Q ss_pred cceeeeC-CeeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecC
Q 011498 213 LGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (484)
Q Consensus 213 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~d 279 (484)
+|+|... ..++||||||++|+|.++|+.... ....+++..++.++.|||.||+|||++ +|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 568999999999999999975422 134589999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCC
Q 011498 280 VKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY 357 (484)
Q Consensus 280 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~ 357 (484)
|||+||||+.++.+||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||+||||+| |..||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654332 33455679999999999999999999999999999999998 9999976
Q ss_pred CCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 358 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...... +. ..+.... .+..+. .+...+.+++.+||+.||++|||+.||++.|+.
T Consensus 291 ~~~~~~--~~----~~i~~g~-----~~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKIDEE--FC----RRLKEGT-----RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCSHH--HH----HHHHHTC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH--HH----HHHHcCC-----CCCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 543211 11 1111111 111222 234568889999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=431.80 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=208.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
..|...+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46899999999999999999975 58999999997665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
+||+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999753 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....+||+.|||||++.+..|+.++|||||||+||||++|++||...... .....+. .. ..+.+.
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~---~~------~~~~~~- 368 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR---DN------LPPRLK- 368 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH---HS------CCCCCS-
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHH---cC------CCCCCc-
Confidence 345578999999999999999999999999999999999999999754321 1111111 11 111111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........+.+|+.+||..||++|||++|+++
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11123456888999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=405.75 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=190.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|... +|+.||||++.... ......+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999964 58999999986543 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+ +|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 67999999765 4699999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .....+||+.|+|||++.+..+ +.++|||||||+||||+||+.||...+. ........... .
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~-------~ 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGV-------Y 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-------C
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCC-------C
Confidence 22 2345689999999999998876 5799999999999999999999975431 11111111110 1
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.++. .....+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPK----FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 12346788999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=414.55 Aligned_cols=242 Identities=22% Similarity=0.283 Sum_probs=193.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|.+.+.||+|+||+||+|+.. .++.||||++..... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888999999999999999852 367899999865431 223467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
|||||+||+|.++|+.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999764 4699999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
..... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.. .+ ....... .
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~i~~~-------~ 242 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ET---MTMILKA-------K 242 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHC-------C
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HH---HHHHHcC-------C
Confidence 43322 234568999999999999999999999999999999999999999754321 11 1111111 0
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
..++. .....+.+|+.+||+.||++|||+
T Consensus 243 ~~~p~----~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 LGMPQ----FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCC----cCCHHHHHHHHHHcccCHHHCCCC
Confidence 11111 233468889999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=395.84 Aligned_cols=250 Identities=23% Similarity=0.426 Sum_probs=189.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCC--------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-------- 220 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------- 220 (484)
++|.+.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888899999999999999975 58999999986543 334567899999999999999999999987543
Q ss_pred ----eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEe
Q 011498 221 ----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 221 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
.+|+|||||++|+|.++++... ......+..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999997542 223456778899999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCce-----------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccc
Q 011498 297 DFGLAKLLCSERSY-----------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 365 (484)
Q Consensus 297 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~ 365 (484)
|||+|+........ .....+||+.|||||++.+..|+.++|||||||+||||++ ||.... +
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H
Confidence 99999876433211 1234579999999999999999999999999999999996 764211 1
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+... .....+. ........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~---------~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDV---------RNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH---------HTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH---------hcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 1111111 12233455678999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=390.68 Aligned_cols=294 Identities=44% Similarity=0.773 Sum_probs=254.4
Q ss_pred CCccccHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchh-hHHHHHHHHHHHhccCCCceeeecce
Q 011498 137 WGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
....+++.++....++|.+.+.||+|+||.||+|...+++.||||++...... ....+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34568899999999999999999999999999999888999999998655422 23368899999999999999999999
Q ss_pred eeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
+......++||||+++|+|.++++........+++..++.++.|++.||+|||+.+.++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999877666677999999999999999999999876679999999999999999999999
Q ss_pred eeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCC--CCCccchhhhhhhh
Q 011498 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR--PQGEVNLVDWLKTM 373 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~--~~~~~~~~~~~~~~ 373 (484)
+|||++...............||+.|+|||++.+..++.++|||||||++|||+||..||.... .........|+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998775554444555679999999999999999999999999999999999999996321 22344556666666
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcc
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 430 (484)
..........+..+...........+.+++.+||+.||.+|||+.+|++.|+.....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 667777778888887778888999999999999999999999999999999975543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=388.67 Aligned_cols=284 Identities=38% Similarity=0.688 Sum_probs=247.1
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 220 (484)
+++.++...+++|...+.||+|+||.||+|.++++..||||++........+.+.+|+.+++.++||||+++++++....
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445566788999999999999999999998889999999987766666778999999999999999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976544445699999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 301 AKLLCSER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 301 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....+........|..........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98653322 22233456899999999999999999999999999999999999999887776666677776666666667
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...+++.+...........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 777777777777788899999999999999999999999999999854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=395.13 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=200.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee------CCe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE------GAY 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 221 (484)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56889999999999999999975 58999999996543 2334678889999999999999999998764 357
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
+|||||||. |+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 6899999754 5699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC---ceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 302 KLLCSER---SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 302 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
+.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.... ...+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCC
Confidence 8764321 2233457899999999998875 579999999999999999999999976543221 11111111110
Q ss_pred Cccc-----------cc--CCCCCCCChH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 KSEE-----------VV--DPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ~~~~-----------~~--~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... .. .+........ .....+.+|+.+||..||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00 0011111111 12346788999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=385.31 Aligned_cols=198 Identities=24% Similarity=0.357 Sum_probs=170.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 223 (484)
..+.|.+.+.||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++++.+ +|||||++++++.+.+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 36789999886543 235677899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAK 302 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgla~ 302 (484)
+||||+++|+|.++++ .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999983 489999999999999999999999 99999999999999877 799999999997
Q ss_pred cccCCCc---------------------------eeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCC
Q 011498 303 LLCSERS---------------------------YVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNP 354 (484)
Q Consensus 303 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p 354 (484)
....... ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6432211 112335799999999999875 589999999999999999999999
Q ss_pred CCCC
Q 011498 355 VDYS 358 (484)
Q Consensus 355 ~~~~ 358 (484)
|...
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=409.88 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=209.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||+||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+...+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57899999999999999999975 58999999997766666678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC--CcEEEeeecccccccCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ--WNARVSDFGLAKLLCSE 307 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfgla~~~~~~ 307 (484)
+||+|.++|.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 237 ~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999996432 4689999999999999999999999 99999999999999854 89999999999987544
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. ....+||+.|+|||++.+..|+.++|||||||+||||++|.+||....... . +....... ..+
T Consensus 311 ~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~---~~~i~~~~-------~~~ 375 (573)
T 3uto_A 311 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---T---LRNVKSCD-------WNM 375 (573)
T ss_dssp SE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H---HHHHHTTC-------CCC
T ss_pred Cc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---HHHHHhCC-------CCC
Confidence 32 344689999999999999999999999999999999999999997544221 1 11111100 011
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+..........+.+|+.+||..||.+|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111223456788999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=403.58 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=199.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHH---HHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEK---EFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
.++|.+.+.||+|+||+||+|+.+ +|+.||||++.+... .... ....++.+++.++|||||+++++|.+...+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 357999999999999999999975 589999999864321 1122 233346777888999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|||||||+||+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999764 4699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
...... ....+||+.|||||++.. ..|+.++|||||||+||||++|.+||..........+. ......
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~~~----- 409 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTM----- 409 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHHHC-----
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhhcCC-----
Confidence 764432 345689999999999974 57999999999999999999999999754432221111 111100
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
...++. .....+.+|+.+||..||.+|++ ++||++
T Consensus 410 --~~~~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 --AVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --CCCCCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --CCCCCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111 23446788999999999999998 577765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=361.24 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=211.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||+||+|.+. ++..||+|++........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56888899999999999999975 58899999987766677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.++++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999997642 4689999999999999999999999 999999999999999999999999999987543322
Q ss_pred ee-------------ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 310 YV-------------TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 310 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..||............. ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~---- 238 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRG---- 238 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHH----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhc----
Confidence 11 114579999999999999999999999999999999999999987654322111110 000
Q ss_pred CCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
..+...+. .+...+.+++.+||+.||++|||+.+|++.|+...
T Consensus 239 -----~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 239 -----FLDRYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -----HHHHTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----cccccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111111 12235888999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.23 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=208.2
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||+||+|.. .+++.||||++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35799999999999999999985 46899999998766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999754 489999999999999999999999 99999999999999999999999999998764433
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. ......||+.|+|||++.+..++.++|||||||++|||+||..||........ . ....... ...
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~---~~~~~~~--------~~~ 235 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---L---YLIATNG--------TPE 235 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HHHHHHC--------SCC
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCC--------CCC
Confidence 2 23445799999999999999999999999999999999999999975432111 1 1100000 001
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1112334456889999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=372.23 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=209.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC--------CCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeC
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 219 (484)
.++|.+.+.||+|+||.||+|.+. ++..||||++..... .....+.+|+.+++.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999862 345799999876533 3456789999999999 899999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
...|+||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999976432 124589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccc
Q 011498 288 DRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~ 365 (484)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986543322 12233457889999999999999999999999999999999 999997544221
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+... ..... .+.. +..+...+.+++.+||+.||++|||+.||++.|+..
T Consensus 314 ~~~~----~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LFKL----LKEGH-----RMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHH----HHTTC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----HhcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 11110 0111 122345688899999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=362.07 Aligned_cols=260 Identities=31% Similarity=0.485 Sum_probs=202.1
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.....+|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 344567888999999999999999884 8899999986553 3334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc--eeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 999999999999997542 112489999999999999999999998 8 9999999999999999999999999997
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... .......||+.|+|||++.+..++.++|||||||++|||+||..||....... .. .......
T Consensus 188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~---~~~~~~~----- 255 (309)
T 3p86_A 188 LKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VV---AAVGFKC----- 255 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH---HHHHHSC-----
T ss_pred cccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhcC-----
Confidence 643322 12334579999999999999999999999999999999999999997543211 11 1110000
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
....++ ......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 256 ~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 256 KRLEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp CCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111 12334688899999999999999999999999753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=348.55 Aligned_cols=280 Identities=37% Similarity=0.639 Sum_probs=227.0
Q ss_pred ccccHHHHHHHhcCCCcC------ceeccCCceEEEEEEECCCCEEEEEEecccc----hhhHHHHHHHHHHHhccCCCc
Q 011498 139 RWYTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN 208 (484)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~------~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~H~n 208 (484)
..|++.++..++.+|... +.||+|+||.||+|.. ++..||||++.... ....+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 448899999999999887 8999999999999987 48899999986532 234567899999999999999
Q ss_pred eeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
|+++++++.+....++||||+++|+|.+++.... ...++++..++.++.|++.||.|||+. +++|+||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999997432 235689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccCCC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh
Q 011498 289 RQWNARVSDFGLAKLLCSER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~ 367 (484)
.++.+||+|||++....... ........||+.|+|||.+.+ .++.++||||||+++|+|++|..||........ ..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LL 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HH
Confidence 99999999999998654322 222334578999999998864 589999999999999999999999976543321 11
Q ss_pred hhhhhhhc-CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 368 DWLKTMVG-SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 368 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+...... .......+++.+. .........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111 1222333444333 33456778899999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=360.81 Aligned_cols=247 Identities=20% Similarity=0.331 Sum_probs=204.8
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788899999999999999997 468999999986542 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999754 4589999999999999999999998 999999999999999999999999999986643
Q ss_pred CCceeecccccccccccccccccCCCC-cccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .....+||+.|+|||++.+..++ .++|||||||++|||+||..||...... .......... .
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-------~ 231 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLRGK-------Y 231 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------C
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------C
Confidence 32 23456799999999999888775 7999999999999999999999754321 1111111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.++. .....+.+++.+||..||.+|||++|+++
T Consensus 232 ~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 RIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111 12345788999999999999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.53 Aligned_cols=253 Identities=27% Similarity=0.458 Sum_probs=209.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56888899999999999999998889999999875443 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999997542 4689999999999999999999998 9999999999999999999999999999866443322
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... +........ ..+..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~------~~~~~-- 228 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG------FRLYK-- 228 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT------CCCCC--
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC------ccCCC--
Confidence 3334457788999999999999999999999999999999 99999754321 111111110 01111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+......+.+++.+||+.||++|||+.++++.|+.
T Consensus 229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 229 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 11123468889999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.74 Aligned_cols=260 Identities=26% Similarity=0.358 Sum_probs=214.1
Q ss_pred cccHHHHHHHhcC----------CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCc
Q 011498 140 WYTLRELEAATSG----------LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208 (484)
Q Consensus 140 ~~~~~~~~~~~~~----------~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n 208 (484)
.++.+++..+++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3678888877764 566678999999999999976 68999999997666566678889999999999999
Q ss_pred eeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
|+++++++......++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 99999999999999999999999999999864 3589999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh
Q 011498 289 RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~ 368 (484)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 999999999999987644322 234457999999999999999999999999999999999999999754321 1111
Q ss_pred hhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+.. . ..+.+. ........+.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~---~------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLRD---S------PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHH---S------SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhc---C------CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 0 111111 11223456888999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=360.29 Aligned_cols=255 Identities=28% Similarity=0.487 Sum_probs=205.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||.||+|.+. .+..||||.+.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999974 34569999997653 34456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.++++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 129 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999996542 4689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCc--eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .. ......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~---~~~~~~------ 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VI---SSVEEG------ 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH---HHHHTT------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HH---HHHHcC------
Confidence 3322 12223346778999999999999999999999999999999 999996543211 11 111110
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.....+..+...+.+++.+||..||++|||+.+|++.|+..
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111122345688899999999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=359.64 Aligned_cols=267 Identities=25% Similarity=0.369 Sum_probs=207.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC----eeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv 225 (484)
.++|.+.+.||+|+||.||+|++. ++.||||++.... .....+..|+.+++.++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367888999999999999999986 7899999886543 23345566899999999999999999998744 46999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC-------CCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL-------EPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
|||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999753 4899999999999999999999751 238999999999999999999999999
Q ss_pred cccccccCCCce-eecccccccccccccccccC-----CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh---
Q 011498 299 GLAKLLCSERSY-VTTRVMGTFGYVAPEYACTG-----MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW--- 369 (484)
Q Consensus 299 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~--- 369 (484)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876443322 23335799999999999763 566789999999999999999999986554332222111
Q ss_pred ------hhhhhcCCCcccccCCCCCCC-ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 370 ------LKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 370 ------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+...... ....+.++.. ........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 256 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 256 HPSLEDMQEVVVH----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCchhhhhhhhhc----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0010100 1111111111 1224566799999999999999999999999999853
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=349.56 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=211.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||+|.++++..||+|.+..... ....+.+|+.++..++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457888899999999999999998888999998865443 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997542 3589999999999999999999998 999999999999999999999999999987655444
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......+|+.|+|||++.+..++.++||||||+++|||+| |..||....... ......... ....+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~------~~~~~ 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGH------RLYRP 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC------CCCCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCC------CCCCC
Confidence 43444556788999999998899999999999999999999 999997543211 111111100 00111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
......+.+++.+||+.||++|||+.+|++.|+...
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112346888999999999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=353.31 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=204.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57888999999999999999965 58899999885432 334467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++... .++++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999754 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
..........||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ........... . .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~-~-----~ 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSV-P-----N 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCC-C-----C
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccC-C-----C
Confidence 4333344567999999999999999999999999999999999999999754321 11111111100 0 0
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEAD 427 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~ 427 (484)
............+.+++.+||..||.+|| +++++.+.|+..
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 00001112345688899999999999998 899999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=358.26 Aligned_cols=262 Identities=22% Similarity=0.379 Sum_probs=204.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-----CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC--Ceee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~ 223 (484)
++|.+.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++.++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 56888899999999999999852 5789999999877666667899999999999999999999998653 4589
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 90 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999997653 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCC---------Cccchhhhhhh
Q 011498 304 LCSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ---------GEVNLVDWLKT 372 (484)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~---------~~~~~~~~~~~ 372 (484)
....... ......++..|+|||++.+..++.++||||||+++|||+||..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433221 122345777899999999999999999999999999999999998632110 00000000111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.... ......+..+...+.+++.+||+.||++|||+.||++.|+..
T Consensus 244 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhc---------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1100 111111223445788999999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=348.93 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=201.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhc--cCCCceeeecceeeeC----Ceee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEG----AYRM 223 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~~~ 223 (484)
.++|.+.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788999999999999999998 5899999988543 23445556666665 7999999999987643 4579
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhh--------cCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH--------EGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
+||||+++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999953 35899999999999999999999 77 9999999999999999999999
Q ss_pred eeecccccccCCCcee---ecccccccccccccccccC------CCCcccceecchhHHHHHHhC----------CCCCC
Q 011498 296 SDFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITG----------RNPVD 356 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltG----------~~p~~ 356 (484)
+|||++.......... .....||+.|+|||++.+. .++.++|||||||++|||+|| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997664433221 2234799999999999876 455799999999999999999 77876
Q ss_pred CCCCCCccchhhhhhhhhcCCCcccccCCCCCC-CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 357 YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
........ ... ........ ...+.++. .........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 235 ~~~~~~~~-~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS-FED-MRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC-HHH-HHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc-hhh-hhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54332211 111 11111111 11111211 12345678899999999999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=369.16 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=207.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|.+. +++.||||.+..... .....|.+|+.+++.++||||+++++++......++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999986 688999998865432 334568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.++++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999997542 3589999999999999999999999 9999999999999999999999999999865332
Q ss_pred Cceee-cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 308 RSYVT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 308 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
..... ....++..|+|||++.+..++.++|||||||++|||+| |..||....... .. ....... ..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~~-----~~ 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TR----EFVEKGG-----RL 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HH----HHHHTTC-----CC
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC-----CC
Confidence 21111 11235678999999998999999999999999999999 999997543211 11 1111110 00
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.. +..+...+.+++.+||+.||++|||+.+|++.|+..
T Consensus 335 ~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 PC----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11 112345688899999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=359.83 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=205.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh------hHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
.+.|.+.+.||+|+||.||+|..+ +|..||+|.+...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357888999999999999999975 5889999998654322 346788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC----cEEEeee
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDF 298 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 298 (484)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999653 4699999999999999999999998 999999999999998876 7999999
Q ss_pred cccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .........
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~~- 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAVS- 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC-
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-
Confidence 9998764432 2344579999999999999999999999999999999999999997543211 111111100
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+..........+.+++.+||..||.+|||+.|+++
T Consensus 235 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 ------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000001123356888999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=350.79 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=206.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457888899999999999999998888999999865432 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999997532 4589999999999999999999998 999999999999999999999999999987644332
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......+|+.|+|||++.+..++.++||||||+++|||+| |..||....... .. ...... .....+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~---~~~~~~------~~~~~~ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA---EHIAQG------LRLYRP 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---HHHHTT------CCCCCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HH---HHHhcc------cCCCCC
Confidence 22333456788999999998999999999999999999998 999997543211 11 111110 011111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......+.+++.+||+.||.+|||+.++++.|+.
T Consensus 244 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 244 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1123468889999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=375.86 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=210.5
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
+...++|.+.+.||+|+||.||+|.++++..||||++.... ...+.|.+|+.+++.++||||+++++++. ....++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 44457788899999999999999999888899999987544 34678999999999999999999999987 56789999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999997432 13578999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
..........++..|+|||++....++.++|||||||+||||+| |..||...... .....+.. .. .
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~---~~------~- 403 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALER---GY------R- 403 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHH---TC------C-
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc---CC------C-
Confidence 22222223346788999999998999999999999999999999 99999754321 11111111 00 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
...+..+...+.+++.+||+.||++|||+.+|++.|+...
T Consensus 404 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 404 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0111223457889999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=365.45 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=196.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.+|.+.+.||+|+||.||+|++. ++..||||.+.... ....+.|.+|+.+++.++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 46789999986543 34456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.++++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999997542 4689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ... .. ....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~---~~-i~~~----- 266 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVI---KA-VDEG----- 266 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHH---HH-HHTT-----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HH-HHcC-----
Confidence 33221 1122235778999999999999999999999999999998 99999754321 111 11 1111
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
........+...+.+++.+||+.||.+||++.+|++.|+..
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 00011122345688999999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=377.72 Aligned_cols=257 Identities=24% Similarity=0.410 Sum_probs=212.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
...+|.+.+.||+|+||.||+|.++. +..||||.+.... ...+.|.+|+.++++++||||++++++|......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34668888999999999999999875 7899999986543 335679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999997642 24689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.........++..|+|||++.+..++.++|||||||+||||+| |..||....... ....+. ..
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~--------- 435 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----KD--------- 435 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TT---------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC---------
Confidence 3333333456789999999999999999999999999999999 999997654221 111111 11
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.....+..+...+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11111222345688899999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=354.30 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=204.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+.+ +|+.||+|++.... ......+..|+.+++.++||||+++++++.+....|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999975 58999999986542 233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999754 4689999999999999999999998 999999999999999999999999999986432
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ....... ..
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~i~~~~-------~~ 223 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELILMEE-------IR 223 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCC-------CC
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHH---HHHHcCC-------CC
Confidence 22 2234567999999999999999999999999999999999999999754321 111 1111110 11
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHML 424 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~L 424 (484)
++. .....+.+++.+||+.||.+|| +++||++.-
T Consensus 224 ~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 224 FPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 111 2334678899999999999999 888887743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=354.06 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=202.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999976 688999998864432 234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999744 4589999999999999999999998 9999999999999999999999999999865332
Q ss_pred C-ceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 308 R-SYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 308 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+.. .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~----~--------- 224 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----K--------- 224 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT----T---------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc----c---------
Confidence 2 122334679999999999987765 7799999999999999999999975543211 1111111 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.............+.+|+.+||..||++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01111122334567889999999999999999999763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=364.83 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=207.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
.++|.+.+.||+|+||.||+|.+. ++..||||++.... ......+..|+.+++.++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888899999999999999953 35689999986543 34456788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCC---CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC---cEEEe
Q 011498 223 MLVYEYVDNGNLDQWLHGDV---GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVS 296 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~ 296 (484)
++||||+++|+|.++++... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 2234589999999999999999999999 999999999999999554 59999
Q ss_pred eecccccccCCC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhh
Q 011498 297 DFGLAKLLCSER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 297 Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||+| |..||...... ... ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~---~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL---EFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH---HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHH
Confidence 999997643221 112233567899999999999999999999999999999998 99999754321 111 1111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... .......+...+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 301 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 0011112334688899999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=363.36 Aligned_cols=268 Identities=25% Similarity=0.409 Sum_probs=213.4
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeee
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRL 212 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l 212 (484)
+....++...++|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445666677889999999999999999999842 357899999976433 3446789999999999 89999999
Q ss_pred cceeeeCC-eeeEEEEecCCCCHHHHhhcCCCC-----------------------------------------------
Q 011498 213 LGYCVEGA-YRMLVYEYVDNGNLDQWLHGDVGD----------------------------------------------- 244 (484)
Q Consensus 213 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------- 244 (484)
++++.+.. ..++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998754 489999999999999999765321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC-
Q 011498 245 ---------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER- 308 (484)
Q Consensus 245 ---------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~- 308 (484)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999999 99999999999999999999999999998654332
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
........||+.|+|||++.+..++.++|||||||++|||+| |..||........ ....+.. .. ....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~----~~-----~~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKE----GT-----RMRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHH----TC-----CCCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHc----CC-----CCCC
Confidence 223344568899999999999999999999999999999999 9999976543211 1111110 00 0111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+ ......+.+++.+||+.||++|||+.||++.|+.
T Consensus 318 ~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 318 P----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1 1123468889999999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=345.62 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=212.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCC--eeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 568888999999999999999764 8899999986543 233567788999999999999999999998755 779999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE----cCCCcEEEeeecccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAK 302 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfgla~ 302 (484)
||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++.
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999976432 23489999999999999999999999 99999999999999 788889999999998
Q ss_pred cccCCCceeecccccccccccccccc--------cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYAC--------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
....... .....||+.|+|||++. +..++.++|||||||++|||+||..||......... .+.+....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHh
Confidence 7644332 23456999999999886 578899999999999999999999999754322111 11111111
Q ss_pred cCC---Ccccc---------c--CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 375 GSR---KSEEV---------V--DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 375 ~~~---~~~~~---------~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
... ....+ . .-.............+.+++.+||+.||++|||++|+++...++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 110 00000 0 011122344667788999999999999999999999999887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=353.26 Aligned_cols=251 Identities=16% Similarity=0.268 Sum_probs=205.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367888999999999999999975 47889999886443 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC--CCcEEEeeecccccccC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCS 306 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfgla~~~~~ 306 (484)
+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999996532 4689999999999999999999999 9999999999999987 78999999999987644
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ........ .
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~-------~ 221 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII---ENIMNAEY-------T 221 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHHTCC-------C
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHH---HHHHcCCC-------C
Confidence 332 33456899999999999988999999999999999999999999754321 111 11111000 0
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+..........+.+++.+||..||.+|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000001123456889999999999999999999988
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=354.18 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=201.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999997 468899999886432 222357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+ +|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 67999998754 4589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .....+||+.|+|||++.+..+ ++++|||||||++|+|++|..||............ .. ...
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------~~-~~~ 225 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------NS-CVY 225 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC------------CS-SCC
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH------------Hc-CCC
Confidence 32 2334579999999999988776 78999999999999999999999754432211100 00 000
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+ ......+.+++.+||..||.+|||++|+++
T Consensus 226 ~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 VMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 123346788999999999999999999976
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=349.79 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=202.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||+||+|...+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 367888999999999999999998899999999865432 234678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 8888886542 4589999999999999999999998 9999999999999999999999999999876432
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc----
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV---- 382 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 382 (484)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .+............
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGT
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhh
Confidence 22 2334568999999999876 568999999999999999999999997655432211 11111111100000
Q ss_pred --------cCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 --------VDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 --------~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......... ......+.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000 112356789999999999999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=352.96 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=204.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch------hhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
+.|.+.+.||+|+||.||+|... +|..||+|.+..... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888899999999999999975 588999998865432 13567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC----cEEEeeec
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 299 (484)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999654 4689999999999999999999998 999999999999999887 79999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. .......
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~~~~~~-- 233 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANVSAVN-- 233 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHTC--
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHhcC--
Confidence 9987643322 234579999999999999999999999999999999999999997543211 11 1111000
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
...+..........+.+++.+||..||.+|||+.++++.
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001100011223568889999999999999999999873
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=367.22 Aligned_cols=249 Identities=33% Similarity=0.419 Sum_probs=204.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC-eeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-YRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||+|.++ ++.||||.+.... ..+.|.+|+.++++++||||+++++++.... ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888899999999999999986 7899999987543 4567999999999999999999999987765 78999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++|+|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999997642 23478999999999999999999999 9999999999999999999999999999854322
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.....++..|+|||++.+..++.++|||||||+||||+| |..||........ ...+. ...
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~----~~~--------- 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE----KGY--------- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHHH----TTC---------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----cCC---------
Confidence 122357889999999999999999999999999999999 9999976543221 11111 110
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
....+..+...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 011112234578899999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.89 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=209.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 221 (484)
..++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3467888999999999999999862 35789999986543 3445678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCC
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG--------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK 281 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlk 281 (484)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999976432 123488999999999999999999998 99999999
Q ss_pred CCcEEEcCCCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCC
Q 011498 282 SSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSR 359 (484)
Q Consensus 282 p~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~ 359 (484)
|+||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876443322 2233457889999999999999999999999999999999 999997654
Q ss_pred CCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 360 PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... ....+. ... .+.. +......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 258 ~~~---~~~~~~----~~~-----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 258 PER---LFNLLK----TGH-----RMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GGG---HHHHHH----TTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH---HHHHhh----cCC-----cCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 321 111111 110 0111 12234568899999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=356.42 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=211.8
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeee
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 218 (484)
+....++|.+.+.||+|+||.||+|... ++..||||.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999975 24789999987553 3345678999999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeec
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--------------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~ 278 (484)
....++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 99999999999999999999764211 25689999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCC
Q 011498 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVD 356 (484)
Q Consensus 279 dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~ 356 (484)
||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999976543221 12234567899999999999999999999999999999999 999997
Q ss_pred CCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 357 YSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
..... .. ..... .... +..+ ..+...+.+++.+||+.||++|||+.+|++.|+...
T Consensus 279 ~~~~~---~~---~~~~~-~~~~-----~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 279 GMAHE---EV---IYYVR-DGNI-----LACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TSCHH---HH---HHHHH-TTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCChH---HH---HHHHh-CCCc-----CCCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 54321 11 11111 1111 0111 123356888999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=357.61 Aligned_cols=252 Identities=18% Similarity=0.255 Sum_probs=206.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 356888999999999999999975 5889999998766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC--CCcEEEeeecccccccC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCS 306 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfgla~~~~~ 306 (484)
+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999996532 4589999999999999999999998 9999999999999974 46799999999987644
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... .....||+.|+|||++.+..++.++|||||||++|||+||..||...... ... ....... ..
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~---~~i~~~~-------~~ 268 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETL---QNVKRCD-------WE 268 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH---HHHHHCC-------CC
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCC-------CC
Confidence 332 23346999999999999999999999999999999999999999754321 111 1111100 00
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............+.+++.+||..||.+|||+.|+++
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111111223456889999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=355.24 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=203.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999975 47899999886532 223467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999754 4699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeccccccccccccccccc---CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.. .....+||+.|+|||++.. ..++.++|||||||++|||++|..||..............+.. .
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~------- 235 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---T------- 235 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---C-------
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---c-------
Confidence 32 2345679999999999864 4589999999999999999999999975543322222111111 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~ 422 (484)
....+ ......+.+|+.+||+.||.+||+ +++|++
T Consensus 236 ~~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 VVTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01111 123356888999999999999999 677665
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=360.36 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=210.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC--------CCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeC
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 219 (484)
.++|.+.+.||+|+||.||+|... .+..||||++..... .....+.+|+++++.+ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999852 235799999876533 3446788999999999 999999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
...++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999976531 124699999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccc
Q 011498 288 DRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~ 365 (484)
+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||...... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999986643322 22333457889999999999999999999999999999999 99999754321 1
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
+. .... ... .... +..+...+.+++.+||+.||++|||+.+|++.|+...
T Consensus 302 ~~---~~~~-~~~-----~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 302 LF---KLLK-EGH-----RMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HH---HHHH-TTC-----CCCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHHH-cCC-----CCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1111 110 0111 1123456888999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=358.36 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=204.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
+.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56889999999999999999975 58999999885432 1235678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc---EEEeeeccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLA 301 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfgla 301 (484)
||||+++|+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988865433345689999999999999999999999 9999999999999987654 999999999
Q ss_pred ccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ... ........
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~~~~~--- 249 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGIIKGKY--- 249 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHHHTCC---
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHHcCCC---
Confidence 87644322 23445799999999999999999999999999999999999999975321 111 11110000
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.............+.+++.+||..||++|||+.++++
T Consensus 250 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 ----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000123456889999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=372.14 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=203.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
..++|.+.+.||+|+||.||+|.++++..||||.+.... ...+.|.+|+.++++++||||+++++++.+ ...++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 446788889999999999999999877889999987544 235678999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++|+|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999997432 13589999999999999999999998 99999999999999999999999999998764433
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
........++..|+|||++.+..++.++|||||||+||||+| |..||......+ .. ..... . .
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~---~~i~~-~---------~ 398 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL---DQVER-G---------Y 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH---HHHHT-T---------C
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHc-C---------C
Confidence 222333456789999999999999999999999999999999 999997543211 11 11111 1 0
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
....+..+...+.+++.+||+.||++|||+++|++.|+..
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111123445688999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=345.20 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=194.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. ....++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678888999999999999999743 4569999886543 344567889999999999999999999985 456899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997542 4589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .... ......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~---i~~~~~----- 235 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR---IENGER----- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---HHTTCC-----
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH---HHcCCC-----
Confidence 5433333334457789999999998999999999999999999997 999997554221 1111 111100
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... +......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 236 -~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 -LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011 112345688899999999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=343.55 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=208.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56888899999999999999998888999999875543 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999997642 4589999999999999999999999 9999999999999999999999999999865433222
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......++..|+|||++.+..++.++||||||+++|+|++ |..||...... .......... ....+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~~------~~~~~- 227 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGF------RLYKP- 227 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTC------CCCCC-
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcCC------cCCCC-
Confidence 2233457788999999998999999999999999999999 89999754321 1111111110 01111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......+.+++.+||+.||++|||+.++++.|+.
T Consensus 228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 228 ---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1123468889999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=357.01 Aligned_cols=253 Identities=20% Similarity=0.317 Sum_probs=205.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
..++|.+.+.||+|+||.||+|..+ ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999975 58899999986543 23446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC---cEEEeeecccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAK 302 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfgla~ 302 (484)
|||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999754 4689999999999999999999999 999999999999998654 59999999998
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+...+.. ..
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~---~~----- 246 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKA---GA----- 246 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---TC-----
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh---CC-----
Confidence 764332 233457999999999999999999999999999999999999999754321 11111111 00
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
...+..........+.+++.+||..||++|||+.++++.
T Consensus 247 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 --YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111112334568899999999999999999999763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.00 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=204.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
..++|.+.+.||+|+||.||+|... +|..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467889999999999999999864 58899999986544 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc---CCCcEEEeeecccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAK 302 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfgla~ 302 (484)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999765 4589999999999999999999999 999999999999998 45789999999998
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ....... .
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~---~~i~~~~-~--- 230 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLY---QQIKAGA-Y--- 230 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHHTC-C---
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHH---HHHHhCC-C---
Confidence 7644322 233467999999999999999999999999999999999999999654321 111 1111100 0
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+..........+.+++.+||+.||.+|||+.|+++
T Consensus 231 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 ---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0111111123456888999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=364.92 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=210.1
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeee
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 218 (484)
+.++....++|.+.+.||+|+||+||+|+.+ +++.||+|++..... .....+..|+.+++.++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4555566789999999999999999999976 478999999864321 122357789999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
....|+||||+++|+|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999753 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCceeecccccccccccccccccCC----CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM----LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|+++.............+||+.|+|||++.+.. ++.++|||||||+||||+||..||....... . .....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~---~~~i~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSKIM 286 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---H---HHHHH
Confidence 999876554444445678999999999998665 8899999999999999999999997543211 1 11111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHh
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHMLE 425 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~L~ 425 (484)
... ... ..+. .......+.+|+.+||..+|.+ ||+++||++.--
T Consensus 287 ~~~--~~~---~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 287 NHK--NSL---TFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp THH--HHC---CCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred hcc--ccc---cCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 000 000 0111 0112346788889999999988 999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=356.98 Aligned_cols=248 Identities=20% Similarity=0.304 Sum_probs=199.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||+||+|+.+ +++.||||++.... ......+..|..++..+ +||||+++++++.+....|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999975 48899999986542 23345677899999988 79999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999764 4589999999999999999999999 9999999999999999999999999999754
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ........
T Consensus 175 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~~~i~~~~------- 240 (353)
T 3txo_A 175 ICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DL---FEAILNDE------- 240 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCC-------
T ss_pred ccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HH---HHHHHcCC-------
Confidence 322 22344567999999999999989999999999999999999999999754321 11 11111110
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKM------GHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~evl~ 422 (484)
...+. .....+.+++.+||..||.+||++ ++|++
T Consensus 241 ~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01111 133457888999999999999998 67765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.93 Aligned_cols=265 Identities=20% Similarity=0.239 Sum_probs=211.1
Q ss_pred cHHHHHHHhcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceee
Q 011498 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217 (484)
Q Consensus 142 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 217 (484)
.+.++....++|.+.+.||+|+||+||+|+.+. ++.||+|++..... .....+..|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 355666677899999999999999999999764 78899999865321 12234788999999999999999999999
Q ss_pred eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEee
Q 011498 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (484)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 297 (484)
+....|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999997532 4689999999999999999999998 999999999999999999999999
Q ss_pred ecccccccCCCceeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
||+++.............+||+.|+|||++. ...++.++|||||||+||||++|+.||......+. . ..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~---~~ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---Y---GK 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---H---Hh
Confidence 9999876555444445568999999999987 56799999999999999999999999975432211 1 11
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHH
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATK--RPKMGHVIHML 424 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~L 424 (484)
..... .....|... ......+.+|+.+||..+|++ ||+++||++.-
T Consensus 293 i~~~~--~~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 293 IMNHK--ERFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHTHH--HHCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred hhhcc--ccccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 11000 000111110 112345788888999888888 99999998743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.26 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=198.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||+||+|+.+ +++.||+|++..... .....+..|..++.++ +||||+++++++.+....|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888999999999999999976 478899999875432 2234577889998887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999754 4589999999999999999999999 9999999999999999999999999999863
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCc--cchhhhhhhhhcCCCcccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE--VNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 382 (484)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||........ ......+.......
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 277 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 277 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence 2222 234456899999999999999999999999999999999999999975432211 11111111111111
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
...++. .....+.+|+.+||+.||.+||++
T Consensus 278 -~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 -QIRIPR----SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCCCCT----TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -ccCCCC----cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 011111 233467889999999999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=353.21 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=207.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 220 (484)
..++|.+.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3467888999999999999999962 35689999986543 23346788999999999 9999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCC
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGD-------------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK 281 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlk 281 (484)
..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999764321 13489999999999999999999998 99999999
Q ss_pred CCcEEEcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCC
Q 011498 282 SSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSR 359 (484)
Q Consensus 282 p~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~ 359 (484)
|+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986643322 22344567889999999999999999999999999999998 999997654
Q ss_pred CCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 360 PQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.... ... ..... ..+.. +......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 280 ~~~~--~~~----~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 280 VDAN--FYK----LIQNG-----FKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp CSHH--HHH----HHHTT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHH--HHH----HHhcC-----CCCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 3211 111 11111 01111 112345688899999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=345.34 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=213.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
..++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678889999999999999999764 7889999886543 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999997642 25689999999999999999999999 9999999999999999999999999999877655
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.. .
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~~----~--------- 228 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEK----D--------- 228 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHT----T---------
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc----c---------
Confidence 4444455567889999999999999999999999999999999 999997554221 1111111 0
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.....+......+.+++.+||..||.+|||+.+|++.|+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 01111122345688999999999999999999999999753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=340.19 Aligned_cols=251 Identities=29% Similarity=0.551 Sum_probs=201.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhh-------HHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQA-------EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
++|.+.+.||+|+||.||+|.+. +++.||+|++....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 56888899999999999999974 68899999886543221 167889999999999999999999987654
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc--eeecCCCCCcEEEcCCCc-----EEE
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWN-----ARV 295 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--ivH~dlkp~NIll~~~~~-----~kl 295 (484)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999986542 4689999999999999999999998 8 999999999999988776 999
Q ss_pred eeecccccccCCCceeecccccccccccccccc--cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhh
Q 011498 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC--TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
+|||++..... ......||+.|+|||++. ...++.++|||||||++|||++|..||........ ... ...
T Consensus 171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~---~~~ 242 (287)
T 4f0f_A 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFI---NMI 242 (287)
T ss_dssp CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHH---HHH
T ss_pred CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHH---HHH
Confidence 99999975432 233457999999999983 55688999999999999999999999975543211 111 111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.... ..+.. .......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 243 ~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 REEG-----LRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHSC-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred hccC-----CCCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111 11111 12234568899999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=341.47 Aligned_cols=253 Identities=30% Similarity=0.498 Sum_probs=194.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccch----hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG----QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888899999999999999985 88999998865432 2246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC--------CCcEEEee
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--------QWNARVSD 297 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~--------~~~~kl~D 297 (484)
|||+++++|.++++. ..+++..++.++.|++.||.|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999953 35899999999999999999999981112999999999999986 67899999
Q ss_pred ecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~- 229 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAMN- 229 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHTS-
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhcC-
Confidence 99997654322 223468999999999999999999999999999999999999997543211 01111111
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......+......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 --------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11111112234568899999999999999999999999974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.45 Aligned_cols=257 Identities=16% Similarity=0.200 Sum_probs=206.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||+|.. .+++.||||.+..... ...+..|+.+++.+ +||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5688899999999999999996 4688999998864432 24578899999999 999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc-----EEEeeeccccc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-----ARVSDFGLAKL 303 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfgla~~ 303 (484)
+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 89999999754 24699999999999999999999998 9999999999999998887 99999999987
Q ss_pred ccCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 304 LCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 304 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..||..............+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 5433221 1234679999999999999999999999999999999999999998765332222221111110000
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... .. .. ..+ .+.+++..||+.||.+||++.+|++.|+.
T Consensus 240 ~~~-~~----~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 240 PIE-VL----CE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp CHH-HH----TT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CHH-HH----hc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000 00 00 012 68899999999999999999999998874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=351.49 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=199.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|...+.||+|+||.||+|.+. ++. +||+|.+.... ......+.+|+.+++.++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888899999999999999964 343 46888775433 344578999999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999997643 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||....... ....+. ..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~----~~----- 235 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KG----- 235 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TT-----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHHH----cC-----
Confidence 443322 2233456889999999999999999999999999999999 999997554321 111111 11
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.....+..+...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 236 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111122345688899999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=340.25 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=199.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999998899999999865432 2236788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.+ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 9999987542 4589999999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc------c-
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS------E- 380 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~- 380 (484)
. ......||+.|+|||++.+ ..++.++|||||||++|||+||..||....... ....+......... .
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 1 2233468999999999876 458999999999999999999999997543211 11111111110000 0
Q ss_pred -cccCCCCCC-------CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 -EVVDPKLPK-------MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 -~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...++.... .........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000111100 001123456788999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=347.48 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=209.9
Q ss_pred hcCCCcCceeccCCceEEEEEEE------CCCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
.++|.+.+.||+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788899999999999999985 2467899999875543 3456788999999999 99999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCC--------------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGD--------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 99999999999999999765321 23589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccc
Q 011498 288 DRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~ 365 (484)
+.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||+| |..||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 99999999999999876543322 2334457889999999999999999999999999999999 9999976543211
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
....+.. . ..... .......+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 257 ~~~~~~~----~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 257 FYKMIKE----G-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHHH----T-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcc----C-----CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1111111 0 01111 11234568889999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=355.53 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=189.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
..++|.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567889999999999999999986 47889999986543 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeecccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLL 304 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfgla~~~ 304 (484)
|+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999754 4589999999999999999999998 9999999999999975 889999999999865
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .. .........
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~~~i~~~~~------ 268 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM---FRRILNCEY------ 268 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH---HHHHHTTCC------
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH---HHHHHhCCC------
Confidence 4322 2334578999999999999999999999999999999999999996443211 01 111111100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.............+.+++.+||+.||++|||+.++++
T Consensus 269 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 -YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111223456888999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=349.60 Aligned_cols=260 Identities=22% Similarity=0.396 Sum_probs=193.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCC----CEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSDG----TKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~----~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
..++|.+.+.||+|+||.||+|.+... ..||||.+... .....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 346799999999999999999996542 27999988654 234457889999999999999999999999876655
Q ss_pred ------eEEEEecCCCCHHHHhhcCC--CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEE
Q 011498 223 ------MLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (484)
Q Consensus 223 ------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 294 (484)
++||||+.+|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 99999999999999996432 2223689999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhh
Q 011498 295 VSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 295 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~ 372 (484)
|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .. ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~---~~ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY---NY 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH---HH
Confidence 9999999865433221 1223456788999999999999999999999999999999 999997554321 11 11
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...... ..........+.+++.+||+.||++|||+.++++.|++.
T Consensus 252 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 252 LIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111110 011122345688999999999999999999999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=346.75 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=203.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|+.. +|+.||+|++..... .....+..|+.+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999975 589999999865421 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999764 4589999999999999999999998 999999999999999999999999999986533
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .......... ..
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-------~~ 221 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAE-------LR 221 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCC-------CC
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------CC
Confidence 2 23457999999999999999999999999999999999999999754321 1111111110 11
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
++. .....+.+++.+||..||.+|| ++++|++.
T Consensus 222 ~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 FPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111 1234688899999999999999 88888764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=353.14 Aligned_cols=253 Identities=20% Similarity=0.274 Sum_probs=194.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||++... +++.||||++..... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357888999999999999999976 688999999865432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc--EEEeeecccccccC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKLLCS 306 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfgla~~~~~ 306 (484)
+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999754 3589999999999999999999998 9999999999999987765 99999999975322
Q ss_pred CCceeecccccccccccccccccCCCCcc-cceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEK-SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....+......
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~--------- 237 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV--------- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT---------
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC---------
Confidence 21 2234569999999999988887766 8999999999999999999976543221 11112211111
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.............+.+|+.+||..||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111123467889999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.01 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=205.4
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee----CCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~l 224 (484)
.++|.+.+.||+|+||.||++.. .+++.||||++..........+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36788899999999999999997 4689999999876666667789999999999999999999999873 347799
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+.+|+|.+++.........+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999976433446799999999999999999999999 9999999999999999999999999998754
Q ss_pred cCCCce--------eecccccccccccccccccCC---CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhh
Q 011498 305 CSERSY--------VTTRVMGTFGYVAPEYACTGM---LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 305 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
...... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----
Confidence 321100 012235799999999987554 78999999999999999999999963211111 11100
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
... .............+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000 0000111123356888999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=353.07 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=203.1
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCee
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 222 (484)
...++|.+.+.||+|+||.||+|+.+ +|+.||+|++.... ......+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44578999999999999999999975 58899999986542 22345677788888877 999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999754 3589999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ......
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~---~~i~~~------ 233 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF---HSIRMD------ 233 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHC------
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHhC------
Confidence 643222 2234567999999999999999999999999999999999999999754321 111 111111
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMG-HVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~ 422 (484)
.+..+. .....+.+++.+||..||++||++. +|++
T Consensus 234 -~~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 234 -NPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -CCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111111 1334688899999999999999997 6654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.52 Aligned_cols=260 Identities=16% Similarity=0.184 Sum_probs=207.8
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.+++.+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688899999999999999996 468899999885433 234577899999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc-----EEEeeecccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-----ARVSDFGLAK 302 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfgla~ 302 (484)
|+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 999999997542 3589999999999999999999998 9999999999999987766 9999999998
Q ss_pred cccCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 303 LLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 303 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76443221 133457999999999999999999999999999999999999999875533222222111111100
Q ss_pred CCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 377 RKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
....... ......+.+++.+||+.||++||++++|++.|+..
T Consensus 240 ~~~~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 240 TPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp SCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccHHHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0000000 01235688999999999999999999999999853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=352.60 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=195.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCC--CceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRH--KNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++...+++.||||++.... ......+.+|+.++..++| |||+++++++.+....++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 5688889999999999999998889999999886443 3344678899999999976 99999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
| +.+++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++.....
T Consensus 89 e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp C-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred e-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9 5578999999864 4689999999999999999999998 999999999999997 56899999999987643
Q ss_pred CCce-eeccccccccccccccccc-----------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 307 ERSY-VTTRVMGTFGYVAPEYACT-----------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 307 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ....+....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence 3221 2334579999999999865 6789999999999999999999999964321 111111111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
. +......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 D---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp C---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 111111111123467889999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.32 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=194.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh--------------------------hHHHHHHHHHHHhc
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ--------------------------AEKEFKVEVEVIGR 203 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--------------------------~~~~~~~e~~~l~~ 203 (484)
++|.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.+++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999965 5789999998654311 12468889999999
Q ss_pred cCCCceeeecceeee--CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCC
Q 011498 204 VRHKNLVRLLGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK 281 (484)
Q Consensus 204 l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlk 281 (484)
++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.||+.||+|||++ +|+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 999999999999986 5688999999999999887542 4699999999999999999999999 99999999
Q ss_pred CCcEEEcCCCcEEEeeecccccccCCCceeecccccccccccccccccCC---CCcccceecchhHHHHHHhCCCCCCCC
Q 011498 282 SSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM---LNEKSDVYSFGILIMEIITGRNPVDYS 358 (484)
Q Consensus 282 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltG~~p~~~~ 358 (484)
|+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987644332 234457999999999997665 478999999999999999999999743
Q ss_pred CCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 359 RPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. ......... ... ..+. .......+.+++.+||+.||++|||+.||++
T Consensus 244 ~~------~~~~~~~~~-~~~---~~~~-----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI------MCLHSKIKS-QAL---EFPD-----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH------HHHHHHHHH-CCC---CCCS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH------HHHHHHHhc-ccC---CCCC-----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 111111111 000 0011 1123346888999999999999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=348.14 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=194.4
Q ss_pred cCCCcCceeccCCceEEEEEEE----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
++|.+.+.||+|+||.||+++. .+++.||+|++.... ......+..|+.+++.++||||+++++++......
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688899999999999999997 468999999987542 22345677899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999754 4588999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..........
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~----- 237 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCK----- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC-----
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC-----
Confidence 543222 2234457999999999999999999999999999999999999999754321 1111111110
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHML 424 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~L 424 (484)
..++. .....+.+++.+||..||++|| ++.++++.-
T Consensus 238 --~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 238 --LNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp --CCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred --CCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 11111 2234688899999999999999 677887643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=346.49 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=199.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||.||+|+.+ +++.||+|++.... ......+..|..++..+ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999976 47899999996543 23345678899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999754 4589999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCcc--chhhhhhhhhcCCCccccc
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV--NLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 383 (484)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... .....+........
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 222 2234567999999999999999999999999999999999999999753321110 11111111111110
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
..++. .....+.+++.+||+.||.+||++
T Consensus 236 -~~~p~----~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -IRIPR----SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CCCCT----TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCCC----CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11111 233468889999999999999996
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=342.26 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=207.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++||||+++++++.. ...++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 46788899999999999999999888899999886543 235678899999999999999999999874 4689999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++++|.+++.... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999996431 12589999999999999999999998 999999999999999999999999999987654443
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......++..|+|||++.+..++.++||||||+++|||++ |..||...... ... ....... ....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---~~~~~~~------~~~~- 231 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI---QNLERGY------RMVR- 231 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH---HHHHTTC------CCCC-
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH---HHHhccc------CCCC-
Confidence 33344457889999999998899999999999999999999 99999754321 111 1111110 0111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.......+.+++.+||..||++|||+.+|++.|+..
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 112345688899999999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=352.57 Aligned_cols=265 Identities=18% Similarity=0.213 Sum_probs=203.3
Q ss_pred cCCCcCceeccC--CceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEG--GYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+| +||.||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 568889999999 99999999976 58999999986543 33456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999997642 24589999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCc------eeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc--
Q 011498 306 SERS------YVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG-- 375 (484)
Q Consensus 306 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~-- 375 (484)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcc
Confidence 2211 11223468999999999987 67999999999999999999999999765432211 000000000
Q ss_pred --C------------------CCcccccC--------CC-CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 --S------------------RKSEEVVD--------PK-LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 --~------------------~~~~~~~~--------~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ........ .. ............+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 00000000 00 000112223456889999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.04 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=202.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|+++ +..||||++.... ....+.+.+|+.+++.++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999986 8899999986543 34456799999999999999999999999876 7789999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc--eeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||+++|+|.+++.... ...+++..++.++.|++.||.|||+. + ++||||||+||+++.++.++|+|||+....
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999997642 23689999999999999999999998 7 999999999999999999999999887543
Q ss_pred cCCCceeecccccccccccccccccCCCCc---ccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNE---KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
.. ....||+.|+|||++.+..++. ++|||||||++|||+||..||....... .........
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~---- 227 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEG---- 227 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSC----
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcC----
Confidence 22 2346899999999998765544 8999999999999999999997543211 111111111
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
..+..+ ......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 228 -~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 -LRPTIP----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111121 22345688899999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=345.49 Aligned_cols=251 Identities=21% Similarity=0.402 Sum_probs=199.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCC-------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------- 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------- 220 (484)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999986 68999999986543 345578999999999999999999999986543
Q ss_pred --------------------------------------------------eeeEEEEecCCCCHHHHhhcCCCCCCCCCH
Q 011498 221 --------------------------------------------------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250 (484)
Q Consensus 221 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 250 (484)
..++||||+++|+|.++++... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 2799999999999999998653 3345677
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc-----------eeeccccccc
Q 011498 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-----------YVTTRVMGTF 319 (484)
Q Consensus 251 ~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~ 319 (484)
..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999998 999999999999999999999999999987654321 1123356999
Q ss_pred ccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHH
Q 011498 320 GYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRV 399 (484)
Q Consensus 320 ~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 399 (484)
.|+|||++.+..++.++|||||||++|||++|..|+... ........ .... ..........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~~---------~~~~-~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDVR---------NLKF-PLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHHH---------TTCC-CHHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHhh---------ccCC-CcccccCChhH
Confidence 999999999999999999999999999999987665311 11111100 0011 11123345667
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHH
Q 011498 400 LLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 400 ~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+++.+||+.||.+|||+.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 89999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=345.03 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=198.5
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
..+|.+.+.||+|+||.||+|.. .+|..||+|++... .......+.+|+.+++.++||||+++++++......++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688899999999999999996 46899999998653 234456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999975333345689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ......... ..
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~~-------- 253 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-QC-------- 253 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHH-TT--------
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhh-cc--------
Confidence 3222 223356899999999999999999999999999999999999999644321 111111111 11
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
..+..........+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111122345688899999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.98 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=196.9
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
.+.||+|+||.||+|... +|..||+|++........+.+.+|+.+++.++||||+++++++.+....++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999964 5899999999776656667899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE--cCCCcEEEeeecccccccCCCceee
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL--DRQWNARVSDFGLAKLLCSERSYVT 312 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~ 312 (484)
.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++........ .
T Consensus 174 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 99986532 3589999999999999999999998 99999999999999 5678999999999987644322 2
Q ss_pred cccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCCh
Q 011498 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392 (484)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (484)
....||+.|+|||++.+..++.++|||||||++|||++|..||...... +.+........ .+.....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~-------~~~~~~~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRW-------DLEDEEF 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-------CSCSGGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccC-------CCChhhh
Confidence 3346999999999999999999999999999999999999999754321 11111111100 0111111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 393 SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 393 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+.+++.+||+.||.+|||+.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 123456889999999999999999999988
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=339.29 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=202.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4668888999999999999998643 2359999887653 34457789999999999999999999998754 5689
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999997542 4589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
............+++.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+.. ..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~---~~------ 231 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK---GD------ 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH---TC------
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc---CC------
Confidence 5433333334457889999999998999999999999999999998 999997543221 1111111 00
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
....+ ......+.+++.+||..||++|||+.+|++.|+..
T Consensus 232 ~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 RLPKP----DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 00111 11334688899999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=358.68 Aligned_cols=265 Identities=22% Similarity=0.247 Sum_probs=209.5
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeeccee
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYC 216 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~ 216 (484)
+.+.+.....++|.+.+.||+|+||+||+|+.+ +|+.||+|++..... .....+..|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566666789999999999999999999975 589999999865321 2234578899999999999999999999
Q ss_pred eeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEe
Q 011498 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
.+....|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997542 3689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccCCCceeecccccccccccccccc-------cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh
Q 011498 297 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC-------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 297 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~ 369 (484)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------ 278 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------ 278 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------
Confidence 99999876554443344568999999999987 35789999999999999999999999975432211
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHH
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR---PKMGHVIHML 424 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~L 424 (484)
........ .....+.. .......+.+|+.+||. +|.+| |+++||++.-
T Consensus 279 ~~~i~~~~--~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 279 YGKIVHYK--EHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHHHTHH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HHHHHhcc--cCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 11111000 00001111 11233468889999999 99998 5888887643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=350.89 Aligned_cols=245 Identities=23% Similarity=0.275 Sum_probs=203.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 58999999986542 123457888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999754 3589999999999999999999998 999999999999999999999999999987543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .......... ..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-------~~ 256 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-------VR 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------CC
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHcCC-------CC
Confidence 2 23457999999999999999999999999999999999999999754321 1111111110 11
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIHM 423 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~ 423 (484)
++. .....+.+++.+||+.||.+||+ +++|++.
T Consensus 257 ~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 FPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111 23346888999999999999998 7887664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=353.72 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=209.7
Q ss_pred cCCCcCceeccCCceEEEEEEE-----CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceee--eCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV--EGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~ 223 (484)
++|.+.+.||+|+||.||+|++ .++..||||++........+.+.+|+.+++.++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688889999999999999984 357899999998776666778999999999999999999999987 455689
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999997532 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCC--------Cccchhhhhhhh
Q 011498 304 LCSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ--------GEVNLVDWLKTM 373 (484)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~--------~~~~~~~~~~~~ 373 (484)
....... ......+|..|+|||++.+..++.++|||||||++|+|++|..||...... ........+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6443322 223345788899999999999999999999999999999999998643210 000000001111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
. ...........+...+.+++.+||+.||++|||+.+|++.|+...
T Consensus 257 ~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 257 L---------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp H---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred h---------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111111122234457889999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=344.77 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=179.8
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 5889999998543 3456778999999996 9999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC---cEEEeeecccccccCCCce
Q 011498 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~ 310 (484)
|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++........
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99999765 4699999999999999999999998 999999999999997765 899999999986543322
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..............+........ ......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~------~~~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD------FSFEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC------CCCCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC------CCCCcc
Confidence 23345689999999999999999999999999999999999999976543211111111111111110 011111
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........+.+|+.+||+.||.+|||++++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11224567889999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=342.88 Aligned_cols=255 Identities=30% Similarity=0.475 Sum_probs=197.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46778899999999999999986 788999988543 345678899999999999999999999874 4799999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc-EEEeeecccccccCCCc
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERS 309 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~ 309 (484)
+|+|.++++... ....+++..++.++.|++.||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 999999997542 2235789999999999999999999932129999999999999998886 799999999765322
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||....... ......... .. .+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~-----~~~~-- 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GT-----RPPL-- 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TC-----CCCC--
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CC-----CCCc--
Confidence 223458999999999999999999999999999999999999997543211 111111111 00 0111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL 429 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 429 (484)
.......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 226 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 226 --IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11233468889999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=350.28 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=202.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||+||+|+.+. ++.||+|++.... ......+..|..++..+ +||||+++++++.+....|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4678899999999999999999864 7889999986542 23345677899999888 89999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999754 3589999999999999999999998 9999999999999999999999999999864
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..........
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~------- 237 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN------- 237 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC-------
Confidence 3222 2234567999999999999999999999999999999999999999754321 1111111110
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKM-----GHVIHM 423 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~ 423 (484)
..++ ......+.+++.+||..||.+||++ ++|++.
T Consensus 238 ~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 1234568889999999999999964 666553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.48 Aligned_cols=257 Identities=20% Similarity=0.252 Sum_probs=198.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 477999999999999999999975 588999998865432 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999754 4689999999999999999999999 99999999999999999999999999997764
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC-CcccccC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR-KSEEVVD 384 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 384 (484)
...........|++.|+|||++.+..++.++||||||+++|||++|..||...... .+....... ......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~- 257 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPSTV- 257 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGGT-
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCcccc-
Confidence 43333334456899999999999999999999999999999999999999754311 111111111 000011
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcCC
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEADD 428 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~~~ 428 (484)
.......+.+++.+||+.||++|| +++++++.|+...
T Consensus 258 -------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 258 -------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 112234688899999999999999 9999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=339.14 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=199.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999975 58899999986543 2334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+.+ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 6666665432 4699999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeecccccccccccccccccCC-CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc------
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE------ 380 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 380 (484)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..||..... .......+..........
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence 22 233457899999999998765 89999999999999999998887532221 111111111111110000
Q ss_pred cccC---------CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVD---------PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+ ..............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00000111223456788999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=375.55 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=207.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||.||+|.++++..||||++.... ...+.|.+|+.+|+.++||||+++++++.+ ...++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45677788999999999999999877889999987544 234679999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.+|+|.++|+... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999997432 13589999999999999999999998 999999999999999999999999999986543221
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......++..|+|||++.+..++.++|||||||+||||+| |..||...... ... .... ... .
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~---~~i~-~~~---------~ 482 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL---DQVE-RGY---------R 482 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHH---HHHH-TTC---------C
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHH-cCC---------C
Confidence 12223346788999999999999999999999999999999 99999754321 111 1111 110 0
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...+..+...+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=348.04 Aligned_cols=267 Identities=23% Similarity=0.412 Sum_probs=212.9
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecce
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
.++++...++|.+.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3444555678999999999999999999864 367899999865433 344578899999999999999999999
Q ss_pred eeeCCeeeEEEEecCCCCHHHHhhcCC------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC
Q 011498 216 CVEGAYRMLVYEYVDNGNLDQWLHGDV------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289 (484)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~ 289 (484)
+.+....++||||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 999999999999999999999996421 1224578999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchh
Q 011498 290 QWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLV 367 (484)
Q Consensus 290 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~ 367 (484)
++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 247 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------ 247 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------
Confidence 999999999999865433221 1233457889999999999999999999999999999999 89999754321
Q ss_pred hhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
........ ... +.. .......+.+++.+||+.||.+|||+.++++.|+...
T Consensus 248 ~~~~~~~~-~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 248 QVLRFVME-GGL-----LDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHHT-TCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHHc-CCc-----CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11111111 110 011 1123456888999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=346.19 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=208.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeC
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 219 (484)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888899999999999999863 46789999987553 33456788999999999 899999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGD------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
...++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999765321 23489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccc
Q 011498 288 DRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~ 365 (484)
+.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||...... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence 99999999999999876443322 2233457789999999998899999999999999999999 99999754321 1
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
+...+.. .. ....+ ..+...+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 268 ~~~~~~~---~~------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 268 LFKLLKE---GH------RMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHHHH---TC------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhc---CC------CCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111 00 01111 123356888999999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=345.16 Aligned_cols=265 Identities=21% Similarity=0.363 Sum_probs=189.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999865 588999999865432 234678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCC--CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 228 YVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|++ |+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999986432 2234589999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC---ccc
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK---SEE 381 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 381 (484)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||..||........ ...+........ ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhh
Confidence 3222 2234568999999999876 4689999999999999999999999975542211 111111111000 000
Q ss_pred -----ccCCCCC---CC---------ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 382 -----VVDPKLP---KM---------PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 382 -----~~~~~~~---~~---------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+.+. .. ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 00 00012346889999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=340.96 Aligned_cols=260 Identities=24% Similarity=0.411 Sum_probs=203.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeC--Cee
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~ 222 (484)
..|.+.+.||+|+||.||+|++ .+++.||+|++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477788999999999999984 357899999987543 23446788999999999999999999999876 568
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+|+||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996542 4589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCc--eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCC--------C-CCccchhhhhh
Q 011498 303 LLCSERS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR--------P-QGEVNLVDWLK 371 (484)
Q Consensus 303 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~--------~-~~~~~~~~~~~ 371 (484)
....... .......+|..|+|||++.+..++.++||||||+++|||+||..|+.... + ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7654432 22334568888999999999999999999999999999999998864221 0 00111111111
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... . ......+......+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 255 ~~~-~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 255 TLK-E---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHH-T---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh-c---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111 0 11111122234568899999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=347.71 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=204.7
Q ss_pred CCcCceeccCCceEEEEEEEC-----CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeC--CeeeE
Q 011498 153 LCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRML 224 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l 224 (484)
|.+.+.||+|+||.||++.+. +++.||||++..... .....+.+|+.+++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377889999999999998753 578899999976543 4456789999999999999999999999874 57899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++... .+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 389999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......+|..|+|||++.+..++.++||||||+++|||+||..||...... ......+.............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHHHHHHH
Confidence 543321 233445788899999999999999999999999999999999998643210 00000000000000000011
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+...........+...+.+++.+||+.||++|||+.+|++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111112223445788999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=335.04 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=183.1
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35688899999999999999997 4689999999864322 2246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997542 4689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .. .. .+.
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~----~~---~~~ 229 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KV----VL---ADY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C----CS---SCC
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HH----hh---ccc
Confidence 3222 1223568999999999999899999999999999999999999997554321110 00 00 011
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+. .....+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111 23346788999999999999999999876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=343.18 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=193.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCe----e
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----R 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~ 222 (484)
++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788899999999999999996 4688999999966432 334578899999999999999999999876543 4
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+||||+++++|.++++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999754 4689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSERS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCC
Confidence 6543322 12234568999999999999999999999999999999999999997543211 111111111000
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+..........+.+++.+||+.||++||+..+++.
T Consensus 239 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp -------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00000113456888999999999999998777665
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=349.35 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=200.6
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhccCCCceeeecceeeeCC
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 220 (484)
....++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 445678999999999999999999974 57899999886432 234567889999999999999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGD------------------------------------VSPLTWDIRMNIILGTAKGL 264 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~al 264 (484)
..++||||+++|+|.+++...... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521100 11235677889999999999
Q ss_pred HhhhcCCCCceeecCCCCCcEEEcCCC--cEEEeeecccccccCCC---ceeeccccccccccccccccc--CCCCcccc
Q 011498 265 AYLHEGLEPKVVHRDVKSSNILLDRQW--NARVSDFGLAKLLCSER---SYVTTRVMGTFGYVAPEYACT--GMLNEKSD 337 (484)
Q Consensus 265 ~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 337 (484)
+|||+. +|+||||||+|||++.++ .+||+|||++....... ........||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 89999999998653321 112344579999999999865 67899999
Q ss_pred eecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 338 VYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 338 vwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
||||||++|||++|..||....... .......... .............+.+++.+||+.||.+|||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999999999999997543211 1111111110 01111112234568899999999999999999
Q ss_pred HHHHH
Q 011498 418 GHVIH 422 (484)
Q Consensus 418 ~evl~ 422 (484)
.++++
T Consensus 326 ~~~l~ 330 (345)
T 3hko_A 326 MRALQ 330 (345)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.25 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=198.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHH-HhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEV-IGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||+||+|+.+ ++..||+|++..... .....+..|..+ ++.++||||+++++++.+....|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999976 478899999865432 223445566665 5678999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999754 4588999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... +......... .
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~-------~ 256 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKP-------L 256 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSC-------C
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcc-------c
Confidence 322 2244568999999999999999999999999999999999999999754321 1111111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCcc
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~~ 430 (484)
.++. .....+.+++.+||+.||.+||++.+.+..+....++
T Consensus 257 ~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 257 QLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp CCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred CCCC----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 1111 1234678889999999999999997666666665544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=359.77 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=203.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999975 689999999865432 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999754 4699999999999999999999998 999999999999999999999999999987643
Q ss_pred CCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .....+||+.|+|||++.+..+ +.++|||||||++|||++|..||...... .......... .
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~-------~ 233 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDGI-------F 233 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTTC-------C
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCC-------c
Confidence 32 2334579999999999988765 68999999999999999999999754321 1111111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+. .....+.+++.+||..||.+|||+.+|++
T Consensus 234 ~~p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTPQ----YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCc----cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111 12346788999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=337.01 Aligned_cols=250 Identities=20% Similarity=0.272 Sum_probs=203.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||+|.... +..||+|++........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 3568889999999999999999764 678999999766555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---cCCCcEEEeeeccccccc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfgla~~~~ 305 (484)
+++++|.+++... ..+++..++.++.|++.||.|||++ +|+|+||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998754 4589999999999999999999999 99999999999999 788899999999998764
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... ......||+.|+|||++.+. ++.++||||||+++|||++|..||...... ... ....... .
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~-------~ 224 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVM---LKIREGT-------F 224 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCC-------C
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHhCC-------C
Confidence 332 23345699999999988654 999999999999999999999999754321 111 1111000 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+..........+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000123457889999999999999999999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.90 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=194.3
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|.+. ..||+|++.... ....+.+.+|+.+++.++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 367888999999999999999875 359999886543 33456789999999999999999999965 4456899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999996442 4689999999999999999999998 9999999999999999999999999999765332
Q ss_pred C-ceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 308 R-SYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 308 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
. ........||+.|+|||++. +..++.++||||||+++|||++|+.||....... .....+. .....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~----~~~~~--- 244 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVG----RGSLS--- 244 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHH----HTSCC---
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhc----ccccC---
Confidence 1 22233456899999999986 6678999999999999999999999997544221 1111111 11111
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+.+. .....+...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 245 -~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 245 -PDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp -CCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -cchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1110 11122345788999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=342.83 Aligned_cols=244 Identities=24% Similarity=0.269 Sum_probs=191.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|...+.||+|+||+||+|... +++.||||++..... .....+..|+..+..+ +||||++++++|.+....++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 689999998865432 2233444555555555 9999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+ +++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 669999887542 4699999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .. ... ... .
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~----~~~-~~~--------~ 268 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GW----QQL-RQG--------Y 268 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HH----HHH-TTT--------C
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HH----HHH-hcc--------C
Confidence 22 2334569999999998875 79999999999999999999976654211 00 011 000 1
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+..........+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111123457889999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=336.55 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=201.9
Q ss_pred cCCCcCceeccCCceEEEEEEECC-C-------CEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-G-------TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
++|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568888999999999999998653 3 47999998776666678899999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc--------EE
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------AR 294 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~k 294 (484)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999997642 3489999999999999999999999 9999999999999998887 99
Q ss_pred EeeecccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCC-CCCCCCCCCCccchhhhhhh
Q 011498 295 VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGR-NPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 295 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~-~p~~~~~~~~~~~~~~~~~~ 372 (484)
|+|||++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|. +||...... .....
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQF 230 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHHH
Confidence 999999875432 123457899999999987 77999999999999999999954 455432211 11111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
..... ..+.. ....+.+++.+||+.||++|||+.++++.|+...
T Consensus 231 ~~~~~--------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 231 YEDRH--------QLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHTTC--------CCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred hhccC--------CCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11100 11111 1234788899999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=343.45 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=204.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh------hHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
++|.+.+.||+|+||.||+|... +|..||+|.+...... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 56888999999999999999975 5889999998654321 3567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC----cEEEeeec
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 299 (484)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999754 4689999999999999999999998 999999999999999887 79999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... +.........
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~-- 234 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSVS-- 234 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC--
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcc--
Confidence 998764332 223456899999999999999999999999999999999999999754321 1111111100
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+..........+.+++.+||..||++|||+.|+++
T Consensus 235 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 -----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000001122356888999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=337.02 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=204.5
Q ss_pred cCCCcCc-eeccCCceEEEEEEEC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEEN-VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++ .....++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999853 47789999997653 34456788999999999999999999999 45568999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999643 24689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcee--ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... .....+|+.|+|||++.+..++.++||||||+++|||+| |..||...... .....+. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~----~~~---- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGK---- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----TTC----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHh----cCC----
Confidence 433221 222346889999999998899999999999999999999 99999755432 1111111 110
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+..+ ......+.+++.+||+.||++||++.+|++.|+..
T Consensus 231 -~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 -RMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -CCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCC----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111 22345788899999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=342.98 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=197.4
Q ss_pred cCCCc-CceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCE-ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~-~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 227 (484)
+.|.+ .+.||+|+||.||+|... +++.||||++..........+.+|+.++.++ +||||+++++++.+....++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 378999999999999954 6899999999766555567888999999885 79999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc---EEEeeecccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLL 304 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfgla~~~ 304 (484)
|+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999764 4589999999999999999999999 9999999999999998766 999999998765
Q ss_pred cCCCc------eeeccccccccccccccccc-----CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccch-------
Q 011498 305 CSERS------YVTTRVMGTFGYVAPEYACT-----GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL------- 366 (484)
Q Consensus 305 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~------- 366 (484)
..... ......+||+.|+|||++.. ..++.++|||||||++|||++|..||...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32111 11223469999999999875 5688999999999999999999999976543221000
Q ss_pred -hhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 367 -VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 367 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+........ ...+..........+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGK------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCC------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccC------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000000000 00110000113456889999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=348.09 Aligned_cols=207 Identities=22% Similarity=0.283 Sum_probs=178.1
Q ss_pred cHHHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-----CCceeeecce
Q 011498 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----HKNLVRLLGY 215 (484)
Q Consensus 142 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~~~ 215 (484)
++.+.....++|.+.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.+. ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33344445678999999999999999999974 5889999988643 334456777999999886 9999999999
Q ss_pred eeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC------
Q 011498 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR------ 289 (484)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~------ 289 (484)
+......++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 99999999999999 889999997653 24589999999999999999999998 9999999999999975
Q ss_pred -------------------CCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh
Q 011498 290 -------------------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350 (484)
Q Consensus 290 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 350 (484)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 788999999999864332 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 011498 351 GRNPVDYSR 359 (484)
Q Consensus 351 G~~p~~~~~ 359 (484)
|+.||....
T Consensus 255 g~~pf~~~~ 263 (360)
T 3llt_A 255 GSLLFRTHE 263 (360)
T ss_dssp SSCSCCCSS
T ss_pred CCCCCCCCc
Confidence 999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=345.28 Aligned_cols=269 Identities=25% Similarity=0.410 Sum_probs=213.1
Q ss_pred ccHHHHHHHhcCCCcCceeccCCceEEEEEEE------CCCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeee
Q 011498 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRL 212 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l 212 (484)
+....+....++|.+.+.||+|+||.||+|.+ .+++.||||.+..... .....+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 33455555678899999999999999999985 2457899999876543 3446788999999999 79999999
Q ss_pred cceeeeCC-eeeEEEEecCCCCHHHHhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecC
Q 011498 213 LGYCVEGA-YRMLVYEYVDNGNLDQWLHGDVGD------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (484)
Q Consensus 213 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~d 279 (484)
++++.... ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988754 589999999999999999765321 22388999999999999999999998 999999
Q ss_pred CCCCcEEEcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCC
Q 011498 280 VKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDY 357 (484)
Q Consensus 280 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~ 357 (484)
|||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986643322 22344567889999999999999999999999999999998 9999975
Q ss_pred CCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 358 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...... ....+.. .. ....+. .....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 254 ~~~~~~--~~~~~~~----~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDEE--FCRRLKE----GT-----RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSHH--HHHHHHH----TC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHH--HHHHhcc----Cc-----cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 543211 1111111 00 011111 1234688899999999999999999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=352.86 Aligned_cols=250 Identities=20% Similarity=0.362 Sum_probs=196.4
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccC--CCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 226 (484)
.+|.+.+.||+|+||.||+|...+++.||||++.... ......+.+|+.+++.++ ||||+++++++......|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588889999999999999998889999999886543 344577899999999996 599999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
| +.+++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5678999999865 3688999999999999999999998 999999999999996 57999999999987643
Q ss_pred CCc-eeeccccccccccccccccc-----------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 307 ERS-YVTTRVMGTFGYVAPEYACT-----------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 307 ~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
... ......+||+.|+|||++.+ ..++.++|||||||+||||++|..||..... ....+....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence 322 12344679999999999865 4689999999999999999999999964321 111111111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.... ....+.. ....+.+|+.+||+.||.+|||+.||++.
T Consensus 282 ~~~~-----~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNH-----EIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTS-----CCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cccc-----cCCCCcc----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1110 0111111 13467889999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=349.23 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=190.5
Q ss_pred cCCCcC-ceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhc-cCCCceeeecceeee----CCeee
Q 011498 151 SGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVE----GAYRM 223 (484)
Q Consensus 151 ~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~----~~~~~ 223 (484)
++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 445554 68999999999999975 5889999988532 345668877644 589999999999875 56789
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeecc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGL 300 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfgl 300 (484)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999997642 24689999999999999999999998 9999999999999997 78899999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccc-hhhhhhhhhcCCCc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN-LVDWLKTMVGSRKS 379 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 379 (484)
++...... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.......... ....+. ....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc
Confidence 98654322 2344678999999999999999999999999999999999999997654322111 111111 0000
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..+..........+.+|+.+||+.||++|||+.+|++.
T Consensus 285 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111112234568889999999999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=339.04 Aligned_cols=264 Identities=25% Similarity=0.441 Sum_probs=200.5
Q ss_pred HHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhc--cCCCceeeecceeeeC----Ce
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEG----AY 221 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~ 221 (484)
...++|.+.+.||+|+||.||+|++. ++.||||++.... ...+..|.+++.. ++||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34568999999999999999999986 8999999885432 2334445555555 4999999999999877 67
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC-----CCceeecCCCCCcEEEcCCCcEEEe
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL-----EPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 89999999999999999753 5899999999999999999999751 3389999999999999999999999
Q ss_pred eecccccccCCCcee---ecccccccccccccccccCCCCcc------cceecchhHHHHHHhC----------CCCCCC
Q 011498 297 DFGLAKLLCSERSYV---TTRVMGTFGYVAPEYACTGMLNEK------SDVYSFGILIMEIITG----------RNPVDY 357 (484)
Q Consensus 297 Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~elltG----------~~p~~~ 357 (484)
|||++.......... .....||+.|+|||++.+..++.+ +|||||||++|||+|| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997654332211 224579999999999987766665 9999999999999999 555544
Q ss_pred CCCCCccchhhhhhhhhcCCCcccccCCCCCCC-ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 358 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
....... .......... ....+..+.. ....+...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 265 ~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 265 LVPSDPS--YEDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TSCSSCC--HHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCCc--hhhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 3322111 1111111111 1111222211 123677889999999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=347.41 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=199.9
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CC----EEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|.+.+.||+|+||.||+|.+.. +. +||+|.+.... ......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 568888999999999999999653 43 38888775433 2233467779999999999999999999864 56889
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999997542 4588899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......+|..|+|||++.+..++.++|||||||++|||+| |..||........ ...+. ... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~--~~ 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLLE----KGE--RL 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHHH----TTC--BC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHHH----cCC--CC
Confidence 443322 2334567889999999999999999999999999999999 9999986543221 11111 110 00
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
..+ ..+...+.+++.+||..||.+|||+.+|++.|+...
T Consensus 237 ---~~~----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 ---AQP----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---CCC----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---CCC----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011 112234778899999999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=351.18 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=193.1
Q ss_pred CCCcCceeccCCceEEEEEEECC--C--CEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeee-CCeeeEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILSD--G--TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLV 225 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv 225 (484)
.|.+.+.||+|+||.||+|.+.+ + ..||+|.+.... ......+.+|+.++++++||||+++++++.. ....++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35567899999999999998642 2 368999886543 3445789999999999999999999998764 4578999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.++++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997542 4588999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCce---eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 306 SERSY---VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 306 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
..... ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||....... ....+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~---~~~~--- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL---QGRR--- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHH---TTCC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHH---cCCC---
Confidence 32211 1223457789999999999999999999999999999999 788887554322 111111 1100
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... +..+...+.+++.+||+.||++|||+.+|++.|+..
T Consensus 315 ---~~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 ---LLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 112334688899999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=349.78 Aligned_cols=264 Identities=19% Similarity=0.255 Sum_probs=201.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccchhhH-----------HHHHHHHHHHhccCCCceeee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAE-----------KEFKVEVEVIGRVRHKNLVRL 212 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~e~~~l~~l~H~niv~l 212 (484)
.++|.+.+.||+|+||.||+|.+.. +..||||++........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999999764 36899998865542211 123345667778899999999
Q ss_pred cceeeeC----CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 213 LGYCVEG----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 213 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9998764 4579999999 999999997642 4699999999999999999999999 999999999999999
Q ss_pred --CCCcEEEeeecccccccCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCC
Q 011498 289 --RQWNARVSDFGLAKLLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP 360 (484)
Q Consensus 289 --~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~ 360 (484)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999775432211 11334599999999999999999999999999999999999999985432
Q ss_pred CCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 361 QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... ......... ......++++.+.. ...+..+.+++..||..||.+||++.+|++.|+.
T Consensus 267 ~~~--~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 267 DPK--YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp CHH--HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CHH--HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 211 111111100 01111222222211 1123468888999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.29 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=204.9
Q ss_pred cCCCcCceeccCCceEEEEEEE----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+..|+.+++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999997 368999999986432 12334566799999999 79999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999754 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCceeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
+.............+||+.|+|||++.+ ..++.++|||||||+||||+||..||........ ...........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc---
Confidence 8764433333445679999999999985 3578999999999999999999999975543221 11111111110
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhcCC
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHMLEADD 428 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~L~~~~ 428 (484)
.+..+ ......+.+|+.+||..||.+|| +++++++..-...
T Consensus 282 ----~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 282 ----EPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp ----CCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ----CCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 11111 12334678899999999999999 9999988665443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=344.57 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=199.5
Q ss_pred cCCCcCceeccCCceEEEEEEECC-----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|...+.||+|+||.||+|.+.. +..||||.+.... ......+.+|+.+++.++||||+++++++......++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456777899999999999998653 2359999987543 3344678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999997542 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 305 CSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 305 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .. ........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~---~~~~~~~~---- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EV---MKAINDGF---- 267 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHTTC----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HH---HHHHHCCC----
Confidence 433211 1222346788999999999999999999999999999999 99999654321 11 11111110
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... ........+.+++.+||+.||.+||++.+|++.|+..
T Consensus 268 --~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 268 --RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp --CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001 1112345688899999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=333.59 Aligned_cols=251 Identities=20% Similarity=0.325 Sum_probs=203.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 48899999986543 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc---EEEeeeccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL 303 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfgla~~ 303 (484)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988754 4589999999999999999999999 9999999999999987655 99999999976
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+.. .. .
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~---~~-~---- 224 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKA---GA-Y---- 224 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---TC-C----
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHh---cc-c----
Confidence 643322 23456899999999999999999999999999999999999999654321 11111110 00 0
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+..........+.+++.+||+.||++|||+.|+++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111111123356888999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=338.58 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=197.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888899999999999999975 588999999865542 3457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---cCCCcEEEeeeccccccc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfgla~~~~ 305 (484)
+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865432335699999999999999999999998 99999999999999 456789999999997654
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... ......||+.|+|||++. ..++.++||||||+++|||++|..||....... .. ....... +
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~---~~~~~~~-------~ 242 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQ---QKATYKE-------P 242 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCC-------C
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HH---hhhccCC-------c
Confidence 322 233456899999999885 568999999999999999999999997543211 11 1110000 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... ........+.+++.+||+.||++|||+.||++
T Consensus 243 ~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00012346788999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=371.70 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=197.6
Q ss_pred eeccCCceEEEEEEEC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCCCC
Q 011498 158 VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (484)
Q Consensus 158 ~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (484)
.||+|+||.||+|.++ ++..||||++.... ....+.+.+|+.+++.++||||++++++|.. ...++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999987653 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceee-
Q 011498 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT- 312 (484)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 312 (484)
|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999654 24689999999999999999999999 999999999999999999999999999987643322211
Q ss_pred -cccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC
Q 011498 313 -TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390 (484)
Q Consensus 313 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (484)
....+++.|+|||++.+..++.++|||||||+||||+| |..||......+ ....+. ... ...
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~----~~~---------~~~ 559 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----QGK---------RME 559 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHH----TTC---------CCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCC---------CCC
Confidence 22335689999999999999999999999999999998 999997654321 111111 111 011
Q ss_pred ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 391 PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 391 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+..+...+.+|+.+||+.||++||++.+|++.|+..
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122445788999999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=340.54 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=198.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999975 489999998865433 334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999988644 4589999999999999999999999 9999999999999999999999999999876433
Q ss_pred Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC----------
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS---------- 376 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 376 (484)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||........... +......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhcccccccccccc
Confidence 22 2334568999999999876 6789999999999999999999999976543211111 1111000
Q ss_pred -C-CcccccCCCCCCCCh-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 -R-KSEEVVDPKLPKMPA-----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 -~-~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. .......+....... ......+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000000000000 123456888999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=343.20 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=198.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
++|.+.+.||+|+||.||+|.+. +++ +||+|.+... .......+.+|+.+++.++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888999999999999999964 344 4678877543 2345678899999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 94 v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999997643 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ....+. ..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~----~~----- 235 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KG----- 235 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TT-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cC-----
Confidence 43322 12223456788999999999999999999999999999999 999997654321 111111 11
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.....+......+.+++.+||..||.+|||+.||++.|+..
T Consensus 236 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 236 ----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00111122344688899999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=346.13 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=199.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|..+ +++.||+|++...... ...|++++.++ +||||+++++++.+....|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457889999999999999999975 5889999998655432 34577788777 79999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC----CcEEEeeeccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKL 303 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfgla~~ 303 (484)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++..
T Consensus 97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999754 4689999999999999999999999 99999999999998543 3599999999987
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..........+. ..... ...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~-~~~---- 240 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---ARIGS-GKF---- 240 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---HHHHH-CCC----
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---HHHcc-CCc----
Confidence 644332 233457899999999998888999999999999999999999999754322111111 11111 110
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+...........+.+|+.+||..||++|||+.++++
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111223456888999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=349.06 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=208.2
Q ss_pred hcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
.++|.+.+.||+|+||.||+|.... ...||+|.+..... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678889999999999999999643 24799999866533 3456788999999999 89999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG----------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999964311 124589999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhh
Q 011498 292 NARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 292 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~ 369 (484)
.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||........ ....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYKL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHHH
Confidence 999999999986543322 22334457889999999999999999999999999999999 9999975543211 1111
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... . .....+ ......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 280 ~~~----~-----~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 VKD----G-----YQMAQP----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHH----T-----CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhc----C-----CCCCCC----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111 0 001111 11234688899999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=335.28 Aligned_cols=246 Identities=27% Similarity=0.435 Sum_probs=199.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456888999999999999999875 46789999885532 22346788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999754 4589999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ........ ...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-------~~~ 224 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISR-------VEF 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-------TCC
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHh-------CCC
Confidence 222 23456899999999999999999999999999999999999999744321 11111110 011
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+. .....+.+++.+||+.||.+|||+.||++
T Consensus 225 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 TFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 12346788999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=346.59 Aligned_cols=265 Identities=17% Similarity=0.261 Sum_probs=198.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccchh-----------hHHHHHHHHHHHhccCCCceeeecce
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQ-----------AEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
++|.+.+.||+|+||.||+|... ++..||+|.+...... ....+..|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999975 4678999988655322 11246678888999999999999999
Q ss_pred eee----CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC
Q 011498 216 CVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 216 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
+.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 987 67889999999 99999999754 2689999999999999999999998 999999999999999887
Q ss_pred --cEEEeeecccccccCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCc
Q 011498 292 --NARVSDFGLAKLLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363 (484)
Q Consensus 292 --~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~ 363 (484)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||..||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999865432111 11345799999999999999999999999999999999999999964322111
Q ss_pred cchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCCc
Q 011498 364 VNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDL 429 (484)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~~ 429 (484)
........... .. ...+....+ .......+.+++.+||..||++|||+++|++.|+....
T Consensus 269 -~~~~~~~~~~~-~~-~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 -AVQTAKTNLLD-EL-PQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHHHH-TT-THHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHHHHhhcc-cc-cHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111000 00 000000000 00233468889999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=360.43 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=195.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+..|+.+++.++||||+++++++......++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999965 58899999986532 22335677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999754 468999999999999999999997 7 9999999999999999999999999999764
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
..... .....+||+.|+|||++.+..++.++|||||||+||||++|..||...... .... ......
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~------- 365 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LILMEE------- 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCC-------
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH---HHHhCC-------
Confidence 33222 234467999999999999999999999999999999999999999754321 1111 111110
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHML 424 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~L 424 (484)
..++. .....+.+|+.+||+.||.+|| +++|+++.-
T Consensus 366 ~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 366 IRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 11111 1234688899999999999999 999998743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=347.34 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=198.9
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
..|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999996 468899999986543 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+. |+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 58888886432 4689999999999999999999999 999999999999999999999999999976533
Q ss_pred CCceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
. ....||+.|+|||++. ...++.++|||||||++|||++|..||...... ..+.......
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~------ 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE------ 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC------
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC------
Confidence 2 2356999999999884 567899999999999999999999999644321 1111111111
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.+... .......+.+++.+||+.||++|||++++++.
T Consensus 270 ~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 11223457888999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.39 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=200.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceee-eCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~l 224 (484)
.+|.+.+.||+|+||.||+|.+.+ ...||+|.+..... .....+.+|+.++++++||||+++++++. .....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778899999999999998643 23589998875433 34567889999999999999999999865 4567899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.++++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997532 4589999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCc---eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 305 CSERS---YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 305 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||....... ..... ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~---~~~~--- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQGR--- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHH---HTTC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH---hcCC---
Confidence 43221 11233457889999999999999999999999999999999 666776443321 11111 1100
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.... +......+.+++.+||+.||++|||+.++++.|+..
T Consensus 250 ---~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 ---RLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ---CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011 111234688899999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=333.40 Aligned_cols=260 Identities=18% Similarity=0.248 Sum_probs=201.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeeccee-eeCCeeeEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC-VEGAYRMLVY 226 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~ 226 (484)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+..|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346799999999999999999996 4688999997654332 23577899999999888877766655 5677889999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---cCCCcEEEeeeccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKL 303 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfgla~~ 303 (484)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 899999997432 4589999999999999999999999 99999999999999 7889999999999987
Q ss_pred ccCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 304 LCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 304 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6443221 1234578999999999999999999999999999999999999998765443332222211110000
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.... .. ......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 238 ~~~~-~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 238 PIEV-LC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp CHHH-HT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hhhh-hh--------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 0000 00 1123468899999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=331.38 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=204.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888999999999999999975 58899999886443 3345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998643 4689999999999999999999998 9999999999999999999999999999765332
Q ss_pred Cc-eeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 308 RS-YVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 308 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .......||+.|+|||++.+..+ +.++||||||+++|||++|..||........ ....+. ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~-------- 225 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKK-------- 225 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTC--------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcc--------
Confidence 21 12334568999999999987765 7799999999999999999999975443211 111111 100
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............+.+++.+||+.||++|||+.+|++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000111223456888999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=359.03 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=204.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|...+.||+|+||+||+|+.+ +|+.||+|++..... .....+..|+.+++.++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999975 589999999865432 23457888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||++||+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999976544446799999999999999999999998 999999999999999999999999999987643
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... .....+||+.|+|||++.+..++.++|||||||++|||+||..||........ ............ ..
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~-------~~ 411 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA-------VT 411 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC-------CC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc-------cC
Confidence 322 23345799999999999999999999999999999999999999976543211 111111111110 01
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMG 418 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 418 (484)
.+ ......+.+++.+||+.||.+||++.
T Consensus 412 ~p----~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 412 YP----DKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp CC----TTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred CC----cccCHHHHHHHHHhccCCHhHCCCCc
Confidence 11 12345688899999999999999763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.38 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=197.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC--
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-- 220 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-- 220 (484)
..++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 35678888999999999999998642 4489999886542 334467889999999999999999999998754
Q ss_pred ---eeeEEEEecCCCCHHHHhhcCC--CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 221 ---YRMLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 221 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 3499999999999999985332 2335699999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhh
Q 011498 296 SDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ... ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD---YL 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH---HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH---HH
Confidence 999999865433221 1223457889999999999999999999999999999999 999997554221 111 11
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.... ....+......+.+++.+||..||.+|||+.+|++.|+..
T Consensus 263 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 263 LHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1110 0111122345688999999999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=338.40 Aligned_cols=262 Identities=25% Similarity=0.357 Sum_probs=198.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch-----hhHHHHHHHHHHHhcc---CCCceeeecceeeeC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG-----QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEG 219 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~ 219 (484)
..++|.+.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 4588999999864321 1234566677777666 599999999999875
Q ss_pred C-----eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEE
Q 011498 220 A-----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (484)
Q Consensus 220 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 294 (484)
. ..++||||+. |+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 4 5799999997 59999997653 23489999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 295 VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 295 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+....
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 99999998654322 2344678999999999999999999999999999999999999997544221 111111111
Q ss_pred cCCCccc----------ccCCCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 375 GSRKSEE----------VVDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 375 ~~~~~~~----------~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....... ...+. .... .......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPR-GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCC-CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCC-CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1100000 00000 0000 0123456888999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=332.54 Aligned_cols=259 Identities=19% Similarity=0.255 Sum_probs=204.1
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeeccee-eeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC-VEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+..|+.+++.++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788899999999999999996 4689999998865432 24588899999999988877666655 56678899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---cCCCcEEEeeecccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLL 304 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfgla~~~ 304 (484)
|+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 889999997432 4689999999999999999999999 99999999999999 48889999999999876
Q ss_pred cCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 305 CSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 305 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 443221 12345799999999999999999999999999999999999999987554333222222111100000
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.. ... ......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 239 ~~-~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 239 IE-VLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HH-HHT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hH-HHH--------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 00 000 1123568889999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=361.85 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=206.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.+.||+|+||.||+|..+ +|+.||+|++.... ......+..|+.+++.++||||+++++++.+....|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457888999999999999999975 58999999986532 22345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999997542 24589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... .. ....... ..
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i-~~~i~~~------~~ 406 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EV-ERLVKEV------PE 406 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HH-HHHHHHC------CC
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HH-HHHhhcc------cc
Confidence 3322 234579999999999999999999999999999999999999997654321111 11 1111000 01
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
..+ ......+.+|+.+||+.||.+|| +++||++.
T Consensus 407 ~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 EYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111 12335688899999999999999 67888763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=345.15 Aligned_cols=243 Identities=20% Similarity=0.362 Sum_probs=201.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhccCCCceeeecceeeeC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 219 (484)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+..|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467999999999999999999964 588999999865431 1233567799999999999999999999999
Q ss_pred CeeeEEEEecCCC-CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 220 AYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 220 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
...++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 999999754 4699999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
|++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|..||...... . .
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~---~------ 238 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V---E------ 238 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T---T------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H---h------
Confidence 99987644332 234569999999999988776 88999999999999999999999642110 0 0
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.... .+. .....+.+++.+||+.||++|||+.++++.
T Consensus 239 ---~~~~--~~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ---AAIH--PPY----LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TCCC--CSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hccC--CCc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011 123468889999999999999999999884
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=341.36 Aligned_cols=262 Identities=22% Similarity=0.381 Sum_probs=206.8
Q ss_pred cCCCcCceeccCCceEEEEEEE-----CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC--eee
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~ 223 (484)
++|.+.+.||+|+||.||+|.+ .+++.||||++........+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5578889999999999999984 358899999998766666778999999999999999999999987644 689
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 121 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999997653 4589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcee--ecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCC--------CCc-cchhhhhhh
Q 011498 304 LCSERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRP--------QGE-VNLVDWLKT 372 (484)
Q Consensus 304 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~--------~~~-~~~~~~~~~ 372 (484)
........ .....++..|+|||.+.+..++.++||||||+++|||+||..||..... ... ......+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65433221 2234567789999999988999999999999999999999998863210 000 000000111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.... ......+..+...+.+++.+||+.||++|||+.+|++.|+..
T Consensus 275 ~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhhc---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 001111122345688999999999999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=347.98 Aligned_cols=268 Identities=21% Similarity=0.248 Sum_probs=209.6
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCC--eeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|.+.. ++.||||++.... ......+.+|+++++.++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 468888999999999999999764 8999999986543 233567788999999999999999999998755 679999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE----cCCCcEEEeeecccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAK 302 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfgla~ 302 (484)
||+++|+|.++++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999975432 23489999999999999999999999 99999999999999 788889999999998
Q ss_pred cccCCCceeeccccccccccccccccc--------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACT--------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
....... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......... .+.+....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence 7643322 234569999999998865 56788999999999999999999999754322111 11111111
Q ss_pred cCCCc---cc---------cc--CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 375 GSRKS---EE---------VV--DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 375 ~~~~~---~~---------~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..... .. .. +..............+.+++.+||+.||++||++.++++.++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11100 00 00 0111122346677889999999999999999999999998865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.87 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=202.3
Q ss_pred hcCCCcCc-eeccCCceEEEEEEEC---CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 150 TSGLCEEN-VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 150 ~~~~~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
.++|.+.+ .||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.+++.++||||+++++++ .....+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35577777 9999999999999643 36789999986543 23356789999999999999999999999 556789
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999764 4589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCcee--ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 304 LCSERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 304 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
........ .....+++.|+|||++.+..++.++||||||+++|||+| |..||...... ..... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~~-- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----LEKGE-- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCC--
Confidence 64433322 122346788999999998889999999999999999999 99999754321 11111 11110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+.. +......+.+++.+||+.||.+||++.+|++.|++.
T Consensus 238 ---~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 238 ---RMGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---CCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111 122345688999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=338.97 Aligned_cols=264 Identities=26% Similarity=0.388 Sum_probs=207.6
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhc--cCCCceeeecceeeeCC---
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEGA--- 220 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~--- 220 (484)
-....++|.+.+.||+|+||.||+|++. ++.||||.+... ....+..|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3445678999999999999999999985 899999988543 34567778888877 79999999999998775
Q ss_pred -eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhh--------cCCCCceeecCCCCCcEEEcCCC
Q 011498 221 -YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH--------EGLEPKVVHRDVKSSNILLDRQW 291 (484)
Q Consensus 221 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~~ivH~dlkp~NIll~~~~ 291 (484)
..++||||+++|+|.++++.. .+++..++.++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence 789999999999999999753 5899999999999999999999 77 999999999999999999
Q ss_pred cEEEeeecccccccCCCce---eecccccccccccccccccC------CCCcccceecchhHHHHHHhC----------C
Q 011498 292 NARVSDFGLAKLLCSERSY---VTTRVMGTFGYVAPEYACTG------MLNEKSDVYSFGILIMEIITG----------R 352 (484)
Q Consensus 292 ~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltG----------~ 352 (484)
.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||+|| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876544322 22345799999999998765 234789999999999999999 6
Q ss_pred CCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCC-ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 353 NPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM-PASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 353 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.||........ ....+... ... ....+.++.. ....+...+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 265 ~p~~~~~~~~~-~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 265 LPYYDLVPSDP-SVEEMRKV-VCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CTTTTTSCSSC-CHHHHHHH-HTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCccccCcCcc-cHHHHHHH-HHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 77765433211 11111111 111 1112222211 1235677899999999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.50 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=200.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch------hhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888899999999999999976 588999998865432 13567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC----cEEEeeec
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 299 (484)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999754 4689999999999999999999998 999999999999998877 89999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... .........
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-- 227 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAVN-- 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC--
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhcc--
Confidence 9986543222 234568999999999999999999999999999999999999997543211 111111000
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+..........+.+++.+||..||++|||+.++++
T Consensus 228 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 -----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000001122356888999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.92 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=201.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 56888999999999999999975 58999999997665545567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---cCCCcEEEeeecccccccC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfgla~~~~~ 306 (484)
++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998754 4589999999999999999999998 99999999999999 7888999999999875432
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... ...... . .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~---~i~~~~-~------~ 225 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE---KIKEGY-Y------E 225 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHHCC-C------C
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHcCC-C------C
Confidence 2 123346899999999999999999999999999999999999999754321 1111 111100 0 0
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............+.+++.+||..||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111223456888999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=337.00 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=204.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee--CCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv 225 (484)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+.+++.++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 56888899999999999999975 58899999986543 3345678899999999999999999998854 5678999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc-----eeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-----VVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
|||+++++|.+++.........+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999976543445699999999999999999999998 7 99999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+.. ...
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~----~~~- 233 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE----GKF- 233 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH----TCC-
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHhh----ccc-
Confidence 987543322 123346899999999999989999999999999999999999999754321 11111111 110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+.++ ......+.+++.+||+.||++|||+.||++.+..
T Consensus 234 ----~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ----RRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----ccCC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 1234568889999999999999999999986653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.63 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=201.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCE--EEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTK--VAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~--vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||.||+|... ++.. +|+|.+.... ......+.+|+.+++++ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999964 4554 4999886532 23345788999999999 999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 226 YEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 2235789999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhh
Q 011498 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~ 372 (484)
||+|||++....... ......+++.|+|||++.+..++.++|||||||++|||+| |..||...... .....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK 253 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHHH
Confidence 999999987432211 1223356889999999998899999999999999999998 99999754321 11111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
... . ..... +......+.+++.+||..||.+|||+.++++.|+.
T Consensus 254 ~~~-~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 254 LPQ-G-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp GGG-T-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhc-C-----CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111 0 00111 11234568889999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=342.29 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=187.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceee--------eC
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCV--------EG 219 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~--------~~ 219 (484)
..+|.+.+.||+|+||.||+|.+. +++.||||++..........+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357888999999999999999974 58899999987766666778899999999995 999999999984 34
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc--eeecCCCCCcEEEcCCCcEEEee
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSD 297 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~D 297 (484)
...+++|||+. |+|.+++.... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 45799999996 69999986522 124699999999999999999999998 7 99999999999999999999999
Q ss_pred ecccccccCCCcee-----------eccccccccccccccc---ccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCc
Q 011498 298 FGLAKLLCSERSYV-----------TTRVMGTFGYVAPEYA---CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363 (484)
Q Consensus 298 fgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~ 363 (484)
||++.......... .....||+.|+|||++ .+..++.++|||||||++|||+||..||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99998764332211 1134589999999998 566789999999999999999999999974432110
Q ss_pred cchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 364 VNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
. . ..............+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 262 ---~---~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 262 ---V---N-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---h---c-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 0000000111123477889999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.42 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=199.4
Q ss_pred CCcCceeccCCceEEEEEEECC-C---CEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCee-eEEE
Q 011498 153 LCEENVIGEGGYGIVYRGILSD-G---TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR-MLVY 226 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv~ 226 (484)
|...+.||+|+||.||+|.+.+ + ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.... ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4456889999999999998532 2 3799998865433 3456788999999999999999999999876655 9999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 103 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999753 25689999999999999999999999 999999999999999999999999999976533
Q ss_pred CCc---eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCC-CCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 307 ERS---YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN-PVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 307 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
... .......+|+.|+|||.+.+..++.++||||||+++|+|++|.. ||...... .....+.. ..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~----~~---- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFLAQ----GR---- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHHHT----TC----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHhhc----CC----
Confidence 221 12233467889999999999999999999999999999999554 45433221 11111111 10
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
... .+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus 246 -~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 246 -RLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001 1112234688899999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=354.36 Aligned_cols=262 Identities=23% Similarity=0.253 Sum_probs=195.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeC------C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 220 (484)
.++|.+.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999865 5889999999654 233456788999999999999999999999654 3
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999976 57777642 388999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh------------
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD------------ 368 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~------------ 368 (484)
++...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+....+.
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98654322 2344679999999999999999999999999999999999999997654211110000
Q ss_pred ----hhhhhhcCCCc------ccccCCC-CCCC--ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 369 ----WLKTMVGSRKS------EEVVDPK-LPKM--PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 369 ----~~~~~~~~~~~------~~~~~~~-~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
........... ....... .+.. ........+.+|+.+||..||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000000 0000 011225678899999999999999999999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=342.34 Aligned_cols=251 Identities=14% Similarity=0.168 Sum_probs=200.7
Q ss_pred HhcCCCcCceeccCCceEEEEEE------ECCCCEEEEEEecccchhhHHHHHHHHHHHhccC---CCceeeecceeeeC
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGI------LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEG 219 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~ 219 (484)
..++|.+.+.||+|+||.||+|. ..+++.||||++.... ..++..|+.++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678889999999999999994 3458899999986543 346677777777776 99999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---------
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVG-DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--------- 289 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~--------- 289 (484)
...++||||+++|+|.++++.... ....+++..++.++.||+.||+|||+. +|+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999974221 235699999999999999999999998 9999999999999998
Q ss_pred --CCcEEEeeecccccccC-CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccch
Q 011498 290 --QWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366 (484)
Q Consensus 290 --~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~ 366 (484)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||....... .
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~-- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-C-- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-E--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-e--
Confidence 89999999999976532 22333455679999999999999999999999999999999999999985432210 0
Q ss_pred hhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhc
Q 011498 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR-PKMGHVIHMLEA 426 (484)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Ps~~evl~~L~~ 426 (484)
.....+..... ...+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 294 ---------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 294 ---------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ---------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ---------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 01111122222 3345667779999999999 678888887765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=335.77 Aligned_cols=250 Identities=32% Similarity=0.424 Sum_probs=196.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC-CeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-AYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||+|... |+.||||.+.... ..+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 367888999999999999999985 8899999886543 456788999999999999999999997654 478999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999997542 12378999999999999999999998 99999999999999999999999999987653321
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
....+++.|+|||.+.+..++.++||||||+++|||+| |..||....... .. ... ... .....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~~-~~~-----~~~~~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PRV-EKG-----YKMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH---HHH-TTT-----CCCCC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHH-hcC-----CCCCC
Confidence 22357889999999999999999999999999999998 999997543211 11 111 111 01111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.......+.+++.+||+.||++|||+.++++.|+..
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 122345688899999999999999999999999763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.97 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=203.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
.++|.+.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 367888999999999999999842 46789999986543 34456788999999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEe
Q 011498 223 MLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVS 296 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~ 296 (484)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976532 224589999999999999999999998 9999999999999984 4469999
Q ss_pred eecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhh
Q 011498 297 DFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 297 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
|||++........ .......+|+.|+|||++.+..++.++||||||+++|||+| |..||...... .....+ .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~---~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV---T 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH---H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH---h
Confidence 9999976533221 12233467889999999999999999999999999999998 99999754321 111111 1
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.... +.. ...+...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 260 ~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGR------MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC------CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1100 011 112334688899999999999999999999999854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.73 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=196.6
Q ss_pred ceeccCCceEEEEEEEC---CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||.||+|.+. .+..||||++..... ...+.+.+|+.+++.++|||||++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 357899999875432 345789999999999999999999999975 457899999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce-
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY- 310 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~- 310 (484)
|+|.++++.. ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999754 4689999999999999999999998 9999999999999999999999999999876443221
Q ss_pred -eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 311 -VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 311 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
......+|+.|+|||++.+..++.++|||||||+||||+| |..||....... .... +.... ....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~----i~~~~-----~~~~- 593 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAM----LEKGE-----RMGC- 593 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTTC-----CCCC-
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC-----CCCC-
Confidence 1223346788999999999999999999999999999998 999997554221 1111 11111 0111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+..+...+.+|+.+||+.||++||++.+|++.|+.
T Consensus 594 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12234578899999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=353.76 Aligned_cols=242 Identities=16% Similarity=0.194 Sum_probs=187.8
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEeccc---chhhHHHHHHHH---HHHhccCCCceeeec-------cee
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEV---EVIGRVRHKNLVRLL-------GYC 216 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~~ 216 (484)
++|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+ .+++.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5677789999999999999995 46899999998643 334457788999 455556899999999 555
Q ss_pred eeCC-----------------eeeEEEEecCCCCHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 011498 217 VEGA-----------------YRMLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276 (484)
Q Consensus 217 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iv 276 (484)
.+.+ ..|+||||+ +|+|.+++..... ....+++..++.++.||+.||+|||++ +|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4442 278999999 6799999975311 112344688889999999999999999 999
Q ss_pred ecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccccccccccccccccC-----------CCCcccceecchhHH
Q 011498 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-----------MLNEKSDVYSFGILI 345 (484)
Q Consensus 277 H~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~~l 345 (484)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999985322 2334567 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 346 MEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 346 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
|||+||+.||............ .. ... .....+.+++.+||+.||++|||+.++++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~---------------~~-~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI---------------FR-SCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CCSGGG---------------GS-SCC-----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccchhhh---------------hh-hcc-----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999755432211110 00 011 12346888999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=339.36 Aligned_cols=266 Identities=28% Similarity=0.411 Sum_probs=196.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHH--HhccCCCceeeecceeee-----CCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLVRLLGYCVE-----GAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~-----~~~~ 222 (484)
.++|.+.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36788899999999999999988 58999999885433 2333334444 555899999999986542 3356
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC------CCceeecCCCCCcEEEcCCCcEEEe
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL------EPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
++||||+++|+|.++++.. ..++..++.++.||+.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 8999999999999999754 3588999999999999999999752 2389999999999999999999999
Q ss_pred eecccccccCCCc-------eeeccccccccccccccccc-------CCCCcccceecchhHHHHHHhCCCCCCCCCCCC
Q 011498 297 DFGLAKLLCSERS-------YVTTRVMGTFGYVAPEYACT-------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQG 362 (484)
Q Consensus 297 Dfgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~ 362 (484)
|||++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987643221 11224569999999999976 456779999999999999999977764333221
Q ss_pred ccchh-----------hhhhhhhcCCCcccccCCCCCC--CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 363 EVNLV-----------DWLKTMVGSRKSEEVVDPKLPK--MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 363 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
..... ........... ..+.++. .........+.+++.+||+.||++|||+.||++.|+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11110 00011111111 1111111 122346678999999999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=333.61 Aligned_cols=246 Identities=20% Similarity=0.314 Sum_probs=198.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 225 (484)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456888999999999999999976 68999999987542 33456788899999998 999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC----------------
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---------------- 289 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---------------- 289 (484)
|||+++++|.+++.........+++..++.++.||+.||.|||++ +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976433335689999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEeeecccccccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccc
Q 011498 290 ---QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN 365 (484)
Q Consensus 290 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~ 365 (484)
...+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----Q 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----H
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----H
Confidence 4479999999998764322 23589999999999766 66789999999999999999988764221 1
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. ... ... .+.++. .....+.+++.+||+.||++|||+.++++
T Consensus 237 ~~----~~~-~~~-----~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 WH----EIR-QGR-----LPRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH----HHH-TTC-----CCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----HHH-cCC-----CCCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 111 111 111211 22346888999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.10 Aligned_cols=247 Identities=20% Similarity=0.340 Sum_probs=203.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+..|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56788899999999999999976 47889999886542 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998754 4689999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... +......... ..
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-------~~ 233 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNE-------YS 233 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC-------CC
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhcc-------CC
Confidence 222 233456899999999999989999999999999999999999999754321 1111111110 01
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
++. .....+.+++.+||+.||++|||++++++
T Consensus 234 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 IPK----HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred Ccc----ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111 12346788999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=330.44 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=198.6
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
+|.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++......++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555669999999999999964 578999999877665566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeecccccccCCCc
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~ 309 (484)
+++|.+++..... ...+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999976432 24567899999999999999999998 9999999999999987 89999999999986543221
Q ss_pred eeecccccccccccccccccCC--CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..||........ ..+..... ...+.+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~-------~~~~~~ 247 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMF-------KVHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHH-------CCCCCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhccc-------cccccc
Confidence 223456899999999987643 88999999999999999999999964322110 00000000 011122
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+ ......+.+++.+||+.||++|||+.++++
T Consensus 248 ~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 P----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 223446888999999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.43 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=191.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccC-CCceeeecceeeeCC--ee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGA--YR 222 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~ 222 (484)
..++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 5899999998643 2334466778999999996 999999999997544 68
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+||||+. |+|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 5999999753 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCC--------------------Cceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCC
Q 011498 303 LLCSE--------------------RSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361 (484)
Q Consensus 303 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~ 361 (484)
..... ........+||+.|+|||++.+ ..++.++|||||||+||||++|++||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 1112234579999999999876 67999999999999999999999999765422
Q ss_pred CccchhhhhhhhhcCCCcccc---c------------------CCCCCCCCh------------HHHHHHHHHHHHhcCC
Q 011498 362 GEVNLVDWLKTMVGSRKSEEV---V------------------DPKLPKMPA------------SKALKRVLLVALRCVD 408 (484)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~---~------------------~~~~~~~~~------------~~~~~~l~~l~~~cl~ 408 (484)
.. ...+....+......+ . ......... ......+.+|+.+||.
T Consensus 238 ~~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQ---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HH---HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HH---HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 11 1111111110000000 0 000000000 0123468899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 011498 409 PDATKRPKMGHVIHM 423 (484)
Q Consensus 409 ~dp~~RPs~~evl~~ 423 (484)
.||++|||++|+++.
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=330.02 Aligned_cols=245 Identities=24% Similarity=0.404 Sum_probs=195.7
Q ss_pred CCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee----CCeeeEE
Q 011498 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLV 225 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv 225 (484)
|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 566778999999999999975 57889999886543 3445678899999999999999999999875 3568999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCc--eeecCCCCCcEEEc-CCCcEEEeeecccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLD-RQWNARVSDFGLAK 302 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfgla~ 302 (484)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. + |+|+||||+|||++ .++.+||+|||++.
T Consensus 108 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999754 4589999999999999999999998 7 99999999999998 78899999999997
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... .....||+.|+|||++. +.++.++|||||||++|+|++|..||...... ......... ...
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~--- 247 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS-GVK--- 247 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT-TCC---
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhc-cCC---
Confidence 643322 23356899999999886 45999999999999999999999999754321 111111111 100
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+..........+.+++.+||+.||.+|||+.+|++
T Consensus 248 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111112246889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=341.61 Aligned_cols=261 Identities=20% Similarity=0.306 Sum_probs=192.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.++|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 467899999999999999999864 588999999865432 22456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE-----cCCCcEEEeeeccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLA 301 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll-----~~~~~~kl~Dfgla 301 (484)
||+++ +|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 113 e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99985 999999765 4589999999999999999999999 99999999999999 45556999999999
Q ss_pred ccccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ +.. +..........
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFK-IFEVLGLPDDT 260 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHH-HHHHhCCCchh
Confidence 87643222 23345689999999999874 589999999999999999999999975432111 111 11110000000
Q ss_pred -----------cccCCCCCCCChHH-----HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 -----------EVVDPKLPKMPASK-----ALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 -----------~~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+......... ....+.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00001111111111 2356789999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=346.14 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=202.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999976 58899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.++++.. ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999764 35899999999999999999999731 7999999999999999999999999999755322
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhh------------------
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL------------------ 370 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~------------------ 370 (484)
......||+.|+|||++.+..++.++|||||||++|+|+||..||...............
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 123357899999999999999999999999999999999999999754321100000000
Q ss_pred -hhhh----cCC----CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 371 -KTMV----GSR----KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 371 -~~~~----~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... ... ....+.....+..........+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 000 000000011111111223456889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=349.54 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=192.6
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhccCCCceeeecceeee
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 218 (484)
...++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999975 478999999865321 112247889999999999999999999754
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC---cEEE
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARV 295 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl 295 (484)
...++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 5579999999999999998654 4689999999999999999999998 999999999999997544 5999
Q ss_pred eeecccccccCCCceeeccccccccccccccccc---CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|+||..||....... .+...+.
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~- 358 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT- 358 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH-
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh-
Confidence 9999998764322 2344679999999999863 678899999999999999999999997543221 1111111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..... ............+.+++.+||+.||++|||++|+++
T Consensus 359 ---~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 ---SGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---TTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---cCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 000001123456889999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=343.11 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=204.9
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhcc-CCCceeeec
Q 011498 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRV-RHKNLVRLL 213 (484)
Q Consensus 144 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~l~ 213 (484)
.......++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+..|+.+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334445678999999999999999999985 689999998865431 1235678899999999 899999999
Q ss_pred ceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
+++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999754 4689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCceeeccccccccccccccccc------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh
Q 011498 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV 367 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~ 367 (484)
||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||..||...... ...
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~ 314 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LML 314 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHH
Confidence 9999999987643322 334679999999998863 35889999999999999999999999653211 111
Q ss_pred hhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 368 DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....... . .............+.+++.+||+.||++|||+.++++
T Consensus 315 ---~~i~~~~-~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 ---RMIMEGQ-Y------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHTC-C------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHhCC-C------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111000 0 0000000112346888999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=340.70 Aligned_cols=248 Identities=20% Similarity=0.345 Sum_probs=204.1
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
..+|.+.+.||+|+||.||++...+ ++.||+|.+.... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3568888999999999999999764 7889999886542 33456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998754 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..||...... +......... .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~-------~ 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNE-------Y 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC-------C
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCC-------C
Confidence 3222 233456899999999999999999999999999999999999999754311 1111111110 1
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.++. .....+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPK----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 12345788999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=339.01 Aligned_cols=255 Identities=20% Similarity=0.268 Sum_probs=200.9
Q ss_pred HHhcCCCcC-ceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCee
Q 011498 148 AATSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 148 ~~~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~ 222 (484)
...+.|.+. +.||+|+||.||+|... +++.||+|++..... .....+.+|+.++..+ +||||+++++++.+....
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 344566666 88999999999999976 589999998865432 3356788899999999 569999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeec
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFG 299 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg 299 (484)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999998643 235689999999999999999999999 9999999999999987 7899999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+...
T Consensus 180 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~------ 248 (327)
T 3lm5_A 180 MSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYLNISQV------ 248 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT------
T ss_pred cccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHhc------
Confidence 998764322 2234579999999999999999999999999999999999999997543211 11001100
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....+..........+.+++.+||+.||++|||++++++
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 ----NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 001111111223456888999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.48 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=201.8
Q ss_pred cCCCcCceeccCCceEEEEEEECC---------CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceee----------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD---------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR---------- 211 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~---------- 211 (484)
++|.+.+.||+|+||.||+|.... ++.||+|.+... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 568888999999999999999763 788999988644 35778999999999999988
Q ss_pred -----ecceeee-CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcE
Q 011498 212 -----LLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285 (484)
Q Consensus 212 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NI 285 (484)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5666665 67889999999 999999997542 24699999999999999999999999 999999999999
Q ss_pred EEcCCC--cEEEeeecccccccCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCC
Q 011498 286 LLDRQW--NARVSDFGLAKLLCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDY 357 (484)
Q Consensus 286 ll~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~ 357 (484)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|..||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999765432211 11334799999999999999999999999999999999999999986
Q ss_pred CCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 358 SRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...... ............ ...+.+.... .......+.+++.+||+.||++|||+++|++.|+..
T Consensus 271 ~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCHH-HHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCHH-HHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 542211 111111111111 1111111110 011235688899999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.47 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=199.3
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||.||+|.... |+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 568888999999999999999754 88999998865432 334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999998887643 4589999999999999999999999 9999999999999999999999999999765432
Q ss_pred CceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh-----------hhc
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT-----------MVG 375 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~ 375 (484)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ...... +..
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL--YHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhCCCChhhhhHhhh
Confidence 22 23345689999999999875 7899999999999999999999999755422111 000000 000
Q ss_pred CCCcccccCCCCCCCCh-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRKSEEVVDPKLPKMPA-----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+....... ......+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00001111111111111 123467889999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=331.56 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=202.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999976 47789999886532 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999754 3589999999999999999999998 999999999999999999999999999876533
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... ......... +..
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~-------~~~ 230 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNV-------DLK 230 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTT-------CCC
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcc-------ccC
Confidence 22 23456899999999999999999999999999999999999999754321 111111110 111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
++. .....+.+++.+||..||.+|||+.++++
T Consensus 231 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111 22346788999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=343.03 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=194.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhh-HHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999976 68899999886543221 12445699999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 975 9999987542 4689999999999999999999998 99999999999999999999999999997653322
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc---cc--
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE---EV-- 382 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 382 (484)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ....+.......... ..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 2 2233468999999999876 568999999999999999999999997654221 111111111110000 00
Q ss_pred -------cCCCCCCCC----hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 -------VDPKLPKMP----ASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 -------~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+...... .......+.+|+.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 0112356789999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=332.05 Aligned_cols=248 Identities=24% Similarity=0.402 Sum_probs=204.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+.|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45788899999999999999864 58899999986543 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999964 3589999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ... ...... ..+.+.
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~~------~~~~~~ 240 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVL---FLIPKN------NPPTLE 240 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHS------CCCCCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHH---HHhhcC------CCCCCc
Confidence 2 233456899999999999999999999999999999999999999754321 111 111100 011111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
. .....+.+++.+||+.||.+|||+.+|++.
T Consensus 241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred c----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 223468889999999999999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.25 Aligned_cols=247 Identities=23% Similarity=0.431 Sum_probs=201.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee----------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE---------- 218 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------- 218 (484)
..+|.+.+.||+|+||.||+|... +++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456888999999999999999986 68999999986554 346679999999999999999998864
Q ss_pred ------CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc
Q 011498 219 ------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (484)
Q Consensus 219 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~ 292 (484)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 345799999999999999997542 24689999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+... ......
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH
Confidence 99999999987644322 23346899999999999999999999999999999999999887421 111111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
.. ...++.. ....+.+++.+||+.||.+|||+.|+++.|+...
T Consensus 231 ~~---------~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 LR---------DGIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HH---------TTCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hh---------ccccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11 1111111 2245778899999999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=356.15 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=197.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
+.|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888999999999999999975 58899999986543 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC---CcEEEeeecccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLL 304 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfgla~~~ 304 (484)
|+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.. +.+||+|||++...
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999998754 4589999999999999999999998 99999999999999764 45999999999876
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||....... .. ........
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~~------ 254 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---IL---RKVEKGKY------ 254 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHTCC------
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCC------
Confidence 4332 234457999999999886 569999999999999999999999997544221 11 11111000
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.............+.+++.+||+.||.+|||+.++++
T Consensus 255 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 -TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0001111123456888999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=355.03 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=201.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888999999999999999975 68899999985432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc---CCCcEEEeeeccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKL 303 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfgla~~ 303 (484)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999998754 4589999999999999999999999 999999999999995 456799999999986
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ... ........
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~----- 239 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL---KRVETGKY----- 239 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCC-----
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCC-----
Confidence 54332 2334579999999999875 5999999999999999999999999754321 111 11111000
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.............+.+++.+||..||.+|||+.++++
T Consensus 240 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 240 --AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp --CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011111233456889999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=357.53 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=203.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999975 68999999985432 334577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---cCCCcEEEeeeccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKL 303 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfgla~~ 303 (484)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++..
T Consensus 106 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999754 4689999999999999999999999 99999999999999 5678999999999987
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...... ... ........
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~----- 244 (484)
T 3nyv_A 179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL---KKVEKGKY----- 244 (484)
T ss_dssp BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCC-----
T ss_pred ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHcCCC-----
Confidence 64332 2334579999999999865 6999999999999999999999999754321 111 11111100
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 245 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 --TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0011111234456889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=328.62 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=194.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999976 68999999886542 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999754 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...... ... ....... .
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~-------~ 228 (276)
T 2h6d_A 164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF---KKIRGGV-------F 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCC-------C
T ss_pred Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH---HHhhcCc-------c
Confidence 22 1233468999999999987765 68999999999999999999999643211 111 1111100 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+. .....+.+++.+||+.||++|||+.+|++
T Consensus 229 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 YIPE----YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCch----hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1111 12346888999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=334.38 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=198.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||+|... ++..||+|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 367888999999999999999986 4889999998766555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999986532 4589999999999999999999998 99999999999999999999999999875432111
Q ss_pred ceeeccccccccccccccc-----ccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 309 SYVTTRVMGTFGYVAPEYA-----CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
.......||+.|+|||++ ....++.++||||||+++|+|++|..||...... ...........
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~----- 239 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDP----- 239 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-----
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCC-----
Confidence 112234689999999988 4667899999999999999999999999754321 11111111100
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+ ...........+.+++.+||+.||++|||+.++++
T Consensus 240 -~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 -P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 01112233456889999999999999999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.25 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=166.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Cee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 222 (484)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 57888999999999999999975 47889999996532 33456788999999999999999999999766 568
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+||||+. |+|.++++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 99999997 5999999754 4699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc---------------------eeeccccccccccccccc-ccCCCCcccceecchhHHHHHHhCCCCCC
Q 011498 303 LLCSERS---------------------YVTTRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIITGRNPVD 356 (484)
Q Consensus 303 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltG~~p~~ 356 (484)
....... ......+||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 7643221 112456799999999986 56679999999999999999998655543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=347.09 Aligned_cols=263 Identities=20% Similarity=0.323 Sum_probs=196.4
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC------
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------ 219 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------ 219 (484)
+...++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999986 46899999998655332 23589999999999999999998543
Q ss_pred --------------------------------CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 011498 220 --------------------------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267 (484)
Q Consensus 220 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~L 267 (484)
...++||||+++ +|.+.+.........+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 347899999985 88887764323346799999999999999999999
Q ss_pred hcCCCCceeecCCCCCcEEEc-CCCcEEEeeecccccccCCCceeecccccccccccccccccC-CCCcccceecchhHH
Q 011498 268 HEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILI 345 (484)
Q Consensus 268 H~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l 345 (484)
|+. +|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999998 688999999999987643332 2345689999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCCccchhhhhhhhhcCC----------CcccccCCCCCCCC-----hHHHHHHHHHHHHhcCCCC
Q 011498 346 MEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR----------KSEEVVDPKLPKMP-----ASKALKRVLLVALRCVDPD 410 (484)
Q Consensus 346 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~d 410 (484)
|||++|+.||......+. +.. +....+.. ......-+...... +......+.+|+.+||..|
T Consensus 233 ~ell~g~~pf~~~~~~~~--~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQ--LVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHH--HHH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999976542211 111 11111100 00011111111111 1123456889999999999
Q ss_pred CCCCCCHHHHHH
Q 011498 411 ATKRPKMGHVIH 422 (484)
Q Consensus 411 p~~RPs~~evl~ 422 (484)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=347.19 Aligned_cols=192 Identities=25% Similarity=0.364 Sum_probs=153.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Cee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 222 (484)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67889999999999999999865 58899999986532 33456788999999999999999999998543 568
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+||||+. |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 99999985 6999999754 4699999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCc--------------------------eeeccccccccccccccc-ccCCCCcccceecchhHHHHHHh
Q 011498 303 LLCSERS--------------------------YVTTRVMGTFGYVAPEYA-CTGMLNEKSDVYSFGILIMEIIT 350 (484)
Q Consensus 303 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ellt 350 (484)
....... ......+||+.|+|||++ ....++.++|||||||+||||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 7542211 122345789999999976 46679999999999999999999
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=344.11 Aligned_cols=270 Identities=24% Similarity=0.295 Sum_probs=200.8
Q ss_pred cHHHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccch-----------hhHHHHHHHHHHHhccCCCcee
Q 011498 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-----------QAEKEFKVEVEVIGRVRHKNLV 210 (484)
Q Consensus 142 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~e~~~l~~l~H~niv 210 (484)
.+.++....++|.+.+.||+|+||.||+|...+|..||||++..... ...+.+.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 36778888999999999999999999999988899999998854322 1236788999999999999999
Q ss_pred eecceeeeC-----CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcE
Q 011498 211 RLLGYCVEG-----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285 (484)
Q Consensus 211 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NI 285 (484)
++++++... ...++||||+. |+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998542 36799999998 5898888743 24689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeecccccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCcc
Q 011498 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEV 364 (484)
Q Consensus 286 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~ 364 (484)
|++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999999999997543322 2334568999999999876 679999999999999999999999997543211
Q ss_pred chhhhhhhhhcCCCcc-----------cccC---CCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 365 NLVDWLKTMVGSRKSE-----------EVVD---PKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 365 ~~~~~~~~~~~~~~~~-----------~~~~---~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
....+.......... .... ...+.... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111100000 0000 00111111 1123568899999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=339.04 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=197.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
..++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 5899999988643221 124677899999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 8999886542 4588889999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||....... ....+...........
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTT
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhh
Confidence 7643322 23345789999999998754 58999999999999999999999997543211 1111111111100000
Q ss_pred ----------ccCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 382 ----------VVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 382 ----------~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
......+.... ......+.+++.+||..||++|||+.|+++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00001111111 12235788999999999999999999998743
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.83 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=199.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+++.++||||+++++++......++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 467888999999999999999976 48999999886543 346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999996432 4689999999999999999999998 99999999999999999999999999997654332
Q ss_pred ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 309 SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......... .+..
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~~~- 245 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNP------PPTF- 245 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC------CCCC-
T ss_pred c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCC------Cccc-
Confidence 2 2334568999999999999999999999999999999999999997543211 011110000 0011
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.........+.+++.+||..||.+|||+.++++
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112223456889999999999999999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.99 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=199.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-------------hhHHHHHHHHHHHhccCCCceeeecce
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-------------QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
.++|.+.+.||+|+||+||+|... ++..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999975 478999999865431 234678899999999999999999999
Q ss_pred eeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC---c
Q 011498 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---N 292 (484)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~---~ 292 (484)
+.+....++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999754 4589999999999999999999998 999999999999998775 6
Q ss_pred EEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... .. ..
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~ 258 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---II---KK 258 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HH
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HH
Confidence 9999999998764332 233457999999999986 569999999999999999999999997544221 11 11
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...... ..+..........+.+++.+||..||.+|||++|+++
T Consensus 259 i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKY-------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCC-------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCC-------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111000 0000000123456889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=338.53 Aligned_cols=258 Identities=18% Similarity=0.294 Sum_probs=203.8
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhh-----------------HHHHHHHHHHHhccCCCceeee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA-----------------EKEFKVEVEVIGRVRHKNLVRL 212 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~e~~~l~~l~H~niv~l 212 (484)
.++|.+.+.||+|+||.||+|.. ++..||+|.+....... ...+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788899999999999999999 79999999986442211 1788999999999999999999
Q ss_pred cceeeeCCeeeEEEEecCCCCHHHH------hhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcE
Q 011498 213 LGYCVEGAYRMLVYEYVDNGNLDQW------LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNI 285 (484)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NI 285 (484)
++++.+....++||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ . +++|+||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 5432 23679999999999999999999998 7 999999999999
Q ss_pred EEcCCCcEEEeeecccccccCCCceeecccccccccccccccccC-CCCc-ccceecchhHHHHHHhCCCCCCCCCCCCc
Q 011498 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNE-KSDVYSFGILIMEIITGRNPVDYSRPQGE 363 (484)
Q Consensus 286 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~elltG~~p~~~~~~~~~ 363 (484)
+++.++.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|||++|..||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 9999999999999999875433 23445789999999999877 6766 9999999999999999999997554311
Q ss_pred cchhhhhhhhhcCCCccc------ccCCCCC---CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 364 VNLVDWLKTMVGSRKSEE------VVDPKLP---KMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .... ...... ...+... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 260 -~~~---~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 -ELF---NNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHH---HHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHH---HHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1111 110000 0000000 0001223457889999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=342.69 Aligned_cols=253 Identities=11% Similarity=0.003 Sum_probs=180.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhcc--CCCceeeec-------ceee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV--RHKNLVRLL-------GYCV 217 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l--~H~niv~l~-------~~~~ 217 (484)
.+|...+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34777899999999999999975 688999999976542 3345677785544444 699988755 3443
Q ss_pred eC-----------------CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHH------HHHHHHHHHHHHhhhcCCCCc
Q 011498 218 EG-----------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR------MNIILGTAKGLAYLHEGLEPK 274 (484)
Q Consensus 218 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~al~~LH~~~~~~ 274 (484)
.. ...|+||||++ |+|.+++.... ..+.+..+ +.++.||+.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 22 34799999999 79999997542 12344455 67889999999999998 9
Q ss_pred eeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeeccccccccccccccccc--CCCCcccceecchhHHHHHHhCC
Q 011498 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGR 352 (484)
Q Consensus 275 ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~ 352 (484)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865321 213457799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 353 NPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 353 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.||....+......... .....................+.+|+.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRP--------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCCBC--------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchhhh--------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99987643321111100 000000111111111123456888999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.70 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=203.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeee
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 223 (484)
..++|.+.+.||+|+||+||+|..+ +++.||||++.... ......+..|..++..+ +||||+++++++.+....|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467888999999999999999975 47889999986532 23345677899999987 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++|+|.++++.. ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999864 3589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
..... ......+||+.|+|||++.+..++.++|||||||+||||++|..||...+.. +.........
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~------ 558 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN------ 558 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSSC------
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC------
Confidence 43222 2344568999999999999999999999999999999999999999754321 1111111111
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKM-----GHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~ 422 (484)
..++ ......+.+|+.+||+.||++||++ +||++
T Consensus 559 -~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 -VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111 1234568889999999999999998 55554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.56 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=195.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC--CCC--EEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS--DGT--KVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~--~~~--~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
++|.+.+.||+|+||.||+|.+. ++. .||+|++.... ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999863 233 68999886542 344567889999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999997542 3588999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 304 LCSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
....... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||...... +..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~-- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE-- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCC--
Confidence 6443322 1223457788999999998889999999999999999999 99999754321 11111111110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
...........+.+++.+||..||++|||+.+|++.|+..
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 0011122345688999999999999999999999999854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.57 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=202.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---------hhhHHHHHHHHHHHhccC-CCceeeecceeee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---------GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVE 218 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~ 218 (484)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 57899999986542 122356788999999995 9999999999999
Q ss_pred CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeee
Q 011498 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (484)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 298 (484)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999754 4689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCceeecccccccccccccccc------cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 299 GLAKLLCSERSYVTTRVMGTFGYVAPEYAC------TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 299 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
|++....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||...... .....
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRM 240 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHHH
Confidence 9998764332 233456899999999885 456889999999999999999999999644311 11111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..... ..............+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGN-------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTC-------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCC-------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11110 01111112234567889999999999999999999976
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.96 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=198.9
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeC--------
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-------- 219 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------- 219 (484)
++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688899999999999999997 4689999998855432 2345678899999999999999999999873
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...++||||+.+ +|.+.+.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 8888776442 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC---ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 300 LAKLLCSER---SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 300 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||+||..||......... ..+.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhC
Confidence 998654221 112234568999999998876 56899999999999999999999999765422111 11111111
Q ss_pred CCCc-----------ccccC-CCCCCCChHHH------HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRKS-----------EEVVD-PKLPKMPASKA------LKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~-----------~~~~~-~~~~~~~~~~~------~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... ..... ........... ...+.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 00000 00000111111 245789999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.10 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=186.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999854 58899999885443 233467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcC----CCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 227 EYVDNGNLDQWLHGD----VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 227 e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
||+++++|.+++... ......+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998641 11235689999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCc----eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 303 LLCSERS----YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 303 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||......... .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~ 243 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQND 243 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHTSS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhccC
Confidence 6543211 11234568999999999875 56899999999999999999999999765432111 1111110
Q ss_pred C---cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 K---SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. .....++... ......+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0001111111 122346888999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=346.09 Aligned_cols=259 Identities=17% Similarity=0.235 Sum_probs=204.2
Q ss_pred hcCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccCC-CceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+..|+++++.++| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36788999999999999999996 4589999998754432 2357789999999976 566666667778888999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---cCCCcEEEeeecccccc
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLL 304 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfgla~~~ 304 (484)
|+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 899999997532 4699999999999999999999999 99999999999999 68899999999999876
Q ss_pred cCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 305 CSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 305 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543221 12246799999999999999999999999999999999999999987654332222222111110011
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...+. ..+...+.+++..||+.||++||++.+|++.|+.
T Consensus 237 ~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 237 IEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11110 1123568899999999999999999999998875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.60 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=193.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 220 (484)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 356888899999999999999974 58999999985432 234467889999999999999999999998653
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|+||||+ +++|.++++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999975 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+....+....
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 9875432 234578999999999877 6899999999999999999999999975542111 1111110000000
Q ss_pred ------------------ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 ------------------EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.......+. .........+.+|+.+||..||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000 0011223568889999999999999999999883
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.82 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=187.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+..+...++.++||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999974 688999999865432 22234445555688889999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++ +|.+++.........+++..++.++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99975 99888765333346799999999999999999999974 2899999999999999999999999999986543
Q ss_pred CCceeeccccccccccccccc----ccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYA----CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
... .....||+.|+|||++ .+..++.++|||||||++|+|+||..||...... .. .+.......
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~----- 230 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQ-QLKQVVEEP----- 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HH-HHHHHHHSC-----
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HH-HHHHHhccC-----
Confidence 322 2334689999999996 5667899999999999999999999999743211 11 111111111
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+..........+.+++.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 ----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111223456888999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=335.36 Aligned_cols=260 Identities=25% Similarity=0.272 Sum_probs=191.6
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC------e
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------Y 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~ 221 (484)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 67888999999999999999865 58899999986532 334467888999999999999999999997654 6
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.++||||+.+ +|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7999999975 88888862 488999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh--------------
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-------------- 367 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~-------------- 367 (484)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 8653321 233457899999999999999999999999999999999999999754321100000
Q ss_pred --hhhhhhhcCCC------cccccCC-CCCCC--ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 368 --DWLKTMVGSRK------SEEVVDP-KLPKM--PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 368 --~~~~~~~~~~~------~~~~~~~-~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........... ....... ..+.. ........+.+|+.+||..||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000000 0000000 00000 11223567899999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.04 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=193.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC------eeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------YRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~l 224 (484)
.+|.+.+.||+|+||.||+|+...+..||+|++....... .+|+.+++.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~----~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC----CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH----HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4588889999999999999998777779999886554322 35899999999999999999996543 3789
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-CCCcEEEeeeccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKL 303 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfgla~~ 303 (484)
||||++++ +...+.........+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999874 4444332111235689999999999999999999998 999999999999999 789999999999987
Q ss_pred ccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC-----
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR----- 377 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 377 (484)
...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ +...+ ...+..
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~-~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEII-KVLGTPSREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCCHHHH
Confidence 643322 2345689999999998765 599999999999999999999999976542211 11111 100000
Q ss_pred -----CcccccCCCCCCCChH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 378 -----KSEEVVDPKLPKMPAS-----KALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 378 -----~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
......-+........ .....+.+|+.+||..||.+|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000011111111111 133578899999999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=343.82 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=194.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC------Ceee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------AYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~ 223 (484)
.+|...+.||+|+||.||+|++. +|+.||||++..... .+.+|+++++.++||||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999985 589999999865432 233589999999999999999998642 2367
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-CcEEEeeecccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAK 302 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfgla~ 302 (484)
+||||+++ +|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 77776653222335799999999999999999999998 99999999999999965 578999999998
Q ss_pred cccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC-----
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS----- 376 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 376 (484)
....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+ .+...+. ..+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~-~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK-VLGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCCHHH
Confidence 7543322 2345789999999998765 79999999999999999999999997643211 1111111 1000
Q ss_pred -----CCcccccCCCCCCCCh-----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 377 -----RKSEEVVDPKLPKMPA-----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 377 -----~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
........+.+..... ......+.+|+.+||..||.+|||+.|+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0111111122211111 1224578899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=341.53 Aligned_cols=199 Identities=21% Similarity=0.287 Sum_probs=171.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc------CCCceeeecceeeeCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV------RHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~~ 222 (484)
..+|.+.+.||+|+||.||+|... +++.||||++.... .....+..|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 356888999999999999999865 47899999986543 3345677788887776 577999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc--EEEeeecc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGL 300 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfgl 300 (484)
++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 59999997653 24589999999999999999999998 9999999999999999887 99999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
+...... .....||+.|+|||++.+..++.++|||||||+||||+||.+||....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9764322 233578999999999999999999999999999999999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=326.25 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=197.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc----hhhHHHHHHHHHHHhccCCCceeeecceee--eCCee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCV--EGAYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~ 222 (484)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 57899999986543 234567899999999999999999999984 44578
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+.++ |.+++.... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999886 777776542 24689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCC-CceeecccccccccccccccccCC--CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 303 LLCSE-RSYVTTRVMGTFGYVAPEYACTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 303 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
..... .........||+.|+|||++.+.. ++.++||||||+++|||++|..||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~~-- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIGKGS-- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHhcCC--
Confidence 75432 122233456899999999987644 478999999999999999999999754311 1111111100
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
..++. .....+.+++.+||+.||.+|||+.++++.
T Consensus 230 -----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 -----YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 223467889999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=332.37 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=196.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhccCCCceeeecceeeeCC
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 220 (484)
.++|.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457889999999999999999975 478999998865321 12235788999999999999999999987655
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc---EEEee
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSD 297 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~D 297 (484)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 89999999999999998644 4689999999999999999999998 9999999999999987654 99999
Q ss_pred ecccccccCCCceeecccccccccccccccc---cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +...+..
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~-- 234 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS-- 234 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH--
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh--
Confidence 99998754321 123456899999999874 56789999999999999999999999975543221 1111111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .............+.+++.+||..||++|||+.++++
T Consensus 235 --~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Ccc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000 0000001123456889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=331.40 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=198.3
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeee--CCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVE--GAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|.. .+++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999986 468899999986433 467888999999996 9999999999987 56789999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeeccccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLC 305 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~~~ 305 (484)
||+.+++|.++++ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999984 388999999999999999999998 999999999999999776 89999999998654
Q ss_pred CCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh------------hhhh
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD------------WLKT 372 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~------------~~~~ 372 (484)
.... .....+|..|+|||++.+ ..++.++|||||||++|||++|..||....... ..+.. ++..
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHH
Confidence 3322 234568999999999877 679999999999999999999999995432210 00000 0000
Q ss_pred -----------hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 -----------MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..... ....................+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRH-SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCC-CCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhc-cccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00000011111122224567889999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=331.95 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=195.5
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeee------C
Q 011498 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE------G 219 (484)
Q Consensus 148 ~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~ 219 (484)
...++|.+.+.||+|+||.||+|.+. +++.||||++.... .....+..|+.+++.+ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34577888999999999999999974 68899999886543 3346788899999999 89999999999987 4
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence 67899999999999999997642 24689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCceeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhh
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 374 (484)
++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||....... . .....
T Consensus 175 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---A---LFLIP 247 (326)
T ss_dssp TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHH
T ss_pred CceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---H---HHHhh
Confidence 9976543221 223356899999999987 5678999999999999999999999996443211 1 11111
Q ss_pred cCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .+... .......+.+++.+||..||.+|||+.++++
T Consensus 248 ~~~------~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNP------APRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSC------CCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCc------cccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 100 01111 1112346888999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=337.73 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=200.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC--------CCceeeecceee----
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--------HKNLVRLLGYCV---- 217 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~---- 217 (484)
++|.+.+.||+|+||+||+|... +++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 67889999999999999999864 5789999988644 334567888999999885 788999999987
Q ss_pred eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC------
Q 011498 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW------ 291 (484)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~------ 291 (484)
.....++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 55777776543 2246899999999999999999999853 899999999999999775
Q ss_pred -------------------------------------------cEEEeeecccccccCCCceeecccccccccccccccc
Q 011498 292 -------------------------------------------NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328 (484)
Q Consensus 292 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 328 (484)
.+||+|||++...... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999865432 23356899999999999
Q ss_pred cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh---hhhhhhcCC-------------------CcccccCCC
Q 011498 329 TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD---WLKTMVGSR-------------------KSEEVVDPK 386 (484)
Q Consensus 329 ~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~---~~~~~~~~~-------------------~~~~~~~~~ 386 (484)
+..++.++|||||||+||||+||..||............. .+....+.. ....+.+..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999997655432211111 111111100 000000000
Q ss_pred C---------CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 L---------PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~---------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ...........+.+|+.+||+.||++|||++||++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 00123556778999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=361.70 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=202.0
Q ss_pred hcCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 4678888999999999999999743 4579999886543 3444678999999999999999999999854 56899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.++++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 468 v~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999997542 4589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .....+. ...
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~---~~~------ 609 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE---NGE------ 609 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH---HTC------
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH---cCC------
Confidence 5443333334457789999999999999999999999999999997 99999754321 1111111 110
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
....+ ..+...+.+++.+||..||.+|||+.+|++.|+.
T Consensus 610 ~~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 610 RLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCC----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01111 1234568889999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=333.46 Aligned_cols=269 Identities=19% Similarity=0.250 Sum_probs=190.5
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCe-
Q 011498 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY- 221 (484)
Q Consensus 144 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~- 221 (484)
.......++|.+.+.||+|+||.||+|... ++..||||++...... ...+..++..++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345667789999999999999999999975 5889999988654322 2345667888888999999999999975433
Q ss_pred ------eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhh--cCCCCceeecCCCCCcEEEcC-CCc
Q 011498 222 ------RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH--EGLEPKVVHRDVKSSNILLDR-QWN 292 (484)
Q Consensus 222 ------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--~~~~~~ivH~dlkp~NIll~~-~~~ 292 (484)
.++||||+.+ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999987 665555432233467899999999999999999999 77 9999999999999997 899
Q ss_pred EEEeeecccccccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 371 (484)
+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ...+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIV 245 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHH
Confidence 99999999987644332 2345689999999998665 489999999999999999999999976542211 11111
Q ss_pred hhhcC------------CCcccccCCC-C-----CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 372 TMVGS------------RKSEEVVDPK-L-----PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 372 ~~~~~------------~~~~~~~~~~-~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..... .......+.. . ...........+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 10000 0000000000 0 00011123567889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=331.36 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=200.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Ceee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~ 223 (484)
.+|.+.+.||+|+||.||+|... ++..||||++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 57888999999999999999965 57889999987543 33346788999999999999999999998764 3679
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+.+ +|.++++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 107 iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 107 IVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999975 999999753 489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCce--eecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 304 LCSERSY--VTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
....... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... ..+..........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHH
Confidence 5432221 123457999999999865 455899999999999999999999999765432211 1111111110000
Q ss_pred c-----------c--cCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 381 E-----------V--VDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 381 ~-----------~--~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
. . ..+....... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 0000000000 1123568899999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=337.30 Aligned_cols=258 Identities=25% Similarity=0.358 Sum_probs=182.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeC------C
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~ 220 (484)
.++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367888999999999999999864 5889999998653 233456788899999999999999999998754 4
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..++||||+ +++|.++++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 579999999 6799998864 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+....+....
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 9865322 234578999999999876 679999999999999999999999997654221 11111111111000
Q ss_pred c-----------ccc--CCCCCCCChH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 E-----------EVV--DPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ~-----------~~~--~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
. ..+ .+..+..... .....+.+|+.+||..||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 0011111111 123467889999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=338.73 Aligned_cols=202 Identities=22% Similarity=0.359 Sum_probs=155.0
Q ss_pred CCCc-CceeccCCceEEEEEEEC---CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee--CCeeeEE
Q 011498 152 GLCE-ENVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLV 225 (484)
Q Consensus 152 ~~~~-~~~Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv 225 (484)
.|.+ .++||+|+||.||+|.++ ++..||||++.... ....+.+|+.+++.++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 458999999999999975 47889999886443 23467889999999999999999999964 6688999
Q ss_pred EEecCCCCHHHHhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE----cCCCcEEEe
Q 011498 226 YEYVDNGNLDQWLHGDV-----GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVS 296 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~ 296 (484)
|||+.+ +|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 8888875321 1223589999999999999999999999 99999999999999 677899999
Q ss_pred eecccccccCCCc--eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 297 DFGLAKLLCSERS--YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 297 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
|||+++....... ......+||+.|+|||++.+ ..++.++|||||||+||||+||..||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987643211 22334678999999999987 459999999999999999999999997554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=328.26 Aligned_cols=251 Identities=21% Similarity=0.365 Sum_probs=195.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccC--CCceeeecceeeeCCeeeE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~l 224 (484)
..++|.+.+.||+|+||.||++...+++.||||.+.... ......+.+|+.+++.++ ||||+++++++......++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 346788899999999999999998889999999986442 344567889999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||| +.+++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||++...
T Consensus 106 v~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999 5678999999764 4689999999999999999999999 9999999999999975 79999999999865
Q ss_pred cCCCce-eeccccccccccccccccc-----------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 305 CSERSY-VTTRVMGTFGYVAPEYACT-----------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 305 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|..||...... ......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~ 251 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA 251 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHH
Confidence 433221 2234568999999999865 47889999999999999999999999643321 111111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...... ....+.. ....+.+++.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 IIDPNH-----EIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHCTTS-----CCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhccc-----ccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111110 0111111 2346888999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=326.97 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=200.7
Q ss_pred cCCCcCceeccCCceEEEEEEE-C-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCC------ceeeecceeeeCCee
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-S-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK------NLVRLLGYCVEGAYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~------niv~l~~~~~~~~~~ 222 (484)
++|.+.+.||+|+||.||+|.. . +++.||||++... ......+..|+.+++.++|+ +++++++++......
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788899999999999999986 3 5789999988643 23456788899999888655 499999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-------------
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR------------- 289 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~------------- 289 (484)
++||||+ +++|.+++.... ..++++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 889999997652 24689999999999999999999998 9999999999999987
Q ss_pred ------CCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCc
Q 011498 290 ------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363 (484)
Q Consensus 290 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~ 363 (484)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999764322 2345689999999999999999999999999999999999999975542211
Q ss_pred cchhhhhhhhhcCCC--------cccc---------------------cCCC-CCCCChHHHHHHHHHHHHhcCCCCCCC
Q 011498 364 VNLVDWLKTMVGSRK--------SEEV---------------------VDPK-LPKMPASKALKRVLLVALRCVDPDATK 413 (484)
Q Consensus 364 ~~~~~~~~~~~~~~~--------~~~~---------------------~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~ 413 (484)
.. .+........ .... ..+. ............+.+++.+||+.||.+
T Consensus 243 ~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 LA---MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HH---HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HH---HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11 1111100000 0000 0000 000112345677899999999999999
Q ss_pred CCCHHHHHH
Q 011498 414 RPKMGHVIH 422 (484)
Q Consensus 414 RPs~~evl~ 422 (484)
|||+.||++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=330.11 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=198.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEE--CCCCEEEEEEecccch--hhHHHHHHHHHHHhcc---CCCceeeecceee----
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGIL--SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCV---- 217 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~~~~~---- 217 (484)
..++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346789999999999999999997 3578899998864332 1123455677766665 8999999999987
Q ss_pred -eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEe
Q 011498 218 -EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (484)
Q Consensus 218 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 296 (484)
.....++||||+. |+|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 59999997653 24589999999999999999999998 99999999999999999999999
Q ss_pred eecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC
Q 011498 297 DFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376 (484)
Q Consensus 297 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 376 (484)
|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+......
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCC
Confidence 999997653222 2234568999999999999999999999999999999999999997543211 11111111110
Q ss_pred CCcc----------cccCCC---CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 RKSE----------EVVDPK---LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 ~~~~----------~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... ...... ............+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000000 000011123456788999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=336.77 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=199.9
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee
Q 011498 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 145 ~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 222 (484)
++....++|.+.+.||+|+||.||+|.+++ .||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334446788999999999999999999863 49999886442 22234577799999999999999999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+||+++ ++.+||+|||++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred EEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999999997542 4688999999999999999999999 999999999999998 6799999999987
Q ss_pred cccCCC----ceeeccccccccccccccccc---------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhh
Q 011498 303 LLCSER----SYVTTRVMGTFGYVAPEYACT---------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDW 369 (484)
Q Consensus 303 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~ 369 (484)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~ 251 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------I 251 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------H
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H
Confidence 543211 112233458999999998864 457899999999999999999999997543211 1
Q ss_pred hhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 370 LKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
..... ... .+.... ......+.+++.+||..||++|||+.+|++.|+...
T Consensus 252 ~~~~~-~~~-----~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 252 IWQMG-TGM-----KPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHH-TTC-----CCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHHhc-cCC-----CCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111 111 111111 112235888999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=321.78 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=191.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee----------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE---------- 218 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------- 218 (484)
.++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356888999999999999999974 6899999988543 3345678899999999999999999998865
Q ss_pred ---CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 219 ---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 219 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 356799999999999999997542 4578899999999999999999999 9999999999999999999999
Q ss_pred eeecccccccCCC-------------ceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCC
Q 011498 296 SDFGLAKLLCSER-------------SYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQ 361 (484)
Q Consensus 296 ~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~ 361 (484)
+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999997653221 1112345689999999999764 68999999999999999998 443111
Q ss_pred CccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 362 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............ ....+..........+.+++.+||+.||.+|||+.++++
T Consensus 233 ---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ---ERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hHHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111110 111222222334456888999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.47 Aligned_cols=252 Identities=20% Similarity=0.234 Sum_probs=172.5
Q ss_pred hcCCCcC-ceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee----CCeee
Q 011498 150 TSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRM 223 (484)
Q Consensus 150 ~~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~ 223 (484)
.++|.+. +.||+|+||.||+|... +++.||||++..... ........++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3567774 46999999999999976 589999999865321 12222334566799999999999876 44589
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeecc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGL 300 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfgl 300 (484)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999997542 24699999999999999999999999 9999999999999976 45599999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
+....... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||............ .....
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~----- 246 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIR----- 246 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhh-----
Confidence 98654322 23456899999999998889999999999999999999999999755432111000 00000
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+..........+.+++.+||+.||.+|||+.|+++
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 247 -LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00001111111234456888999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.16 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=201.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4567999999999999999999975 58899999986543 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC---CcEEEeeecccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAK 302 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfgla~ 302 (484)
|||+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998654 3589999999999999999999998 99999999999999764 469999999998
Q ss_pred cccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 303 LLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
....... .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||...... ... ........ .
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~~-~-- 240 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL---KRVETGKY-A-- 240 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCC-C--
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCCC-C--
Confidence 6543322 223458899999998865 4899999999999999999999999754321 111 11111100 0
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............+.+++.+||..||++|||+.++++
T Consensus 241 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000001123456888999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=330.55 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=195.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCee----
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR---- 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~---- 222 (484)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999965 58899999986542 23356788999999999999999999999876654
Q ss_pred --eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 223 --MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 223 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 58988874 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ...+........
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~- 262 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPG- 262 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC-
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCc-
Confidence 9865322 234568999999999887 6899999999999999999999999975432111 111100000000
Q ss_pred cccc--------------CCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 EEVV--------------DPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ~~~~--------------~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
.+.. .+....... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 000000000 1124568899999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=327.84 Aligned_cols=260 Identities=20% Similarity=0.337 Sum_probs=192.4
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceee------------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV------------ 217 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~------------ 217 (484)
++|.+.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 578888999999999999999764 8899999987766666678899999999999999999998873
Q ss_pred --eCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-CCCcEE
Q 011498 218 --EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNAR 294 (484)
Q Consensus 218 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-~~~~~k 294 (484)
.....++||||+. |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 599999963 3589999999999999999999998 999999999999997 567999
Q ss_pred EeeecccccccCCCc--eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhh
Q 011498 295 VSDFGLAKLLCSERS--YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 295 l~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 371 (484)
|+|||++........ .......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||........ ...+.
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 999999986543211 11233457899999998865 6799999999999999999999999975542111 11000
Q ss_pred hhhcCCC----------c-----ccccCCCCCC-CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 372 TMVGSRK----------S-----EEVVDPKLPK-MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 372 ~~~~~~~----------~-----~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
....... . .....+..+. .........+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 0 0000000000 000113456889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=329.15 Aligned_cols=202 Identities=21% Similarity=0.290 Sum_probs=170.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-CC-----ceeeecceeeeCCe
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HK-----NLVRLLGYCVEGAY 221 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~ 221 (484)
..++|.+.+.||+|+||+||+|... +++.||||++.... .....+..|+.+++.++ |+ +|+++++++.....
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999975 57889999886432 33456777888888874 55 49999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc--CCCcEEEeeec
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFG 299 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg 299 (484)
.++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCCC-CHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999965 9999997652 24589999999999999999999952 23999999999999994 47789999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCC
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSR 359 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~ 359 (484)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876432 234578999999999999999999999999999999999999998654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.41 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=187.3
Q ss_pred CCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEecCC
Q 011498 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
|...+.||+|+||+||.+...+|+.||||++.... .+.+..|+.++..+ +||||+++++++.+....++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 44567899999999987766679999999886532 34577899999876 89999999999999999999999996
Q ss_pred CCHHHHhhcCCCCCCC---CCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC-------------CcEEE
Q 011498 232 GNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-------------WNARV 295 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~-------------~~~kl 295 (484)
|+|.+++......... ..+..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 5999999764322111 13334678999999999999998 99999999999999754 48999
Q ss_pred eeecccccccCCCce---eeccccccccccccccccc-------CCCCcccceecchhHHHHHHh-CCCCCCCCCCCCcc
Q 011498 296 SDFGLAKLLCSERSY---VTTRVMGTFGYVAPEYACT-------GMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEV 364 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~ 364 (484)
+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 999999876543221 1234579999999999865 678999999999999999999 999996443211
Q ss_pred chhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 365 NLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...... .. ..+.............+.+++.+||+.||.+|||+.+|++
T Consensus 248 --~~i~~~---~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRG---IF-----SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHT---CC-----CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcC---CC-----CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111 00 0111222234556778999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=328.21 Aligned_cols=261 Identities=22% Similarity=0.328 Sum_probs=197.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Cee
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~ 222 (484)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 367888999999999999999975 58899999986443 33456788899999999999999999988754 678
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
++||||+. |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599999875 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCce---------eeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhh
Q 011498 303 LLCSERSY---------VTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 303 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 372 (484)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..||........ ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence 75432111 1123468999999998764 7799999999999999999999999975532111 000111
Q ss_pred hhcCCCccc------------cc--CCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 373 MVGSRKSEE------------VV--DPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 373 ~~~~~~~~~------------~~--~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+...... .. .+..+.... ......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111000000 00 000000000 123456889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=328.91 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=194.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCe------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY------ 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------ 221 (484)
++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999975 58899999986542 2334678899999999999999999999987654
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58888874 2489999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC---
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR--- 377 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 377 (484)
...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|..||........ ...+....+..
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 764322 233568999999999876 6789999999999999999999999976542111 11110000000
Q ss_pred ---------------CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 ---------------KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ---------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......+.+. .........+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000111 011223457889999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.65 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=178.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHH-HHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVE-VIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|...+.||+|+||.||+|... +|+.||||++..... .....+..|+. +++.++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888899999999999999975 588999999876532 33345555655 7777899999999999999999999999
Q ss_pred ecCCCCHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 228 YVDNGNLDQWLHGDV-GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|+.+ +|.+++.... .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9986 8888775311 1235689999999999999999999974 2899999999999999999999999999976543
Q ss_pred CCceeeccccccccccccccc----ccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 307 ERSYVTTRVMGTFGYVAPEYA----CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
... .....||+.|+|||++ .+..++.++|||||||++|||++|..||........ .+.... ..
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~------~~ 245 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV------KG 245 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC------CS
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh------cC
Confidence 221 2334689999999998 466789999999999999999999999975432110 000000 00
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+.+...........+.+++.+||+.||++|||+.+|++
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0111111111223456889999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.94 Aligned_cols=262 Identities=19% Similarity=0.239 Sum_probs=197.1
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhccC-----------CCceeeecceeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----------HKNLVRLLGYCVE 218 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~ 218 (484)
++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+..|+.+++.++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788899999999999999996 458899999886433 34466788999988876 8999999999986
Q ss_pred CC----eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc------
Q 011498 219 GA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD------ 288 (484)
Q Consensus 219 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~------ 288 (484)
.. ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 54 789999999 889999997642 245899999999999999999999842 899999999999994
Q ss_pred CCCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh
Q 011498 289 RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~ 368 (484)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||..||.............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999865432 233468999999999999999999999999999999999999997654221111111
Q ss_pred ---hhhhhhcC------------------C-CcccccCCC---------CCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 369 ---WLKTMVGS------------------R-KSEEVVDPK---------LPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 369 ---~~~~~~~~------------------~-~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
.+....+. . ....+.... ............+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111100 0 000000000 0012335667889999999999999999999
Q ss_pred HHHHH
Q 011498 418 GHVIH 422 (484)
Q Consensus 418 ~evl~ 422 (484)
+||++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.90 Aligned_cols=258 Identities=20% Similarity=0.292 Sum_probs=198.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CC-CEEEEEEecccchhhHHHHHHHHHHHhccCCCc------eeeecceeeeCCee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DG-TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN------LVRLLGYCVEGAYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~ 222 (484)
++|.+.+.||+|+||.||+|... ++ ..||+|++... ......+..|+.+++.++|++ ++.+++++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 67888999999999999999974 34 68999988643 334567788999999987655 89999999999999
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE---------------
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL--------------- 287 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll--------------- 287 (484)
++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 668888776542 24689999999999999999999998 99999999999999
Q ss_pred ----cCCCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCc
Q 011498 288 ----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGE 363 (484)
Q Consensus 288 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~ 363 (484)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 66789999999999764332 2345789999999999999999999999999999999999999975442211
Q ss_pred cchhhhhhhhhcCCC---------cccccCCC---------------------CCCCChHHHHHHHHHHHHhcCCCCCCC
Q 011498 364 VNLVDWLKTMVGSRK---------SEEVVDPK---------------------LPKMPASKALKRVLLVALRCVDPDATK 413 (484)
Q Consensus 364 ~~~~~~~~~~~~~~~---------~~~~~~~~---------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~ 413 (484)
...+........ ........ ............+.+|+.+||+.||++
T Consensus 248 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 248 ---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp ---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 111111110000 00000000 000112234567889999999999999
Q ss_pred CCCHHHHHH
Q 011498 414 RPKMGHVIH 422 (484)
Q Consensus 414 RPs~~evl~ 422 (484)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.04 Aligned_cols=244 Identities=27% Similarity=0.430 Sum_probs=189.7
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh------hHHHHHHHHHHHhcc----CCCceeeecc
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ------AEKEFKVEVEVIGRV----RHKNLVRLLG 214 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l----~H~niv~l~~ 214 (484)
.....++|.+.+.||+|+||.||+|... +++.||||++...... ....+..|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999864 5889999998654321 223455688888888 8999999999
Q ss_pred eeeeCCeeeEEEEe-cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-CCCc
Q 011498 215 YCVEGAYRMLVYEY-VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWN 292 (484)
Q Consensus 215 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-~~~~ 292 (484)
++......++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 7899999999764 4589999999999999999999999 999999999999999 8899
Q ss_pred EEEeeecccccccCCCceeecccccccccccccccccCCCC-cccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN-EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 371 (484)
+||+|||++....... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.... ....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~ 247 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EILE 247 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHhh
Confidence 9999999998764332 2345689999999998877664 58999999999999999999996321 0000
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. ..++ ......+.+++.+||+.||++|||+.|+++
T Consensus 248 ----~~-------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 ----AE-------LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----TC-------CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----hc-------cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0111 112346888999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=327.94 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=198.6
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchh------hHHHHHHHHHHHhccC--CCceeeecc
Q 011498 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ------AEKEFKVEVEVIGRVR--HKNLVRLLG 214 (484)
Q Consensus 144 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~--H~niv~l~~ 214 (484)
.+.....++|.+.+.||+|+||.||+|... +++.||||.+...... ....+..|+.+++.++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 334445678999999999999999999864 5889999998654321 2245667899999996 599999999
Q ss_pred eeeeCCeeeEEEEecCC-CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-CCCc
Q 011498 215 YCVEGAYRMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWN 292 (484)
Q Consensus 215 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-~~~~ 292 (484)
++......++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999986 8999999754 4689999999999999999999998 999999999999999 7889
Q ss_pred EEEeeecccccccCCCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhh
Q 011498 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 293 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 371 (484)
+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||.... ....
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~ 257 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIR 257 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhhc
Confidence 9999999998764322 233568999999999887665 688999999999999999999996321 0000
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHML 424 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L 424 (484)
.. ...+. .....+.+++.+||+.||++|||+++|++.-
T Consensus 258 ----~~-------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 258 ----GQ-------VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp ----CC-------CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ----cc-------ccccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00 00111 1234688899999999999999999998743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=315.86 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=179.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hh-HHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QA-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
.++|.+.+.||+|+||.||+|... +|+.||||++..... .. .+.+..+..+++.++||||+++++++......++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888899999999999999975 589999999865432 22 234444556788889999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
||+ ++.+..++... ...+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 55666655432 2468999999999999999999997 5 89999999999999999999999999997654
Q ss_pred CCCceeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 306 SERSYVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
.... .....+|+.|+|||++. ...++.++|||||||++|||++|..||...... ...+........
T Consensus 177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~-- 247 (318)
T 2dyl_A 177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP-- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC--
T ss_pred CCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC--
Confidence 3222 23356899999999984 557889999999999999999999999753321 111111111110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.++. .......+.+++.+||+.||.+|||+.+|++
T Consensus 248 ----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11111 0112346888999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.11 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=185.0
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.+|...+.||+|+||+||.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45777889999999996655555789999999865432 2345689999998 8999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-----CCcEEEeeecccccc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKLL 304 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfgla~~~ 304 (484)
. |+|.+++..... .+.+..++.++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++..
T Consensus 101 ~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 599999976532 234445678999999999999998 9999999999999953 335889999999876
Q ss_pred cCCCc--eeecccccccccccccccc---cCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 305 CSERS--YVTTRVMGTFGYVAPEYAC---TGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 305 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
..... .......||+.|+|||++. ...++.++|||||||++|||+| |..||....... .........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence 43321 1234467999999999997 4567889999999999999999 999996432210 011111100
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. ... .........+.+|+.+||+.||.+|||+.+|++
T Consensus 247 ~-----~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 L-----DCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-----TTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-----ccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 011 112234456788999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=311.94 Aligned_cols=228 Identities=12% Similarity=0.080 Sum_probs=182.0
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||.||+|.... ++.||||.+..... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 568888999999999999999764 88999999875532 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++++|.++++.. .....+..++.|++.||+|||++ +|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999532 35557888999999999999999 99999999999999999999997443
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
|++| ++.++|||||||+||||+||+.||............. . .....
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--~----------~~~~~ 221 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--R----------DTAGQ 221 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--B----------CTTSC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--H----------HhccC
Confidence 3333 6889999999999999999999998655432110000 0 00000
Q ss_pred CCC--CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 387 LPK--MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 387 ~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
... .........+.+++.+||+.||.+| |+.|+++.|+...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000 0001234568899999999999999 9999999998644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.24 Aligned_cols=259 Identities=23% Similarity=0.321 Sum_probs=198.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeee------CCee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE------GAYR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~ 222 (484)
++|.+.+.||+|+||.||+|... +|..||||++... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999864 5889999988654 33445678999999999999999999998765 6678
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCc---EEEeeec
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFG 299 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg 299 (484)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999998643 234588899999999999999999998 9999999999999997664 9999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc----
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG---- 375 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 375 (484)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...|......
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence 998764332 23445799999999999999999999999999999999999999964321 0111000000
Q ss_pred --------CCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 011498 376 --------SRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHV 420 (484)
Q Consensus 376 --------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev 420 (484)
............+..........+.+++.+||..||++|||+.++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000000011222334567789999999999999999999774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.44 Aligned_cols=238 Identities=23% Similarity=0.334 Sum_probs=192.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC--CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCe-----
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----- 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----- 221 (484)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+..|+.+++.++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999975 58899999886543 3445678899999999999999999999987655
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999988753 589999999999999999999998 99999999999999986 8999999999
Q ss_pred ccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE 381 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (484)
...... ....||+.|+|||++.+.. +.++|||||||+||+|++|..||.......
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 875432 3456999999999987654 899999999999999999998876321110
Q ss_pred ccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHhc
Q 011498 382 VVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIHMLEA 426 (484)
Q Consensus 382 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~L~~ 426 (484)
+ ............+.+++.+||+.||.+||+ ++++...|..
T Consensus 284 ~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 011112233467889999999999999996 5555555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=304.91 Aligned_cols=228 Identities=20% Similarity=0.254 Sum_probs=176.4
Q ss_pred cCCCcC-ceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHH-hccCCCceeeecceeee----CCeee
Q 011498 151 SGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVI-GRVRHKNLVRLLGYCVE----GAYRM 223 (484)
Q Consensus 151 ~~~~~~-~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~ 223 (484)
++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 446555 78999999999999974 5889999988542 3466688877 55699999999999987 67789
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeecc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGL 300 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfgl 300 (484)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998652 24689999999999999999999998 9999999999999998 78899999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
+.... +..++.++|||||||++|||+||..||........... ...
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-----------~~~ 212 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----------MKT 212 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----------SCC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----------HHH
Confidence 86432 23467899999999999999999999975432211000 000
Q ss_pred cccCCCCCCC--ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKM--PASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.+........ ........+.+++.+||+.||++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000011000 00123467889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.77 Aligned_cols=242 Identities=17% Similarity=0.163 Sum_probs=179.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCC-Cceeeec------------
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRH-KNLVRLL------------ 213 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H-~niv~l~------------ 213 (484)
..|...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.++| +|...+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34667789999999999999954 589999998874332 235678899999999977 3221111
Q ss_pred ---------ceeee-----CCeeeEEEEecCCCCHHHHhhcC---CCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCcee
Q 011498 214 ---------GYCVE-----GAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276 (484)
Q Consensus 214 ---------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iv 276 (484)
.++.. ....+++|+++ +++|.++++.. ......+++..++.++.||+.||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11111 12346677765 57999988421 12234578889999999999999999998 999
Q ss_pred ecCCCCCcEEEcCCCcEEEeeecccccccCCCceeeccccccccccccccc----------ccCCCCcccceecchhHHH
Q 011498 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA----------CTGMLNEKSDVYSFGILIM 346 (484)
Q Consensus 277 H~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~~l~ 346 (484)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998764322 344567 999999999 5566889999999999999
Q ss_pred HHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 347 EIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 347 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
||+||+.||.......... .++. .... ....+.+|+.+||+.||++||++.++++
T Consensus 309 elltg~~Pf~~~~~~~~~~---------------~~~~-~~~~-----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE---------------WIFR-SCKN-----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG---------------GGGS-SCCC-----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhHH---------------HHHh-hccc-----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999997544221111 1111 0111 1246888999999999999999888865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=311.87 Aligned_cols=240 Identities=15% Similarity=0.133 Sum_probs=181.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccc--------hhhHHHHHHHHHHHhccC---------CCceeee-
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--------GQAEKEFKVEVEVIGRVR---------HKNLVRL- 212 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~e~~~l~~l~---------H~niv~l- 212 (484)
++|.+.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5577889999999999999998 58999999996543 122367888999888886 5555554
Q ss_pred ----------------cceeee-------------CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 011498 213 ----------------LGYCVE-------------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263 (484)
Q Consensus 213 ----------------~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a 263 (484)
++++.+ ....|+||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHH
Confidence 444443 6789999999999987776643 358999999999999999
Q ss_pred HHhhh-cCCCCceeecCCCCCcEEEcCCC--------------------cEEEeeecccccccCCCceeecccccccccc
Q 011498 264 LAYLH-EGLEPKVVHRDVKSSNILLDRQW--------------------NARVSDFGLAKLLCSERSYVTTRVMGTFGYV 322 (484)
Q Consensus 264 l~~LH-~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ 322 (484)
|+||| +. +|+||||||+|||++.++ .+||+|||+++..... ..+||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 88 999999999999999887 8999999999876432 246999999
Q ss_pred cccccccCCCCcccceecchhH-HHHHHhCCCCCCCCCCCCccchhh-hhhhhhcCCCcccccCCCCCCCChHHHHHHHH
Q 011498 323 APEYACTGMLNEKSDVYSFGIL-IMEIITGRNPVDYSRPQGEVNLVD-WLKTMVGSRKSEEVVDPKLPKMPASKALKRVL 400 (484)
Q Consensus 323 aPE~~~~~~~~~~~DvwslG~~-l~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 400 (484)
|||++.+.. +.++|||||+++ .+++++|..||... .... ......... .................+.
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM----TFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC----CCSSCCCSHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh----ccCcccchhhhhhcCHHHH
Confidence 999998766 899999998777 77889999998421 0000 000111000 0011111122345778899
Q ss_pred HHHHhcCCCCCCCCCCHHHHH
Q 011498 401 LVALRCVDPDATKRPKMGHVI 421 (484)
Q Consensus 401 ~l~~~cl~~dp~~RPs~~evl 421 (484)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999977 998887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=281.01 Aligned_cols=184 Identities=17% Similarity=0.101 Sum_probs=129.7
Q ss_pred eccCCceEEEEEE-ECCCCEEEEEEecccc----------hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEEE
Q 011498 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----------GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 159 Lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++.|++|.+..++ ..-|+.|++|.+.... ....++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666655544 2237889999986542 12335799999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||++|++|.++|... .+++.. +|+.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999754 456654 5789999999999999 999999999999999999999999999987644
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p 354 (484)
... .....+||+.|+|||++.+ .+..++|+|++|+++++|.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 322 2445689999999999865 467789999999999888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-28 Score=252.44 Aligned_cols=184 Identities=17% Similarity=0.216 Sum_probs=145.8
Q ss_pred CcCceeccCCceEEEEEEECCCCEEEEEEecccch--------hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 154 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
...+.||+|+||.||+|.. .+..+++|+...... ...+.+.+|++++++++||||+++..++......|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 478899998754321 1134588999999999999999777777777888999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++++|.++++. ++.++.|++.||+|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999964 468999999999999998 9999999999999999 99999999998764
Q ss_pred CCCcee------eccccccccccccccccc--CCCCcccceecchhHHHHHHhCCCCC
Q 011498 306 SERSYV------TTRVMGTFGYVAPEYACT--GMLNEKSDVYSFGILIMEIITGRNPV 355 (484)
Q Consensus 306 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltG~~p~ 355 (484)
...... .....||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 432211 234679999999999976 67888999999988888888776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=207.95 Aligned_cols=153 Identities=14% Similarity=0.080 Sum_probs=122.3
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccch------------------hhHHHHHHHHHHHhcc
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG------------------QAEKEFKVEVEVIGRV 204 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~e~~~l~~l 204 (484)
+..+......|.+.+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+.+++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344444566777799999999999999997799999999864321 1345688999999999
Q ss_pred CCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCc
Q 011498 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (484)
Q Consensus 205 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~N 284 (484)
+ | +++.+++.. ...++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 9 5 777776544 56699999999999998 521 12346999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeecccccccCCCceeecccccccccccccccc
Q 011498 285 ILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328 (484)
Q Consensus 285 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 328 (484)
||++ ++.+||+|||+++. +..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999 99999999999863 33478888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.7e-20 Score=176.36 Aligned_cols=136 Identities=21% Similarity=0.174 Sum_probs=105.5
Q ss_pred CCcCceeccCCceEEEEEEE-CCCCE--EEEEEecccchh------------------------hHHHHHHHHHHHhccC
Q 011498 153 LCEENVIGEGGYGIVYRGIL-SDGTK--VAVKNLLNNRGQ------------------------AEKEFKVEVEVIGRVR 205 (484)
Q Consensus 153 ~~~~~~Lg~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~e~~~l~~l~ 205 (484)
|.+.+.||+|+||.||+|.+ .+|+. ||||++...... ....+..|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 999987543211 1236788999999998
Q ss_pred CCce--eeecceeeeCCeeeEEEEecCC-C----CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhh-cCCCCceee
Q 011498 206 HKNL--VRLLGYCVEGAYRMLVYEYVDN-G----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-EGLEPKVVH 277 (484)
Q Consensus 206 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~~ivH 277 (484)
|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| .. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8764 333332 356899999942 4 67776532 123456789999999999999 88 9999
Q ss_pred cCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 278 RDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 278 ~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
|||||.|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=9e-18 Score=165.77 Aligned_cols=142 Identities=13% Similarity=0.030 Sum_probs=98.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccch--------------hhHHHHHHHHHHHhccCCCceeeecce
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--------------QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
..-|.+.+.||+|+||.||+|...+|+.||||+++.... ........+.++.....|+|+.+++..
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 344888999999999999999988899999998753211 011122222223333334444443322
Q ss_pred eee------CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC
Q 011498 216 CVE------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289 (484)
Q Consensus 216 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~ 289 (484)
... ....+|||||+.|++|..+... .....++.|++.+|.|||.. |||||||||.|||+++
T Consensus 174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp TCSCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 111 1123799999999888765421 12356789999999999998 9999999999999987
Q ss_pred CC----------cEEEeeecccccc
Q 011498 290 QW----------NARVSDFGLAKLL 304 (484)
Q Consensus 290 ~~----------~~kl~Dfgla~~~ 304 (484)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=123.63 Aligned_cols=147 Identities=14% Similarity=0.051 Sum_probs=113.2
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeE
Q 011498 146 LEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 146 ~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 224 (484)
+......|.....++.|+.+.||++... +..+++|............+..|+.+++.+. +.++.++++++...+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567888888888899999999864 6889999886432222345788999998884 6778899999998889999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG---------------------------------- 270 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~---------------------------------- 270 (484)
||||++|.+|.+.+.. ......++.+++.+|..||+.
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999876421 112346788899999999981
Q ss_pred ----------------------CCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 271 ----------------------LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 271 ----------------------~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
..+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01368999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.2e-11 Score=114.53 Aligned_cols=129 Identities=19% Similarity=0.117 Sum_probs=95.2
Q ss_pred ccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCc--eeeecceeeeCCeeeEEEEecCCCCHHHH
Q 011498 160 GEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN--LVRLLGYCVEGAYRMLVYEYVDNGNLDQW 237 (484)
Q Consensus 160 g~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 237 (484)
+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998777788999986543 2245677888888885444 556888888777889999999998874
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC----------------------------------------------
Q 011498 238 LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL---------------------------------------------- 271 (484)
Q Consensus 238 l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~---------------------------------------------- 271 (484)
.. ... ...++.+++..|..||...
T Consensus 104 ~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 21 111 1256677777888888641
Q ss_pred ---------CCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 272 ---------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 272 ---------~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.5e-10 Score=112.95 Aligned_cols=142 Identities=14% Similarity=0.196 Sum_probs=105.5
Q ss_pred cCceeccCCceEEEEEEECCCCEEEEEEec--ccch-hhHHHHHHHHHHHhccC--CCceeeecceeeeC---CeeeEEE
Q 011498 155 EENVIGEGGYGIVYRGILSDGTKVAVKNLL--NNRG-QAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEG---AYRMLVY 226 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~--~~~~-~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~ 226 (484)
..+.|+.|.++.||+.... +..+++|+.. .... .....+..|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999876 4678888665 3221 22346778999999886 45678888888776 3479999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC-----------------------------------
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL----------------------------------- 271 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~----------------------------------- 271 (484)
||++|..+.+.. ...++......++.+++..|+.||...
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999997774421 134678888899999999999999720
Q ss_pred --------------------CCceeecCCCCCcEEEcCCCc--EEEeeeccccc
Q 011498 272 --------------------EPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKL 303 (484)
Q Consensus 272 --------------------~~~ivH~dlkp~NIll~~~~~--~kl~Dfgla~~ 303 (484)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.8e-10 Score=109.90 Aligned_cols=183 Identities=18% Similarity=0.166 Sum_probs=117.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCc--eeeecceeeeCC---eeeEEEEec
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKN--LVRLLGYCVEGA---YRMLVYEYV 229 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~n--iv~l~~~~~~~~---~~~lv~e~~ 229 (484)
.+.++.|.+..||+.. ..+++|..... .....+..|..+++.+ .+.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 56888975432 3346788899999887 3332 344444433332 348999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG--------------------------------------- 270 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~--------------------------------------- 270 (484)
+|.+|.+... ..++...+..++.+++..|+.||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988765332 2356666777777777777777751
Q ss_pred ----------------CCCceeecCCCCCcEEEcC--CCcEEEeeecccccccCCCceeeccccccccc---ccccccc-
Q 011498 271 ----------------LEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSERSYVTTRVMGTFGY---VAPEYAC- 328 (484)
Q Consensus 271 ----------------~~~~ivH~dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~- 328 (484)
..+.++|+|++|.||++++ ...+.|+||+.+...... .... ....+ ..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~----~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFI----SLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHH----TTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHH----HHHhhccccCHHHHHH
Confidence 1246899999999999998 556789999988653211 0000 00001 1222110
Q ss_pred ----cCCC---------CcccceecchhHHHHHHhCCCCC
Q 011498 329 ----TGML---------NEKSDVYSFGILIMEIITGRNPV 355 (484)
Q Consensus 329 ----~~~~---------~~~~DvwslG~~l~elltG~~p~ 355 (484)
.+.. ..-.+.|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0111 11258899999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=8.7e-07 Score=85.35 Aligned_cols=135 Identities=18% Similarity=0.161 Sum_probs=89.8
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC---ceeeecceee-eCCeeeEEEEecCCC
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK---NLVRLLGYCV-EGAYRMLVYEYVDNG 232 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~~g 232 (484)
+.++.|....||+. |..+++|+-. .......+..|..+|..+.+. .+.+++.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46888888999997 5668888642 223456788899999998642 3556666664 345678999999998
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC------------------------------------------
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG------------------------------------------ 270 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~------------------------------------------ 270 (484)
.|.+..- ..++......++.+++..|..||+.
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 7765211 1123333334444444444444321
Q ss_pred ---------------CCCceeecCCCCCcEEEcC---CCc-EEEeeeccccc
Q 011498 271 ---------------LEPKVVHRDVKSSNILLDR---QWN-ARVSDFGLAKL 303 (484)
Q Consensus 271 ---------------~~~~ivH~dlkp~NIll~~---~~~-~kl~Dfgla~~ 303 (484)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1336799999999999987 455 48999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.1e-06 Score=82.90 Aligned_cols=135 Identities=18% Similarity=0.108 Sum_probs=92.6
Q ss_pred eeccCCce-EEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 158 VIGEGGYG-IVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 158 ~Lg~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
.+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455554 68988754 4567889965332 3456778888888774 33467888899988999999999999887
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC--------------------------------------------
Q 011498 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG-------------------------------------------- 270 (484)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-------------------------------------------- 270 (484)
.+..... ......+..+++..|.-||..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7654321 111223444555555555532
Q ss_pred -----------CCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 271 -----------LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 271 -----------~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012479999999999999887777999987753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=1.4e-06 Score=85.75 Aligned_cols=79 Identities=13% Similarity=0.014 Sum_probs=53.4
Q ss_pred cee-ccCCceEEEEEEEC-------CCCEEEEEEecccc---hhhHHHHHHHHHHHhccC-C--CceeeecceeeeC---
Q 011498 157 NVI-GEGGYGIVYRGILS-------DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR-H--KNLVRLLGYCVEG--- 219 (484)
Q Consensus 157 ~~L-g~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~--- 219 (484)
+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 88889999998764 25678998654322 001235667888887773 2 3567778777654
Q ss_pred CeeeEEEEecCCCCHH
Q 011498 220 AYRMLVYEYVDNGNLD 235 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~ 235 (484)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.1e-05 Score=75.29 Aligned_cols=141 Identities=18% Similarity=0.266 Sum_probs=78.2
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC--CCceeeecc------eeeeCCeeeEEEEe
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--HKNLVRLLG------YCVEGAYRMLVYEY 228 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~------~~~~~~~~~lv~e~ 228 (484)
+.|+.|..+.||+....+| .+++|+..... ..+..|..++..+. .-.+++++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999988654 58999886522 22333444444442 112333332 22345678999999
Q ss_pred cCCCCHH--------------HHhhcCCCCC----------CCCCHHHHH------------------------------
Q 011498 229 VDNGNLD--------------QWLHGDVGDV----------SPLTWDIRM------------------------------ 254 (484)
Q Consensus 229 ~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~~------------------------------ 254 (484)
++|..+. ..+|...... ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1122110000 011232110
Q ss_pred -HHHHHHHHHHHhhhc----------CCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 255 -NIILGTAKGLAYLHE----------GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 255 -~i~~~ia~al~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666653 013489999999999999888889999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.4e-05 Score=78.09 Aligned_cols=75 Identities=13% Similarity=0.146 Sum_probs=48.3
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccch-------hhHHHHHHHHHHHhccCC--Cc-eeeecceeeeCCeeeE
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-------QAEKEFKVEVEVIGRVRH--KN-LVRLLGYCVEGAYRML 224 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~H--~n-iv~l~~~~~~~~~~~l 224 (484)
.+.||.|.++.||++... ++..++||....... .....+..|.++++.+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999754 467899997643211 122345678888887732 33 4455543 3455689
Q ss_pred EEEecCCC
Q 011498 225 VYEYVDNG 232 (484)
Q Consensus 225 v~e~~~~g 232 (484)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.88 E-value=7.7e-05 Score=71.69 Aligned_cols=139 Identities=14% Similarity=0.091 Sum_probs=90.8
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC---CCceeeecceeeeCCeeeEEEEecCCC
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~g 232 (484)
.+.|+.|....+|+.... +..+++|..... ....+..|...|+.+. ...+++++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 457899999999999864 678899976432 2456788888888873 356888888888778899999999987
Q ss_pred CHH--------H---HhhcCCC--CC----------------CCCCHHHHH---HHH----------------HHHHHH-
Q 011498 233 NLD--------Q---WLHGDVG--DV----------------SPLTWDIRM---NII----------------LGTAKG- 263 (484)
Q Consensus 233 sL~--------~---~l~~~~~--~~----------------~~l~~~~~~---~i~----------------~~ia~a- 263 (484)
.+. . .|+.... .. ..-+|.... ++. ..++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 1 1232211 00 012343321 111 111111
Q ss_pred HHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 264 LAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 264 l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2256899999999999999887 8888973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00017 Score=68.38 Aligned_cols=78 Identities=23% Similarity=0.307 Sum_probs=55.7
Q ss_pred CCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC---ceeeecceeeeCCeeeEEEEe
Q 011498 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK---NLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~~~~~lv~e~ 228 (484)
.....+.+|.|..+.||+.+..+|+.|++|+-..........|..|...|+.+.-. -+++++++ + ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 34445678999999999999999999999976544444345678898888887421 23444443 2 24789999
Q ss_pred cCCCC
Q 011498 229 VDNGN 233 (484)
Q Consensus 229 ~~~gs 233 (484)
+.++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00027 Score=71.01 Aligned_cols=76 Identities=9% Similarity=0.025 Sum_probs=45.4
Q ss_pred CceeecCCCCCcEEEcCCCcEEEeeecccccccCCCceeecccc--cccccccccccccC---CCCcccceecchhHHHH
Q 011498 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM--GTFGYVAPEYACTG---MLNEKSDVYSFGILIME 347 (484)
Q Consensus 273 ~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~e 347 (484)
..++|+|+++.|||++.++ ++|+||+.+....... . ..... -...|.+|+..... ......++......+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 9999999886532110 0 00000 11245666544311 11123445567777777
Q ss_pred HHhC
Q 011498 348 IITG 351 (484)
Q Consensus 348 lltG 351 (484)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7665
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00033 Score=66.90 Aligned_cols=71 Identities=11% Similarity=0.083 Sum_probs=42.3
Q ss_pred CceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCce-eeecceeeeCCeeeEEEEec-CCCC
Q 011498 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYV-DNGN 233 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 233 (484)
.+.|+.|....+|+. ..+++|+....... ..+...|+.+++.+...++ .+++++ +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 467888999999998 45888876543211 1123447766666632222 455544 333457899999 5543
Q ss_pred H
Q 011498 234 L 234 (484)
Q Consensus 234 L 234 (484)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0033 Score=60.29 Aligned_cols=159 Identities=14% Similarity=0.093 Sum_probs=85.0
Q ss_pred ccHHHHHHHhcCCCcC-----ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCc--eeeec
Q 011498 141 YTLRELEAATSGLCEE-----NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN--LVRLL 213 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~-----~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~ 213 (484)
.+.+++......|... +.|+.|....+|+....+| .+++|...... ....+..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 3455555555556542 3466788899999988655 68899775521 1234445666666653211 33333
Q ss_pred ce------eeeCCeeeEEEEecCCCCHHH--------------HhhcCCCCC-C----CC---CHHHHHHH---------
Q 011498 214 GY------CVEGAYRMLVYEYVDNGNLDQ--------------WLHGDVGDV-S----PL---TWDIRMNI--------- 256 (484)
Q Consensus 214 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~-~----~l---~~~~~~~i--------- 256 (484)
.. ....+..+++|+|++|..+.. .++...... . .. .|...+.-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123456789999999854311 122110000 0 01 12221100
Q ss_pred ---HHHHHHHHHhhhc----CCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 257 ---ILGTAKGLAYLHE----GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 257 ---~~~ia~al~~LH~----~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
...+...+++++. .....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0113334444442 123479999999999999987666899998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0009 Score=67.32 Aligned_cols=72 Identities=19% Similarity=0.253 Sum_probs=47.3
Q ss_pred CceeccCCceEEEEEEECC--------CCEEEEEEecccchhhHHHHHHHHHHHhccCCCce-eeecceeeeCCeeeEEE
Q 011498 156 ENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~ 226 (484)
.+.|+.|....+|++...+ +..+++|+..... ....+..|..+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999998753 4789999774321 11344568888887743333 566665432 3899
Q ss_pred EecCCCC
Q 011498 227 EYVDNGN 233 (484)
Q Consensus 227 e~~~~gs 233 (484)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0038 Score=59.99 Aligned_cols=143 Identities=13% Similarity=0.120 Sum_probs=79.6
Q ss_pred ceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCC--ceeeecce-----eeeCCeeeEEEEec
Q 011498 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLLGY-----CVEGAYRMLVYEYV 229 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~-----~~~~~~~~lv~e~~ 229 (484)
..|+ |....||+....+|..+++|...... .....+..|..++..+... .+++++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 88889999887667789999875332 1234556677777766321 23444432 22245567899999
Q ss_pred CCCCHH-----HH---------hhcC----CC-CCCCCCHHHH----------------------HHHHHHHHHHHHhhh
Q 011498 230 DNGNLD-----QW---------LHGD----VG-DVSPLTWDIR----------------------MNIILGTAKGLAYLH 268 (484)
Q Consensus 230 ~~gsL~-----~~---------l~~~----~~-~~~~l~~~~~----------------------~~i~~~ia~al~~LH 268 (484)
+|..+. .+ ++.. .. ......+... ...+..++..+.-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874331 11 1110 00 0111222111 111112222222111
Q ss_pred -cCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 269 -EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 269 -~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
......++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11234789999999999999 4 899999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0017 Score=62.75 Aligned_cols=32 Identities=38% Similarity=0.417 Sum_probs=27.5
Q ss_pred CCceeecCCCCCcEEEcCC----CcEEEeeeccccc
Q 011498 272 EPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKL 303 (484)
Q Consensus 272 ~~~ivH~dlkp~NIll~~~----~~~kl~Dfgla~~ 303 (484)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3489999999999999874 6789999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0014 Score=58.55 Aligned_cols=97 Identities=16% Similarity=0.138 Sum_probs=64.6
Q ss_pred CHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhh-cCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 233 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
+|.+.|+... .++++.++|.++.|.+.+|.-+- .+ .-..+=+.|..|+|..+|++.+.+ ..+.
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 7999987653 68999999999999999887662 11 111334457899999999988764 1110
Q ss_pred ecccccccccccccccccCCCCcccceecchhHHHHHHh
Q 011498 312 TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT 350 (484)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 350 (484)
.....+.+||... ...+.+.-|||||++||..+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888763 345678899999999999886
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00092 Score=41.64 Aligned_cols=31 Identities=35% Similarity=0.486 Sum_probs=23.6
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHHhhhc
Q 011498 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSRR 51 (484)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~li~~~~~~~~rr 51 (484)
+++-+.++||++|+++.+++++.+.++..||
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 6789999999999988877666655555554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0013 Score=64.74 Aligned_cols=141 Identities=16% Similarity=0.136 Sum_probs=80.7
Q ss_pred ceeccCCceEEEEEEEC--------CCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEE
Q 011498 157 NVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 227 (484)
+.|..|-...+|++... ++..|++|+.-. .......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45767888899999864 247899997522 2222345667888888773 3223566666543 28999
Q ss_pred ecCCCCHHH--------------H---hhcCC-CCCCCC--CHHHHHHHHHHHHH-------------------HHHhhh
Q 011498 228 YVDNGNLDQ--------------W---LHGDV-GDVSPL--TWDIRMNIILGTAK-------------------GLAYLH 268 (484)
Q Consensus 228 ~~~~gsL~~--------------~---l~~~~-~~~~~l--~~~~~~~i~~~ia~-------------------al~~LH 268 (484)
|++|.+|.. . ||... ...... -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999855421 0 12111 011122 24455555544322 122222
Q ss_pred ----c-CCCCceeecCCCCCcEEEcCC----CcEEEeeecccc
Q 011498 269 ----E-GLEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAK 302 (484)
Q Consensus 269 ----~-~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfgla~ 302 (484)
. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 123478999999999999876 689999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.009 Score=57.91 Aligned_cols=31 Identities=19% Similarity=0.338 Sum_probs=27.3
Q ss_pred CceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 273 ~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999977653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0017 Score=63.70 Aligned_cols=72 Identities=15% Similarity=0.069 Sum_probs=42.0
Q ss_pred ceeccCCceEEEEEEECC---------CCEEEEEEecccchhhHHHHHHHHHHHhccCCCc-eeeecceeeeCCeeeEEE
Q 011498 157 NVIGEGGYGIVYRGILSD---------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~ 226 (484)
+.|+.|....+|+....+ +..+++|+........ .+...|..+++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778889999998754 2688888664432211 12355777777764223 34565443 2 37899
Q ss_pred EecCCCC
Q 011498 227 EYVDNGN 233 (484)
Q Consensus 227 e~~~~gs 233 (484)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0049 Score=62.34 Aligned_cols=73 Identities=14% Similarity=0.117 Sum_probs=45.6
Q ss_pred ceeccCCceEEEEEEECC-CCEEEEEEecccchhhHHHHHHHHHHHhccCCCce-eeecceeeeCCeeeEEEEecCCCCH
Q 011498 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
+.|+.|-...+|++...+ +..+++|+........ -+...|..++..+...++ .++++++. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467788889999998864 4788888764322111 112468888888854444 46666653 2 359999987443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0021 Score=41.14 Aligned_cols=30 Identities=17% Similarity=0.287 Sum_probs=15.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhccccc
Q 011498 26 VVIGILLGSLIVLALFLLSLCLTSRRKKHN 55 (484)
Q Consensus 26 ~~i~i~~g~~~~l~li~~~~~~~~rr~~~~ 55 (484)
+..|++.|++++++++++++++++||++++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 344444445555555555556666655443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.002 Score=41.37 Aligned_cols=28 Identities=21% Similarity=0.187 Sum_probs=14.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcccc
Q 011498 27 VIGILLGSLIVLALFLLSLCLTSRRKKH 54 (484)
Q Consensus 27 ~i~i~~g~~~~l~li~~~~~~~~rr~~~ 54 (484)
..|++.|++++++++++++++++||+++
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3444445555555555555566665544
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0043 Score=39.63 Aligned_cols=30 Identities=30% Similarity=0.409 Sum_probs=15.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhhccc
Q 011498 24 LWVVIGILLGSLIVLALFLLSLCLTSRRKK 53 (484)
Q Consensus 24 ~~~~i~i~~g~~~~l~li~~~~~~~~rr~~ 53 (484)
...++++++|+++++++.+++++|.+||+.
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 455677777744444444444445555443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.035 Score=55.40 Aligned_cols=141 Identities=16% Similarity=0.173 Sum_probs=81.4
Q ss_pred ceeccCCceEEEEEEECC--------CCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEE
Q 011498 157 NVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 227 (484)
+.|..|-...+|+....+ +..|++|+.-.... ..-+..+|..+++.+. +.-..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457778889999998753 57899997533221 1122345777777773 322345554332 378999
Q ss_pred ecCCCCHHH--------------H---hhcC-------CC--CCCCCCHHHHHHHHHHH-------------------HH
Q 011498 228 YVDNGNLDQ--------------W---LHGD-------VG--DVSPLTWDIRMNIILGT-------------------AK 262 (484)
Q Consensus 228 ~~~~gsL~~--------------~---l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------a~ 262 (484)
|++|..|.. . ||.. .. ...+..+.++..+..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 0 1110 00 11222344444443322 11
Q ss_pred HHHhhh---------------------cCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 263 GLAYLH---------------------EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 263 al~~LH---------------------~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
.+.+|. ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223322 111346899999999999 7788999999987753
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=94.50 E-value=0.049 Score=32.56 Aligned_cols=30 Identities=27% Similarity=0.485 Sum_probs=24.4
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHHhhh
Q 011498 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSR 50 (484)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~li~~~~~~~~r 50 (484)
+++.+.++||++|.+++.+++++.++++.|
T Consensus 3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 567889999999999998877777776654
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.81 E-value=0.043 Score=34.82 Aligned_cols=26 Identities=23% Similarity=0.409 Sum_probs=12.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhh
Q 011498 24 LWVVIGILLGSLIVLALFLLSLCLTS 49 (484)
Q Consensus 24 ~~~~i~i~~g~~~~l~li~~~~~~~~ 49 (484)
.++++++++|++++++++++++++++
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~r 38 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHR 38 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred EEEEeehhHHHHHHHHHHHHheeEee
Confidence 45555666565554434444444333
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.94 E-value=0.25 Score=33.08 Aligned_cols=24 Identities=29% Similarity=0.767 Sum_probs=16.8
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHH
Q 011498 22 LRLWVVIGILLGSLIVLALFLLSL 45 (484)
Q Consensus 22 ~~~~~~i~i~~g~~~~l~li~~~~ 45 (484)
..+|++++.++|.+++++++++++
T Consensus 10 vp~wiIi~svl~GLllL~li~~~L 33 (54)
T 2knc_A 10 IPIWWVLVGVLGGLLLLTILVLAM 33 (54)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHHHH
Confidence 468998888887777766555444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.44 E-value=0.68 Score=45.60 Aligned_cols=30 Identities=27% Similarity=0.412 Sum_probs=24.7
Q ss_pred ceeecCCCCCcEEE------cCCCcEEEeeeccccc
Q 011498 274 KVVHRDVKSSNILL------DRQWNARVSDFGLAKL 303 (484)
Q Consensus 274 ~ivH~dlkp~NIll------~~~~~~kl~Dfgla~~ 303 (484)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 3456799999987753
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.08 E-value=0.29 Score=32.62 Aligned_cols=24 Identities=33% Similarity=0.746 Sum_probs=16.8
Q ss_pred chHHHHHHHHHHHHHHHHHHHHHH
Q 011498 22 LRLWVVIGILLGSLIVLALFLLSL 45 (484)
Q Consensus 22 ~~~~~~i~i~~g~~~~l~li~~~~ 45 (484)
..+|++++.++|.+++++++++++
T Consensus 7 vp~WiIi~svl~GLLLL~Lii~~L 30 (54)
T 2l8s_A 7 VPLWVILLSAFAGLLLLMLLILAL 30 (54)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHH
T ss_pred CchHHHHHHHHHHHHHHHHHHHHH
Confidence 468998888887777766555444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.64 E-value=0.66 Score=41.18 Aligned_cols=116 Identities=9% Similarity=0.069 Sum_probs=77.3
Q ss_pred CCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCc
Q 011498 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (484)
Q Consensus 205 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~N 284 (484)
.||+++.. .+-.+.+.+.+.++.-+++.=+..+ ...+...+++++.+|+....+++.. +|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888866 4555666655555554422112223 3477889999999999888777754 788899999
Q ss_pred EEEcCCCcEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCC
Q 011498 285 ILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVD 356 (484)
Q Consensus 285 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~ 356 (484)
|+++.++.+++.-.|+...+.+.. +++..=.-.+=|++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~~-----------------------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPLP-----------------------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCCC-----------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCCCC-----------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998887654332110 0111112245578888999988875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.56 E-value=1.3 Score=39.43 Aligned_cols=85 Identities=9% Similarity=-0.046 Sum_probs=61.7
Q ss_pred CCCceeeecceeeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHH-hhhcCCCCceeecCCCCC
Q 011498 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA-YLHEGLEPKVVHRDVKSS 283 (484)
Q Consensus 205 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~-~LH~~~~~~ivH~dlkp~ 283 (484)
.||++ -..+-.+.+.+.+.++.-+++.=+..++ .++...+++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 67877 3334456666667676654443333442 3778899999999988877 6664 477789999
Q ss_pred cEEEcCCCcEEEeeeccccc
Q 011498 284 NILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 284 NIll~~~~~~kl~Dfgla~~ 303 (484)
||++|.++.++|.-.|+-..
T Consensus 114 NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp GEEECTTCCEEESCCEETTT
T ss_pred eEEEeCCCcEEEEEcCCccc
Confidence 99999999999988886543
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=88.58 E-value=0.23 Score=29.92 Aligned_cols=25 Identities=32% Similarity=0.539 Sum_probs=10.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhc
Q 011498 27 VIGILLGSLIVLALFLLSLCLTSRR 51 (484)
Q Consensus 27 ~i~i~~g~~~~l~li~~~~~~~~rr 51 (484)
++..++|.++++++.+.+.++.+||
T Consensus 10 IaagVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 10 IIATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred eHHHHHHHHHHHHHHHHhheEEeec
Confidence 4444445333333333444444544
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=86.21 E-value=1.5 Score=27.65 Aligned_cols=26 Identities=27% Similarity=0.701 Sum_probs=18.1
Q ss_pred CchHHHHHHHHHHHHHHHHHHHHHHH
Q 011498 21 GLRLWVVIGILLGSLIVLALFLLSLC 46 (484)
Q Consensus 21 ~~~~~~~i~i~~g~~~~l~li~~~~~ 46 (484)
+..+|++++.++|.++++++++++++
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 34689988888877777666555543
|
| >1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A* | Back alignment and structure |
|---|
Probab=83.02 E-value=0.24 Score=54.24 Aligned_cols=34 Identities=38% Similarity=0.519 Sum_probs=0.0
Q ss_pred ccCchHHHHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 011498 19 IFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRK 52 (484)
Q Consensus 19 ~~~~~~~~~i~i~~g~~~~l~li~~~~~~~~rr~ 52 (484)
..|++.|++++|++++++++++++++++++|||+
T Consensus 699 ~~~l~~~aii~il~~~~~ll~~~ll~~~~~~~~~ 732 (880)
T 1q55_A 699 VGGFDLPIILVILGSVLALLILFLLLLLFLKRKK 732 (880)
T ss_dssp ----------------------------------
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 3478899999998888887777666666655543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.47 E-value=0.18 Score=50.87 Aligned_cols=61 Identities=8% Similarity=0.017 Sum_probs=18.2
Q ss_pred cCceeccCCceEEEEEEECC-CCEEEE------EEecccch--hhHHHHHHHHHHHhccCCCceeeecceeee
Q 011498 155 EENVIGEGGYGIVYRGILSD-GTKVAV------KNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (484)
Q Consensus 155 ~~~~Lg~G~~g~Vy~~~~~~-~~~vav------K~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 218 (484)
..+.|| ||.||+|.+.. ..+||+ |....... .....+..|..+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999864 367888 76644221 223467788888999999999999887653
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.75 E-value=1.3 Score=32.47 Aligned_cols=22 Identities=23% Similarity=0.465 Sum_probs=10.2
Q ss_pred hHHHHHHHHHHHHHHHHHHHHH
Q 011498 23 RLWVVIGILLGSLIVLALFLLS 44 (484)
Q Consensus 23 ~~~~~i~i~~g~~~~l~li~~~ 44 (484)
+++.+++.++|+++++++++++
T Consensus 9 n~~~Iv~gvi~gilliGlllll 30 (79)
T 2knc_B 9 DILVVLLSVMGAILLIGLAALL 30 (79)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHHHHHH
Confidence 4555554444444444443333
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.20 E-value=0.79 Score=33.59 Aligned_cols=10 Identities=50% Similarity=0.308 Sum_probs=4.3
Q ss_pred HHHHHHHHHH
Q 011498 24 LWVVIGILLG 33 (484)
Q Consensus 24 ~~~~i~i~~g 33 (484)
++++.|+++.
T Consensus 15 ~gvi~gilli 24 (79)
T 2knc_B 15 LSVMGAILLI 24 (79)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 3444444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 484 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 3e-71
Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 26/276 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+V ++ + +L LH ++I TA+G+ YLH +
Sbjct: 73 STAP-QLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACT---GM 331
+HRD+KS+NI L ++ DFGLA + S+ ++ G+ ++APE
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 332 LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMP 391
+ +SDVY+FGI++ E++TG+ P +N D + MVG + P L K+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVG----RGYLSPDLSKVR 235
Query: 392 A--SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ KA+KR++ C+ +RP ++ +E
Sbjct: 236 SNCPKAMKRLM---AECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 2e-68
Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 26/271 (9%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G V+ G + TKVAVK L + F E ++ +++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ ++ EY++NG+L +L G LT + +++ A+G+A++ E +
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD++++NIL+ + +++DFGLA+L+ + APE G KS
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEV--NLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
DV+SFGIL+ EI+T EV NL + + EE+
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ---------- 241
Query: 395 ALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ C RP ++ +LE
Sbjct: 242 -------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 4e-66
Identities = 70/293 (23%), Positives = 129/293 (44%), Gaps = 30/293 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+ IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 216 CVEG----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ LV +Y ++G+L +L+ +T + + + L TA GLA+LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 272 -----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGYVA 323
+P + HRD+KS NIL+ + ++D GLA S + +GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 324 PEYACTGM------LNEKSDVYSFGILIMEIITGRNP----VDYSRPQGEVNLVDWLKTM 373
PE + +++D+Y+ G++ EI + DY P ++ D
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 374 VGSRKSEEVVDPKLPKMPASK-ALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ E+ + P +P S AL+ + + C + R + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-65
Identities = 69/269 (25%), Positives = 125/269 (46%), Gaps = 22/269 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+E A LV+E++++G L +L + + + L +G+AYL E V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L+ +VSDFG+ + + ++ +T + +PE + KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
DV+SFG+L+ E+ + +R E +V+ + + P+L AS +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI------STGFRLYKPRL----ASTHV 231
Query: 397 KRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+++ C RP ++ L
Sbjct: 232 YQIM---NHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-65
Identities = 58/269 (21%), Positives = 108/269 (40%), Gaps = 22/269 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ ++ EY+ NG L +L + + + + YL + +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKS 336
HRD+ + N L++ Q +VSDFGL++ + + + + PE + KS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 337 DVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKAL 396
D+++FG+L+ EI + E +E + P A
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSET--------------AEHIAQGLRLYRP-HLAS 227
Query: 397 KRVLLVALRCVDPDATKRPKMGHVIHMLE 425
++V + C A +RP ++ +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (521), Expect = 6e-63
Identities = 79/304 (25%), Positives = 132/304 (43%), Gaps = 41/304 (13%)
Query: 141 YTLRELEAATSGLCEE---------NVIGEGGYGIVYRGILSDGTK----VAVKNL-LNN 186
+T + A +E VIG G +G V G L K VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
+ ++F E ++G+ H N++ L G + M++ E+++NG+LD +L + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
T + ++ G A G+ YL + VHRD+ + NIL++ +VSDFGL++ L
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 307 ERSYVTTR----VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQ 361
+ S T + APE SDV+S+GI++ E+++ G P Q
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 362 GEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+N ++ D +LP P + + L C D RPK G ++
Sbjct: 241 DVINAIEQ--------------DYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 422 HMLE 425
+ L+
Sbjct: 285 NTLD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-63
Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 22/270 (8%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G+G +G V+ G + T+VA+K L + + F E +V+ ++RH+ LV+L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E +V EY+ G+L +L G+ G L +++ A G+AY+
Sbjct: 81 VSEEPI-YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNY 134
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
VHRD++++NIL+ +V+DFGLA+L+ + APE A G K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 336 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 395
SDV+SFGIL+ E+ T EV + E P ++
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV-----------LDQVERGYRMPCPP-ECPES 242
Query: 396 LKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
L ++ +C + +RP ++ LE
Sbjct: 243 LHDLM---CQCWRKEPEERPTFEYLQAFLE 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-61
Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 11/278 (3%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+ +G G G+V++ G +A K + L + + E++V+ +V G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ E++D G+LDQ L + I + + KGL YL E + K
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHK 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
++HRDVK SNIL++ + ++ DFG++ L +GT Y++PE +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSV 182
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
+SD++S G+ ++E+ GR P+ + + + P P
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 395 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFR 432
+ + + PK+ + LE D + +
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (508), Expect = 3e-61
Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 22/282 (7%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGR 203
+ E + + ++ +G G YG VY G+ VAVK L + + E EF E V+
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
++H NLV+LLG C ++ E++ GNL +L + ++ + + + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVA 323
+ YL + +HRD+ + N L+ +V+DFGL++L+ + + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 324 PEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383
PE + KSDV++FG+L+ EI T +V E++
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELL 229
Query: 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ ++V + C + + RP + E
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-61
Identities = 80/270 (29%), Positives = 113/270 (41%), Gaps = 28/270 (10%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + + F E V+ ++RH NLV+LLG
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 217 VEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
VE +V EY+ G+L +L S L D + L + + YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
VHRD+ + N+L+ A+VSDFGL K S + + APE + K
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTK 180
Query: 336 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 395
SDV+SFGIL+ EI + P + L D + + E+ P A
Sbjct: 181 SDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV------PRVEKGYKMDAPD-GCPPA 228
Query: 396 LKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ V+ C DA RP + LE
Sbjct: 229 VYEVM---KNCWHLDAAMRPSFLQLREQLE 255
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 1e-60
Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 46/311 (14%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNL-LNNRGQAEKEFK 195
L LE + + IGEG +G V++ T VAVK L + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG--------------- 240
E ++ + N+V+LLG C G L++EY+ G+L+++L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 241 -----DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
PL+ ++ I A G+AYL E K VHRD+ + N L+ ++
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 296 SDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNP 354
+DFGL++ + S Y ++ PE +SDV+++G+++ EI +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 355 VDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKR 414
Y EV V D + P + + C R
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADR 286
Query: 415 PKMGHVIHMLE 425
P + +L+
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-60
Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 33/292 (11%)
Query: 144 RELEAATSGLCEENV-IGEGGYGIVYRGIL---SDGTKVAVKNLLNNRGQAE-KEFKVEV 198
++L L ++ +G G +G V +G+ VA+K L +A+ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
+++ ++ + +VRL+G C + MLV E G L ++L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VM 316
+ G+ YL E VHRD+ + N+LL + A++SDFGL+K L ++ SY T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 317 GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS 376
+ APE + +SDV+S+G+ + E ++ P ++ + +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVM------ 222
Query: 377 RKSEEVVDPKLPKMP--ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+ K + P L ++ C RP V + A
Sbjct: 223 ---AFIEQGKRMECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-60
Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 30/280 (10%)
Query: 156 ENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLV 210
VIG G +G VY G L D AVK+L E +F E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 211 RLLGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ ++V Y+ +G+L ++ + T + L AKG+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGYVAPEY 326
K VHRD+ + N +LD ++ +V+DFGLA+ + + + T ++A E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
T KSDV+SFG+L+ E++T P P +VN D ++ + ++ P+
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLL---QGRRLLQPE 257
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
L V L+C P A RP ++ + A
Sbjct: 258 Y----CPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 8e-60
Identities = 73/287 (25%), Positives = 131/287 (45%), Gaps = 29/287 (10%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGT-----KVAVKNLLNNRGQAEK-EFKVEVEV 200
E S + + VIG G +G VY+G+L + VA+K L + ++ +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT 260
+G+ H N++RL G + M++ EY++NG LD++L G + + ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 119
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVMGT 318
A G+ YL VHRD+ + NIL++ +VSDFGL+++L E +Y T+
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
+ APE SDV+SFGI++ E++T + EV
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ ++ + + ++C + +RPK ++ +L+
Sbjct: 223 -MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-59
Identities = 71/298 (23%), Positives = 123/298 (41%), Gaps = 47/298 (15%)
Query: 158 VIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
V+G G +G V +VAVK L +E+E E++++ ++ H+N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG-------------------DVGDVSPLTW 250
V LLG C L++EY G+L +L + D++ LT+
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
+ + AKG+ +L VHRD+ + N+L+ ++ DFGLA+ + S+ +Y
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 311 VT-TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVD 368
V ++APE G+ KSDV+S+GIL+ EI + G NP
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF---- 276
Query: 369 WLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
+++ A + + ++ C D+ KRP ++ L
Sbjct: 277 -----------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-59
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 34/280 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD---GTKVAVKNLLN--NRGQAEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G VAVK L N N + E E V+ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VR++G C ++ MLV E + G L+++L + + + ++ + G+ YL E
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGYVAPEYA 327
VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
+ KSDV+SFG+L+ E + EV + + +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------TAMLEKGER 228
Query: 388 PKMPA--SKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
PA + + ++ C D RP V L
Sbjct: 229 MGCPAGCPREMYDLM---NLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-58
Identities = 61/274 (22%), Positives = 115/274 (41%), Gaps = 28/274 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG G YG + SDG + K + + ++ EV ++ ++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 214 GYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
++ +V EY + G+L + + L + + ++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 272 E--PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT 329
+ V+HRD+K +N+ LD + N ++ DFGLA++L + S+ +GT Y++PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
NEKSD++S G L+ E+ P + ++ + K +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---------------GKIREGKFRR 233
Query: 390 MPA--SKALKRVLLVALRCVDPDATKRPKMGHVI 421
+P S L ++ R ++ RP + ++
Sbjct: 234 IPYRYSDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-58
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 156 ENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHK 207
+G G +G V VAVK L + E+E E++V+ + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG--------------DVGDVSPLTWDIR 253
N+V LLG C G +++ EY G+L +L D L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VT 312
++ AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +Y V
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 313 TRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372
++APE + +SDV+S+GI + E+ + + P
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------- 255
Query: 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
K +++ + A + + C D D KRP ++ ++E
Sbjct: 256 -----KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (485), Expect = 1e-57
Identities = 62/270 (22%), Positives = 101/270 (37%), Gaps = 34/270 (12%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ IG G +G VY + + VA+K + + ++ EV + ++RH N +
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ G + LV EY D PL + G +GLAYLH
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH-- 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACT- 329
++HRDVK+ NILL ++ DFG A ++ +GT ++APE
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAM 186
Query: 330 --GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
G + K DV+S GI +E+ + P+ + + P L
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------YHIAQNESPAL 234
Query: 388 PKMPASKALKRVLLVALRCVDPDATKRPKM 417
S+ + + C+ RP
Sbjct: 235 QSGHWSEYFRNFV---DSCLQKIPQDRPTS 261
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-57
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 38/287 (13%)
Query: 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLN---NRGQAEKEF 194
R + L + E +G+G +G VY +A+K L + E +
Sbjct: 1 RQWALEDFE-------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM 254
+ EVE+ +RH N++RL GY + L+ EY G + + L +S
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA 109
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
I A L+Y H +V+HRD+K N+LL +++DFG + S R T
Sbjct: 110 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 163
Query: 315 VMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
+ GT Y+ PE M +EK D++S G+L E + G+ P + + Q + ++
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 223
Query: 375 GSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVI 421
+E D + R + + ++RP + V+
Sbjct: 224 PDFVTEGARD-----------------LISRLLKHNPSQRPMLREVL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-57
Identities = 63/287 (21%), Positives = 116/287 (40%), Gaps = 37/287 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDG---TKVAVKNL-LNNRGQAEKEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + + A+K + ++F E+EV+ ++ H N++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNIIL 258
LLG C Y L EY +GNL +L S L+ ++
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ T
Sbjct: 135 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLP 189
Query: 319 FGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
++A E + SDV+S+G+L+ EI++ P + +
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY-------- 236
Query: 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
E++ + P V + +C +RP ++ L
Sbjct: 237 -EKLPQGYRLEKP-LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-57
Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRL 212
+ IG G + VY+G+ ++ +VA L + + + FK E E++ ++H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 213 LGYCVEGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+LV E + +G L +L + + + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH 129
Query: 269 EGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
P ++HRD+K NI + + ++ D GLA L R+ V+GT ++APE
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
+E DVY+FG+ ++E+ T P + ++ R+ V P
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----------RRVTSGVKPAS 233
Query: 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422
A +K ++ C+ + +R + +++
Sbjct: 234 FDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 9e-56
Identities = 78/325 (24%), Positives = 140/325 (43%), Gaps = 36/325 (11%)
Query: 157 NVIGEGGYGIVYRGILSD-----GTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ VA+K L +A KE E V+ V + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RLLG C+ L+ + + G L ++ ++ +N + AKG+ YL +
Sbjct: 75 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNYLED- 129
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYVAPEYACT 329
++VHRD+ + N+L+ + +++DFGLAKLL + E+ Y ++A E
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 330 GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389
+ +SDV+S+G+ + E++T + P E+ S + +
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSILEKGERLP 233
Query: 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDERRI----GREPSNSY 445
P V ++ ++C DA RPK +I + RD +R G E +
Sbjct: 234 QP-PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK---MARDPQRYLVIQGDERMHLP 289
Query: 446 GEENRDFARKVGDKQLGEGASDTSE 470
+ +F R + D++ + D E
Sbjct: 290 SPTDSNFYRALMDEEDMDDVVDADE 314
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-55
Identities = 58/267 (21%), Positives = 108/267 (40%), Gaps = 27/267 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G +G VY+ A K + + +++ VE++++ H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ E+ G +D + PLT + T L YLH + K+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML--- 332
+HRD+K+ NIL + +++DFG++ + + GT ++APE
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 333 --NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ K+DV+S GI ++E+ P P + + KSE + +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---------AKSEPPTLAQPSRW 241
Query: 391 PASKALKRVLLVALRCVDPDATKRPKM 417
S K L +C++ + R
Sbjct: 242 --SSNFKDFL---KKCLEKNVDARWTT 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 6e-55
Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 30/278 (10%)
Query: 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNL 209
+G+G +G+V RG VAVK L + ++ +A +F EV + + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+RL G + +M V E G+L L G + A+G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYVAPEYA 327
+ +HRD+ + N+LL + ++ DFGL + L + + F + APE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
T + SD + FG+ + E+ T P +N L + E P+
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKID----KEGERLPRP 237
Query: 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
P + + V ++C RP + L
Sbjct: 238 EDCP-----QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 9e-55
Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 24/262 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G G VY + ++ G +VA++ + + ++ E+ V+ ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ G +V EY+ G+L + + + + + L +LH +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEK 335
+HRD+KS NILL + +++DFG + E+S +T V GT ++APE K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 336 SDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKA 395
D++S GI+ +E+I G P P + L+ + + + P+ S
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----------ATNGTPELQNPE-KLSAI 245
Query: 396 LKRVLLVALRCVDPDATKRPKM 417
+ L RC+D D KR
Sbjct: 246 FRDFL---NRCLDMDVEKRGSA 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-54
Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 34/287 (11%)
Query: 156 ENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
IGEG +G V++GI VA+K N + +E F E + + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L L + + LAYL
Sbjct: 72 KLIGVITEN-PVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES- 126
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ ++APE
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
SDV+ FG+ + EI+ P V D + + + + M
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVI---------GRIENGERLPM 230
Query: 391 P--ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRDER 435
P L ++ +C D ++RP+ + L + +E+
Sbjct: 231 PPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST---ILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-54
Identities = 73/324 (22%), Positives = 131/324 (40%), Gaps = 40/324 (12%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNL-LNNRGQAEKE 193
Y E E A + +G+G +G+VY G+ T+VA+K + + E
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH------GDVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 308 RSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNL 366
Y + + +++PE G+ SDV+SFG+++ EI T +V
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-- 244
Query: 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426
V++ L P + + C + RP +I ++
Sbjct: 245 ------------LRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK- 290
Query: 427 DDLLFRDERRIG-REPSNSYGEEN 449
+E G RE S Y EEN
Sbjct: 291 ------EEMEPGFREVSFYYSEEN 308
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 3e-54
Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 25/268 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + + + K E+ + + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH---GIG 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT YVAPE +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 334 -EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
E DV+S GI++ ++ G P D + K ++ K+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------EYSDWKEKKTYLNPWKKI-- 232
Query: 393 SKALKRVLLVALRCVDPDATKRPKMGHV 420
A +L + + + + R + +
Sbjct: 233 DSAPLALL---HKILVENPSARITIPDI 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 9e-53
Identities = 67/336 (19%), Positives = 122/336 (36%), Gaps = 40/336 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +++YE++ G L + + + ++ D + + KGL ++HE V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 277 HRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
H D+K NI+ + + + DFGL L ++S T GT + APE A +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 204
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
+D++S G+L +++G +P + V KS + S+
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----------KSCDWNMDDSAFSGISE 254
Query: 395 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL----FRDERRIGRE---PSNSYGE 447
K + + + D R L GR+ PS+ Y +
Sbjct: 255 DGKDFI---RKLLLADPNTRMT---------IHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
Query: 448 ENRDFARKVGDKQLGEGASDTSEGDGSRNNHRPTMR 483
K S HRP
Sbjct: 303 IRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEY 338
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 7e-51
Identities = 66/293 (22%), Positives = 120/293 (40%), Gaps = 41/293 (13%)
Query: 156 ENVIGEGGYGIVYRGIL--------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-R 205
+GEG +G V + TKVAVK L ++ + + + E+E++ + +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH------------GDVGDVSPLTWDIR 253
HKN++ LLG C + ++ EY GNL ++L L+
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++ A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y T
Sbjct: 138 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 314 RVM-GTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKT 372
++APE + +SDV+SFG+L+ EI T P E+
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-------- 246
Query: 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ + + P S + ++ C ++RP ++ L+
Sbjct: 247 ------FKLLKEGHRMDKP-SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-50
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 39/292 (13%)
Query: 156 ENVIGEGGYGIVYRGI------LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGR-VRHK 207
+G G +G V + VAVK L +E + E++++ H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 208 NLVRLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRM 254
N+V LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TT 313
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 138 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 314 RVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 373
++APE + +SDV+SFG+L+ EI + P V + +
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRR 249
Query: 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
+ +E + P + + L C + ++RP ++ L
Sbjct: 250 L-----KEGTRMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 2e-50
Identities = 64/336 (19%), Positives = 124/336 (36%), Gaps = 39/336 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V+R + + G K + + K E+ ++ ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +L+ E++ G L + + ++ +N + +GL ++H E +V
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 277 HRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
H D+K NI+ + + + V DFGLA L + + T + APE +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF 207
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
+D+++ G+L +++G +P GE +L + +E + S
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPF-----AGEDDLETLQNVKRCDWEFDEDAFSSV-----SP 257
Query: 395 ALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL----FRD--ERRIGREPSNSYGEE 448
K + + + KR D L + R PS+ Y +
Sbjct: 258 EAKDFI---KNLLQKEPRKRLT---------VHDALEHPWLKGDHSNLTSRIPSSRYNKI 305
Query: 449 NRDFARKVGDKQLGEGASDTSEGDGSRNNHRPTMRR 484
+ K D + A S HRP +
Sbjct: 306 RQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQ 341
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-48
Identities = 57/265 (21%), Positives = 103/265 (38%), Gaps = 29/265 (10%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVR 211
++GEG + V L+ + A+K L E E +V+ R+ H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L + Y NG L +++ + L YLH
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K NILL+ + +++DFG AK+L E + +GT YV+PE
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
+ SD+++ G +I +++ G P + + + K + + P+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKL--------EYDFPE- 231
Query: 391 PASKALKRVLLVALRCVDPDATKRP 415
+ ++ + + DATKR
Sbjct: 232 KFFPKARDLV---EKLLVLDATKRL 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 5e-48
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 31/281 (11%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
++G GG V+ L VAVK L L F+ E + + H +V
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 212 LLGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ G +V EYVD L +H P+T + +I + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGYVAPE 325
H+ ++HRDVK +NI++ +V DFG+A+ + + V T V+GT Y++PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 326 YACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
A ++ +SDVYS G ++ E++TG P P E+ + P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----------VREDPIPP 234
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPK-MGHVIHMLE 425
S L V+ L+ + + R + + L
Sbjct: 235 SARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 3e-47
Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 32/272 (11%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR---HKN 208
+IG GG+G VY +D G A+K L R Q E E ++ V
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + + + ++ G+L L + GL ++H
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
VV+RD+K +NILLD + R+SD GLA ++ +GT GY+APE
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQ 178
Query: 329 TGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
G+ + +D +S G ++ +++ G +P + + + + TM +L
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------AVEL 228
Query: 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGH 419
P S L+ +L + D +R
Sbjct: 229 PD-SFSPELRSLL---EGLLQRDVNRRLGCLG 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 7e-47
Identities = 44/263 (16%), Positives = 102/263 (38%), Gaps = 25/263 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +GIV+R + S K + +G + K E+ ++ RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++++E++ ++ + ++ L ++ + + L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 277 HRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
H D++ NI+ + ++ + +FG A+ L ++ Y APE +++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASK 394
+D++S G L+ +++G NP Q + + + E + S
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----------MNAEYTFDEEAFKEISI 232
Query: 395 ALKRVLLVALRCVDPDATKRPKM 417
+ R + + R
Sbjct: 233 EAMDFV---DRLLVKERKSRMTA 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-45
Identities = 58/265 (21%), Positives = 101/265 (38%), Gaps = 30/265 (11%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRV-RHKNLV 210
++G+G +G V+ A+K L + + + VE V+ H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ V EY++ G+L + GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+V+RD+K NILLD+ + +++DFG+ K + T GT Y+APE
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
N D +SFG+L+ E++ G++P + L ++ +P P+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMD----------NPFYPRW 225
Query: 391 PASKALKRVLLVALRCVDPDATKRP 415
K K +L ++ + KR
Sbjct: 226 -LEKEAKDLL---VKLFVREPEKRL 246
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 5e-45
Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 39/279 (13%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL---------LNNRGQAEKEFKVEVEVIGRVR 205
+ ++G G +V R I + AVK + + + EV+++ +V
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 206 -HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
H N+++L + LV++ + G L +L V L+ I+ + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVI 123
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAP 324
LH+ +VHRD+K NILLD N +++DFG + L V GT Y+AP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAP 178
Query: 325 EYACTGML------NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378
E M ++ D++S G+++ ++ G P + + + ++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------MSG 230
Query: 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
+ + P+ S +K ++ R + KR
Sbjct: 231 NYQFGSPEWDDY--SDTVKDLV---SRFLVVQPQKRYTA 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 2e-44
Identities = 60/267 (22%), Positives = 105/267 (39%), Gaps = 27/267 (10%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
+V+G G + V VA+K + + E + E+ V+ +++H N+V L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G + L+ + V G L + T +I + YLH +
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLH---DL 126
Query: 274 KVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
+VHRD+K N+L D +SDFGL+K+ + V + GT GYVAPE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQK 184
Query: 331 MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKM 390
++ D +S G++ ++ G P + N + ++ + E P +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQIL--KAEYEFDSPYWDDI 236
Query: 391 PASKALKRVLLVALRCVDPDATKRPKM 417
S + K + ++ D KR
Sbjct: 237 --SDSAKDFI---RHLMEKDPEKRFTC 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 3e-44
Identities = 50/289 (17%), Positives = 96/289 (33%), Gaps = 31/289 (10%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G +G +Y G ++ G +VA+K + +E ++ ++ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 215 YC-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+C EG Y ++V E + D + + + + + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 274 KVVHRDVKSSNIL---LDRQWNARVSDFGLAKLLCSERSYV------TTRVMGTFGYVAP 324
+HRDVK N L + + DFGLAK R++ + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 325 EYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384
+ + D+ S G ++M G P + + + + S E +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLLFRD 433
L C +P ++ + +L R
Sbjct: 243 ------GYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFR--NLFHRQ 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (390), Expect = 5e-44
Identities = 53/275 (19%), Positives = 106/275 (38%), Gaps = 21/275 (7%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IGEG YG+VY+ + G A+K L E+ ++ ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+LV+E++D + L + +L G+AY H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
V+HRD+K N+L++R+ +++DFGLA+ T ++ + + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD--------PK 386
D++S G + E++ G ++ + + S+ V +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 387 LPKMPASKALKRVLLVAL----RCVDPDATKRPKM 417
+P LK + + + + D +R
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 58/280 (20%), Positives = 117/280 (41%), Gaps = 23/280 (8%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG 214
+ IGEG YG+V + +VA+K + Q + E++++ R RH+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ Y+ + L+ + L+ D + +GL Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGYVAPEYACTGML 332
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y APE
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 333 -NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTMVGSRKSEE 381
+ D++S G ++ E+++ R ++N + D + ++
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 382 VVDPKLPKMPASKALKRVLLVAL----RCVDPDATKRPKM 417
+ P K+P ++ AL + + + KR ++
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 2e-43
Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 32/263 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G +G V+ +G A+K L + R + + E ++ V H ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G + ++ +Y++ G L L +P+ + L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-------CLALEYLHS 122
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
+++RD+K NILLD+ + +++DFG AK + + GT Y+APE T
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPY 178
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
N+ D +SFGILI E++ G P S + +E P
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI---------LNAELRFPPFF----- 224
Query: 393 SKALKRVLLVALRCVDPDATKRP 415
++ +K +L R + D ++R
Sbjct: 225 NEDVKDLL---SRLITRDLSQRL 244
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 6e-43
Identities = 56/301 (18%), Positives = 109/301 (36%), Gaps = 41/301 (13%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+G G G V + K A+K +L + +A +E ++ + ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRAS---QCPHIVRIVD 72
Query: 215 YC----VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++V E +D G L + T I+ + + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREASEIMKSIGEAIQYLHS- 129
Query: 271 LEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
+ HRDVK N+L + +++DFG AK S S T T YVAPE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 328 CTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387
++ D++S G+++ ++ G P + M + + P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------AISPGMKTRIRMGQYEFPNP 239
Query: 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL----FRDERRIGREPSN 443
S+ +K ++ + + T+R + + ++ + P +
Sbjct: 240 EWSEVSEEVKMLI---RNLLKTEPTQRMT---------ITEFMNHPWIMQSTKVPQTPLH 287
Query: 444 S 444
+
Sbjct: 288 T 288
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-42
Identities = 54/279 (19%), Positives = 104/279 (37%), Gaps = 26/279 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ +GEG + VY+ + VA+K + + + E++++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL + LV+++++ LT +L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTG 330
++HRD+K +N+LLD +++DFGLAK S T +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 331 ML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-------DWLKTMVGSRKSEEV 382
+ D+++ G ++ E++ + ++ + + + V
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 383 VDPKLPKMPASKALKRVLLVAL----RCVDPDATKRPKM 417
P +P L + R
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-42
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 31/292 (10%)
Query: 152 GLCEEN-------VIGEGGYGIVYRG--ILSDGTKVAVKNLLNNRGQAEKEFKVEVEV-- 200
GLC + IGEG YG V++ + + G VA+K + G+ EV
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 60
Query: 201 ---IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQW--LHGDVGDVSPLTWDIRMN 255
+ H N+VRL C + ++DQ + D + + +
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
++ +GL +LH +VVHRD+K NIL+ +++DFGLA++ + + T V
Sbjct: 121 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSV 175
Query: 316 MGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-------- 367
+ T Y APE D++S G + E+ + S ++ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 368 --DWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
DW + + R++ + + + + + L+C+ + KR
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-42
Identities = 59/281 (20%), Positives = 107/281 (38%), Gaps = 29/281 (10%)
Query: 155 EENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L G VA+K +L + ++ E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLR 79
Query: 214 GYCVEGA------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ Y LV +YV H L + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
H + HRD+K N+LLD ++ DFG AK L + + +
Sbjct: 139 HS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELI 194
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWL-------KTMVGSRKS 379
DV+S G ++ E++ G+ ++ + + + +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 380 EEVVDPKLPKMPASKALKRVL---LVAL--RCVDPDATKRP 415
E P++ P +K + +AL R ++ T R
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 8e-42
Identities = 55/276 (19%), Positives = 104/276 (37%), Gaps = 21/276 (7%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+VY+ G VA+K L E+ ++ + H N+V+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+E++ + + + + + +GLA+ H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHS---H 121
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+V+HRD+K N+L++ + +++DFGLA+ T V+ + +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 334 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV--------DWLKTMVGSRKSEEVVDP 385
D++S G + E++T R ++ + + + V S + P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 386 KLPKMPASKALKRVLLVAL----RCVDPDATKRPKM 417
K + SK + + + + D KR
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 60/271 (22%), Positives = 110/271 (40%), Gaps = 33/271 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G G + +V + S G + A K + + RG + ++ + EV ++ ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L+ E V G L +L + LT + + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKLLCSERSYVTTRVMGTFGYVAPEY 326
++ H D+K NI+L + + + DFGLA + + + GT +VAPE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 187
Query: 327 ACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
L ++D++S G++ +++G +P Q + V S + E D
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--------SAVNYEFEDEY 239
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKM 417
S K + R + D KR +
Sbjct: 240 FSNT--SALAKDFI---RRLLVKDPKKRMTI 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 1e-40
Identities = 43/283 (15%), Positives = 90/283 (31%), Gaps = 31/283 (10%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLL 213
IGEG +G+++ G L + +VA+K R + + E + + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ EG + +LV + + D + + +HE
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 274 KVVHRDVKSSNILLDRQWN-----ARVSDFGLAKLLCSERS------YVTTRVMGTFGYV 322
+V+RD+K N L+ R + V DFG+ K + + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 323 APEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382
+ + + D+ + G + M + G P + + + S E+
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425
P + + + + P ++ +
Sbjct: 241 ----CAGFP--EEFYKYM---HYARNLAFDATPDYDYLQGLFS 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 33/278 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRL 212
++G+G +G V + G A+K L A+ E E V+ RH L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
V EY + G L L + T + L YLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS--- 123
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGML 332
VV+RD+K N++LD+ + +++DFGL K S+ + GT Y+APE
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDY 182
Query: 333 NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPA 392
D + G+++ E++ GR P + + ++ + + P+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME-------EIRFPR-TL 228
Query: 393 SKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430
S K +L + D +R G +A +++
Sbjct: 229 SPEAKSLL---AGLLKKDPKQRLGGG----PSDAKEVM 259
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-38
Identities = 58/271 (21%), Positives = 104/271 (38%), Gaps = 43/271 (15%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE------FKVEVEVIGRVR--HKN 208
++G GG+G VY GI +SD VA+K++ +R E +EV ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + + G L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
V+HRD+K NIL+D ++ DFG LL T GT Y PE+
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 328 CTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386
+ V+S GIL+ +++ G P ++ E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------------------EEIIRGQV 221
Query: 387 LPKMPASKALKRVLLVALRCVDPDATKRPKM 417
+ S + ++ C+ + RP
Sbjct: 222 FFRQRVSSECQHLI---RWCLALRPSDRPTF 249
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-38
Identities = 49/280 (17%), Positives = 98/280 (35%), Gaps = 29/280 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG V++ VA+K L ++ E+ ++ ++HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+E+ D + + L +I + + KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
V+HRD+K N+L++R ++++FGLA+ + V+ + + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 334 EKSDVYSFGILIMEIITGRNP----------------VDYSRPQGEVNLVDWLKTMVGSR 377
D++S G + E+ P + + + + + L
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKM 417
+ + +L + + +R
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLL---QNLLKCNPVQRISA 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-37
Identities = 57/291 (19%), Positives = 115/291 (39%), Gaps = 37/291 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G +G V++ G KVA+K +L N + E++++ ++H+N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 214 GYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
C A LV+++ ++ + + T ++ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYV 322
Y+H K++HRD+K++N+L+ R +++DFGLA+ ++ T + T Y
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 323 APEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV---------DWLKT 372
PE D++ G ++ E+ T + + Q ++ L+ +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVAL------RCVDPDATKRPKM 417
+ E++ K K LK + + + D +R
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 7e-37
Identities = 58/263 (22%), Positives = 96/263 (36%), Gaps = 32/263 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLL 213
+G G +G V G A+K L + K+ E ++ V LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EYV G + L + + YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---L 160
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
+++RD+K N+L+D+Q +V+DFG AK + + GT +APE + N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYN 216
Query: 334 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPAS 393
+ D ++ G+LI E+ G P +P + K S S ++ D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD--------- 267
Query: 394 KALKRVLLVALRCVDPDATKRPK 416
+ + D TKR
Sbjct: 268 --------LLRNLLQVDLTKRFG 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 61/306 (19%), Positives = 108/306 (35%), Gaps = 36/306 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V + G KVA+K K E+ ++ +RH+N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
++ G + L D ++ KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNE 334
++HRD+K N+ ++ ++ DFGLA+ SE T V+ + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMRYTQ 198
Query: 335 KSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTMVGSRKSEEVVD 384
D++S G ++ E+ITG+ S ++ + + K+
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 385 PKLPKMPASKALKRVLLVAL----RCVDPDATKRPKMGHVIHMLEADDLL----FRDERR 436
P+L K + L +A+ + + DA +R A + L F
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---------AGEALAHPYFESLHD 309
Query: 437 IGREPS 442
EP
Sbjct: 310 TEDEPQ 315
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-34
Identities = 64/285 (22%), Positives = 113/285 (39%), Gaps = 35/285 (12%)
Query: 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHK- 207
V+G G YG V+ G A+K L + + + + + E +V+ +R
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
LV L L+ +Y++ G L L T + L +L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHL 145
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYA 327
H+ +++RD+K NILLD + ++DFGL+K ++ + GT Y+AP+
Sbjct: 146 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 328 CTGM--LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385
G ++ D +S G+L+ E++TG +P + + KSE
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPF-----TVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADDLL 430
++ S K ++ R + D KR G +AD++
Sbjct: 258 EM-----SALAKDLI---QRLLMKDPKKRLGCGP----RDADEIK 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 1e-32
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLG 214
+G G Y V+ I +++ KV VK L + +K+ K E++++ +R N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 215 YCVEGAYRM--LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ R LV+E+V+N + Q LT + K L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS--- 147
Query: 273 PKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGM 331
++HRDVK N+++D + R+ D+GLA+ + Y + + + PE
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQ 205
Query: 332 L-NEKSDVYSFGILIMEIITGRNP 354
+ + D++S G ++ +I + P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 61/307 (19%), Positives = 111/307 (36%), Gaps = 36/307 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ +G G YG V G +VAVK + K E+ ++ ++H+N++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ +L ++ LT D +I +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLN 333
++HRD+K SN+ ++ ++ DFGLA +T V + N
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 334 EKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV----------DWLKTMVGSRKSEEVV 383
+ D++S G ++ E++TGR + ++ L+ K S ++
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 384 DPKLPKMPASKALKRVLLVAL----RCVDPDATKRPKMGHVIHMLEADDLL----FRDER 435
++PKM + +A+ + + D+ KR A L F
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---------AAQALAHAYFAQYH 308
Query: 436 RIGREPS 442
EP
Sbjct: 309 DPDDEPV 315
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-29
Identities = 60/292 (20%), Positives = 103/292 (35%), Gaps = 46/292 (15%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G GIV VA+K + K E+ ++ V HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 215 YCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
E LV E +D + ++ G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYAC 328
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL 191
Query: 329 TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV---------DWLKTMVGSRKS 379
E D++S G ++ E++ + + N V +++K + + ++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 380 EEVVDPKLPKMPASKALKRVLLVAL----------------RCVDPDATKRP 415
PK + K L A + + D KR
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 1e-27
Identities = 38/234 (16%), Positives = 80/234 (34%), Gaps = 18/234 (7%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G + V+ + + T VA+K ++ + + E++++ RV + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 215 YCVEGAYRMLVYEYVDNGNL------------DQWLHGDVGDVSPLTWDIRMNIILGTAK 262
++L + N + + + I
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVT-TRVMGTFG 320
GL Y+H ++H D+K N+L++ + +A L + T + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 321 YVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMV 374
Y +PE +D++S LI E+ITG + D + ++
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 5e-20
Identities = 33/203 (16%), Positives = 64/203 (31%), Gaps = 29/203 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK----------NLLNNRGQAEKEFKVEVEVIGRVRH 206
++GEG V+ + VK + R + F V R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ L +L G V VY + N L + + + ++ + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--YVTTRVMGTFGYVAP 324
+ +VH D+ N+L+ + + DF + + E + V Y +
Sbjct: 119 FY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 325 EYACTGMLNEKSDVYSFGILIME 347
Y + D+ S I++
Sbjct: 175 TY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 484 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.68 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=412.33 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=198.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|.+.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|+|......++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999888899999986543 345689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999987542 5689999999999999999999998 9999999999999999999999999999876554443
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......||+.|+|||++.+..++.++|||||||+||||+| |.+||...... .+...+.. . ..+..+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~----~-----~~~~~p- 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST----G-----FRLYKP- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH----T-----CCCCCC-
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh----c-----CCCCCc-
Confidence 3444678999999999999999999999999999999999 56666533211 11111111 0 011111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..+...+.+++.+||+.||++|||++||++.|+.
T Consensus 225 ---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1223568899999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=408.31 Aligned_cols=257 Identities=29% Similarity=0.471 Sum_probs=201.6
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||+||+|+++ ..||||++... .....+.|.+|+.++++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999875 35999998644 23455789999999999999999999998765 46899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.++++... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999997542 4689999999999999999999998 9999999999999999999999999999876433
Q ss_pred C-ceeeccccccccccccccccc---CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 308 R-SYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 308 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
. ........||+.|+|||++.+ ..|+.++|||||||+||||+||+.||........ +. ....... .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~----~~~~~~~----~ 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----FMVGRGY----L 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHHHTS----C
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HH----HHHhcCC----C
Confidence 2 223345679999999999864 3589999999999999999999999975543211 11 1111111 1
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+.+. .....++..+.+|+.+||+.||++|||++||++.|+.
T Consensus 228 ~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 228 SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp CCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11110 1112234578899999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=406.41 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=203.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+....|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999975 589999999865432 3345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
|++|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999644 4699999999999999999999998 99999999999999999999999999998764332
Q ss_pred c-eeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 309 S-YVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 309 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. ......+||+.|+|||++.+..+ +.++|||||||+||||+||+.||......... . ...... .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~----~~~~~~---------~ 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y----SDWKEK---------K 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-H----HHHHTT---------C
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-H----HHHhcC---------C
Confidence 2 22345689999999999988776 57899999999999999999999755432111 1 111110 1
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
............+.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111112223456778999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=408.42 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=208.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+++.++|||||++++++.+.+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999964 58999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 589999999999999999999999 999999999999999999999999999987644332
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.....+||+.|+|||++.+..++.++|||||||++|||+||+.||....... . +....... .+. .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~~~~~~------~~~--~ 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---A---LYLIATNG------TPE--L 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHHHC------SCC--C
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---H---HHHHHhCC------CCC--C
Confidence 2345679999999999999999999999999999999999999997543211 1 11111100 001 1
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112334457889999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-54 Score=414.72 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=212.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 149 ~~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
..++|.+.+.||+|+||+||+|.++ +++.||||++..... ..++|.+|+.++++++|||||+++++|.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467888899999999999999986 478999998865443 35679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 94 ~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999997542 35689999999999999999999998 9999999999999999999999999999987655
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.........|++.|+|||++.+..++.++|||||||++|||++|..||...... .... ...... ..+..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~----~~i~~~-----~~~~~ 237 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVY----ELLEKD-----YRMER 237 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH----HHHHTT-----CCCCC
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHH----HHHhcC-----CCCCC
Confidence 554455556899999999999999999999999999999999976665432211 1111 111111 11111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
+......+.+|+.+||+.||++|||++||++.|+..
T Consensus 238 ----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 238 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122345688999999999999999999999988753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=400.61 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=212.6
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 230 (484)
++|++.+.||+|+||+||+|+++++..||||++..... ..++|.+|+.++++++||||++++|+|.++...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57899999999999999999998888999999876443 35689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCce
Q 011498 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (484)
Q Consensus 231 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 310 (484)
+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999976543 4588999999999999999999998 9999999999999999999999999999876554444
Q ss_pred eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 311 VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. .. +.... .+..+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~---~~-i~~~~-----~~~~p- 223 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA---EH-IAQGL-----RLYRP- 223 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH---HH-HHTTC-----CCCCC-
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH---HH-HHhCC-----CCCCc-
Confidence 4445678999999999999999999999999999999998 89999755422 111 11 11110 01111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......+.+|+.+||+.||++|||+++|++.|.+
T Consensus 224 ---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1233568899999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=411.72 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=207.4
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||+||+|.++++..||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46788889999999999999999888899999986543 345679999999999999999999998865 5679999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999886432 23589999999999999999999998 999999999999999999999999999998765554
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCC-CCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRN-PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.......||+.|+|||++.++.++.++|||||||+||||+||.. |+...... ... .... .. ..+..+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~---~~i~-~~-----~~~~~p 232 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI---QNLE-RG-----YRMVRP 232 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH---HHHH-TT-----CCCCCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHH---HHHH-hc-----CCCCCc
Confidence 44555678999999999999999999999999999999999554 44432211 111 1111 11 111111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..+...+.+|+.+||+.||++|||+++|++.|+.
T Consensus 233 ----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 ----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2234568889999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=403.65 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=205.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+.+ +++.||+|++.... ......+.+|+.+++.++|||||++++++.+....|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999975 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|||++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999754 4699999999999999999999998 999999999999999999999999999986543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
.. .....||+.|+|||++.+..++.++|||||||+||||+||+.||...... +........ ...
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~-------~~~ 222 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRV-------EFT 222 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTT-------CCC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHcC-------CCC
Confidence 32 33457999999999999999999999999999999999999999754321 111111111 111
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
++. .....+.+|+.+||+.||++|||++|+++
T Consensus 223 ~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPD----FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 23356788999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-53 Score=409.40 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=197.0
Q ss_pred cCCCcCceeccCCceEEEEEEECC-C---CEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-G---TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||+||+|.++. + ..||||.+.... ....+.|.+|+.+|++++|||||+++|+|.+....++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456677899999999999999753 2 358999886543 34456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
||||++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999987542 4689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcee----ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 306 SERSYV----TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 306 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
...... .....||+.|+|||++.++.++.++|||||||+||||+| |+.||...... .+...+. ..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~----~~--- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE----QD--- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TT---
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cC---
Confidence 432211 122457899999999999999999999999999999998 89999755422 1111111 11
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.....+..+...+.+|+.+||+.||++|||+.||++.|+.
T Consensus 250 ------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 250 ------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0111122344578899999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=405.66 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=194.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee--CCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv 225 (484)
++|.+.+.||+|+||+||+|+.+ +|+.||||.+.... ....+.+.+|++++++++|||||++++++.+ +..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999975 58999999986543 3334678899999999999999999999865 4568999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC--CCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
||||++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754333467999999999999999999999861 11499999999999999999999999999987
Q ss_pred ccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
...... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+. .... ....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~---~~i~-~~~~---- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA---GKIR-EGKF---- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHH-HTCC----
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH---HHHH-cCCC----
Confidence 644332 234567999999999999999999999999999999999999999754321 111 1111 1111
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.++ ......+.+|+.+||+.||.+|||++||++
T Consensus 232 -~~~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -RRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 123446888999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-53 Score=405.32 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=206.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
+.|.+.+.||+|+||+||+|.+. ++..||||++........+.+.+|+++++.++|||||++++++.+....++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788899999999999999975 58899999997766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.+++.... .++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999986532 4699999999999999999999999 99999999999999999999999999997643221
Q ss_pred eeecccccccccccccccc-----cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 310 YVTTRVMGTFGYVAPEYAC-----TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.......||+.|+|||++. +..|+.++|||||||+||||+||+.||........ . ........
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~---~~i~~~~~------ 232 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---L---LKIAKSEP------ 232 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHHHSCC------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---H---HHHHcCCC------
Confidence 1233467999999999884 45689999999999999999999999976543211 1 11111100
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+. ...+......+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 1112334567889999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=400.62 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=205.4
Q ss_pred cCCCcCce-eccCCceEEEEEEEC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENV-IGEGGYGIVYRGILS---DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~-Lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+. ||+|+||+||+|.++ ++..||||++.... ....+.|.+|+++|++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34556664 999999999999864 34579999987554 3345789999999999999999999999875 457999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999986432 4689999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCcee--ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 306 SERSYV--TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 306 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+... +....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~~~~---- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGK---- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC----
Confidence 443322 233468999999999999999999999999999999998 99999755422 11111 11111
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+..+ ..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 230 -~~~~p----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 -RMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -CCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCC----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 22345688999999999999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=408.93 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=206.5
Q ss_pred hcCCCcCceeccCCceEEEEEEECC-C-----CEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD-G-----TKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
.++|.+.+.||+|+||+||+|++.. + ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999999653 2 269999886543 33446788999999998 89999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCC
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG-------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp 282 (484)
.++|||||++|+|.++|+.... ....+++..++.++.||+.||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976432 124589999999999999999999998 999999999
Q ss_pred CcEEEcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCC
Q 011498 283 SNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRP 360 (484)
Q Consensus 283 ~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~ 360 (484)
+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||+||||+| |..||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987644332 23345678999999999999999999999999999999998 8999976543
Q ss_pred CCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Q 011498 361 QGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLE 425 (484)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~ 425 (484)
... +. ...... ..+.. +..+...+.+|+.+||+.||++|||++||++.|.
T Consensus 273 ~~~--~~----~~~~~~-----~~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN--FY----KLIQNG-----FKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH--HH----HHHHTT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HH----HHHhcC-----CCCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 11 111111 01111 1223456889999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=394.45 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=195.1
Q ss_pred CcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee----CCeeeEEE
Q 011498 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVY 226 (484)
Q Consensus 154 ~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~ 226 (484)
.+.+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|++++++++|||||++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999975 57899999986543 3344678999999999999999999999875 34679999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc-CCCcEEEeeeccccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLC 305 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfgla~~~~ 305 (484)
||+++|+|.++++.. ..+++..++.++.||+.||+|||++ .++|+||||||+||||+ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999754 4689999999999999999999998 12399999999999996 57899999999998643
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... ....+||+.|+|||++.+ .++.++|||||||+||||+||+.||...... ........ ....
T Consensus 167 ~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~-~~~~------ 230 (270)
T d1t4ha_ 167 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVT-SGVK------ 230 (270)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHT-TTCC------
T ss_pred CCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHH-cCCC------
Confidence 322 334679999999998865 6999999999999999999999999744321 11111111 1110
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+..........+.+|+.+||+.||++|||++|+++
T Consensus 231 --~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111122345788999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=397.85 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=198.3
Q ss_pred ceeccCCceEEEEEEECC---CCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEecCC
Q 011498 157 NVIGEGGYGIVYRGILSD---GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 231 (484)
+.||+|+||+||+|.+++ ++.||||++.... ....+.|.+|+.++++++|||||+++++|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998653 4579999986543 23456799999999999999999999998654 57899999999
Q ss_pred CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCcee
Q 011498 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (484)
Q Consensus 232 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 311 (484)
|+|.++++.. ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999765 4699999999999999999999998 99999999999999999999999999998765433322
Q ss_pred --ecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 312 --TTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 312 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+.. .+.... .+..+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~~~-----~~~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGE-----RMGCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTC-----CCCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHcCC-----CCCCC
Confidence 233568999999999999999999999999999999998 89999754321 1111 111111 01111
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..++..+.+|+.+||+.||++|||+++|++.|+.
T Consensus 233 ----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2234568899999999999999999999998875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=397.49 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=198.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCC-----CEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
+.|+..++||+|+||+||+|.++++ ..||||++..... .....|.+|+.++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577788999999999999997642 3699999865443 344578999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999886543 4699999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCc--eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERS--YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
..... .......||+.|+|||++.++.++.++|||||||+||||+||..|+...... .+...... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~-~~----- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAIN-DG----- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHH-TT-----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHHHHh-cc-----
Confidence 43322 1233356899999999999999999999999999999999965554322211 11111111 11
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+...+..++..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 230 ----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 1111122344578899999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=407.73 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=204.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.++|.+.+.||+|+||+||+|+.. +|+.||+|++.... ......+.+|+.+|+.++|||||+++++|.+....|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467889999999999999999975 58899999986543 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||+ + +|+||||||+||||+.++++||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999754 458999999999999999999996 5 899999999999999999999999999987543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC---------
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR--------- 377 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 377 (484)
.. ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+.... .... ........
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL-ELMF-GCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH-HHHC------------------
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH-HHHhcCCcccCCccccc
Confidence 22 2346899999999999999999999999999999999999999976542211 0000 00000000
Q ss_pred ---C-----------------cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 ---K-----------------SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ---~-----------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
. .........+..........+.+++.+||..||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 00000000011111112356888999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=401.23 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=202.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999975 58999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999998755 4699999999999999999999999 999999999999999999999999999987643
Q ss_pred CC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 307 ER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 307 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.. .......+||+.|+|||++.+..++.++|||||||+||||+||+.||...+.. .. ...... . ..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~---~~~i~~-~------~~ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LI---FQKIIK-L------EY 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHT-T------CC
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HH---HHHHHc-C------CC
Confidence 32 22234467999999999999999999999999999999999999999754321 11 111111 1 01
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.++. .....+.+|+.+||+.||++|||++|++.
T Consensus 228 ~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1211 23346888999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=398.74 Aligned_cols=257 Identities=27% Similarity=0.390 Sum_probs=201.7
Q ss_pred hcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++|.+.+.||+|+||+||+|.++++..||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35788999999999999999999888899999986543 345679999999999999999999999865 5679999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|..++.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999986532 24589999999999999999999998 999999999999999999999999999987654443
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPK 389 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (484)
.......||+.|+|||++..+.++.++|||||||+||||+||..|+...... ......+. ... .+..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----~~~-----~~~~-- 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----RGY-----RMPC-- 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----TTC-----CCCC--
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----hcC-----CCCC--
Confidence 3344467899999999999999999999999999999999965555432211 11111111 110 1111
Q ss_pred CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCC
Q 011498 390 MPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEADD 428 (484)
Q Consensus 390 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~~ 428 (484)
+..+.+.+.+++.+||+.||++|||+++|+++|+...
T Consensus 236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 2223457889999999999999999999999998643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-51 Score=405.79 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=209.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+....|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57899999999999999999975 58999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC--CCcEEEeeecccccccCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 307 (484)
++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999996432 4699999999999999999999999 9999999999999964 578999999999876544
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.+....... ...
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~-------~~~ 244 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD-------WNM 244 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-------CCS
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------CCC
Confidence 33 33457999999999999999999999999999999999999999754321 1111111100 111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
+..........+.+|+.+||..||++|||++|+++.
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122334568899999999999999999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-52 Score=401.52 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=189.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
+.|.+.+.||+|+||+||+|..+ +|+.||||++..... .....+.+|+.+++.++|||||++++++.++...|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888999999999999999975 588999999865432 3345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc---CCCcEEEeeeccccccc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLC 305 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfgla~~~~ 305 (484)
|+||+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999754 4699999999999999999999998 999999999999994 57899999999998654
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
... .....+||+.|+|||++.+..++.++|||||||+||||+||+.||...... ... ....... .
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~---~~i~~~~-------~ 226 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLF---EQILKAE-------Y 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHTTC-------C
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHH---HHHhccC-------C
Confidence 332 233467999999999999999999999999999999999999999754321 111 1111110 0
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..+..........+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111112233456889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-51 Score=403.45 Aligned_cols=251 Identities=18% Similarity=0.269 Sum_probs=208.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||+||+|... +|+.||||++..........+.+|+.++++++|||||++++++.++...|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 56888999999999999999974 68999999997766556678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc--CCCcEEEeeecccccccCC
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfgla~~~~~~ 307 (484)
++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||||+ .++.+||+|||++......
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999987643 24699999999999999999999998 999999999999998 5789999999999887544
Q ss_pred CceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKL 387 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (484)
.. .....||+.|+|||++.+..++.++|||||||+||||+||..||...... ... ...... +...
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~---~~i~~~-------~~~~ 247 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETL---QNVKRC-------DWEF 247 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH---HHHHHC-------CCCC
T ss_pred Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhC-------CCCC
Confidence 32 33457999999999999999999999999999999999999999754321 111 111110 0111
Q ss_pred CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 388 PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 388 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+..........+.+|+.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112223456888999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-51 Score=398.68 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=200.1
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
.|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+....|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4788899999999999999964 588999999865432 334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
||.+|+|..++... .++++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999998777544 4699999999999999999999999 999999999999999999999999999986533
Q ss_pred Cceeeccccccccccccccccc---CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccC
Q 011498 308 RSYVTTRVMGTFGYVAPEYACT---GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVD 384 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (484)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|..||...... +.+....... .
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~------~ 231 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE------S 231 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC------C
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC------C
Confidence 233579999999999864 46899999999999999999999999754321 1111111110 1
Q ss_pred CCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 385 PKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 385 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
+.+. .......+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 1123456888999999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=393.16 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=205.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch------hhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
+.|.+.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+....|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56889999999999999999974 689999999864321 23568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC----cEEEeeec
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 299 (484)
+|||||++|+|.++|... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999764 4699999999999999999999999 999999999999998776 49999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++........ .....||+.|+|||++.+..++.++|||||||+||||+||+.||....... .........
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-- 232 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVN-- 232 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC--
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcC--
Confidence 9987643322 334579999999999999999999999999999999999999997543221 111111100
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
...+..........+.+|+.+||+.||++|||++|+++
T Consensus 233 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111111123456888999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=392.15 Aligned_cols=254 Identities=22% Similarity=0.372 Sum_probs=195.9
Q ss_pred hcCCCcCceeccCCceEEEEEEECC----CCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.++|.+.+.||+|+||+||+|++.. +..||||.+.... ....+.|.+|+.++++++|||||++++++.+ ...++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3578889999999999999998743 3468999886543 3345679999999999999999999999864 57899
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999886543 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCccccc
Q 011498 305 CSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVV 383 (484)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (484)
............||+.|+|||++.+..++.++|||||||+||||+| |.+||....... +...+. ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~----~~~~---- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NGER---- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TTCC----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCCC----
Confidence 5544444455678999999999999999999999999999999998 899997654321 111111 1110
Q ss_pred CCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 384 DPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 384 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+.. +..++..+.+|+.+||+.||++|||+.||++.|+.
T Consensus 228 -~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 -LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111 12234568899999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-51 Score=394.28 Aligned_cols=266 Identities=25% Similarity=0.391 Sum_probs=212.3
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecce
Q 011498 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 143 ~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
+.+++...++|.+.+.||+|+||+||+|+++ +++.||||++..... ...++|.+|+.+++.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445556778999999999999999999964 246899999865543 345679999999999999999999999
Q ss_pred eeeCCeeeEEEEecCCCCHHHHhhcCC--------------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCce
Q 011498 216 CVEGAYRMLVYEYVDNGNLDQWLHGDV--------------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275 (484)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i 275 (484)
|......+++|||+++|+|.++|+... .....+++..++.++.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999996432 1224589999999999999999999998 99
Q ss_pred eecCCCCCcEEEcCCCcEEEeeecccccccCCC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCC-C
Q 011498 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR-N 353 (484)
Q Consensus 276 vH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~-~ 353 (484)
+||||||+|||||.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||+||||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998664332 22234467899999999999999999999999999999999985 5
Q ss_pred CCCCCCCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 354 PVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 354 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
||...... ... .. +..... +..+ ..++..+.+|+.+||+.||++||||.||+++|+..
T Consensus 242 p~~~~~~~---e~~---~~-v~~~~~-----~~~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHE---EVI---YY-VRDGNI-----LACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHH---HHH---HH-HHTTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHH---HHH---HH-HHcCCC-----CCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 77654322 111 11 111111 1111 22334688999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=386.04 Aligned_cols=248 Identities=33% Similarity=0.444 Sum_probs=196.5
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeee-CCeeeEEEEec
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVYEYV 229 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 229 (484)
++|.+.+.||+|+||.||+|.++ |..||||++.... ..+.|.+|++++++++||||++++|+|.+ ....++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45777889999999999999996 7899999986543 34679999999999999999999999865 45689999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.++|.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999996532 23589999999999999999999998 9999999999999999999999999999865332
Q ss_pred eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCCCC
Q 011498 310 YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPKLP 388 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (484)
.....+|..|+|||++.+..+++++|||||||++|||+| |++||...... ++...+. .. ..+.++
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~----~~-----~~~~~~ 222 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KG-----YKMDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT----TT-----CCCCCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cC-----CCCCCC
Confidence 223457899999999999999999999999999999998 78888654322 2222211 11 111222
Q ss_pred CCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 389 KMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 389 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
. .....+.+|+.+||+.||.+|||+.+|+++|+.
T Consensus 223 ~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 D----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2 233568899999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=393.81 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=205.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+.+ +|+.||||++.... ......+.+|+.+|+.++||||+++++++.+....|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56889999999999999999974 68999999986542 223467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999865 4689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... .....+||+.|+|||++.+..|+.++|||||||+||||+||++||...+... +. ...... ...
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~---~~i~~~-------~~~ 223 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---ELILME-------EIR 223 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHC-------CCC
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HH---HHHhcC-------CCC
Confidence 322 3445689999999999999999999999999999999999999997654221 11 111111 011
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
++. .....+.+|+.+||+.||.+||+ ++|+++
T Consensus 224 ~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222 23346788999999999999995 677765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=389.36 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=200.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 224 (484)
.+|.+.+.||+|+||+||+|.+. +|+ +||+|++.... ....+.|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888999999999999999975 333 68999886543 34567899999999999999999999999875 5678
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
++||+.+|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887543 5689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 305 CSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 305 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
...... ......||+.|+|||++.++.++.++|||||||+||||+| |.+||....... +...+.. ..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~----~~---- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK----GE---- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHH----TC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----CC----
Confidence 543322 2333468999999999999999999999999999999999 899997554321 1111111 10
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+.. +..+...+.+|+.+||+.||++|||+.||++.|+.
T Consensus 231 -~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 231 -RLPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCC----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0111 12234568899999999999999999999998864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=385.28 Aligned_cols=265 Identities=25% Similarity=0.348 Sum_probs=200.2
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCC----eeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~ 226 (484)
.+|...+.||+|+||+||+|+++ |+.||||++..... ....+..|+..+..++|||||++++++.+.. ..|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 34667789999999999999984 89999998854432 1222334555666789999999999998653 579999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcC-----CCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG-----LEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
||+++|+|.++|+.. .++|..++.++.|++.||+|||+. ...+|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999754 589999999999999999999962 1249999999999999999999999999999
Q ss_pred ccccCCCce---eecccccccccccccccccCC------CCcccceecchhHHHHHHhCCCCCCCCCCCCccc-------
Q 011498 302 KLLCSERSY---VTTRVMGTFGYVAPEYACTGM------LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN------- 365 (484)
Q Consensus 302 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~------- 365 (484)
+........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543322 223467999999999987543 6779999999999999999998886543221110
Q ss_pred -hhhhhhhhhcCCCcccccCCCCCCCC-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 366 -LVDWLKTMVGSRKSEEVVDPKLPKMP-ASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 366 -~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
......... ......|.++... ..+....+.+|+.+||+.||++|||+.||++.|++
T Consensus 236 ~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 001111111 1112223332222 34566779999999999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-49 Score=379.30 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=204.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---------hhHHHHHHHHHHHhccC-CCceeeecceeeeC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---------QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEG 219 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~ 219 (484)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999974 688999999865431 12346888999999996 99999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...|+||||+++|+|.++|+.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999754 4699999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCceeeccccccccccccccccc------CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhh
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACT------GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTM 373 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 373 (484)
+++....... .....||+.|+|||.+.+ ..++.++||||+||+||||+||+.||....... .. ...
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~---~~i 227 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML---RMI 227 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HH---HHH
Confidence 9987654322 344679999999998853 357889999999999999999999997554211 11 111
Q ss_pred hcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 374 VGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... ...+..........+.+|+.+||+.||++|||++||++
T Consensus 228 ~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGN-------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTC-------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCC-------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 01112222334567889999999999999999999865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.9e-50 Score=387.56 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=203.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+++.++|||||++++++.+....|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999974 58999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||++||+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999999765 4578899999999999999999998 999999999999999999999999999987643
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. ....+||+.|+|||++.+..|+.++|||||||+||||+||+.||...+.. +........ ...
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~-------~~~ 219 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA-------ELR 219 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC-------CCC
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcC-------CCC
Confidence 2 23467999999999999999999999999999999999999999754321 111111111 011
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIHM 423 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~ 423 (484)
.+. .....+.+++.+||..||.+|| |++++++.
T Consensus 220 ~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111 1234678899999999999996 88888763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=385.40 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=195.6
Q ss_pred cCCCcCceeccCCceEEEEEEECC--C--CEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD--G--TKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
++|++.+.||+|+||+||+|++.. + ..||||++.... ....++|.+|+.++++++|||||+++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 468888999999999999998642 2 378999886542 33456899999999999999999999999764 678
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999886542 4589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCce--eecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 304 LCSERSY--VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
....... ......|+..|+|||++.+..++.++|||||||++|||+| |..||...... +..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~-- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE-- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC--
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCC--
Confidence 6443322 2233457889999999999999999999999999999998 89999754322 11112111111
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.+.. +...+..+.+|+.+||+.||++|||+++|++.|++
T Consensus 233 ---~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 ---RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0111 12233568899999999999999999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=387.47 Aligned_cols=267 Identities=24% Similarity=0.375 Sum_probs=200.2
Q ss_pred cHHHHHHHhcCCCcCceeccCCceEEEEEEECC------CCEEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeec
Q 011498 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLL 213 (484)
Q Consensus 142 ~~~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~ 213 (484)
....++...++|.+.+.||+|+||+||+|.+.. ++.||||++.... ....+.+..|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 344444555789999999999999999999642 3589999986543 33445677788877777 789999999
Q ss_pred ceeeeC-CeeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCC
Q 011498 214 GYCVEG-AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (484)
Q Consensus 214 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dl 280 (484)
+++... ...++|||||++|+|.++|+.... ....+++..++.++.||+.||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998764 468999999999999999975432 124589999999999999999999998 9999999
Q ss_pred CCCcEEEcCCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHhC-CCCCCCC
Q 011498 281 KSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITG-RNPVDYS 358 (484)
Q Consensus 281 kp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG-~~p~~~~ 358 (484)
||+||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986543332 223446799999999999999999999999999999999996 5677654
Q ss_pred CCCCccchhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 359 RPQGEVNLVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
..... +. ....... .+..+. .....+.+++.+||+.||++|||++||++.|+.
T Consensus 241 ~~~~~--~~----~~~~~~~-----~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 KIDEE--FC----RRLKEGT-----RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCSHH--HH----HHHHHTC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHH--HH----HHHhcCC-----CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 32211 11 1111111 111221 233468899999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-49 Score=380.84 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=199.3
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCC----ee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YR 222 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~ 222 (484)
++|.+.+.||+|+||+||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56889999999999999999964 68999999996543 233457899999999999999999999998654 37
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+.
T Consensus 87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 8999999999999998754 4699999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCC--ceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 303 LLCSER--SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 303 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
...... .......+||+.|+|||++.+..++.++|||||||+||||+||++||...... +...........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC-
Confidence 653322 12234467999999999999999999999999999999999999999754321 111111111110
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhc
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRP-KMGHVIHMLEA 426 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~L~~ 426 (484)
.+..........+.+++.+||+.||++|| |++++++.|..
T Consensus 233 ------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 00111112335688899999999999999 89999887753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-49 Score=389.31 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=198.4
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch---hhHHHHH---HHHHHHhccCCCceeeecceeeeCCeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFK---VEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~ 223 (484)
++|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+. .++.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999975 589999999854321 1222333 3467788889999999999999999999
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+||||+++|+|.++|... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999764 4688999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccc
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEV 382 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (484)
..... ....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+ .......
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~----- 224 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM----- 224 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSC-----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccC-----
Confidence 64432 334579999999999874 5689999999999999999999999976543321111 1111000
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 383 VDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 383 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
....+ ......+.+|+.+||+.||++||| ++|+++
T Consensus 225 -~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -AVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCCC----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCC----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111 123346888999999999999999 577765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=385.39 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=209.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeCCe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~ 221 (484)
.++|.+.+.||+|+||.||+|++. ++..||||++..... .....|.+|+.+++++ +|||||+++++|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888899999999999999863 356899999976543 3445788999999999 79999999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEE
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVG--------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll 287 (484)
.++|||||++|+|.++++.... ....+++..++.++.||+.||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999975431 234689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecccccccCCC-ceeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccc
Q 011498 288 DRQWNARVSDFGLAKLLCSER-SYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVN 365 (484)
Q Consensus 288 ~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~ 365 (484)
+.++.+||+|||+++...... ........||+.|+|||++.++.++.++|||||||++|||+| |.+||......+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998765433 233445679999999999999999999999999999999999 6666654443221
Q ss_pred hhhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 366 LVDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
+...+. .. .+...+......+.+|+.+||+.||.+|||+++|+++|+.
T Consensus 257 ~~~~i~----~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 FYKMIK----EG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHH----HT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHh----cC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111 11 1111112234568899999999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=384.15 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=198.6
Q ss_pred cCCCcC-ceeccCCceEEEEEEE-CCCCEEEEEEecccchhhHHHHHHHHHHHhcc-CCCceeeecceeee----CCeee
Q 011498 151 SGLCEE-NVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE----GAYRM 223 (484)
Q Consensus 151 ~~~~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~~ 223 (484)
++|.+. +.||+|+||+||+|+. .+++.||||++... ..+.+|+.++.++ +|||||+++++|.+ ....|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 567765 4699999999999996 45899999988542 4566788886654 89999999999875 45789
Q ss_pred EEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC---CCcEEEeeecc
Q 011498 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGL 300 (484)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfgl 300 (484)
+|||||+||+|.++|.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999997542 24699999999999999999999999 9999999999999985 45799999999
Q ss_pred cccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE 380 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (484)
++....... ....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||............ ....
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i------ 229 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRI------ 229 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC------
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHH------
Confidence 987654332 34467999999999999999999999999999999999999999765432211100 0000
Q ss_pred cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 381 EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......++..........+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000111222223345677999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=380.20 Aligned_cols=251 Identities=29% Similarity=0.456 Sum_probs=199.6
Q ss_pred CceeccCCceEEEEEEECCC----CEEEEEEeccc-chhhHHHHHHHHHHHhccCCCceeeecceeee-CCeeeEEEEec
Q 011498 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVYEYV 229 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 229 (484)
.++||+|+||+||+|.+.++ ..||||++... .....++|.+|++++++++||||++++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 25899998653 34445789999999999999999999999876 45789999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999987543 4578889999999999999999998 999999999999999999999999999987644322
Q ss_pred e---eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 310 Y---VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 310 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. ......||+.|+|||.+.+..++.++||||||++||||+||..||...... ......+ .... . +.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~g~---~---~~ 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGR---R---LL 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC---C---CC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HcCC---C---CC
Confidence 2 122356899999999999999999999999999999999977777543221 1111111 1111 0 11
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.+ ..+...+.+|+.+||+.||++|||+.||++.|+..
T Consensus 255 ~p----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 255 QP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 12335688899999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=385.90 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=202.3
Q ss_pred cCCCcCceeccCCceEEEEEEECC-CC--EEEEEEecccc-hhhHHHHHHHHHHHhcc-CCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD-GT--KVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||+||+|++++ |. .||||++.... ....+.|.+|+++|+++ +|||||+++++|.+....++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568888999999999999999754 33 57888875433 33456799999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 226 YEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
|||+++|+|.++|+... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997541 2346799999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCC-CCCCCCCCCCccchhhhhhh
Q 011498 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGR-NPVDYSRPQGEVNLVDWLKT 372 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~-~p~~~~~~~~~~~~~~~~~~ 372 (484)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||...... .+...+.
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~~~~i~- 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP- 240 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHGG-
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---HHHHHHH-
Confidence 999999997643222 123346899999999999999999999999999999999965 567544321 1111111
Q ss_pred hhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 373 MVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
.. ..+.. +......+.+|+.+||+.||++|||++||++.|+..
T Consensus 241 ---~~-----~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 241 ---QG-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ---GT-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hc-----CCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 01111 122345788999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=384.18 Aligned_cols=251 Identities=16% Similarity=0.266 Sum_probs=204.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
.++|.+.+.||+|+||+||+|... +++.||||.+.... .....+.+|+++|+.++|||||++++++.+....|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467899999999999999999975 58899999986554 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCC--CcEEEeeecccccccC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ--WNARVSDFGLAKLLCS 306 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfgla~~~~~ 306 (484)
|+||+|.++++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999997542 3689999999999999999999998 99999999999999854 5899999999987644
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
... .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||....... . ........ ..
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~---~~~i~~~~-------~~ 221 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---I---IENIMNAE-------YT 221 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHTC-------CC
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCC-------CC
Confidence 332 334578999999999999999999999999999999999999997554221 1 11111100 00
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
++..........+.+|+.+||..||++|||++|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111001123456889999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=382.66 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=204.1
Q ss_pred cCCCcCceeccCCceEEEEEEECC--------CCEEEEEEecccch-hhHHHHHHHHHHHhcc-CCCceeeecceeeeCC
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~ 220 (484)
++|.+.+.||+|+||.||+|+... +..||||++..... ....++..|...+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578888999999999999998532 24799999876543 3346788898888888 8999999999999999
Q ss_pred eeeEEEEecCCCCHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~ 288 (484)
..++||||+++|+|.++|..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999975431 235689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeecccccccCCCc-eeecccccccccccccccccCCCCcccceecchhHHHHHHh-CCCCCCCCCCCCccch
Q 011498 289 RQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIIT-GRNPVDYSRPQGEVNL 366 (484)
Q Consensus 289 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-G~~p~~~~~~~~~~~~ 366 (484)
.++.+||+|||+++....... .......+|+.|+|||.+.++.|+.++|||||||++|||+| |.+||...... .+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HH
Confidence 999999999999987644322 22344578999999999999999999999999999999998 78888754422 11
Q ss_pred hhhhhhhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 367 VDWLKTMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
. ..+.... .+..+. .....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 247 ~----~~i~~~~-----~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 F----KLLKEGH-----RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H----HHHHTTC-----CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHcCC-----CCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 1111111 111111 2334688999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-49 Score=387.10 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=203.5
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46888999999999999999975 68999999986432 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccC
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~ 306 (484)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999755 4689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCCC
Q 011498 307 ERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDPK 386 (484)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (484)
. .....||+.|+|||++.+..++.++|||||||+||||+||+.||...... .. ........ +.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~---~~~i~~~~-------~~ 256 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QI---YEKIVSGK-------VR 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCC-------CC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HH---HHHHhcCC-------CC
Confidence 2 23457999999999999999999999999999999999999999754321 11 11111110 11
Q ss_pred CCCCChHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 011498 387 LPKMPASKALKRVLLVALRCVDPDATKRP-----KMGHVIH 422 (484)
Q Consensus 387 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~ 422 (484)
.+ ......+.+++.+||..||.+|+ |+++|++
T Consensus 257 ~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11 12344688899999999999994 8888876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=385.70 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=201.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc---hhhHHHHHHHHHHHh-ccCCCceeeecceeeeCCeeeEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIG-RVRHKNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv 225 (484)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+..|..++. .++|||||++++++.++...|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999975 58899999996532 222345566666655 68999999999999999999999
Q ss_pred EEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccccccc
Q 011498 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (484)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~ 305 (484)
|||+++|+|.++++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999765 4589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcccccCC
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEEVVDP 385 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (484)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+... +. ...... .+
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~---~~i~~~-------~~ 220 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LF---HSIRMD-------NP 220 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHC-------CC
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HH---HHHHcC-------CC
Confidence 3332 3344679999999999999999999999999999999999999997544221 11 111100 11
Q ss_pred CCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHH
Q 011498 386 KLPKMPASKALKRVLLVALRCVDPDATKRPKMG-HVIH 422 (484)
Q Consensus 386 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~ 422 (484)
..+. .....+.+|+.+||..||.+|||+. +|++
T Consensus 221 ~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2222 2234688899999999999999985 6654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=385.28 Aligned_cols=262 Identities=23% Similarity=0.429 Sum_probs=211.0
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEC------CCCEEEEEEecccch-hhHHHHHHHHHHHhccCCCceeeecceeeeC
Q 011498 147 EAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219 (484)
Q Consensus 147 ~~~~~~~~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 219 (484)
+...++|.+.+.||+|+||+||+|.++ +++.||||++..... .....|.+|+.++++++|||||+++++|...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 334567888999999999999999864 256899999965433 3345789999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHHHHhhcCC------CCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcE
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDV------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 293 (484)
...++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999999986421 2335689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccCCCce-eecccccccccccccccccCCCCcccceecchhHHHHHHhC-CCCCCCCCCCCccchhhhhh
Q 011498 294 RVSDFGLAKLLCSERSY-VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITG-RNPVDYSRPQGEVNLVDWLK 371 (484)
Q Consensus 294 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG-~~p~~~~~~~~~~~~~~~~~ 371 (484)
||+|||+++........ ......||+.|+|||.+.+..++.++|||||||+||||+|| .+||...... +...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~~~ 246 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLR 246 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 99999999876443322 23344689999999999999999999999999999999997 5777644321 2222
Q ss_pred hhhcCCCcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Q 011498 372 TMVGSRKSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEAD 427 (484)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~~ 427 (484)
....... +..+ ..+...+.+++.+||+.||++|||+++|++.|+..
T Consensus 247 ~i~~~~~------~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 FVMEGGL------LDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHTTCC------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHhCCC------CCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2111110 1111 12335688999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=376.57 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=194.6
Q ss_pred CceeccCCceEEEEEEEC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEec
Q 011498 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (484)
Q Consensus 156 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 229 (484)
.++||+|+||+||+|+.+ +|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999964 5899999998644321 1246888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCCc
Q 011498 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (484)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 309 (484)
.++++..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 998777666433 4688899999999999999999999 999999999999999999999999999987644332
Q ss_pred eeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCccc-------
Q 011498 310 YVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSEE------- 381 (484)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 381 (484)
. ....+||+.|+|||++.. ..++.++|||||||++|||+||.+||......+ ....+...........
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhcc
Confidence 2 334579999999998865 468999999999999999999999997554221 1111111111100000
Q ss_pred ---ccCCCCCCCChH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 382 ---VVDPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 382 ---~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
......+..... .....+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000111111111 12356889999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=370.91 Aligned_cols=262 Identities=21% Similarity=0.337 Sum_probs=198.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||+||+|+. .+|+.||||++..... .....+.+|++++++++|||||++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788899999999999999997 4689999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
|+.+ ++.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976 555555433 225699999999999999999999999 9999999999999999999999999999876443
Q ss_pred CceeecccccccccccccccccCC-CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc-----------
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG----------- 375 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------- 375 (484)
.. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..+.. .........
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGGG
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HHHHHhcCCCchhhcccccc
Confidence 32 234457999999999877655 578999999999999999999999754321110 000000000
Q ss_pred CCCcccccCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRKSEEVVDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
........ +....... ......+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 233 MPDYKPSF-PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp STTCCTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccc-ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000000 00111110 112356788999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.4e-48 Score=370.21 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=199.8
Q ss_pred cCCCcCceeccCCceEEEEEEECCCCEEEEEEecccch--hhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|...+.||+|+||+||+|++++|+.||||++..... ...+.+.+|+.+|++++|||||++++++......+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888899999999999999998899999999965432 2356889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCCC
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 308 (484)
+.++.+..+.+.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887777766533 5699999999999999999999998 99999999999999999999999999998764432
Q ss_pred ceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcC-----------
Q 011498 309 SYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGS----------- 376 (484)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 376 (484)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ...+......
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhh
Confidence 2 2334468999999999875 4579999999999999999999999975432111 1000000000
Q ss_pred -CCcc---cccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 377 -RKSE---EVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 377 -~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... ....+.............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000000111123356889999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=370.69 Aligned_cols=239 Identities=24% Similarity=0.400 Sum_probs=194.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccch------hhHHHHHHHHHHHhccC--CCceeeecceeeeCCe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAY 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~ 221 (484)
++|.+.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57888999999999999999974 689999999864321 11234667999999986 8999999999999999
Q ss_pred eeEEEEecCC-CCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-CCcEEEeeec
Q 011498 222 RMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFG 299 (484)
Q Consensus 222 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg 299 (484)
.++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 6888888654 4699999999999999999999999 9999999999999985 4799999999
Q ss_pred ccccccCCCceeecccccccccccccccccCCC-CcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCC
Q 011498 300 LAKLLCSERSYVTTRVMGTFGYVAPEYACTGML-NEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRK 378 (484)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 378 (484)
+++..... ......||+.|+|||++.+..+ +.++|||||||+||||+||+.||.... .. .. ..
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i---~~---~~-- 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI---IR---GQ-- 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH---HH---CC--
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH---hh---cc--
Confidence 99865332 2344679999999999987765 567999999999999999999996421 00 00 00
Q ss_pred cccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 379 SEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
..++.. ....+.+|+.+||+.||++|||++|+++
T Consensus 221 ------~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ------VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011111 2346888999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=367.61 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=194.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-C-CCEEEEEEecccch--hhHHHHHHHHHHHhcc---CCCceeeecceeee----
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-D-GTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVE---- 218 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~---- 218 (484)
.++|.+.+.||+|+||+||+|++. + ++.||||++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 56799999864322 2223455677766655 89999999999863
Q ss_pred -CCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEee
Q 011498 219 -GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (484)
Q Consensus 219 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 297 (484)
....+++|||+.++++....... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34679999999987765554332 25689999999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 298 FGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 298 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
||++....... ......||+.|+|||++.+..|+.++|||||||++|||+||++||......+.. ..+.......
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCC
Confidence 99987653322 234567999999999999999999999999999999999999999755422111 1111111000
Q ss_pred Cc----------ccccCCCC---CCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 KS----------EEVVDPKL---PKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ~~----------~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.. ........ ...........+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000000 00011122346778899999999999999999876
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=359.27 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=194.1
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhccCCCceeeecceeee--------C
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--------G 219 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~ 219 (484)
++|.+.+.||+|+||+||+|++. +|+.||||++... .......+.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999974 6899999988544 23345678899999999999999999998865 3
Q ss_pred CeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeec
Q 011498 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (484)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 299 (484)
...|+||||+.++++..+... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 457999999988766655432 25688999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCce---eecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhc
Q 011498 300 LAKLLCSERSY---VTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVG 375 (484)
Q Consensus 300 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 375 (484)
++......... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcC
Confidence 99765432211 22335699999999998765 6899999999999999999999999754321111 11111111
Q ss_pred CCC-----------cc-cccCCCCCCCChHH------HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 376 SRK-----------SE-EVVDPKLPKMPASK------ALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 376 ~~~-----------~~-~~~~~~~~~~~~~~------~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... .. .............+ ....+.+|+.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 100 00 00000001111111 1235678999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=363.68 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=190.9
Q ss_pred CCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceeeecceeeeC------CeeeE
Q 011498 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------AYRML 224 (484)
Q Consensus 152 ~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~l 224 (484)
+|...++||+|+||+||+|++. +|+.||||++...... +.+|+.+|++++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4777889999999999999975 5899999999665432 23589999999999999999998643 35789
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeeccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKL 303 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~ 303 (484)
||||++++.+..+.+ .......+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998754433332 112235799999999999999999999998 999999999999999775 899999999987
Q ss_pred ccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh---------hhhhhh
Q 011498 304 LCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV---------DWLKTM 373 (484)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~---------~~~~~~ 373 (484)
...... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+ ++....
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 644332 334579999999998765 57899999999999999999999999754421111000 000000
Q ss_pred hcCC---CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 374 VGSR---KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 374 ~~~~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... .....................+.+|+.+||..||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000000000011123446888999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=360.62 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=201.8
Q ss_pred cCCCcCceeccCCceEEEEEEEC----CCCEEEEEEecccc----hhhHHHHHHHHHHHhccCC-CceeeecceeeeCCe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAY 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~ 221 (484)
++|.+.+.||+|+||+||+|... +|+.||||.+.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999852 47899999886432 2234567789999999966 899999999999999
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.+++|||+.+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999765 3578889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCceeecccccccccccccccccC--CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTG--MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
+.+............|++.|+|||.+.+. .++.++|||||||+||||+||+.||............ .......
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~--- 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS--- 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC---
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccC---
Confidence 87655444444556799999999998754 4788999999999999999999999866543322111 1111100
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPK-----MGHVIH 422 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~ 422 (484)
.+..+ ......+.+++.+||+.||++||| ++|+++
T Consensus 252 ----~~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----EPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111 224457888999999999999995 677765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=356.96 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=195.4
Q ss_pred cCCCcCceeccCCceEEEEEEE-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhccCCCceeeecceeeeCC----eeeE
Q 011498 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRML 224 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~l 224 (484)
++|.+.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5688889999999999999986 468999999996543 344567889999999999999999999987643 2355
Q ss_pred EEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccc
Q 011498 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (484)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~ 304 (484)
+++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++...
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66777799999999753 589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCc--eeecccccccccccccccc-cCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCcc-
Q 011498 305 CSERS--YVTTRVMGTFGYVAPEYAC-TGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKSE- 380 (484)
Q Consensus 305 ~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 380 (484)
..... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||......+..... ..........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhh
Confidence 43221 1234467999999999985 456789999999999999999999999755422111110 0000000000
Q ss_pred ------------cccCCCCCCCChH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 381 ------------EVVDPKLPKMPAS----KALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 381 ------------~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
....+........ .....+.+|+.+||+.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000111111111 112457889999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-44 Score=347.88 Aligned_cols=258 Identities=16% Similarity=0.185 Sum_probs=203.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCC-CceeeecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||+||+|++. +|+.||||++..... ...+..|++.++.+.| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57889999999999999999965 588999998754332 2346778889998865 8999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcC-----CCcEEEeeeccccc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKL 303 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfgla~~ 303 (484)
+ +++|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 83 ~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 679999987543 4689999999999999999999999 9999999999999964 56899999999987
Q ss_pred ccCCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC
Q 011498 304 LCSERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR 377 (484)
Q Consensus 304 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 377 (484)
....... .....+||+.|+|||++.+..++.++|||||||++|||+||..||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6432211 2334579999999999999999999999999999999999999998665443322221111111001
Q ss_pred CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 378 KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
...++. . ..++.+.+++..|+..+|++||+++.+.+.|+.
T Consensus 236 ~~~~l~-----~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRELC-----A----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHHHT-----T----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHHhc-----C----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111110 1 123468888889999999999999998887764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-44 Score=349.34 Aligned_cols=258 Identities=18% Similarity=0.223 Sum_probs=195.0
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccCCCceee-ecceeeeCCeeeEEEEe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR-LLGYCVEGAYRMLVYEY 228 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~e~ 228 (484)
++|.+.+.||+|+||+||+|++. +|+.||||.+..... ...+..|+++++.++|+|++. +.+++.+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46888999999999999999974 588999998765432 245778999999998776555 45556777888999999
Q ss_pred cCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEc---CCCcEEEeeeccccccc
Q 011498 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLC 305 (484)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfgla~~~~ 305 (484)
+. ++|.+.+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++...
T Consensus 85 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred cC-Cchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 94 57777665432 4689999999999999999999999 999999999999985 35579999999998765
Q ss_pred CCCce------eecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 306 SERSY------VTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 306 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
..... ......||+.|+|||++.+..++.++|||||||++|||+||..||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43221 233457999999999999999999999999999999999999999866543322222111110000000
Q ss_pred ccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Q 011498 380 EEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIHMLEA 426 (484)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~L~~ 426 (484)
.. . ...++..+.+++.+||+.||++||+++++.+.|+.
T Consensus 238 ~~-~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 EV-L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HH-H--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred hH-h--------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00 0 01123568889999999999999999999888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=345.97 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=201.9
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCCeeeEEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 227 (484)
++|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888999999999999999974 68899999986443 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecccccccCC
Q 011498 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (484)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 307 (484)
++.+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999998887644 5688999999999999999999998 9999999999999999999999999999876433
Q ss_pred CceeecccccccccccccccccCC-CCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCC---------
Q 011498 308 RSYVTTRVMGTFGYVAPEYACTGM-LNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSR--------- 377 (484)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 377 (484)
.. ......+++.|+|||++.... ++.++|||||||++|||++|..||...... ......+.......
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence 32 233345788999999887655 689999999999999999999997432211 11111111111100
Q ss_pred ------CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 378 ------KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 378 ------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.....................+.+|+.+||+.||.+|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000011111223456788899999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=355.48 Aligned_cols=258 Identities=25% Similarity=0.344 Sum_probs=191.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeCC------
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------ 220 (484)
.++|.+.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888899999999999999975 58999999986532 234467889999999999999999999997654
Q ss_pred eeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeecc
Q 011498 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (484)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgl 300 (484)
..|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 5588887754 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeccccccccccccccccc-CCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc
Q 011498 301 AKLLCSERSYVTTRVMGTFGYVAPEYACT-GMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS 379 (484)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (484)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||........... ..........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE---IMKVTGTPPA 240 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH---HHhccCCCcH
Confidence 9876432 234579999999999876 4578999999999999999999999976532111100 0000000000
Q ss_pred c-------------cccCCCCCCC----ChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 011498 380 E-------------EVVDPKLPKM----PASKALKRVLLVALRCVDPDATKRPKMGHVIHM 423 (484)
Q Consensus 380 ~-------------~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~ 423 (484)
. ....+..... ........+.+|+.+||..||.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000000 001123457789999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-44 Score=350.98 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=195.7
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeC--CeeeEEE
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEG--AYRMLVY 226 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~ 226 (484)
++|.+.+.||+|+||+||+|+.. +|+.||||++.... .+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 56889999999999999999974 58899999986543 456888999999995 99999999999743 4689999
Q ss_pred EecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCC-cEEEeeeccccccc
Q 011498 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLC 305 (484)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfgla~~~~ 305 (484)
||+.+++|..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999998764 3589999999999999999999999 999999999999998655 69999999998764
Q ss_pred CCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccc--h---------hhhhhhh
Q 011498 306 SERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVN--L---------VDWLKTM 373 (484)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~--~---------~~~~~~~ 373 (484)
.... .....+|+.|+|||.+.+. .++.++|||||||++|||++|..||.......... . ..+....
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4322 3445789999999998765 57999999999999999999999997543211000 0 0000000
Q ss_pred hcCC----------CcccccCCCCCCCChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 374 VGSR----------KSEEVVDPKLPKMPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 374 ~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.... .....................+.+|+.+||..||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000001111122233456888999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=347.89 Aligned_cols=260 Identities=23% Similarity=0.248 Sum_probs=189.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeee------CCe
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE------GAY 221 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~ 221 (484)
++|.+.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.+++.++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999975 58999999996543 2334578899999999999999999999964 367
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999764 555553 3489999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchh--------------
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLV-------------- 367 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~-------------- 367 (484)
+...... .....++|+.|+|||++.+..+++++||||+||++|||++|+.||...........+
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 7654322 234457899999999999999999999999999999999999999754321100000
Q ss_pred --hhhhhhhcCC------CcccccC-CCCCC--CChHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 368 --DWLKTMVGSR------KSEEVVD-PKLPK--MPASKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 368 --~~~~~~~~~~------~~~~~~~-~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
.......... ....... ..... .........+.+|+.+||..||++|||++||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 0000000 00111 112335667899999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=344.04 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=193.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhccCCCceeeecceeeeC-----Ce
Q 011498 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AY 221 (484)
Q Consensus 150 ~~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~ 221 (484)
.++|.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457889999999999999999964 68999999986543 23345788999999999999999999998643 34
Q ss_pred eeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEEeeeccc
Q 011498 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (484)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla 301 (484)
.+++|+|+.+|+|.++++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4777888899999999954 3599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeecccccccccccccccccC-CCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhhhhhhhhcCCCc-
Q 011498 302 KLLCSERSYVTTRVMGTFGYVAPEYACTG-MLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVDWLKTMVGSRKS- 379 (484)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 379 (484)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.... ...+.........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAE 241 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHH
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChH
Confidence 75432 23345689999999987765 468999999999999999999999975432111 1100000000000
Q ss_pred ----------ccc--cCCCCCCCCh----HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 011498 380 ----------EEV--VDPKLPKMPA----SKALKRVLLVALRCVDPDATKRPKMGHVIH 422 (484)
Q Consensus 380 ----------~~~--~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~ 422 (484)
... ..+..+.... ......+.+|+.+||..||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 0001111111 012345788999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-38 Score=312.14 Aligned_cols=262 Identities=18% Similarity=0.198 Sum_probs=188.2
Q ss_pred cCCCcCceeccCCceEEEEEEEC-CCCEEEEEEecccchhhHHHHHHHHHHHhccC-----------CCceeeecceeee
Q 011498 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----------HKNLVRLLGYCVE 218 (484)
Q Consensus 151 ~~~~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~ 218 (484)
.+|.+.+.||+|+||+||+|+.. +|+.||||++..... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35888999999999999999974 689999999875532 3456777888888775 5789999998864
Q ss_pred C--CeeeEEEEecCCCCHHH-HhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhc-CCCCceeecCCCCCcEEEcCCC---
Q 011498 219 G--AYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQW--- 291 (484)
Q Consensus 219 ~--~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~dlkp~NIll~~~~--- 291 (484)
. ...+++|+++..+.... +.... ....+++..+..++.||+.||+|||+ . +|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 3 45667777766554333 22222 33568899999999999999999997 5 999999999999998665
Q ss_pred ---cEEEeeecccccccCCCceeecccccccccccccccccCCCCcccceecchhHHHHHHhCCCCCCCCCCCCccchhh
Q 011498 292 ---NARVSDFGLAKLLCSERSYVTTRVMGTFGYVAPEYACTGMLNEKSDVYSFGILIMEIITGRNPVDYSRPQGEVNLVD 368 (484)
Q Consensus 292 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltG~~p~~~~~~~~~~~~~~ 368 (484)
.++++|||.+...... ....+||+.|+|||++....++.++||||+||++++|++|+.||............+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 3999999999764322 234579999999999999999999999999999999999999997543322111111
Q ss_pred hhh---hhhcC------------------CCcccccCCC----------CCCCChHHHHHHHHHHHHhcCCCCCCCCCCH
Q 011498 369 WLK---TMVGS------------------RKSEEVVDPK----------LPKMPASKALKRVLLVALRCVDPDATKRPKM 417 (484)
Q Consensus 369 ~~~---~~~~~------------------~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 417 (484)
.+. ...+. .......... ............+.+|+.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 100 00000 0000000000 0112234567789999999999999999999
Q ss_pred HHHHH
Q 011498 418 GHVIH 422 (484)
Q Consensus 418 ~evl~ 422 (484)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3.2e-24 Score=191.83 Aligned_cols=161 Identities=14% Similarity=0.147 Sum_probs=118.4
Q ss_pred CcCceeccCCceEEEEEEECCCCEEEEEEecccch------------------hhHHHHHHHHHHHhccCCCceeeecce
Q 011498 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG------------------QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (484)
Q Consensus 154 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~~~ 215 (484)
.+.+.||+|+||+||+|...+|+.||||+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988899999998753211 112234568888999999999888765
Q ss_pred eeeCCeeeEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCCCCceeecCCCCCcEEEcCCCcEEE
Q 011498 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (484)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 295 (484)
. ..+++|||+++..+.+ ++......++.|++.+|+|||+. +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2379999998865543 23334567899999999999998 99999999999999976 5899
Q ss_pred eeecccccccCCCceeecccccccccccc------cccccCCCCcccceecchh
Q 011498 296 SDFGLAKLLCSERSYVTTRVMGTFGYVAP------EYACTGMLNEKSDVYSFGI 343 (484)
Q Consensus 296 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~ 343 (484)
+|||++......... .|... +. ....|+.++|+||..-
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 999999765432211 11111 11 2456788999999643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=5.1e-08 Score=89.31 Aligned_cols=149 Identities=14% Similarity=0.076 Sum_probs=99.0
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCee
Q 011498 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYR 222 (484)
Q Consensus 144 ~~~~~~~~~~~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~ 222 (484)
.++......|...+..+-++.+.||+... ++..+++|+...........+..|...+..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35566666776655544445578999875 46678889775544333445667877777663 43366788888888889
Q ss_pred eEEEEecCCCCHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHhhhcCC-------------------------------
Q 011498 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL------------------------------- 271 (484)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------------------------------- 271 (484)
++||++++|.++.+..... .. ...++.+++..++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998886644211 11 1223444444555555320
Q ss_pred -------------------------CCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 272 -------------------------EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 272 -------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247999999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=6.2e-06 Score=74.52 Aligned_cols=73 Identities=18% Similarity=0.109 Sum_probs=51.4
Q ss_pred eccCCc-eEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccC--CCceeeecceeeeCCeeeEEEEecCCCCH
Q 011498 159 IGEGGY-GIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (484)
Q Consensus 159 Lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (484)
+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++.++.+.+..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 445543 689999988788889997644432 24556777776663 23366778888888888999999988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00022 Score=68.55 Aligned_cols=75 Identities=15% Similarity=0.184 Sum_probs=46.4
Q ss_pred ceeccCCceEEEEEEECC-CCEEEEEEeccc-------chhhHHHHHHHHHHHhcc-CC--CceeeecceeeeCCeeeEE
Q 011498 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLNN-------RGQAEKEFKVEVEVIGRV-RH--KNLVRLLGYCVEGAYRMLV 225 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~e~~~l~~l-~H--~niv~l~~~~~~~~~~~lv 225 (484)
+.||.|....||+....+ ++.|+||.-... ..........|.+.|+.+ .+ ..+++++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998644 678999964321 111223344577777665 22 345555544 45566899
Q ss_pred EEecCCCC
Q 011498 226 YEYVDNGN 233 (484)
Q Consensus 226 ~e~~~~gs 233 (484)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.21 E-value=0.00093 Score=62.20 Aligned_cols=136 Identities=15% Similarity=0.137 Sum_probs=76.9
Q ss_pred eEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCCCce-----eeec--ceeeeCCeeeEEEEecCCCCH---
Q 011498 165 GIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-----VRLL--GYCVEGAYRMLVYEYVDNGNL--- 234 (484)
Q Consensus 165 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~ni-----v~l~--~~~~~~~~~~lv~e~~~~gsL--- 234 (484)
-.||++..++|..|++|+.+... ....++..|+..+..|...++ +..- ..+......+.+++++.|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 58999999899999999876543 234556678887777642221 2221 123445667889999876322
Q ss_pred --HHH---------hhc----C-CCCCCCCCHH----------------------HHHHHHHHHHHHHHh-hhcCCCCce
Q 011498 235 --DQW---------LHG----D-VGDVSPLTWD----------------------IRMNIILGTAKGLAY-LHEGLEPKV 275 (484)
Q Consensus 235 --~~~---------l~~----~-~~~~~~l~~~----------------------~~~~i~~~ia~al~~-LH~~~~~~i 275 (484)
..+ ++. . ......+++. .....+..+...+.- +......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 110 0 0011111111 112223333333322 222234579
Q ss_pred eecCCCCCcEEEcCCCcEEEeeeccccc
Q 011498 276 VHRDVKSSNILLDRQWNARVSDFGLAKL 303 (484)
Q Consensus 276 vH~dlkp~NIll~~~~~~kl~Dfgla~~ 303 (484)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899987754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.01 Score=54.38 Aligned_cols=159 Identities=13% Similarity=0.031 Sum_probs=82.0
Q ss_pred ccHHHHHHHhcCCCcCcee-----ccCCceEEEEEEECCCCEEEEEEecccchhhHHHHHHHHHHHhccCC-----Ccee
Q 011498 141 YTLRELEAATSGLCEENVI-----GEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-----KNLV 210 (484)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~L-----g~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H-----~niv 210 (484)
.+.++++....+|.+.+.. ..|---+.|+.+..+| .+++|+...... ..++..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4567788888888776554 3555678899998765 489998754322 2334445566665532 2222
Q ss_pred eecc---eeeeCCeeeEEEEecCCCCHHH--------------Hhhc---CCC-C-CCCCCHH-----------------
Q 011498 211 RLLG---YCVEGAYRMLVYEYVDNGNLDQ--------------WLHG---DVG-D-VSPLTWD----------------- 251 (484)
Q Consensus 211 ~l~~---~~~~~~~~~lv~e~~~~gsL~~--------------~l~~---~~~-~-~~~l~~~----------------- 251 (484)
...+ +.........++.+..+..... .++. ... . .......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 2211 1223445566777766532211 0110 000 0 0000000
Q ss_pred -HHHHHHHHHHHHHHhhh-cCCCCceeecCCCCCcEEEcCCCcEEEeeecccc
Q 011498 252 -IRMNIILGTAKGLAYLH-EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (484)
Q Consensus 252 -~~~~i~~~ia~al~~LH-~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfgla~ 302 (484)
.....+..+...+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111222222222222 1224489999999999999998777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.68 E-value=0.0025 Score=60.85 Aligned_cols=72 Identities=19% Similarity=0.212 Sum_probs=47.5
Q ss_pred ceeccCCceEEEEEEECC--------CCEEEEEEecccchhhHHHHHHHHHHHhccC-CCceeeecceeeeCCeeeEEEE
Q 011498 157 NVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (484)
Q Consensus 157 ~~Lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 227 (484)
+.|+.|-.-.+|++...+ ...|++++.- ... ......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 568888889999998654 2456766543 322 2335567888888874 4334567777643 68999
Q ss_pred ecCCCCH
Q 011498 228 YVDNGNL 234 (484)
Q Consensus 228 ~~~~gsL 234 (484)
|++|..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987433
|